*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 C 88 ASP B 53 ASP~? 5.10 ZN ZN B2003 C 89 ASP B 54 ASP~? -2.43 ZN ZN B2003s C 92 ASP B 48 ASP~? 8.81 ZN ZN B2003 C 115 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 35.82 109.51 58.11 36.79 111.39 58.16 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 34.50 112.32 53.52 36.24 113.36 54.10 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 44.76 111.03 53.07 46.05 111.62 51.50 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 43.88 105.59 49.49 44.98 111.77 48.53 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 C 88 ASP B 54 ASP~? -2.43 ZN ZN B2003s C 89 ASP B 53 ASP~? 5.10 ZN ZN B2003 C 92 ASP B 48 ASP~? 8.81 ZN ZN B2003 C 115 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 35.82 109.51 58.11 36.79 111.39 58.16 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 34.50 112.32 53.52 36.24 113.36 54.10 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 44.76 111.03 53.07 46.05 111.62 51.50 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 43.88 105.59 49.49 44.98 111.77 48.53 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 3 4 # 3 C 88 ASP C 53 ASP~? 35.43 ZN ZN B2003 C 89 ASP C 54 ASP~? 34.22 ZN ZN B2003 C 92 ASP C 48 ASP~? 37.52 ZN ZN B2003 C 115 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 35.82 109.51 58.11 36.79 111.39 58.16 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 34.50 112.32 53.52 36.24 113.36 54.10 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 44.76 111.03 53.07 46.05 111.62 51.50 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 43.88 105.59 49.49 44.98 111.77 48.53 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 4 4 # 4 C 88 ASP C 54 ASP~? 34.22 ZN ZN B2003 C 89 ASP C 53 ASP~? 35.43 ZN ZN B2003 C 92 ASP C 48 ASP~? 37.52 ZN ZN B2003 C 115 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 35.82 109.51 58.11 36.79 111.39 58.16 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 34.50 112.32 53.52 36.24 113.36 54.10 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 44.76 111.03 53.07 46.05 111.62 51.50 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 43.88 105.59 49.49 44.98 111.77 48.53 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 5 4 # 5 C 88 ASP E 53 ASP~? 5.07 ZN ZN E2002 C 89 ASP E 54 ASP~? -2.11 ZN ZN E2002s C 92 ASP E 48 ASP~? 8.41 ZN ZN E2002 C 115 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 35.82 109.51 58.11 36.79 111.39 58.16 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 34.50 112.32 53.52 36.24 113.36 54.10 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 44.76 111.03 53.07 46.05 111.62 51.50 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 43.88 105.59 49.49 44.98 111.77 48.53 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 6 4 # 6 C 88 ASP E 54 ASP~? -2.11 ZN ZN E2002s C 89 ASP E 53 ASP~? 5.07 ZN ZN E2002 C 92 ASP E 48 ASP~? 8.41 ZN ZN E2002 C 115 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 35.82 109.51 58.11 36.79 111.39 58.16 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 34.50 112.32 53.52 36.24 113.36 54.10 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 44.76 111.03 53.07 46.05 111.62 51.50 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 43.88 105.59 49.49 44.98 111.77 48.53 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 7 4 # 7 C 88 ASP G 53 ASP~? 4.94 ZN ZN G2004 C 89 ASP G 54 ASP~? -2.04 ZN ZN G2004s C 92 ASP G 48 ASP~? 8.81 ZN ZN G2004 C 115 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 35.82 109.51 58.11 36.79 111.39 58.16 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 34.50 112.32 53.52 36.24 113.36 54.10 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 44.76 111.03 53.07 46.05 111.62 51.50 33.55 0.62 19.07 33.72 1.88 17.35 coo 43.88 105.59 49.49 44.98 111.77 48.53 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 8 4 # 8 C 88 ASP G 54 ASP~? -2.04 ZN ZN G2004s C 89 ASP G 53 ASP~? 4.94 ZN ZN G2004 C 92 ASP G 48 ASP~? 8.81 ZN ZN G2004 C 115 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 35.82 109.51 58.11 36.79 111.39 58.16 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 34.50 112.32 53.52 36.24 113.36 54.10 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 44.76 111.03 53.07 46.05 111.62 51.50 33.55 0.62 19.07 33.72 1.88 17.35 coo 43.88 105.59 49.49 44.98 111.77 48.53 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 9 4 # 9 C 88 ASP I 53 ASP~? 35.51 ZN ZN J2001 C 89 ASP I 54 ASP~? 33.46 ZN ZN J2001 C 92 ASP I 48 ASP~? 38.35 ZN ZN J2001 C 115 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 35.82 109.51 58.11 36.79 111.39 58.16 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 34.50 112.32 53.52 36.24 113.36 54.10 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 44.76 111.03 53.07 46.05 111.62 51.50 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 43.88 105.59 49.49 44.98 111.77 48.53 7.62 -53.38 -6.85 6.38 -57.85 -3.68 1a95_c00 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 9 hits 1a95_c00 naa= 4 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 A 88 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 89 ASP B 54 ASP~? -2.43 ZN ZN B2003s A 92 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 115 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 28.94 110.40 17.72 27.05 109.42 17.78 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 27.21 110.68 22.97 26.09 108.99 22.41 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 28.82 100.59 20.87 28.57 98.90 22.12 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 34.37 100.82 23.64 28.36 99.87 25.42 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 A 88 ASP B 54 ASP~? -2.43 ZN ZN B2003s A 89 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 92 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 115 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 28.94 110.40 17.72 27.05 109.42 17.78 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 27.21 110.68 22.97 26.09 108.99 22.41 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 28.82 100.59 20.87 28.57 98.90 22.12 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 34.37 100.82 23.64 28.36 99.87 25.42 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 3 4 # 3 A 88 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 89 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 92 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 115 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 28.94 110.40 17.72 27.05 109.42 17.78 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 27.21 110.68 22.97 26.09 108.99 22.41 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 28.82 100.59 20.87 28.57 98.90 22.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 34.37 100.82 23.64 28.36 99.87 25.42 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 4 4 # 4 A 88 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 89 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 92 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 115 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 28.94 110.40 17.72 27.05 109.42 17.78 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 27.21 110.68 22.97 26.09 108.99 22.41 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 28.82 100.59 20.87 28.57 98.90 22.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 34.37 100.82 23.64 28.36 99.87 25.42 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 5 4 # 5 A 88 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 89 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 92 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 115 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 28.94 110.40 17.72 27.05 109.42 17.78 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 27.21 110.68 22.97 26.09 108.99 22.41 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 28.82 100.59 20.87 28.57 98.90 22.12 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 34.37 100.82 23.64 28.36 99.87 25.42 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 6 4 # 6 A 88 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 89 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 92 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 115 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 28.94 110.40 17.72 27.05 109.42 17.78 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 27.21 110.68 22.97 26.09 108.99 22.41 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 28.82 100.59 20.87 28.57 98.90 22.12 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 34.37 100.82 23.64 28.36 99.87 25.42 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 7 4 # 7 A 88 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 89 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 92 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 115 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 28.94 110.40 17.72 27.05 109.42 17.78 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 27.21 110.68 22.97 26.09 108.99 22.41 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 28.82 100.59 20.87 28.57 98.90 22.12 33.55 0.62 19.07 33.72 1.88 17.35 coo 34.37 100.82 23.64 28.36 99.87 25.42 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 8 4 # 8 A 88 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 89 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 92 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 115 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 28.94 110.40 17.72 27.05 109.42 17.78 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 27.21 110.68 22.97 26.09 108.99 22.41 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 28.82 100.59 20.87 28.57 98.90 22.12 33.55 0.62 19.07 33.72 1.88 17.35 coo 34.37 100.82 23.64 28.36 99.87 25.42 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 9 4 # 9 A 88 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 89 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 92 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 115 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 28.94 110.40 17.72 27.05 109.42 17.78 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 27.21 110.68 22.97 26.09 108.99 22.41 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 28.82 100.59 20.87 28.57 98.90 22.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 34.37 100.82 23.64 28.36 99.87 25.42 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 10 4 # 10 A 88 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 89 ASP J 54 ASP~? -2.24 ZN ZN J2001s A 92 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 115 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 28.94 110.40 17.72 27.05 109.42 17.78 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 27.21 110.68 22.97 26.09 108.99 22.41 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 28.82 100.59 20.87 28.57 98.90 22.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 34.37 100.82 23.64 28.36 99.87 25.42 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 11 4 # 11 A 88 ASP J 54 ASP~? -2.24 ZN ZN J2001s A 89 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 92 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 115 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 28.94 110.40 17.72 27.05 109.42 17.78 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 27.21 110.68 22.97 26.09 108.99 22.41 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 28.82 100.59 20.87 28.57 98.90 22.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 34.37 100.82 23.64 28.36 99.87 25.42 26.17 -30.49 -34.43 27.88 -35.84 -34.06 1a95_c01 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 11 hits 1a95_c01 naa= 4 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 B 88 ASP B 53 ASP~? 5.10 ZN ZN B2003 B 89 ASP B 54 ASP~? -2.43 ZN ZN B2003s B 92 ASP B 48 ASP~? 8.81 ZN ZN B2003 B 115 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 15.87 130.02 20.98 17.78 130.94 20.91 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 18.52 128.66 25.62 19.66 130.36 25.09 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 17.38 138.95 26.03 17.97 140.13 27.68 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 11.86 138.01 29.49 18.01 139.06 30.49 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 B 88 ASP B 54 ASP~? -2.43 ZN ZN B2003s B 89 ASP B 53 ASP~? 5.10 ZN ZN B2003 B 92 ASP B 48 ASP~? 8.81 ZN ZN B2003 B 115 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 15.87 130.02 20.98 17.78 130.94 20.91 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 18.52 128.66 25.62 19.66 130.36 25.09 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 17.38 138.95 26.03 17.97 140.13 27.68 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 11.86 138.01 29.49 18.01 139.06 30.49 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 3 4 # 3 B 88 ASP C 53 ASP~? 35.43 ZN ZN B2003 B 89 ASP C 54 ASP~? 34.22 ZN ZN B2003 B 92 ASP C 48 ASP~? 37.52 ZN ZN B2003 B 115 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 15.87 130.02 20.98 17.78 130.94 20.91 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 18.52 128.66 25.62 19.66 130.36 25.09 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 17.38 138.95 26.03 17.97 140.13 27.68 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 11.86 138.01 29.49 18.01 139.06 30.49 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 4 4 # 4 B 88 ASP C 54 ASP~? 34.22 ZN ZN B2003 B 89 ASP C 53 ASP~? 35.43 ZN ZN B2003 B 92 ASP C 48 ASP~? 37.52 ZN ZN B2003 B 115 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 15.87 130.02 20.98 17.78 130.94 20.91 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 18.52 128.66 25.62 19.66 130.36 25.09 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 17.38 138.95 26.03 17.97 140.13 27.68 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 11.86 138.01 29.49 18.01 139.06 30.49 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 5 4 # 5 B 88 ASP E 53 ASP~? 5.07 ZN ZN E2002 B 89 ASP E 54 ASP~? -2.11 ZN ZN E2002s B 92 ASP E 48 ASP~? 8.41 ZN ZN E2002 B 115 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 15.87 130.02 20.98 17.78 130.94 20.91 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 18.52 128.66 25.62 19.66 130.36 25.09 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 17.38 138.95 26.03 17.97 140.13 27.68 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 11.86 138.01 29.49 18.01 139.06 30.49 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 6 4 # 6 B 88 ASP E 54 ASP~? -2.11 ZN ZN E2002s B 89 ASP E 53 ASP~? 5.07 ZN ZN E2002 B 92 ASP E 48 ASP~? 8.41 ZN ZN E2002 B 115 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 15.87 130.02 20.98 17.78 130.94 20.91 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 18.52 128.66 25.62 19.66 130.36 25.09 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 17.38 138.95 26.03 17.97 140.13 27.68 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 11.86 138.01 29.49 18.01 139.06 30.49 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 7 4 # 7 B 88 ASP G 53 ASP~? 4.94 ZN ZN G2004 B 89 ASP G 54 ASP~? -2.04 ZN ZN G2004s B 92 ASP G 48 ASP~? 8.81 ZN ZN G2004 B 115 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 15.87 130.02 20.98 17.78 130.94 20.91 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 18.52 128.66 25.62 19.66 130.36 25.09 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 17.38 138.95 26.03 17.97 140.13 27.68 33.55 0.62 19.07 33.72 1.88 17.35 coo 11.86 138.01 29.49 18.01 139.06 30.49 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 8 4 # 8 B 88 ASP G 54 ASP~? -2.04 ZN ZN G2004s B 89 ASP G 53 ASP~? 4.94 ZN ZN G2004 B 92 ASP G 48 ASP~? 8.81 ZN ZN G2004 B 115 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 15.87 130.02 20.98 17.78 130.94 20.91 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 18.52 128.66 25.62 19.66 130.36 25.09 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 17.38 138.95 26.03 17.97 140.13 27.68 33.55 0.62 19.07 33.72 1.88 17.35 coo 11.86 138.01 29.49 18.01 139.06 30.49 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 9 4 # 9 B 88 ASP I 53 ASP~? 35.51 ZN ZN J2001 B 89 ASP I 54 ASP~? 33.46 ZN ZN J2001 B 92 ASP I 48 ASP~? 38.35 ZN ZN J2001 B 115 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 15.87 130.02 20.98 17.78 130.94 20.91 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 18.52 128.66 25.62 19.66 130.36 25.09 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 17.38 138.95 26.03 17.97 140.13 27.68 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 11.86 138.01 29.49 18.01 139.06 30.49 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 10 4 # 10 B 88 ASP I 54 ASP~? 33.46 ZN ZN J2001 B 89 ASP I 53 ASP~? 35.51 ZN ZN J2001 B 92 ASP I 48 ASP~? 38.35 ZN ZN J2001 B 115 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 15.87 130.02 20.98 17.78 130.94 20.91 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 18.52 128.66 25.62 19.66 130.36 25.09 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 17.38 138.95 26.03 17.97 140.13 27.68 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 11.86 138.01 29.49 18.01 139.06 30.49 7.62 -53.38 -6.85 6.38 -57.85 -3.68 1a95_c02 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 10 hits 1a95_c02 naa= 4 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 D 88 ASP B 53 ASP~? 5.10 ZN ZN B2003 D 89 ASP B 54 ASP~? -2.43 ZN ZN B2003s D 92 ASP B 48 ASP~? 8.81 ZN ZN B2003 D 115 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 16.10 122.43 61.36 15.17 120.52 61.32 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 16.52 120.83 56.08 14.84 119.68 56.64 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 6.41 122.44 58.21 4.75 122.21 56.90 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 6.66 128.09 55.52 5.74 122.11 53.55 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 D 88 ASP B 54 ASP~? -2.43 ZN ZN B2003s D 89 ASP B 53 ASP~? 5.10 ZN ZN B2003 D 92 ASP B 48 ASP~? 8.81 ZN ZN B2003 D 115 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 16.10 122.43 61.36 15.17 120.52 61.32 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 16.52 120.83 56.08 14.84 119.68 56.64 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 6.41 122.44 58.21 4.75 122.21 56.90 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 6.66 128.09 55.52 5.74 122.11 53.55 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 3 4 # 3 D 88 ASP C 53 ASP~? 35.43 ZN ZN B2003 D 89 ASP C 54 ASP~? 34.22 ZN ZN B2003 D 92 ASP C 48 ASP~? 37.52 ZN ZN B2003 D 115 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 16.10 122.43 61.36 15.17 120.52 61.32 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 16.52 120.83 56.08 14.84 119.68 56.64 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 6.41 122.44 58.21 4.75 122.21 56.90 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 6.66 128.09 55.52 5.74 122.11 53.55 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 4 4 # 4 D 88 ASP C 54 ASP~? 34.22 ZN ZN B2003 D 89 ASP C 53 ASP~? 35.43 ZN ZN B2003 D 92 ASP C 48 ASP~? 37.52 ZN ZN B2003 D 115 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 16.10 122.43 61.36 15.17 120.52 61.32 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 16.52 120.83 56.08 14.84 119.68 56.64 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 6.41 122.44 58.21 4.75 122.21 56.90 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 6.66 128.09 55.52 5.74 122.11 53.55 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 5 4 # 5 D 88 ASP E 53 ASP~? 5.07 ZN ZN E2002 D 89 ASP E 54 ASP~? -2.11 ZN ZN E2002s D 92 ASP E 48 ASP~? 8.41 ZN ZN E2002 D 115 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 16.10 122.43 61.36 15.17 120.52 61.32 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 16.52 120.83 56.08 14.84 119.68 56.64 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 6.41 122.44 58.21 4.75 122.21 56.90 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 6.66 128.09 55.52 5.74 122.11 53.55 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 6 4 # 6 D 88 ASP E 54 ASP~? -2.11 ZN ZN E2002s D 89 ASP E 53 ASP~? 5.07 ZN ZN E2002 D 92 ASP E 48 ASP~? 8.41 ZN ZN E2002 D 115 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 16.10 122.43 61.36 15.17 120.52 61.32 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 16.52 120.83 56.08 14.84 119.68 56.64 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 6.41 122.44 58.21 4.75 122.21 56.90 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 6.66 128.09 55.52 5.74 122.11 53.55 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 7 4 # 7 D 88 ASP G 53 ASP~? 4.94 ZN ZN G2004 D 89 ASP G 54 ASP~? -2.04 ZN ZN G2004s D 92 ASP G 48 ASP~? 8.81 ZN ZN G2004 D 115 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 16.10 122.43 61.36 15.17 120.52 61.32 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 16.52 120.83 56.08 14.84 119.68 56.64 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 6.41 122.44 58.21 4.75 122.21 56.90 33.55 0.62 19.07 33.72 1.88 17.35 coo 6.66 128.09 55.52 5.74 122.11 53.55 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 8 4 # 8 D 88 ASP G 54 ASP~? -2.04 ZN ZN G2004s D 89 ASP G 53 ASP~? 4.94 ZN ZN G2004 D 92 ASP G 48 ASP~? 8.81 ZN ZN G2004 D 115 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 16.10 122.43 61.36 15.17 120.52 61.32 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 16.52 120.83 56.08 14.84 119.68 56.64 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 6.41 122.44 58.21 4.75 122.21 56.90 33.55 0.62 19.07 33.72 1.88 17.35 coo 6.66 128.09 55.52 5.74 122.11 53.55 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 9 4 # 9 D 88 ASP I 53 ASP~? 35.51 ZN ZN J2001 D 89 ASP I 54 ASP~? 33.46 ZN ZN J2001 D 92 ASP I 48 ASP~? 38.35 ZN ZN J2001 D 115 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 16.10 122.43 61.36 15.17 120.52 61.32 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 16.52 120.83 56.08 14.84 119.68 56.64 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 6.41 122.44 58.21 4.75 122.21 56.90 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 6.66 128.09 55.52 5.74 122.11 53.55 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 10 4 # 10 D 88 ASP J 53 ASP~? 5.09 ZN ZN J2001 D 89 ASP J 54 ASP~? -2.24 ZN ZN J2001s D 92 ASP J 48 ASP~? 8.01 ZN ZN J2001 D 115 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 16.10 122.43 61.36 15.17 120.52 61.32 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 16.52 120.83 56.08 14.84 119.68 56.64 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 6.41 122.44 58.21 4.75 122.21 56.90 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 6.66 128.09 55.52 5.74 122.11 53.55 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 11 4 # 11 D 88 ASP J 54 ASP~? -2.24 ZN ZN J2001s D 89 ASP J 53 ASP~? 5.09 ZN ZN J2001 D 92 ASP J 48 ASP~? 8.01 ZN ZN J2001 D 115 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 16.10 122.43 61.36 15.17 120.52 61.32 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 16.52 120.83 56.08 14.84 119.68 56.64 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 6.41 122.44 58.21 4.75 122.21 56.90 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 6.66 128.09 55.52 5.74 122.11 53.55 26.17 -30.49 -34.43 27.88 -35.84 -34.06 1a95_c03 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 11 hits 1a95_c03 naa= 4 ULMN 4 1bzy_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 A 133 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 134 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 137 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 165 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 13.34 89.40 45.53 11.81 89.79 44.14 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 9.14 89.42 48.04 8.93 88.63 46.06 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 11.51 80.72 44.41 10.38 78.98 44.80 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 13.35 79.17 49.96 8.00 78.73 47.28 7.62 -53.38 -6.85 6.38 -57.85 -3.68 1bzy_c00 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_c00 naa= 4 ULMN 4 1bzy_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 B 133 GLU C 50 GLU~? 38.46 ZN ZN J2001 B 134 ASP C 48 ASP~? 37.52 ZN ZN B2003 B 137 ASP I 48 ASP~? 38.35 ZN ZN J2001 B 165 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo -0.78 112.03 42.85 0.95 111.50 41.80 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 2.83 112.32 46.21 3.45 112.93 44.27 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 1.33 120.54 41.38 2.37 122.32 41.83 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo -1.54 122.74 46.23 4.22 122.84 44.60 7.62 -53.38 -6.85 6.38 -57.85 -3.68 1bzy_c01 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_c01 naa= 4 ULMN 4 1bzy_c02 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 C 133 GLU C 50 GLU~? 38.46 ZN ZN J2001 C 134 ASP C 48 ASP~? 37.52 ZN ZN B2003 C 137 ASP I 48 ASP~? 38.35 ZN ZN J2001 C 165 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 0.15 90.11 85.87 1.29 91.36 87.12 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 4.00 91.31 83.02 4.55 90.96 85.06 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 5.10 82.97 88.07 6.79 81.71 87.85 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 4.16 80.06 82.93 9.22 82.34 85.00 7.62 -53.38 -6.85 6.38 -57.85 -3.68 1bzy_c02 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_c02 naa= 4 ULMN 4 1bzy_c03 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 D 133 GLU C 50 GLU~? 38.46 ZN ZN J2001 D 134 ASP C 48 ASP~? 37.52 ZN ZN B2003 D 137 ASP I 48 ASP~? 38.35 ZN ZN J2001 D 165 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 4.48 116.39 84.65 3.07 115.42 85.88 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 1.16 114.72 81.44 0.30 115.35 83.28 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo -0.72 123.60 84.94 -2.32 124.82 84.32 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 1.15 125.85 79.67 -4.25 124.18 81.47 7.62 -53.38 -6.85 6.38 -57.85 -3.68 1bzy_c03 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_c03 naa= 4 ULMN 4 1cdg_c05 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 4 # 1 229 ASP H 48 ASP.? 18.83 ZN ZN B2003 257 GLU H 50 GLU.? 17.57 ZN ZN B2003 259 PHE B 75 PHE^? 21.46 ZN ZN B2003 328 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 48.97 85.16 40.39 47.18 86.25 40.47 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 51.51 90.72 41.48 51.05 93.41 40.93 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 45.39 90.72 40.63 45.07 89.14 41.90 22.01 -31.06 24.97 24.10 -31.35 25.29 1cdg_c05 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 1 hits 1cdg_c05 naa= 4 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 A 33 ARG A 9 ARG^? 24.21 ZN ZN E2002 A 42 ARG B 9 ARG^? 25.60 ZN ZN B2003 A 197 ARG A 11 ARG.? 22.81 ZN ZN E2002 A 203 ARG A 14 ARG~? 19.76 ZN ZN E2002 coo 23.24 19.51 21.94 24.57 16.76 21.61 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 16.08 17.48 28.78 19.09 16.85 28.49 12.25 -11.70 3.79 14.09 -14.14 4.30 coo 28.26 9.63 19.68 28.71 10.56 22.55 8.14 -2.39 -10.44 6.98 -0.33 -8.47 coo 33.62 12.31 23.18 30.84 12.90 24.36 9.80 2.36 -9.66 10.15 5.25 -8.72 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 A 33 ARG A 9 ARG^? 24.21 ZN ZN E2002 A 42 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 197 ARG A 11 ARG.? 22.81 ZN ZN E2002 A 203 ARG A 14 ARG~? 19.76 ZN ZN E2002 coo 23.24 19.51 21.94 24.57 16.76 21.61 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 16.08 17.48 28.78 19.09 16.85 28.49 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 28.26 9.63 19.68 28.71 10.56 22.55 8.14 -2.39 -10.44 6.98 -0.33 -8.47 coo 33.62 12.31 23.18 30.84 12.90 24.36 9.80 2.36 -9.66 10.15 5.25 -8.72 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 3 4 # 3 A 33 ARG B 9 ARG^? 25.60 ZN ZN B2003 A 42 ARG C 9 ARG^? 24.24 ZN ZN B2003 A 197 ARG B 11 ARG.? 26.38 ZN ZN B2003 A 203 ARG B 14 ARG~? 23.18 ZN ZN B2003 coo 23.24 19.51 21.94 24.57 16.76 21.61 12.25 -11.70 3.79 14.09 -14.14 4.30 coo 16.08 17.48 28.78 19.09 16.85 28.49 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 28.26 9.63 19.68 28.71 10.56 22.55 4.66 -4.03 2.41 2.15 -4.03 4.16 coo 33.62 12.31 23.18 30.84 12.90 24.36 3.43 -2.45 7.59 1.92 -2.40 10.28 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 4 4 # 4 A 33 ARG B 68 ARG^? 23.11 ZN ZN B2003 A 42 ARG A 68 ARG^? 28.72 ZN ZN B2003 A 197 ARG C 68 ARG^? 29.54 ZN ZN B2003 A 203 ARG D 9 ARG^? 32.06 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 16.08 17.48 28.78 19.09 16.85 28.49 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 28.26 9.63 19.68 28.71 10.56 22.55 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 33.62 12.31 23.18 30.84 12.90 24.36 6.94 -24.21 -7.19 9.96 -24.60 -7.73 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 5 4 # 5 A 33 ARG C 9 ARG^? 24.24 ZN ZN B2003 A 42 ARG D 9 ARG^? 32.06 ZN ZN J2001 A 197 ARG C 11 ARG~? 22.62 ZN ZN B2003 A 203 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo 23.24 19.51 21.94 24.57 16.76 21.61 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 16.08 17.48 28.78 19.09 16.85 28.49 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 28.26 9.63 19.68 28.71 10.56 22.55 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo 33.62 12.31 23.18 30.84 12.90 24.36 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 6 4 # 6 A 33 ARG C 11 ARG~? 22.62 ZN ZN B2003 A 42 ARG C 9 ARG^? 24.24 ZN ZN B2003 A 197 ARG B 11 ARG.? 26.38 ZN ZN B2003 A 203 ARG B 14 ARG~? 23.18 ZN ZN B2003 coo 23.24 19.51 21.94 24.57 16.76 21.61 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo 16.08 17.48 28.78 19.09 16.85 28.49 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 28.26 9.63 19.68 28.71 10.56 22.55 4.66 -4.03 2.41 2.15 -4.03 4.16 coo 33.62 12.31 23.18 30.84 12.90 24.36 3.43 -2.45 7.59 1.92 -2.40 10.28 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 7 4 # 7 A 33 ARG D 9 ARG^? 32.06 ZN ZN J2001 A 42 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 197 ARG D 11 ARG.? 35.27 ZN ZN B2003 A 203 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo 23.24 19.51 21.94 24.57 16.76 21.61 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 16.08 17.48 28.78 19.09 16.85 28.49 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 28.26 9.63 19.68 28.71 10.56 22.55 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 33.62 12.31 23.18 30.84 12.90 24.36 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 8 4 # 8 A 33 ARG D 11 ARG.? 35.27 ZN ZN B2003 A 42 ARG D 9 ARG^? 32.06 ZN ZN J2001 A 197 ARG C 11 ARG~? 22.62 ZN ZN B2003 A 203 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo 23.24 19.51 21.94 24.57 16.76 21.61 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 16.08 17.48 28.78 19.09 16.85 28.49 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 28.26 9.63 19.68 28.71 10.56 22.55 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo 33.62 12.31 23.18 30.84 12.90 24.36 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 9 4 # 9 A 33 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 42 ARG A 9 ARG^? 24.21 ZN ZN E2002 A 197 ARG E 11 ARG.? 26.51 ZN ZN E2002 A 203 ARG E 14 ARG~? 23.50 ZN ZN E2002 coo 23.24 19.51 21.94 24.57 16.76 21.61 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 16.08 17.48 28.78 19.09 16.85 28.49 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 28.26 9.63 19.68 28.71 10.56 22.55 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo 33.62 12.31 23.18 30.84 12.90 24.36 4.33 -11.23 -21.43 5.19 -9.07 -23.42 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 10 4 # 10 A 33 ARG E 11 ARG.? 26.51 ZN ZN E2002 A 42 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 197 ARG D 11 ARG.? 35.27 ZN ZN B2003 A 203 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo 23.24 19.51 21.94 24.57 16.76 21.61 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo 16.08 17.48 28.78 19.09 16.85 28.49 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 28.26 9.63 19.68 28.71 10.56 22.55 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 33.62 12.31 23.18 30.84 12.90 24.36 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 11 4 # 11 A 33 ARG F 9 ARG^? 24.10 ZN ZN G2004 A 42 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 197 ARG F 11 ARG.? 21.89 ZN ZN G2004 A 203 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo 23.24 19.51 21.94 24.57 16.76 21.61 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 16.08 17.48 28.78 19.09 16.85 28.49 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 28.26 9.63 19.68 28.71 10.56 22.55 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 33.62 12.31 23.18 30.84 12.90 24.36 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 12 4 # 12 A 33 ARG F 11 ARG.? 21.89 ZN ZN G2004 A 42 ARG F 9 ARG^? 24.10 ZN ZN G2004 A 197 ARG G 11 ARG.? 26.12 ZN ZN G2004 A 203 ARG G 14 ARG~? 23.24 ZN ZN G2004 coo 23.24 19.51 21.94 24.57 16.76 21.61 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 16.08 17.48 28.78 19.09 16.85 28.49 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 28.26 9.63 19.68 28.71 10.56 22.55 34.84 -31.69 12.58 37.28 -30.08 13.59 coo 33.62 12.31 23.18 30.84 12.90 24.36 36.11 -29.59 17.58 37.55 -27.64 19.46 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 13 4 # 13 A 33 ARG F 68 ARG^? 28.83 ZN ZN J2001 A 42 ARG G 68 ARG^? 22.94 ZN ZN G2004 A 197 ARG J 68 ARG^? 19.63 ZN ZN J2001 A 203 ARG I 9 ARG^? 24.03 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 16.08 17.48 28.78 19.09 16.85 28.49 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 28.26 9.63 19.68 28.71 10.56 22.55 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 33.62 12.31 23.18 30.84 12.90 24.36 26.01 -32.03 -7.10 23.09 -31.05 -6.77 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 14 4 # 14 A 33 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 42 ARG F 9 ARG^? 24.10 ZN ZN G2004 A 197 ARG G 11 ARG.? 26.12 ZN ZN G2004 A 203 ARG G 14 ARG~? 23.24 ZN ZN G2004 coo 23.24 19.51 21.94 24.57 16.76 21.61 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 16.08 17.48 28.78 19.09 16.85 28.49 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 28.26 9.63 19.68 28.71 10.56 22.55 34.84 -31.69 12.58 37.28 -30.08 13.59 coo 33.62 12.31 23.18 30.84 12.90 24.36 36.11 -29.59 17.58 37.55 -27.64 19.46 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 15 4 # 15 A 33 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 42 ARG F 9 ARG^? 24.10 ZN ZN G2004 A 197 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 203 ARG I 68 ARG^? 29.76 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 16.08 17.48 28.78 19.09 16.85 28.49 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 28.26 9.63 19.68 28.71 10.56 22.55 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 33.62 12.31 23.18 30.84 12.90 24.36 23.15 -33.63 -1.82 24.18 -35.52 0.40 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 16 4 # 16 A 33 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 42 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 197 ARG H 11 ARG.? 35.53 ZN ZN J2001 A 203 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 16.08 17.48 28.78 19.09 16.85 28.49 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 28.26 9.63 19.68 28.71 10.56 22.55 31.27 -41.17 3.82 32.37 -41.49 6.67 coo 33.62 12.31 23.18 30.84 12.90 24.36 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 17 4 # 17 A 33 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 42 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 197 ARG I 9 ARG^? 24.03 ZN ZN J2001 A 203 ARG J 68 ARG^? 19.63 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 16.08 17.48 28.78 19.09 16.85 28.49 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 28.26 9.63 19.68 28.71 10.56 22.55 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 33.62 12.31 23.18 30.84 12.90 24.36 27.83 -27.99 -9.38 27.89 -30.88 -10.49 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 18 4 # 18 A 33 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 42 ARG H 11 ARG.? 35.53 ZN ZN J2001 A 197 ARG I 9 ARG^? 24.03 ZN ZN J2001 A 203 ARG J 68 ARG^? 19.63 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 16.08 17.48 28.78 19.09 16.85 28.49 31.27 -41.17 3.82 32.37 -41.49 6.67 coo 28.26 9.63 19.68 28.71 10.56 22.55 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 33.62 12.31 23.18 30.84 12.90 24.36 27.83 -27.99 -9.38 27.89 -30.88 -10.49 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 19 4 # 19 A 33 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 42 ARG I 9 ARG^? 24.03 ZN ZN J2001 A 197 ARG H 11 ARG.? 35.53 ZN ZN J2001 A 203 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 16.08 17.48 28.78 19.09 16.85 28.49 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 28.26 9.63 19.68 28.71 10.56 22.55 31.27 -41.17 3.82 32.37 -41.49 6.67 coo 33.62 12.31 23.18 30.84 12.90 24.36 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 20 4 # 20 A 33 ARG I 9 ARG^? 24.03 ZN ZN J2001 A 42 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 197 ARG I 11 ARG.? 22.73 ZN ZN J2001 A 203 ARG I 14 ARG~? 20.11 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 16.08 17.48 28.78 19.09 16.85 28.49 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 28.26 9.63 19.68 28.71 10.56 22.55 35.67 -37.65 -8.31 35.98 -40.29 -6.76 coo 33.62 12.31 23.18 30.84 12.90 24.36 34.67 -42.08 -10.26 33.76 -45.02 -10.11 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 21 4 # 21 A 33 ARG I 9 ARG^? 24.03 ZN ZN J2001 A 42 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 197 ARG I 11 ARG.? 22.73 ZN ZN J2001 A 203 ARG I 14 ARG~? 20.11 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 16.08 17.48 28.78 19.09 16.85 28.49 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 28.26 9.63 19.68 28.71 10.56 22.55 35.67 -37.65 -8.31 35.98 -40.29 -6.76 coo 33.62 12.31 23.18 30.84 12.90 24.36 34.67 -42.08 -10.26 33.76 -45.02 -10.11 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 22 4 # 22 A 33 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 42 ARG I 9 ARG^? 24.03 ZN ZN J2001 A 197 ARG J 11 ARG.? 26.46 ZN ZN J2001 A 203 ARG J 14 ARG~? 23.19 ZN ZN J2001 coo 23.24 19.51 21.94 24.57 16.76 21.61 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 16.08 17.48 28.78 19.09 16.85 28.49 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 28.26 9.63 19.68 28.71 10.56 22.55 42.15 -25.47 -6.25 43.21 -27.78 -7.96 coo 33.62 12.31 23.18 30.84 12.90 24.36 43.92 -26.01 -11.47 44.79 -27.17 -14.19 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 23 4 # 23 A 33 ARG J 11 ARG.? 26.46 ZN ZN J2001 A 42 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 197 ARG F 11 ARG.? 21.89 ZN ZN G2004 A 203 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo 23.24 19.51 21.94 24.57 16.76 21.61 42.15 -25.47 -6.25 43.21 -27.78 -7.96 coo 16.08 17.48 28.78 19.09 16.85 28.49 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 28.26 9.63 19.68 28.71 10.56 22.55 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 33.62 12.31 23.18 30.84 12.90 24.36 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 24 4 # 24 A 33 ARG J 68 ARG^? 19.63 ZN ZN J2001 A 42 ARG F 68 ARG^? 28.83 ZN ZN J2001 A 197 ARG I 68 ARG^? 29.76 ZN ZN J2001 A 203 ARG H 9 ARG^? 32.17 ZN ZN B2003 coo 23.24 19.51 21.94 24.57 16.76 21.61 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 16.08 17.48 28.78 19.09 16.85 28.49 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 28.26 9.63 19.68 28.71 10.56 22.55 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 33.62 12.31 23.18 30.84 12.90 24.36 23.61 -33.80 3.29 21.83 -31.31 3.74 1f75_c00 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 24 hits 1f75_c00 naa= 4 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 B 33 ARG C 9 ARG^? 24.24 ZN ZN B2003 B 42 ARG C 14 ARG~? 19.88 ZN ZN B2003 B 197 ARG D 9 ARG^? 32.06 ZN ZN J2001 B 203 ARG D 68 ARG^? 31.20 ZN ZN E2002 coo 42.69 1.07 -0.40 42.64 1.65 2.61 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -5.73 -18.63 6.20 -7.86 -20.84 6.40 coo 40.75 3.79 10.50 41.03 0.76 9.97 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 10.24 -20.71 -11.26 11.91 -20.64 -8.66 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 B 33 ARG D 11 ARG.? 35.27 ZN ZN B2003 B 42 ARG C 14 ARG~? 19.88 ZN ZN B2003 B 197 ARG D 9 ARG^? 32.06 ZN ZN J2001 B 203 ARG D 68 ARG^? 31.20 ZN ZN E2002 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -5.73 -18.63 6.20 -7.86 -20.84 6.40 coo 40.75 3.79 10.50 41.03 0.76 9.97 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 10.24 -20.71 -11.26 11.91 -20.64 -8.66 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 3 4 # 3 B 33 ARG D 11 ARG.? 35.27 ZN ZN B2003 B 42 ARG D 68 ARG^? 31.20 ZN ZN E2002 B 197 ARG C 11 ARG~? 22.62 ZN ZN B2003 B 203 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 10.24 -20.71 -11.26 11.91 -20.64 -8.66 coo 40.75 3.79 10.50 41.03 0.76 9.97 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 4 4 # 4 B 33 ARG D 11 ARG.? 35.27 ZN ZN B2003 B 42 ARG E 11 ARG.? 26.51 ZN ZN E2002 B 197 ARG C 68 ARG^? 29.54 ZN ZN B2003 B 203 ARG C 9 ARG^? 24.24 ZN ZN B2003 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo 40.75 3.79 10.50 41.03 0.76 9.97 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 7.07 -21.17 3.13 9.35 -23.17 2.50 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 5 4 # 5 B 33 ARG D 68 ARG^? 31.20 ZN ZN E2002 B 42 ARG E 11 ARG.? 26.51 ZN ZN E2002 B 197 ARG C 68 ARG^? 29.54 ZN ZN B2003 B 203 ARG C 9 ARG^? 24.24 ZN ZN B2003 coo 42.69 1.07 -0.40 42.64 1.65 2.61 10.24 -20.71 -11.26 11.91 -20.64 -8.66 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo 40.75 3.79 10.50 41.03 0.76 9.97 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 7.07 -21.17 3.13 9.35 -23.17 2.50 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 6 4 # 6 B 33 ARG F 11 ARG.? 21.89 ZN ZN G2004 B 42 ARG F 68 ARG^? 28.83 ZN ZN J2001 B 197 ARG G 11 ARG.? 26.12 ZN ZN G2004 B 203 ARG G 14 ARG~? 23.24 ZN ZN G2004 coo 42.69 1.07 -0.40 42.64 1.65 2.61 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 40.75 3.79 10.50 41.03 0.76 9.97 34.84 -31.69 12.58 37.28 -30.08 13.59 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 36.11 -29.59 17.58 37.55 -27.64 19.46 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 7 4 # 7 B 33 ARG G 11 ARG.? 26.12 ZN ZN G2004 B 42 ARG G 68 ARG^? 22.94 ZN ZN G2004 B 197 ARG H 11 ARG.? 35.53 ZN ZN J2001 B 203 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo 42.69 1.07 -0.40 42.64 1.65 2.61 34.84 -31.69 12.58 37.28 -30.08 13.59 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 40.75 3.79 10.50 41.03 0.76 9.97 31.27 -41.17 3.82 32.37 -41.49 6.67 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 8 4 # 8 B 33 ARG H 9 ARG^? 32.17 ZN ZN B2003 B 42 ARG H 14 ARG~? 40.46 ZN ZN J2001 B 197 ARG G 9 ARG^? 25.73 ZN ZN G2004 B 203 ARG G 68 ARG^? 22.94 ZN ZN G2004 coo 42.69 1.07 -0.40 42.64 1.65 2.61 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 29.55 -44.56 8.18 29.86 -45.04 11.21 coo 40.75 3.79 10.50 41.03 0.76 9.97 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 30.64 -21.00 5.54 28.49 -18.97 4.58 1f75_c01 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 8 hits 1f75_c01 naa= 4 ULMN 4 1fsg_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 A 146 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 147 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 150 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 178 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 25.15 35.36 -14.10 25.49 37.13 -15.26 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 24.20 39.15 -10.33 23.35 40.02 -12.02 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 14.98 32.15 -10.38 13.23 37.46 -12.31 7.62 -53.38 -6.85 6.38 -57.85 -3.68 1fsg_c00 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1fsg_c00 naa= 4 ULMN 4 1fsg_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 C 146 GLU C 50 GLU~? 38.46 ZN ZN J2001 C 147 ASP C 48 ASP~? 37.52 ZN ZN B2003 C 150 ASP I 48 ASP~? 38.35 ZN ZN J2001 C 178 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 21.13 43.45 27.66 22.75 42.66 28.81 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 23.59 40.44 23.80 23.75 39.21 25.49 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 15.48 36.57 28.52 14.54 34.69 28.40 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 12.35 37.47 23.73 15.50 32.82 25.71 7.62 -53.38 -6.85 6.38 -57.85 -3.68 1fsg_c01 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1fsg_c01 naa= 4 ULMN 4 1m53_c04 ISOMALTULOSE SYNTHASE user 1 4 # 1 A 241 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 295 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 297 PHE G 75 PHE^? 21.55 ZN ZN G2004 A 369 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 16.11 33.72 80.99 14.10 33.54 81.63 22.23 3.81 17.00 24.22 3.69 17.74 coo 14.66 28.57 79.93 13.93 26.21 81.24 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 4 1m53_c04 ISOMALTULOSE SYNTHASE user 2 4 # 2 A 241 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 295 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 297 PHE I 75 PHE^? 34.28 ZN ZN B2003 A 369 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 16.11 33.72 80.99 14.10 33.54 81.63 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 14.66 28.57 79.93 13.93 26.21 81.24 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 4 1m53_c04 ISOMALTULOSE SYNTHASE user 3 4 # 3 A 241 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 295 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 297 PHE J 75 PHE^? 21.52 ZN ZN J2001 A 369 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 16.11 33.72 80.99 14.10 33.54 81.63 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 14.66 28.57 79.93 13.93 26.21 81.24 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 4 1m53_c04 ISOMALTULOSE SYNTHASE user 4 4 # 4 A 241 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 295 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 297 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 369 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 11.74 38.14 80.19 10.63 36.40 80.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 14.66 28.57 79.93 13.93 26.21 81.24 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 4 1m53_c04 ISOMALTULOSE SYNTHASE user 5 4 # 5 A 241 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 295 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 297 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 14.66 28.57 79.93 13.93 26.21 81.24 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 4 1m53_c04 ISOMALTULOSE SYNTHASE user 6 4 # 6 A 241 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 295 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 297 PHE E 75 PHE^? 21.52 ZN ZN E2002 A 369 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 16.11 33.72 80.99 14.10 33.54 81.63 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 14.66 28.57 79.93 13.93 26.21 81.24 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 4 1m53_c04 ISOMALTULOSE SYNTHASE user 7 4 # 7 A 241 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 295 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 297 PHE B 75 PHE^? 21.46 ZN ZN B2003 A 369 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 16.11 33.72 80.99 14.10 33.54 81.63 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 14.66 28.57 79.93 13.93 26.21 81.24 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 4 1m53_c04 ISOMALTULOSE SYNTHASE user 8 4 # 8 A 241 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 295 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 297 PHE C 75 PHE^? 34.12 ZN ZN J2001 A 369 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 16.11 33.72 80.99 14.10 33.54 81.63 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 14.66 28.57 79.93 13.93 26.21 81.24 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 17.18 -52.79 -3.01 18.10 -54.51 -2.17 1m53_c04 source 1m53 ISOMALTULOSE SYNTHASE : 8 hits 1m53_c04 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 15 VAL~? 13.69 ZN ZN E2002 A 194 GLY A 12 GLY.? 16.77 ZN ZN E2002 A 417 ILE B 2 ILE^? 12.90 ZN ZN B2003 A 457 ALA B 4 ALA^? 13.81 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 16.33 1.02 -11.21 17.71 -0.52 -12.09 coo 59.34 89.99 13.88 59.24 89.18 13.73 13.30 -3.59 -12.73 12.78 -3.06 -12.48 coo 39.61 128.90 22.54 40.04 128.24 23.80 12.75 -22.06 26.86 12.28 -23.23 26.47 coo 43.27 124.32 20.47 43.79 125.29 21.53 14.60 -18.17 21.35 13.14 -18.50 21.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL A 15 VAL~? 13.69 ZN ZN E2002 A 194 GLY A 19 GLY~? 15.01 ZN ZN E2002 A 417 ILE B 2 ILE^? 12.90 ZN ZN B2003 A 457 ALA B 4 ALA^? 13.81 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 16.33 1.02 -11.21 17.71 -0.52 -12.09 coo 59.34 89.99 13.88 59.24 89.18 13.73 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 39.61 128.90 22.54 40.04 128.24 23.80 12.75 -22.06 26.86 12.28 -23.23 26.47 coo 43.27 124.32 20.47 43.79 125.29 21.53 14.60 -18.17 21.35 13.14 -18.50 21.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 151 VAL A 31 VAL^? 16.73 ZN ZN E2002 A 194 GLY A 19 GLY~? 15.01 ZN ZN E2002 A 417 ILE B 2 ILE^? 12.90 ZN ZN B2003 A 457 ALA B 4 ALA^? 13.81 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 25.78 4.70 -5.73 23.63 5.19 -5.62 coo 59.34 89.99 13.88 59.24 89.18 13.73 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 39.61 128.90 22.54 40.04 128.24 23.80 12.75 -22.06 26.86 12.28 -23.23 26.47 coo 43.27 124.32 20.47 43.79 125.29 21.53 14.60 -18.17 21.35 13.14 -18.50 21.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 151 VAL B 15 VAL~? 26.07 ZN ZN B2003 A 194 GLY B 12 GLY.? 29.28 ZN ZN B2003 A 417 ILE C 2 ILE^? 34.21 ZN ZN B2003 A 457 ALA C 4 ALA^? 28.51 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 9.99 -2.36 9.69 12.14 -2.61 9.11 coo 59.34 89.99 13.88 59.24 89.18 13.73 10.23 -2.77 3.74 9.49 -2.75 4.04 coo 39.61 128.90 22.54 40.04 128.24 23.80 3.81 -46.06 3.10 4.04 -46.31 1.87 coo 43.27 124.32 20.47 43.79 125.29 21.53 5.41 -39.88 5.21 4.55 -39.53 4.00 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 151 VAL B 15 VAL~? 26.07 ZN ZN B2003 A 194 GLY B 12 GLY.? 29.28 ZN ZN B2003 A 417 ILE H 22 ILE~? 31.04 ZN ZN B2003 A 457 ALA H 42 ALA^? 26.47 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 9.99 -2.36 9.69 12.14 -2.61 9.11 coo 59.34 89.99 13.88 59.24 89.18 13.73 10.23 -2.77 3.74 9.49 -2.75 4.04 coo 39.61 128.90 22.54 40.04 128.24 23.80 19.42 -42.89 14.36 19.82 -41.47 14.56 coo 43.27 124.32 20.47 43.79 125.29 21.53 14.44 -39.21 13.61 15.71 -39.11 14.47 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 151 VAL B 15 VAL~? 26.07 ZN ZN B2003 A 194 GLY B 19 GLY~? 21.58 ZN ZN B2003 A 417 ILE C 2 ILE^? 34.21 ZN ZN B2003 A 457 ALA C 4 ALA^? 28.51 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 9.99 -2.36 9.69 12.14 -2.61 9.11 coo 59.34 89.99 13.88 59.24 89.18 13.73 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 39.61 128.90 22.54 40.04 128.24 23.80 3.81 -46.06 3.10 4.04 -46.31 1.87 coo 43.27 124.32 20.47 43.79 125.29 21.53 5.41 -39.88 5.21 4.55 -39.53 4.00 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 151 VAL B 31 VAL^? 19.97 ZN ZN B2003 A 194 GLY B 19 GLY~? 21.58 ZN ZN B2003 A 417 ILE C 2 ILE^? 34.21 ZN ZN B2003 A 457 ALA C 4 ALA^? 28.51 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 13.91 -6.57 19.51 11.87 -6.02 18.72 coo 59.34 89.99 13.88 59.24 89.18 13.73 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 39.61 128.90 22.54 40.04 128.24 23.80 3.81 -46.06 3.10 4.04 -46.31 1.87 coo 43.27 124.32 20.47 43.79 125.29 21.53 5.41 -39.88 5.21 4.55 -39.53 4.00 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 151 VAL B 66 VAL^? 19.30 ZN ZN B2003 A 194 GLY C 12 GLY~? 16.92 ZN ZN B2003 A 417 ILE D 2 ILE^? 13.93 ZN ZN J2001 A 457 ALA D 4 ALA^? 18.42 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 5.28 -9.98 8.01 4.80 -10.65 10.13 coo 59.34 89.99 13.88 59.24 89.18 13.73 1.25 -16.50 8.28 0.53 -16.71 7.98 coo 39.61 128.90 22.54 40.04 128.24 23.80 16.21 -35.57 -27.74 17.03 -34.72 -28.12 coo 43.27 124.32 20.47 43.79 125.29 21.53 13.82 -34.77 -21.43 13.64 -33.41 -22.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 A 151 VAL C 15 VAL~? 13.85 ZN ZN B2003 A 194 GLY C 12 GLY~? 16.92 ZN ZN B2003 A 417 ILE D 2 ILE^? 13.93 ZN ZN J2001 A 457 ALA D 4 ALA^? 18.42 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 -1.11 -21.50 10.46 0.97 -21.21 11.27 coo 59.34 89.99 13.88 59.24 89.18 13.73 1.25 -16.50 8.28 0.53 -16.71 7.98 coo 39.61 128.90 22.54 40.04 128.24 23.80 16.21 -35.57 -27.74 17.03 -34.72 -28.12 coo 43.27 124.32 20.47 43.79 125.29 21.53 13.82 -34.77 -21.43 13.64 -33.41 -22.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 A 151 VAL C 15 VAL~? 13.85 ZN ZN B2003 A 194 GLY C 19 GLY~? 15.35 ZN ZN B2003 A 417 ILE D 2 ILE^? 13.93 ZN ZN J2001 A 457 ALA D 4 ALA^? 18.42 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 -1.11 -21.50 10.46 0.97 -21.21 11.27 coo 59.34 89.99 13.88 59.24 89.18 13.73 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 39.61 128.90 22.54 40.04 128.24 23.80 16.21 -35.57 -27.74 17.03 -34.72 -28.12 coo 43.27 124.32 20.47 43.79 125.29 21.53 13.82 -34.77 -21.43 13.64 -33.41 -22.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 A 151 VAL C 31 VAL^? 16.84 ZN ZN B2003 A 194 GLY C 19 GLY~? 15.35 ZN ZN B2003 A 417 ILE D 2 ILE^? 13.93 ZN ZN J2001 A 457 ALA D 4 ALA^? 18.42 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 0.45 -32.72 13.09 -1.06 -31.52 12.00 coo 59.34 89.99 13.88 59.24 89.18 13.73 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 39.61 128.90 22.54 40.04 128.24 23.80 16.21 -35.57 -27.74 17.03 -34.72 -28.12 coo 43.27 124.32 20.47 43.79 125.29 21.53 13.82 -34.77 -21.43 13.64 -33.41 -22.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 A 151 VAL D 15 VAL~? 34.99 ZN ZN B2003 A 194 GLY D 12 GLY.? 30.67 ZN ZN B2003 A 417 ILE E 2 ILE^? 12.67 ZN ZN E2002 A 457 ALA E 4 ALA^? 13.80 ZN ZN E2002 coo 60.43 93.31 8.03 62.16 94.30 8.93 -2.14 -29.72 -9.74 -0.73 -30.30 -8.15 coo 59.34 89.99 13.88 59.24 89.18 13.73 -1.47 -26.02 -5.45 -1.91 -25.74 -6.02 coo 39.61 128.90 22.54 40.04 128.24 23.80 32.92 -5.20 -23.09 33.19 -4.42 -22.16 coo 43.27 124.32 20.47 43.79 125.29 21.53 28.27 -10.13 -21.56 27.61 -8.90 -20.94 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 A 151 VAL D 15 VAL~? 34.99 ZN ZN B2003 A 194 GLY D 19 GLY~? 34.83 ZN ZN J2001 A 417 ILE E 2 ILE^? 12.67 ZN ZN E2002 A 457 ALA E 4 ALA^? 13.80 ZN ZN E2002 coo 60.43 93.31 8.03 62.16 94.30 8.93 -2.14 -29.72 -9.74 -0.73 -30.30 -8.15 coo 59.34 89.99 13.88 59.24 89.18 13.73 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 39.61 128.90 22.54 40.04 128.24 23.80 32.92 -5.20 -23.09 33.19 -4.42 -22.16 coo 43.27 124.32 20.47 43.79 125.29 21.53 28.27 -10.13 -21.56 27.61 -8.90 -20.94 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 A 151 VAL D 31 VAL^? 29.92 ZN ZN J2001 A 194 GLY D 19 GLY~? 34.83 ZN ZN J2001 A 417 ILE E 2 ILE^? 12.67 ZN ZN E2002 A 457 ALA E 4 ALA^? 13.80 ZN ZN E2002 coo 60.43 93.31 8.03 62.16 94.30 8.93 3.59 -37.71 -16.46 2.03 -36.23 -16.97 coo 59.34 89.99 13.88 59.24 89.18 13.73 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 39.61 128.90 22.54 40.04 128.24 23.80 32.92 -5.20 -23.09 33.19 -4.42 -22.16 coo 43.27 124.32 20.47 43.79 125.29 21.53 28.27 -10.13 -21.56 27.61 -8.90 -20.94 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 15 4 # 15 A 151 VAL E 15 VAL~? 26.17 ZN ZN E2002 A 194 GLY E 12 GLY.? 29.18 ZN ZN E2002 A 417 ILE A 2 ILE^? 13.96 ZN ZN G2004 A 457 ALA A 4 ALA^? 18.57 ZN ZN G2004 coo 60.43 93.31 8.03 62.16 94.30 8.93 9.05 -15.97 -23.27 9.74 -18.02 -22.72 coo 59.34 89.99 13.88 59.24 89.18 13.73 6.03 -17.90 -18.46 5.93 -17.12 -18.66 coo 39.61 128.90 22.54 40.04 128.24 23.80 30.54 3.16 10.52 30.09 2.20 11.48 coo 43.27 124.32 20.47 43.79 125.29 21.53 28.58 0.21 4.86 27.26 0.45 5.58 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 16 4 # 16 A 151 VAL E 15 VAL~? 26.17 ZN ZN E2002 A 194 GLY E 19 GLY~? 21.67 ZN ZN E2002 A 417 ILE A 2 ILE^? 13.96 ZN ZN G2004 A 457 ALA A 4 ALA^? 18.57 ZN ZN G2004 coo 60.43 93.31 8.03 62.16 94.30 8.93 9.05 -15.97 -23.27 9.74 -18.02 -22.72 coo 59.34 89.99 13.88 59.24 89.18 13.73 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 39.61 128.90 22.54 40.04 128.24 23.80 30.54 3.16 10.52 30.09 2.20 11.48 coo 43.27 124.32 20.47 43.79 125.29 21.53 28.58 0.21 4.86 27.26 0.45 5.58 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 17 4 # 17 A 151 VAL E 31 VAL^? 20.05 ZN ZN E2002 A 194 GLY E 19 GLY~? 21.67 ZN ZN E2002 A 417 ILE A 2 ILE^? 13.96 ZN ZN G2004 A 457 ALA A 4 ALA^? 18.57 ZN ZN G2004 coo 60.43 93.31 8.03 62.16 94.30 8.93 19.36 -14.61 -27.96 17.59 -13.18 -27.95 coo 59.34 89.99 13.88 59.24 89.18 13.73 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 39.61 128.90 22.54 40.04 128.24 23.80 30.54 3.16 10.52 30.09 2.20 11.48 coo 43.27 124.32 20.47 43.79 125.29 21.53 28.58 0.21 4.86 27.26 0.45 5.58 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 18 4 # 18 A 151 VAL E 66 VAL^? 19.36 ZN ZN E2002 A 194 GLY A 12 GLY.? 16.77 ZN ZN E2002 A 417 ILE B 2 ILE^? 12.90 ZN ZN B2003 A 457 ALA B 4 ALA^? 13.81 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 10.71 -9.74 -17.09 11.82 -8.21 -18.25 coo 59.34 89.99 13.88 59.24 89.18 13.73 13.30 -3.59 -12.73 12.78 -3.06 -12.48 coo 39.61 128.90 22.54 40.04 128.24 23.80 12.75 -22.06 26.86 12.28 -23.23 26.47 coo 43.27 124.32 20.47 43.79 125.29 21.53 14.60 -18.17 21.35 13.14 -18.50 21.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 19 4 # 19 A 151 VAL F 15 VAL~? 13.60 ZN ZN G2004 A 194 GLY F 12 GLY.? 16.71 ZN ZN G2004 A 417 ILE J 2 ILE.? 12.95 ZN ZN J2001 A 457 ALA J 4 ALA^? 13.86 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 40.64 -12.97 7.21 38.63 -12.59 8.10 coo 59.34 89.99 13.88 59.24 89.18 13.73 38.22 -18.03 8.72 38.92 -18.19 8.48 coo 39.61 128.90 22.54 40.04 128.24 23.80 22.40 -27.69 -30.84 21.67 -28.68 -30.44 coo 43.27 124.32 20.47 43.79 125.29 21.53 24.92 -24.16 -25.33 25.32 -25.58 -24.95 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 20 4 # 20 A 151 VAL F 15 VAL~? 13.60 ZN ZN G2004 A 194 GLY F 19 GLY~? 15.06 ZN ZN G2004 A 417 ILE J 2 ILE.? 12.95 ZN ZN J2001 A 457 ALA J 4 ALA^? 13.86 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 40.64 -12.97 7.21 38.63 -12.59 8.10 coo 59.34 89.99 13.88 59.24 89.18 13.73 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 39.61 128.90 22.54 40.04 128.24 23.80 22.40 -27.69 -30.84 21.67 -28.68 -30.44 coo 43.27 124.32 20.47 43.79 125.29 21.53 24.92 -24.16 -25.33 25.32 -25.58 -24.95 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 21 4 # 21 A 151 VAL F 31 VAL^? 16.82 ZN ZN G2004 A 194 GLY F 19 GLY~? 15.06 ZN ZN G2004 A 417 ILE J 2 ILE.? 12.95 ZN ZN J2001 A 457 ALA J 4 ALA^? 13.86 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 39.10 -2.99 1.69 40.66 -4.55 1.60 coo 59.34 89.99 13.88 59.24 89.18 13.73 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 39.61 128.90 22.54 40.04 128.24 23.80 22.40 -27.69 -30.84 21.67 -28.68 -30.44 coo 43.27 124.32 20.47 43.79 125.29 21.53 24.92 -24.16 -25.33 25.32 -25.58 -24.95 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 22 4 # 22 A 151 VAL G 15 VAL~? 25.93 ZN ZN G2004 A 194 GLY G 12 GLY.? 29.13 ZN ZN G2004 A 417 ILE F 2 ILE^? 13.86 ZN ZN E2002 A 457 ALA F 4 ALA^? 18.52 ZN ZN E2002 coo 60.43 93.31 8.03 62.16 94.30 8.93 29.69 -27.81 19.23 27.57 -28.16 18.60 coo 59.34 89.99 13.88 59.24 89.18 13.73 29.44 -31.51 14.55 30.18 -31.23 14.75 coo 39.61 128.90 22.54 40.04 128.24 23.80 35.51 0.35 -14.47 34.85 -0.53 -15.47 coo 43.27 124.32 20.47 43.79 125.29 21.53 33.88 -2.80 -8.80 34.75 -3.84 -9.47 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 23 4 # 23 A 151 VAL G 15 VAL~? 25.93 ZN ZN G2004 A 194 GLY G 19 GLY~? 21.50 ZN ZN G2004 A 417 ILE F 2 ILE^? 13.86 ZN ZN E2002 A 457 ALA F 4 ALA^? 18.52 ZN ZN E2002 coo 60.43 93.31 8.03 62.16 94.30 8.93 29.69 -27.81 19.23 27.57 -28.16 18.60 coo 59.34 89.99 13.88 59.24 89.18 13.73 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 39.61 128.90 22.54 40.04 128.24 23.80 35.51 0.35 -14.47 34.85 -0.53 -15.47 coo 43.27 124.32 20.47 43.79 125.29 21.53 33.88 -2.80 -8.80 34.75 -3.84 -9.47 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 24 4 # 24 A 151 VAL G 31 VAL^? 20.00 ZN ZN G2004 A 194 GLY G 19 GLY~? 21.50 ZN ZN G2004 A 417 ILE F 2 ILE^? 13.86 ZN ZN E2002 A 457 ALA F 4 ALA^? 18.52 ZN ZN E2002 coo 60.43 93.31 8.03 62.16 94.30 8.93 25.63 -18.28 23.97 27.74 -19.12 23.92 coo 59.34 89.99 13.88 59.24 89.18 13.73 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 39.61 128.90 22.54 40.04 128.24 23.80 35.51 0.35 -14.47 34.85 -0.53 -15.47 coo 43.27 124.32 20.47 43.79 125.29 21.53 33.88 -2.80 -8.80 34.75 -3.84 -9.47 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 25 4 # 25 A 151 VAL G 66 VAL^? 19.25 ZN ZN G2004 A 194 GLY F 12 GLY.? 16.71 ZN ZN G2004 A 417 ILE J 2 ILE.? 12.95 ZN ZN J2001 A 457 ALA J 4 ALA^? 13.86 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 34.15 -23.28 13.10 34.84 -21.64 14.41 coo 59.34 89.99 13.88 59.24 89.18 13.73 38.22 -18.03 8.72 38.92 -18.19 8.48 coo 39.61 128.90 22.54 40.04 128.24 23.80 22.40 -27.69 -30.84 21.67 -28.68 -30.44 coo 43.27 124.32 20.47 43.79 125.29 21.53 24.92 -24.16 -25.33 25.32 -25.58 -24.95 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 26 4 # 26 A 151 VAL H 15 VAL~? 35.12 ZN ZN J2001 A 194 GLY H 12 GLY.? 30.71 ZN ZN J2001 A 417 ILE G 2 ILE^? 12.84 ZN ZN G2004 A 457 ALA G 4 ALA^? 13.82 ZN ZN G2004 coo 60.43 93.31 8.03 62.16 94.30 8.93 23.05 -44.36 5.89 21.78 -43.52 4.28 coo 59.34 89.99 13.88 59.24 89.18 13.73 26.09 -42.02 1.53 26.51 -42.29 2.12 coo 39.61 128.90 22.54 40.04 128.24 23.80 26.96 -1.71 19.08 27.49 -1.01 18.19 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.06 -8.26 17.54 26.44 -8.23 16.91 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 27 4 # 27 A 151 VAL H 15 VAL~? 35.12 ZN ZN J2001 A 194 GLY H 19 GLY~? 34.96 ZN ZN B2003 A 417 ILE G 2 ILE^? 12.84 ZN ZN G2004 A 457 ALA G 4 ALA^? 13.82 ZN ZN G2004 coo 60.43 93.31 8.03 62.16 94.30 8.93 23.05 -44.36 5.89 21.78 -43.52 4.28 coo 59.34 89.99 13.88 59.24 89.18 13.73 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 39.61 128.90 22.54 40.04 128.24 23.80 26.96 -1.71 19.08 27.49 -1.01 18.19 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.06 -8.26 17.54 26.44 -8.23 16.91 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 28 4 # 28 A 151 VAL H 31 VAL^? 30.05 ZN ZN B2003 A 194 GLY H 19 GLY~? 34.96 ZN ZN B2003 A 417 ILE G 2 ILE^? 12.84 ZN ZN G2004 A 457 ALA G 4 ALA^? 13.82 ZN ZN G2004 coo 60.43 93.31 8.03 62.16 94.30 8.93 13.88 -43.40 12.62 16.08 -43.65 12.65 coo 59.34 89.99 13.88 59.24 89.18 13.73 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 39.61 128.90 22.54 40.04 128.24 23.80 26.96 -1.71 19.08 27.49 -1.01 18.19 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.06 -8.26 17.54 26.44 -8.23 16.91 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 29 4 # 29 A 151 VAL I 15 VAL~? 13.75 ZN ZN J2001 A 194 GLY I 12 GLY.? 16.89 ZN ZN J2001 A 417 ILE H 2 ILE^? 13.97 ZN ZN B2003 A 457 ALA H 4 ALA^? 18.45 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 29.83 -39.37 -14.49 29.07 -37.47 -15.34 coo 59.34 89.99 13.88 59.24 89.18 13.73 33.08 -34.86 -12.28 33.22 -35.59 -11.99 coo 39.61 128.90 22.54 40.04 128.24 23.80 9.07 -31.39 23.78 9.47 -30.29 24.18 coo 43.27 124.32 20.47 43.79 125.29 21.53 10.91 -33.06 17.47 12.20 -32.60 18.13 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 30 4 # 30 A 151 VAL I 15 VAL~? 13.75 ZN ZN J2001 A 194 GLY I 19 GLY~? 15.19 ZN ZN J2001 A 417 ILE H 2 ILE^? 13.97 ZN ZN B2003 A 457 ALA H 4 ALA^? 18.45 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 29.83 -39.37 -14.49 29.07 -37.47 -15.34 coo 59.34 89.99 13.88 59.24 89.18 13.73 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 39.61 128.90 22.54 40.04 128.24 23.80 9.07 -31.39 23.78 9.47 -30.29 24.18 coo 43.27 124.32 20.47 43.79 125.29 21.53 10.91 -33.06 17.47 12.20 -32.60 18.13 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 31 4 # 31 A 151 VAL I 31 VAL^? 16.86 ZN ZN J2001 A 194 GLY I 19 GLY~? 15.19 ZN ZN J2001 A 417 ILE H 2 ILE^? 13.97 ZN ZN B2003 A 457 ALA H 4 ALA^? 18.45 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 19.25 -43.63 -17.09 21.00 -44.45 -16.01 coo 59.34 89.99 13.88 59.24 89.18 13.73 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 39.61 128.90 22.54 40.04 128.24 23.80 9.07 -31.39 23.78 9.47 -30.29 24.18 coo 43.27 124.32 20.47 43.79 125.29 21.53 10.91 -33.06 17.47 12.20 -32.60 18.13 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 32 4 # 32 A 151 VAL I 66 VAL^? 23.22 ZN ZN J2001 A 194 GLY H 12 GLY.? 30.71 ZN ZN J2001 A 417 ILE G 2 ILE^? 12.84 ZN ZN G2004 A 457 ALA G 4 ALA^? 13.82 ZN ZN G2004 coo 60.43 93.31 8.03 62.16 94.30 8.93 28.30 -40.13 -5.63 26.50 -41.37 -5.87 coo 59.34 89.99 13.88 59.24 89.18 13.73 26.09 -42.02 1.53 26.51 -42.29 2.12 coo 39.61 128.90 22.54 40.04 128.24 23.80 26.96 -1.71 19.08 27.49 -1.01 18.19 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.06 -8.26 17.54 26.44 -8.23 16.91 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 33 4 # 33 A 151 VAL J 15 VAL~? 26.13 ZN ZN J2001 A 194 GLY J 12 GLY.? 29.28 ZN ZN J2001 A 417 ILE I 2 ILE^? 34.24 ZN ZN J2001 A 457 ALA I 4 ALA^? 28.54 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 40.92 -20.15 -13.66 39.57 -18.48 -13.06 coo 59.34 89.99 13.88 59.24 89.18 13.73 40.43 -20.16 -7.78 40.79 -20.81 -8.06 coo 39.61 128.90 22.54 40.04 128.24 23.80 6.09 -47.52 -7.10 5.71 -47.23 -5.78 coo 43.27 124.32 20.47 43.79 125.29 21.53 10.71 -42.92 -9.19 11.36 -43.44 -7.92 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 34 4 # 34 A 151 VAL J 15 VAL~? 26.13 ZN ZN J2001 A 194 GLY J 19 GLY~? 21.52 ZN ZN J2001 A 417 ILE I 2 ILE^? 34.24 ZN ZN J2001 A 457 ALA I 4 ALA^? 28.54 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 40.92 -20.15 -13.66 39.57 -18.48 -13.06 coo 59.34 89.99 13.88 59.24 89.18 13.73 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 39.61 128.90 22.54 40.04 128.24 23.80 6.09 -47.52 -7.10 5.71 -47.23 -5.78 coo 43.27 124.32 20.47 43.79 125.29 21.53 10.71 -42.92 -9.19 11.36 -43.44 -7.92 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 35 4 # 35 A 151 VAL J 31 VAL^? 20.05 ZN ZN J2001 A 194 GLY J 19 GLY~? 21.52 ZN ZN J2001 A 417 ILE I 2 ILE^? 34.24 ZN ZN J2001 A 457 ALA I 4 ALA^? 28.54 ZN ZN J2001 coo 60.43 93.31 8.03 62.16 94.30 8.93 35.33 -18.82 -23.49 36.77 -20.42 -22.75 coo 59.34 89.99 13.88 59.24 89.18 13.73 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 39.61 128.90 22.54 40.04 128.24 23.80 6.09 -47.52 -7.10 5.71 -47.23 -5.78 coo 43.27 124.32 20.47 43.79 125.29 21.53 10.71 -42.92 -9.19 11.36 -43.44 -7.92 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 36 4 # 36 A 151 VAL J 66 VAL^? 19.26 ZN ZN J2001 A 194 GLY I 12 GLY.? 16.89 ZN ZN J2001 A 417 ILE H 2 ILE^? 13.97 ZN ZN B2003 A 457 ALA H 4 ALA^? 18.45 ZN ZN B2003 coo 60.43 93.31 8.03 62.16 94.30 8.93 36.71 -28.09 -12.07 36.33 -28.89 -14.15 coo 59.34 89.99 13.88 59.24 89.18 13.73 33.08 -34.86 -12.28 33.22 -35.59 -11.99 coo 39.61 128.90 22.54 40.04 128.24 23.80 9.07 -31.39 23.78 9.47 -30.29 24.18 coo 43.27 124.32 20.47 43.79 125.29 21.53 10.91 -33.06 17.47 12.20 -32.60 18.13 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 36 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL A 15 VAL~? 13.69 ZN ZN E2002 B 194 GLY A 12 GLY.? 16.77 ZN ZN E2002 B 417 ILE B 2 ILE^? 12.90 ZN ZN B2003 B 457 ALA B 4 ALA^? 13.81 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 16.33 1.02 -11.21 17.71 -0.52 -12.09 coo 50.40 126.23 20.48 50.46 127.00 20.75 13.30 -3.59 -12.73 12.78 -3.06 -12.48 coo 68.38 85.45 19.33 67.41 85.52 20.41 12.75 -22.06 26.86 12.28 -23.23 26.47 coo 65.50 91.13 17.77 64.65 89.88 18.00 14.60 -18.17 21.35 13.14 -18.50 21.07 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL A 15 VAL~? 13.69 ZN ZN E2002 B 194 GLY A 19 GLY~? 15.01 ZN ZN E2002 B 417 ILE B 2 ILE^? 12.90 ZN ZN B2003 B 457 ALA B 4 ALA^? 13.81 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 16.33 1.02 -11.21 17.71 -0.52 -12.09 coo 50.40 126.23 20.48 50.46 127.00 20.75 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 68.38 85.45 19.33 67.41 85.52 20.41 12.75 -22.06 26.86 12.28 -23.23 26.47 coo 65.50 91.13 17.77 64.65 89.88 18.00 14.60 -18.17 21.35 13.14 -18.50 21.07 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 B 151 VAL A 31 VAL^? 16.73 ZN ZN E2002 B 194 GLY A 19 GLY~? 15.01 ZN ZN E2002 B 417 ILE B 2 ILE^? 12.90 ZN ZN B2003 B 457 ALA B 4 ALA^? 13.81 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 25.78 4.70 -5.73 23.63 5.19 -5.62 coo 50.40 126.23 20.48 50.46 127.00 20.75 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 68.38 85.45 19.33 67.41 85.52 20.41 12.75 -22.06 26.86 12.28 -23.23 26.47 coo 65.50 91.13 17.77 64.65 89.88 18.00 14.60 -18.17 21.35 13.14 -18.50 21.07 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 B 151 VAL A 56 VAL~? 25.56 ZN ZN G2004 B 194 GLY B 12 GLY.? 29.28 ZN ZN B2003 B 417 ILE J 22 ILE~? 16.74 ZN ZN J2001 B 457 ALA J 42 ALA^? 16.44 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 18.11 2.18 5.06 19.18 0.24 5.13 coo 50.40 126.23 20.48 50.46 127.00 20.75 10.23 -2.77 3.74 9.49 -2.75 4.04 coo 68.38 85.45 19.33 67.41 85.52 20.41 37.71 -24.65 -21.64 36.66 -24.79 -20.71 coo 65.50 91.13 17.77 64.65 89.88 18.00 32.05 -21.47 -22.61 32.66 -22.92 -22.56 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 B 151 VAL A 66 VAL^? 23.36 ZN ZN E2002 B 194 GLY B 12 GLY.? 29.28 ZN ZN B2003 B 417 ILE C 2 ILE^? 34.21 ZN ZN B2003 B 457 ALA C 4 ALA^? 28.51 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 12.55 -1.59 -3.47 13.31 -0.11 -2.02 coo 50.40 126.23 20.48 50.46 127.00 20.75 10.23 -2.77 3.74 9.49 -2.75 4.04 coo 68.38 85.45 19.33 67.41 85.52 20.41 3.81 -46.06 3.10 4.04 -46.31 1.87 coo 65.50 91.13 17.77 64.65 89.88 18.00 5.41 -39.88 5.21 4.55 -39.53 4.00 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 B 151 VAL B 15 VAL~? 26.07 ZN ZN B2003 B 194 GLY B 12 GLY.? 29.28 ZN ZN B2003 B 417 ILE C 2 ILE^? 34.21 ZN ZN B2003 B 457 ALA C 4 ALA^? 28.51 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 9.99 -2.36 9.69 12.14 -2.61 9.11 coo 50.40 126.23 20.48 50.46 127.00 20.75 10.23 -2.77 3.74 9.49 -2.75 4.04 coo 68.38 85.45 19.33 67.41 85.52 20.41 3.81 -46.06 3.10 4.04 -46.31 1.87 coo 65.50 91.13 17.77 64.65 89.88 18.00 5.41 -39.88 5.21 4.55 -39.53 4.00 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 B 151 VAL B 15 VAL~? 26.07 ZN ZN B2003 B 194 GLY B 19 GLY~? 21.58 ZN ZN B2003 B 417 ILE C 2 ILE^? 34.21 ZN ZN B2003 B 457 ALA C 4 ALA^? 28.51 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 9.99 -2.36 9.69 12.14 -2.61 9.11 coo 50.40 126.23 20.48 50.46 127.00 20.75 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 68.38 85.45 19.33 67.41 85.52 20.41 3.81 -46.06 3.10 4.04 -46.31 1.87 coo 65.50 91.13 17.77 64.65 89.88 18.00 5.41 -39.88 5.21 4.55 -39.53 4.00 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 B 151 VAL B 31 VAL^? 19.97 ZN ZN B2003 B 194 GLY B 19 GLY~? 21.58 ZN ZN B2003 B 417 ILE C 2 ILE^? 34.21 ZN ZN B2003 B 457 ALA C 4 ALA^? 28.51 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 13.91 -6.57 19.51 11.87 -6.02 18.72 coo 50.40 126.23 20.48 50.46 127.00 20.75 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 68.38 85.45 19.33 67.41 85.52 20.41 3.81 -46.06 3.10 4.04 -46.31 1.87 coo 65.50 91.13 17.77 64.65 89.88 18.00 5.41 -39.88 5.21 4.55 -39.53 4.00 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 B 151 VAL B 66 VAL^? 19.30 ZN ZN B2003 B 194 GLY C 12 GLY~? 16.92 ZN ZN B2003 B 417 ILE D 2 ILE^? 13.93 ZN ZN J2001 B 457 ALA D 4 ALA^? 18.42 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 5.28 -9.98 8.01 4.80 -10.65 10.13 coo 50.40 126.23 20.48 50.46 127.00 20.75 1.25 -16.50 8.28 0.53 -16.71 7.98 coo 68.38 85.45 19.33 67.41 85.52 20.41 16.21 -35.57 -27.74 17.03 -34.72 -28.12 coo 65.50 91.13 17.77 64.65 89.88 18.00 13.82 -34.77 -21.43 13.64 -33.41 -22.07 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 B 151 VAL B 66 VAL^? 19.30 ZN ZN B2003 B 194 GLY C 12 GLY~? 16.92 ZN ZN B2003 B 417 ILE J 2 ILE.? 12.95 ZN ZN J2001 B 457 ALA J 74 ALA^? 18.57 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 5.28 -9.98 8.01 4.80 -10.65 10.13 coo 50.40 126.23 20.48 50.46 127.00 20.75 1.25 -16.50 8.28 0.53 -16.71 7.98 coo 68.38 85.45 19.33 67.41 85.52 20.41 22.40 -27.69 -30.84 21.67 -28.68 -30.44 coo 65.50 91.13 17.77 64.65 89.88 18.00 19.54 -23.33 -26.22 20.33 -22.37 -27.09 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 B 151 VAL C 15 VAL~? 13.85 ZN ZN B2003 B 194 GLY C 12 GLY~? 16.92 ZN ZN B2003 B 417 ILE D 2 ILE^? 13.93 ZN ZN J2001 B 457 ALA D 4 ALA^? 18.42 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 -1.11 -21.50 10.46 0.97 -21.21 11.27 coo 50.40 126.23 20.48 50.46 127.00 20.75 1.25 -16.50 8.28 0.53 -16.71 7.98 coo 68.38 85.45 19.33 67.41 85.52 20.41 16.21 -35.57 -27.74 17.03 -34.72 -28.12 coo 65.50 91.13 17.77 64.65 89.88 18.00 13.82 -34.77 -21.43 13.64 -33.41 -22.07 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 B 151 VAL C 15 VAL~? 13.85 ZN ZN B2003 B 194 GLY C 19 GLY~? 15.35 ZN ZN B2003 B 417 ILE D 2 ILE^? 13.93 ZN ZN J2001 B 457 ALA D 4 ALA^? 18.42 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 -1.11 -21.50 10.46 0.97 -21.21 11.27 coo 50.40 126.23 20.48 50.46 127.00 20.75 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 68.38 85.45 19.33 67.41 85.52 20.41 16.21 -35.57 -27.74 17.03 -34.72 -28.12 coo 65.50 91.13 17.77 64.65 89.88 18.00 13.82 -34.77 -21.43 13.64 -33.41 -22.07 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 B 151 VAL C 31 VAL^? 16.84 ZN ZN B2003 B 194 GLY C 19 GLY~? 15.35 ZN ZN B2003 B 417 ILE D 2 ILE^? 13.93 ZN ZN J2001 B 457 ALA D 4 ALA^? 18.42 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 0.45 -32.72 13.09 -1.06 -31.52 12.00 coo 50.40 126.23 20.48 50.46 127.00 20.75 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 68.38 85.45 19.33 67.41 85.52 20.41 16.21 -35.57 -27.74 17.03 -34.72 -28.12 coo 65.50 91.13 17.77 64.65 89.88 18.00 13.82 -34.77 -21.43 13.64 -33.41 -22.07 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 B 151 VAL C 56 VAL~? 28.41 ZN ZN B2003 B 194 GLY D 12 GLY.? 30.67 ZN ZN B2003 B 417 ILE G 22 ILE~? 16.65 ZN ZN G2004 B 457 ALA G 42 ALA^? 16.36 ZN ZN G2004 coo 52.95 126.71 13.21 51.34 125.24 13.19 -1.58 -33.93 -0.28 0.64 -33.97 -0.35 coo 50.40 126.23 20.48 50.46 127.00 20.75 -1.47 -26.02 -5.45 -1.91 -25.74 -6.02 coo 68.38 85.45 19.33 67.41 85.52 20.41 31.77 -18.85 21.81 31.37 -18.77 20.50 coo 65.50 91.13 17.77 64.65 89.88 18.00 26.32 -15.83 20.54 27.87 -15.68 20.40 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 15 4 # 15 B 151 VAL C 66 VAL.? 23.18 ZN ZN B2003 B 194 GLY D 12 GLY.? 30.67 ZN ZN B2003 B 417 ILE E 2 ILE^? 12.67 ZN ZN E2002 B 457 ALA E 4 ALA^? 13.80 ZN ZN E2002 coo 52.95 126.71 13.21 51.34 125.24 13.19 -0.96 -23.26 1.87 -2.14 -25.12 1.84 coo 50.40 126.23 20.48 50.46 127.00 20.75 -1.47 -26.02 -5.45 -1.91 -25.74 -6.02 coo 68.38 85.45 19.33 67.41 85.52 20.41 32.92 -5.20 -23.09 33.19 -4.42 -22.16 coo 65.50 91.13 17.77 64.65 89.88 18.00 28.27 -10.13 -21.56 27.61 -8.90 -20.94 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 16 4 # 16 B 151 VAL D 15 VAL~? 34.99 ZN ZN B2003 B 194 GLY D 12 GLY.? 30.67 ZN ZN B2003 B 417 ILE E 2 ILE^? 12.67 ZN ZN E2002 B 457 ALA E 4 ALA^? 13.80 ZN ZN E2002 coo 52.95 126.71 13.21 51.34 125.24 13.19 -2.14 -29.72 -9.74 -0.73 -30.30 -8.15 coo 50.40 126.23 20.48 50.46 127.00 20.75 -1.47 -26.02 -5.45 -1.91 -25.74 -6.02 coo 68.38 85.45 19.33 67.41 85.52 20.41 32.92 -5.20 -23.09 33.19 -4.42 -22.16 coo 65.50 91.13 17.77 64.65 89.88 18.00 28.27 -10.13 -21.56 27.61 -8.90 -20.94 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 17 4 # 17 B 151 VAL D 15 VAL~? 34.99 ZN ZN B2003 B 194 GLY D 19 GLY~? 34.83 ZN ZN J2001 B 417 ILE E 2 ILE^? 12.67 ZN ZN E2002 B 457 ALA E 4 ALA^? 13.80 ZN ZN E2002 coo 52.95 126.71 13.21 51.34 125.24 13.19 -2.14 -29.72 -9.74 -0.73 -30.30 -8.15 coo 50.40 126.23 20.48 50.46 127.00 20.75 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 68.38 85.45 19.33 67.41 85.52 20.41 32.92 -5.20 -23.09 33.19 -4.42 -22.16 coo 65.50 91.13 17.77 64.65 89.88 18.00 28.27 -10.13 -21.56 27.61 -8.90 -20.94 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 18 4 # 18 B 151 VAL D 31 VAL^? 29.92 ZN ZN J2001 B 194 GLY D 19 GLY~? 34.83 ZN ZN J2001 B 417 ILE E 2 ILE^? 12.67 ZN ZN E2002 B 457 ALA E 4 ALA^? 13.80 ZN ZN E2002 coo 52.95 126.71 13.21 51.34 125.24 13.19 3.59 -37.71 -16.46 2.03 -36.23 -16.97 coo 50.40 126.23 20.48 50.46 127.00 20.75 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 68.38 85.45 19.33 67.41 85.52 20.41 32.92 -5.20 -23.09 33.19 -4.42 -22.16 coo 65.50 91.13 17.77 64.65 89.88 18.00 28.27 -10.13 -21.56 27.61 -8.90 -20.94 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 19 4 # 19 B 151 VAL E 15 VAL~? 26.17 ZN ZN E2002 B 194 GLY E 12 GLY.? 29.18 ZN ZN E2002 B 417 ILE A 2 ILE^? 13.96 ZN ZN G2004 B 457 ALA A 4 ALA^? 18.57 ZN ZN G2004 coo 52.95 126.71 13.21 51.34 125.24 13.19 9.05 -15.97 -23.27 9.74 -18.02 -22.72 coo 50.40 126.23 20.48 50.46 127.00 20.75 6.03 -17.90 -18.46 5.93 -17.12 -18.66 coo 68.38 85.45 19.33 67.41 85.52 20.41 30.54 3.16 10.52 30.09 2.20 11.48 coo 65.50 91.13 17.77 64.65 89.88 18.00 28.58 0.21 4.86 27.26 0.45 5.58 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 20 4 # 20 B 151 VAL E 15 VAL~? 26.17 ZN ZN E2002 B 194 GLY E 19 GLY~? 21.67 ZN ZN E2002 B 417 ILE A 2 ILE^? 13.96 ZN ZN G2004 B 457 ALA A 4 ALA^? 18.57 ZN ZN G2004 coo 52.95 126.71 13.21 51.34 125.24 13.19 9.05 -15.97 -23.27 9.74 -18.02 -22.72 coo 50.40 126.23 20.48 50.46 127.00 20.75 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 68.38 85.45 19.33 67.41 85.52 20.41 30.54 3.16 10.52 30.09 2.20 11.48 coo 65.50 91.13 17.77 64.65 89.88 18.00 28.58 0.21 4.86 27.26 0.45 5.58 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 21 4 # 21 B 151 VAL E 31 VAL^? 20.05 ZN ZN E2002 B 194 GLY E 19 GLY~? 21.67 ZN ZN E2002 B 417 ILE A 2 ILE^? 13.96 ZN ZN G2004 B 457 ALA A 4 ALA^? 18.57 ZN ZN G2004 coo 52.95 126.71 13.21 51.34 125.24 13.19 19.36 -14.61 -27.96 17.59 -13.18 -27.95 coo 50.40 126.23 20.48 50.46 127.00 20.75 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 68.38 85.45 19.33 67.41 85.52 20.41 30.54 3.16 10.52 30.09 2.20 11.48 coo 65.50 91.13 17.77 64.65 89.88 18.00 28.58 0.21 4.86 27.26 0.45 5.58 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 22 4 # 22 B 151 VAL E 56 VAL~? 10.70 ZN ZN E2002 B 194 GLY A 12 GLY.? 16.77 ZN ZN E2002 B 417 ILE I 22 ILE~? 20.17 ZN ZN J2001 B 457 ALA I 42 ALA^? 20.90 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 19.82 -4.07 -19.68 20.81 -5.70 -18.51 coo 50.40 126.23 20.48 50.46 127.00 20.75 13.30 -3.59 -12.73 12.78 -3.06 -12.48 coo 68.38 85.45 19.33 67.41 85.52 20.41 22.95 -45.97 -12.27 22.74 -45.87 -10.97 coo 65.50 91.13 17.77 64.65 89.88 18.00 17.70 -42.69 -13.42 18.31 -43.66 -12.42 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 23 4 # 23 B 151 VAL E 66 VAL^? 19.36 ZN ZN E2002 B 194 GLY A 12 GLY.? 16.77 ZN ZN E2002 B 417 ILE B 2 ILE^? 12.90 ZN ZN B2003 B 457 ALA B 4 ALA^? 13.81 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 10.71 -9.74 -17.09 11.82 -8.21 -18.25 coo 50.40 126.23 20.48 50.46 127.00 20.75 13.30 -3.59 -12.73 12.78 -3.06 -12.48 coo 68.38 85.45 19.33 67.41 85.52 20.41 12.75 -22.06 26.86 12.28 -23.23 26.47 coo 65.50 91.13 17.77 64.65 89.88 18.00 14.60 -18.17 21.35 13.14 -18.50 21.07 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 24 4 # 24 B 151 VAL F 15 VAL~? 13.60 ZN ZN G2004 B 194 GLY F 12 GLY.? 16.71 ZN ZN G2004 B 417 ILE J 2 ILE.? 12.95 ZN ZN J2001 B 457 ALA J 4 ALA^? 13.86 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.64 -12.97 7.21 38.63 -12.59 8.10 coo 50.40 126.23 20.48 50.46 127.00 20.75 38.22 -18.03 8.72 38.92 -18.19 8.48 coo 68.38 85.45 19.33 67.41 85.52 20.41 22.40 -27.69 -30.84 21.67 -28.68 -30.44 coo 65.50 91.13 17.77 64.65 89.88 18.00 24.92 -24.16 -25.33 25.32 -25.58 -24.95 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 25 4 # 25 B 151 VAL F 15 VAL~? 13.60 ZN ZN G2004 B 194 GLY F 19 GLY~? 15.06 ZN ZN G2004 B 417 ILE J 2 ILE.? 12.95 ZN ZN J2001 B 457 ALA J 4 ALA^? 13.86 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.64 -12.97 7.21 38.63 -12.59 8.10 coo 50.40 126.23 20.48 50.46 127.00 20.75 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 68.38 85.45 19.33 67.41 85.52 20.41 22.40 -27.69 -30.84 21.67 -28.68 -30.44 coo 65.50 91.13 17.77 64.65 89.88 18.00 24.92 -24.16 -25.33 25.32 -25.58 -24.95 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 26 4 # 26 B 151 VAL F 31 VAL^? 16.82 ZN ZN G2004 B 194 GLY F 19 GLY~? 15.06 ZN ZN G2004 B 417 ILE J 2 ILE.? 12.95 ZN ZN J2001 B 457 ALA J 4 ALA^? 13.86 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 39.10 -2.99 1.69 40.66 -4.55 1.60 coo 50.40 126.23 20.48 50.46 127.00 20.75 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 68.38 85.45 19.33 67.41 85.52 20.41 22.40 -27.69 -30.84 21.67 -28.68 -30.44 coo 65.50 91.13 17.77 64.65 89.88 18.00 24.92 -24.16 -25.33 25.32 -25.58 -24.95 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 27 4 # 27 B 151 VAL F 56 VAL~? 25.42 ZN ZN E2002 B 194 GLY J 12 GLY.? 29.28 ZN ZN J2001 B 417 ILE B 22 ILE~? 16.56 ZN ZN B2003 B 457 ALA B 42 ALA^? 16.34 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.79 -10.86 -9.07 38.58 -10.88 -9.06 coo 50.40 126.23 20.48 50.46 127.00 20.75 40.43 -20.16 -7.78 40.79 -20.81 -8.06 coo 68.38 85.45 19.33 67.41 85.52 20.41 7.88 -7.28 17.66 7.86 -8.60 16.85 coo 65.50 91.13 17.77 64.65 89.88 18.00 13.31 -10.73 18.58 11.78 -11.01 18.51 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 28 4 # 28 B 151 VAL F 66 VAL^? 23.41 ZN ZN G2004 B 194 GLY F 12 GLY.? 16.71 ZN ZN G2004 B 417 ILE C 2 ILE^? 34.21 ZN ZN B2003 B 457 ALA C 74 ALA^? 31.37 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.37 -17.69 -0.61 41.44 -16.34 -1.99 coo 50.40 126.23 20.48 50.46 127.00 20.75 38.22 -18.03 8.72 38.92 -18.19 8.48 coo 68.38 85.45 19.33 67.41 85.52 20.41 3.81 -46.06 3.10 4.04 -46.31 1.87 coo 65.50 91.13 17.77 64.65 89.88 18.00 9.85 -43.01 3.92 9.61 -43.24 5.40 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 29 4 # 29 B 151 VAL F 66 VAL^? 23.41 ZN ZN G2004 B 194 GLY J 12 GLY.? 29.28 ZN ZN J2001 B 417 ILE C 2 ILE^? 34.21 ZN ZN B2003 B 457 ALA C 74 ALA^? 31.37 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.37 -17.69 -0.61 41.44 -16.34 -1.99 coo 50.40 126.23 20.48 50.46 127.00 20.75 40.43 -20.16 -7.78 40.79 -20.81 -8.06 coo 68.38 85.45 19.33 67.41 85.52 20.41 3.81 -46.06 3.10 4.04 -46.31 1.87 coo 65.50 91.13 17.77 64.65 89.88 18.00 9.85 -43.01 3.92 9.61 -43.24 5.40 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 30 4 # 30 B 151 VAL F 66 VAL^? 23.41 ZN ZN G2004 B 194 GLY J 12 GLY.? 29.28 ZN ZN J2001 B 417 ILE I 2 ILE^? 34.24 ZN ZN J2001 B 457 ALA I 4 ALA^? 28.54 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.37 -17.69 -0.61 41.44 -16.34 -1.99 coo 50.40 126.23 20.48 50.46 127.00 20.75 40.43 -20.16 -7.78 40.79 -20.81 -8.06 coo 68.38 85.45 19.33 67.41 85.52 20.41 6.09 -47.52 -7.10 5.71 -47.23 -5.78 coo 65.50 91.13 17.77 64.65 89.88 18.00 10.71 -42.92 -9.19 11.36 -43.44 -7.92 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 31 4 # 31 B 151 VAL G 15 VAL~? 25.93 ZN ZN G2004 B 194 GLY G 12 GLY.? 29.13 ZN ZN G2004 B 417 ILE F 2 ILE^? 13.86 ZN ZN E2002 B 457 ALA F 4 ALA^? 18.52 ZN ZN E2002 coo 52.95 126.71 13.21 51.34 125.24 13.19 29.69 -27.81 19.23 27.57 -28.16 18.60 coo 50.40 126.23 20.48 50.46 127.00 20.75 29.44 -31.51 14.55 30.18 -31.23 14.75 coo 68.38 85.45 19.33 67.41 85.52 20.41 35.51 0.35 -14.47 34.85 -0.53 -15.47 coo 65.50 91.13 17.77 64.65 89.88 18.00 33.88 -2.80 -8.80 34.75 -3.84 -9.47 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 32 4 # 32 B 151 VAL G 15 VAL~? 25.93 ZN ZN G2004 B 194 GLY G 19 GLY~? 21.50 ZN ZN G2004 B 417 ILE F 2 ILE^? 13.86 ZN ZN E2002 B 457 ALA F 4 ALA^? 18.52 ZN ZN E2002 coo 52.95 126.71 13.21 51.34 125.24 13.19 29.69 -27.81 19.23 27.57 -28.16 18.60 coo 50.40 126.23 20.48 50.46 127.00 20.75 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 68.38 85.45 19.33 67.41 85.52 20.41 35.51 0.35 -14.47 34.85 -0.53 -15.47 coo 65.50 91.13 17.77 64.65 89.88 18.00 33.88 -2.80 -8.80 34.75 -3.84 -9.47 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 33 4 # 33 B 151 VAL G 31 VAL^? 20.00 ZN ZN G2004 B 194 GLY G 19 GLY~? 21.50 ZN ZN G2004 B 417 ILE F 2 ILE^? 13.86 ZN ZN E2002 B 457 ALA F 4 ALA^? 18.52 ZN ZN E2002 coo 52.95 126.71 13.21 51.34 125.24 13.19 25.63 -18.28 23.97 27.74 -19.12 23.92 coo 50.40 126.23 20.48 50.46 127.00 20.75 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 68.38 85.45 19.33 67.41 85.52 20.41 35.51 0.35 -14.47 34.85 -0.53 -15.47 coo 65.50 91.13 17.77 64.65 89.88 18.00 33.88 -2.80 -8.80 34.75 -3.84 -9.47 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 34 4 # 34 B 151 VAL G 56 VAL~? 10.55 ZN ZN G2004 B 194 GLY F 12 GLY.? 16.71 ZN ZN G2004 B 417 ILE C 22 ILE~? 20.16 ZN ZN B2003 B 457 ALA C 42 ALA^? 20.98 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 34.48 -12.50 15.71 32.62 -12.34 14.46 coo 50.40 126.23 20.48 50.46 127.00 20.75 38.22 -18.03 8.72 38.92 -18.19 8.48 coo 68.38 85.45 19.33 67.41 85.52 20.41 -3.30 -30.79 8.32 -2.99 -30.80 6.99 coo 65.50 91.13 17.77 64.65 89.88 18.00 2.10 -33.69 9.44 0.99 -33.67 8.41 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 35 4 # 35 B 151 VAL G 66 VAL^? 19.25 ZN ZN G2004 B 194 GLY F 12 GLY.? 16.71 ZN ZN G2004 B 417 ILE J 2 ILE.? 12.95 ZN ZN J2001 B 457 ALA J 4 ALA^? 13.86 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 34.15 -23.28 13.10 34.84 -21.64 14.41 coo 50.40 126.23 20.48 50.46 127.00 20.75 38.22 -18.03 8.72 38.92 -18.19 8.48 coo 68.38 85.45 19.33 67.41 85.52 20.41 22.40 -27.69 -30.84 21.67 -28.68 -30.44 coo 65.50 91.13 17.77 64.65 89.88 18.00 24.92 -24.16 -25.33 25.32 -25.58 -24.95 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 36 4 # 36 B 151 VAL H 15 VAL~? 35.12 ZN ZN J2001 B 194 GLY H 12 GLY.? 30.71 ZN ZN J2001 B 417 ILE G 2 ILE^? 12.84 ZN ZN G2004 B 457 ALA G 4 ALA^? 13.82 ZN ZN G2004 coo 52.95 126.71 13.21 51.34 125.24 13.19 23.05 -44.36 5.89 21.78 -43.52 4.28 coo 50.40 126.23 20.48 50.46 127.00 20.75 26.09 -42.02 1.53 26.51 -42.29 2.12 coo 68.38 85.45 19.33 67.41 85.52 20.41 26.96 -1.71 19.08 27.49 -1.01 18.19 coo 65.50 91.13 17.77 64.65 89.88 18.00 25.06 -8.26 17.54 26.44 -8.23 16.91 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 37 4 # 37 B 151 VAL H 15 VAL~? 35.12 ZN ZN J2001 B 194 GLY H 19 GLY~? 34.96 ZN ZN B2003 B 417 ILE G 2 ILE^? 12.84 ZN ZN G2004 B 457 ALA G 4 ALA^? 13.82 ZN ZN G2004 coo 52.95 126.71 13.21 51.34 125.24 13.19 23.05 -44.36 5.89 21.78 -43.52 4.28 coo 50.40 126.23 20.48 50.46 127.00 20.75 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 68.38 85.45 19.33 67.41 85.52 20.41 26.96 -1.71 19.08 27.49 -1.01 18.19 coo 65.50 91.13 17.77 64.65 89.88 18.00 25.06 -8.26 17.54 26.44 -8.23 16.91 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 38 4 # 38 B 151 VAL H 31 VAL^? 30.05 ZN ZN B2003 B 194 GLY H 19 GLY~? 34.96 ZN ZN B2003 B 417 ILE G 2 ILE^? 12.84 ZN ZN G2004 B 457 ALA G 4 ALA^? 13.82 ZN ZN G2004 coo 52.95 126.71 13.21 51.34 125.24 13.19 13.88 -43.40 12.62 16.08 -43.65 12.65 coo 50.40 126.23 20.48 50.46 127.00 20.75 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 68.38 85.45 19.33 67.41 85.52 20.41 26.96 -1.71 19.08 27.49 -1.01 18.19 coo 65.50 91.13 17.77 64.65 89.88 18.00 25.06 -8.26 17.54 26.44 -8.23 16.91 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 39 4 # 39 B 151 VAL H 56 VAL~? 25.61 ZN ZN B2003 B 194 GLY G 12 GLY.? 29.13 ZN ZN G2004 B 417 ILE D 22 ILE~? 31.09 ZN ZN J2001 B 457 ALA D 42 ALA^? 26.46 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 21.41 -34.47 19.11 20.49 -32.96 17.74 coo 50.40 126.23 20.48 50.46 127.00 20.75 29.44 -31.51 14.55 30.18 -31.23 14.75 coo 68.38 85.45 19.33 67.41 85.52 20.41 1.08 -32.10 -18.37 2.03 -31.07 -18.58 coo 65.50 91.13 17.77 64.65 89.88 18.00 6.79 -34.86 -17.54 6.23 -33.71 -18.38 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 40 4 # 40 B 151 VAL H 56 VAL~? 25.61 ZN ZN B2003 B 194 GLY G 12 GLY.? 29.13 ZN ZN G2004 B 417 ILE D 60 ILE.? 28.88 ZN ZN J2001 B 457 ALA D 42 ALA^? 26.46 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 21.41 -34.47 19.11 20.49 -32.96 17.74 coo 50.40 126.23 20.48 50.46 127.00 20.75 29.44 -31.51 14.55 30.18 -31.23 14.75 coo 68.38 85.45 19.33 67.41 85.52 20.41 4.43 -27.27 -20.02 5.07 -28.26 -19.36 coo 65.50 91.13 17.77 64.65 89.88 18.00 6.79 -34.86 -17.54 6.23 -33.71 -18.38 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 41 4 # 41 B 151 VAL I 15 VAL~? 13.75 ZN ZN J2001 B 194 GLY I 12 GLY.? 16.89 ZN ZN J2001 B 417 ILE H 2 ILE^? 13.97 ZN ZN B2003 B 457 ALA H 4 ALA^? 18.45 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 29.83 -39.37 -14.49 29.07 -37.47 -15.34 coo 50.40 126.23 20.48 50.46 127.00 20.75 33.08 -34.86 -12.28 33.22 -35.59 -11.99 coo 68.38 85.45 19.33 67.41 85.52 20.41 9.07 -31.39 23.78 9.47 -30.29 24.18 coo 65.50 91.13 17.77 64.65 89.88 18.00 10.91 -33.06 17.47 12.20 -32.60 18.13 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 42 4 # 42 B 151 VAL I 15 VAL~? 13.75 ZN ZN J2001 B 194 GLY I 19 GLY~? 15.19 ZN ZN J2001 B 417 ILE H 2 ILE^? 13.97 ZN ZN B2003 B 457 ALA H 4 ALA^? 18.45 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 29.83 -39.37 -14.49 29.07 -37.47 -15.34 coo 50.40 126.23 20.48 50.46 127.00 20.75 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 68.38 85.45 19.33 67.41 85.52 20.41 9.07 -31.39 23.78 9.47 -30.29 24.18 coo 65.50 91.13 17.77 64.65 89.88 18.00 10.91 -33.06 17.47 12.20 -32.60 18.13 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 43 4 # 43 B 151 VAL I 31 VAL^? 16.86 ZN ZN J2001 B 194 GLY I 19 GLY~? 15.19 ZN ZN J2001 B 417 ILE H 2 ILE^? 13.97 ZN ZN B2003 B 457 ALA H 4 ALA^? 18.45 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 19.25 -43.63 -17.09 21.00 -44.45 -16.01 coo 50.40 126.23 20.48 50.46 127.00 20.75 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 68.38 85.45 19.33 67.41 85.52 20.41 9.07 -31.39 23.78 9.47 -30.29 24.18 coo 65.50 91.13 17.77 64.65 89.88 18.00 10.91 -33.06 17.47 12.20 -32.60 18.13 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 44 4 # 44 B 151 VAL I 56 VAL~? 28.32 ZN ZN J2001 B 194 GLY H 12 GLY.? 30.71 ZN ZN J2001 B 417 ILE E 22 ILE~? 16.85 ZN ZN E2002 B 457 ALA E 42 ALA^? 16.45 ZN ZN E2002 coo 52.95 126.71 13.21 51.34 125.24 13.19 19.22 -45.95 -3.76 18.10 -44.04 -3.74 coo 50.40 126.23 20.48 50.46 127.00 20.75 26.09 -42.02 1.53 26.51 -42.29 2.12 coo 68.38 85.45 19.33 67.41 85.52 20.41 15.72 -9.65 -25.82 16.00 -9.99 -24.54 coo 65.50 91.13 17.77 64.65 89.88 18.00 21.06 -12.81 -24.50 20.41 -11.39 -24.39 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 45 4 # 45 B 151 VAL I 66 VAL^? 23.22 ZN ZN J2001 B 194 GLY H 12 GLY.? 30.71 ZN ZN J2001 B 417 ILE G 2 ILE^? 12.84 ZN ZN G2004 B 457 ALA G 4 ALA^? 13.82 ZN ZN G2004 coo 52.95 126.71 13.21 51.34 125.24 13.19 28.30 -40.13 -5.63 26.50 -41.37 -5.87 coo 50.40 126.23 20.48 50.46 127.00 20.75 26.09 -42.02 1.53 26.51 -42.29 2.12 coo 68.38 85.45 19.33 67.41 85.52 20.41 26.96 -1.71 19.08 27.49 -1.01 18.19 coo 65.50 91.13 17.77 64.65 89.88 18.00 25.06 -8.26 17.54 26.44 -8.23 16.91 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 46 4 # 46 B 151 VAL J 15 VAL~? 26.13 ZN ZN J2001 B 194 GLY J 12 GLY.? 29.28 ZN ZN J2001 B 417 ILE I 2 ILE^? 34.24 ZN ZN J2001 B 457 ALA I 4 ALA^? 28.54 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.92 -20.15 -13.66 39.57 -18.48 -13.06 coo 50.40 126.23 20.48 50.46 127.00 20.75 40.43 -20.16 -7.78 40.79 -20.81 -8.06 coo 68.38 85.45 19.33 67.41 85.52 20.41 6.09 -47.52 -7.10 5.71 -47.23 -5.78 coo 65.50 91.13 17.77 64.65 89.88 18.00 10.71 -42.92 -9.19 11.36 -43.44 -7.92 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 47 4 # 47 B 151 VAL J 15 VAL~? 26.13 ZN ZN J2001 B 194 GLY J 19 GLY~? 21.52 ZN ZN J2001 B 417 ILE I 2 ILE^? 34.24 ZN ZN J2001 B 457 ALA I 4 ALA^? 28.54 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.92 -20.15 -13.66 39.57 -18.48 -13.06 coo 50.40 126.23 20.48 50.46 127.00 20.75 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 68.38 85.45 19.33 67.41 85.52 20.41 6.09 -47.52 -7.10 5.71 -47.23 -5.78 coo 65.50 91.13 17.77 64.65 89.88 18.00 10.71 -42.92 -9.19 11.36 -43.44 -7.92 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 48 4 # 48 B 151 VAL J 31 VAL^? 20.05 ZN ZN J2001 B 194 GLY J 19 GLY~? 21.52 ZN ZN J2001 B 417 ILE I 2 ILE^? 34.24 ZN ZN J2001 B 457 ALA I 4 ALA^? 28.54 ZN ZN J2001 coo 52.95 126.71 13.21 51.34 125.24 13.19 35.33 -18.82 -23.49 36.77 -20.42 -22.75 coo 50.40 126.23 20.48 50.46 127.00 20.75 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 68.38 85.45 19.33 67.41 85.52 20.41 6.09 -47.52 -7.10 5.71 -47.23 -5.78 coo 65.50 91.13 17.77 64.65 89.88 18.00 10.71 -42.92 -9.19 11.36 -43.44 -7.92 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 49 4 # 49 B 151 VAL J 66 VAL^? 19.26 ZN ZN J2001 B 194 GLY I 12 GLY.? 16.89 ZN ZN J2001 B 417 ILE B 2 ILE^? 12.90 ZN ZN B2003 B 457 ALA B 74 ALA^? 18.49 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 36.71 -28.09 -12.07 36.33 -28.89 -14.15 coo 50.40 126.23 20.48 50.46 127.00 20.75 33.08 -34.86 -12.28 33.22 -35.59 -11.99 coo 68.38 85.45 19.33 67.41 85.52 20.41 12.75 -22.06 26.86 12.28 -23.23 26.47 coo 65.50 91.13 17.77 64.65 89.88 18.00 17.93 -22.48 22.28 18.36 -21.34 23.15 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 50 4 # 50 B 151 VAL J 66 VAL^? 19.26 ZN ZN J2001 B 194 GLY I 12 GLY.? 16.89 ZN ZN J2001 B 417 ILE H 2 ILE^? 13.97 ZN ZN B2003 B 457 ALA H 4 ALA^? 18.45 ZN ZN B2003 coo 52.95 126.71 13.21 51.34 125.24 13.19 36.71 -28.09 -12.07 36.33 -28.89 -14.15 coo 50.40 126.23 20.48 50.46 127.00 20.75 33.08 -34.86 -12.28 33.22 -35.59 -11.99 coo 68.38 85.45 19.33 67.41 85.52 20.41 9.07 -31.39 23.78 9.47 -30.29 24.18 coo 65.50 91.13 17.77 64.65 89.88 18.00 10.91 -33.06 17.47 12.20 -32.60 18.13 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 50 hits 1pix_c01 naa= 4 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 39 ASP.? 16.23 ZN ZN E2002 B 100 ARG F 76 ARG^? 8.13 ZN ZN E2002 B 116 GLN E 58 GLN.? 5.88 ZN ZN E2002 coo 32.18 48.37 12.48 33.96 49.46 12.97 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 39.04 43.25 11.37 38.30 45.35 13.56 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 37.43 42.63 19.41 36.76 44.08 17.97 17.76 2.63 -20.22 18.64 4.31 -21.19 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP C 39 ASP.? 16.40 ZN ZN B2003 B 100 ARG H 76 ARG^? 8.16 ZN ZN B2003 B 116 GLN B 58 GLN.? 6.03 ZN ZN B2003 coo 32.18 48.37 12.48 33.96 49.46 12.97 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 39.04 43.25 11.37 38.30 45.35 13.56 -1.06 -24.66 18.73 -3.81 -23.46 18.10 coo 37.43 42.63 19.41 36.76 44.08 17.97 -1.72 -16.94 18.58 -2.85 -17.28 20.38 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP F 39 ASP.? 16.21 ZN ZN G2004 B 100 ARG A 76 ARG^? 8.06 ZN ZN G2004 B 116 GLN G 58 GLN.? 5.74 ZN ZN G2004 coo 32.18 48.37 12.48 33.96 49.46 12.97 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 39.04 43.25 11.37 38.30 45.35 13.56 40.48 -5.18 11.11 43.34 -6.18 11.48 coo 37.43 42.63 19.41 36.76 44.08 17.97 41.36 -11.03 16.33 42.39 -9.43 17.26 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 4 3 # 4 B 46 ASP I 39 ASP.? 16.30 ZN ZN J2001 B 100 ARG D 76 ARG^? 8.12 ZN ZN J2001 B 116 GLN J 58 GLN.? 5.91 ZN ZN J2001 coo 32.18 48.37 12.48 33.96 49.46 12.97 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 39.04 43.25 11.37 38.30 45.35 13.56 27.03 -40.97 -22.65 29.39 -42.82 -22.15 coo 37.43 42.63 19.41 36.76 44.08 17.97 34.19 -37.59 -22.64 34.36 -38.74 -24.46 12as_c01 source 12as ASPARAGINE SYNTHETASE : 4 hits 12as_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU C 70 GLU^? 28.30 ZN ZN B2003 A 60 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 175 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 46.10 28.27 19.27 45.48 26.99 20.84 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 56.42 28.06 12.93 55.01 27.92 14.50 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 45.02 22.04 15.38 46.16 24.00 13.76 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU E 70 GLU^? 21.70 ZN ZN E2002 A 60 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 175 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 46.10 28.27 19.27 45.48 26.99 20.84 22.93 -13.24 -13.07 23.13 -14.10 -11.19 coo 56.42 28.06 12.93 55.01 27.92 14.50 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 45.02 22.04 15.38 46.16 24.00 13.76 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU G 70 GLU^? 21.12 ZN ZN G2004 A 60 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 175 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 46.10 28.27 19.27 45.48 26.99 20.84 24.92 -14.52 9.07 24.76 -14.12 6.99 coo 56.42 28.06 12.93 55.01 27.92 14.50 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 45.02 22.04 15.38 46.16 24.00 13.76 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU H 70 GLU^? 24.54 ZN ZN B2003 A 60 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 175 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 46.10 28.27 19.27 45.48 26.99 20.84 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 56.42 28.06 12.93 55.01 27.92 14.50 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 45.02 22.04 15.38 46.16 24.00 13.76 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU J 70 GLU^? 22.09 ZN ZN J2001 A 60 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 175 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 46.10 28.27 19.27 45.48 26.99 20.84 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 56.42 28.06 12.93 55.01 27.92 14.50 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 45.02 22.04 15.38 46.16 24.00 13.76 28.75 -20.75 -12.61 27.09 -22.87 -11.86 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 5 hits 1a50_c03 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 53 ASP~? 26.24 ZN ZN G2004 214 ASP G 39 ASP.? 27.24 ZN ZN G2004 289 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 17.64 3.84 11.72 15.55 3.44 11.90 coo 26.86 59.76 46.36 25.42 58.23 45.92 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 9.42 68.07 30.27 7.35 68.27 30.10 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 53 ASP~? 5.10 ZN ZN B2003 214 ASP H 39 ASP.? 32.15 ZN ZN J2001 289 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 26.86 59.76 46.36 25.42 58.23 45.92 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 9.42 68.07 30.27 7.35 68.27 30.10 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP C 53 ASP~? 35.43 ZN ZN B2003 214 ASP I 39 ASP.? 16.30 ZN ZN J2001 289 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 26.86 59.76 46.36 25.42 58.23 45.92 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP D 53 ASP~? 26.48 ZN ZN J2001 214 ASP E 53 ASP~? 5.07 ZN ZN E2002 289 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 26.86 59.76 46.36 25.42 58.23 45.92 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 9.42 68.07 30.27 7.35 68.27 30.10 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP E 53 ASP~? 5.07 ZN ZN E2002 214 ASP A 53 ASP~? 26.24 ZN ZN G2004 289 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 17.64 3.84 11.72 15.55 3.44 11.90 coo 9.42 68.07 30.27 7.35 68.27 30.10 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP E 53 ASP~? 5.07 ZN ZN E2002 214 ASP F 39 ASP.? 16.21 ZN ZN G2004 289 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 9.42 68.07 30.27 7.35 68.27 30.10 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP F 53 ASP~? 26.13 ZN ZN E2002 214 ASP E 39 ASP.? 27.23 ZN ZN E2002 289 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 26.86 59.76 46.36 25.42 58.23 45.92 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 9.42 68.07 30.27 7.35 68.27 30.10 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP F 53 ASP~? 26.13 ZN ZN E2002 214 ASP J 53 ASP~? 5.09 ZN ZN J2001 289 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 26.86 59.76 46.36 25.42 58.23 45.92 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 9.42 68.07 30.27 7.35 68.27 30.10 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP G 53 ASP~? 4.94 ZN ZN G2004 214 ASP A 39 ASP.? 16.23 ZN ZN E2002 289 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 26.86 59.76 46.36 25.42 58.23 45.92 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 9.42 68.07 30.27 7.35 68.27 30.10 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP G 53 ASP~? 4.94 ZN ZN G2004 214 ASP F 53 ASP~? 26.13 ZN ZN E2002 289 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 26.86 59.76 46.36 25.42 58.23 45.92 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 9.42 68.07 30.27 7.35 68.27 30.10 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP H 53 ASP~? 26.49 ZN ZN B2003 214 ASP G 53 ASP~? 4.94 ZN ZN G2004 289 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 26.86 59.76 46.36 25.42 58.23 45.92 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 9.42 68.07 30.27 7.35 68.27 30.10 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP J 53 ASP~? 5.09 ZN ZN J2001 214 ASP D 39 ASP.? 32.27 ZN ZN B2003 289 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 26.86 59.76 46.36 25.42 58.23 45.92 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.01 -35.27 -13.87 27.04 -33.54 -13.28 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 12 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 48 ASP~? 19.05 ZN ZN G2004 204 GLU A 50 GLU~? 17.52 ZN ZN G2004 289 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.93 6.24 15.37 25.45 7.75 15.31 coo 4.34 62.44 32.05 4.22 64.48 32.53 22.23 3.81 17.00 24.22 3.69 17.74 coo 9.42 68.07 30.27 7.35 68.27 30.10 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 48 ASP~? 19.05 ZN ZN G2004 204 GLU A 50 GLU~? 17.52 ZN ZN G2004 289 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.93 6.24 15.37 25.45 7.75 15.31 coo 4.34 62.44 32.05 4.22 64.48 32.53 22.23 3.81 17.00 24.22 3.69 17.74 coo 9.42 68.07 30.27 7.35 68.27 30.10 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 48 ASP~? 19.05 ZN ZN G2004 204 GLU A 51 GLU~? 22.57 ZN ZN G2004 289 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.93 6.24 15.37 25.45 7.75 15.31 coo 4.34 62.44 32.05 4.22 64.48 32.53 23.15 8.42 10.27 24.62 9.66 9.42 coo 9.42 68.07 30.27 7.35 68.27 30.10 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 53 ASP~? 26.24 ZN ZN G2004 204 GLU A 51 GLU~? 22.57 ZN ZN G2004 289 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 17.64 3.84 11.72 15.55 3.44 11.90 coo 4.34 62.44 32.05 4.22 64.48 32.53 23.15 8.42 10.27 24.62 9.66 9.42 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 48 ASP~? 8.81 ZN ZN B2003 204 GLU B 50 GLU~? -2.41 ZN ZN B2003s 289 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo -0.62 65.95 29.97 0.31 67.47 31.05 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 4.34 62.44 32.05 4.22 64.48 32.53 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 48 ASP~? 8.81 ZN ZN B2003 204 GLU B 51 GLU~? 6.60 ZN ZN B2003 289 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 4.34 62.44 32.05 4.22 64.48 32.53 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 48 ASP~? 37.52 ZN ZN B2003 204 GLU C 50 GLU~? 38.46 ZN ZN J2001 289 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 4.34 62.44 32.05 4.22 64.48 32.53 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 48 ASP~? 37.52 ZN ZN B2003 204 GLU C 50 GLU~? 38.46 ZN ZN J2001 289 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 4.34 62.44 32.05 4.22 64.48 32.53 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 48 ASP~? 37.52 ZN ZN B2003 204 GLU C 51 GLU~? 32.75 ZN ZN B2003 289 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 4.34 62.44 32.05 4.22 64.48 32.53 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 9.42 68.07 30.27 7.35 68.27 30.10 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP C 53 ASP~? 35.43 ZN ZN B2003 204 GLU C 51 GLU~? 32.75 ZN ZN B2003 289 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 4.34 62.44 32.05 4.22 64.48 32.53 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 9.42 68.07 30.27 7.35 68.27 30.10 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 54 ASP~? 34.22 ZN ZN B2003 204 GLU C 51 GLU~? 32.75 ZN ZN B2003 289 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 4.34 62.44 32.05 4.22 64.48 32.53 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 9.42 68.07 30.27 7.35 68.27 30.10 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP D 48 ASP.? 19.00 ZN ZN J2001 204 GLU D 50 GLU.? 17.54 ZN ZN J2001 289 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 4.34 62.44 32.05 4.22 64.48 32.53 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP D 48 ASP.? 19.00 ZN ZN J2001 204 GLU D 50 GLU.? 17.54 ZN ZN J2001 289 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 4.34 62.44 32.05 4.22 64.48 32.53 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP D 48 ASP.? 19.00 ZN ZN J2001 204 GLU D 51 GLU~? 22.34 ZN ZN J2001 289 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 4.34 62.44 32.05 4.22 64.48 32.53 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP D 53 ASP~? 26.48 ZN ZN J2001 204 GLU D 51 GLU~? 22.34 ZN ZN J2001 289 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 4.34 62.44 32.05 4.22 64.48 32.53 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP E 48 ASP~? 8.41 ZN ZN E2002 204 GLU E 50 GLU~? -2.01 ZN ZN E2002s 289 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo -0.62 65.95 29.97 0.31 67.47 31.05 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 4.34 62.44 32.05 4.22 64.48 32.53 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP E 48 ASP~? 8.41 ZN ZN E2002 204 GLU E 51 GLU~? 6.76 ZN ZN E2002 289 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 4.34 62.44 32.05 4.22 64.48 32.53 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP E 53 ASP~? 5.07 ZN ZN E2002 204 GLU E 50 GLU~? -2.01 ZN ZN E2002s 289 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 4.34 62.44 32.05 4.22 64.48 32.53 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP E 54 ASP~? -2.11 ZN ZN E2002s 204 GLU E 50 GLU~? -2.01 ZN ZN E2002s 289 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 4.34 62.44 32.05 4.22 64.48 32.53 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP F 48 ASP.? 18.92 ZN ZN E2002 204 GLU F 50 GLU.? 17.33 ZN ZN E2002 289 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 4.34 62.44 32.05 4.22 64.48 32.53 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP F 48 ASP.? 18.92 ZN ZN E2002 204 GLU F 50 GLU.? 17.33 ZN ZN E2002 289 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 4.34 62.44 32.05 4.22 64.48 32.53 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP F 48 ASP.? 18.92 ZN ZN E2002 204 GLU F 51 GLU~? 22.25 ZN ZN E2002 289 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 4.34 62.44 32.05 4.22 64.48 32.53 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP F 53 ASP~? 26.13 ZN ZN E2002 204 GLU F 51 GLU~? 22.25 ZN ZN E2002 289 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 4.34 62.44 32.05 4.22 64.48 32.53 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP F 54 ASP~? 25.15 ZN ZN E2002 204 GLU F 51 GLU~? 22.25 ZN ZN E2002 289 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 4.34 62.44 32.05 4.22 64.48 32.53 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP G 48 ASP~? 8.81 ZN ZN G2004 204 GLU G 50 GLU~? -2.28 ZN ZN G2004s 289 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo -0.62 65.95 29.97 0.31 67.47 31.05 33.55 0.62 19.07 33.72 1.88 17.35 coo 4.34 62.44 32.05 4.22 64.48 32.53 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 9.42 68.07 30.27 7.35 68.27 30.10 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP G 48 ASP~? 8.81 ZN ZN G2004 204 GLU G 51 GLU~? 6.79 ZN ZN G2004 289 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 33.55 0.62 19.07 33.72 1.88 17.35 coo 4.34 62.44 32.05 4.22 64.48 32.53 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 9.42 68.07 30.27 7.35 68.27 30.10 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 27 3 # 27 179 ASP G 53 ASP~? 4.94 ZN ZN G2004 204 GLU G 51 GLU~? 6.79 ZN ZN G2004 289 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 4.34 62.44 32.05 4.22 64.48 32.53 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 9.42 68.07 30.27 7.35 68.27 30.10 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 28 3 # 28 179 ASP G 54 ASP~? -2.04 ZN ZN G2004s 204 GLU G 51 GLU~? 6.79 ZN ZN G2004 289 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 4.34 62.44 32.05 4.22 64.48 32.53 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 9.42 68.07 30.27 7.35 68.27 30.10 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 29 3 # 29 179 ASP H 48 ASP.? 18.83 ZN ZN B2003 204 GLU H 50 GLU.? 17.57 ZN ZN B2003 289 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 4.34 62.44 32.05 4.22 64.48 32.53 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 30 3 # 30 179 ASP H 48 ASP.? 18.83 ZN ZN B2003 204 GLU H 50 GLU.? 17.57 ZN ZN B2003 289 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 4.34 62.44 32.05 4.22 64.48 32.53 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 9.42 68.07 30.27 7.35 68.27 30.10 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 31 3 # 31 179 ASP H 48 ASP.? 18.83 ZN ZN B2003 204 GLU H 51 GLU~? 22.00 ZN ZN B2003 289 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 4.34 62.44 32.05 4.22 64.48 32.53 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 32 3 # 32 179 ASP H 53 ASP~? 26.49 ZN ZN B2003 204 GLU H 50 GLU.? 17.57 ZN ZN B2003 289 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 4.34 62.44 32.05 4.22 64.48 32.53 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 9.42 68.07 30.27 7.35 68.27 30.10 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 33 3 # 33 179 ASP H 53 ASP~? 26.49 ZN ZN B2003 204 GLU H 51 GLU~? 22.00 ZN ZN B2003 289 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 4.34 62.44 32.05 4.22 64.48 32.53 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 9.42 68.07 30.27 7.35 68.27 30.10 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 34 3 # 34 179 ASP I 48 ASP~? 38.35 ZN ZN J2001 204 GLU I 50 GLU~? 38.38 ZN ZN B2003 289 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 4.34 62.44 32.05 4.22 64.48 32.53 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 9.42 68.07 30.27 7.35 68.27 30.10 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 35 3 # 35 179 ASP I 48 ASP~? 38.35 ZN ZN J2001 204 GLU I 50 GLU~? 38.38 ZN ZN B2003 289 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 4.34 62.44 32.05 4.22 64.48 32.53 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 9.42 68.07 30.27 7.35 68.27 30.10 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 36 3 # 36 179 ASP I 48 ASP~? 38.35 ZN ZN J2001 204 GLU I 51 GLU~? 32.52 ZN ZN J2001 289 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 4.34 62.44 32.05 4.22 64.48 32.53 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 37 3 # 37 179 ASP I 53 ASP~? 35.51 ZN ZN J2001 204 GLU I 51 GLU~? 32.52 ZN ZN J2001 289 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 4.34 62.44 32.05 4.22 64.48 32.53 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 38 3 # 38 179 ASP I 54 ASP~? 33.46 ZN ZN J2001 204 GLU I 51 GLU~? 32.52 ZN ZN J2001 289 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 4.34 62.44 32.05 4.22 64.48 32.53 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 39 3 # 39 179 ASP J 48 ASP~? 8.01 ZN ZN J2001 204 GLU J 50 GLU~? -2.50 ZN ZN J2001s 289 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo -0.62 65.95 29.97 0.31 67.47 31.05 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 4.34 62.44 32.05 4.22 64.48 32.53 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 9.42 68.07 30.27 7.35 68.27 30.10 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 40 3 # 40 179 ASP J 48 ASP~? 8.01 ZN ZN J2001 204 GLU J 51 GLU~? 6.72 ZN ZN J2001 289 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 4.34 62.44 32.05 4.22 64.48 32.53 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 28.87 -37.23 -24.52 29.85 -38.89 -23.63 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 40 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 39 ASP.? 16.23 ZN ZN E2002 227 GLU A 24 GLU.? 19.69 ZN ZN E2002 289 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 3.96 55.76 41.24 4.83 57.69 41.17 18.55 13.29 -4.55 20.34 13.88 -5.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 39 ASP.? 16.23 ZN ZN E2002 227 GLU A 30 GLU^? 19.82 ZN ZN E2002 289 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 3.96 55.76 41.24 4.83 57.69 41.17 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 9.42 68.07 30.27 7.35 68.27 30.10 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 53 ASP~? 26.24 ZN ZN G2004 227 GLU B 30 GLU^? 21.92 ZN ZN G2004 289 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 17.64 3.84 11.72 15.55 3.44 11.90 coo 3.96 55.76 41.24 4.83 57.69 41.17 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 53 ASP~? 26.24 ZN ZN G2004 227 GLU B 30 GLU^? 21.92 ZN ZN G2004 289 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 17.64 3.84 11.72 15.55 3.44 11.90 coo 3.96 55.76 41.24 4.83 57.69 41.17 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 39 ASP.? 27.28 ZN ZN B2003 227 GLU B 30 GLU^? 21.92 ZN ZN G2004 289 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 3.96 55.76 41.24 4.83 57.69 41.17 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 53 ASP~? 5.10 ZN ZN B2003 227 GLU C 30 GLU^? 20.32 ZN ZN B2003 289 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 3.96 55.76 41.24 4.83 57.69 41.17 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 54 ASP~? -2.43 ZN ZN B2003s 227 GLU C 20 GLU~? -13.13 ZN ZN B2003s 289 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 3.96 55.76 41.24 4.83 57.69 41.17 -6.90 -26.36 14.56 -8.07 -24.73 15.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 39 ASP.? 16.40 ZN ZN B2003 227 GLU C 24 GLU~? 19.76 ZN ZN B2003 289 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 3.96 55.76 41.24 4.83 57.69 41.17 -10.63 -31.97 11.09 -10.50 -32.62 13.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 39 ASP.? 16.40 ZN ZN B2003 227 GLU C 30 GLU^? 20.32 ZN ZN B2003 289 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 3.96 55.76 41.24 4.83 57.69 41.17 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP C 53 ASP~? 35.43 ZN ZN B2003 227 GLU D 24 GLU~? 35.30 ZN ZN J2001 289 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 3.96 55.76 41.24 4.83 57.69 41.17 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 53 ASP~? 35.43 ZN ZN B2003 227 GLU D 30 GLU^? 25.95 ZN ZN J2001 289 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 3.96 55.76 41.24 4.83 57.69 41.17 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP C 53 ASP~? 35.43 ZN ZN B2003 227 GLU D 30 GLU^? 25.95 ZN ZN J2001 289 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 3.96 55.76 41.24 4.83 57.69 41.17 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP D 39 ASP.? 32.27 ZN ZN B2003 227 GLU D 24 GLU~? 35.30 ZN ZN J2001 289 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 3.96 55.76 41.24 4.83 57.69 41.17 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 coo 9.42 68.07 30.27 7.35 68.27 30.10 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP D 39 ASP.? 32.27 ZN ZN B2003 227 GLU D 30 GLU^? 25.95 ZN ZN J2001 289 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 3.96 55.76 41.24 4.83 57.69 41.17 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP D 53 ASP~? 26.48 ZN ZN J2001 227 GLU E 30 GLU^? 22.13 ZN ZN J2001 289 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 3.96 55.76 41.24 4.83 57.69 41.17 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 9.42 68.07 30.27 7.35 68.27 30.10 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP E 39 ASP.? 27.23 ZN ZN E2002 227 GLU E 30 GLU^? 22.13 ZN ZN J2001 289 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP E 53 ASP~? 5.07 ZN ZN E2002 227 GLU A 30 GLU^? 19.82 ZN ZN E2002 289 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 3.96 55.76 41.24 4.83 57.69 41.17 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 9.42 68.07 30.27 7.35 68.27 30.10 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP E 53 ASP~? 5.07 ZN ZN E2002 227 GLU A 30 GLU^? 19.82 ZN ZN E2002 289 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 3.96 55.76 41.24 4.83 57.69 41.17 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP E 54 ASP~? -2.11 ZN ZN E2002s 227 GLU A 20 GLU~? -13.24 ZN ZN E2002s 289 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 3.96 55.76 41.24 4.83 57.69 41.17 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP F 39 ASP.? 16.21 ZN ZN G2004 227 GLU F 24 GLU.? 19.67 ZN ZN G2004 289 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 3.96 55.76 41.24 4.83 57.69 41.17 50.14 -4.90 0.74 49.85 -2.99 1.69 coo 9.42 68.07 30.27 7.35 68.27 30.10 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP F 39 ASP.? 16.21 ZN ZN G2004 227 GLU F 30 GLU^? 19.95 ZN ZN G2004 289 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 3.96 55.76 41.24 4.83 57.69 41.17 38.23 2.77 0.52 36.38 3.82 0.63 coo 9.42 68.07 30.27 7.35 68.27 30.10 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP F 53 ASP~? 26.13 ZN ZN E2002 227 GLU J 30 GLU^? 21.96 ZN ZN E2002 289 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 3.96 55.76 41.24 4.83 57.69 41.17 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP F 53 ASP~? 26.13 ZN ZN E2002 227 GLU J 30 GLU^? 21.96 ZN ZN E2002 289 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 3.96 55.76 41.24 4.83 57.69 41.17 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP G 39 ASP.? 27.24 ZN ZN G2004 227 GLU G 30 GLU^? 22.02 ZN ZN B2003 289 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 3.96 55.76 41.24 4.83 57.69 41.17 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP G 53 ASP~? 4.94 ZN ZN G2004 227 GLU F 30 GLU^? 19.95 ZN ZN G2004 289 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 3.96 55.76 41.24 4.83 57.69 41.17 38.23 2.77 0.52 36.38 3.82 0.63 coo 9.42 68.07 30.27 7.35 68.27 30.10 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP G 53 ASP~? 4.94 ZN ZN G2004 227 GLU F 30 GLU^? 19.95 ZN ZN G2004 289 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 3.96 55.76 41.24 4.83 57.69 41.17 38.23 2.77 0.52 36.38 3.82 0.63 coo 9.42 68.07 30.27 7.35 68.27 30.10 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 27 3 # 27 179 ASP G 54 ASP~? -2.04 ZN ZN G2004s 227 GLU F 20 GLU~? -13.12 ZN ZN G2004s 289 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 3.96 55.76 41.24 4.83 57.69 41.17 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 28 3 # 28 179 ASP H 39 ASP.? 32.15 ZN ZN J2001 227 GLU H 30 GLU^? 26.29 ZN ZN B2003 289 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 3.96 55.76 41.24 4.83 57.69 41.17 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 29 3 # 29 179 ASP H 53 ASP~? 26.49 ZN ZN B2003 227 GLU G 30 GLU^? 22.02 ZN ZN B2003 289 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo -0.62 65.95 29.97 0.31 67.47 31.05 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 9.42 68.07 30.27 7.35 68.27 30.10 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 30 3 # 30 179 ASP I 39 ASP.? 16.30 ZN ZN J2001 227 GLU I 24 GLU~? 19.88 ZN ZN J2001 289 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 25.57 -52.88 -14.93 24.90 -53.17 -16.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 31 3 # 31 179 ASP I 39 ASP.? 16.30 ZN ZN J2001 227 GLU I 30 GLU^? 20.10 ZN ZN J2001 289 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 32 3 # 32 179 ASP I 53 ASP~? 35.51 ZN ZN J2001 227 GLU H 30 GLU^? 26.29 ZN ZN B2003 289 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 3.96 55.76 41.24 4.83 57.69 41.17 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 33 3 # 33 179 ASP J 39 ASP.? 27.27 ZN ZN J2001 227 GLU J 30 GLU^? 21.96 ZN ZN E2002 289 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo -0.62 65.95 29.97 0.31 67.47 31.05 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 3.96 55.76 41.24 4.83 57.69 41.17 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 34 3 # 34 179 ASP J 53 ASP~? 5.09 ZN ZN J2001 227 GLU I 30 GLU^? 20.10 ZN ZN J2001 289 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo -0.62 65.95 29.97 0.31 67.47 31.05 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.01 -35.27 -13.87 27.04 -33.54 -13.28 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 34 hits 1amy_c06 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG F 11 ARG.? 21.89 ZN ZN G2004 A 342 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 531 ARG F 68 ARG^? 28.83 ZN ZN J2001 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 32.78 -19.96 -4.34 30.63 -22.19 -4.53 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 1 hits 1asy_c01 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG C 68 ARG^? 29.54 ZN ZN B2003 D 141 THR D 35 THR.? 33.61 ZN ZN B2003 D 235 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo -8.33 92.80 100.06 -7.71 95.33 98.44 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo -9.24 93.49 108.77 -7.37 94.21 109.61 7.36 -35.75 -4.03 7.88 -37.62 -3.11 coo -14.64 87.74 89.51 -12.89 87.43 90.65 4.44 -22.79 9.98 5.37 -21.07 9.21 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG C 68 ARG^? 29.54 ZN ZN B2003 C 141 THR D 35 THR.? 33.61 ZN ZN B2003 C 235 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo -5.79 67.26 36.83 -4.57 64.58 37.74 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo -6.81 68.31 28.28 -4.82 68.47 27.57 7.36 -35.75 -4.03 7.88 -37.62 -3.11 coo -13.01 70.96 47.58 -11.44 71.65 46.34 4.44 -22.79 9.98 5.37 -21.07 9.21 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG C 68 ARG^? 29.54 ZN ZN B2003 B 141 THR D 35 THR.? 33.61 ZN ZN B2003 B 235 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 8.13 67.41 100.27 7.18 68.35 97.45 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 8.28 67.78 108.81 6.22 67.65 109.43 7.36 -35.75 -4.03 7.88 -37.62 -3.11 coo 14.55 73.52 89.47 12.81 73.95 90.56 4.44 -22.79 9.98 5.37 -21.07 9.21 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c03 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 48 ASP~? 19.05 ZN ZN G2004 435 GLU A 50 GLU~? 17.52 ZN ZN G2004 510 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 88.62 69.90 41.16 89.05 70.67 43.04 26.93 6.24 15.37 25.45 7.75 15.31 coo 89.52 76.11 40.17 89.01 75.16 41.97 22.23 3.81 17.00 24.22 3.69 17.74 coo 84.89 77.60 46.67 85.63 75.79 46.03 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 48 ASP~? 19.05 ZN ZN G2004 435 GLU A 50 GLU~? 17.52 ZN ZN G2004 510 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo 88.62 69.90 41.16 89.05 70.67 43.04 26.93 6.24 15.37 25.45 7.75 15.31 coo 89.52 76.11 40.17 89.01 75.16 41.97 22.23 3.81 17.00 24.22 3.69 17.74 coo 84.89 77.60 46.67 85.63 75.79 46.03 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP A 48 ASP~? 19.05 ZN ZN G2004 435 GLU A 51 GLU~? 22.57 ZN ZN G2004 510 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 88.62 69.90 41.16 89.05 70.67 43.04 26.93 6.24 15.37 25.45 7.75 15.31 coo 89.52 76.11 40.17 89.01 75.16 41.97 23.15 8.42 10.27 24.62 9.66 9.42 coo 84.89 77.60 46.67 85.63 75.79 46.03 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP A 53 ASP~? 26.24 ZN ZN G2004 435 GLU A 51 GLU~? 22.57 ZN ZN G2004 510 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 88.62 69.90 41.16 89.05 70.67 43.04 17.64 3.84 11.72 15.55 3.44 11.90 coo 89.52 76.11 40.17 89.01 75.16 41.97 23.15 8.42 10.27 24.62 9.66 9.42 coo 84.89 77.60 46.67 85.63 75.79 46.03 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1bf2_c00 ISOAMYLASE user 5 3 # 5 375 ASP B 48 ASP~? 8.81 ZN ZN B2003 435 GLU B 50 GLU~? -2.41 ZN ZN B2003s 510 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 88.62 69.90 41.16 89.05 70.67 43.04 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 89.52 76.11 40.17 89.01 75.16 41.97 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 84.89 77.60 46.67 85.63 75.79 46.03 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1bf2_c00 ISOAMYLASE user 6 3 # 6 375 ASP B 48 ASP~? 8.81 ZN ZN B2003 435 GLU B 51 GLU~? 6.60 ZN ZN B2003 510 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 89.52 76.11 40.17 89.01 75.16 41.97 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 84.89 77.60 46.67 85.63 75.79 46.03 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1bf2_c00 ISOAMYLASE user 7 3 # 7 375 ASP C 48 ASP~? 37.52 ZN ZN B2003 435 GLU C 50 GLU~? 38.46 ZN ZN J2001 510 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 89.52 76.11 40.17 89.01 75.16 41.97 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 84.89 77.60 46.67 85.63 75.79 46.03 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1bf2_c00 ISOAMYLASE user 8 3 # 8 375 ASP C 48 ASP~? 37.52 ZN ZN B2003 435 GLU C 50 GLU~? 38.46 ZN ZN J2001 510 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 89.52 76.11 40.17 89.01 75.16 41.97 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 84.89 77.60 46.67 85.63 75.79 46.03 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 1bf2_c00 ISOAMYLASE user 9 3 # 9 375 ASP C 48 ASP~? 37.52 ZN ZN B2003 435 GLU C 51 GLU~? 32.75 ZN ZN B2003 510 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 89.52 76.11 40.17 89.01 75.16 41.97 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 84.89 77.60 46.67 85.63 75.79 46.03 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1bf2_c00 ISOAMYLASE user 10 3 # 10 375 ASP C 53 ASP~? 35.43 ZN ZN B2003 435 GLU C 51 GLU~? 32.75 ZN ZN B2003 510 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 89.52 76.11 40.17 89.01 75.16 41.97 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 84.89 77.60 46.67 85.63 75.79 46.03 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1bf2_c00 ISOAMYLASE user 11 3 # 11 375 ASP C 54 ASP~? 34.22 ZN ZN B2003 435 GLU C 51 GLU~? 32.75 ZN ZN B2003 510 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 89.52 76.11 40.17 89.01 75.16 41.97 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 84.89 77.60 46.67 85.63 75.79 46.03 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1bf2_c00 ISOAMYLASE user 12 3 # 12 375 ASP D 48 ASP.? 19.00 ZN ZN J2001 435 GLU D 50 GLU.? 17.54 ZN ZN J2001 510 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 89.52 76.11 40.17 89.01 75.16 41.97 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 84.89 77.60 46.67 85.63 75.79 46.03 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1bf2_c00 ISOAMYLASE user 13 3 # 13 375 ASP D 48 ASP.? 19.00 ZN ZN J2001 435 GLU D 50 GLU.? 17.54 ZN ZN J2001 510 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 89.52 76.11 40.17 89.01 75.16 41.97 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 84.89 77.60 46.67 85.63 75.79 46.03 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 1bf2_c00 ISOAMYLASE user 14 3 # 14 375 ASP D 48 ASP.? 19.00 ZN ZN J2001 435 GLU D 51 GLU~? 22.34 ZN ZN J2001 510 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 89.52 76.11 40.17 89.01 75.16 41.97 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 84.89 77.60 46.67 85.63 75.79 46.03 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1bf2_c00 ISOAMYLASE user 15 3 # 15 375 ASP D 53 ASP~? 26.48 ZN ZN J2001 435 GLU D 51 GLU~? 22.34 ZN ZN J2001 510 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 89.52 76.11 40.17 89.01 75.16 41.97 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 84.89 77.60 46.67 85.63 75.79 46.03 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1bf2_c00 ISOAMYLASE user 16 3 # 16 375 ASP E 48 ASP~? 8.41 ZN ZN E2002 435 GLU E 50 GLU~? -2.01 ZN ZN E2002s 510 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 88.62 69.90 41.16 89.05 70.67 43.04 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 89.52 76.11 40.17 89.01 75.16 41.97 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 84.89 77.60 46.67 85.63 75.79 46.03 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1bf2_c00 ISOAMYLASE user 17 3 # 17 375 ASP E 48 ASP~? 8.41 ZN ZN E2002 435 GLU E 51 GLU~? 6.76 ZN ZN E2002 510 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 88.62 69.90 41.16 89.05 70.67 43.04 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 89.52 76.11 40.17 89.01 75.16 41.97 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 84.89 77.60 46.67 85.63 75.79 46.03 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1bf2_c00 ISOAMYLASE user 18 3 # 18 375 ASP F 48 ASP.? 18.92 ZN ZN E2002 435 GLU F 50 GLU.? 17.33 ZN ZN E2002 510 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 88.62 69.90 41.16 89.05 70.67 43.04 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 89.52 76.11 40.17 89.01 75.16 41.97 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 84.89 77.60 46.67 85.63 75.79 46.03 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1bf2_c00 ISOAMYLASE user 19 3 # 19 375 ASP F 48 ASP.? 18.92 ZN ZN E2002 435 GLU F 50 GLU.? 17.33 ZN ZN E2002 510 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo 88.62 69.90 41.16 89.05 70.67 43.04 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 89.52 76.11 40.17 89.01 75.16 41.97 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 84.89 77.60 46.67 85.63 75.79 46.03 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 3 1bf2_c00 ISOAMYLASE user 20 3 # 20 375 ASP F 48 ASP.? 18.92 ZN ZN E2002 435 GLU F 51 GLU~? 22.25 ZN ZN E2002 510 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 88.62 69.90 41.16 89.05 70.67 43.04 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 89.52 76.11 40.17 89.01 75.16 41.97 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 84.89 77.60 46.67 85.63 75.79 46.03 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1bf2_c00 ISOAMYLASE user 21 3 # 21 375 ASP F 53 ASP~? 26.13 ZN ZN E2002 435 GLU F 51 GLU~? 22.25 ZN ZN E2002 510 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 88.62 69.90 41.16 89.05 70.67 43.04 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 89.52 76.11 40.17 89.01 75.16 41.97 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 84.89 77.60 46.67 85.63 75.79 46.03 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1bf2_c00 ISOAMYLASE user 22 3 # 22 375 ASP F 54 ASP~? 25.15 ZN ZN E2002 435 GLU F 51 GLU~? 22.25 ZN ZN E2002 510 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 88.62 69.90 41.16 89.05 70.67 43.04 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 89.52 76.11 40.17 89.01 75.16 41.97 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 84.89 77.60 46.67 85.63 75.79 46.03 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1bf2_c00 ISOAMYLASE user 23 3 # 23 375 ASP G 48 ASP~? 8.81 ZN ZN G2004 435 GLU G 50 GLU~? -2.28 ZN ZN G2004s 510 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo 88.62 69.90 41.16 89.05 70.67 43.04 33.55 0.62 19.07 33.72 1.88 17.35 coo 89.52 76.11 40.17 89.01 75.16 41.97 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 84.89 77.60 46.67 85.63 75.79 46.03 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1bf2_c00 ISOAMYLASE user 24 3 # 24 375 ASP G 48 ASP~? 8.81 ZN ZN G2004 435 GLU G 51 GLU~? 6.79 ZN ZN G2004 510 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 88.62 69.90 41.16 89.05 70.67 43.04 33.55 0.62 19.07 33.72 1.88 17.35 coo 89.52 76.11 40.17 89.01 75.16 41.97 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 84.89 77.60 46.67 85.63 75.79 46.03 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1bf2_c00 ISOAMYLASE user 25 3 # 25 375 ASP H 48 ASP.? 18.83 ZN ZN B2003 435 GLU H 50 GLU.? 17.57 ZN ZN B2003 510 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 89.52 76.11 40.17 89.01 75.16 41.97 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 84.89 77.60 46.67 85.63 75.79 46.03 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1bf2_c00 ISOAMYLASE user 26 3 # 26 375 ASP H 48 ASP.? 18.83 ZN ZN B2003 435 GLU H 50 GLU.? 17.57 ZN ZN B2003 510 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 89.52 76.11 40.17 89.01 75.16 41.97 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 84.89 77.60 46.67 85.63 75.79 46.03 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 3 1bf2_c00 ISOAMYLASE user 27 3 # 27 375 ASP H 48 ASP.? 18.83 ZN ZN B2003 435 GLU H 51 GLU~? 22.00 ZN ZN B2003 510 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 89.52 76.11 40.17 89.01 75.16 41.97 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 84.89 77.60 46.67 85.63 75.79 46.03 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1bf2_c00 ISOAMYLASE user 28 3 # 28 375 ASP H 53 ASP~? 26.49 ZN ZN B2003 435 GLU H 51 GLU~? 22.00 ZN ZN B2003 510 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 88.62 69.90 41.16 89.05 70.67 43.04 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 89.52 76.11 40.17 89.01 75.16 41.97 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 84.89 77.60 46.67 85.63 75.79 46.03 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1bf2_c00 ISOAMYLASE user 29 3 # 29 375 ASP I 48 ASP~? 38.35 ZN ZN J2001 435 GLU I 50 GLU~? 38.38 ZN ZN B2003 510 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 89.52 76.11 40.17 89.01 75.16 41.97 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 84.89 77.60 46.67 85.63 75.79 46.03 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1bf2_c00 ISOAMYLASE user 30 3 # 30 375 ASP I 48 ASP~? 38.35 ZN ZN J2001 435 GLU I 50 GLU~? 38.38 ZN ZN B2003 510 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 89.52 76.11 40.17 89.01 75.16 41.97 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 84.89 77.60 46.67 85.63 75.79 46.03 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1bf2_c00 ISOAMYLASE user 31 3 # 31 375 ASP I 48 ASP~? 38.35 ZN ZN J2001 435 GLU I 51 GLU~? 32.52 ZN ZN J2001 510 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 89.52 76.11 40.17 89.01 75.16 41.97 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 84.89 77.60 46.67 85.63 75.79 46.03 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1bf2_c00 ISOAMYLASE user 32 3 # 32 375 ASP I 53 ASP~? 35.51 ZN ZN J2001 435 GLU I 51 GLU~? 32.52 ZN ZN J2001 510 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 89.52 76.11 40.17 89.01 75.16 41.97 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 84.89 77.60 46.67 85.63 75.79 46.03 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1bf2_c00 ISOAMYLASE user 33 3 # 33 375 ASP I 54 ASP~? 33.46 ZN ZN J2001 435 GLU I 51 GLU~? 32.52 ZN ZN J2001 510 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 89.52 76.11 40.17 89.01 75.16 41.97 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 84.89 77.60 46.67 85.63 75.79 46.03 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1bf2_c00 ISOAMYLASE user 34 3 # 34 375 ASP J 48 ASP~? 8.01 ZN ZN J2001 435 GLU J 50 GLU~? -2.50 ZN ZN J2001s 510 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 88.62 69.90 41.16 89.05 70.67 43.04 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 89.52 76.11 40.17 89.01 75.16 41.97 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 84.89 77.60 46.67 85.63 75.79 46.03 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 1bf2_c00 ISOAMYLASE user 35 3 # 35 375 ASP J 48 ASP~? 8.01 ZN ZN J2001 435 GLU J 51 GLU~? 6.72 ZN ZN J2001 510 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 88.62 69.90 41.16 89.05 70.67 43.04 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 89.52 76.11 40.17 89.01 75.16 41.97 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 84.89 77.60 46.67 85.63 75.79 46.03 28.87 -37.23 -24.52 29.85 -38.89 -23.63 1bf2_c00 source 1bf2 ISOAMYLASE : 35 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 24 GLU.? 19.69 ZN ZN E2002 A 503 TYR F 78 TYR.? 11.63 ZN ZN E2002 A 537 GLU A 20 GLU~? -13.24 ZN ZN E2002s coo 24.06 146.21 11.09 22.89 146.18 9.36 18.55 13.29 -4.55 20.34 13.88 -5.60 coo 15.91 140.69 8.32 15.71 143.39 9.13 22.38 6.39 -10.32 21.34 4.29 -11.84 coo 16.65 144.44 13.24 18.34 145.22 12.33 18.69 9.20 -10.94 17.52 9.95 -12.50 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU B 24 GLU~? 19.88 ZN ZN B2003 A 503 TYR G 78 TYR.? 24.68 ZN ZN B2003 A 537 GLU B 20 GLU~? 25.90 ZN ZN B2003 coo 24.06 146.21 11.09 22.89 146.18 9.36 4.20 -2.38 22.67 5.80 -1.47 23.74 coo 15.91 140.69 8.32 15.71 143.39 9.13 12.17 -1.26 17.53 12.70 -0.59 14.88 coo 16.65 144.44 13.24 18.34 145.22 12.33 7.89 1.30 17.42 7.18 2.96 16.29 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU C 24 GLU~? 19.76 ZN ZN B2003 A 503 TYR H 78 TYR.? 11.76 ZN ZN B2003 A 537 GLU C 20 GLU~? -13.13 ZN ZN B2003s coo 24.06 146.21 11.09 22.89 146.18 9.36 -10.63 -31.97 11.09 -10.50 -32.62 13.14 coo 15.91 140.69 8.32 15.71 143.39 9.13 -2.69 -28.08 15.14 -1.32 -25.64 14.90 coo 16.65 144.44 13.24 18.34 145.22 12.33 -6.90 -26.36 14.56 -8.07 -24.73 15.22 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU D 24 GLU~? 35.30 ZN ZN J2001 A 503 TYR I 78 TYR.? 35.62 ZN ZN J2001 A 537 GLU D 20 GLU~? 40.68 ZN ZN J2001 coo 24.06 146.21 11.09 22.89 146.18 9.36 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 coo 15.91 140.69 8.32 15.71 143.39 9.13 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 coo 16.65 144.44 13.24 18.34 145.22 12.33 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 5 3 # 5 A 461 GLU E 24 GLU~? 19.82 ZN ZN E2002 A 503 TYR J 78 TYR.? 24.76 ZN ZN E2002 A 537 GLU E 20 GLU~? 26.08 ZN ZN E2002 coo 24.06 146.21 11.09 22.89 146.18 9.36 13.67 -6.82 -33.09 14.57 -7.33 -34.94 coo 15.91 140.69 8.32 15.71 143.39 9.13 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 16.65 144.44 13.24 18.34 145.22 12.33 9.85 -13.14 -31.23 7.79 -13.45 -31.58 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 6 3 # 6 A 461 GLU F 24 GLU.? 19.67 ZN ZN G2004 A 503 TYR A 78 TYR.? 11.65 ZN ZN G2004 A 537 GLU F 20 GLU~? -13.12 ZN ZN G2004s coo 24.06 146.21 11.09 22.89 146.18 9.36 50.14 -4.90 0.74 49.85 -2.99 1.69 coo 15.91 140.69 8.32 15.71 143.39 9.13 42.29 -5.11 6.34 41.03 -7.11 7.84 coo 16.65 144.44 13.24 18.34 145.22 12.33 46.58 -6.83 6.99 47.75 -7.54 8.57 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 7 3 # 7 A 461 GLU G 24 GLU~? 19.71 ZN ZN G2004 A 503 TYR B 78 TYR.? 24.55 ZN ZN G2004 A 537 GLU G 20 GLU~? 25.94 ZN ZN G2004 coo 24.06 146.21 11.09 22.89 146.18 9.36 35.34 -19.32 28.91 34.28 -18.98 30.72 coo 15.91 140.69 8.32 15.71 143.39 9.13 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 16.65 144.44 13.24 18.34 145.22 12.33 31.62 -25.65 27.15 32.27 -27.58 27.75 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 8 3 # 8 A 461 GLU H 24 GLU~? 35.52 ZN ZN B2003 A 503 TYR C 78 TYR^? 35.69 ZN ZN B2003 A 537 GLU H 20 GLU~? 40.75 ZN ZN B2003 coo 24.06 146.21 11.09 22.89 146.18 9.36 20.30 -49.47 18.65 18.48 -50.29 19.42 coo 15.91 140.69 8.32 15.71 143.39 9.13 16.52 -47.66 10.31 18.03 -47.38 7.99 coo 16.65 144.44 13.24 18.34 145.22 12.33 20.26 -50.51 11.36 21.36 -52.05 10.39 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 9 3 # 9 A 461 GLU I 24 GLU~? 19.88 ZN ZN J2001 A 503 TYR D 78 TYR.? 11.76 ZN ZN J2001 A 537 GLU I 20 GLU~? -12.94 ZN ZN J2001s coo 24.06 146.21 11.09 22.89 146.18 9.36 25.57 -52.88 -14.93 24.90 -53.17 -16.94 coo 15.91 140.69 8.32 15.71 143.39 9.13 24.81 -44.15 -19.15 26.32 -41.78 -18.93 coo 16.65 144.44 13.24 18.34 145.22 12.33 28.55 -46.90 -18.54 30.50 -46.99 -19.33 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 10 3 # 10 A 461 GLU J 24 GLU.? 19.48 ZN ZN J2001 A 503 TYR E 78 TYR.? 24.67 ZN ZN J2001 A 537 GLU J 20 GLU~? 25.99 ZN ZN J2001 coo 24.06 146.21 11.09 22.89 146.18 9.36 43.53 -25.45 -26.61 43.80 -24.04 -28.14 coo 15.91 140.69 8.32 15.71 143.39 9.13 40.71 -17.77 -21.60 40.95 -16.95 -18.92 coo 16.65 144.44 13.24 18.34 145.22 12.33 45.09 -20.14 -21.38 46.92 -19.89 -20.33 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 10 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 24 GLU.? 19.69 ZN ZN E2002 A 504 TYR F 78 TYR.? 11.63 ZN ZN E2002 A 540 GLU A 20 GLU~? -13.24 ZN ZN E2002s coo 81.34 87.29 87.22 82.36 86.09 88.61 18.55 13.29 -4.55 20.34 13.88 -5.60 coo 80.85 81.34 94.77 81.70 80.16 92.41 22.38 6.39 -10.32 21.34 4.29 -11.84 coo 79.94 80.46 88.84 81.11 81.36 87.27 18.69 9.20 -10.94 17.52 9.95 -12.50 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU B 24 GLU~? 19.88 ZN ZN B2003 A 504 TYR G 78 TYR.? 24.68 ZN ZN B2003 A 540 GLU B 20 GLU~? 25.90 ZN ZN B2003 coo 81.34 87.29 87.22 82.36 86.09 88.61 4.20 -2.38 22.67 5.80 -1.47 23.74 coo 80.85 81.34 94.77 81.70 80.16 92.41 12.17 -1.26 17.53 12.70 -0.59 14.88 coo 79.94 80.46 88.84 81.11 81.36 87.27 7.89 1.30 17.42 7.18 2.96 16.29 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU C 24 GLU~? 19.76 ZN ZN B2003 A 504 TYR H 78 TYR.? 11.76 ZN ZN B2003 A 540 GLU C 20 GLU~? -13.13 ZN ZN B2003s coo 81.34 87.29 87.22 82.36 86.09 88.61 -10.63 -31.97 11.09 -10.50 -32.62 13.14 coo 80.85 81.34 94.77 81.70 80.16 92.41 -2.69 -28.08 15.14 -1.32 -25.64 14.90 coo 79.94 80.46 88.84 81.11 81.36 87.27 -6.90 -26.36 14.56 -8.07 -24.73 15.22 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 4 3 # 4 A 451 GLU D 24 GLU~? 35.30 ZN ZN J2001 A 504 TYR I 78 TYR.? 35.62 ZN ZN J2001 A 540 GLU D 20 GLU~? 40.68 ZN ZN J2001 coo 81.34 87.29 87.22 82.36 86.09 88.61 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 coo 80.85 81.34 94.77 81.70 80.16 92.41 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 coo 79.94 80.46 88.84 81.11 81.36 87.27 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 5 3 # 5 A 451 GLU E 24 GLU~? 19.82 ZN ZN E2002 A 504 TYR J 78 TYR.? 24.76 ZN ZN E2002 A 540 GLU E 20 GLU~? 26.08 ZN ZN E2002 coo 81.34 87.29 87.22 82.36 86.09 88.61 13.67 -6.82 -33.09 14.57 -7.33 -34.94 coo 80.85 81.34 94.77 81.70 80.16 92.41 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 79.94 80.46 88.84 81.11 81.36 87.27 9.85 -13.14 -31.23 7.79 -13.45 -31.58 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 6 3 # 6 A 451 GLU F 24 GLU.? 19.67 ZN ZN G2004 A 504 TYR A 78 TYR.? 11.65 ZN ZN G2004 A 540 GLU F 20 GLU~? -13.12 ZN ZN G2004s coo 81.34 87.29 87.22 82.36 86.09 88.61 50.14 -4.90 0.74 49.85 -2.99 1.69 coo 80.85 81.34 94.77 81.70 80.16 92.41 42.29 -5.11 6.34 41.03 -7.11 7.84 coo 79.94 80.46 88.84 81.11 81.36 87.27 46.58 -6.83 6.99 47.75 -7.54 8.57 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 7 3 # 7 A 451 GLU G 24 GLU~? 19.71 ZN ZN G2004 A 504 TYR B 78 TYR.? 24.55 ZN ZN G2004 A 540 GLU G 20 GLU~? 25.94 ZN ZN G2004 coo 81.34 87.29 87.22 82.36 86.09 88.61 35.34 -19.32 28.91 34.28 -18.98 30.72 coo 80.85 81.34 94.77 81.70 80.16 92.41 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 79.94 80.46 88.84 81.11 81.36 87.27 31.62 -25.65 27.15 32.27 -27.58 27.75 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 8 3 # 8 A 451 GLU H 24 GLU~? 35.52 ZN ZN B2003 A 504 TYR C 78 TYR^? 35.69 ZN ZN B2003 A 540 GLU H 20 GLU~? 40.75 ZN ZN B2003 coo 81.34 87.29 87.22 82.36 86.09 88.61 20.30 -49.47 18.65 18.48 -50.29 19.42 coo 80.85 81.34 94.77 81.70 80.16 92.41 16.52 -47.66 10.31 18.03 -47.38 7.99 coo 79.94 80.46 88.84 81.11 81.36 87.27 20.26 -50.51 11.36 21.36 -52.05 10.39 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 9 3 # 9 A 451 GLU I 24 GLU~? 19.88 ZN ZN J2001 A 504 TYR D 78 TYR.? 11.76 ZN ZN J2001 A 540 GLU I 20 GLU~? -12.94 ZN ZN J2001s coo 81.34 87.29 87.22 82.36 86.09 88.61 25.57 -52.88 -14.93 24.90 -53.17 -16.94 coo 80.85 81.34 94.77 81.70 80.16 92.41 24.81 -44.15 -19.15 26.32 -41.78 -18.93 coo 79.94 80.46 88.84 81.11 81.36 87.27 28.55 -46.90 -18.54 30.50 -46.99 -19.33 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 10 3 # 10 A 451 GLU J 24 GLU.? 19.48 ZN ZN J2001 A 504 TYR E 78 TYR.? 24.67 ZN ZN J2001 A 540 GLU J 20 GLU~? 25.99 ZN ZN J2001 coo 81.34 87.29 87.22 82.36 86.09 88.61 43.53 -25.45 -26.61 43.80 -24.04 -28.14 coo 80.85 81.34 94.77 81.70 80.16 92.41 40.71 -17.77 -21.60 40.95 -16.95 -18.92 coo 79.94 80.46 88.84 81.11 81.36 87.27 45.09 -20.14 -21.38 46.92 -19.89 -20.33 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 10 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 76 ARG^? 8.06 ZN ZN G2004 A 451 GLU G 51 GLU~? 6.79 ZN ZN G2004 A 540 GLU G 50 GLU~? -2.28 ZN ZN G2004s coo 79.04 80.20 80.81 79.58 81.40 83.63 40.48 -5.18 11.11 43.34 -6.18 11.48 coo 81.34 87.29 87.22 82.36 86.09 88.61 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 79.94 80.46 88.84 81.11 81.36 87.27 37.44 -1.74 17.09 38.96 -3.21 16.73 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG B 76 ARG^? 28.58 ZN ZN B2003 A 451 GLU H 51 GLU~? 22.00 ZN ZN B2003 A 540 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 79.04 80.20 80.81 79.58 81.40 83.63 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 79.94 80.46 88.84 81.11 81.36 87.27 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG B 80 ARG.? 21.50 ZN ZN G2004 A 451 GLU G 20 GLU~? 25.94 ZN ZN G2004 A 540 GLU G 24 GLU~? 19.71 ZN ZN G2004 coo 79.04 80.20 80.81 79.58 81.40 83.63 32.12 -19.85 34.68 34.30 -17.68 34.59 coo 81.34 87.29 87.22 82.36 86.09 88.61 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 79.94 80.46 88.84 81.11 81.36 87.27 35.34 -19.32 28.91 34.28 -18.98 30.72 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG E 76 ARG^? 28.35 ZN ZN E2002 A 451 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 540 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo 79.04 80.20 80.81 79.58 81.40 83.63 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 81.34 87.29 87.22 82.36 86.09 88.61 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 79.94 80.46 88.84 81.11 81.36 87.27 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG E 80 ARG.? 21.10 ZN ZN J2001 A 451 GLU J 20 GLU~? 25.99 ZN ZN J2001 A 540 GLU J 24 GLU.? 19.48 ZN ZN J2001 coo 79.04 80.20 80.81 79.58 81.40 83.63 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo 81.34 87.29 87.22 82.36 86.09 88.61 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 79.94 80.46 88.84 81.11 81.36 87.27 43.53 -25.45 -26.61 43.80 -24.04 -28.14 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG F 76 ARG^? 8.13 ZN ZN E2002 A 451 GLU E 51 GLU~? 6.76 ZN ZN E2002 A 540 GLU E 50 GLU~? -2.01 ZN ZN E2002s coo 79.04 80.20 80.81 79.58 81.40 83.63 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 81.34 87.29 87.22 82.36 86.09 88.61 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 79.94 80.46 88.84 81.11 81.36 87.27 27.40 4.08 -19.70 26.14 4.32 -21.40 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 7 3 # 7 A 382 ARG G 76 ARG^? 28.48 ZN ZN G2004 A 451 GLU A 51 GLU~? 22.57 ZN ZN G2004 A 540 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo 79.04 80.20 80.81 79.58 81.40 83.63 15.16 1.90 14.98 12.60 3.57 14.85 coo 81.34 87.29 87.22 82.36 86.09 88.61 23.15 8.42 10.27 24.62 9.66 9.42 coo 79.94 80.46 88.84 81.11 81.36 87.27 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 8 3 # 8 A 382 ARG J 76 ARG^? 28.65 ZN ZN J2001 A 451 GLU D 51 GLU~? 22.34 ZN ZN J2001 A 540 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 79.04 80.20 80.81 79.58 81.40 83.63 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 81.34 87.29 87.22 82.36 86.09 88.61 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 79.94 80.46 88.84 81.11 81.36 87.27 15.39 -26.34 -33.01 16.88 -27.76 -33.58 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 9 3 # 9 A 382 ARG J 80 ARG.? 22.24 ZN ZN E2002 A 451 GLU E 20 GLU~? 26.08 ZN ZN E2002 A 540 GLU E 24 GLU~? 19.82 ZN ZN E2002 coo 79.04 80.20 80.81 79.58 81.40 83.63 15.29 -10.38 -39.34 14.75 -7.48 -38.50 coo 81.34 87.29 87.22 82.36 86.09 88.61 9.85 -13.14 -31.23 7.79 -13.45 -31.58 coo 79.94 80.46 88.84 81.11 81.36 87.27 13.67 -6.82 -33.09 14.57 -7.33 -34.94 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 9 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 76 ARG^? 8.06 ZN ZN G2004 B 451 GLU G 51 GLU~? 6.79 ZN ZN G2004 B 540 GLU G 50 GLU~? -2.28 ZN ZN G2004s coo 82.21 41.07 119.14 83.95 40.66 116.59 40.48 -5.18 11.11 43.34 -6.18 11.48 coo 86.52 35.28 112.74 87.08 36.38 110.99 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 83.38 41.19 112.55 85.47 40.59 112.72 37.44 -1.74 17.09 38.96 -3.21 16.73 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 80 ARG.? 21.33 ZN ZN G2004 B 451 GLU F 20 GLU~? -13.12 ZN ZN G2004s B 540 GLU F 24 GLU.? 19.67 ZN ZN G2004 coo 82.21 41.07 119.14 83.95 40.66 116.59 51.38 -0.29 4.19 53.35 -1.78 2.33 coo 86.52 35.28 112.74 87.08 36.38 110.99 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 83.38 41.19 112.55 85.47 40.59 112.72 50.14 -4.90 0.74 49.85 -2.99 1.69 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 76 ARG^? 28.58 ZN ZN B2003 B 451 GLU H 51 GLU~? 22.00 ZN ZN B2003 B 540 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 82.21 41.07 119.14 83.95 40.66 116.59 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 86.52 35.28 112.74 87.08 36.38 110.99 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 83.38 41.19 112.55 85.47 40.59 112.72 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG B 80 ARG.? 21.50 ZN ZN G2004 B 451 GLU G 20 GLU~? 25.94 ZN ZN G2004 B 540 GLU G 24 GLU~? 19.71 ZN ZN G2004 coo 82.21 41.07 119.14 83.95 40.66 116.59 32.12 -19.85 34.68 34.30 -17.68 34.59 coo 86.52 35.28 112.74 87.08 36.38 110.99 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 83.38 41.19 112.55 85.47 40.59 112.72 35.34 -19.32 28.91 34.28 -18.98 30.72 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG C 80 ARG.? 36.99 ZN ZN B2003 B 451 GLU H 20 GLU~? 40.75 ZN ZN B2003 B 540 GLU H 24 GLU~? 35.52 ZN ZN B2003 coo 82.21 41.07 119.14 83.95 40.66 116.59 16.13 -52.20 20.46 17.69 -52.87 23.04 coo 86.52 35.28 112.74 87.08 36.38 110.99 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 83.38 41.19 112.55 85.47 40.59 112.72 20.30 -49.47 18.65 18.48 -50.29 19.42 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 6 3 # 6 B 382 ARG D 76 ARG^? 8.12 ZN ZN J2001 B 451 GLU J 51 GLU~? 6.72 ZN ZN J2001 B 540 GLU J 50 GLU~? -2.50 ZN ZN J2001s coo 82.21 41.07 119.14 83.95 40.66 116.59 27.03 -40.97 -22.65 29.39 -42.82 -22.15 coo 86.52 35.28 112.74 87.08 36.38 110.99 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 83.38 41.19 112.55 85.47 40.59 112.72 26.62 -37.54 -29.35 27.87 -38.52 -28.01 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 7 3 # 7 B 382 ARG D 80 ARG.? 21.06 ZN ZN J2001 B 451 GLU I 20 GLU~? -12.94 ZN ZN J2001s B 540 GLU I 24 GLU~? 19.88 ZN ZN J2001 coo 82.21 41.07 119.14 83.95 40.66 116.59 25.19 -53.81 -20.43 26.22 -56.09 -18.61 coo 86.52 35.28 112.74 87.08 36.38 110.99 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 83.38 41.19 112.55 85.47 40.59 112.72 25.57 -52.88 -14.93 24.90 -53.17 -16.94 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 8 3 # 8 B 382 ARG E 76 ARG^? 28.35 ZN ZN E2002 B 451 GLU F 51 GLU~? 22.25 ZN ZN E2002 B 540 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo 82.21 41.07 119.14 83.95 40.66 116.59 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 86.52 35.28 112.74 87.08 36.38 110.99 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 83.38 41.19 112.55 85.47 40.59 112.72 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 9 3 # 9 B 382 ARG E 80 ARG.? 21.10 ZN ZN J2001 B 451 GLU J 20 GLU~? 25.99 ZN ZN J2001 B 540 GLU J 24 GLU.? 19.48 ZN ZN J2001 coo 82.21 41.07 119.14 83.95 40.66 116.59 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo 86.52 35.28 112.74 87.08 36.38 110.99 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 83.38 41.19 112.55 85.47 40.59 112.72 43.53 -25.45 -26.61 43.80 -24.04 -28.14 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 10 3 # 10 B 382 ARG F 76 ARG^? 8.13 ZN ZN E2002 B 451 GLU E 51 GLU~? 6.76 ZN ZN E2002 B 540 GLU E 50 GLU~? -2.01 ZN ZN E2002s coo 82.21 41.07 119.14 83.95 40.66 116.59 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 86.52 35.28 112.74 87.08 36.38 110.99 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 83.38 41.19 112.55 85.47 40.59 112.72 27.40 4.08 -19.70 26.14 4.32 -21.40 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 11 3 # 11 B 382 ARG F 80 ARG.? 21.51 ZN ZN E2002 B 451 GLU A 20 GLU~? -13.24 ZN ZN E2002s B 540 GLU A 24 GLU.? 19.69 ZN ZN E2002 coo 82.21 41.07 119.14 83.95 40.66 116.59 21.15 15.99 -8.11 19.39 17.73 -6.23 coo 86.52 35.28 112.74 87.08 36.38 110.99 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 83.38 41.19 112.55 85.47 40.59 112.72 18.55 13.29 -4.55 20.34 13.88 -5.60 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 12 3 # 12 B 382 ARG G 76 ARG^? 28.48 ZN ZN G2004 B 451 GLU A 51 GLU~? 22.57 ZN ZN G2004 B 540 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo 82.21 41.07 119.14 83.95 40.66 116.59 15.16 1.90 14.98 12.60 3.57 14.85 coo 86.52 35.28 112.74 87.08 36.38 110.99 23.15 8.42 10.27 24.62 9.66 9.42 coo 83.38 41.19 112.55 85.47 40.59 112.72 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 13 3 # 13 B 382 ARG G 80 ARG.? 23.71 ZN ZN B2003 B 451 GLU B 20 GLU~? 25.90 ZN ZN B2003 B 540 GLU B 24 GLU~? 19.88 ZN ZN B2003 coo 82.21 41.07 119.14 83.95 40.66 116.59 6.63 1.91 25.77 5.01 2.67 23.24 coo 86.52 35.28 112.74 87.08 36.38 110.99 7.89 1.30 17.42 7.18 2.96 16.29 coo 83.38 41.19 112.55 85.47 40.59 112.72 4.20 -2.38 22.67 5.80 -1.47 23.74 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 14 3 # 14 B 382 ARG I 80 ARG.? 37.40 ZN ZN J2001 B 451 GLU D 20 GLU~? 40.68 ZN ZN J2001 B 540 GLU D 24 GLU~? 35.30 ZN ZN J2001 coo 82.21 41.07 119.14 83.95 40.66 116.59 -5.55 -40.08 -24.00 -7.09 -38.67 -26.29 coo 86.52 35.28 112.74 87.08 36.38 110.99 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 83.38 41.19 112.55 85.47 40.59 112.72 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 15 3 # 15 B 382 ARG J 76 ARG^? 28.65 ZN ZN J2001 B 451 GLU D 51 GLU~? 22.34 ZN ZN J2001 B 540 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 82.21 41.07 119.14 83.95 40.66 116.59 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 86.52 35.28 112.74 87.08 36.38 110.99 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 83.38 41.19 112.55 85.47 40.59 112.72 15.39 -26.34 -33.01 16.88 -27.76 -33.58 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 16 3 # 16 B 382 ARG J 80 ARG.? 22.24 ZN ZN E2002 B 451 GLU E 20 GLU~? 26.08 ZN ZN E2002 B 540 GLU E 24 GLU~? 19.82 ZN ZN E2002 coo 82.21 41.07 119.14 83.95 40.66 116.59 15.29 -10.38 -39.34 14.75 -7.48 -38.50 coo 86.52 35.28 112.74 87.08 36.38 110.99 9.85 -13.14 -31.23 7.79 -13.45 -31.58 coo 83.38 41.19 112.55 85.47 40.59 112.72 13.67 -6.82 -33.09 14.57 -7.33 -34.94 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 16 hits 1bhg_c05 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 80 ARG.? 21.33 ZN ZN G2004 A 128 GLU F 20 GLU~? -13.12 ZN ZN G2004s A 225 GLU F 24 GLU.? 19.67 ZN ZN G2004 coo 38.56 19.11 14.83 37.12 21.00 16.76 51.38 -0.29 4.19 53.35 -1.78 2.33 coo 36.48 24.43 22.02 36.86 26.34 21.13 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 40.16 23.71 17.01 38.52 24.96 17.40 50.14 -4.90 0.74 49.85 -2.99 1.69 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG B 80 ARG.? 21.50 ZN ZN G2004 A 128 GLU G 20 GLU~? 25.94 ZN ZN G2004 A 225 GLU G 24 GLU~? 19.71 ZN ZN G2004 coo 38.56 19.11 14.83 37.12 21.00 16.76 32.12 -19.85 34.68 34.30 -17.68 34.59 coo 36.48 24.43 22.02 36.86 26.34 21.13 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 40.16 23.71 17.01 38.52 24.96 17.40 35.34 -19.32 28.91 34.28 -18.98 30.72 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG C 80 ARG.? 36.99 ZN ZN B2003 A 128 GLU H 20 GLU~? 40.75 ZN ZN B2003 A 225 GLU H 24 GLU~? 35.52 ZN ZN B2003 coo 38.56 19.11 14.83 37.12 21.00 16.76 16.13 -52.20 20.46 17.69 -52.87 23.04 coo 36.48 24.43 22.02 36.86 26.34 21.13 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 40.16 23.71 17.01 38.52 24.96 17.40 20.30 -49.47 18.65 18.48 -50.29 19.42 ULMN 3 1bqc_c01 BETA-MANNANASE user 4 3 # 4 A 50 ARG D 80 ARG.? 21.06 ZN ZN J2001 A 128 GLU I 20 GLU~? -12.94 ZN ZN J2001s A 225 GLU I 24 GLU~? 19.88 ZN ZN J2001 coo 38.56 19.11 14.83 37.12 21.00 16.76 25.19 -53.81 -20.43 26.22 -56.09 -18.61 coo 36.48 24.43 22.02 36.86 26.34 21.13 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 40.16 23.71 17.01 38.52 24.96 17.40 25.57 -52.88 -14.93 24.90 -53.17 -16.94 ULMN 3 1bqc_c01 BETA-MANNANASE user 5 3 # 5 A 50 ARG E 80 ARG.? 21.10 ZN ZN J2001 A 128 GLU J 20 GLU~? 25.99 ZN ZN J2001 A 225 GLU J 24 GLU.? 19.48 ZN ZN J2001 coo 38.56 19.11 14.83 37.12 21.00 16.76 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo 36.48 24.43 22.02 36.86 26.34 21.13 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 40.16 23.71 17.01 38.52 24.96 17.40 43.53 -25.45 -26.61 43.80 -24.04 -28.14 ULMN 3 1bqc_c01 BETA-MANNANASE user 6 3 # 6 A 50 ARG F 76 ARG^? 8.13 ZN ZN E2002 A 128 GLU E 51 GLU~? 6.76 ZN ZN E2002 A 225 GLU E 50 GLU~? -2.01 ZN ZN E2002s coo 38.56 19.11 14.83 37.12 21.00 16.76 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 36.48 24.43 22.02 36.86 26.34 21.13 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 40.16 23.71 17.01 38.52 24.96 17.40 27.40 4.08 -19.70 26.14 4.32 -21.40 ULMN 3 1bqc_c01 BETA-MANNANASE user 7 3 # 7 A 50 ARG F 80 ARG.? 21.51 ZN ZN E2002 A 128 GLU A 20 GLU~? -13.24 ZN ZN E2002s A 225 GLU A 24 GLU.? 19.69 ZN ZN E2002 coo 38.56 19.11 14.83 37.12 21.00 16.76 21.15 15.99 -8.11 19.39 17.73 -6.23 coo 36.48 24.43 22.02 36.86 26.34 21.13 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 40.16 23.71 17.01 38.52 24.96 17.40 18.55 13.29 -4.55 20.34 13.88 -5.60 ULMN 3 1bqc_c01 BETA-MANNANASE user 8 3 # 8 A 50 ARG G 80 ARG.? 23.71 ZN ZN B2003 A 128 GLU B 20 GLU~? 25.90 ZN ZN B2003 A 225 GLU B 24 GLU~? 19.88 ZN ZN B2003 coo 38.56 19.11 14.83 37.12 21.00 16.76 6.63 1.91 25.77 5.01 2.67 23.24 coo 36.48 24.43 22.02 36.86 26.34 21.13 7.89 1.30 17.42 7.18 2.96 16.29 coo 40.16 23.71 17.01 38.52 24.96 17.40 4.20 -2.38 22.67 5.80 -1.47 23.74 ULMN 3 1bqc_c01 BETA-MANNANASE user 9 3 # 9 A 50 ARG I 80 ARG.? 37.40 ZN ZN J2001 A 128 GLU D 20 GLU~? 40.68 ZN ZN J2001 A 225 GLU D 24 GLU~? 35.30 ZN ZN J2001 coo 38.56 19.11 14.83 37.12 21.00 16.76 -5.55 -40.08 -24.00 -7.09 -38.67 -26.29 coo 36.48 24.43 22.02 36.86 26.34 21.13 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 40.16 23.71 17.01 38.52 24.96 17.40 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 1bqc_c01 source 1bqc BETA-MANNANASE : 9 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 75 PHE^? 9.36 ZN ZN G2004 A 205 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 236 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 4.14 2.10 36.34 6.69 3.08 36.92 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 26.93 6.24 15.37 25.45 7.75 15.31 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 75 PHE^? 21.46 ZN ZN B2003 A 205 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 236 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 4.14 2.10 36.34 6.69 3.08 36.92 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE C 75 PHE^? 34.12 ZN ZN J2001 A 205 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 236 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 4.14 2.10 36.34 6.69 3.08 36.92 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE D 75 PHE^? 9.38 ZN ZN J2001 A 205 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 236 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE E 75 PHE^? 21.52 ZN ZN E2002 A 205 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 236 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 4.14 2.10 36.34 6.69 3.08 36.92 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 205 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 236 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 4.14 2.10 36.34 6.69 3.08 36.92 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE G 75 PHE^? 21.55 ZN ZN G2004 A 205 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 236 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 4.14 2.10 36.34 6.69 3.08 36.92 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 33.55 0.62 19.07 33.72 1.88 17.35 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE H 5 PHE^? 19.49 ZN ZN B2003 A 205 ASP H 54 ASP~? 25.78 ZN ZN B2003 A 236 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 4.14 2.10 36.34 6.69 3.08 36.92 9.42 -34.06 13.06 6.66 -34.10 13.61 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE H 75 PHE^? 9.39 ZN ZN B2003 A 205 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 236 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 4.14 2.10 36.34 6.69 3.08 36.92 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE I 75 PHE^? 34.28 ZN ZN B2003 A 205 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 236 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 4.14 2.10 36.34 6.69 3.08 36.92 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE J 75 PHE^? 21.52 ZN ZN J2001 A 205 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 236 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 4.14 2.10 36.34 6.69 3.08 36.92 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 12.18 -35.43 -32.57 13.23 -33.76 -37.61 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 11 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 27 GLN.? 7.28 ZN ZN B2003 A 91 LEU B 46 LEU^? 9.45 ZN ZN B2003 A 133 GLU B 50 GLU~? -2.41 ZN ZN B2003s coo 43.58 43.67 66.73 42.32 42.78 68.15 6.18 -14.72 26.39 4.16 -14.59 25.66 coo 38.58 45.09 70.44 38.28 45.21 72.59 9.51 -19.51 26.22 9.15 -19.11 24.09 coo 44.05 36.87 70.65 43.15 38.64 69.97 2.06 -23.31 25.35 0.50 -22.72 24.07 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN G 27 GLN.? 7.24 ZN ZN G2004 A 91 LEU G 46 LEU^? 9.61 ZN ZN G2004 A 133 GLU G 50 GLU~? -2.28 ZN ZN G2004s coo 43.58 43.67 66.73 42.32 42.78 68.15 33.29 -7.45 23.57 35.31 -7.97 23.08 coo 38.58 45.09 70.44 38.28 45.21 72.59 30.07 -4.18 20.40 30.26 -5.96 19.13 coo 44.05 36.87 70.65 43.15 38.64 69.97 37.44 -1.74 17.09 38.96 -3.21 16.73 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN J 27 GLN.? 7.43 ZN ZN J2001 A 91 LEU J 46 LEU.? 9.51 ZN ZN J2001 A 133 GLU J 50 GLU~? -2.50 ZN ZN J2001s coo 43.58 43.67 66.73 42.32 42.78 68.15 32.11 -29.81 -30.36 33.38 -31.34 -29.56 coo 38.58 45.09 70.44 38.28 45.21 72.59 26.41 -29.17 -30.16 26.91 -29.22 -28.03 coo 44.05 36.87 70.65 43.15 38.64 69.97 26.62 -37.54 -29.35 27.87 -38.52 -28.01 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 3 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN B 27 GLN.? 7.28 ZN ZN B2003 B 591 LEU B 46 LEU^? 9.45 ZN ZN B2003 B 633 GLU B 50 GLU~? -2.41 ZN ZN B2003s coo 88.06 44.34 57.19 89.06 45.53 55.74 6.18 -14.72 26.39 4.16 -14.59 25.66 coo 86.70 48.66 52.61 87.15 48.69 50.51 9.51 -19.51 26.22 9.15 -19.11 24.09 coo 95.42 44.52 54.43 93.46 45.31 54.70 2.06 -23.31 25.35 0.50 -22.72 24.07 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN G 27 GLN.? 7.24 ZN ZN G2004 B 591 LEU G 46 LEU^? 9.61 ZN ZN G2004 B 633 GLU G 50 GLU~? -2.28 ZN ZN G2004s coo 88.06 44.34 57.19 89.06 45.53 55.74 33.29 -7.45 23.57 35.31 -7.97 23.08 coo 86.70 48.66 52.61 87.15 48.69 50.51 30.07 -4.18 20.40 30.26 -5.96 19.13 coo 95.42 44.52 54.43 93.46 45.31 54.70 37.44 -1.74 17.09 38.96 -3.21 16.73 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN J 27 GLN.? 7.43 ZN ZN J2001 B 591 LEU J 46 LEU.? 9.51 ZN ZN J2001 B 633 GLU J 50 GLU~? -2.50 ZN ZN J2001s coo 88.06 44.34 57.19 89.06 45.53 55.74 32.11 -29.81 -30.36 33.38 -31.34 -29.56 coo 86.70 48.66 52.61 87.15 48.69 50.51 26.41 -29.17 -30.16 26.91 -29.22 -28.03 coo 95.42 44.52 54.43 93.46 45.31 54.70 26.62 -37.54 -29.35 27.87 -38.52 -28.01 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 3 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 16 GLN~? 8.86 ZN ZN E2002 C1091 LEU A 18 LEU~? 18.84 ZN ZN E2002 C1133 GLU A 20 GLU~? -13.24 ZN ZN E2002s coo 68.29 34.44 43.03 66.67 34.74 44.37 17.90 4.40 -14.76 17.54 4.89 -16.79 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.57 3.11 -6.71 13.63 2.37 -6.07 coo 63.14 29.39 46.25 63.84 31.31 45.74 18.69 9.20 -10.94 17.52 9.95 -12.50 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN B 27 GLN.? 7.28 ZN ZN B2003 C1091 LEU B 46 LEU^? 9.45 ZN ZN B2003 C1133 GLU B 50 GLU~? -2.41 ZN ZN B2003s coo 68.29 34.44 43.03 66.67 34.74 44.37 6.18 -14.72 26.39 4.16 -14.59 25.66 coo 65.83 38.95 47.05 65.46 38.90 49.20 9.51 -19.51 26.22 9.15 -19.11 24.09 coo 63.14 29.39 46.25 63.84 31.31 45.74 2.06 -23.31 25.35 0.50 -22.72 24.07 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN G 27 GLN.? 7.24 ZN ZN G2004 C1091 LEU G 46 LEU^? 9.61 ZN ZN G2004 C1133 GLU G 50 GLU~? -2.28 ZN ZN G2004s coo 68.29 34.44 43.03 66.67 34.74 44.37 33.29 -7.45 23.57 35.31 -7.97 23.08 coo 65.83 38.95 47.05 65.46 38.90 49.20 30.07 -4.18 20.40 30.26 -5.96 19.13 coo 63.14 29.39 46.25 63.84 31.31 45.74 37.44 -1.74 17.09 38.96 -3.21 16.73 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN J 27 GLN.? 7.43 ZN ZN J2001 C1091 LEU J 46 LEU.? 9.51 ZN ZN J2001 C1133 GLU J 50 GLU~? -2.50 ZN ZN J2001s coo 68.29 34.44 43.03 66.67 34.74 44.37 32.11 -29.81 -30.36 33.38 -31.34 -29.56 coo 65.83 38.95 47.05 65.46 38.90 49.20 26.41 -29.17 -30.16 26.91 -29.22 -28.03 coo 63.14 29.39 46.25 63.84 31.31 45.74 26.62 -37.54 -29.35 27.87 -38.52 -28.01 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 27 GLN.? 7.28 ZN ZN B2003 A 91 LEU B 46 LEU^? 9.45 ZN ZN B2003 A 133 GLU B 50 GLU~? -2.41 ZN ZN B2003s coo 38.23 53.34 67.59 38.84 53.87 69.56 6.18 -14.72 26.39 4.16 -14.59 25.66 coo 35.40 53.22 73.30 35.37 54.87 74.74 9.51 -19.51 26.22 9.15 -19.11 24.09 coo 45.08 56.04 70.60 43.15 55.19 70.77 2.06 -23.31 25.35 0.50 -22.72 24.07 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN G 27 GLN.? 7.24 ZN ZN G2004 A 91 LEU G 46 LEU^? 9.61 ZN ZN G2004 A 133 GLU G 50 GLU~? -2.28 ZN ZN G2004s coo 38.23 53.34 67.59 38.84 53.87 69.56 33.29 -7.45 23.57 35.31 -7.97 23.08 coo 35.40 53.22 73.30 35.37 54.87 74.74 30.07 -4.18 20.40 30.26 -5.96 19.13 coo 45.08 56.04 70.60 43.15 55.19 70.77 37.44 -1.74 17.09 38.96 -3.21 16.73 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN J 27 GLN.? 7.43 ZN ZN J2001 A 91 LEU J 46 LEU.? 9.51 ZN ZN J2001 A 133 GLU J 50 GLU~? -2.50 ZN ZN J2001s coo 38.23 53.34 67.59 38.84 53.87 69.56 32.11 -29.81 -30.36 33.38 -31.34 -29.56 coo 35.40 53.22 73.30 35.37 54.87 74.74 26.41 -29.17 -30.16 26.91 -29.22 -28.03 coo 45.08 56.04 70.60 43.15 55.19 70.77 26.62 -37.54 -29.35 27.87 -38.52 -28.01 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 3 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 354 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 421 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo 31.05 49.37 64.51 31.97 51.11 63.85 26.93 6.24 15.37 25.45 7.75 15.31 coo 29.07 50.42 58.36 29.02 52.18 59.49 22.23 3.81 17.00 24.22 3.69 17.74 coo 30.82 59.76 58.47 31.12 59.02 60.40 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 354 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 421 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo 31.05 49.37 64.51 31.97 51.11 63.85 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 29.07 50.42 58.36 29.02 52.18 59.49 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 30.82 59.76 58.47 31.12 59.02 60.40 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 354 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 421 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 31.05 49.37 64.51 31.97 51.11 63.85 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 29.07 50.42 58.36 29.02 52.18 59.49 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 30.82 59.76 58.47 31.12 59.02 60.40 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 354 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 421 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo 31.05 49.37 64.51 31.97 51.11 63.85 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 29.07 50.42 58.36 29.02 52.18 59.49 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 30.82 59.76 58.47 31.12 59.02 60.40 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 354 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 421 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo 31.05 49.37 64.51 31.97 51.11 63.85 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 29.07 50.42 58.36 29.02 52.18 59.49 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 30.82 59.76 58.47 31.12 59.02 60.40 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 354 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 421 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo 31.05 49.37 64.51 31.97 51.11 63.85 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 29.07 50.42 58.36 29.02 52.18 59.49 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 30.82 59.76 58.47 31.12 59.02 60.40 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 354 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 421 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 31.05 49.37 64.51 31.97 51.11 63.85 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 29.07 50.42 58.36 29.02 52.18 59.49 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 30.82 59.76 58.47 31.12 59.02 60.40 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 354 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 421 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 31.05 49.37 64.51 31.97 51.11 63.85 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 29.07 50.42 58.36 29.02 52.18 59.49 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 30.82 59.76 58.47 31.12 59.02 60.40 15.88 -49.61 0.98 17.43 -49.51 2.42 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 8 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 48 ASP~? 19.05 ZN ZN G2004 B 354 GLU A 50 GLU~? 17.52 ZN ZN G2004 B 421 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo 25.90 8.19 53.87 25.36 6.97 52.29 26.93 6.24 15.37 25.45 7.75 15.31 coo 27.87 10.66 47.95 27.82 8.60 48.27 22.23 3.81 17.00 24.22 3.69 17.74 coo 26.02 1.87 43.38 25.90 1.97 45.49 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP C 48 ASP~? 37.52 ZN ZN B2003 B 354 GLU C 50 GLU~? 38.46 ZN ZN J2001 B 421 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo 25.90 8.19 53.87 25.36 6.97 52.29 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 27.87 10.66 47.95 27.82 8.60 48.27 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 26.02 1.87 43.38 25.90 1.97 45.49 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP D 48 ASP.? 19.00 ZN ZN J2001 B 354 GLU D 50 GLU.? 17.54 ZN ZN J2001 B 421 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo 25.90 8.19 53.87 25.36 6.97 52.29 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 27.87 10.66 47.95 27.82 8.60 48.27 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 26.02 1.87 43.38 25.90 1.97 45.49 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP F 48 ASP.? 18.92 ZN ZN E2002 B 354 GLU F 50 GLU.? 17.33 ZN ZN E2002 B 421 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo 25.90 8.19 53.87 25.36 6.97 52.29 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 27.87 10.66 47.95 27.82 8.60 48.27 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 26.02 1.87 43.38 25.90 1.97 45.49 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP I 48 ASP~? 38.35 ZN ZN J2001 B 354 GLU I 50 GLU~? 38.38 ZN ZN B2003 B 421 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 25.90 8.19 53.87 25.36 6.97 52.29 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 27.87 10.66 47.95 27.82 8.60 48.27 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 26.02 1.87 43.38 25.90 1.97 45.49 17.18 -52.79 -3.01 18.10 -54.51 -2.17 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 5 hits 1bvz_c09 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 14 ARG~? 19.76 ZN ZN E2002 127 ARG A 11 ARG.? 22.81 ZN ZN E2002 270 GLU E 64 GLU.? 24.43 ZN ZN E2002 coo -0.83 25.63 1.57 0.97 28.05 0.90 9.80 2.36 -9.66 10.15 5.25 -8.72 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 8.14 -2.39 -10.44 6.98 -0.33 -8.47 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 4.37 -6.45 -19.88 3.54 -7.63 -18.34 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 68 ARG^? 28.72 ZN ZN B2003 127 ARG B 9 ARG^? 25.60 ZN ZN B2003 270 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.25 -11.70 3.79 14.09 -14.14 4.30 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 68 ARG^? 28.72 ZN ZN B2003 127 ARG B 9 ARG^? 25.60 ZN ZN B2003 270 GLU G 70 GLU^? 21.12 ZN ZN G2004 coo -0.83 25.63 1.57 0.97 28.05 0.90 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.25 -11.70 3.79 14.09 -14.14 4.30 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 24.92 -14.52 9.07 24.76 -14.12 6.99 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG B 68 ARG^? 23.11 ZN ZN B2003 127 ARG C 9 ARG^? 24.24 ZN ZN B2003 270 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG B 68 ARG^? 23.11 ZN ZN B2003 127 ARG C 9 ARG^? 24.24 ZN ZN B2003 270 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG C 9 ARG^? 24.24 ZN ZN B2003 127 ARG B 68 ARG^? 23.11 ZN ZN B2003 270 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 9.32 -17.65 5.25 11.20 -19.96 4.50 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 7 3 # 7 71 ARG C 14 ARG~? 19.88 ZN ZN B2003 127 ARG C 11 ARG~? 22.62 ZN ZN B2003 270 GLU B 64 GLU.? 24.26 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 -5.73 -18.63 6.20 -7.86 -20.84 6.40 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.77 -5.06 7.96 0.08 -4.98 5.99 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 8 3 # 8 71 ARG C 68 ARG^? 29.54 ZN ZN B2003 127 ARG D 9 ARG^? 32.06 ZN ZN J2001 270 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo -0.83 25.63 1.57 0.97 28.05 0.90 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 15.16 -26.68 -14.16 16.30 -26.65 -12.35 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 9 3 # 9 71 ARG C 68 ARG^? 29.54 ZN ZN B2003 127 ARG D 9 ARG^? 32.06 ZN ZN J2001 270 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo -0.83 25.63 1.57 0.97 28.05 0.90 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 10 3 # 10 71 ARG D 9 ARG^? 32.06 ZN ZN J2001 127 ARG C 68 ARG^? 29.54 ZN ZN B2003 270 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo -0.83 25.63 1.57 0.97 28.05 0.90 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 11 3 # 11 71 ARG D 68 ARG^? 31.20 ZN ZN E2002 127 ARG D 9 ARG^? 32.06 ZN ZN J2001 270 GLU C 67 GLU.? 23.10 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 10.24 -20.71 -11.26 11.91 -20.64 -8.66 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 1.93 -19.21 0.76 2.90 -17.72 1.93 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 12 3 # 12 71 ARG D 68 ARG^? 31.20 ZN ZN E2002 127 ARG E 9 ARG^? 26.78 ZN ZN E2002 270 GLU E 70 GLU^? 21.70 ZN ZN E2002 coo -0.83 25.63 1.57 0.97 28.05 0.90 10.24 -20.71 -11.26 11.91 -20.64 -8.66 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 22.93 -13.24 -13.07 23.13 -14.10 -11.19 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 13 3 # 13 71 ARG D 68 ARG^? 31.20 ZN ZN E2002 127 ARG E 9 ARG^? 26.78 ZN ZN E2002 270 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo -0.83 25.63 1.57 0.97 28.05 0.90 10.24 -20.71 -11.26 11.91 -20.64 -8.66 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 14 3 # 14 71 ARG E 14 ARG~? 23.50 ZN ZN E2002 127 ARG E 11 ARG.? 26.51 ZN ZN E2002 270 GLU D 64 GLU.? 37.94 ZN ZN E2002 coo -0.83 25.63 1.57 0.97 28.05 0.90 4.33 -11.23 -21.43 5.19 -9.07 -23.42 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 15 3 # 15 71 ARG E 68 ARG^? 24.88 ZN ZN E2002 127 ARG A 9 ARG^? 24.21 ZN ZN E2002 270 GLU A 70 GLU^? 23.78 ZN ZN G2004 coo -0.83 25.63 1.57 0.97 28.05 0.90 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.92 -8.51 2.63 23.34 -9.97 2.05 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 16 3 # 16 71 ARG F 14 ARG~? 19.67 ZN ZN G2004 127 ARG F 11 ARG.? 21.89 ZN ZN G2004 270 GLU G 64 GLU.? 24.28 ZN ZN G2004 coo -0.83 25.63 1.57 0.97 28.05 0.90 45.17 -17.96 5.85 47.53 -16.30 4.80 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 41.25 -22.37 6.05 44.11 -21.50 5.36 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 39.99 -27.18 15.98 39.71 -28.44 14.30 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 17 3 # 17 71 ARG F 68 ARG^? 28.83 ZN ZN J2001 127 ARG J 9 ARG^? 25.67 ZN ZN J2001 270 GLU E 70 GLU^? 21.70 ZN ZN E2002 coo -0.83 25.63 1.57 0.97 28.05 0.90 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 22.93 -13.24 -13.07 23.13 -14.10 -11.19 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 18 3 # 18 71 ARG F 68 ARG^? 28.83 ZN ZN J2001 127 ARG J 9 ARG^? 25.67 ZN ZN J2001 270 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo -0.83 25.63 1.57 0.97 28.05 0.90 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 19 3 # 19 71 ARG G 68 ARG^? 22.94 ZN ZN G2004 127 ARG F 9 ARG^? 24.10 ZN ZN G2004 270 GLU F 70 GLU^? 24.01 ZN ZN E2002 coo -0.83 25.63 1.57 0.97 28.05 0.90 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 32.42 -18.19 2.00 30.08 -17.10 0.27 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 29.66 -12.84 -6.57 27.71 -12.58 -5.78 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 20 3 # 20 71 ARG H 9 ARG^? 32.17 ZN ZN B2003 127 ARG I 68 ARG^? 29.76 ZN ZN J2001 270 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 21 3 # 21 71 ARG H 14 ARG~? 40.46 ZN ZN J2001 127 ARG H 11 ARG.? 35.53 ZN ZN J2001 270 GLU I 64 GLU.? 25.65 ZN ZN J2001 coo -0.83 25.63 1.57 0.97 28.05 0.90 29.55 -44.56 8.18 29.86 -45.04 11.21 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 31.27 -41.17 3.82 32.37 -41.49 6.67 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 34.90 -43.61 -5.62 35.57 -42.49 -3.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 22 3 # 22 71 ARG H 68 ARG^? 29.79 ZN ZN G2004 127 ARG G 9 ARG^? 25.73 ZN ZN G2004 270 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 26.96 -25.00 8.90 25.51 -22.83 7.22 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 23 3 # 23 71 ARG H 68 ARG^? 29.79 ZN ZN G2004 127 ARG G 9 ARG^? 25.73 ZN ZN G2004 270 GLU G 70 GLU^? 21.12 ZN ZN G2004 coo -0.83 25.63 1.57 0.97 28.05 0.90 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 26.96 -25.00 8.90 25.51 -22.83 7.22 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 24.92 -14.52 9.07 24.76 -14.12 6.99 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 24 3 # 24 71 ARG I 9 ARG^? 24.03 ZN ZN J2001 127 ARG J 68 ARG^? 19.63 ZN ZN J2001 270 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo -0.83 25.63 1.57 0.97 28.05 0.90 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 15.16 -26.68 -14.16 16.30 -26.65 -12.35 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 25 3 # 25 71 ARG I 14 ARG~? 20.11 ZN ZN J2001 127 ARG I 11 ARG.? 22.73 ZN ZN J2001 270 GLU J 64 GLU.? 23.99 ZN ZN J2001 coo -0.83 25.63 1.57 0.97 28.05 0.90 34.67 -42.08 -10.26 33.76 -45.02 -10.11 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 35.67 -37.65 -8.31 35.98 -40.29 -6.76 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 44.01 -30.69 -11.59 43.10 -30.84 -9.69 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 26 3 # 26 71 ARG I 68 ARG^? 29.76 ZN ZN J2001 127 ARG H 9 ARG^? 32.17 ZN ZN B2003 270 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 23.61 -33.80 3.29 21.83 -31.31 3.74 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 27 3 # 27 71 ARG I 68 ARG^? 29.76 ZN ZN J2001 127 ARG H 9 ARG^? 32.17 ZN ZN B2003 270 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 23.61 -33.80 3.29 21.83 -31.31 3.74 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 28 3 # 28 71 ARG J 68 ARG^? 19.63 ZN ZN J2001 127 ARG I 9 ARG^? 24.03 ZN ZN J2001 270 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo -0.83 25.63 1.57 0.97 28.05 0.90 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 15.16 -26.68 -14.16 16.30 -26.65 -12.35 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 28 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 48 ASP~? 19.05 ZN ZN G2004 264 GLU A 70 GLU^? 23.78 ZN ZN G2004 328 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 26.93 6.24 15.37 25.45 7.75 15.31 coo 59.69 92.71 39.85 58.53 92.03 41.47 21.92 -8.51 2.63 23.34 -9.97 2.05 coo 45.39 90.72 40.63 45.07 89.14 41.90 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 48 ASP~? 19.05 ZN ZN G2004 264 GLU B 20 GLU~? 25.90 ZN ZN B2003 328 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 26.93 6.24 15.37 25.45 7.75 15.31 coo 59.69 92.71 39.85 58.53 92.03 41.47 7.89 1.30 17.42 7.18 2.96 16.29 coo 45.39 90.72 40.63 45.07 89.14 41.90 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 53 ASP~? 26.24 ZN ZN G2004 264 GLU A 67 GLU^? 23.17 ZN ZN E2002 328 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 17.64 3.84 11.72 15.55 3.44 11.90 coo 59.69 92.71 39.85 58.53 92.03 41.47 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 45.39 90.72 40.63 45.07 89.14 41.90 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 53 ASP~? 26.24 ZN ZN G2004 264 GLU B 64 GLU.? 24.26 ZN ZN B2003 328 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 17.64 3.84 11.72 15.55 3.44 11.90 coo 59.69 92.71 39.85 58.53 92.03 41.47 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo 45.39 90.72 40.63 45.07 89.14 41.90 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP A 53 ASP~? 26.24 ZN ZN G2004 264 GLU G 70 GLU^? 21.12 ZN ZN G2004 328 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 17.64 3.84 11.72 15.55 3.44 11.90 coo 59.69 92.71 39.85 58.53 92.03 41.47 24.92 -14.52 9.07 24.76 -14.12 6.99 coo 45.39 90.72 40.63 45.07 89.14 41.90 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 48 ASP~? 8.81 ZN ZN B2003 264 GLU B 70 GLU^? 21.67 ZN ZN B2003 328 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 59.69 92.71 39.85 58.53 92.03 41.47 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 45.39 90.72 40.63 45.07 89.14 41.90 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP B 48 ASP~? 8.81 ZN ZN B2003 264 GLU C 20 GLU~? -13.13 ZN ZN B2003s 328 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 45.62 80.42 43.69 45.65 82.01 45.07 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 59.69 92.71 39.85 58.53 92.03 41.47 -6.90 -26.36 14.56 -8.07 -24.73 15.22 coo 45.39 90.72 40.63 45.07 89.14 41.90 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP B 53 ASP~? 5.10 ZN ZN B2003 264 GLU B 67 GLU^? 26.37 ZN ZN B2003 328 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 59.69 92.71 39.85 58.53 92.03 41.47 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 45.39 90.72 40.63 45.07 89.14 41.90 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP B 53 ASP~? 5.10 ZN ZN B2003 264 GLU C 64 GLU.? 25.72 ZN ZN B2003 328 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 59.69 92.71 39.85 58.53 92.03 41.47 -7.33 -19.22 1.68 -6.59 -18.32 -0.10 coo 45.39 90.72 40.63 45.07 89.14 41.90 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP B 53 ASP~? 5.10 ZN ZN B2003 264 GLU H 70 GLU^? 24.54 ZN ZN B2003 328 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 59.69 92.71 39.85 58.53 92.03 41.47 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 45.39 90.72 40.63 45.07 89.14 41.90 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP C 48 ASP~? 37.52 ZN ZN B2003 264 GLU C 70 GLU^? 28.30 ZN ZN B2003 328 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 59.69 92.71 39.85 58.53 92.03 41.47 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 45.39 90.72 40.63 45.07 89.14 41.90 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP C 48 ASP~? 37.52 ZN ZN B2003 264 GLU D 20 GLU~? 40.68 ZN ZN J2001 328 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 59.69 92.71 39.85 58.53 92.03 41.47 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP C 53 ASP~? 35.43 ZN ZN B2003 264 GLU C 67 GLU.? 23.10 ZN ZN B2003 328 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 59.69 92.71 39.85 58.53 92.03 41.47 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP C 53 ASP~? 35.43 ZN ZN B2003 264 GLU D 64 GLU.? 37.94 ZN ZN E2002 328 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 59.69 92.71 39.85 58.53 92.03 41.47 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP C 53 ASP~? 35.43 ZN ZN B2003 264 GLU I 70 GLU^? 28.28 ZN ZN J2001 328 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 59.69 92.71 39.85 58.53 92.03 41.47 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP D 48 ASP.? 19.00 ZN ZN J2001 264 GLU D 70 GLU^? 24.25 ZN ZN J2001 328 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 59.69 92.71 39.85 58.53 92.03 41.47 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 45.39 90.72 40.63 45.07 89.14 41.90 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 17 3 # 17 229 ASP D 48 ASP.? 19.00 ZN ZN J2001 264 GLU E 20 GLU~? 26.08 ZN ZN E2002 328 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 59.69 92.71 39.85 58.53 92.03 41.47 9.85 -13.14 -31.23 7.79 -13.45 -31.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 18 3 # 18 229 ASP D 53 ASP~? 26.48 ZN ZN J2001 264 GLU D 67 GLU^? 32.75 ZN ZN B2003 328 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 59.69 92.71 39.85 58.53 92.03 41.47 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 45.39 90.72 40.63 45.07 89.14 41.90 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 19 3 # 19 229 ASP D 53 ASP~? 26.48 ZN ZN J2001 264 GLU E 64 GLU.? 24.43 ZN ZN E2002 328 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 59.69 92.71 39.85 58.53 92.03 41.47 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo 45.39 90.72 40.63 45.07 89.14 41.90 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 20 3 # 20 229 ASP D 53 ASP~? 26.48 ZN ZN J2001 264 GLU J 70 GLU^? 22.09 ZN ZN J2001 328 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 59.69 92.71 39.85 58.53 92.03 41.47 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 45.39 90.72 40.63 45.07 89.14 41.90 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 21 3 # 21 229 ASP E 48 ASP~? 8.41 ZN ZN E2002 264 GLU A 20 GLU~? -13.24 ZN ZN E2002s 328 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 45.62 80.42 43.69 45.65 82.01 45.07 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 59.69 92.71 39.85 58.53 92.03 41.47 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 22 3 # 22 229 ASP E 53 ASP~? 5.07 ZN ZN E2002 264 GLU A 30 GLU^? 19.82 ZN ZN E2002 328 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 45.39 90.72 40.63 45.07 89.14 41.90 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 23 3 # 23 229 ASP E 53 ASP~? 5.07 ZN ZN E2002 264 GLU A 64 GLU.? 24.42 ZN ZN E2002 328 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 7.18 3.59 -5.93 6.39 1.65 -6.13 coo 45.39 90.72 40.63 45.07 89.14 41.90 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 24 3 # 24 229 ASP E 53 ASP~? 5.07 ZN ZN E2002 264 GLU F 70 GLU^? 24.01 ZN ZN E2002 328 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 29.66 -12.84 -6.57 27.71 -12.58 -5.78 coo 45.39 90.72 40.63 45.07 89.14 41.90 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 25 3 # 25 229 ASP F 48 ASP.? 18.92 ZN ZN E2002 264 GLU F 70 GLU^? 24.01 ZN ZN E2002 328 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 59.69 92.71 39.85 58.53 92.03 41.47 29.66 -12.84 -6.57 27.71 -12.58 -5.78 coo 45.39 90.72 40.63 45.07 89.14 41.90 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 26 3 # 26 229 ASP F 48 ASP.? 18.92 ZN ZN E2002 264 GLU J 20 GLU~? 25.99 ZN ZN J2001 328 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 59.69 92.71 39.85 58.53 92.03 41.47 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 45.39 90.72 40.63 45.07 89.14 41.90 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 27 3 # 27 229 ASP F 53 ASP~? 26.13 ZN ZN E2002 264 GLU E 51 GLU~? 6.76 ZN ZN E2002 328 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 59.69 92.71 39.85 58.53 92.03 41.47 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 28 3 # 28 229 ASP F 53 ASP~? 26.13 ZN ZN E2002 264 GLU E 70 GLU^? 21.70 ZN ZN E2002 328 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 59.69 92.71 39.85 58.53 92.03 41.47 22.93 -13.24 -13.07 23.13 -14.10 -11.19 coo 45.39 90.72 40.63 45.07 89.14 41.90 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 29 3 # 29 229 ASP F 53 ASP~? 26.13 ZN ZN E2002 264 GLU F 67 GLU^? 23.19 ZN ZN G2004 328 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 59.69 92.71 39.85 58.53 92.03 41.47 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 45.39 90.72 40.63 45.07 89.14 41.90 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 30 3 # 30 229 ASP F 53 ASP~? 26.13 ZN ZN E2002 264 GLU J 64 GLU.? 23.99 ZN ZN J2001 328 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 59.69 92.71 39.85 58.53 92.03 41.47 44.01 -30.69 -11.59 43.10 -30.84 -9.69 coo 45.39 90.72 40.63 45.07 89.14 41.90 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 31 3 # 31 229 ASP G 48 ASP~? 8.81 ZN ZN G2004 264 GLU F 20 GLU~? -13.12 ZN ZN G2004s 328 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo 45.62 80.42 43.69 45.65 82.01 45.07 33.55 0.62 19.07 33.72 1.88 17.35 coo 59.69 92.71 39.85 58.53 92.03 41.47 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 45.39 90.72 40.63 45.07 89.14 41.90 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 32 3 # 32 229 ASP G 53 ASP~? 4.94 ZN ZN G2004 264 GLU A 70 GLU^? 23.78 ZN ZN G2004 328 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 59.69 92.71 39.85 58.53 92.03 41.47 21.92 -8.51 2.63 23.34 -9.97 2.05 coo 45.39 90.72 40.63 45.07 89.14 41.90 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 33 3 # 33 229 ASP G 53 ASP~? 4.94 ZN ZN G2004 264 GLU F 30 GLU^? 19.95 ZN ZN G2004 328 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 59.69 92.71 39.85 58.53 92.03 41.47 38.23 2.77 0.52 36.38 3.82 0.63 coo 45.39 90.72 40.63 45.07 89.14 41.90 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 34 3 # 34 229 ASP G 53 ASP~? 4.94 ZN ZN G2004 264 GLU F 64 GLU.? 24.41 ZN ZN G2004 328 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 59.69 92.71 39.85 58.53 92.03 41.47 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 45.39 90.72 40.63 45.07 89.14 41.90 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 35 3 # 35 229 ASP H 48 ASP.? 18.83 ZN ZN B2003 264 GLU G 20 GLU~? 25.94 ZN ZN G2004 328 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 59.69 92.71 39.85 58.53 92.03 41.47 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 45.39 90.72 40.63 45.07 89.14 41.90 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 36 3 # 36 229 ASP H 48 ASP.? 18.83 ZN ZN B2003 264 GLU H 70 GLU^? 24.54 ZN ZN B2003 328 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 59.69 92.71 39.85 58.53 92.03 41.47 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 45.39 90.72 40.63 45.07 89.14 41.90 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 37 3 # 37 229 ASP H 53 ASP~? 26.49 ZN ZN B2003 264 GLU B 51 GLU~? 6.60 ZN ZN B2003 328 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 59.69 92.71 39.85 58.53 92.03 41.47 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 45.39 90.72 40.63 45.07 89.14 41.90 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 38 3 # 38 229 ASP H 53 ASP~? 26.49 ZN ZN B2003 264 GLU B 70 GLU^? 21.67 ZN ZN B2003 328 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 59.69 92.71 39.85 58.53 92.03 41.47 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 45.39 90.72 40.63 45.07 89.14 41.90 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 39 3 # 39 229 ASP H 53 ASP~? 26.49 ZN ZN B2003 264 GLU G 64 GLU.? 24.28 ZN ZN G2004 328 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 59.69 92.71 39.85 58.53 92.03 41.47 39.99 -27.18 15.98 39.71 -28.44 14.30 coo 45.39 90.72 40.63 45.07 89.14 41.90 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 40 3 # 40 229 ASP H 53 ASP~? 26.49 ZN ZN B2003 264 GLU H 67 GLU^? 32.59 ZN ZN J2001 328 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 59.69 92.71 39.85 58.53 92.03 41.47 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 45.39 90.72 40.63 45.07 89.14 41.90 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 41 3 # 41 229 ASP I 48 ASP~? 38.35 ZN ZN J2001 264 GLU H 20 GLU~? 40.75 ZN ZN B2003 328 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 59.69 92.71 39.85 58.53 92.03 41.47 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 45.39 90.72 40.63 45.07 89.14 41.90 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 42 3 # 42 229 ASP I 48 ASP~? 38.35 ZN ZN J2001 264 GLU I 70 GLU^? 28.28 ZN ZN J2001 328 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 59.69 92.71 39.85 58.53 92.03 41.47 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 45.39 90.72 40.63 45.07 89.14 41.90 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 43 3 # 43 229 ASP I 53 ASP~? 35.51 ZN ZN J2001 264 GLU C 70 GLU^? 28.30 ZN ZN B2003 328 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 59.69 92.71 39.85 58.53 92.03 41.47 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 45.39 90.72 40.63 45.07 89.14 41.90 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 44 3 # 44 229 ASP I 53 ASP~? 35.51 ZN ZN J2001 264 GLU H 64 GLU.? 37.89 ZN ZN G2004 328 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 59.69 92.71 39.85 58.53 92.03 41.47 32.53 -42.71 11.25 33.49 -41.02 10.38 coo 45.39 90.72 40.63 45.07 89.14 41.90 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 45 3 # 45 229 ASP I 53 ASP~? 35.51 ZN ZN J2001 264 GLU I 67 GLU^? 22.99 ZN ZN J2001 328 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 59.69 92.71 39.85 58.53 92.03 41.47 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 45.39 90.72 40.63 45.07 89.14 41.90 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 46 3 # 46 229 ASP J 48 ASP~? 8.01 ZN ZN J2001 264 GLU I 20 GLU~? -12.94 ZN ZN J2001s 328 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 45.62 80.42 43.69 45.65 82.01 45.07 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 45.39 90.72 40.63 45.07 89.14 41.90 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 47 3 # 47 229 ASP J 48 ASP~? 8.01 ZN ZN J2001 264 GLU J 70 GLU^? 22.09 ZN ZN J2001 328 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 45.39 90.72 40.63 45.07 89.14 41.90 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 48 3 # 48 229 ASP J 53 ASP~? 5.09 ZN ZN J2001 264 GLU D 70 GLU^? 24.25 ZN ZN J2001 328 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.01 -35.27 -13.87 27.04 -33.54 -13.28 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 49 3 # 49 229 ASP J 53 ASP~? 5.09 ZN ZN J2001 264 GLU I 64 GLU.? 25.65 ZN ZN J2001 328 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 34.90 -43.61 -5.62 35.57 -42.49 -3.95 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.01 -35.27 -13.87 27.04 -33.54 -13.28 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 50 3 # 50 229 ASP J 53 ASP~? 5.09 ZN ZN J2001 264 GLU J 67 GLU^? 26.37 ZN ZN J2001 328 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.01 -35.27 -13.87 27.04 -33.54 -13.28 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 50 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 48 ASP~? 19.05 ZN ZN G2004 257 GLU A 50 GLU~? 17.52 ZN ZN G2004 328 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 26.93 6.24 15.37 25.45 7.75 15.31 coo 48.97 85.16 40.39 47.18 86.25 40.47 22.23 3.81 17.00 24.22 3.69 17.74 coo 45.39 90.72 40.63 45.07 89.14 41.90 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 48 ASP~? 19.05 ZN ZN G2004 257 GLU A 51 GLU~? 22.57 ZN ZN G2004 328 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 26.93 6.24 15.37 25.45 7.75 15.31 coo 48.97 85.16 40.39 47.18 86.25 40.47 23.15 8.42 10.27 24.62 9.66 9.42 coo 45.39 90.72 40.63 45.07 89.14 41.90 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 53 ASP~? 26.24 ZN ZN G2004 257 GLU A 50 GLU~? 17.52 ZN ZN G2004 328 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 17.64 3.84 11.72 15.55 3.44 11.90 coo 48.97 85.16 40.39 47.18 86.25 40.47 22.23 3.81 17.00 24.22 3.69 17.74 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 53 ASP~? 26.24 ZN ZN G2004 257 GLU A 51 GLU~? 22.57 ZN ZN G2004 328 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 17.64 3.84 11.72 15.55 3.44 11.90 coo 48.97 85.16 40.39 47.18 86.25 40.47 23.15 8.42 10.27 24.62 9.66 9.42 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 48 ASP~? 8.81 ZN ZN B2003 257 GLU B 50 GLU~? -2.41 ZN ZN B2003s 328 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 48.97 85.16 40.39 47.18 86.25 40.47 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 45.39 90.72 40.63 45.07 89.14 41.90 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 48 ASP~? 8.81 ZN ZN B2003 257 GLU B 50 GLU~? -2.41 ZN ZN B2003s 328 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 45.62 80.42 43.69 45.65 82.01 45.07 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 48.97 85.16 40.39 47.18 86.25 40.47 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 45.39 90.72 40.63 45.07 89.14 41.90 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP B 48 ASP~? 8.81 ZN ZN B2003 257 GLU B 51 GLU~? 6.60 ZN ZN B2003 328 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 48.97 85.16 40.39 47.18 86.25 40.47 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 45.39 90.72 40.63 45.07 89.14 41.90 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP B 48 ASP~? 8.81 ZN ZN B2003 257 GLU B 51 GLU~? 6.60 ZN ZN B2003 328 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 45.62 80.42 43.69 45.65 82.01 45.07 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 48.97 85.16 40.39 47.18 86.25 40.47 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 45.39 90.72 40.63 45.07 89.14 41.90 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP B 53 ASP~? 5.10 ZN ZN B2003 257 GLU B 50 GLU~? -2.41 ZN ZN B2003s 328 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 48.97 85.16 40.39 47.18 86.25 40.47 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 45.39 90.72 40.63 45.07 89.14 41.90 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP B 53 ASP~? 5.10 ZN ZN B2003 257 GLU B 51 GLU~? 6.60 ZN ZN B2003 328 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 48.97 85.16 40.39 47.18 86.25 40.47 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 45.39 90.72 40.63 45.07 89.14 41.90 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP B 54 ASP~? -2.43 ZN ZN B2003s 257 GLU B 50 GLU~? -2.41 ZN ZN B2003s 328 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 48.97 85.16 40.39 47.18 86.25 40.47 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 45.39 90.72 40.63 45.07 89.14 41.90 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP B 54 ASP~? -2.43 ZN ZN B2003s 257 GLU B 51 GLU~? 6.60 ZN ZN B2003 328 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 48.97 85.16 40.39 47.18 86.25 40.47 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 45.39 90.72 40.63 45.07 89.14 41.90 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP C 48 ASP~? 37.52 ZN ZN B2003 257 GLU C 50 GLU~? 38.46 ZN ZN J2001 328 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 48.97 85.16 40.39 47.18 86.25 40.47 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 45.39 90.72 40.63 45.07 89.14 41.90 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP C 48 ASP~? 37.52 ZN ZN B2003 257 GLU C 51 GLU~? 32.75 ZN ZN B2003 328 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 48.97 85.16 40.39 47.18 86.25 40.47 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 45.39 90.72 40.63 45.07 89.14 41.90 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP C 53 ASP~? 35.43 ZN ZN B2003 257 GLU C 50 GLU~? 38.46 ZN ZN J2001 328 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 48.97 85.16 40.39 47.18 86.25 40.47 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP C 53 ASP~? 35.43 ZN ZN B2003 257 GLU C 51 GLU~? 32.75 ZN ZN B2003 328 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 48.97 85.16 40.39 47.18 86.25 40.47 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 17 3 # 17 229 ASP D 48 ASP.? 19.00 ZN ZN J2001 257 GLU D 50 GLU.? 17.54 ZN ZN J2001 328 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 48.97 85.16 40.39 47.18 86.25 40.47 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 18 3 # 18 229 ASP D 48 ASP.? 19.00 ZN ZN J2001 257 GLU D 51 GLU~? 22.34 ZN ZN J2001 328 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 48.97 85.16 40.39 47.18 86.25 40.47 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 45.39 90.72 40.63 45.07 89.14 41.90 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 19 3 # 19 229 ASP D 53 ASP~? 26.48 ZN ZN J2001 257 GLU D 50 GLU.? 17.54 ZN ZN J2001 328 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 48.97 85.16 40.39 47.18 86.25 40.47 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 20 3 # 20 229 ASP D 53 ASP~? 26.48 ZN ZN J2001 257 GLU D 51 GLU~? 22.34 ZN ZN J2001 328 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 48.97 85.16 40.39 47.18 86.25 40.47 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 45.39 90.72 40.63 45.07 89.14 41.90 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 21 3 # 21 229 ASP E 48 ASP~? 8.41 ZN ZN E2002 257 GLU E 50 GLU~? -2.01 ZN ZN E2002s 328 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 22 3 # 22 229 ASP E 48 ASP~? 8.41 ZN ZN E2002 257 GLU E 50 GLU~? -2.01 ZN ZN E2002s 328 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 45.62 80.42 43.69 45.65 82.01 45.07 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 23 3 # 23 229 ASP E 48 ASP~? 8.41 ZN ZN E2002 257 GLU E 51 GLU~? 6.76 ZN ZN E2002 328 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 24 3 # 24 229 ASP E 48 ASP~? 8.41 ZN ZN E2002 257 GLU E 51 GLU~? 6.76 ZN ZN E2002 328 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 45.62 80.42 43.69 45.65 82.01 45.07 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 25 3 # 25 229 ASP E 53 ASP~? 5.07 ZN ZN E2002 257 GLU E 51 GLU~? 6.76 ZN ZN E2002 328 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 48.97 85.16 40.39 47.18 86.25 40.47 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 26 3 # 26 229 ASP E 54 ASP~? -2.11 ZN ZN E2002s 257 GLU E 50 GLU~? -2.01 ZN ZN E2002s 328 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 48.97 85.16 40.39 47.18 86.25 40.47 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 27 3 # 27 229 ASP E 54 ASP~? -2.11 ZN ZN E2002s 257 GLU E 51 GLU~? 6.76 ZN ZN E2002 328 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 48.97 85.16 40.39 47.18 86.25 40.47 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 28 3 # 28 229 ASP F 48 ASP.? 18.92 ZN ZN E2002 257 GLU F 50 GLU.? 17.33 ZN ZN E2002 328 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 45.39 90.72 40.63 45.07 89.14 41.90 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 29 3 # 29 229 ASP F 48 ASP.? 18.92 ZN ZN E2002 257 GLU F 51 GLU~? 22.25 ZN ZN E2002 328 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 30 3 # 30 229 ASP F 53 ASP~? 26.13 ZN ZN E2002 257 GLU F 50 GLU.? 17.33 ZN ZN E2002 328 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 48.97 85.16 40.39 47.18 86.25 40.47 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 45.39 90.72 40.63 45.07 89.14 41.90 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 31 3 # 31 229 ASP F 53 ASP~? 26.13 ZN ZN E2002 257 GLU F 51 GLU~? 22.25 ZN ZN E2002 328 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 45.62 80.42 43.69 45.65 82.01 45.07 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 48.97 85.16 40.39 47.18 86.25 40.47 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 32 3 # 32 229 ASP G 48 ASP~? 8.81 ZN ZN G2004 257 GLU G 50 GLU~? -2.28 ZN ZN G2004s 328 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 33.55 0.62 19.07 33.72 1.88 17.35 coo 48.97 85.16 40.39 47.18 86.25 40.47 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 45.39 90.72 40.63 45.07 89.14 41.90 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 33 3 # 33 229 ASP G 48 ASP~? 8.81 ZN ZN G2004 257 GLU G 50 GLU~? -2.28 ZN ZN G2004s 328 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo 45.62 80.42 43.69 45.65 82.01 45.07 33.55 0.62 19.07 33.72 1.88 17.35 coo 48.97 85.16 40.39 47.18 86.25 40.47 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 45.39 90.72 40.63 45.07 89.14 41.90 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 34 3 # 34 229 ASP G 48 ASP~? 8.81 ZN ZN G2004 257 GLU G 51 GLU~? 6.79 ZN ZN G2004 328 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 33.55 0.62 19.07 33.72 1.88 17.35 coo 48.97 85.16 40.39 47.18 86.25 40.47 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 45.39 90.72 40.63 45.07 89.14 41.90 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 35 3 # 35 229 ASP G 48 ASP~? 8.81 ZN ZN G2004 257 GLU G 51 GLU~? 6.79 ZN ZN G2004 328 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo 45.62 80.42 43.69 45.65 82.01 45.07 33.55 0.62 19.07 33.72 1.88 17.35 coo 48.97 85.16 40.39 47.18 86.25 40.47 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 45.39 90.72 40.63 45.07 89.14 41.90 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 36 3 # 36 229 ASP G 53 ASP~? 4.94 ZN ZN G2004 257 GLU G 50 GLU~? -2.28 ZN ZN G2004s 328 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 48.97 85.16 40.39 47.18 86.25 40.47 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 45.39 90.72 40.63 45.07 89.14 41.90 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 37 3 # 37 229 ASP G 53 ASP~? 4.94 ZN ZN G2004 257 GLU G 51 GLU~? 6.79 ZN ZN G2004 328 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 48.97 85.16 40.39 47.18 86.25 40.47 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 45.39 90.72 40.63 45.07 89.14 41.90 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 38 3 # 38 229 ASP G 54 ASP~? -2.04 ZN ZN G2004s 257 GLU G 50 GLU~? -2.28 ZN ZN G2004s 328 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 48.97 85.16 40.39 47.18 86.25 40.47 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 45.39 90.72 40.63 45.07 89.14 41.90 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 39 3 # 39 229 ASP G 54 ASP~? -2.04 ZN ZN G2004s 257 GLU G 51 GLU~? 6.79 ZN ZN G2004 328 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 45.62 80.42 43.69 45.65 82.01 45.07 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 48.97 85.16 40.39 47.18 86.25 40.47 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 45.39 90.72 40.63 45.07 89.14 41.90 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 40 3 # 40 229 ASP H 48 ASP.? 18.83 ZN ZN B2003 257 GLU H 50 GLU.? 17.57 ZN ZN B2003 328 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 48.97 85.16 40.39 47.18 86.25 40.47 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 45.39 90.72 40.63 45.07 89.14 41.90 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 41 3 # 41 229 ASP H 48 ASP.? 18.83 ZN ZN B2003 257 GLU H 51 GLU~? 22.00 ZN ZN B2003 328 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 48.97 85.16 40.39 47.18 86.25 40.47 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 45.39 90.72 40.63 45.07 89.14 41.90 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 42 3 # 42 229 ASP H 53 ASP~? 26.49 ZN ZN B2003 257 GLU H 50 GLU.? 17.57 ZN ZN B2003 328 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 48.97 85.16 40.39 47.18 86.25 40.47 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 45.39 90.72 40.63 45.07 89.14 41.90 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 43 3 # 43 229 ASP H 53 ASP~? 26.49 ZN ZN B2003 257 GLU H 51 GLU~? 22.00 ZN ZN B2003 328 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 48.97 85.16 40.39 47.18 86.25 40.47 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 45.39 90.72 40.63 45.07 89.14 41.90 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 44 3 # 44 229 ASP I 48 ASP~? 38.35 ZN ZN J2001 257 GLU I 50 GLU~? 38.38 ZN ZN B2003 328 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 48.97 85.16 40.39 47.18 86.25 40.47 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 45.39 90.72 40.63 45.07 89.14 41.90 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 45 3 # 45 229 ASP I 48 ASP~? 38.35 ZN ZN J2001 257 GLU I 51 GLU~? 32.52 ZN ZN J2001 328 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 48.97 85.16 40.39 47.18 86.25 40.47 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 46 3 # 46 229 ASP I 48 ASP~? 38.35 ZN ZN J2001 257 GLU I 51 GLU~? 32.52 ZN ZN J2001 328 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 48.97 85.16 40.39 47.18 86.25 40.47 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 47 3 # 47 229 ASP I 53 ASP~? 35.51 ZN ZN J2001 257 GLU I 50 GLU~? 38.38 ZN ZN B2003 328 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 48.97 85.16 40.39 47.18 86.25 40.47 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 45.39 90.72 40.63 45.07 89.14 41.90 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 48 3 # 48 229 ASP I 53 ASP~? 35.51 ZN ZN J2001 257 GLU I 51 GLU~? 32.52 ZN ZN J2001 328 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 48.97 85.16 40.39 47.18 86.25 40.47 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 49 3 # 49 229 ASP I 54 ASP~? 33.46 ZN ZN J2001 257 GLU I 51 GLU~? 32.52 ZN ZN J2001 328 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 48.97 85.16 40.39 47.18 86.25 40.47 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 50 3 # 50 229 ASP J 48 ASP~? 8.01 ZN ZN J2001 257 GLU J 50 GLU~? -2.50 ZN ZN J2001s 328 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 48.97 85.16 40.39 47.18 86.25 40.47 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 45.39 90.72 40.63 45.07 89.14 41.90 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 51 3 # 51 229 ASP J 48 ASP~? 8.01 ZN ZN J2001 257 GLU J 50 GLU~? -2.50 ZN ZN J2001s 328 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 45.62 80.42 43.69 45.65 82.01 45.07 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 48.97 85.16 40.39 47.18 86.25 40.47 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 45.39 90.72 40.63 45.07 89.14 41.90 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 52 3 # 52 229 ASP J 48 ASP~? 8.01 ZN ZN J2001 257 GLU J 51 GLU~? 6.72 ZN ZN J2001 328 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 48.97 85.16 40.39 47.18 86.25 40.47 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 45.39 90.72 40.63 45.07 89.14 41.90 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 53 3 # 53 229 ASP J 48 ASP~? 8.01 ZN ZN J2001 257 GLU J 51 GLU~? 6.72 ZN ZN J2001 328 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 45.62 80.42 43.69 45.65 82.01 45.07 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 48.97 85.16 40.39 47.18 86.25 40.47 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 45.39 90.72 40.63 45.07 89.14 41.90 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 54 3 # 54 229 ASP J 53 ASP~? 5.09 ZN ZN J2001 257 GLU J 50 GLU~? -2.50 ZN ZN J2001s 328 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 48.97 85.16 40.39 47.18 86.25 40.47 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 45.39 90.72 40.63 45.07 89.14 41.90 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 55 3 # 55 229 ASP J 53 ASP~? 5.09 ZN ZN J2001 257 GLU J 51 GLU~? 6.72 ZN ZN J2001 328 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 48.97 85.16 40.39 47.18 86.25 40.47 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 45.39 90.72 40.63 45.07 89.14 41.90 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 56 3 # 56 229 ASP J 54 ASP~? -2.24 ZN ZN J2001s 257 GLU J 50 GLU~? -2.50 ZN ZN J2001s 328 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 45.39 90.72 40.63 45.07 89.14 41.90 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 57 3 # 57 229 ASP J 54 ASP~? -2.24 ZN ZN J2001s 257 GLU J 51 GLU~? 6.72 ZN ZN J2001 328 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 45.62 80.42 43.69 45.65 82.01 45.07 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 45.39 90.72 40.63 45.07 89.14 41.90 24.29 -34.17 -32.69 23.20 -35.63 -31.63 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 57 hits 1cdg_c04 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 19 GLY~? 15.01 ZN ZN E2002 A 228 SER A 33 SER^? 10.82 ZN ZN E2002 A 549 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 24.11 0.27 -11.15 22.21 1.00 -12.37 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY B 19 GLY~? 21.58 ZN ZN B2003 A 228 SER B 33 SER^? 25.06 ZN ZN G2004 A 549 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 16.53 -3.90 13.46 15.60 -2.57 11.76 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY C 19 GLY~? 15.35 ZN ZN B2003 A 228 SER C 33 SER^? 10.88 ZN ZN B2003 A 549 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 3.43 -26.43 14.79 2.44 -24.23 14.78 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY D 19 GLY~? 34.83 ZN ZN J2001 A 228 SER D 33 SER^? 35.89 ZN ZN J2001 A 549 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 2.59 -36.27 -9.47 0.68 -35.09 -8.48 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY D 19 GLY~? 34.83 ZN ZN J2001 A 228 SER D 33 SER^? 35.89 ZN ZN J2001 A 549 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 2.59 -36.27 -9.47 0.68 -35.09 -8.48 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY E 19 GLY~? 21.67 ZN ZN E2002 A 228 SER E 33 SER^? 25.01 ZN ZN J2001 A 549 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 15.44 -19.85 -25.13 13.12 -20.20 -24.71 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 A 198 GLY F 19 GLY~? 15.06 ZN ZN G2004 A 228 SER F 33 SER^? 10.76 ZN ZN G2004 A 549 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 36.12 -6.61 7.18 37.60 -7.96 8.48 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 A 198 GLY G 19 GLY~? 21.50 ZN ZN G2004 A 228 SER G 33 SER^? 25.21 ZN ZN B2003 A 549 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 23.02 -24.31 21.04 24.40 -26.04 22.01 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 A 198 GLY H 19 GLY~? 34.96 ZN ZN B2003 A 228 SER H 33 SER^? 35.60 ZN ZN B2003 A 549 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 15.17 -43.47 5.63 17.27 -44.35 4.77 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 10 3 # 10 A 198 GLY H 19 GLY~? 34.96 ZN ZN B2003 A 228 SER H 33 SER^? 35.60 ZN ZN B2003 A 549 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 15.17 -43.47 5.63 17.27 -44.35 4.77 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 11 3 # 11 A 198 GLY I 19 GLY~? 15.19 ZN ZN J2001 A 228 SER I 33 SER^? 10.94 ZN ZN J2001 A 549 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 23.35 -37.96 -18.73 25.76 -37.61 -18.66 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 26.01 -35.27 -13.87 27.04 -33.54 -13.28 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 12 3 # 12 A 198 GLY J 19 GLY~? 21.52 ZN ZN J2001 A 228 SER J 33 SER^? 25.08 ZN ZN E2002 A 549 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 36.27 -15.21 -17.30 38.62 -15.44 -16.82 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 35.13 -18.57 -12.25 34.79 -18.46 -10.18 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 12 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 19 GLY~? 15.01 ZN ZN E2002 B1228 SER A 33 SER^? 10.82 ZN ZN E2002 B1549 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 126.34 72.75 125.66 125.95 73.27 126.11 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 131.65 74.68 129.41 130.31 72.73 128.82 24.11 0.27 -11.15 22.21 1.00 -12.37 coo 134.72 69.43 130.42 133.03 70.65 130.08 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 19 GLY~? 15.01 ZN ZN E2002 B1228 SER A 33 SER^? 10.82 ZN ZN E2002 B1549 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 126.34 72.75 125.66 125.95 73.27 126.11 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 131.65 74.68 129.41 130.31 72.73 128.82 24.11 0.27 -11.15 22.21 1.00 -12.37 coo 134.72 69.43 130.42 133.03 70.65 130.08 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 19 GLY~? 21.58 ZN ZN B2003 B1228 SER B 33 SER^? 25.06 ZN ZN G2004 B1549 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 126.34 72.75 125.66 125.95 73.27 126.11 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 131.65 74.68 129.41 130.31 72.73 128.82 16.53 -3.90 13.46 15.60 -2.57 11.76 coo 134.72 69.43 130.42 133.03 70.65 130.08 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 19 GLY~? 21.58 ZN ZN B2003 B1228 SER B 33 SER^? 25.06 ZN ZN G2004 B1549 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 126.34 72.75 125.66 125.95 73.27 126.11 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 131.65 74.68 129.41 130.31 72.73 128.82 16.53 -3.90 13.46 15.60 -2.57 11.76 coo 134.72 69.43 130.42 133.03 70.65 130.08 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY C 19 GLY~? 15.35 ZN ZN B2003 B1228 SER C 33 SER^? 10.88 ZN ZN B2003 B1549 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 126.34 72.75 125.66 125.95 73.27 126.11 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 131.65 74.68 129.41 130.31 72.73 128.82 3.43 -26.43 14.79 2.44 -24.23 14.78 coo 134.72 69.43 130.42 133.03 70.65 130.08 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY C 19 GLY~? 15.35 ZN ZN B2003 B1228 SER C 33 SER^? 10.88 ZN ZN B2003 B1549 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 126.34 72.75 125.66 125.95 73.27 126.11 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 131.65 74.68 129.41 130.31 72.73 128.82 3.43 -26.43 14.79 2.44 -24.23 14.78 coo 134.72 69.43 130.42 133.03 70.65 130.08 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 B1198 GLY D 19 GLY~? 34.83 ZN ZN J2001 B1228 SER D 33 SER^? 35.89 ZN ZN J2001 B1549 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 126.34 72.75 125.66 125.95 73.27 126.11 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 131.65 74.68 129.41 130.31 72.73 128.82 2.59 -36.27 -9.47 0.68 -35.09 -8.48 coo 134.72 69.43 130.42 133.03 70.65 130.08 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 B1198 GLY D 19 GLY~? 34.83 ZN ZN J2001 B1228 SER D 33 SER^? 35.89 ZN ZN J2001 B1549 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 126.34 72.75 125.66 125.95 73.27 126.11 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 131.65 74.68 129.41 130.31 72.73 128.82 2.59 -36.27 -9.47 0.68 -35.09 -8.48 coo 134.72 69.43 130.42 133.03 70.65 130.08 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 B1198 GLY E 19 GLY~? 21.67 ZN ZN E2002 B1228 SER E 33 SER^? 25.01 ZN ZN J2001 B1549 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 126.34 72.75 125.66 125.95 73.27 126.11 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 131.65 74.68 129.41 130.31 72.73 128.82 15.44 -19.85 -25.13 13.12 -20.20 -24.71 coo 134.72 69.43 130.42 133.03 70.65 130.08 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 10 3 # 10 B1198 GLY E 19 GLY~? 21.67 ZN ZN E2002 B1228 SER E 33 SER^? 25.01 ZN ZN J2001 B1549 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 126.34 72.75 125.66 125.95 73.27 126.11 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 131.65 74.68 129.41 130.31 72.73 128.82 15.44 -19.85 -25.13 13.12 -20.20 -24.71 coo 134.72 69.43 130.42 133.03 70.65 130.08 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 11 3 # 11 B1198 GLY F 19 GLY~? 15.06 ZN ZN G2004 B1228 SER F 33 SER^? 10.76 ZN ZN G2004 B1549 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 126.34 72.75 125.66 125.95 73.27 126.11 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 131.65 74.68 129.41 130.31 72.73 128.82 36.12 -6.61 7.18 37.60 -7.96 8.48 coo 134.72 69.43 130.42 133.03 70.65 130.08 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 12 3 # 12 B1198 GLY F 19 GLY~? 15.06 ZN ZN G2004 B1228 SER F 33 SER^? 10.76 ZN ZN G2004 B1549 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 126.34 72.75 125.66 125.95 73.27 126.11 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 131.65 74.68 129.41 130.31 72.73 128.82 36.12 -6.61 7.18 37.60 -7.96 8.48 coo 134.72 69.43 130.42 133.03 70.65 130.08 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 13 3 # 13 B1198 GLY G 19 GLY~? 21.50 ZN ZN G2004 B1228 SER G 33 SER^? 25.21 ZN ZN B2003 B1549 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 126.34 72.75 125.66 125.95 73.27 126.11 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 131.65 74.68 129.41 130.31 72.73 128.82 23.02 -24.31 21.04 24.40 -26.04 22.01 coo 134.72 69.43 130.42 133.03 70.65 130.08 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 14 3 # 14 B1198 GLY G 19 GLY~? 21.50 ZN ZN G2004 B1228 SER G 33 SER^? 25.21 ZN ZN B2003 B1549 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 126.34 72.75 125.66 125.95 73.27 126.11 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 131.65 74.68 129.41 130.31 72.73 128.82 23.02 -24.31 21.04 24.40 -26.04 22.01 coo 134.72 69.43 130.42 133.03 70.65 130.08 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 15 3 # 15 B1198 GLY H 19 GLY~? 34.96 ZN ZN B2003 B1228 SER H 33 SER^? 35.60 ZN ZN B2003 B1549 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 126.34 72.75 125.66 125.95 73.27 126.11 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 131.65 74.68 129.41 130.31 72.73 128.82 15.17 -43.47 5.63 17.27 -44.35 4.77 coo 134.72 69.43 130.42 133.03 70.65 130.08 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 16 3 # 16 B1198 GLY H 19 GLY~? 34.96 ZN ZN B2003 B1228 SER H 33 SER^? 35.60 ZN ZN B2003 B1549 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 126.34 72.75 125.66 125.95 73.27 126.11 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 131.65 74.68 129.41 130.31 72.73 128.82 15.17 -43.47 5.63 17.27 -44.35 4.77 coo 134.72 69.43 130.42 133.03 70.65 130.08 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 17 3 # 17 B1198 GLY I 19 GLY~? 15.19 ZN ZN J2001 B1228 SER I 33 SER^? 10.94 ZN ZN J2001 B1549 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 126.34 72.75 125.66 125.95 73.27 126.11 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 131.65 74.68 129.41 130.31 72.73 128.82 23.35 -37.96 -18.73 25.76 -37.61 -18.66 coo 134.72 69.43 130.42 133.03 70.65 130.08 26.01 -35.27 -13.87 27.04 -33.54 -13.28 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 18 3 # 18 B1198 GLY I 19 GLY~? 15.19 ZN ZN J2001 B1228 SER I 33 SER^? 10.94 ZN ZN J2001 B1549 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 126.34 72.75 125.66 125.95 73.27 126.11 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 131.65 74.68 129.41 130.31 72.73 128.82 23.35 -37.96 -18.73 25.76 -37.61 -18.66 coo 134.72 69.43 130.42 133.03 70.65 130.08 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 19 3 # 19 B1198 GLY J 19 GLY~? 21.52 ZN ZN J2001 B1228 SER J 33 SER^? 25.08 ZN ZN E2002 B1549 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 126.34 72.75 125.66 125.95 73.27 126.11 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 131.65 74.68 129.41 130.31 72.73 128.82 36.27 -15.21 -17.30 38.62 -15.44 -16.82 coo 134.72 69.43 130.42 133.03 70.65 130.08 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 20 3 # 20 B1198 GLY J 19 GLY~? 21.52 ZN ZN J2001 B1228 SER J 33 SER^? 25.08 ZN ZN E2002 B1549 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 126.34 72.75 125.66 125.95 73.27 126.11 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 131.65 74.68 129.41 130.31 72.73 128.82 36.27 -15.21 -17.30 38.62 -15.44 -16.82 coo 134.72 69.43 130.42 133.03 70.65 130.08 35.13 -18.57 -12.25 34.79 -18.46 -10.18 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 20 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU B 67 GLU^? 26.37 ZN ZN B2003 A 89 GLU B 64 GLU.? 24.26 ZN ZN B2003 A 120 SER B 62 SER.? 13.24 ZN ZN B2003 coo -24.35 9.53 67.64 -25.07 11.29 68.60 6.86 -10.14 3.77 7.81 -9.34 2.09 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -0.92 -12.20 12.92 -1.40 -11.36 15.15 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU E 67 GLU^? 26.75 ZN ZN E2002 A 89 GLU E 64 GLU.? 24.43 ZN ZN E2002 A 120 SER E 62 SER.? 13.28 ZN ZN E2002 coo -24.35 9.53 67.64 -25.07 11.29 68.60 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo -31.18 6.91 75.60 -32.39 8.51 74.91 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo -34.73 8.57 68.21 -33.63 9.08 70.28 11.73 -1.93 -19.14 12.33 -1.01 -21.31 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU G 67 GLU^? 26.62 ZN ZN G2004 A 89 GLU G 64 GLU.? 24.28 ZN ZN G2004 A 120 SER G 62 SER.? 12.88 ZN ZN G2004 coo -24.35 9.53 67.64 -25.07 11.29 68.60 32.75 -26.36 9.71 31.95 -28.10 8.81 coo -31.18 6.91 75.60 -32.39 8.51 74.91 39.99 -27.18 15.98 39.71 -28.44 14.30 coo -34.73 8.57 68.21 -33.63 9.08 70.28 40.40 -18.47 15.18 40.81 -17.30 17.24 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU J 67 GLU^? 26.37 ZN ZN J2001 A 89 GLU J 64 GLU.? 23.99 ZN ZN J2001 A 120 SER J 62 SER.? 13.22 ZN ZN J2001 coo -24.35 9.53 67.64 -25.07 11.29 68.60 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo -31.18 6.91 75.60 -32.39 8.51 74.91 44.01 -30.69 -11.59 43.10 -30.84 -9.69 coo -34.73 8.57 68.21 -33.63 9.08 70.28 37.90 -34.48 -16.81 38.74 -34.62 -19.09 1cns_c00 source 1cns CHITINASE : 4 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 20 GLU~? -13.24 ZN ZN E2002s B 89 GLU E 50 GLU~? -2.01 ZN ZN E2002s B 120 SER A 33 SER^? 10.82 ZN ZN E2002 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 24.11 0.27 -11.15 22.21 1.00 -12.37 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU B 67 GLU^? 26.37 ZN ZN B2003 B 89 GLU B 64 GLU.? 24.26 ZN ZN B2003 B 120 SER B 62 SER.? 13.24 ZN ZN B2003 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -0.92 -12.20 12.92 -1.40 -11.36 15.15 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU D 67 GLU^? 32.75 ZN ZN B2003 B 89 GLU D 64 GLU.? 37.94 ZN ZN E2002 B 120 SER D 62 SER.? 34.27 ZN ZN J2001 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 0.94 -21.68 -22.18 -0.33 -23.43 -23.36 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU E 50 GLU~? -2.01 ZN ZN E2002s B 89 GLU A 20 GLU~? -13.24 ZN ZN E2002s B 120 SER A 33 SER^? 10.82 ZN ZN E2002 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 24.11 0.27 -11.15 22.21 1.00 -12.37 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU E 67 GLU^? 26.75 ZN ZN E2002 B 89 GLU E 64 GLU.? 24.43 ZN ZN E2002 B 120 SER E 62 SER.? 13.28 ZN ZN E2002 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 11.73 -1.93 -19.14 12.33 -1.01 -21.31 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU F 67 GLU^? 23.19 ZN ZN G2004 B 89 GLU F 64 GLU.? 24.41 ZN ZN G2004 B 120 SER F 62 SER.? 27.86 ZN ZN G2004 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 46.13 -16.43 -6.44 47.56 -14.48 -6.34 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU H 67 GLU^? 32.59 ZN ZN J2001 B 89 GLU H 64 GLU.? 37.89 ZN ZN G2004 B 120 SER H 62 SER~? 34.41 ZN ZN B2003 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 32.53 -42.71 11.25 33.49 -41.02 10.38 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 28.76 -38.18 18.22 27.96 -39.85 19.82 ULMN 3 1cns_c01 CHITINASE user 8 3 # 8 B 67 GLU J 67 GLU^? 26.37 ZN ZN J2001 B 89 GLU J 64 GLU.? 23.99 ZN ZN J2001 B 120 SER J 62 SER.? 13.22 ZN ZN J2001 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 44.01 -30.69 -11.59 43.10 -30.84 -9.69 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 37.90 -34.48 -16.81 38.74 -34.62 -19.09 1cns_c01 source 1cns CHITINASE : 8 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 38 TYR.? 23.20 ZN ZN E2002 A 173 ASP A 39 ASP.? 16.23 ZN ZN E2002 C 48 ARG A 68 ARG^? 28.72 ZN ZN B2003 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 24.35 4.55 25.11 25.94 3.23 25.53 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 14.21 -9.24 0.28 13.24 -12.17 0.61 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 38 TYR.? 23.16 ZN ZN B2003 A 173 ASP B 39 ASP.? 27.28 ZN ZN B2003 C 48 ARG B 68 ARG^? 23.11 ZN ZN B2003 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 24.35 4.55 25.11 25.94 3.23 25.53 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 9.32 -17.65 5.25 11.20 -19.96 4.50 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR C 38 TYR.? 23.27 ZN ZN B2003 A 173 ASP C 39 ASP.? 16.40 ZN ZN B2003 C 48 ARG C 68 ARG^? 29.54 ZN ZN B2003 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 24.35 4.55 25.11 25.94 3.23 25.53 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 6.46 -25.65 -2.21 6.49 -23.14 -4.00 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR E 38 TYR.? 23.24 ZN ZN E2002 A 173 ASP E 39 ASP.? 27.23 ZN ZN E2002 C 48 ARG E 68 ARG^? 24.88 ZN ZN E2002 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 24.35 4.55 25.11 25.94 3.23 25.53 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 14.73 -11.32 -9.64 13.98 -11.79 -6.67 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR F 38 TYR.? 23.19 ZN ZN G2004 A 173 ASP F 39 ASP.? 16.21 ZN ZN G2004 C 48 ARG F 68 ARG^? 28.83 ZN ZN J2001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 24.35 4.55 25.11 25.94 3.23 25.53 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 32.78 -19.96 -4.34 30.63 -22.19 -4.53 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 101 TYR G 38 TYR.? 23.24 ZN ZN G2004 A 173 ASP G 39 ASP.? 27.24 ZN ZN G2004 C 48 ARG G 68 ARG^? 22.94 ZN ZN G2004 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 24.35 4.55 25.11 25.94 3.23 25.53 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 30.64 -21.00 5.54 28.49 -18.97 4.58 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 101 TYR H 38 TYR.? 28.65 ZN ZN B2003 A 173 ASP H 39 ASP.? 32.15 ZN ZN J2001 C 48 ARG H 68 ARG^? 29.79 ZN ZN G2004 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 24.35 4.55 25.11 25.94 3.23 25.53 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 24.82 -29.19 7.91 24.68 -26.94 5.81 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 101 TYR I 38 TYR.? 23.18 ZN ZN J2001 A 173 ASP I 39 ASP.? 16.30 ZN ZN J2001 C 48 ARG I 68 ARG^? 29.76 ZN ZN J2001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 24.35 4.55 25.11 25.94 3.23 25.53 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 23.15 -33.63 -1.82 24.18 -35.52 0.40 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 68 ARG^? 28.72 ZN ZN B2003 C 101 TYR A 38 TYR.? 23.20 ZN ZN E2002 C 173 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 32.27 5.62 48.15 31.93 6.48 51.06 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 29.64 3.64 57.39 31.22 5.14 55.65 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 68 ARG^? 23.11 ZN ZN B2003 C 101 TYR B 38 TYR.? 23.16 ZN ZN B2003 C 173 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 32.27 5.62 48.15 31.93 6.48 51.06 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 29.64 3.64 57.39 31.22 5.14 55.65 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG C 68 ARG^? 29.54 ZN ZN B2003 C 101 TYR C 38 TYR.? 23.27 ZN ZN B2003 C 173 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 32.27 5.62 48.15 31.93 6.48 51.06 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 29.64 3.64 57.39 31.22 5.14 55.65 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG E 68 ARG^? 24.88 ZN ZN E2002 C 101 TYR E 38 TYR.? 23.24 ZN ZN E2002 C 173 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 32.27 5.62 48.15 31.93 6.48 51.06 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 29.64 3.64 57.39 31.22 5.14 55.65 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG F 68 ARG^? 28.83 ZN ZN J2001 C 101 TYR F 38 TYR.? 23.19 ZN ZN G2004 C 173 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 32.27 5.62 48.15 31.93 6.48 51.06 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 29.64 3.64 57.39 31.22 5.14 55.65 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG G 68 ARG^? 22.94 ZN ZN G2004 C 101 TYR G 38 TYR.? 23.24 ZN ZN G2004 C 173 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 32.27 5.62 48.15 31.93 6.48 51.06 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 29.64 3.64 57.39 31.22 5.14 55.65 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 48 ARG H 68 ARG^? 29.79 ZN ZN G2004 C 101 TYR H 38 TYR.? 28.65 ZN ZN B2003 C 173 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 32.27 5.62 48.15 31.93 6.48 51.06 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 29.64 3.64 57.39 31.22 5.14 55.65 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 48 ARG I 68 ARG^? 29.76 ZN ZN J2001 C 101 TYR I 38 TYR.? 23.18 ZN ZN J2001 C 173 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 32.27 5.62 48.15 31.93 6.48 51.06 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 29.64 3.64 57.39 31.22 5.14 55.65 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 26.01 -35.27 -13.87 27.04 -33.54 -13.28 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 48 ARG J 68 ARG^? 19.63 ZN ZN J2001 C 101 TYR J 38 TYR.? 23.16 ZN ZN J2001 C 173 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 32.27 5.62 48.15 31.93 6.48 51.06 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 29.64 3.64 57.39 31.22 5.14 55.65 28.75 -20.75 -12.61 27.09 -22.87 -11.86 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 35.13 -18.57 -12.25 34.79 -18.46 -10.18 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 68 ARG^? 28.72 ZN ZN B2003 D 101 TYR A 38 TYR.? 23.20 ZN ZN E2002 D 173 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 69.08 8.58 32.60 69.70 10.81 30.58 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 71.77 11.86 24.26 70.23 12.22 26.56 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 71.60 6.14 19.25 70.26 6.87 20.69 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 68 ARG^? 23.11 ZN ZN B2003 D 101 TYR B 38 TYR.? 23.16 ZN ZN B2003 D 173 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 69.08 8.58 32.60 69.70 10.81 30.58 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 71.77 11.86 24.26 70.23 12.22 26.56 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 71.60 6.14 19.25 70.26 6.87 20.69 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG C 68 ARG^? 29.54 ZN ZN B2003 D 101 TYR C 38 TYR.? 23.27 ZN ZN B2003 D 173 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 69.08 8.58 32.60 69.70 10.81 30.58 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 71.77 11.86 24.26 70.23 12.22 26.56 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 71.60 6.14 19.25 70.26 6.87 20.69 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG D 68 ARG^? 31.20 ZN ZN E2002 D 101 TYR D 38 TYR.? 28.62 ZN ZN J2001 D 173 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 69.08 8.58 32.60 69.70 10.81 30.58 10.24 -20.71 -11.26 11.91 -20.64 -8.66 coo 71.77 11.86 24.26 70.23 12.22 26.56 10.18 -28.96 -9.74 11.62 -26.73 -10.53 coo 71.60 6.14 19.25 70.26 6.87 20.69 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG E 68 ARG^? 24.88 ZN ZN E2002 D 101 TYR E 38 TYR.? 23.24 ZN ZN E2002 D 173 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 69.08 8.58 32.60 69.70 10.81 30.58 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 71.77 11.86 24.26 70.23 12.22 26.56 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 71.60 6.14 19.25 70.26 6.87 20.69 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG F 68 ARG^? 28.83 ZN ZN J2001 D 101 TYR F 38 TYR.? 23.19 ZN ZN G2004 D 173 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 69.08 8.58 32.60 69.70 10.81 30.58 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 71.77 11.86 24.26 70.23 12.22 26.56 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 71.60 6.14 19.25 70.26 6.87 20.69 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 48 ARG G 68 ARG^? 22.94 ZN ZN G2004 D 101 TYR G 38 TYR.? 23.24 ZN ZN G2004 D 173 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 69.08 8.58 32.60 69.70 10.81 30.58 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 71.77 11.86 24.26 70.23 12.22 26.56 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 71.60 6.14 19.25 70.26 6.87 20.69 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 48 ARG H 68 ARG^? 29.79 ZN ZN G2004 D 101 TYR H 38 TYR.? 28.65 ZN ZN B2003 D 173 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 69.08 8.58 32.60 69.70 10.81 30.58 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 71.77 11.86 24.26 70.23 12.22 26.56 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 71.60 6.14 19.25 70.26 6.87 20.69 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 48 ARG I 68 ARG^? 29.76 ZN ZN J2001 D 101 TYR I 38 TYR.? 23.18 ZN ZN J2001 D 173 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 69.08 8.58 32.60 69.70 10.81 30.58 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 71.77 11.86 24.26 70.23 12.22 26.56 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 71.60 6.14 19.25 70.26 6.87 20.69 26.01 -35.27 -13.87 27.04 -33.54 -13.28 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 48 ARG J 68 ARG^? 19.63 ZN ZN J2001 D 101 TYR J 38 TYR.? 23.16 ZN ZN J2001 D 173 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 69.08 8.58 32.60 69.70 10.81 30.58 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 71.77 11.86 24.26 70.23 12.22 26.56 28.75 -20.75 -12.61 27.09 -22.87 -11.86 coo 71.60 6.14 19.25 70.26 6.87 20.69 35.13 -18.57 -12.25 34.79 -18.46 -10.18 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 38 TYR.? 23.20 ZN ZN E2002 B 173 ASP A 39 ASP.? 16.23 ZN ZN E2002 D 48 ARG A 68 ARG^? 28.72 ZN ZN B2003 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 14.21 -9.24 0.28 13.24 -12.17 0.61 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 38 TYR.? 23.16 ZN ZN B2003 B 173 ASP B 39 ASP.? 27.28 ZN ZN B2003 D 48 ARG B 68 ARG^? 23.11 ZN ZN B2003 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 9.32 -17.65 5.25 11.20 -19.96 4.50 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR C 38 TYR.? 23.27 ZN ZN B2003 B 173 ASP C 39 ASP.? 16.40 ZN ZN B2003 D 48 ARG C 68 ARG^? 29.54 ZN ZN B2003 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 6.46 -25.65 -2.21 6.49 -23.14 -4.00 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR E 38 TYR.? 23.24 ZN ZN E2002 B 173 ASP E 39 ASP.? 27.23 ZN ZN E2002 D 48 ARG E 68 ARG^? 24.88 ZN ZN E2002 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 14.73 -11.32 -9.64 13.98 -11.79 -6.67 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR F 38 TYR.? 23.19 ZN ZN G2004 B 173 ASP F 39 ASP.? 16.21 ZN ZN G2004 D 48 ARG F 68 ARG^? 28.83 ZN ZN J2001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 32.78 -19.96 -4.34 30.63 -22.19 -4.53 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR G 38 TYR.? 23.24 ZN ZN G2004 B 173 ASP G 39 ASP.? 27.24 ZN ZN G2004 D 48 ARG G 68 ARG^? 22.94 ZN ZN G2004 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 30.64 -21.00 5.54 28.49 -18.97 4.58 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 101 TYR H 38 TYR.? 28.65 ZN ZN B2003 B 173 ASP H 39 ASP.? 32.15 ZN ZN J2001 D 48 ARG H 68 ARG^? 29.79 ZN ZN G2004 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 24.82 -29.19 7.91 24.68 -26.94 5.81 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 101 TYR I 38 TYR.? 23.18 ZN ZN J2001 B 173 ASP I 39 ASP.? 16.30 ZN ZN J2001 D 48 ARG I 68 ARG^? 29.76 ZN ZN J2001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 23.15 -33.63 -1.82 24.18 -35.52 0.40 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 101 TYR J 38 TYR.? 23.16 ZN ZN J2001 B 173 ASP J 39 ASP.? 27.27 ZN ZN J2001 D 48 ARG J 68 ARG^? 19.63 ZN ZN J2001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 28.75 -20.75 -12.61 27.09 -22.87 -11.86 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 27.83 -27.99 -9.38 27.89 -30.88 -10.49 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 53 ASP~? 26.24 ZN ZN G2004 315 GLU A 50 GLU~? 17.52 ZN ZN G2004 390 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 32.46 99.13 19.34 30.94 100.38 20.07 17.64 3.84 11.72 15.55 3.44 11.90 coo 32.04 94.22 18.23 30.57 94.75 16.88 22.23 3.81 17.00 24.22 3.69 17.74 coo 21.10 94.74 18.36 23.09 96.71 18.59 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP B 53 ASP~? 5.10 ZN ZN B2003 315 GLU B 50 GLU~? -2.41 ZN ZN B2003s 390 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 32.46 99.13 19.34 30.94 100.38 20.07 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 32.04 94.22 18.23 30.57 94.75 16.88 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 21.10 94.74 18.36 23.09 96.71 18.59 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP E 53 ASP~? 5.07 ZN ZN E2002 315 GLU E 50 GLU~? -2.01 ZN ZN E2002s 390 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 32.46 99.13 19.34 30.94 100.38 20.07 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 32.04 94.22 18.23 30.57 94.75 16.88 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 21.10 94.74 18.36 23.09 96.71 18.59 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP F 53 ASP~? 26.13 ZN ZN E2002 315 GLU F 50 GLU.? 17.33 ZN ZN E2002 390 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 32.46 99.13 19.34 30.94 100.38 20.07 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 32.04 94.22 18.23 30.57 94.75 16.88 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 21.10 94.74 18.36 23.09 96.71 18.59 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 3 # 5 313 ASP G 53 ASP~? 4.94 ZN ZN G2004 315 GLU G 50 GLU~? -2.28 ZN ZN G2004s 390 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 32.46 99.13 19.34 30.94 100.38 20.07 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 32.04 94.22 18.23 30.57 94.75 16.88 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 21.10 94.74 18.36 23.09 96.71 18.59 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 3 # 6 313 ASP H 53 ASP~? 26.49 ZN ZN B2003 315 GLU H 50 GLU.? 17.57 ZN ZN B2003 390 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 32.46 99.13 19.34 30.94 100.38 20.07 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 32.04 94.22 18.23 30.57 94.75 16.88 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 21.10 94.74 18.36 23.09 96.71 18.59 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 3 # 7 313 ASP I 53 ASP~? 35.51 ZN ZN J2001 315 GLU I 50 GLU~? 38.38 ZN ZN B2003 390 TYR H 32 TYR^? 29.55 ZN ZN B2003 coo 32.46 99.13 19.34 30.94 100.38 20.07 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 32.04 94.22 18.23 30.57 94.75 16.88 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 21.10 94.74 18.36 23.09 96.71 18.59 10.73 -43.63 9.08 8.41 -44.48 10.38 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 8 3 # 8 313 ASP J 53 ASP~? 5.09 ZN ZN J2001 315 GLU J 50 GLU~? -2.50 ZN ZN J2001s 390 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 32.46 99.13 19.34 30.94 100.38 20.07 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 32.04 94.22 18.23 30.57 94.75 16.88 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 21.10 94.74 18.36 23.09 96.71 18.59 18.53 -40.66 -20.20 16.59 -42.17 -21.51 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 8 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 340 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 395 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 26.93 6.24 15.37 25.45 7.75 15.31 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 22.23 3.81 17.00 24.22 3.69 17.74 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 340 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 395 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 26.93 6.24 15.37 25.45 7.75 15.31 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 22.23 3.81 17.00 24.22 3.69 17.74 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 340 GLU A 51 GLU~? 22.57 ZN ZN G2004 A 395 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 26.93 6.24 15.37 25.45 7.75 15.31 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 23.15 8.42 10.27 24.62 9.66 9.42 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1cwy_c00 AMYLOMALTASE user 4 3 # 4 A 293 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 340 GLU B 50 GLU~? -2.41 ZN ZN B2003s A 395 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 6.05 -23.93 28.50 5.91 -26.02 28.02 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 2.06 -23.31 25.35 0.50 -22.72 24.07 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1cwy_c00 AMYLOMALTASE user 5 3 # 5 A 293 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 340 GLU B 51 GLU~? 6.60 ZN ZN B2003 A 395 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 6.05 -23.93 28.50 5.91 -26.02 28.02 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 4.51 -19.61 26.84 5.05 -18.05 28.12 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1cwy_c00 AMYLOMALTASE user 6 3 # 6 A 293 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 340 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 395 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1cwy_c00 AMYLOMALTASE user 7 3 # 7 A 293 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 340 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 395 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 1cwy_c00 AMYLOMALTASE user 8 3 # 8 A 293 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 340 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 395 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1cwy_c00 AMYLOMALTASE user 9 3 # 9 A 293 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 340 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 395 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1cwy_c00 AMYLOMALTASE user 10 3 # 10 A 293 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 340 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 395 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1cwy_c00 AMYLOMALTASE user 11 3 # 11 A 293 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 340 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 395 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 1cwy_c00 AMYLOMALTASE user 12 3 # 12 A 293 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 340 GLU D 51 GLU~? 22.34 ZN ZN J2001 A 395 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1cwy_c00 AMYLOMALTASE user 13 3 # 13 A 293 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 340 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 395 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 31.72 1.73 -23.06 32.51 2.58 -21.24 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 27.40 4.08 -19.70 26.14 4.32 -21.40 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1cwy_c00 AMYLOMALTASE user 14 3 # 14 A 293 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 340 GLU E 51 GLU~? 6.76 ZN ZN E2002 A 395 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 31.72 1.73 -23.06 32.51 2.58 -21.24 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 27.30 0.80 -24.68 27.41 0.15 -26.66 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1cwy_c00 AMYLOMALTASE user 15 3 # 15 A 293 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 340 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 395 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1cwy_c00 AMYLOMALTASE user 16 3 # 16 A 293 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 340 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 395 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 3 1cwy_c00 AMYLOMALTASE user 17 3 # 17 A 293 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 340 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 395 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1cwy_c00 AMYLOMALTASE user 18 3 # 18 A 293 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 340 GLU G 50 GLU~? -2.28 ZN ZN G2004s A 395 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 33.55 0.62 19.07 33.72 1.88 17.35 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 37.44 -1.74 17.09 38.96 -3.21 16.73 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1cwy_c00 AMYLOMALTASE user 19 3 # 19 A 293 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 340 GLU G 51 GLU~? 6.79 ZN ZN G2004 A 395 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 33.55 0.62 19.07 33.72 1.88 17.35 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 34.98 -4.76 20.96 34.28 -3.47 22.45 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1cwy_c00 AMYLOMALTASE user 20 3 # 20 A 293 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 340 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 395 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 12.54 -30.52 29.41 14.40 -31.25 30.10 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 17.55 -27.49 28.97 15.58 -26.87 29.52 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1cwy_c00 AMYLOMALTASE user 21 3 # 21 A 293 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 340 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 395 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 12.54 -30.52 29.41 14.40 -31.25 30.10 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 17.55 -27.49 28.97 15.58 -26.87 29.52 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 3 1cwy_c00 AMYLOMALTASE user 22 3 # 22 A 293 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 340 GLU H 51 GLU~? 22.00 ZN ZN B2003 A 395 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 12.54 -30.52 29.41 14.40 -31.25 30.10 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 16.31 -35.44 26.90 14.59 -36.70 27.16 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1cwy_c00 AMYLOMALTASE user 23 3 # 23 A 293 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 340 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 395 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 9.27 -51.61 2.10 7.43 -50.53 2.04 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1cwy_c00 AMYLOMALTASE user 24 3 # 24 A 293 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 340 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 395 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 9.27 -51.61 2.10 7.43 -50.53 2.04 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1cwy_c00 AMYLOMALTASE user 25 3 # 25 A 293 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 340 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 395 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1cwy_c00 AMYLOMALTASE user 26 3 # 26 A 293 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 340 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 395 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1cwy_c00 AMYLOMALTASE user 27 3 # 27 A 293 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 340 GLU J 51 GLU~? 6.72 ZN ZN J2001 A 395 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 28.87 -37.23 -24.52 29.85 -38.89 -23.63 1cwy_c00 source 1cwy AMYLOMALTASE : 27 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 56 ILE A 22 ILE~? 20.07 ZN ZN E2002 A 82 TYR F 78 TYR.? 11.63 ZN ZN E2002 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 19.95 5.59 -3.42 19.33 4.92 -2.41 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 22.38 6.39 -10.32 21.34 4.29 -11.84 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 56 ILE B 22 ILE~? 16.56 ZN ZN B2003 A 82 TYR G 78 TYR.? 24.68 ZN ZN B2003 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 7.88 -7.28 17.66 7.86 -8.60 16.85 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 12.17 -1.26 17.53 12.70 -0.59 14.88 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 56 ILE C 22 ILE~? 20.16 ZN ZN B2003 A 82 TYR H 78 TYR.? 11.76 ZN ZN B2003 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -3.30 -30.79 8.32 -2.99 -30.80 6.99 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -2.69 -28.08 15.14 -1.32 -25.64 14.90 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 56 ILE D 22 ILE~? 31.09 ZN ZN J2001 A 82 TYR I 78 TYR.? 35.62 ZN ZN J2001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 1.08 -32.10 -18.37 2.03 -31.07 -18.58 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 56 ILE E 22 ILE~? 16.85 ZN ZN E2002 A 82 TYR J 78 TYR.? 24.76 ZN ZN E2002 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 15.72 -9.65 -25.82 16.00 -9.99 -24.54 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 13.85 -15.66 -29.81 12.10 -17.30 -28.36 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 56 ILE F 22 ILE~? 19.96 ZN ZN G2004 A 82 TYR A 78 TYR.? 11.65 ZN ZN G2004 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 42.76 -7.57 -0.50 42.43 -8.46 -1.46 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 42.29 -5.11 6.34 41.03 -7.11 7.84 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 56 ILE G 22 ILE~? 16.65 ZN ZN G2004 A 82 TYR B 78 TYR.? 24.55 ZN ZN G2004 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 31.77 -18.85 21.81 31.37 -18.77 20.50 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 27.46 -23.45 25.85 26.96 -25.77 24.34 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 56 ILE H 22 ILE~? 31.04 ZN ZN B2003 A 82 TYR C 78 TYR^? 35.69 ZN ZN B2003 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 19.42 -42.89 14.36 19.82 -41.47 14.56 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 16.52 -47.66 10.31 18.03 -47.38 7.99 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 9 3 # 9 A 37 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 56 ILE I 22 ILE~? 20.17 ZN ZN J2001 A 82 TYR D 78 TYR.? 11.76 ZN ZN J2001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 22.95 -45.97 -12.27 22.74 -45.87 -10.97 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 24.81 -44.15 -19.15 26.32 -41.78 -18.93 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 10 3 # 10 A 37 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 56 ILE J 22 ILE~? 16.74 ZN ZN J2001 A 82 TYR E 78 TYR.? 24.67 ZN ZN J2001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 37.71 -24.65 -21.64 36.66 -24.79 -20.71 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 40.71 -17.77 -21.60 40.95 -16.95 -18.92 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 10 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 39 ASP.? 16.23 ZN ZN E2002 B 56 ILE A 22 ILE~? 20.07 ZN ZN E2002 B 82 TYR F 78 TYR.? 11.63 ZN ZN E2002 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 19.95 5.59 -3.42 19.33 4.92 -2.41 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 22.38 6.39 -10.32 21.34 4.29 -11.84 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 39 ASP.? 27.28 ZN ZN B2003 B 56 ILE B 22 ILE~? 16.56 ZN ZN B2003 B 82 TYR G 78 TYR.? 24.68 ZN ZN B2003 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 7.88 -7.28 17.66 7.86 -8.60 16.85 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 12.17 -1.26 17.53 12.70 -0.59 14.88 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP C 39 ASP.? 16.40 ZN ZN B2003 B 56 ILE C 22 ILE~? 20.16 ZN ZN B2003 B 82 TYR H 78 TYR.? 11.76 ZN ZN B2003 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -3.30 -30.79 8.32 -2.99 -30.80 6.99 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -2.69 -28.08 15.14 -1.32 -25.64 14.90 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP D 39 ASP.? 32.27 ZN ZN B2003 B 56 ILE D 22 ILE~? 31.09 ZN ZN J2001 B 82 TYR I 78 TYR.? 35.62 ZN ZN J2001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 1.08 -32.10 -18.37 2.03 -31.07 -18.58 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP E 39 ASP.? 27.23 ZN ZN E2002 B 56 ILE E 22 ILE~? 16.85 ZN ZN E2002 B 82 TYR J 78 TYR.? 24.76 ZN ZN E2002 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 15.72 -9.65 -25.82 16.00 -9.99 -24.54 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 13.85 -15.66 -29.81 12.10 -17.30 -28.36 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP F 39 ASP.? 16.21 ZN ZN G2004 B 56 ILE F 22 ILE~? 19.96 ZN ZN G2004 B 82 TYR A 78 TYR.? 11.65 ZN ZN G2004 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 42.76 -7.57 -0.50 42.43 -8.46 -1.46 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 42.29 -5.11 6.34 41.03 -7.11 7.84 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP G 39 ASP.? 27.24 ZN ZN G2004 B 56 ILE G 22 ILE~? 16.65 ZN ZN G2004 B 82 TYR B 78 TYR.? 24.55 ZN ZN G2004 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 31.77 -18.85 21.81 31.37 -18.77 20.50 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 27.46 -23.45 25.85 26.96 -25.77 24.34 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP H 39 ASP.? 32.15 ZN ZN J2001 B 56 ILE H 22 ILE~? 31.04 ZN ZN B2003 B 82 TYR C 78 TYR^? 35.69 ZN ZN B2003 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 19.42 -42.89 14.36 19.82 -41.47 14.56 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 16.52 -47.66 10.31 18.03 -47.38 7.99 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 9 3 # 9 B 37 ASP I 39 ASP.? 16.30 ZN ZN J2001 B 56 ILE I 22 ILE~? 20.17 ZN ZN J2001 B 82 TYR D 78 TYR.? 11.76 ZN ZN J2001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 22.95 -45.97 -12.27 22.74 -45.87 -10.97 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 24.81 -44.15 -19.15 26.32 -41.78 -18.93 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 10 3 # 10 B 37 ASP J 39 ASP.? 27.27 ZN ZN J2001 B 56 ILE J 22 ILE~? 16.74 ZN ZN J2001 B 82 TYR E 78 TYR.? 24.67 ZN ZN J2001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 37.71 -24.65 -21.64 36.66 -24.79 -20.71 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 40.71 -17.77 -21.60 40.95 -16.95 -18.92 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 10 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 38 TYR.? 23.20 ZN ZN E2002 A 243 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 272 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 2.03 68.31 21.46 0.66 68.36 23.90 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 16.93 55.67 9.65 17.16 54.23 11.19 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 38 TYR.? 23.20 ZN ZN E2002 A 243 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 272 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 2.03 68.31 21.46 0.66 68.36 23.90 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 16.93 55.67 9.65 17.16 54.23 11.19 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR B 38 TYR.? 23.16 ZN ZN B2003 A 243 ASP A 54 ASP~? 25.58 ZN ZN G2004 A 272 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 2.03 68.31 21.46 0.66 68.36 23.90 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 16.93 55.67 9.65 17.16 54.23 11.19 19.11 8.17 8.99 18.99 8.60 11.06 coo 14.13 45.79 13.40 14.25 49.41 18.30 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR C 38 TYR.? 23.27 ZN ZN B2003 A 243 ASP B 54 ASP~? -2.43 ZN ZN B2003s A 272 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 2.03 68.31 21.46 0.66 68.36 23.90 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 16.93 55.67 9.65 17.16 54.23 11.19 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR C 38 TYR.? 23.27 ZN ZN B2003 A 243 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 272 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 2.03 68.31 21.46 0.66 68.36 23.90 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 16.93 55.67 9.65 17.16 54.23 11.19 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 14.13 45.79 13.40 14.25 49.41 18.30 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR D 38 TYR.? 28.62 ZN ZN J2001 A 243 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 272 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 2.03 68.31 21.46 0.66 68.36 23.90 10.18 -28.96 -9.74 11.62 -26.73 -10.53 coo 16.93 55.67 9.65 17.16 54.23 11.19 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 14.13 45.79 13.40 14.25 49.41 18.30 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR D 38 TYR.? 28.62 ZN ZN J2001 A 243 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 272 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 2.03 68.31 21.46 0.66 68.36 23.90 10.18 -28.96 -9.74 11.62 -26.73 -10.53 coo 16.93 55.67 9.65 17.16 54.23 11.19 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 14.13 45.79 13.40 14.25 49.41 18.30 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR E 38 TYR.? 23.24 ZN ZN E2002 A 243 ASP D 54 ASP~? 25.75 ZN ZN J2001 A 272 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 2.03 68.31 21.46 0.66 68.36 23.90 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 16.93 55.67 9.65 17.16 54.23 11.19 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 14.13 45.79 13.40 14.25 49.41 18.30 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR F 38 TYR.? 23.19 ZN ZN G2004 A 243 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 272 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 2.03 68.31 21.46 0.66 68.36 23.90 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 16.93 55.67 9.65 17.16 54.23 11.19 26.93 6.24 15.37 25.45 7.75 15.31 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR F 38 TYR.? 23.19 ZN ZN G2004 A 243 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 272 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 2.03 68.31 21.46 0.66 68.36 23.90 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 16.93 55.67 9.65 17.16 54.23 11.19 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR G 38 TYR.? 23.24 ZN ZN G2004 A 243 ASP H 54 ASP~? 25.78 ZN ZN B2003 A 272 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 2.03 68.31 21.46 0.66 68.36 23.90 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 16.93 55.67 9.65 17.16 54.23 11.19 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR H 38 TYR.? 28.65 ZN ZN B2003 A 243 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 272 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 2.03 68.31 21.46 0.66 68.36 23.90 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 16.93 55.67 9.65 17.16 54.23 11.19 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 14.13 45.79 13.40 14.25 49.41 18.30 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR I 38 TYR.? 23.18 ZN ZN J2001 A 243 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 272 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 2.03 68.31 21.46 0.66 68.36 23.90 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 16.93 55.67 9.65 17.16 54.23 11.19 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 14.13 45.79 13.40 14.25 49.41 18.30 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 173 TYR I 38 TYR.? 23.18 ZN ZN J2001 A 243 ASP J 54 ASP~? -2.24 ZN ZN J2001s A 272 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 2.03 68.31 21.46 0.66 68.36 23.90 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 16.93 55.67 9.65 17.16 54.23 11.19 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 14.13 45.79 13.40 14.25 49.41 18.30 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 173 TYR J 38 TYR.? 23.16 ZN ZN J2001 A 243 ASP F 54 ASP~? 25.15 ZN ZN E2002 A 272 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 2.03 68.31 21.46 0.66 68.36 23.90 28.75 -20.75 -12.61 27.09 -22.87 -11.86 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 14.13 45.79 13.40 14.25 49.41 18.30 41.41 1.47 -15.85 45.79 3.58 -18.60 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 15 hits 1d7r_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY C 36 GLY.? 18.57 ZN ZN B2003 B 144 GLU B 70 GLU^? 21.67 ZN ZN B2003 B 164 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo 88.87 114.43 152.30 88.45 115.15 152.32 12.11 -24.01 11.10 11.56 -23.46 11.17 coo 85.20 111.99 152.05 86.60 110.89 150.91 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 88.14 113.46 145.73 86.79 113.92 147.30 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY D 36 GLY.? 32.57 ZN ZN B2003 B 144 GLU C 70 GLU^? 28.30 ZN ZN B2003 B 164 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo 88.87 114.43 152.30 88.45 115.15 152.32 9.85 -32.90 -3.74 9.09 -32.64 -3.84 coo 85.20 111.99 152.05 86.60 110.89 150.91 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 88.14 113.46 145.73 86.79 113.92 147.30 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY E 36 GLY.? 22.06 ZN ZN J2001 B 144 GLU D 70 GLU^? 24.25 ZN ZN J2001 B 164 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo 88.87 114.43 152.30 88.45 115.15 152.32 17.76 -24.27 -16.69 17.02 -24.07 -16.89 coo 85.20 111.99 152.05 86.60 110.89 150.91 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 88.14 113.46 145.73 86.79 113.92 147.30 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 4 3 # 4 B 141 GLY G 36 GLY.? 21.99 ZN ZN B2003 B 144 GLU H 70 GLU^? 24.54 ZN ZN B2003 B 164 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo 88.87 114.43 152.30 88.45 115.15 152.32 17.97 -24.43 12.71 18.50 -24.97 12.93 coo 85.20 111.99 152.05 86.60 110.89 150.91 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 88.14 113.46 145.73 86.79 113.92 147.30 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 5 3 # 5 B 141 GLY H 36 GLY.? 32.47 ZN ZN B2003 B 144 GLU I 70 GLU^? 28.28 ZN ZN J2001 B 164 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo 88.87 114.43 152.30 88.45 115.15 152.32 14.40 -35.53 -0.18 15.01 -36.05 -0.15 coo 85.20 111.99 152.05 86.60 110.89 150.91 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 88.14 113.46 145.73 86.79 113.92 147.30 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 6 3 # 6 B 141 GLY I 36 GLY.? 18.47 ZN ZN J2001 B 144 GLU J 70 GLU^? 22.09 ZN ZN J2001 B 164 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo 88.87 114.43 152.30 88.45 115.15 152.32 21.13 -29.09 -15.26 21.86 -29.39 -15.29 coo 85.20 111.99 152.05 86.60 110.89 150.91 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 88.14 113.46 145.73 86.79 113.92 147.30 15.16 -26.68 -14.16 16.30 -26.65 -12.35 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 6 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY C 36 GLY.? 18.57 ZN ZN B2003 C 144 GLU B 70 GLU^? 21.67 ZN ZN B2003 C 164 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo 56.28 104.55 135.84 56.09 105.34 136.05 12.11 -24.01 11.10 11.56 -23.46 11.17 coo 58.46 103.90 139.48 57.57 102.00 139.16 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 51.71 102.03 140.09 53.02 103.62 140.54 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY D 36 GLY.? 32.57 ZN ZN B2003 C 144 GLU C 70 GLU^? 28.30 ZN ZN B2003 C 164 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo 56.28 104.55 135.84 56.09 105.34 136.05 9.85 -32.90 -3.74 9.09 -32.64 -3.84 coo 58.46 103.90 139.48 57.57 102.00 139.16 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 51.71 102.03 140.09 53.02 103.62 140.54 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY E 36 GLY.? 22.06 ZN ZN J2001 C 144 GLU D 70 GLU^? 24.25 ZN ZN J2001 C 164 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo 56.28 104.55 135.84 56.09 105.34 136.05 17.76 -24.27 -16.69 17.02 -24.07 -16.89 coo 58.46 103.90 139.48 57.57 102.00 139.16 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 51.71 102.03 140.09 53.02 103.62 140.54 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 4 3 # 4 C 141 GLY G 36 GLY.? 21.99 ZN ZN B2003 C 144 GLU H 70 GLU^? 24.54 ZN ZN B2003 C 164 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo 56.28 104.55 135.84 56.09 105.34 136.05 17.97 -24.43 12.71 18.50 -24.97 12.93 coo 58.46 103.90 139.48 57.57 102.00 139.16 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 51.71 102.03 140.09 53.02 103.62 140.54 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 5 3 # 5 C 141 GLY H 36 GLY.? 32.47 ZN ZN B2003 C 144 GLU I 70 GLU^? 28.28 ZN ZN J2001 C 164 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo 56.28 104.55 135.84 56.09 105.34 136.05 14.40 -35.53 -0.18 15.01 -36.05 -0.15 coo 58.46 103.90 139.48 57.57 102.00 139.16 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 51.71 102.03 140.09 53.02 103.62 140.54 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 6 3 # 6 C 141 GLY I 36 GLY.? 18.47 ZN ZN J2001 C 144 GLU J 70 GLU^? 22.09 ZN ZN J2001 C 164 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo 56.28 104.55 135.84 56.09 105.34 136.05 21.13 -29.09 -15.26 21.86 -29.39 -15.29 coo 58.46 103.90 139.48 57.57 102.00 139.16 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 51.71 102.03 140.09 53.02 103.62 140.54 15.16 -26.68 -14.16 16.30 -26.65 -12.35 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 6 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY C 36 GLY.? 18.57 ZN ZN B2003 D 144 GLU B 70 GLU^? 21.67 ZN ZN B2003 D 164 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo 86.19 80.64 132.77 86.38 79.85 132.93 12.11 -24.01 11.10 11.56 -23.46 11.17 coo 84.75 81.24 136.88 85.62 83.14 136.43 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 91.47 83.05 136.24 90.35 81.38 136.84 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY D 36 GLY.? 32.57 ZN ZN B2003 D 144 GLU C 70 GLU^? 28.30 ZN ZN B2003 D 164 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo 86.19 80.64 132.77 86.38 79.85 132.93 9.85 -32.90 -3.74 9.09 -32.64 -3.84 coo 84.75 81.24 136.88 85.62 83.14 136.43 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 91.47 83.05 136.24 90.35 81.38 136.84 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY E 36 GLY.? 22.06 ZN ZN J2001 D 144 GLU D 70 GLU^? 24.25 ZN ZN J2001 D 164 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo 86.19 80.64 132.77 86.38 79.85 132.93 17.76 -24.27 -16.69 17.02 -24.07 -16.89 coo 84.75 81.24 136.88 85.62 83.14 136.43 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 91.47 83.05 136.24 90.35 81.38 136.84 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 4 3 # 4 D 141 GLY G 36 GLY.? 21.99 ZN ZN B2003 D 144 GLU H 70 GLU^? 24.54 ZN ZN B2003 D 164 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo 86.19 80.64 132.77 86.38 79.85 132.93 17.97 -24.43 12.71 18.50 -24.97 12.93 coo 84.75 81.24 136.88 85.62 83.14 136.43 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 91.47 83.05 136.24 90.35 81.38 136.84 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 5 3 # 5 D 141 GLY H 36 GLY.? 32.47 ZN ZN B2003 D 144 GLU I 70 GLU^? 28.28 ZN ZN J2001 D 164 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo 86.19 80.64 132.77 86.38 79.85 132.93 14.40 -35.53 -0.18 15.01 -36.05 -0.15 coo 84.75 81.24 136.88 85.62 83.14 136.43 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 91.47 83.05 136.24 90.35 81.38 136.84 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 6 3 # 6 D 141 GLY I 36 GLY.? 18.47 ZN ZN J2001 D 144 GLU J 70 GLU^? 22.09 ZN ZN J2001 D 164 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo 86.19 80.64 132.77 86.38 79.85 132.93 21.13 -29.09 -15.26 21.86 -29.39 -15.29 coo 84.75 81.24 136.88 85.62 83.14 136.43 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 91.47 83.05 136.24 90.35 81.38 136.84 15.16 -26.68 -14.16 16.30 -26.65 -12.35 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 6 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY C 36 GLY.? 18.57 ZN ZN B2003 E 144 GLU B 70 GLU^? 21.67 ZN ZN B2003 E 164 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo 90.07 81.07 170.50 90.23 80.26 170.38 12.11 -24.01 11.10 11.56 -23.46 11.17 coo 87.05 81.30 167.53 86.38 82.74 168.94 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 84.40 80.02 173.80 85.08 79.06 172.03 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY D 36 GLY.? 32.57 ZN ZN B2003 E 144 GLU C 70 GLU^? 28.30 ZN ZN B2003 E 164 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo 90.07 81.07 170.50 90.23 80.26 170.38 9.85 -32.90 -3.74 9.09 -32.64 -3.84 coo 87.05 81.30 167.53 86.38 82.74 168.94 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 84.40 80.02 173.80 85.08 79.06 172.03 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY E 36 GLY.? 22.06 ZN ZN J2001 E 144 GLU D 70 GLU^? 24.25 ZN ZN J2001 E 164 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo 90.07 81.07 170.50 90.23 80.26 170.38 17.76 -24.27 -16.69 17.02 -24.07 -16.89 coo 87.05 81.30 167.53 86.38 82.74 168.94 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 84.40 80.02 173.80 85.08 79.06 172.03 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 4 3 # 4 E 141 GLY G 36 GLY.? 21.99 ZN ZN B2003 E 144 GLU H 70 GLU^? 24.54 ZN ZN B2003 E 164 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo 90.07 81.07 170.50 90.23 80.26 170.38 17.97 -24.43 12.71 18.50 -24.97 12.93 coo 87.05 81.30 167.53 86.38 82.74 168.94 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 84.40 80.02 173.80 85.08 79.06 172.03 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 5 3 # 5 E 141 GLY H 36 GLY.? 32.47 ZN ZN B2003 E 144 GLU I 70 GLU^? 28.28 ZN ZN J2001 E 164 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo 90.07 81.07 170.50 90.23 80.26 170.38 14.40 -35.53 -0.18 15.01 -36.05 -0.15 coo 87.05 81.30 167.53 86.38 82.74 168.94 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 84.40 80.02 173.80 85.08 79.06 172.03 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 6 3 # 6 E 141 GLY I 36 GLY.? 18.47 ZN ZN J2001 E 144 GLU J 70 GLU^? 22.09 ZN ZN J2001 E 164 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo 90.07 81.07 170.50 90.23 80.26 170.38 21.13 -29.09 -15.26 21.86 -29.39 -15.29 coo 87.05 81.30 167.53 86.38 82.74 168.94 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 84.40 80.02 173.80 85.08 79.06 172.03 15.16 -26.68 -14.16 16.30 -26.65 -12.35 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 6 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY C 36 GLY.? 18.57 ZN ZN B2003 F 144 GLU B 70 GLU^? 21.67 ZN ZN B2003 F 164 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo 57.12 70.68 155.10 57.52 69.95 155.02 12.11 -24.01 11.10 11.56 -23.46 11.17 coo 60.62 73.13 154.21 59.05 74.26 153.35 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 56.75 71.71 148.46 58.44 71.01 149.54 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY D 36 GLY.? 32.57 ZN ZN B2003 F 144 GLU C 70 GLU^? 28.30 ZN ZN B2003 F 164 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo 57.12 70.68 155.10 57.52 69.95 155.02 9.85 -32.90 -3.74 9.09 -32.64 -3.84 coo 60.62 73.13 154.21 59.05 74.26 153.35 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 56.75 71.71 148.46 58.44 71.01 149.54 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY E 36 GLY.? 22.06 ZN ZN J2001 F 144 GLU D 70 GLU^? 24.25 ZN ZN J2001 F 164 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo 57.12 70.68 155.10 57.52 69.95 155.02 17.76 -24.27 -16.69 17.02 -24.07 -16.89 coo 60.62 73.13 154.21 59.05 74.26 153.35 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 56.75 71.71 148.46 58.44 71.01 149.54 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 4 3 # 4 F 141 GLY G 36 GLY.? 21.99 ZN ZN B2003 F 144 GLU H 70 GLU^? 24.54 ZN ZN B2003 F 164 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo 57.12 70.68 155.10 57.52 69.95 155.02 17.97 -24.43 12.71 18.50 -24.97 12.93 coo 60.62 73.13 154.21 59.05 74.26 153.35 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 56.75 71.71 148.46 58.44 71.01 149.54 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 5 3 # 5 F 141 GLY H 36 GLY.? 32.47 ZN ZN B2003 F 144 GLU I 70 GLU^? 28.28 ZN ZN J2001 F 164 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo 57.12 70.68 155.10 57.52 69.95 155.02 14.40 -35.53 -0.18 15.01 -36.05 -0.15 coo 60.62 73.13 154.21 59.05 74.26 153.35 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 56.75 71.71 148.46 58.44 71.01 149.54 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 6 3 # 6 F 141 GLY I 36 GLY.? 18.47 ZN ZN J2001 F 144 GLU J 70 GLU^? 22.09 ZN ZN J2001 F 164 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo 57.12 70.68 155.10 57.52 69.95 155.02 21.13 -29.09 -15.26 21.86 -29.39 -15.29 coo 60.62 73.13 154.21 59.05 74.26 153.35 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 56.75 71.71 148.46 58.44 71.01 149.54 15.16 -26.68 -14.16 16.30 -26.65 -12.35 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 6 hits 1dub_c17 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 74 ALA^? 13.77 ZN ZN G2004 A 257 ALA A 77 ALA^? 12.13 ZN ZN G2004 A 328 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 39.84 24.12 8.44 38.50 24.23 9.11 32.45 -2.50 7.64 33.20 -1.63 6.65 coo 43.22 26.73 5.37 41.81 27.09 5.79 39.53 -1.20 7.47 39.55 0.29 7.32 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 77 ALA^? 12.13 ZN ZN G2004 A 257 ALA A 74 ALA^? 13.77 ZN ZN G2004 A 328 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 39.84 24.12 8.44 38.50 24.23 9.11 39.53 -1.20 7.47 39.55 0.29 7.32 coo 43.22 26.73 5.37 41.81 27.09 5.79 32.45 -2.50 7.64 33.20 -1.63 6.65 coo 38.17 34.10 6.67 37.72 32.06 6.84 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 77 ALA^? 12.13 ZN ZN G2004 A 257 ALA A 74 ALA^? 13.77 ZN ZN G2004 A 328 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 39.84 24.12 8.44 38.50 24.23 9.11 39.53 -1.20 7.47 39.55 0.29 7.32 coo 43.22 26.73 5.37 41.81 27.09 5.79 32.45 -2.50 7.64 33.20 -1.63 6.65 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA B 74 ALA^? 18.49 ZN ZN B2003 A 257 ALA B 77 ALA^? 22.81 ZN ZN B2003 A 328 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 17.93 -22.48 22.28 18.36 -21.34 23.15 coo 43.22 26.73 5.37 41.81 27.09 5.79 23.01 -22.59 27.52 22.37 -21.86 28.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA B 77 ALA^? 22.81 ZN ZN B2003 A 257 ALA B 74 ALA^? 18.49 ZN ZN B2003 A 328 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 23.01 -22.59 27.52 22.37 -21.86 28.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 17.93 -22.48 22.28 18.36 -21.34 23.15 coo 38.17 34.10 6.67 37.72 32.06 6.84 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA D 74 ALA^? 13.84 ZN ZN J2001 A 257 ALA D 77 ALA^? 11.91 ZN ZN J2001 A 328 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 39.84 24.12 8.44 38.50 24.23 9.11 19.07 -36.11 -21.79 18.30 -37.42 -21.64 coo 43.22 26.73 5.37 41.81 27.09 5.79 21.94 -42.74 -22.61 20.91 -43.37 -23.52 coo 38.17 34.10 6.67 37.72 32.06 6.84 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA D 77 ALA^? 11.91 ZN ZN J2001 A 257 ALA D 74 ALA^? 13.84 ZN ZN J2001 A 328 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 39.84 24.12 8.44 38.50 24.23 9.11 21.94 -42.74 -22.61 20.91 -43.37 -23.52 coo 43.22 26.73 5.37 41.81 27.09 5.79 19.07 -36.11 -21.79 18.30 -37.42 -21.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 26.01 -35.27 -13.87 27.04 -33.54 -13.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA D 77 ALA^? 11.91 ZN ZN J2001 A 257 ALA D 74 ALA^? 13.84 ZN ZN J2001 A 328 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 39.84 24.12 8.44 38.50 24.23 9.11 21.94 -42.74 -22.61 20.91 -43.37 -23.52 coo 43.22 26.73 5.37 41.81 27.09 5.79 19.07 -36.11 -21.79 18.30 -37.42 -21.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA F 74 ALA^? 13.64 ZN ZN E2002 A 257 ALA F 77 ALA^? 12.00 ZN ZN E2002 A 328 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 39.84 24.12 8.44 38.50 24.23 9.11 29.56 -0.81 -11.65 30.01 0.29 -10.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 27.03 5.94 -11.49 28.30 6.74 -11.29 coo 38.17 34.10 6.67 37.72 32.06 6.84 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA F 77 ALA^? 12.00 ZN ZN E2002 A 257 ALA F 74 ALA^? 13.64 ZN ZN E2002 A 328 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 39.84 24.12 8.44 38.50 24.23 9.11 27.03 5.94 -11.49 28.30 6.74 -11.29 coo 43.22 26.73 5.37 41.81 27.09 5.79 29.56 -0.81 -11.65 30.01 0.29 -10.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA F 77 ALA^? 12.00 ZN ZN E2002 A 257 ALA F 74 ALA^? 13.64 ZN ZN E2002 A 328 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 39.84 24.12 8.44 38.50 24.23 9.11 27.03 5.94 -11.49 28.30 6.74 -11.29 coo 43.22 26.73 5.37 41.81 27.09 5.79 29.56 -0.81 -11.65 30.01 0.29 -10.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA G 74 ALA^? 18.58 ZN ZN G2004 A 257 ALA G 77 ALA^? 22.77 ZN ZN G2004 A 328 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 39.84 24.12 8.44 38.50 24.23 9.11 21.64 -4.56 15.34 21.18 -4.94 16.73 coo 43.22 26.73 5.37 41.81 27.09 5.79 16.64 -1.08 19.32 17.31 -0.83 20.66 coo 38.17 34.10 6.67 37.72 32.06 6.84 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA G 77 ALA^? 22.77 ZN ZN G2004 A 257 ALA G 74 ALA^? 18.58 ZN ZN G2004 A 328 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 39.84 24.12 8.44 38.50 24.23 9.11 16.64 -1.08 19.32 17.31 -0.83 20.66 coo 43.22 26.73 5.37 41.81 27.09 5.79 21.64 -4.56 15.34 21.18 -4.94 16.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA H 74 ALA^? 13.82 ZN ZN B2003 A 257 ALA H 77 ALA^? 11.91 ZN ZN B2003 A 328 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 7.07 -29.25 17.84 6.29 -30.56 17.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 -0.08 -30.01 18.67 -0.22 -31.20 19.56 coo 38.17 34.10 6.67 37.72 32.06 6.84 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA H 77 ALA^? 11.91 ZN ZN B2003 A 257 ALA H 74 ALA^? 13.82 ZN ZN B2003 A 328 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.08 -30.01 18.67 -0.22 -31.20 19.56 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.07 -29.25 17.84 6.29 -30.56 17.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA H 77 ALA^? 11.91 ZN ZN B2003 A 257 ALA H 74 ALA^? 13.82 ZN ZN B2003 A 328 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.08 -30.01 18.67 -0.22 -31.20 19.56 coo 43.22 26.73 5.37 41.81 27.09 5.79 7.07 -29.25 17.84 6.29 -30.56 17.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA I 74 ALA^? 31.19 ZN ZN J2001 A 257 ALA I 77 ALA^? 34.16 ZN ZN J2001 A 328 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 5.80 -40.70 -8.02 5.78 -41.01 -9.50 coo 43.22 26.73 5.37 41.81 27.09 5.79 0.10 -41.33 -12.51 0.27 -42.78 -12.94 coo 38.17 34.10 6.67 37.72 32.06 6.84 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA I 77 ALA^? 34.16 ZN ZN J2001 A 257 ALA I 74 ALA^? 31.19 ZN ZN J2001 A 328 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 0.10 -41.33 -12.51 0.27 -42.78 -12.94 coo 43.22 26.73 5.37 41.81 27.09 5.79 5.80 -40.70 -8.02 5.78 -41.01 -9.50 coo 38.17 34.10 6.67 37.72 32.06 6.84 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA J 74 ALA^? 18.57 ZN ZN J2001 A 257 ALA J 77 ALA^? 22.82 ZN ZN J2001 A 328 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 39.84 24.12 8.44 38.50 24.23 9.11 19.54 -23.33 -26.22 20.33 -22.37 -27.09 coo 43.22 26.73 5.37 41.81 27.09 5.79 16.86 -19.07 -31.47 17.83 -19.27 -32.60 coo 38.17 34.10 6.67 37.72 32.06 6.84 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA J 77 ALA^? 22.82 ZN ZN J2001 A 257 ALA J 74 ALA^? 18.57 ZN ZN J2001 A 328 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 39.84 24.12 8.44 38.50 24.23 9.11 16.86 -19.07 -31.47 17.83 -19.27 -32.60 coo 43.22 26.73 5.37 41.81 27.09 5.79 19.54 -23.33 -26.22 20.33 -22.37 -27.09 coo 38.17 34.10 6.67 37.72 32.06 6.84 10.06 -24.15 -28.86 8.79 -22.48 -29.14 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 20 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 47 LYS.? 18.77 ZN ZN G2004 A 193 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 217 VAL A 49 VAL~? 15.56 ZN ZN G2004 coo 2.10 10.68 61.44 -2.14 13.16 60.61 28.57 8.89 11.92 28.49 10.48 16.93 coo -5.33 11.71 69.72 -4.62 11.92 67.73 22.23 3.81 17.00 24.22 3.69 17.74 coo 0.07 12.29 66.53 -0.24 11.95 64.38 25.79 2.52 13.47 26.37 0.63 14.40 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS C 47 LYS.? 38.38 ZN ZN B2003 A 193 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 217 VAL C 49 VAL~? 36.23 ZN ZN B2003 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -1.77 -47.88 3.17 -5.89 -51.57 3.00 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 0.07 12.29 66.53 -0.24 11.95 64.38 1.76 -44.45 -1.69 3.75 -45.18 -2.28 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS D 47 LYS.? 19.69 ZN ZN J2001 A 193 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 217 VAL D 49 VAL.? 15.54 ZN ZN J2001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 12.18 -35.43 -32.57 13.23 -33.76 -37.61 coo -5.33 11.71 69.72 -4.62 11.92 67.73 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 0.07 12.29 66.53 -0.24 11.95 64.38 15.93 -30.21 -29.51 17.82 -29.95 -28.43 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS E 47 LYS.? 6.58 ZN ZN E2002 A 193 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 217 VAL E 49 VAL~? 9.65 ZN ZN E2002 coo 2.10 10.68 61.44 -2.14 13.16 60.61 31.89 -0.94 -26.86 29.14 3.95 -26.91 coo -5.33 11.71 69.72 -4.62 11.92 67.73 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 0.07 12.29 66.53 -0.24 11.95 64.38 30.42 -1.45 -20.08 31.93 -1.92 -18.51 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS F 47 LYS.? 21.75 ZN ZN E2002 A 193 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 217 VAL F 49 VAL.? 15.43 ZN ZN E2002 coo 2.10 10.68 61.44 -2.14 13.16 60.61 41.41 1.47 -15.85 45.79 3.58 -18.60 coo -5.33 11.71 69.72 -4.62 11.92 67.73 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 0.07 12.29 66.53 -0.24 11.95 64.38 37.23 -4.14 -17.45 35.28 -4.54 -18.34 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS H 47 LYS.? 19.70 ZN ZN B2003 A 193 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 217 VAL H 49 VAL.? 15.58 ZN ZN B2003 coo 2.10 10.68 61.44 -2.14 13.16 60.61 10.99 -34.83 28.58 12.07 -33.13 33.66 coo -5.33 11.71 69.72 -4.62 11.92 67.73 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 0.07 12.29 66.53 -0.24 11.95 64.38 13.86 -29.01 25.57 13.20 -27.16 24.57 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 159 LYS I 47 LYS.? 39.82 ZN ZN J2001 A 193 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 217 VAL I 49 VAL~? 36.29 ZN ZN J2001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 7.62 -53.38 -6.85 6.38 -57.85 -3.68 coo -5.33 11.71 69.72 -4.62 11.92 67.73 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 0.07 12.29 66.53 -0.24 11.95 64.38 8.55 -48.14 -2.15 6.99 -46.80 -1.35 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 7 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 3 THR^? 17.13 ZN ZN G2004 A 159 LYS A 47 LYS.? 18.77 ZN ZN G2004 A 193 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo -2.58 16.31 54.79 -4.02 14.93 55.64 31.40 2.44 6.14 32.79 2.66 4.51 coo 2.10 10.68 61.44 -2.14 13.16 60.61 28.57 8.89 11.92 28.49 10.48 16.93 coo -5.33 11.71 69.72 -4.62 11.92 67.73 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR C 3 THR^? 28.49 ZN ZN B2003 A 159 LYS C 47 LYS.? 38.38 ZN ZN B2003 A 193 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo -2.58 16.31 54.79 -4.02 14.93 55.64 4.98 -43.31 6.77 5.68 -43.40 8.80 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -1.77 -47.88 3.17 -5.89 -51.57 3.00 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR D 3 THR^? 17.12 ZN ZN J2001 A 159 LYS D 47 LYS.? 19.69 ZN ZN J2001 A 193 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo -2.58 16.31 54.79 -4.02 14.93 55.64 14.49 -37.59 -23.92 14.22 -39.41 -22.73 coo 2.10 10.68 61.44 -2.14 13.16 60.61 12.18 -35.43 -32.57 13.23 -33.76 -37.61 coo -5.33 11.71 69.72 -4.62 11.92 67.73 15.39 -26.34 -33.01 16.88 -27.76 -33.58 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR E 3 THR^? 17.44 ZN ZN E2002 A 159 LYS E 47 LYS.? 6.58 ZN ZN E2002 A 193 GLU E 50 GLU~? -2.01 ZN ZN E2002s coo -2.58 16.31 54.79 -4.02 14.93 55.64 31.04 -9.46 -24.06 31.31 -11.30 -25.24 coo 2.10 10.68 61.44 -2.14 13.16 60.61 31.89 -0.94 -26.86 29.14 3.95 -26.91 coo -5.33 11.71 69.72 -4.62 11.92 67.73 27.40 4.08 -19.70 26.14 4.32 -21.40 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR F 3 THR^? 17.05 ZN ZN E2002 A 159 LYS F 47 LYS.? 21.75 ZN ZN E2002 A 193 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo -2.58 16.31 54.79 -4.02 14.93 55.64 34.40 0.76 -10.06 33.91 2.11 -8.44 coo 2.10 10.68 61.44 -2.14 13.16 60.61 41.41 1.47 -15.85 45.79 3.58 -18.60 coo -5.33 11.71 69.72 -4.62 11.92 67.73 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR H 3 THR^? 17.15 ZN ZN B2003 A 159 LYS H 47 LYS.? 19.70 ZN ZN B2003 A 193 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 8.15 -33.89 19.96 6.73 -35.07 18.81 coo 2.10 10.68 61.44 -2.14 13.16 60.61 10.99 -34.83 28.58 12.07 -33.13 33.66 coo -5.33 11.71 69.72 -4.62 11.92 67.73 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR I 3 THR^? 28.47 ZN ZN J2001 A 159 LYS I 47 LYS.? 39.82 ZN ZN J2001 A 193 GLU I 50 GLU~? 38.38 ZN ZN B2003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 7.95 -45.10 -10.68 7.53 -44.40 -12.69 coo 2.10 10.68 61.44 -2.14 13.16 60.61 7.62 -53.38 -6.85 6.38 -57.85 -3.68 coo -5.33 11.71 69.72 -4.62 11.92 67.73 9.27 -51.61 2.10 7.43 -50.53 2.04 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 7 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 260 ARG A 45 ARG^? 20.10 ZN ZN G2004 A 270 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 50.99 29.43 12.86 52.11 29.45 14.65 22.23 3.81 17.00 24.22 3.69 17.74 coo 39.80 27.50 22.98 42.20 26.56 21.34 32.14 6.60 3.52 34.39 5.41 1.81 coo 48.83 21.70 19.50 47.44 24.99 15.25 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 260 ARG I 45 ARG^? 26.51 ZN ZN J2001 A 270 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 50.99 29.43 12.86 52.11 29.45 14.65 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 39.80 27.50 22.98 42.20 26.56 21.34 9.19 -47.86 -14.39 8.02 -46.02 -16.58 coo 48.83 21.70 19.50 47.44 24.99 15.25 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 260 ARG D 45 ARG^? 20.03 ZN ZN J2001 A 270 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 50.99 29.43 12.86 52.11 29.45 14.65 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 39.80 27.50 22.98 42.20 26.56 21.34 10.69 -40.60 -24.75 11.69 -42.61 -22.61 coo 48.83 21.70 19.50 47.44 24.99 15.25 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 260 ARG E 45 ARG^? 19.39 ZN ZN E2002 A 270 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 50.99 29.43 12.86 52.11 29.45 14.65 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 39.80 27.50 22.98 42.20 26.56 21.34 29.50 -9.81 -28.77 30.55 -12.66 -29.14 coo 48.83 21.70 19.50 47.44 24.99 15.25 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 260 ARG E 45 ARG^? 19.39 ZN ZN E2002 A 270 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 50.99 29.43 12.86 52.11 29.45 14.65 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 39.80 27.50 22.98 42.20 26.56 21.34 29.50 -9.81 -28.77 30.55 -12.66 -29.14 coo 48.83 21.70 19.50 47.44 24.99 15.25 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 260 ARG F 45 ARG^? 20.07 ZN ZN E2002 A 270 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 50.99 29.43 12.86 52.11 29.45 14.65 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 39.80 27.50 22.98 42.20 26.56 21.34 37.54 3.46 -7.45 35.47 4.92 -5.67 coo 48.83 21.70 19.50 47.44 24.99 15.25 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 260 ARG H 45 ARG^? 19.95 ZN ZN B2003 A 270 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 50.99 29.43 12.86 52.11 29.45 14.65 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 39.80 27.50 22.98 42.20 26.56 21.34 7.47 -38.69 20.81 5.22 -38.73 18.67 coo 48.83 21.70 19.50 47.44 24.99 15.25 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 8 3 # 8 A 34 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 260 ARG I 45 ARG^? 26.51 ZN ZN J2001 A 270 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 50.99 29.43 12.86 52.11 29.45 14.65 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 39.80 27.50 22.98 42.20 26.56 21.34 9.19 -47.86 -14.39 8.02 -46.02 -16.58 coo 48.83 21.70 19.50 47.44 24.99 15.25 7.62 -53.38 -6.85 6.38 -57.85 -3.68 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 8 hits 1euy_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 74 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 98 GLU B 51 GLU~? 6.60 ZN ZN B2003 coo 17.19 9.05 25.28 15.77 9.98 26.53 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 15.99 8.54 17.36 14.96 7.80 19.05 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 16.31 12.85 18.11 16.71 11.79 19.90 4.51 -19.61 26.84 5.05 -18.05 28.12 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 2 3 # 2 A 68 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 74 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 98 GLU E 51 GLU~? 6.76 ZN ZN E2002 coo 17.19 9.05 25.28 15.77 9.98 26.53 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 15.99 8.54 17.36 14.96 7.80 19.05 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 16.31 12.85 18.11 16.71 11.79 19.90 27.30 0.80 -24.68 27.41 0.15 -26.66 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 3 3 # 3 A 68 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 74 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 98 GLU E 50 GLU~? -2.01 ZN ZN E2002s coo 17.19 9.05 25.28 15.77 9.98 26.53 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 15.99 8.54 17.36 14.96 7.80 19.05 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 16.31 12.85 18.11 16.71 11.79 19.90 27.40 4.08 -19.70 26.14 4.32 -21.40 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 4 3 # 4 A 68 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 74 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 98 GLU G 51 GLU~? 6.79 ZN ZN G2004 coo 17.19 9.05 25.28 15.77 9.98 26.53 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 15.99 8.54 17.36 14.96 7.80 19.05 33.55 0.62 19.07 33.72 1.88 17.35 coo 16.31 12.85 18.11 16.71 11.79 19.90 34.98 -4.76 20.96 34.28 -3.47 22.45 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 5 3 # 5 A 68 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 74 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 98 GLU G 50 GLU~? -2.28 ZN ZN G2004s coo 17.19 9.05 25.28 15.77 9.98 26.53 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 15.99 8.54 17.36 14.96 7.80 19.05 33.55 0.62 19.07 33.72 1.88 17.35 coo 16.31 12.85 18.11 16.71 11.79 19.90 37.44 -1.74 17.09 38.96 -3.21 16.73 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 6 3 # 6 A 68 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 74 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 98 GLU J 51 GLU~? 6.72 ZN ZN J2001 coo 17.19 9.05 25.28 15.77 9.98 26.53 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 15.99 8.54 17.36 14.96 7.80 19.05 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 16.31 12.85 18.11 16.71 11.79 19.90 28.89 -33.61 -30.77 29.81 -32.28 -32.11 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 7 3 # 7 A 68 ASP J 54 ASP~? -2.24 ZN ZN J2001s A 74 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 98 GLU J 50 GLU~? -2.50 ZN ZN J2001s coo 17.19 9.05 25.28 15.77 9.98 26.53 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 15.99 8.54 17.36 14.96 7.80 19.05 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 16.31 12.85 18.11 16.71 11.79 19.90 26.62 -37.54 -29.35 27.87 -38.52 -28.01 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 7 hits 1eyi_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 75 PHE^? 9.36 ZN ZN G2004 A 210 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 244 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 9.23 46.77 25.11 11.48 48.39 24.76 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 10.51 37.86 19.71 9.07 39.38 20.04 33.55 0.62 19.07 33.72 1.88 17.35 coo -1.20 42.34 17.67 3.19 45.13 19.06 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE B 75 PHE^? 21.46 ZN ZN B2003 A 210 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 244 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 9.23 46.77 25.11 11.48 48.39 24.76 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 10.51 37.86 19.71 9.07 39.38 20.04 12.54 -30.52 29.41 14.40 -31.25 30.10 coo -1.20 42.34 17.67 3.19 45.13 19.06 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE C 75 PHE^? 34.12 ZN ZN J2001 A 210 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 244 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 9.23 46.77 25.11 11.48 48.39 24.76 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 10.51 37.86 19.71 9.07 39.38 20.04 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo -1.20 42.34 17.67 3.19 45.13 19.06 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE D 75 PHE^? 9.38 ZN ZN J2001 A 210 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 244 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 9.23 46.77 25.11 11.48 48.39 24.76 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 10.51 37.86 19.71 9.07 39.38 20.04 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo -1.20 42.34 17.67 3.19 45.13 19.06 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE E 75 PHE^? 21.52 ZN ZN E2002 A 210 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 244 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 9.23 46.77 25.11 11.48 48.39 24.76 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 10.51 37.86 19.71 9.07 39.38 20.04 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 210 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 244 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 9.23 46.77 25.11 11.48 48.39 24.76 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 10.51 37.86 19.71 9.07 39.38 20.04 31.72 1.73 -23.06 32.51 2.58 -21.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE G 75 PHE^? 21.55 ZN ZN G2004 A 210 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 244 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 9.23 46.77 25.11 11.48 48.39 24.76 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 10.51 37.86 19.71 9.07 39.38 20.04 26.93 6.24 15.37 25.45 7.75 15.31 coo -1.20 42.34 17.67 3.19 45.13 19.06 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE H 75 PHE^? 9.39 ZN ZN B2003 A 210 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 244 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 9.23 46.77 25.11 11.48 48.39 24.76 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 6.05 -23.93 28.50 5.91 -26.02 28.02 coo -1.20 42.34 17.67 3.19 45.13 19.06 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE I 75 PHE^? 34.28 ZN ZN B2003 A 210 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 244 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 9.23 46.77 25.11 11.48 48.39 24.76 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 10.51 37.86 19.71 9.07 39.38 20.04 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo -1.20 42.34 17.67 3.19 45.13 19.06 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE J 75 PHE^? 21.52 ZN ZN J2001 A 210 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 244 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 9.23 46.77 25.11 11.48 48.39 24.76 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 10.51 37.86 19.71 9.07 39.38 20.04 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo -1.20 42.34 17.67 3.19 45.13 19.06 26.17 -30.49 -34.43 27.88 -35.84 -34.06 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 10 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 75 PHE^? 9.36 ZN ZN G2004 B 210 ASP G 48 ASP~? 8.81 ZN ZN G2004 B 244 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 8.76 47.85 34.91 11.08 46.36 35.41 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 9.06 56.85 40.30 7.71 55.27 39.90 33.55 0.62 19.07 33.72 1.88 17.35 coo -2.38 51.82 41.62 2.07 49.19 40.42 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 75 PHE^? 9.36 ZN ZN G2004 B 210 ASP G 54 ASP~? -2.04 ZN ZN G2004s B 244 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 8.76 47.85 34.91 11.08 46.36 35.41 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 9.06 56.85 40.30 7.71 55.27 39.90 38.23 -8.03 19.86 39.37 -6.28 19.45 coo -2.38 51.82 41.62 2.07 49.19 40.42 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE B 75 PHE^? 21.46 ZN ZN B2003 B 210 ASP H 48 ASP.? 18.83 ZN ZN B2003 B 244 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 8.76 47.85 34.91 11.08 46.36 35.41 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 9.06 56.85 40.30 7.71 55.27 39.90 12.54 -30.52 29.41 14.40 -31.25 30.10 coo -2.38 51.82 41.62 2.07 49.19 40.42 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE C 75 PHE^? 34.12 ZN ZN J2001 B 210 ASP I 48 ASP~? 38.35 ZN ZN J2001 B 244 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 8.76 47.85 34.91 11.08 46.36 35.41 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 9.06 56.85 40.30 7.71 55.27 39.90 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo -2.38 51.82 41.62 2.07 49.19 40.42 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE D 75 PHE^? 9.38 ZN ZN J2001 B 210 ASP J 48 ASP~? 8.01 ZN ZN J2001 B 244 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 8.76 47.85 34.91 11.08 46.36 35.41 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 9.06 56.85 40.30 7.71 55.27 39.90 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo -2.38 51.82 41.62 2.07 49.19 40.42 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE E 75 PHE^? 21.52 ZN ZN E2002 B 210 ASP F 48 ASP.? 18.92 ZN ZN E2002 B 244 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 8.76 47.85 34.91 11.08 46.36 35.41 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 9.06 56.85 40.30 7.71 55.27 39.90 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE F 75 PHE^? 9.34 ZN ZN E2002 B 210 ASP E 48 ASP~? 8.41 ZN ZN E2002 B 244 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 8.76 47.85 34.91 11.08 46.36 35.41 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 9.06 56.85 40.30 7.71 55.27 39.90 31.72 1.73 -23.06 32.51 2.58 -21.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE F 75 PHE^? 9.34 ZN ZN E2002 B 210 ASP E 54 ASP~? -2.11 ZN ZN E2002s B 244 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 8.76 47.85 34.91 11.08 46.36 35.41 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 9.06 56.85 40.30 7.71 55.27 39.90 22.00 1.44 -23.80 22.91 3.31 -23.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE G 75 PHE^? 21.55 ZN ZN G2004 B 210 ASP A 48 ASP~? 19.05 ZN ZN G2004 B 244 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 8.76 47.85 34.91 11.08 46.36 35.41 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 9.06 56.85 40.30 7.71 55.27 39.90 26.93 6.24 15.37 25.45 7.75 15.31 coo -2.38 51.82 41.62 2.07 49.19 40.42 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE H 75 PHE^? 9.39 ZN ZN B2003 B 210 ASP B 48 ASP~? 8.81 ZN ZN B2003 B 244 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 8.76 47.85 34.91 11.08 46.36 35.41 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 6.05 -23.93 28.50 5.91 -26.02 28.02 coo -2.38 51.82 41.62 2.07 49.19 40.42 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE H 75 PHE^? 9.39 ZN ZN B2003 B 210 ASP B 54 ASP~? -2.43 ZN ZN B2003s B 244 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 8.76 47.85 34.91 11.08 46.36 35.41 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 1.40 -16.75 23.23 0.16 -18.07 24.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE I 75 PHE^? 34.28 ZN ZN B2003 B 210 ASP C 48 ASP~? 37.52 ZN ZN B2003 B 244 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 8.76 47.85 34.91 11.08 46.36 35.41 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 9.06 56.85 40.30 7.71 55.27 39.90 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo -2.38 51.82 41.62 2.07 49.19 40.42 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE I 75 PHE^? 34.28 ZN ZN B2003 B 210 ASP C 54 ASP~? 34.22 ZN ZN B2003 B 244 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 8.76 47.85 34.91 11.08 46.36 35.41 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 9.06 56.85 40.30 7.71 55.27 39.90 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo -2.38 51.82 41.62 2.07 49.19 40.42 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE J 75 PHE^? 21.52 ZN ZN J2001 B 210 ASP D 48 ASP.? 19.00 ZN ZN J2001 B 244 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 8.76 47.85 34.91 11.08 46.36 35.41 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 9.06 56.85 40.30 7.71 55.27 39.90 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo -2.38 51.82 41.62 2.07 49.19 40.42 26.17 -30.49 -34.43 27.88 -35.84 -34.06 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 14 hits 1fc4_c03 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 80 ARG.? 21.33 ZN ZN G2004 A 136 GLU F 20 GLU~? -13.12 ZN ZN G2004s A 246 GLU F 24 GLU.? 19.67 ZN ZN G2004 coo 13.48 30.30 107.06 11.75 30.99 109.44 51.38 -0.29 4.19 53.35 -1.78 2.33 coo 9.46 32.37 115.82 8.50 34.20 115.47 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 11.99 34.33 109.92 10.08 34.19 110.77 50.14 -4.90 0.74 49.85 -2.99 1.69 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 80 ARG.? 21.50 ZN ZN G2004 A 136 GLU G 20 GLU~? 25.94 ZN ZN G2004 A 246 GLU G 24 GLU~? 19.71 ZN ZN G2004 coo 13.48 30.30 107.06 11.75 30.99 109.44 32.12 -19.85 34.68 34.30 -17.68 34.59 coo 9.46 32.37 115.82 8.50 34.20 115.47 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 11.99 34.33 109.92 10.08 34.19 110.77 35.34 -19.32 28.91 34.28 -18.98 30.72 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 80 ARG.? 36.99 ZN ZN B2003 A 136 GLU H 20 GLU~? 40.75 ZN ZN B2003 A 246 GLU H 24 GLU~? 35.52 ZN ZN B2003 coo 13.48 30.30 107.06 11.75 30.99 109.44 16.13 -52.20 20.46 17.69 -52.87 23.04 coo 9.46 32.37 115.82 8.50 34.20 115.47 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 11.99 34.33 109.92 10.08 34.19 110.77 20.30 -49.47 18.65 18.48 -50.29 19.42 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG D 80 ARG.? 21.06 ZN ZN J2001 A 136 GLU I 20 GLU~? -12.94 ZN ZN J2001s A 246 GLU I 24 GLU~? 19.88 ZN ZN J2001 coo 13.48 30.30 107.06 11.75 30.99 109.44 25.19 -53.81 -20.43 26.22 -56.09 -18.61 coo 9.46 32.37 115.82 8.50 34.20 115.47 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 11.99 34.33 109.92 10.08 34.19 110.77 25.57 -52.88 -14.93 24.90 -53.17 -16.94 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG E 80 ARG.? 21.10 ZN ZN J2001 A 136 GLU J 20 GLU~? 25.99 ZN ZN J2001 A 246 GLU J 24 GLU.? 19.48 ZN ZN J2001 coo 13.48 30.30 107.06 11.75 30.99 109.44 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo 9.46 32.37 115.82 8.50 34.20 115.47 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 11.99 34.33 109.92 10.08 34.19 110.77 43.53 -25.45 -26.61 43.80 -24.04 -28.14 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG F 76 ARG^? 8.13 ZN ZN E2002 A 136 GLU E 51 GLU~? 6.76 ZN ZN E2002 A 246 GLU E 50 GLU~? -2.01 ZN ZN E2002s coo 13.48 30.30 107.06 11.75 30.99 109.44 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 9.46 32.37 115.82 8.50 34.20 115.47 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 11.99 34.33 109.92 10.08 34.19 110.77 27.40 4.08 -19.70 26.14 4.32 -21.40 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG G 80 ARG.? 23.71 ZN ZN B2003 A 136 GLU B 20 GLU~? 25.90 ZN ZN B2003 A 246 GLU B 24 GLU~? 19.88 ZN ZN B2003 coo 13.48 30.30 107.06 11.75 30.99 109.44 6.63 1.91 25.77 5.01 2.67 23.24 coo 9.46 32.37 115.82 8.50 34.20 115.47 7.89 1.30 17.42 7.18 2.96 16.29 coo 11.99 34.33 109.92 10.08 34.19 110.77 4.20 -2.38 22.67 5.80 -1.47 23.74 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG I 80 ARG.? 37.40 ZN ZN J2001 A 136 GLU D 20 GLU~? 40.68 ZN ZN J2001 A 246 GLU D 24 GLU~? 35.30 ZN ZN J2001 coo 13.48 30.30 107.06 11.75 30.99 109.44 -5.55 -40.08 -24.00 -7.09 -38.67 -26.29 coo 9.46 32.37 115.82 8.50 34.20 115.47 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 11.99 34.33 109.92 10.08 34.19 110.77 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 8 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 80 ARG.? 21.33 ZN ZN G2004 A 136 GLU F 20 GLU~? -13.12 ZN ZN G2004s A 246 GLU F 24 GLU.? 19.67 ZN ZN G2004 coo 13.94 29.84 106.80 11.67 30.40 108.79 51.38 -0.29 4.19 53.35 -1.78 2.33 coo 9.52 31.97 115.23 8.45 33.74 114.72 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 11.92 33.82 109.35 10.10 33.50 110.39 50.14 -4.90 0.74 49.85 -2.99 1.69 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 80 ARG.? 21.50 ZN ZN G2004 A 136 GLU G 20 GLU~? 25.94 ZN ZN G2004 A 246 GLU G 24 GLU~? 19.71 ZN ZN G2004 coo 13.94 29.84 106.80 11.67 30.40 108.79 32.12 -19.85 34.68 34.30 -17.68 34.59 coo 9.52 31.97 115.23 8.45 33.74 114.72 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 11.92 33.82 109.35 10.10 33.50 110.39 35.34 -19.32 28.91 34.28 -18.98 30.72 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 80 ARG.? 36.99 ZN ZN B2003 A 136 GLU H 20 GLU~? 40.75 ZN ZN B2003 A 246 GLU H 24 GLU~? 35.52 ZN ZN B2003 coo 13.94 29.84 106.80 11.67 30.40 108.79 16.13 -52.20 20.46 17.69 -52.87 23.04 coo 9.52 31.97 115.23 8.45 33.74 114.72 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 11.92 33.82 109.35 10.10 33.50 110.39 20.30 -49.47 18.65 18.48 -50.29 19.42 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG D 80 ARG.? 21.06 ZN ZN J2001 A 136 GLU I 20 GLU~? -12.94 ZN ZN J2001s A 246 GLU I 24 GLU~? 19.88 ZN ZN J2001 coo 13.94 29.84 106.80 11.67 30.40 108.79 25.19 -53.81 -20.43 26.22 -56.09 -18.61 coo 9.52 31.97 115.23 8.45 33.74 114.72 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 11.92 33.82 109.35 10.10 33.50 110.39 25.57 -52.88 -14.93 24.90 -53.17 -16.94 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG E 80 ARG.? 21.10 ZN ZN J2001 A 136 GLU J 20 GLU~? 25.99 ZN ZN J2001 A 246 GLU J 24 GLU.? 19.48 ZN ZN J2001 coo 13.94 29.84 106.80 11.67 30.40 108.79 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo 9.52 31.97 115.23 8.45 33.74 114.72 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 11.92 33.82 109.35 10.10 33.50 110.39 43.53 -25.45 -26.61 43.80 -24.04 -28.14 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG F 76 ARG^? 8.13 ZN ZN E2002 A 136 GLU E 51 GLU~? 6.76 ZN ZN E2002 A 246 GLU E 50 GLU~? -2.01 ZN ZN E2002s coo 13.94 29.84 106.80 11.67 30.40 108.79 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 9.52 31.97 115.23 8.45 33.74 114.72 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 11.92 33.82 109.35 10.10 33.50 110.39 27.40 4.08 -19.70 26.14 4.32 -21.40 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG G 80 ARG.? 23.71 ZN ZN B2003 A 136 GLU B 20 GLU~? 25.90 ZN ZN B2003 A 246 GLU B 24 GLU~? 19.88 ZN ZN B2003 coo 13.94 29.84 106.80 11.67 30.40 108.79 6.63 1.91 25.77 5.01 2.67 23.24 coo 9.52 31.97 115.23 8.45 33.74 114.72 7.89 1.30 17.42 7.18 2.96 16.29 coo 11.92 33.82 109.35 10.10 33.50 110.39 4.20 -2.38 22.67 5.80 -1.47 23.74 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG I 80 ARG.? 37.40 ZN ZN J2001 A 136 GLU D 20 GLU~? 40.68 ZN ZN J2001 A 246 GLU D 24 GLU~? 35.30 ZN ZN J2001 coo 13.94 29.84 106.80 11.67 30.40 108.79 -5.55 -40.08 -24.00 -7.09 -38.67 -26.29 coo 9.52 31.97 115.23 8.45 33.74 114.72 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 11.92 33.82 109.35 10.10 33.50 110.39 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 8 hits 1fob_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 281 ARG J 76 ARG^? 28.65 ZN ZN J2001 A 289 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 54.86 40.00 47.23 55.57 38.60 48.67 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 52.08 40.18 50.14 50.83 38.93 47.73 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 57.82 31.70 50.73 57.94 34.00 49.17 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 281 ARG E 76 ARG^? 28.35 ZN ZN E2002 A 289 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 54.86 40.00 47.23 55.57 38.60 48.67 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 52.08 40.18 50.14 50.83 38.93 47.73 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 57.82 31.70 50.73 57.94 34.00 49.17 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 281 ARG B 76 ARG^? 28.58 ZN ZN B2003 A 289 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 54.86 40.00 47.23 55.57 38.60 48.67 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 52.08 40.18 50.14 50.83 38.93 47.73 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 57.82 31.70 50.73 57.94 34.00 49.17 21.50 -19.82 24.15 20.71 -18.09 26.19 1foh_c00 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 53 ASP~? 26.24 ZN ZN G2004 B 281 ARG G 76 ARG^? 28.48 ZN ZN G2004 B 289 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 90.56 80.24 98.04 90.36 81.53 96.34 17.64 3.84 11.72 15.55 3.44 11.90 coo 86.62 80.67 97.51 87.37 82.00 100.10 15.16 1.90 14.98 12.60 3.57 14.85 coo 91.83 88.28 92.88 92.60 85.93 94.14 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP D 53 ASP~? 26.48 ZN ZN J2001 B 281 ARG J 76 ARG^? 28.65 ZN ZN J2001 B 289 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 90.56 80.24 98.04 90.36 81.53 96.34 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 86.62 80.67 97.51 87.37 82.00 100.10 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 91.83 88.28 92.88 92.60 85.93 94.14 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP E 53 ASP~? 5.07 ZN ZN E2002 B 281 ARG F 76 ARG^? 8.13 ZN ZN E2002 B 289 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 90.56 80.24 98.04 90.36 81.53 96.34 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 86.62 80.67 97.51 87.37 82.00 100.10 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 91.83 88.28 92.88 92.60 85.93 94.14 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 4 3 # 4 B 54 ASP F 53 ASP~? 26.13 ZN ZN E2002 B 281 ARG E 76 ARG^? 28.35 ZN ZN E2002 B 289 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 90.56 80.24 98.04 90.36 81.53 96.34 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 86.62 80.67 97.51 87.37 82.00 100.10 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 91.83 88.28 92.88 92.60 85.93 94.14 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 5 3 # 5 B 54 ASP H 53 ASP~? 26.49 ZN ZN B2003 B 281 ARG B 76 ARG^? 28.58 ZN ZN B2003 B 289 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 90.56 80.24 98.04 90.36 81.53 96.34 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 86.62 80.67 97.51 87.37 82.00 100.10 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 91.83 88.28 92.88 92.60 85.93 94.14 21.50 -19.82 24.15 20.71 -18.09 26.19 1foh_c01 source 1foh PHENOL HYDROXYLASE : 5 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 53 ASP~? 26.24 ZN ZN G2004 C 281 ARG G 76 ARG^? 28.48 ZN ZN G2004 C 289 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 42.34 76.83 49.10 43.06 78.59 50.01 17.64 3.84 11.72 15.55 3.44 11.90 coo 46.12 77.15 48.13 44.44 77.61 45.70 15.16 1.90 14.98 12.60 3.57 14.85 coo 42.69 86.18 51.69 41.59 83.63 51.54 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP D 53 ASP~? 26.48 ZN ZN J2001 C 281 ARG J 76 ARG^? 28.65 ZN ZN J2001 C 289 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 42.34 76.83 49.10 43.06 78.59 50.01 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 46.12 77.15 48.13 44.44 77.61 45.70 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 42.69 86.18 51.69 41.59 83.63 51.54 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP E 53 ASP~? 5.07 ZN ZN E2002 C 281 ARG F 76 ARG^? 8.13 ZN ZN E2002 C 289 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 42.34 76.83 49.10 43.06 78.59 50.01 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 46.12 77.15 48.13 44.44 77.61 45.70 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 42.69 86.18 51.69 41.59 83.63 51.54 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 4 3 # 4 C 54 ASP F 53 ASP~? 26.13 ZN ZN E2002 C 281 ARG E 76 ARG^? 28.35 ZN ZN E2002 C 289 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 42.34 76.83 49.10 43.06 78.59 50.01 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 46.12 77.15 48.13 44.44 77.61 45.70 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 42.69 86.18 51.69 41.59 83.63 51.54 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 5 3 # 5 C 54 ASP H 53 ASP~? 26.49 ZN ZN B2003 C 281 ARG B 76 ARG^? 28.58 ZN ZN B2003 C 289 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 42.34 76.83 49.10 43.06 78.59 50.01 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 46.12 77.15 48.13 44.44 77.61 45.70 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 42.69 86.18 51.69 41.59 83.63 51.54 21.50 -19.82 24.15 20.71 -18.09 26.19 1foh_c02 source 1foh PHENOL HYDROXYLASE : 5 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 53 ASP~? 26.24 ZN ZN G2004 D 281 ARG G 76 ARG^? 28.48 ZN ZN G2004 D 289 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 75.05 45.80 106.18 74.73 43.88 105.51 17.64 3.84 11.72 15.55 3.44 11.90 coo 78.52 44.93 104.78 78.72 44.49 107.76 15.16 1.90 14.98 12.60 3.57 14.85 coo 72.35 36.51 104.82 72.00 39.20 105.46 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP B 53 ASP~? 5.10 ZN ZN B2003 D 281 ARG H 76 ARG^? 8.16 ZN ZN B2003 D 289 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 75.05 45.80 106.18 74.73 43.88 105.51 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 78.52 44.93 104.78 78.72 44.49 107.76 -1.06 -24.66 18.73 -3.81 -23.46 18.10 coo 72.35 36.51 104.82 72.00 39.20 105.46 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 3 3 # 3 D 54 ASP D 53 ASP~? 26.48 ZN ZN J2001 D 281 ARG J 76 ARG^? 28.65 ZN ZN J2001 D 289 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 75.05 45.80 106.18 74.73 43.88 105.51 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 78.52 44.93 104.78 78.72 44.49 107.76 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 72.35 36.51 104.82 72.00 39.20 105.46 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 4 3 # 4 D 54 ASP E 53 ASP~? 5.07 ZN ZN E2002 D 281 ARG F 76 ARG^? 8.13 ZN ZN E2002 D 289 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 75.05 45.80 106.18 74.73 43.88 105.51 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 78.52 44.93 104.78 78.72 44.49 107.76 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 72.35 36.51 104.82 72.00 39.20 105.46 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 5 3 # 5 D 54 ASP F 53 ASP~? 26.13 ZN ZN E2002 D 281 ARG E 76 ARG^? 28.35 ZN ZN E2002 D 289 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 75.05 45.80 106.18 74.73 43.88 105.51 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 78.52 44.93 104.78 78.72 44.49 107.76 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 72.35 36.51 104.82 72.00 39.20 105.46 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 6 3 # 6 D 54 ASP G 53 ASP~? 4.94 ZN ZN G2004 D 281 ARG A 76 ARG^? 8.06 ZN ZN G2004 D 289 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 75.05 45.80 106.18 74.73 43.88 105.51 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 78.52 44.93 104.78 78.72 44.49 107.76 40.48 -5.18 11.11 43.34 -6.18 11.48 coo 72.35 36.51 104.82 72.00 39.20 105.46 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 7 3 # 7 D 54 ASP H 53 ASP~? 26.49 ZN ZN B2003 D 281 ARG B 76 ARG^? 28.58 ZN ZN B2003 D 289 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 75.05 45.80 106.18 74.73 43.88 105.51 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 78.52 44.93 104.78 78.72 44.49 107.76 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 72.35 36.51 104.82 72.00 39.20 105.46 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 8 3 # 8 D 54 ASP J 53 ASP~? 5.09 ZN ZN J2001 D 281 ARG D 76 ARG^? 8.12 ZN ZN J2001 D 289 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 75.05 45.80 106.18 74.73 43.88 105.51 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 78.52 44.93 104.78 78.72 44.49 107.76 27.03 -40.97 -22.65 29.39 -42.82 -22.15 coo 72.35 36.51 104.82 72.00 39.20 105.46 18.53 -40.66 -20.20 16.59 -42.17 -21.51 1foh_c03 source 1foh PHENOL HYDROXYLASE : 8 hits 1foh_c03 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 51 GLU~? 22.57 ZN ZN G2004 A 319 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 359 ARG G 76 ARG^? 28.48 ZN ZN G2004 coo 14.41 12.40 16.42 12.92 13.74 15.71 23.15 8.42 10.27 24.62 9.66 9.42 coo 12.25 13.04 23.85 11.56 15.02 23.93 17.64 3.84 11.72 15.55 3.44 11.90 coo 10.89 14.95 28.28 12.39 12.53 29.31 15.16 1.90 14.98 12.60 3.57 14.85 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU B 51 GLU~? 6.60 ZN ZN B2003 A 319 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 359 ARG H 76 ARG^? 8.16 ZN ZN B2003 coo 14.41 12.40 16.42 12.92 13.74 15.71 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 12.25 13.04 23.85 11.56 15.02 23.93 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 10.89 14.95 28.28 12.39 12.53 29.31 -1.06 -24.66 18.73 -3.81 -23.46 18.10 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 319 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 359 ARG I 76 ARG^? 39.27 ZN ZN B2003 coo 14.41 12.40 16.42 12.92 13.74 15.71 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 12.25 13.04 23.85 11.56 15.02 23.93 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 10.89 14.95 28.28 12.39 12.53 29.31 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU D 51 GLU~? 22.34 ZN ZN J2001 A 319 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 359 ARG J 76 ARG^? 28.65 ZN ZN J2001 coo 14.41 12.40 16.42 12.92 13.74 15.71 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 12.25 13.04 23.85 11.56 15.02 23.93 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 10.89 14.95 28.28 12.39 12.53 29.31 11.46 -20.49 -30.64 9.14 -18.90 -31.92 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 A 317 GLU E 51 GLU~? 6.76 ZN ZN E2002 A 319 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 359 ARG F 76 ARG^? 8.13 ZN ZN E2002 coo 14.41 12.40 16.42 12.92 13.74 15.71 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 12.25 13.04 23.85 11.56 15.02 23.93 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 10.89 14.95 28.28 12.39 12.53 29.31 23.22 4.91 -15.14 20.87 6.80 -15.45 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 A 317 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 319 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 359 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 14.41 12.40 16.42 12.92 13.74 15.71 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 12.25 13.04 23.85 11.56 15.02 23.93 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 10.89 14.95 28.28 12.39 12.53 29.31 42.07 -13.66 -19.07 44.91 -14.78 -18.77 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 A 317 GLU G 51 GLU~? 6.79 ZN ZN G2004 A 319 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 359 ARG A 76 ARG^? 8.06 ZN ZN G2004 coo 14.41 12.40 16.42 12.92 13.74 15.71 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 12.25 13.04 23.85 11.56 15.02 23.93 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 10.89 14.95 28.28 12.39 12.53 29.31 40.48 -5.18 11.11 43.34 -6.18 11.48 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 A 317 GLU H 51 GLU~? 22.00 ZN ZN B2003 A 319 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 359 ARG B 76 ARG^? 28.58 ZN ZN B2003 coo 14.41 12.40 16.42 12.92 13.74 15.71 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 12.25 13.04 23.85 11.56 15.02 23.93 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 10.89 14.95 28.28 12.39 12.53 29.31 24.39 -28.01 26.54 26.98 -29.30 27.59 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 9 3 # 9 A 317 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 319 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 359 ARG C 76 ARG^? 39.61 ZN ZN J2001 coo 14.41 12.40 16.42 12.92 13.74 15.71 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 12.25 13.04 23.85 11.56 15.02 23.93 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 10.89 14.95 28.28 12.39 12.53 29.31 15.69 -49.41 6.25 17.68 -51.76 6.33 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 10 3 # 10 A 317 GLU J 51 GLU~? 6.72 ZN ZN J2001 A 319 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 359 ARG D 76 ARG^? 8.12 ZN ZN J2001 coo 14.41 12.40 16.42 12.92 13.74 15.71 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 12.25 13.04 23.85 11.56 15.02 23.93 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 10.89 14.95 28.28 12.39 12.53 29.31 27.03 -40.97 -22.65 29.39 -42.82 -22.15 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 10 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 51 GLU~? 22.57 ZN ZN G2004 B 319 ASP A 53 ASP~? 26.24 ZN ZN G2004 B 359 ARG G 76 ARG^? 28.48 ZN ZN G2004 coo 10.77 13.13 40.94 11.03 14.73 39.51 23.15 8.42 10.27 24.62 9.66 9.42 coo 3.77 12.64 38.21 3.35 14.53 37.39 17.64 3.84 11.72 15.55 3.44 11.90 coo -1.16 15.32 35.60 -3.32 13.56 36.98 15.16 1.90 14.98 12.60 3.57 14.85 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU C 51 GLU~? 32.75 ZN ZN B2003 B 319 ASP C 53 ASP~? 35.43 ZN ZN B2003 B 359 ARG I 76 ARG^? 39.27 ZN ZN B2003 coo 10.77 13.13 40.94 11.03 14.73 39.51 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 3.77 12.64 38.21 3.35 14.53 37.39 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU F 51 GLU~? 22.25 ZN ZN E2002 B 319 ASP F 53 ASP~? 26.13 ZN ZN E2002 B 359 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 10.77 13.13 40.94 11.03 14.73 39.51 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 3.77 12.64 38.21 3.35 14.53 37.39 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo -1.16 15.32 35.60 -3.32 13.56 36.98 42.07 -13.66 -19.07 44.91 -14.78 -18.77 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU I 51 GLU~? 32.52 ZN ZN J2001 B 319 ASP I 53 ASP~? 35.51 ZN ZN J2001 B 359 ARG C 76 ARG^? 39.61 ZN ZN J2001 coo 10.77 13.13 40.94 11.03 14.73 39.51 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 3.77 12.64 38.21 3.35 14.53 37.39 15.88 -49.61 0.98 17.43 -49.51 2.42 coo -1.16 15.32 35.60 -3.32 13.56 36.98 15.69 -49.41 6.25 17.68 -51.76 6.33 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 4 hits 1fr8_c01 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 20 GLU~? -13.24 ZN ZN E2002s A 47 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 161 TYR F 78 TYR.? 11.63 ZN ZN E2002 coo 37.12 18.35 73.76 37.09 16.69 72.44 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 29.81 8.06 73.13 30.21 10.11 72.95 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 37.29 15.56 67.90 37.37 13.79 70.08 22.38 6.39 -10.32 21.34 4.29 -11.84 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU B 20 GLU~? 25.90 ZN ZN B2003 A 47 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 161 TYR G 78 TYR.? 24.68 ZN ZN B2003 coo 37.12 18.35 73.76 37.09 16.69 72.44 7.89 1.30 17.42 7.18 2.96 16.29 coo 29.81 8.06 73.13 30.21 10.11 72.95 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 37.29 15.56 67.90 37.37 13.79 70.08 12.17 -1.26 17.53 12.70 -0.59 14.88 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU C 20 GLU~? -13.13 ZN ZN B2003s A 47 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 161 TYR H 78 TYR.? 11.76 ZN ZN B2003 coo 37.12 18.35 73.76 37.09 16.69 72.44 -6.90 -26.36 14.56 -8.07 -24.73 15.22 coo 29.81 8.06 73.13 30.21 10.11 72.95 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 37.29 15.56 67.90 37.37 13.79 70.08 -2.69 -28.08 15.14 -1.32 -25.64 14.90 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU D 20 GLU~? 40.68 ZN ZN J2001 A 47 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 161 TYR I 78 TYR.? 35.62 ZN ZN J2001 coo 37.12 18.35 73.76 37.09 16.69 72.44 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 29.81 8.06 73.13 30.21 10.11 72.95 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 37.29 15.56 67.90 37.37 13.79 70.08 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU E 20 GLU~? 26.08 ZN ZN E2002 A 47 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 161 TYR J 78 TYR.? 24.76 ZN ZN E2002 coo 37.12 18.35 73.76 37.09 16.69 72.44 9.85 -13.14 -31.23 7.79 -13.45 -31.58 coo 29.81 8.06 73.13 30.21 10.11 72.95 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 37.29 15.56 67.90 37.37 13.79 70.08 13.85 -15.66 -29.81 12.10 -17.30 -28.36 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 A 36 GLU F 20 GLU~? -13.12 ZN ZN G2004s A 47 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 161 TYR A 78 TYR.? 11.65 ZN ZN G2004 coo 37.12 18.35 73.76 37.09 16.69 72.44 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 29.81 8.06 73.13 30.21 10.11 72.95 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 37.29 15.56 67.90 37.37 13.79 70.08 42.29 -5.11 6.34 41.03 -7.11 7.84 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 A 36 GLU G 20 GLU~? 25.94 ZN ZN G2004 A 47 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 161 TYR B 78 TYR.? 24.55 ZN ZN G2004 coo 37.12 18.35 73.76 37.09 16.69 72.44 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 29.81 8.06 73.13 30.21 10.11 72.95 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 37.29 15.56 67.90 37.37 13.79 70.08 27.46 -23.45 25.85 26.96 -25.77 24.34 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 8 3 # 8 A 36 GLU H 20 GLU~? 40.75 ZN ZN B2003 A 47 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 161 TYR C 78 TYR^? 35.69 ZN ZN B2003 coo 37.12 18.35 73.76 37.09 16.69 72.44 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 29.81 8.06 73.13 30.21 10.11 72.95 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.52 -47.66 10.31 18.03 -47.38 7.99 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 9 3 # 9 A 36 GLU I 20 GLU~? -12.94 ZN ZN J2001s A 47 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 161 TYR D 78 TYR.? 11.76 ZN ZN J2001 coo 37.12 18.35 73.76 37.09 16.69 72.44 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 29.81 8.06 73.13 30.21 10.11 72.95 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 37.29 15.56 67.90 37.37 13.79 70.08 24.81 -44.15 -19.15 26.32 -41.78 -18.93 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 10 3 # 10 A 36 GLU J 20 GLU~? 25.99 ZN ZN J2001 A 47 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 161 TYR E 78 TYR.? 24.67 ZN ZN J2001 coo 37.12 18.35 73.76 37.09 16.69 72.44 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 29.81 8.06 73.13 30.21 10.11 72.95 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 37.29 15.56 67.90 37.37 13.79 70.08 40.71 -17.77 -21.60 40.95 -16.95 -18.92 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 10 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 20 GLU~? -13.24 ZN ZN E2002s B 47 ASP A 39 ASP.? 16.23 ZN ZN E2002 B 161 TYR F 78 TYR.? 11.63 ZN ZN E2002 coo 53.87 35.49 53.22 55.44 35.72 54.61 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 63.47 43.65 53.95 61.45 43.07 54.06 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 56.38 35.81 59.19 58.25 35.77 57.10 22.38 6.39 -10.32 21.34 4.29 -11.84 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU B 20 GLU~? 25.90 ZN ZN B2003 B 47 ASP B 39 ASP.? 27.28 ZN ZN B2003 B 161 TYR G 78 TYR.? 24.68 ZN ZN B2003 coo 53.87 35.49 53.22 55.44 35.72 54.61 7.89 1.30 17.42 7.18 2.96 16.29 coo 63.47 43.65 53.95 61.45 43.07 54.06 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 56.38 35.81 59.19 58.25 35.77 57.10 12.17 -1.26 17.53 12.70 -0.59 14.88 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU C 20 GLU~? -13.13 ZN ZN B2003s B 47 ASP C 39 ASP.? 16.40 ZN ZN B2003 B 161 TYR H 78 TYR.? 11.76 ZN ZN B2003 coo 53.87 35.49 53.22 55.44 35.72 54.61 -6.90 -26.36 14.56 -8.07 -24.73 15.22 coo 63.47 43.65 53.95 61.45 43.07 54.06 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 56.38 35.81 59.19 58.25 35.77 57.10 -2.69 -28.08 15.14 -1.32 -25.64 14.90 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU D 20 GLU~? 40.68 ZN ZN J2001 B 47 ASP D 39 ASP.? 32.27 ZN ZN B2003 B 161 TYR I 78 TYR.? 35.62 ZN ZN J2001 coo 53.87 35.49 53.22 55.44 35.72 54.61 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 63.47 43.65 53.95 61.45 43.07 54.06 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 56.38 35.81 59.19 58.25 35.77 57.10 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU E 20 GLU~? 26.08 ZN ZN E2002 B 47 ASP E 39 ASP.? 27.23 ZN ZN E2002 B 161 TYR J 78 TYR.? 24.76 ZN ZN E2002 coo 53.87 35.49 53.22 55.44 35.72 54.61 9.85 -13.14 -31.23 7.79 -13.45 -31.58 coo 63.47 43.65 53.95 61.45 43.07 54.06 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 56.38 35.81 59.19 58.25 35.77 57.10 13.85 -15.66 -29.81 12.10 -17.30 -28.36 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 B 36 GLU F 20 GLU~? -13.12 ZN ZN G2004s B 47 ASP F 39 ASP.? 16.21 ZN ZN G2004 B 161 TYR A 78 TYR.? 11.65 ZN ZN G2004 coo 53.87 35.49 53.22 55.44 35.72 54.61 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 63.47 43.65 53.95 61.45 43.07 54.06 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 56.38 35.81 59.19 58.25 35.77 57.10 42.29 -5.11 6.34 41.03 -7.11 7.84 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 B 36 GLU G 20 GLU~? 25.94 ZN ZN G2004 B 47 ASP G 39 ASP.? 27.24 ZN ZN G2004 B 161 TYR B 78 TYR.? 24.55 ZN ZN G2004 coo 53.87 35.49 53.22 55.44 35.72 54.61 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 63.47 43.65 53.95 61.45 43.07 54.06 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 56.38 35.81 59.19 58.25 35.77 57.10 27.46 -23.45 25.85 26.96 -25.77 24.34 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 8 3 # 8 B 36 GLU H 20 GLU~? 40.75 ZN ZN B2003 B 47 ASP H 39 ASP.? 32.15 ZN ZN J2001 B 161 TYR C 78 TYR^? 35.69 ZN ZN B2003 coo 53.87 35.49 53.22 55.44 35.72 54.61 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 63.47 43.65 53.95 61.45 43.07 54.06 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.52 -47.66 10.31 18.03 -47.38 7.99 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 9 3 # 9 B 36 GLU I 20 GLU~? -12.94 ZN ZN J2001s B 47 ASP I 39 ASP.? 16.30 ZN ZN J2001 B 161 TYR D 78 TYR.? 11.76 ZN ZN J2001 coo 53.87 35.49 53.22 55.44 35.72 54.61 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 63.47 43.65 53.95 61.45 43.07 54.06 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 56.38 35.81 59.19 58.25 35.77 57.10 24.81 -44.15 -19.15 26.32 -41.78 -18.93 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 10 3 # 10 B 36 GLU J 20 GLU~? 25.99 ZN ZN J2001 B 47 ASP J 39 ASP.? 27.27 ZN ZN J2001 B 161 TYR E 78 TYR.? 24.67 ZN ZN J2001 coo 53.87 35.49 53.22 55.44 35.72 54.61 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 63.47 43.65 53.95 61.45 43.07 54.06 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 56.38 35.81 59.19 58.25 35.77 57.10 40.71 -17.77 -21.60 40.95 -16.95 -18.92 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 10 hits 1geq_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 75 PHE^? 9.36 ZN ZN G2004 A 298 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 329 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 12.42 6.10 23.27 9.95 1.57 20.16 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 75 PHE^? 21.46 ZN ZN B2003 A 298 ASP H 54 ASP~? 25.78 ZN ZN B2003 A 329 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 2.59 0.29 25.55 4.65 0.18 25.07 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 12.42 6.10 23.27 9.95 1.57 20.16 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE C 75 PHE^? 34.12 ZN ZN J2001 A 298 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 329 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 2.59 0.29 25.55 4.65 0.18 25.07 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 12.42 6.10 23.27 9.95 1.57 20.16 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE D 75 PHE^? 9.38 ZN ZN J2001 A 298 ASP J 54 ASP~? -2.24 ZN ZN J2001s A 329 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 2.59 0.29 25.55 4.65 0.18 25.07 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 12.42 6.10 23.27 9.95 1.57 20.16 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE E 75 PHE^? 21.52 ZN ZN E2002 A 298 ASP F 54 ASP~? 25.15 ZN ZN E2002 A 329 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 2.59 0.29 25.55 4.65 0.18 25.07 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 12.42 6.10 23.27 9.95 1.57 20.16 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 298 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 329 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 2.59 0.29 25.55 4.65 0.18 25.07 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 12.42 6.10 23.27 9.95 1.57 20.16 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE G 75 PHE^? 21.55 ZN ZN G2004 A 298 ASP A 54 ASP~? 25.58 ZN ZN G2004 A 329 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 2.59 0.29 25.55 4.65 0.18 25.07 19.11 8.17 8.99 18.99 8.60 11.06 coo 12.42 6.10 23.27 9.95 1.57 20.16 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE H 75 PHE^? 9.39 ZN ZN B2003 A 298 ASP B 54 ASP~? -2.43 ZN ZN B2003s A 329 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 2.59 0.29 25.55 4.65 0.18 25.07 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 12.42 6.10 23.27 9.95 1.57 20.16 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE I 75 PHE^? 34.28 ZN ZN B2003 A 298 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 329 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 2.59 0.29 25.55 4.65 0.18 25.07 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 12.42 6.10 23.27 9.95 1.57 20.16 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE J 75 PHE^? 21.52 ZN ZN J2001 A 298 ASP D 54 ASP~? 25.75 ZN ZN J2001 A 329 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 2.59 0.29 25.55 4.65 0.18 25.07 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 12.42 6.10 23.27 9.95 1.57 20.16 12.18 -35.43 -32.57 13.23 -33.76 -37.61 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 10 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 75 PHE^? 9.36 ZN ZN G2004 B 298 ASP G 54 ASP~? -2.04 ZN ZN G2004s B 329 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 75 PHE^? 21.46 ZN ZN B2003 B 298 ASP H 54 ASP~? 25.78 ZN ZN B2003 B 329 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE C 75 PHE^? 34.12 ZN ZN J2001 B 298 ASP I 54 ASP~? 33.46 ZN ZN J2001 B 329 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE D 75 PHE^? 9.38 ZN ZN J2001 B 298 ASP J 54 ASP~? -2.24 ZN ZN J2001s B 329 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE E 75 PHE^? 21.52 ZN ZN E2002 B 298 ASP F 54 ASP~? 25.15 ZN ZN E2002 B 329 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE F 75 PHE^? 9.34 ZN ZN E2002 B 298 ASP E 54 ASP~? -2.11 ZN ZN E2002s B 329 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE G 75 PHE^? 21.55 ZN ZN G2004 B 298 ASP A 54 ASP~? 25.58 ZN ZN G2004 B 329 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 19.11 8.17 8.99 18.99 8.60 11.06 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE H 75 PHE^? 9.39 ZN ZN B2003 B 298 ASP B 54 ASP~? -2.43 ZN ZN B2003s B 329 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE I 75 PHE^? 34.28 ZN ZN B2003 B 298 ASP C 54 ASP~? 34.22 ZN ZN B2003 B 329 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE J 75 PHE^? 21.52 ZN ZN J2001 B 298 ASP D 54 ASP~? 25.75 ZN ZN J2001 B 329 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 12.18 -35.43 -32.57 13.23 -33.76 -37.61 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 10 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 75 PHE^? 9.36 ZN ZN G2004 C 298 ASP G 54 ASP~? -2.04 ZN ZN G2004s C 329 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 17.41 60.57 64.39 18.40 58.12 65.34 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 27.64 56.61 58.17 22.18 57.92 60.36 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 75 PHE^? 21.46 ZN ZN B2003 C 298 ASP H 54 ASP~? 25.78 ZN ZN B2003 C 329 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 17.41 60.57 64.39 18.40 58.12 65.34 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 24.10 66.43 63.33 24.18 64.30 63.40 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 27.64 56.61 58.17 22.18 57.92 60.36 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE C 75 PHE^? 34.12 ZN ZN J2001 C 298 ASP I 54 ASP~? 33.46 ZN ZN J2001 C 329 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 17.41 60.57 64.39 18.40 58.12 65.34 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 24.10 66.43 63.33 24.18 64.30 63.40 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 27.64 56.61 58.17 22.18 57.92 60.36 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE D 75 PHE^? 9.38 ZN ZN J2001 C 298 ASP J 54 ASP~? -2.24 ZN ZN J2001s C 329 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 17.41 60.57 64.39 18.40 58.12 65.34 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 24.10 66.43 63.33 24.18 64.30 63.40 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 27.64 56.61 58.17 22.18 57.92 60.36 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE E 75 PHE^? 21.52 ZN ZN E2002 C 298 ASP F 54 ASP~? 25.15 ZN ZN E2002 C 329 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 17.41 60.57 64.39 18.40 58.12 65.34 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 24.10 66.43 63.33 24.18 64.30 63.40 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 27.64 56.61 58.17 22.18 57.92 60.36 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE F 75 PHE^? 9.34 ZN ZN E2002 C 298 ASP E 54 ASP~? -2.11 ZN ZN E2002s C 329 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 17.41 60.57 64.39 18.40 58.12 65.34 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 24.10 66.43 63.33 24.18 64.30 63.40 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 27.64 56.61 58.17 22.18 57.92 60.36 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE G 75 PHE^? 21.55 ZN ZN G2004 C 298 ASP A 54 ASP~? 25.58 ZN ZN G2004 C 329 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 17.41 60.57 64.39 18.40 58.12 65.34 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 24.10 66.43 63.33 24.18 64.30 63.40 19.11 8.17 8.99 18.99 8.60 11.06 coo 27.64 56.61 58.17 22.18 57.92 60.36 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE H 75 PHE^? 9.39 ZN ZN B2003 C 298 ASP B 54 ASP~? -2.43 ZN ZN B2003s C 329 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 17.41 60.57 64.39 18.40 58.12 65.34 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 24.10 66.43 63.33 24.18 64.30 63.40 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 27.64 56.61 58.17 22.18 57.92 60.36 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE I 75 PHE^? 34.28 ZN ZN B2003 C 298 ASP C 54 ASP~? 34.22 ZN ZN B2003 C 329 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 17.41 60.57 64.39 18.40 58.12 65.34 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 24.10 66.43 63.33 24.18 64.30 63.40 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 27.64 56.61 58.17 22.18 57.92 60.36 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE J 75 PHE^? 21.52 ZN ZN J2001 C 298 ASP D 54 ASP~? 25.75 ZN ZN J2001 C 329 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 17.41 60.57 64.39 18.40 58.12 65.34 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 24.10 66.43 63.33 24.18 64.30 63.40 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 27.64 56.61 58.17 22.18 57.92 60.36 12.18 -35.43 -32.57 13.23 -33.76 -37.61 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 10 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 75 PHE^? 9.36 ZN ZN G2004 D 298 ASP G 54 ASP~? -2.04 ZN ZN G2004s D 329 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 35.44 53.35 83.81 35.65 54.53 81.28 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 36.89 44.91 74.55 37.33 48.94 79.01 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 75 PHE^? 21.46 ZN ZN B2003 D 298 ASP H 54 ASP~? 25.78 ZN ZN B2003 D 329 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 35.44 53.35 83.81 35.65 54.53 81.28 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 29.72 46.46 83.60 30.79 47.36 81.99 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 36.89 44.91 74.55 37.33 48.94 79.01 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE C 75 PHE^? 34.12 ZN ZN J2001 D 298 ASP I 54 ASP~? 33.46 ZN ZN J2001 D 329 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 35.44 53.35 83.81 35.65 54.53 81.28 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 29.72 46.46 83.60 30.79 47.36 81.99 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 36.89 44.91 74.55 37.33 48.94 79.01 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE D 75 PHE^? 9.38 ZN ZN J2001 D 298 ASP J 54 ASP~? -2.24 ZN ZN J2001s D 329 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 35.44 53.35 83.81 35.65 54.53 81.28 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 29.72 46.46 83.60 30.79 47.36 81.99 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 36.89 44.91 74.55 37.33 48.94 79.01 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE E 75 PHE^? 21.52 ZN ZN E2002 D 298 ASP F 54 ASP~? 25.15 ZN ZN E2002 D 329 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 35.44 53.35 83.81 35.65 54.53 81.28 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 29.72 46.46 83.60 30.79 47.36 81.99 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 36.89 44.91 74.55 37.33 48.94 79.01 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE F 75 PHE^? 9.34 ZN ZN E2002 D 298 ASP E 54 ASP~? -2.11 ZN ZN E2002s D 329 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 35.44 53.35 83.81 35.65 54.53 81.28 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 29.72 46.46 83.60 30.79 47.36 81.99 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 36.89 44.91 74.55 37.33 48.94 79.01 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE G 75 PHE^? 21.55 ZN ZN G2004 D 298 ASP A 54 ASP~? 25.58 ZN ZN G2004 D 329 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 35.44 53.35 83.81 35.65 54.53 81.28 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 29.72 46.46 83.60 30.79 47.36 81.99 19.11 8.17 8.99 18.99 8.60 11.06 coo 36.89 44.91 74.55 37.33 48.94 79.01 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE H 75 PHE^? 9.39 ZN ZN B2003 D 298 ASP B 54 ASP~? -2.43 ZN ZN B2003s D 329 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 35.44 53.35 83.81 35.65 54.53 81.28 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 29.72 46.46 83.60 30.79 47.36 81.99 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 36.89 44.91 74.55 37.33 48.94 79.01 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE I 75 PHE^? 34.28 ZN ZN B2003 D 298 ASP C 54 ASP~? 34.22 ZN ZN B2003 D 329 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 35.44 53.35 83.81 35.65 54.53 81.28 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 29.72 46.46 83.60 30.79 47.36 81.99 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 36.89 44.91 74.55 37.33 48.94 79.01 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE J 75 PHE^? 21.52 ZN ZN J2001 D 298 ASP D 54 ASP~? 25.75 ZN ZN J2001 D 329 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 35.44 53.35 83.81 35.65 54.53 81.28 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 29.72 46.46 83.60 30.79 47.36 81.99 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 36.89 44.91 74.55 37.33 48.94 79.01 12.18 -35.43 -32.57 13.23 -33.76 -37.61 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 10 hits 1gtx_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 16 GLN~? 8.86 ZN ZN E2002 A 296 GLU A 20 GLU~? -13.24 ZN ZN E2002s A 383 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 17.90 4.40 -14.76 17.54 4.89 -16.79 coo 40.93 4.45 2.36 38.91 3.75 2.26 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 30.54 7.22 6.23 31.38 5.79 3.97 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN B 16 GLN~? 29.51 ZN ZN B2003 A 296 GLU B 20 GLU~? 25.90 ZN ZN B2003 A 383 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 9.49 2.71 13.32 9.74 4.80 12.97 coo 40.93 4.45 2.36 38.91 3.75 2.26 7.89 1.30 17.42 7.18 2.96 16.29 coo 30.54 7.22 6.23 31.38 5.79 3.97 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN C 16 GLN~? 8.88 ZN ZN B2003 A 296 GLU C 20 GLU~? -13.13 ZN ZN B2003s A 383 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -3.18 -21.19 15.30 -3.89 -19.78 16.71 coo 40.93 4.45 2.36 38.91 3.75 2.26 -6.90 -26.36 14.56 -8.07 -24.73 15.22 coo 30.54 7.22 6.23 31.38 5.79 3.97 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 4 3 # 4 A 271 GLN D 16 GLN~? 38.00 ZN ZN B2003 A 296 GLU D 20 GLU~? 40.68 ZN ZN J2001 A 383 TYR D 32 TYR^? 29.54 ZN ZN J2001 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -5.95 -34.65 -9.91 -7.94 -35.26 -9.42 coo 40.93 4.45 2.36 38.91 3.75 2.26 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 30.54 7.22 6.23 31.38 5.79 3.97 4.78 -40.18 -12.99 5.15 -42.55 -14.41 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 5 3 # 5 A 271 GLN F 16 GLN~? 8.74 ZN ZN G2004 A 296 GLU F 20 GLU~? -13.12 ZN ZN G2004s A 383 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 43.08 -9.74 10.82 43.38 -10.14 12.88 coo 40.93 4.45 2.36 38.91 3.75 2.26 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 30.54 7.22 6.23 31.38 5.79 3.97 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 6 3 # 6 A 271 GLN G 16 GLN~? 29.00 ZN ZN G2004 A 296 GLU G 20 GLU~? 25.94 ZN ZN G2004 A 383 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 29.23 -29.78 24.84 30.23 -30.75 26.43 coo 40.93 4.45 2.36 38.91 3.75 2.26 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 30.54 7.22 6.23 31.38 5.79 3.97 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 7 3 # 7 A 271 GLN H 16 GLN~? 37.84 ZN ZN J2001 A 296 GLU H 20 GLU~? 40.75 ZN ZN B2003 A 383 TYR H 32 TYR^? 29.55 ZN ZN B2003 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 21.32 -50.34 6.36 21.72 -52.20 5.40 coo 40.93 4.45 2.36 38.91 3.75 2.26 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 30.54 7.22 6.23 31.38 5.79 3.97 10.73 -43.63 9.08 8.41 -44.48 10.38 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 8 3 # 8 A 271 GLN I 16 GLN~? 8.71 ZN ZN J2001 A 296 GLU I 20 GLU~? -12.94 ZN ZN J2001s A 383 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 31.04 -41.10 -19.37 32.61 -40.90 -20.76 coo 40.93 4.45 2.36 38.91 3.75 2.26 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 30.54 7.22 6.23 31.38 5.79 3.97 18.53 -40.66 -20.20 16.59 -42.17 -21.51 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 9 3 # 9 A 271 GLN J 16 GLN~? 29.83 ZN ZN J2001 A 296 GLU J 20 GLU~? 25.99 ZN ZN J2001 A 383 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 45.73 -18.03 -17.12 47.36 -16.75 -16.59 coo 40.93 4.45 2.36 38.91 3.75 2.26 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 30.54 7.22 6.23 31.38 5.79 3.97 34.34 -14.57 -22.60 34.05 -13.83 -25.28 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 9 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 327 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 339 ARG C 45 ARG^? 26.07 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 75.11 41.01 160.30 76.65 40.06 161.41 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 1.94 -44.34 10.41 3.55 -43.42 12.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 327 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 339 ARG H 45 ARG^? 19.95 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 75.11 41.01 160.30 76.65 40.06 161.41 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.47 -38.69 20.81 5.22 -38.73 18.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 327 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 339 ARG C 45 ARG^? 26.07 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 75.11 41.01 160.30 76.65 40.06 161.41 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 82.23 40.35 159.87 85.09 40.67 161.01 1.94 -44.34 10.41 3.55 -43.42 12.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 327 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 339 ARG H 45 ARG^? 19.95 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 75.11 41.01 160.30 76.65 40.06 161.41 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.47 -38.69 20.81 5.22 -38.73 18.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 327 GLU H 64 GLU.? 37.89 ZN ZN G2004 A 339 ARG H 11 ARG.? 35.53 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 26.93 6.24 15.37 25.45 7.75 15.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 32.53 -42.71 11.25 33.49 -41.02 10.38 coo 82.23 40.35 159.87 85.09 40.67 161.01 31.27 -41.17 3.82 32.37 -41.49 6.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 327 GLU J 30 GLU^? 21.96 ZN ZN E2002 A 339 ARG E 45 ARG^? 19.39 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 26.93 6.24 15.37 25.45 7.75 15.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 29.50 -9.81 -28.77 30.55 -12.66 -29.14 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 327 GLU E 20 GLU~? 26.08 ZN ZN E2002 A 339 ARG J 76 ARG^? 28.65 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 17.64 3.84 11.72 15.55 3.44 11.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 9.85 -13.14 -31.23 7.79 -13.45 -31.58 coo 82.23 40.35 159.87 85.09 40.67 161.01 11.46 -20.49 -30.64 9.14 -18.90 -31.92 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 327 GLU H 64 GLU.? 37.89 ZN ZN G2004 A 339 ARG H 11 ARG.? 35.53 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 17.64 3.84 11.72 15.55 3.44 11.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 32.53 -42.71 11.25 33.49 -41.02 10.38 coo 82.23 40.35 159.87 85.09 40.67 161.01 31.27 -41.17 3.82 32.37 -41.49 6.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 327 GLU I 20 GLU~? -12.94 ZN ZN J2001s A 339 ARG D 76 ARG^? 8.12 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.03 -40.97 -22.65 29.39 -42.82 -22.15 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 327 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 339 ARG D 45 ARG^? 20.03 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.69 -40.60 -24.75 11.69 -42.61 -22.61 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 327 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 339 ARG I 45 ARG^? 26.51 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 9.19 -47.86 -14.39 8.02 -46.02 -16.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 327 GLU J 50 GLU~? -2.50 ZN ZN J2001s A 339 ARG D 76 ARG^? 8.12 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.03 -40.97 -22.65 29.39 -42.82 -22.15 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 327 GLU F 30 GLU^? 19.95 ZN ZN G2004 A 339 ARG A 45 ARG^? 20.10 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 75.11 41.01 160.30 76.65 40.06 161.41 38.23 2.77 0.52 36.38 3.82 0.63 coo 82.23 40.35 159.87 85.09 40.67 161.01 32.14 6.60 3.52 34.39 5.41 1.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 327 GLU I 64 GLU.? 25.65 ZN ZN J2001 A 339 ARG I 11 ARG.? 22.73 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 75.11 41.01 160.30 76.65 40.06 161.41 34.90 -43.61 -5.62 35.57 -42.49 -3.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 35.67 -37.65 -8.31 35.98 -40.29 -6.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 327 GLU I 64 GLU.? 25.65 ZN ZN J2001 A 339 ARG I 11 ARG.? 22.73 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 75.11 41.01 160.30 76.65 40.06 161.41 34.90 -43.61 -5.62 35.57 -42.49 -3.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 35.67 -37.65 -8.31 35.98 -40.29 -6.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 327 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 339 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 42.07 -13.66 -19.07 44.91 -14.78 -18.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 327 GLU J 30 GLU^? 21.96 ZN ZN E2002 A 339 ARG E 45 ARG^? 19.39 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 29.50 -9.81 -28.77 30.55 -12.66 -29.14 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 327 GLU J 30 GLU^? 21.96 ZN ZN E2002 A 339 ARG J 45 ARG^? 19.30 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.80 -22.06 -31.67 26.75 -19.22 -31.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 327 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 339 ARG B 45 ARG^? 19.26 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 14.90 -14.60 27.65 17.88 -13.95 27.44 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 327 GLU J 64 GLU.? 23.99 ZN ZN J2001 A 339 ARG J 11 ARG.? 26.46 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 44.01 -30.69 -11.59 43.10 -30.84 -9.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 42.15 -25.47 -6.25 43.21 -27.78 -7.96 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 327 GLU B 20 GLU~? 25.90 ZN ZN B2003 A 339 ARG G 76 ARG^? 28.48 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 7.89 1.30 17.42 7.18 2.96 16.29 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.16 1.90 14.98 12.60 3.57 14.85 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 22 3 # 22 A 50 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 327 GLU J 64 GLU.? 23.99 ZN ZN J2001 A 339 ARG J 11 ARG.? 26.46 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 44.01 -30.69 -11.59 43.10 -30.84 -9.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 42.15 -25.47 -6.25 43.21 -27.78 -7.96 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 23 3 # 23 A 50 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 327 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 339 ARG J 45 ARG^? 19.30 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 75.11 41.01 160.30 76.65 40.06 161.41 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.80 -22.06 -31.67 26.75 -19.22 -31.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 24 3 # 24 A 50 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 327 GLU F 30 GLU^? 19.95 ZN ZN G2004 A 339 ARG A 45 ARG^? 20.10 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 75.11 41.01 160.30 76.65 40.06 161.41 38.23 2.77 0.52 36.38 3.82 0.63 coo 82.23 40.35 159.87 85.09 40.67 161.01 32.14 6.60 3.52 34.39 5.41 1.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 25 3 # 25 A 50 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 327 GLU F 30 GLU^? 19.95 ZN ZN G2004 A 339 ARG F 45 ARG^? 20.07 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 75.11 41.01 160.30 76.65 40.06 161.41 38.23 2.77 0.52 36.38 3.82 0.63 coo 82.23 40.35 159.87 85.09 40.67 161.01 37.54 3.46 -7.45 35.47 4.92 -5.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 26 3 # 26 A 50 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 327 GLU F 64 GLU.? 24.41 ZN ZN G2004 A 339 ARG F 11 ARG.? 21.89 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 75.11 41.01 160.30 76.65 40.06 161.41 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 82.23 40.35 159.87 85.09 40.67 161.01 41.25 -22.37 6.05 44.11 -21.50 5.36 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 27 3 # 27 A 50 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 327 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 339 ARG C 45 ARG^? 26.07 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 75.11 41.01 160.30 76.65 40.06 161.41 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 82.23 40.35 159.87 85.09 40.67 161.01 1.94 -44.34 10.41 3.55 -43.42 12.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 28 3 # 28 A 50 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 327 GLU C 20 GLU~? -13.13 ZN ZN B2003s A 339 ARG H 76 ARG^? 8.16 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 75.11 41.01 160.30 76.65 40.06 161.41 -6.90 -26.36 14.56 -8.07 -24.73 15.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.06 -24.66 18.73 -3.81 -23.46 18.10 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 29 3 # 29 A 50 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 327 GLU F 64 GLU.? 24.41 ZN ZN G2004 A 339 ARG F 11 ARG.? 21.89 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 75.11 41.01 160.30 76.65 40.06 161.41 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 82.23 40.35 159.87 85.09 40.67 161.01 41.25 -22.37 6.05 44.11 -21.50 5.36 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 30 3 # 30 A 50 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 327 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 339 ARG B 45 ARG^? 19.26 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 75.11 41.01 160.30 76.65 40.06 161.41 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 14.90 -14.60 27.65 17.88 -13.95 27.44 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 31 3 # 31 A 50 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 327 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 339 ARG G 45 ARG^? 19.42 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 75.11 41.01 160.30 76.65 40.06 161.41 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 24.66 -6.90 24.79 21.69 -7.61 25.11 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 32 3 # 32 A 50 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 327 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 339 ARG B 76 ARG^? 28.58 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 75.11 41.01 160.30 76.65 40.06 161.41 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 82.23 40.35 159.87 85.09 40.67 161.01 24.39 -28.01 26.54 26.98 -29.30 27.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 33 3 # 33 A 50 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 327 GLU G 64 GLU.? 24.28 ZN ZN G2004 A 339 ARG G 11 ARG.? 26.12 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 39.99 -27.18 15.98 39.71 -28.44 14.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 34.84 -31.69 12.58 37.28 -30.08 13.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 34 3 # 34 A 50 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 327 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 339 ARG D 45 ARG^? 20.03 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.69 -40.60 -24.75 11.69 -42.61 -22.61 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 35 3 # 35 A 50 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 327 GLU D 20 GLU~? 40.68 ZN ZN J2001 A 339 ARG I 76 ARG^? 39.27 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 82.23 40.35 159.87 85.09 40.67 161.01 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 36 3 # 36 A 50 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 327 GLU G 64 GLU.? 24.28 ZN ZN G2004 A 339 ARG G 11 ARG.? 26.12 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 39.99 -27.18 15.98 39.71 -28.44 14.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 34.84 -31.69 12.58 37.28 -30.08 13.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 37 3 # 37 A 50 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 327 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 339 ARG G 45 ARG^? 19.42 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 24.66 -6.90 24.79 21.69 -7.61 25.11 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 38 3 # 38 A 50 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 327 GLU D 20 GLU~? 40.68 ZN ZN J2001 A 339 ARG I 76 ARG^? 39.27 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 82.23 40.35 159.87 85.09 40.67 161.01 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 39 3 # 39 A 50 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 327 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 339 ARG I 76 ARG^? 39.27 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 82.23 40.35 159.87 85.09 40.67 161.01 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 40 3 # 40 A 50 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 327 GLU D 30 GLU^? 25.95 ZN ZN J2001 A 339 ARG D 45 ARG^? 20.03 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.69 -40.60 -24.75 11.69 -42.61 -22.61 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 41 3 # 41 A 50 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 327 GLU D 30 GLU^? 25.95 ZN ZN J2001 A 339 ARG I 45 ARG^? 26.51 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 9.19 -47.86 -14.39 8.02 -46.02 -16.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 42 3 # 42 A 50 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 327 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 339 ARG D 45 ARG^? 20.03 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.69 -40.60 -24.75 11.69 -42.61 -22.61 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 43 3 # 43 A 50 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 327 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 339 ARG I 45 ARG^? 26.51 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 9.19 -47.86 -14.39 8.02 -46.02 -16.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 44 3 # 44 A 50 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 327 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 339 ARG G 45 ARG^? 19.42 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 24.66 -6.90 24.79 21.69 -7.61 25.11 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 45 3 # 45 A 50 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 327 GLU D 64 GLU.? 37.94 ZN ZN E2002 A 339 ARG D 11 ARG.? 35.27 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 46 3 # 46 A 50 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 327 GLU D 64 GLU.? 37.94 ZN ZN E2002 A 339 ARG D 11 ARG.? 35.27 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 75.11 41.01 160.30 76.65 40.06 161.41 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 47 3 # 47 A 50 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 327 GLU G 20 GLU~? 25.94 ZN ZN G2004 A 339 ARG B 76 ARG^? 28.58 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 75.11 41.01 160.30 76.65 40.06 161.41 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 24.39 -28.01 26.54 26.98 -29.30 27.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 48 3 # 48 A 50 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 327 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 339 ARG J 76 ARG^? 28.65 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 75.11 41.01 160.30 76.65 40.06 161.41 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 82.23 40.35 159.87 85.09 40.67 161.01 11.46 -20.49 -30.64 9.14 -18.90 -31.92 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 49 3 # 49 A 50 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 327 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 339 ARG E 45 ARG^? 19.39 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 75.11 41.01 160.30 76.65 40.06 161.41 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 82.23 40.35 159.87 85.09 40.67 161.01 29.50 -9.81 -28.77 30.55 -12.66 -29.14 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 50 3 # 50 A 50 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 327 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 339 ARG J 45 ARG^? 19.30 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 75.11 41.01 160.30 76.65 40.06 161.41 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.80 -22.06 -31.67 26.75 -19.22 -31.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 51 3 # 51 A 50 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 327 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 339 ARG H 45 ARG^? 19.95 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 33.55 0.62 19.07 33.72 1.88 17.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.47 -38.69 20.81 5.22 -38.73 18.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 52 3 # 52 A 50 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 327 GLU E 64 GLU.? 24.43 ZN ZN E2002 A 339 ARG E 11 ARG.? 26.51 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 33.55 0.62 19.07 33.72 1.88 17.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo 82.23 40.35 159.87 85.09 40.67 161.01 3.07 -13.39 -16.26 3.11 -10.68 -17.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 53 3 # 53 A 50 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 327 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 339 ARG H 45 ARG^? 19.95 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 33.55 0.62 19.07 33.72 1.88 17.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.47 -38.69 20.81 5.22 -38.73 18.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 54 3 # 54 A 50 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 327 GLU E 64 GLU.? 24.43 ZN ZN E2002 A 339 ARG E 11 ARG.? 26.51 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo 82.23 40.35 159.87 85.09 40.67 161.01 3.07 -13.39 -16.26 3.11 -10.68 -17.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 55 3 # 55 A 50 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 327 GLU H 20 GLU~? 40.75 ZN ZN B2003 A 339 ARG C 76 ARG^? 39.61 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.69 -49.41 6.25 17.68 -51.76 6.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 56 3 # 56 A 50 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 327 GLU H 20 GLU~? 40.75 ZN ZN B2003 A 339 ARG C 76 ARG^? 39.61 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 75.11 41.01 160.30 76.65 40.06 161.41 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.69 -49.41 6.25 17.68 -51.76 6.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 57 3 # 57 A 50 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 327 GLU A 30 GLU^? 19.82 ZN ZN E2002 A 339 ARG A 45 ARG^? 20.10 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 75.11 41.01 160.30 76.65 40.06 161.41 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 82.23 40.35 159.87 85.09 40.67 161.01 32.14 6.60 3.52 34.39 5.41 1.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 58 3 # 58 A 50 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 327 GLU A 30 GLU^? 19.82 ZN ZN E2002 A 339 ARG F 45 ARG^? 20.07 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 75.11 41.01 160.30 76.65 40.06 161.41 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 82.23 40.35 159.87 85.09 40.67 161.01 37.54 3.46 -7.45 35.47 4.92 -5.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 59 3 # 59 A 50 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 327 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 339 ARG F 76 ARG^? 8.13 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 75.11 41.01 160.30 76.65 40.06 161.41 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 82.23 40.35 159.87 85.09 40.67 161.01 23.22 4.91 -15.14 20.87 6.80 -15.45 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 60 3 # 60 A 50 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 327 GLU A 64 GLU.? 24.42 ZN ZN E2002 A 339 ARG A 11 ARG.? 22.81 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 75.11 41.01 160.30 76.65 40.06 161.41 7.18 3.59 -5.93 6.39 1.65 -6.13 coo 82.23 40.35 159.87 85.09 40.67 161.01 8.14 -2.39 -10.44 6.98 -0.33 -8.47 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 61 3 # 61 A 50 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 327 GLU D 30 GLU^? 25.95 ZN ZN J2001 A 339 ARG I 45 ARG^? 26.51 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 75.11 41.01 160.30 76.65 40.06 161.41 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 9.19 -47.86 -14.39 8.02 -46.02 -16.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 62 3 # 62 A 50 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 327 GLU A 64 GLU.? 24.42 ZN ZN E2002 A 339 ARG A 11 ARG.? 22.81 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 7.18 3.59 -5.93 6.39 1.65 -6.13 coo 82.23 40.35 159.87 85.09 40.67 161.01 8.14 -2.39 -10.44 6.98 -0.33 -8.47 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 63 3 # 63 A 50 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 327 GLU I 20 GLU~? -12.94 ZN ZN J2001s A 339 ARG D 76 ARG^? 8.12 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.03 -40.97 -22.65 29.39 -42.82 -22.15 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 64 3 # 64 A 50 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 327 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 339 ARG G 76 ARG^? 28.48 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 22.23 3.81 17.00 24.22 3.69 17.74 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.16 1.90 14.98 12.60 3.57 14.85 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 65 3 # 65 A 50 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 327 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 339 ARG B 45 ARG^? 19.26 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 14.90 -14.60 27.65 17.88 -13.95 27.44 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 66 3 # 66 A 50 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 327 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 339 ARG G 45 ARG^? 19.42 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 24.66 -6.90 24.79 21.69 -7.61 25.11 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 67 3 # 67 A 50 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 327 GLU B 64 GLU.? 24.26 ZN ZN B2003 A 339 ARG B 11 ARG.? 26.38 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 75.11 41.01 160.30 76.65 40.06 161.41 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo 82.23 40.35 159.87 85.09 40.67 161.01 4.66 -4.03 2.41 2.15 -4.03 4.16 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 68 3 # 68 A 50 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 327 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 339 ARG J 45 ARG^? 19.30 ZN ZN J2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 75.11 41.01 160.30 76.65 40.06 161.41 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.80 -22.06 -31.67 26.75 -19.22 -31.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 69 3 # 69 A 50 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 327 GLU B 64 GLU.? 24.26 ZN ZN B2003 A 339 ARG B 11 ARG.? 26.38 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 75.11 41.01 160.30 76.65 40.06 161.41 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo 82.23 40.35 159.87 85.09 40.67 161.01 4.66 -4.03 2.41 2.15 -4.03 4.16 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 70 3 # 70 A 50 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 327 GLU J 20 GLU~? 25.99 ZN ZN J2001 A 339 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 75.11 41.01 160.30 76.65 40.06 161.41 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 42.07 -13.66 -19.07 44.91 -14.78 -18.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 71 3 # 71 A 50 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 327 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 339 ARG B 45 ARG^? 19.26 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 75.11 41.01 160.30 76.65 40.06 161.41 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 14.90 -14.60 27.65 17.88 -13.95 27.44 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 72 3 # 72 A 50 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 327 GLU J 20 GLU~? 25.99 ZN ZN J2001 A 339 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 75.11 41.01 160.30 76.65 40.06 161.41 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 42.07 -13.66 -19.07 44.91 -14.78 -18.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 73 3 # 73 A 50 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 327 GLU B 50 GLU~? -2.41 ZN ZN B2003s A 339 ARG H 76 ARG^? 8.16 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.06 -24.66 18.73 -3.81 -23.46 18.10 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 74 3 # 74 A 50 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 327 GLU C 20 GLU~? -13.13 ZN ZN B2003s A 339 ARG H 76 ARG^? 8.16 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 -6.90 -26.36 14.56 -8.07 -24.73 15.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.06 -24.66 18.73 -3.81 -23.46 18.10 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 75 3 # 75 A 50 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 327 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 339 ARG C 45 ARG^? 26.07 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 1.94 -44.34 10.41 3.55 -43.42 12.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 76 3 # 76 A 50 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 327 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 339 ARG H 45 ARG^? 19.95 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.47 -38.69 20.81 5.22 -38.73 18.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 77 3 # 77 A 50 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 327 GLU A 30 GLU^? 19.82 ZN ZN E2002 A 339 ARG F 45 ARG^? 20.07 ZN ZN E2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 75.11 41.01 160.30 76.65 40.06 161.41 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 82.23 40.35 159.87 85.09 40.67 161.01 37.54 3.46 -7.45 35.47 4.92 -5.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 78 3 # 78 A 50 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 327 GLU C 64 GLU.? 25.72 ZN ZN B2003 A 339 ARG C 11 ARG~? 22.62 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.33 -19.22 1.68 -6.59 -18.32 -0.10 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.98 -15.22 3.59 -4.40 -16.94 2.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 79 3 # 79 A 50 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 327 GLU C 64 GLU.? 25.72 ZN ZN B2003 A 339 ARG C 11 ARG~? 22.62 ZN ZN B2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.33 -19.22 1.68 -6.59 -18.32 -0.10 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.98 -15.22 3.59 -4.40 -16.94 2.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 80 3 # 80 A 50 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 327 GLU F 20 GLU~? -13.12 ZN ZN G2004s A 339 ARG A 76 ARG^? 8.06 ZN ZN G2004 coo 85.81 57.99 116.01 86.03 55.86 115.89 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 75.11 41.01 160.30 76.65 40.06 161.41 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 82.23 40.35 159.87 85.09 40.67 161.01 40.48 -5.18 11.11 43.34 -6.18 11.48 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 80 hits 1hto_c00 naa= 3 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 1 3 # 1 A 267 GLU A 70 GLU^? 23.78 ZN ZN G2004 A 369 ARG A 9 ARG^? 24.21 ZN ZN E2002 A 372 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo 16.47 7.99 31.03 17.36 6.90 32.63 21.92 -8.51 2.63 23.34 -9.97 2.05 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 16.01 4.58 27.39 13.82 5.38 28.94 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 2 3 # 2 A 267 GLU A 70 GLU^? 23.78 ZN ZN G2004 A 369 ARG A 68 ARG^? 28.72 ZN ZN B2003 A 372 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo 16.47 7.99 31.03 17.36 6.90 32.63 21.92 -8.51 2.63 23.34 -9.97 2.05 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 16.01 4.58 27.39 13.82 5.38 28.94 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 3 3 # 3 A 267 GLU C 70 GLU^? 28.30 ZN ZN B2003 A 369 ARG C 9 ARG^? 24.24 ZN ZN B2003 A 372 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 16.47 7.99 31.03 17.36 6.90 32.63 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 16.01 4.58 27.39 13.82 5.38 28.94 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 4 3 # 4 A 267 GLU E 70 GLU^? 21.70 ZN ZN E2002 A 369 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 372 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 16.47 7.99 31.03 17.36 6.90 32.63 22.93 -13.24 -13.07 23.13 -14.10 -11.19 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 16.01 4.58 27.39 13.82 5.38 28.94 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 5 3 # 5 A 267 GLU F 70 GLU^? 24.01 ZN ZN E2002 A 369 ARG F 9 ARG^? 24.10 ZN ZN G2004 A 372 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo 16.47 7.99 31.03 17.36 6.90 32.63 29.66 -12.84 -6.57 27.71 -12.58 -5.78 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 16.01 4.58 27.39 13.82 5.38 28.94 31.03 -12.70 0.17 30.17 -14.19 -2.05 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 6 3 # 6 A 267 GLU F 70 GLU^? 24.01 ZN ZN E2002 A 369 ARG F 68 ARG^? 28.83 ZN ZN J2001 A 372 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo 16.47 7.99 31.03 17.36 6.90 32.63 29.66 -12.84 -6.57 27.71 -12.58 -5.78 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 16.01 4.58 27.39 13.82 5.38 28.94 31.03 -12.70 0.17 30.17 -14.19 -2.05 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 7 3 # 7 A 267 GLU G 70 GLU^? 21.12 ZN ZN G2004 A 369 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 372 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 16.47 7.99 31.03 17.36 6.90 32.63 24.92 -14.52 9.07 24.76 -14.12 6.99 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 16.01 4.58 27.39 13.82 5.38 28.94 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 8 3 # 8 A 267 GLU H 70 GLU^? 24.54 ZN ZN B2003 A 369 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 372 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 16.47 7.99 31.03 17.36 6.90 32.63 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 16.01 4.58 27.39 13.82 5.38 28.94 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 9 3 # 9 A 267 GLU H 70 GLU^? 24.54 ZN ZN B2003 A 369 ARG H 68 ARG^? 29.79 ZN ZN G2004 A 372 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 16.47 7.99 31.03 17.36 6.90 32.63 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 16.01 4.58 27.39 13.82 5.38 28.94 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 10 3 # 10 A 267 GLU I 70 GLU^? 28.28 ZN ZN J2001 A 369 ARG I 9 ARG^? 24.03 ZN ZN J2001 A 372 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo 16.47 7.99 31.03 17.36 6.90 32.63 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 16.01 4.58 27.39 13.82 5.38 28.94 20.76 -33.59 -9.48 20.18 -32.83 -6.85 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 11 3 # 11 A 267 GLU J 70 GLU^? 22.09 ZN ZN J2001 A 369 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 372 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 16.47 7.99 31.03 17.36 6.90 32.63 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 16.01 4.58 27.39 13.82 5.38 28.94 28.75 -20.75 -12.61 27.09 -22.87 -11.86 1i1e_c00 source 1i1e BOTULINUM NEUROTOXIN TYPE B : 11 hits 1i1e_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 15 VAL~? 13.69 ZN ZN E2002 A 200 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 226 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 16.33 1.02 -11.21 17.71 -0.52 -12.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 34.47 51.09 7.19 28.58 51.18 7.53 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 31 VAL^? 16.73 ZN ZN E2002 A 200 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 226 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 25.78 4.70 -5.73 23.63 5.19 -5.62 coo 24.51 43.28 11.18 25.17 44.50 9.58 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 34.47 51.09 7.19 28.58 51.18 7.53 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL B 31 VAL^? 19.97 ZN ZN B2003 A 200 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 226 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 19.13 38.05 1.41 19.72 38.80 -0.53 13.91 -6.57 19.51 11.87 -6.02 18.72 coo 24.51 43.28 11.18 25.17 44.50 9.58 17.64 3.84 11.72 15.55 3.44 11.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL B 44 VAL^? 13.14 ZN ZN B2003 A 200 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 226 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.28 -14.05 23.43 10.50 -14.46 22.20 coo 24.51 43.28 11.18 25.17 44.50 9.58 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 34.47 51.09 7.19 28.58 51.18 7.53 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 55 VAL~? 8.58 ZN ZN B2003 A 200 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 226 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 4.54 -14.98 20.72 6.36 -14.58 21.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 34.47 51.09 7.19 28.58 51.18 7.53 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 56 VAL~? 10.67 ZN ZN B2003 A 200 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 226 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 5.14 -16.24 17.17 7.04 -17.19 16.41 coo 24.51 43.28 11.18 25.17 44.50 9.58 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 34.47 51.09 7.19 28.58 51.18 7.53 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL C 15 VAL~? 13.85 ZN ZN B2003 A 200 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 226 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -1.11 -21.50 10.46 0.97 -21.21 11.27 coo 24.51 43.28 11.18 25.17 44.50 9.58 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL C 31 VAL^? 16.84 ZN ZN B2003 A 200 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 226 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 0.45 -32.72 13.09 -1.06 -31.52 12.00 coo 24.51 43.28 11.18 25.17 44.50 9.58 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL C 44 VAL^? 25.58 ZN ZN B2003 A 200 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 226 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 1.08 -39.14 7.70 0.37 -38.22 5.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 34.47 51.09 7.19 28.58 51.18 7.53 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL C 55 VAL~? 27.95 ZN ZN B2003 A 200 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 226 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -3.71 -36.49 1.64 -2.03 -37.29 2.87 coo 24.51 43.28 11.18 25.17 44.50 9.58 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 34.47 51.09 7.19 28.58 51.18 7.53 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL C 56 VAL~? 28.41 ZN ZN B2003 A 200 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 226 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -1.58 -33.93 -0.28 0.64 -33.97 -0.35 coo 24.51 43.28 11.18 25.17 44.50 9.58 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 34.47 51.09 7.19 28.58 51.18 7.53 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL D 31 VAL^? 29.92 ZN ZN J2001 A 200 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 226 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 3.59 -37.71 -16.46 2.03 -36.23 -16.97 coo 24.51 43.28 11.18 25.17 44.50 9.58 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL E 31 VAL^? 20.05 ZN ZN E2002 A 200 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 226 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 19.36 -14.61 -27.96 17.59 -13.18 -27.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 34.47 51.09 7.19 28.58 51.18 7.53 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL E 44 VAL^? 13.11 ZN ZN E2002 A 200 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 226 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 25.65 -9.01 -25.90 24.32 -7.64 -24.72 coo 24.51 43.28 11.18 25.17 44.50 9.58 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 34.47 51.09 7.19 28.58 51.18 7.53 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL E 55 VAL~? 8.65 ZN ZN E2002 A 200 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 226 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 20.80 -2.80 -23.16 22.23 -4.52 -23.53 coo 24.51 43.28 11.18 25.17 44.50 9.58 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 34.47 51.09 7.19 28.58 51.18 7.53 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL E 56 VAL~? 10.70 ZN ZN E2002 A 200 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 226 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 19.82 -4.07 -19.68 20.81 -5.70 -18.51 coo 24.51 43.28 11.18 25.17 44.50 9.58 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 34.47 51.09 7.19 28.58 51.18 7.53 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL F 15 VAL~? 13.60 ZN ZN G2004 A 200 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 226 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 19.13 38.05 1.41 19.72 38.80 -0.53 40.64 -12.97 7.21 38.63 -12.59 8.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 34.47 51.09 7.19 28.58 51.18 7.53 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL F 31 VAL^? 16.82 ZN ZN G2004 A 200 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 226 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 19.13 38.05 1.41 19.72 38.80 -0.53 39.10 -2.99 1.69 40.66 -4.55 1.60 coo 24.51 43.28 11.18 25.17 44.50 9.58 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 34.47 51.09 7.19 28.58 51.18 7.53 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1i29_c03 CSDB user 19 3 # 19 A 128 VAL G 31 VAL^? 20.00 ZN ZN G2004 A 200 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 226 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 25.63 -18.28 23.97 27.74 -19.12 23.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 34.47 51.09 7.19 28.58 51.18 7.53 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 1i29_c03 CSDB user 20 3 # 20 A 128 VAL G 44 VAL^? 13.13 ZN ZN G2004 A 200 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 226 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 19.13 38.05 1.41 19.72 38.80 -0.53 27.32 -10.05 21.93 29.15 -10.52 20.72 coo 24.51 43.28 11.18 25.17 44.50 9.58 33.55 0.62 19.07 33.72 1.88 17.35 coo 34.47 51.09 7.19 28.58 51.18 7.53 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1i29_c03 CSDB user 21 3 # 21 A 128 VAL G 55 VAL~? 8.60 ZN ZN G2004 A 200 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 226 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 19.13 38.05 1.41 19.72 38.80 -0.53 35.10 -11.09 19.24 32.90 -10.74 19.58 coo 24.51 43.28 11.18 25.17 44.50 9.58 33.55 0.62 19.07 33.72 1.88 17.35 coo 34.47 51.09 7.19 28.58 51.18 7.53 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1i29_c03 CSDB user 22 3 # 22 A 128 VAL G 56 VAL~? 10.55 ZN ZN G2004 A 200 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 226 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 19.13 38.05 1.41 19.72 38.80 -0.53 34.48 -12.50 15.71 32.62 -12.34 14.46 coo 24.51 43.28 11.18 25.17 44.50 9.58 33.55 0.62 19.07 33.72 1.88 17.35 coo 34.47 51.09 7.19 28.58 51.18 7.53 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 1i29_c03 CSDB user 23 3 # 23 A 128 VAL H 31 VAL^? 30.05 ZN ZN B2003 A 200 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 226 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 13.88 -43.40 12.62 16.08 -43.65 12.65 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 34.47 51.09 7.19 28.58 51.18 7.53 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 1i29_c03 CSDB user 24 3 # 24 A 128 VAL I 15 VAL~? 13.75 ZN ZN J2001 A 200 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 226 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 29.83 -39.37 -14.49 29.07 -37.47 -15.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1i29_c03 CSDB user 25 3 # 25 A 128 VAL I 31 VAL^? 16.86 ZN ZN J2001 A 200 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 226 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 19.25 -43.63 -17.09 21.00 -44.45 -16.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1i29_c03 CSDB user 26 3 # 26 A 128 VAL J 31 VAL^? 20.05 ZN ZN J2001 A 200 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 226 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 35.33 -18.82 -23.49 36.77 -20.42 -22.75 coo 24.51 43.28 11.18 25.17 44.50 9.58 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 34.47 51.09 7.19 28.58 51.18 7.53 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 1i29_c03 CSDB user 27 3 # 27 A 128 VAL J 44 VAL^? 13.21 ZN ZN J2001 A 200 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 226 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 29.74 -24.05 -27.49 30.38 -25.77 -26.23 coo 24.51 43.28 11.18 25.17 44.50 9.58 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 1i29_c03 CSDB user 28 3 # 28 A 128 VAL J 55 VAL~? 8.67 ZN ZN J2001 A 200 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 226 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 32.83 -31.31 -24.86 31.82 -29.40 -25.42 coo 24.51 43.28 11.18 25.17 44.50 9.58 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 1i29_c03 CSDB user 29 3 # 29 A 128 VAL J 56 VAL~? 10.69 ZN ZN J2001 A 200 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 226 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 31.47 -31.34 -21.25 29.81 -30.05 -20.43 coo 24.51 43.28 11.18 25.17 44.50 9.58 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 12.18 -35.43 -32.57 13.23 -33.76 -37.61 1i29_c03 source 1i29 CSDB : 29 hits 1i29_c03 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER D 33 SER^? 35.89 ZN ZN J2001 A 173 ARG C 68 ARG^? 29.54 ZN ZN B2003 A 211 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 22.72 76.24 0.23 24.60 76.86 -1.25 2.59 -36.27 -9.47 0.68 -35.09 -8.48 coo 18.77 77.82 11.69 20.55 80.22 10.73 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER D 33 SER^? 35.89 ZN ZN J2001 A 173 ARG D 9 ARG^? 32.06 ZN ZN J2001 A 211 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 22.72 76.24 0.23 24.60 76.86 -1.25 2.59 -36.27 -9.47 0.68 -35.09 -8.48 coo 18.77 77.82 11.69 20.55 80.22 10.73 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER E 33 SER^? 25.01 ZN ZN J2001 A 173 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 211 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 22.72 76.24 0.23 24.60 76.86 -1.25 15.44 -19.85 -25.13 13.12 -20.20 -24.71 coo 18.77 77.82 11.69 20.55 80.22 10.73 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER E 33 SER^? 25.01 ZN ZN J2001 A 173 ARG J 45 ARG^? 19.30 ZN ZN J2001 A 211 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 22.72 76.24 0.23 24.60 76.86 -1.25 15.44 -19.85 -25.13 13.12 -20.20 -24.71 coo 18.77 77.82 11.69 20.55 80.22 10.73 27.80 -22.06 -31.67 26.75 -19.22 -31.33 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1ig8_c00 HEXOKINASE PII user 5 3 # 5 A 158 SER E 33 SER^? 25.01 ZN ZN J2001 A 173 ARG J 45 ARG^? 19.30 ZN ZN J2001 A 211 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 22.72 76.24 0.23 24.60 76.86 -1.25 15.44 -19.85 -25.13 13.12 -20.20 -24.71 coo 18.77 77.82 11.69 20.55 80.22 10.73 27.80 -22.06 -31.67 26.75 -19.22 -31.33 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1ig8_c00 HEXOKINASE PII user 6 3 # 6 A 158 SER G 33 SER^? 25.21 ZN ZN B2003 A 173 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 211 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 22.72 76.24 0.23 24.60 76.86 -1.25 23.02 -24.31 21.04 24.40 -26.04 22.01 coo 18.77 77.82 11.69 20.55 80.22 10.73 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1ig8_c00 HEXOKINASE PII user 7 3 # 7 A 158 SER G 33 SER^? 25.21 ZN ZN B2003 A 173 ARG H 68 ARG^? 29.79 ZN ZN G2004 A 211 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 22.72 76.24 0.23 24.60 76.86 -1.25 23.02 -24.31 21.04 24.40 -26.04 22.01 coo 18.77 77.82 11.69 20.55 80.22 10.73 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1ig8_c00 HEXOKINASE PII user 8 3 # 8 A 158 SER H 33 SER^? 35.60 ZN ZN B2003 A 173 ARG C 45 ARG^? 26.07 ZN ZN B2003 A 211 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 22.72 76.24 0.23 24.60 76.86 -1.25 15.17 -43.47 5.63 17.27 -44.35 4.77 coo 18.77 77.82 11.69 20.55 80.22 10.73 1.94 -44.34 10.41 3.55 -43.42 12.90 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1ig8_c00 HEXOKINASE PII user 9 3 # 9 A 158 SER H 33 SER^? 35.60 ZN ZN B2003 A 173 ARG C 45 ARG^? 26.07 ZN ZN B2003 A 211 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 22.72 76.24 0.23 24.60 76.86 -1.25 15.17 -43.47 5.63 17.27 -44.35 4.77 coo 18.77 77.82 11.69 20.55 80.22 10.73 1.94 -44.34 10.41 3.55 -43.42 12.90 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1ig8_c00 HEXOKINASE PII user 10 3 # 10 A 158 SER H 33 SER^? 35.60 ZN ZN B2003 A 173 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 211 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 22.72 76.24 0.23 24.60 76.86 -1.25 15.17 -43.47 5.63 17.27 -44.35 4.77 coo 18.77 77.82 11.69 20.55 80.22 10.73 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1ig8_c00 HEXOKINASE PII user 11 3 # 11 A 158 SER J 33 SER^? 25.08 ZN ZN E2002 A 173 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 211 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 22.72 76.24 0.23 24.60 76.86 -1.25 36.27 -15.21 -17.30 38.62 -15.44 -16.82 coo 18.77 77.82 11.69 20.55 80.22 10.73 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 42.45 -10.50 -15.74 43.20 -12.48 -15.86 1ig8_c00 source 1ig8 HEXOKINASE PII : 11 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP E 39 ASP.? 27.23 ZN ZN E2002 158 THR D 71 THR^? 21.16 ZN ZN J2001 317 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo -2.63 8.40 35.07 -3.66 9.81 36.17 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo -5.30 12.75 41.86 -4.34 13.05 39.99 13.92 -28.99 -18.23 13.08 -28.88 -20.23 coo -12.63 17.64 33.66 -10.65 17.90 34.40 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP G 39 ASP.? 27.24 ZN ZN G2004 158 THR H 71 THR^? 21.04 ZN ZN B2003 317 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo -2.63 8.40 35.07 -3.66 9.81 36.17 25.21 -25.73 15.58 24.96 -27.01 13.97 coo -5.30 12.75 41.86 -4.34 13.05 39.99 15.82 -30.13 14.22 16.16 -30.88 16.24 coo -12.63 17.64 33.66 -10.65 17.90 34.40 20.28 -36.09 25.85 20.67 -35.47 27.83 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 204 GLU B 50 GLU~? -2.41 ZN ZN B2003s A 279 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 5.85 5.60 30.32 5.00 7.49 29.88 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 7.79 1.83 27.81 9.08 3.25 26.92 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 8.22 7.77 18.64 7.58 8.47 21.28 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 204 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 279 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 5.85 5.60 30.32 5.00 7.49 29.88 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 7.79 1.83 27.81 9.08 3.25 26.92 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 8.22 7.77 18.64 7.58 8.47 21.28 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 204 GLU G 50 GLU~? -2.28 ZN ZN G2004s A 279 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 5.85 5.60 30.32 5.00 7.49 29.88 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 7.79 1.83 27.81 9.08 3.25 26.92 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 8.22 7.77 18.64 7.58 8.47 21.28 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 204 GLU J 50 GLU~? -2.50 ZN ZN J2001s A 279 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 5.85 5.60 30.32 5.00 7.49 29.88 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 7.79 1.83 27.81 9.08 3.25 26.92 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 8.22 7.77 18.64 7.58 8.47 21.28 18.53 -40.66 -20.20 16.59 -42.17 -21.51 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 4 hits 1itx_c00 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 58 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 424 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 58.59 41.80 18.81 58.94 43.89 18.94 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 52.85 46.34 13.34 54.09 44.97 14.42 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 58 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 424 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 58.59 41.80 18.81 58.94 43.89 18.94 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 52.85 46.34 13.34 54.09 44.97 14.42 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP D 54 ASP~? 25.75 ZN ZN J2001 A 58 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 424 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 58.42 47.76 20.67 58.01 49.10 19.12 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 58.59 41.80 18.81 58.94 43.89 18.94 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 52.85 46.34 13.34 54.09 44.97 14.42 15.39 -26.34 -33.01 16.88 -27.76 -33.58 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 3 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 53 ASP~? 26.24 ZN ZN G2004 B 58 ASP A 54 ASP~? 25.58 ZN ZN G2004 B 424 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo 112.10 61.46 19.99 111.82 60.65 18.07 17.64 3.84 11.72 15.55 3.44 11.90 coo 117.85 63.62 21.08 115.96 63.25 20.18 19.11 8.17 8.99 18.99 8.60 11.06 coo 118.47 57.23 15.57 119.32 58.77 16.73 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 54 ASP~? 25.58 ZN ZN G2004 B 58 ASP A 53 ASP~? 26.24 ZN ZN G2004 B 424 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo 112.10 61.46 19.99 111.82 60.65 18.07 19.11 8.17 8.99 18.99 8.60 11.06 coo 117.85 63.62 21.08 115.96 63.25 20.18 17.64 3.84 11.72 15.55 3.44 11.90 coo 118.47 57.23 15.57 119.32 58.77 16.73 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP C 53 ASP~? 35.43 ZN ZN B2003 B 58 ASP C 54 ASP~? 34.22 ZN ZN B2003 B 424 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 117.85 63.62 21.08 115.96 63.25 20.18 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 118.47 57.23 15.57 119.32 58.77 16.73 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP C 54 ASP~? 34.22 ZN ZN B2003 B 58 ASP C 53 ASP~? 35.43 ZN ZN B2003 B 424 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 117.85 63.62 21.08 115.96 63.25 20.18 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 118.47 57.23 15.57 119.32 58.77 16.73 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP D 53 ASP~? 26.48 ZN ZN J2001 B 58 ASP D 54 ASP~? 25.75 ZN ZN J2001 B 424 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 112.10 61.46 19.99 111.82 60.65 18.07 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 117.85 63.62 21.08 115.96 63.25 20.18 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 118.47 57.23 15.57 119.32 58.77 16.73 15.39 -26.34 -33.01 16.88 -27.76 -33.58 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP D 54 ASP~? 25.75 ZN ZN J2001 B 58 ASP D 53 ASP~? 26.48 ZN ZN J2001 B 424 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 112.10 61.46 19.99 111.82 60.65 18.07 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 117.85 63.62 21.08 115.96 63.25 20.18 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 118.47 57.23 15.57 119.32 58.77 16.73 15.39 -26.34 -33.01 16.88 -27.76 -33.58 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP F 53 ASP~? 26.13 ZN ZN E2002 B 58 ASP F 54 ASP~? 25.15 ZN ZN E2002 B 424 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo 112.10 61.46 19.99 111.82 60.65 18.07 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 117.85 63.62 21.08 115.96 63.25 20.18 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 118.47 57.23 15.57 119.32 58.77 16.73 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP F 54 ASP~? 25.15 ZN ZN E2002 B 58 ASP F 53 ASP~? 26.13 ZN ZN E2002 B 424 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo 112.10 61.46 19.99 111.82 60.65 18.07 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 117.85 63.62 21.08 115.96 63.25 20.18 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 118.47 57.23 15.57 119.32 58.77 16.73 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 9 3 # 9 B 55 ASP H 53 ASP~? 26.49 ZN ZN B2003 B 58 ASP H 54 ASP~? 25.78 ZN ZN B2003 B 424 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 112.10 61.46 19.99 111.82 60.65 18.07 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 117.85 63.62 21.08 115.96 63.25 20.18 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 118.47 57.23 15.57 119.32 58.77 16.73 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 10 3 # 10 B 55 ASP H 54 ASP~? 25.78 ZN ZN B2003 B 58 ASP H 53 ASP~? 26.49 ZN ZN B2003 B 424 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 112.10 61.46 19.99 111.82 60.65 18.07 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 117.85 63.62 21.08 115.96 63.25 20.18 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 118.47 57.23 15.57 119.32 58.77 16.73 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 11 3 # 11 B 55 ASP I 53 ASP~? 35.51 ZN ZN J2001 B 58 ASP I 54 ASP~? 33.46 ZN ZN J2001 B 424 GLU I 50 GLU~? 38.38 ZN ZN B2003 coo 112.10 61.46 19.99 111.82 60.65 18.07 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 117.85 63.62 21.08 115.96 63.25 20.18 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 118.47 57.23 15.57 119.32 58.77 16.73 9.27 -51.61 2.10 7.43 -50.53 2.04 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 12 3 # 12 B 55 ASP I 54 ASP~? 33.46 ZN ZN J2001 B 58 ASP I 53 ASP~? 35.51 ZN ZN J2001 B 424 GLU I 50 GLU~? 38.38 ZN ZN B2003 coo 112.10 61.46 19.99 111.82 60.65 18.07 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 117.85 63.62 21.08 115.96 63.25 20.18 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 118.47 57.23 15.57 119.32 58.77 16.73 9.27 -51.61 2.10 7.43 -50.53 2.04 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 12 hits 1js4_c01 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 67 GLU^? 23.17 ZN ZN E2002 A 163 ARG A 9 ARG^? 24.21 ZN ZN E2002 A 222 ARG A 11 ARG.? 22.81 ZN ZN E2002 coo 51.27 81.34 48.31 51.67 80.79 50.28 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 48.06 78.22 50.94 48.51 78.27 53.98 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 54.85 84.16 52.60 54.26 81.23 53.34 8.14 -2.39 -10.44 6.98 -0.33 -8.47 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 67 GLU^? 23.17 ZN ZN E2002 A 163 ARG A 11 ARG.? 22.81 ZN ZN E2002 A 222 ARG A 9 ARG^? 24.21 ZN ZN E2002 coo 51.27 81.34 48.31 51.67 80.79 50.28 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 48.06 78.22 50.94 48.51 78.27 53.98 8.14 -2.39 -10.44 6.98 -0.33 -8.47 coo 54.85 84.16 52.60 54.26 81.23 53.34 15.84 -8.62 -5.83 17.97 -10.19 -4.21 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU A 67 GLU^? 23.17 ZN ZN E2002 A 163 ARG A 11 ARG.? 22.81 ZN ZN E2002 A 222 ARG E 68 ARG^? 24.88 ZN ZN E2002 coo 51.27 81.34 48.31 51.67 80.79 50.28 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 48.06 78.22 50.94 48.51 78.27 53.98 8.14 -2.39 -10.44 6.98 -0.33 -8.47 coo 54.85 84.16 52.60 54.26 81.23 53.34 14.73 -11.32 -9.64 13.98 -11.79 -6.67 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU A 67 GLU^? 23.17 ZN ZN E2002 A 163 ARG A 68 ARG^? 28.72 ZN ZN B2003 A 222 ARG E 68 ARG^? 24.88 ZN ZN E2002 coo 51.27 81.34 48.31 51.67 80.79 50.28 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 48.06 78.22 50.94 48.51 78.27 53.98 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 54.85 84.16 52.60 54.26 81.23 53.34 14.73 -11.32 -9.64 13.98 -11.79 -6.67 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU B 67 GLU^? 26.37 ZN ZN B2003 A 163 ARG B 9 ARG^? 25.60 ZN ZN B2003 A 222 ARG B 11 ARG.? 26.38 ZN ZN B2003 coo 51.27 81.34 48.31 51.67 80.79 50.28 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 48.06 78.22 50.94 48.51 78.27 53.98 12.25 -11.70 3.79 14.09 -14.14 4.30 coo 54.85 84.16 52.60 54.26 81.23 53.34 4.66 -4.03 2.41 2.15 -4.03 4.16 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU B 67 GLU^? 26.37 ZN ZN B2003 A 163 ARG B 11 ARG.? 26.38 ZN ZN B2003 A 222 ARG A 68 ARG^? 28.72 ZN ZN B2003 coo 51.27 81.34 48.31 51.67 80.79 50.28 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 48.06 78.22 50.94 48.51 78.27 53.98 4.66 -4.03 2.41 2.15 -4.03 4.16 coo 54.85 84.16 52.60 54.26 81.23 53.34 14.21 -9.24 0.28 13.24 -12.17 0.61 ULMN 3 1kim_c00 THYMIDINE KINASE user 7 3 # 7 A 83 GLU B 67 GLU^? 26.37 ZN ZN B2003 A 163 ARG B 11 ARG.? 26.38 ZN ZN B2003 A 222 ARG B 9 ARG^? 25.60 ZN ZN B2003 coo 51.27 81.34 48.31 51.67 80.79 50.28 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 48.06 78.22 50.94 48.51 78.27 53.98 4.66 -4.03 2.41 2.15 -4.03 4.16 coo 54.85 84.16 52.60 54.26 81.23 53.34 12.25 -11.70 3.79 14.09 -14.14 4.30 ULMN 3 1kim_c00 THYMIDINE KINASE user 8 3 # 8 A 83 GLU C 67 GLU.? 23.10 ZN ZN B2003 A 163 ARG C 9 ARG^? 24.24 ZN ZN B2003 A 222 ARG C 11 ARG~? 22.62 ZN ZN B2003 coo 51.27 81.34 48.31 51.67 80.79 50.28 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 48.06 78.22 50.94 48.51 78.27 53.98 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 54.85 84.16 52.60 54.26 81.23 53.34 -1.98 -15.22 3.59 -4.40 -16.94 2.77 ULMN 3 1kim_c00 THYMIDINE KINASE user 9 3 # 9 A 83 GLU C 67 GLU.? 23.10 ZN ZN B2003 A 163 ARG C 11 ARG~? 22.62 ZN ZN B2003 A 222 ARG C 9 ARG^? 24.24 ZN ZN B2003 coo 51.27 81.34 48.31 51.67 80.79 50.28 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 48.06 78.22 50.94 48.51 78.27 53.98 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo 54.85 84.16 52.60 54.26 81.23 53.34 7.07 -21.17 3.13 9.35 -23.17 2.50 ULMN 3 1kim_c00 THYMIDINE KINASE user 10 3 # 10 A 83 GLU D 67 GLU^? 32.75 ZN ZN B2003 A 163 ARG D 9 ARG^? 32.06 ZN ZN J2001 A 222 ARG D 11 ARG.? 35.27 ZN ZN B2003 coo 51.27 81.34 48.31 51.67 80.79 50.28 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 48.06 78.22 50.94 48.51 78.27 53.98 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 54.85 84.16 52.60 54.26 81.23 53.34 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 ULMN 3 1kim_c00 THYMIDINE KINASE user 11 3 # 11 A 83 GLU D 67 GLU^? 32.75 ZN ZN B2003 A 163 ARG D 11 ARG.? 35.27 ZN ZN B2003 A 222 ARG D 9 ARG^? 32.06 ZN ZN J2001 coo 51.27 81.34 48.31 51.67 80.79 50.28 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 48.06 78.22 50.94 48.51 78.27 53.98 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 54.85 84.16 52.60 54.26 81.23 53.34 6.94 -24.21 -7.19 9.96 -24.60 -7.73 ULMN 3 1kim_c00 THYMIDINE KINASE user 12 3 # 12 A 83 GLU E 67 GLU^? 26.75 ZN ZN E2002 A 163 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 222 ARG E 11 ARG.? 26.51 ZN ZN E2002 coo 51.27 81.34 48.31 51.67 80.79 50.28 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 48.06 78.22 50.94 48.51 78.27 53.98 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 54.85 84.16 52.60 54.26 81.23 53.34 3.07 -13.39 -16.26 3.11 -10.68 -17.74 ULMN 3 1kim_c00 THYMIDINE KINASE user 13 3 # 13 A 83 GLU E 67 GLU^? 26.75 ZN ZN E2002 A 163 ARG E 11 ARG.? 26.51 ZN ZN E2002 A 222 ARG E 9 ARG^? 26.78 ZN ZN E2002 coo 51.27 81.34 48.31 51.67 80.79 50.28 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 48.06 78.22 50.94 48.51 78.27 53.98 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo 54.85 84.16 52.60 54.26 81.23 53.34 12.49 -16.84 -13.02 14.60 -17.67 -10.91 ULMN 3 1kim_c00 THYMIDINE KINASE user 14 3 # 14 A 83 GLU F 67 GLU^? 23.19 ZN ZN G2004 A 163 ARG F 9 ARG^? 24.10 ZN ZN G2004 A 222 ARG F 11 ARG.? 21.89 ZN ZN G2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 48.06 78.22 50.94 48.51 78.27 53.98 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 54.85 84.16 52.60 54.26 81.23 53.34 41.25 -22.37 6.05 44.11 -21.50 5.36 ULMN 3 1kim_c00 THYMIDINE KINASE user 15 3 # 15 A 83 GLU F 67 GLU^? 23.19 ZN ZN G2004 A 163 ARG F 11 ARG.? 21.89 ZN ZN G2004 A 222 ARG F 9 ARG^? 24.10 ZN ZN G2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 48.06 78.22 50.94 48.51 78.27 53.98 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 54.85 84.16 52.60 54.26 81.23 53.34 32.42 -18.19 2.00 30.08 -17.10 0.27 ULMN 3 1kim_c00 THYMIDINE KINASE user 16 3 # 16 A 83 GLU F 67 GLU^? 23.19 ZN ZN G2004 A 163 ARG F 11 ARG.? 21.89 ZN ZN G2004 A 222 ARG G 68 ARG^? 22.94 ZN ZN G2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 48.06 78.22 50.94 48.51 78.27 53.98 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 54.85 84.16 52.60 54.26 81.23 53.34 30.64 -21.00 5.54 28.49 -18.97 4.58 ULMN 3 1kim_c00 THYMIDINE KINASE user 17 3 # 17 A 83 GLU G 67 GLU^? 26.62 ZN ZN G2004 A 163 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 222 ARG G 11 ARG.? 26.12 ZN ZN G2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 48.06 78.22 50.94 48.51 78.27 53.98 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 54.85 84.16 52.60 54.26 81.23 53.34 34.84 -31.69 12.58 37.28 -30.08 13.59 ULMN 3 1kim_c00 THYMIDINE KINASE user 18 3 # 18 A 83 GLU G 67 GLU^? 26.62 ZN ZN G2004 A 163 ARG G 11 ARG.? 26.12 ZN ZN G2004 A 222 ARG G 9 ARG^? 25.73 ZN ZN G2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 48.06 78.22 50.94 48.51 78.27 53.98 34.84 -31.69 12.58 37.28 -30.08 13.59 coo 54.85 84.16 52.60 54.26 81.23 53.34 26.96 -25.00 8.90 25.51 -22.83 7.22 ULMN 3 1kim_c00 THYMIDINE KINASE user 19 3 # 19 A 83 GLU H 67 GLU^? 32.59 ZN ZN J2001 A 163 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 222 ARG H 11 ARG.? 35.53 ZN ZN J2001 coo 51.27 81.34 48.31 51.67 80.79 50.28 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 48.06 78.22 50.94 48.51 78.27 53.98 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 54.85 84.16 52.60 54.26 81.23 53.34 31.27 -41.17 3.82 32.37 -41.49 6.67 ULMN 3 1kim_c00 THYMIDINE KINASE user 20 3 # 20 A 83 GLU H 67 GLU^? 32.59 ZN ZN J2001 A 163 ARG H 11 ARG.? 35.53 ZN ZN J2001 A 222 ARG H 9 ARG^? 32.17 ZN ZN B2003 coo 51.27 81.34 48.31 51.67 80.79 50.28 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 48.06 78.22 50.94 48.51 78.27 53.98 31.27 -41.17 3.82 32.37 -41.49 6.67 coo 54.85 84.16 52.60 54.26 81.23 53.34 23.61 -33.80 3.29 21.83 -31.31 3.74 ULMN 3 1kim_c00 THYMIDINE KINASE user 21 3 # 21 A 83 GLU J 67 GLU^? 26.37 ZN ZN J2001 A 163 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 222 ARG J 11 ARG.? 26.46 ZN ZN J2001 coo 51.27 81.34 48.31 51.67 80.79 50.28 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 48.06 78.22 50.94 48.51 78.27 53.98 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 54.85 84.16 52.60 54.26 81.23 53.34 42.15 -25.47 -6.25 43.21 -27.78 -7.96 ULMN 3 1kim_c00 THYMIDINE KINASE user 22 3 # 22 A 83 GLU J 67 GLU^? 26.37 ZN ZN J2001 A 163 ARG J 11 ARG.? 26.46 ZN ZN J2001 A 222 ARG F 68 ARG^? 28.83 ZN ZN J2001 coo 51.27 81.34 48.31 51.67 80.79 50.28 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 48.06 78.22 50.94 48.51 78.27 53.98 42.15 -25.47 -6.25 43.21 -27.78 -7.96 coo 54.85 84.16 52.60 54.26 81.23 53.34 32.78 -19.96 -4.34 30.63 -22.19 -4.53 ULMN 3 1kim_c00 THYMIDINE KINASE user 23 3 # 23 A 83 GLU J 67 GLU^? 26.37 ZN ZN J2001 A 163 ARG J 11 ARG.? 26.46 ZN ZN J2001 A 222 ARG J 9 ARG^? 25.67 ZN ZN J2001 coo 51.27 81.34 48.31 51.67 80.79 50.28 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 48.06 78.22 50.94 48.51 78.27 53.98 42.15 -25.47 -6.25 43.21 -27.78 -7.96 coo 54.85 84.16 52.60 54.26 81.23 53.34 31.54 -22.75 -7.85 28.47 -22.56 -8.20 1kim_c00 source 1kim THYMIDINE KINASE : 23 hits 1kim_c00 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 295 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 369 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 16.11 33.72 80.99 14.10 33.54 81.63 22.23 3.81 17.00 24.22 3.69 17.74 coo 12.19 31.08 87.29 11.13 32.66 86.38 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 295 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 369 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 16.11 33.72 80.99 14.10 33.54 81.63 22.23 3.81 17.00 24.22 3.69 17.74 coo 12.19 31.08 87.29 11.13 32.66 86.38 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 295 GLU A 51 GLU~? 22.57 ZN ZN G2004 A 369 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 16.11 33.72 80.99 14.10 33.54 81.63 23.15 8.42 10.27 24.62 9.66 9.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 295 GLU A 51 GLU~? 22.57 ZN ZN G2004 A 369 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 16.11 33.72 80.99 14.10 33.54 81.63 23.15 8.42 10.27 24.62 9.66 9.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 295 GLU B 50 GLU~? -2.41 ZN ZN B2003s A 369 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 11.74 38.14 80.19 10.63 36.40 80.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 16.11 33.72 80.99 14.10 33.54 81.63 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 295 GLU B 51 GLU~? 6.60 ZN ZN B2003 A 369 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 16.11 33.72 80.99 14.10 33.54 81.63 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 295 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 369 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 16.11 33.72 80.99 14.10 33.54 81.63 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 295 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 369 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 16.11 33.72 80.99 14.10 33.54 81.63 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 12.19 31.08 87.29 11.13 32.66 86.38 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 295 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 369 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 16.11 33.72 80.99 14.10 33.54 81.63 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 295 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 16.11 33.72 80.99 14.10 33.54 81.63 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 295 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 16.11 33.72 80.99 14.10 33.54 81.63 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 295 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 369 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 16.11 33.72 80.99 14.10 33.54 81.63 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 295 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 369 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 16.11 33.72 80.99 14.10 33.54 81.63 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 295 GLU D 51 GLU~? 22.34 ZN ZN J2001 A 369 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 16.11 33.72 80.99 14.10 33.54 81.63 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 295 GLU D 51 GLU~? 22.34 ZN ZN J2001 A 369 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 16.11 33.72 80.99 14.10 33.54 81.63 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 295 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 369 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 11.74 38.14 80.19 10.63 36.40 80.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 295 GLU E 51 GLU~? 6.76 ZN ZN E2002 A 369 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 295 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 295 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 295 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 369 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 16.11 33.72 80.99 14.10 33.54 81.63 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 295 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 369 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 16.11 33.72 80.99 14.10 33.54 81.63 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 295 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 369 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 16.11 33.72 80.99 14.10 33.54 81.63 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 23 3 # 23 A 241 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 295 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 369 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 16.11 33.72 80.99 14.10 33.54 81.63 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 24 3 # 24 A 241 ASP F 54 ASP~? 25.15 ZN ZN E2002 A 295 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 369 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 16.11 33.72 80.99 14.10 33.54 81.63 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 25 3 # 25 A 241 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 295 GLU G 50 GLU~? -2.28 ZN ZN G2004s A 369 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo 11.74 38.14 80.19 10.63 36.40 80.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 16.11 33.72 80.99 14.10 33.54 81.63 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 12.19 31.08 87.29 11.13 32.66 86.38 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 26 3 # 26 A 241 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 295 GLU G 51 GLU~? 6.79 ZN ZN G2004 A 369 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 16.11 33.72 80.99 14.10 33.54 81.63 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 27 3 # 27 A 241 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 295 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 369 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 16.11 33.72 80.99 14.10 33.54 81.63 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 28 3 # 28 A 241 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 295 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 369 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 16.11 33.72 80.99 14.10 33.54 81.63 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 29 3 # 29 A 241 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 295 GLU H 51 GLU~? 22.00 ZN ZN B2003 A 369 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 16.11 33.72 80.99 14.10 33.54 81.63 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 30 3 # 30 A 241 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 295 GLU H 51 GLU~? 22.00 ZN ZN B2003 A 369 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 16.11 33.72 80.99 14.10 33.54 81.63 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 31 3 # 31 A 241 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 295 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 369 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 16.11 33.72 80.99 14.10 33.54 81.63 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 32 3 # 32 A 241 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 295 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 369 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 16.11 33.72 80.99 14.10 33.54 81.63 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 33 3 # 33 A 241 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 295 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 369 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 16.11 33.72 80.99 14.10 33.54 81.63 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 34 3 # 34 A 241 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 295 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 369 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 16.11 33.72 80.99 14.10 33.54 81.63 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 35 3 # 35 A 241 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 295 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 369 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 16.11 33.72 80.99 14.10 33.54 81.63 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 36 3 # 36 A 241 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 295 GLU J 50 GLU~? -2.50 ZN ZN J2001s A 369 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 11.74 38.14 80.19 10.63 36.40 80.65 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 16.11 33.72 80.99 14.10 33.54 81.63 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 12.19 31.08 87.29 11.13 32.66 86.38 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 37 3 # 37 A 241 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 295 GLU J 51 GLU~? 6.72 ZN ZN J2001 A 369 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 16.11 33.72 80.99 14.10 33.54 81.63 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 12.19 31.08 87.29 11.13 32.66 86.38 28.87 -37.23 -24.52 29.85 -38.89 -23.63 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 37 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 265 GLU A 24 GLU.? 19.69 ZN ZN E2002 A 369 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 17.36 23.57 72.04 18.68 21.92 71.98 18.55 13.29 -4.55 20.34 13.88 -5.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 265 GLU A 30 GLU^? 19.82 ZN ZN E2002 A 369 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 17.36 23.57 72.04 18.68 21.92 71.98 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 12.19 31.08 87.29 11.13 32.66 86.38 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 265 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 369 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 265 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 369 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 265 GLU F 30 GLU^? 19.95 ZN ZN G2004 A 369 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 17.36 23.57 72.04 18.68 21.92 71.98 38.23 2.77 0.52 36.38 3.82 0.63 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 265 GLU B 24 GLU~? 19.88 ZN ZN B2003 A 369 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 17.36 23.57 72.04 18.68 21.92 71.98 4.20 -2.38 22.67 5.80 -1.47 23.74 coo 12.19 31.08 87.29 11.13 32.66 86.38 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 265 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 369 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 265 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 369 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP A 54 ASP~? 25.58 ZN ZN G2004 A 265 GLU B 20 GLU~? 25.90 ZN ZN B2003 A 369 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.11 8.17 8.99 18.99 8.60 11.06 coo 17.36 23.57 72.04 18.68 21.92 71.98 7.89 1.30 17.42 7.18 2.96 16.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 265 GLU B 24 GLU~? 19.88 ZN ZN B2003 A 369 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 17.36 23.57 72.04 18.68 21.92 71.98 4.20 -2.38 22.67 5.80 -1.47 23.74 coo 12.19 31.08 87.29 11.13 32.66 86.38 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 265 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 369 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 265 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 369 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 17.36 23.57 72.04 18.68 21.92 71.98 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 265 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 369 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 17.36 23.57 72.04 18.68 21.92 71.98 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 265 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 369 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 17.36 23.57 72.04 18.68 21.92 71.98 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 265 GLU C 24 GLU~? 19.76 ZN ZN B2003 A 369 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 17.36 23.57 72.04 18.68 21.92 71.98 -10.63 -31.97 11.09 -10.50 -32.62 13.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 265 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 369 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 17.36 23.57 72.04 18.68 21.92 71.98 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 265 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 369 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 17.36 23.57 72.04 18.68 21.92 71.98 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 265 GLU C 24 GLU~? 19.76 ZN ZN B2003 A 369 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 17.36 23.57 72.04 18.68 21.92 71.98 -10.63 -31.97 11.09 -10.50 -32.62 13.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 265 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 369 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 17.36 23.57 72.04 18.68 21.92 71.98 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 265 GLU D 30 GLU^? 25.95 ZN ZN J2001 A 369 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 265 GLU D 30 GLU^? 25.95 ZN ZN J2001 A 369 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 265 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 369 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 17.36 23.57 72.04 18.68 21.92 71.98 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 23 3 # 23 A 241 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 265 GLU D 24 GLU~? 35.30 ZN ZN J2001 A 369 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 24 3 # 24 A 241 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 265 GLU D 30 GLU^? 25.95 ZN ZN J2001 A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 25 3 # 25 A 241 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 265 GLU D 30 GLU^? 25.95 ZN ZN J2001 A 369 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 26 3 # 26 A 241 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 265 GLU D 24 GLU~? 35.30 ZN ZN J2001 A 369 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 17.36 23.57 72.04 18.68 21.92 71.98 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 27 3 # 27 A 241 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 265 GLU D 30 GLU^? 25.95 ZN ZN J2001 A 369 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 28 3 # 28 A 241 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 265 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 369 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 17.36 23.57 72.04 18.68 21.92 71.98 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 29 3 # 29 A 241 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 265 GLU E 24 GLU~? 19.82 ZN ZN E2002 A 369 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 17.36 23.57 72.04 18.68 21.92 71.98 13.67 -6.82 -33.09 14.57 -7.33 -34.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 30 3 # 30 A 241 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 265 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 369 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 17.36 23.57 72.04 18.68 21.92 71.98 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 31 3 # 31 A 241 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 265 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 369 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 17.36 23.57 72.04 18.68 21.92 71.98 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 32 3 # 32 A 241 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 265 GLU E 24 GLU~? 19.82 ZN ZN E2002 A 369 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 13.67 -6.82 -33.09 14.57 -7.33 -34.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 33 3 # 33 A 241 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 265 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 369 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 34 3 # 34 A 241 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 265 GLU A 30 GLU^? 19.82 ZN ZN E2002 A 369 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 17.36 23.57 72.04 18.68 21.92 71.98 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 12.19 31.08 87.29 11.13 32.66 86.38 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 35 3 # 35 A 241 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 265 GLU A 30 GLU^? 19.82 ZN ZN E2002 A 369 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 17.36 23.57 72.04 18.68 21.92 71.98 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 36 3 # 36 A 241 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 265 GLU J 30 GLU^? 21.96 ZN ZN E2002 A 369 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 17.36 23.57 72.04 18.68 21.92 71.98 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 37 3 # 37 A 241 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 265 GLU A 24 GLU.? 19.69 ZN ZN E2002 A 369 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 18.55 13.29 -4.55 20.34 13.88 -5.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 38 3 # 38 A 241 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 265 GLU A 30 GLU^? 19.82 ZN ZN E2002 A 369 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 12.19 31.08 87.29 11.13 32.66 86.38 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 39 3 # 39 A 241 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 265 GLU A 30 GLU^? 19.82 ZN ZN E2002 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 40 3 # 40 A 241 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 265 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 41 3 # 41 A 241 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 265 GLU F 24 GLU.? 19.67 ZN ZN G2004 A 369 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 17.36 23.57 72.04 18.68 21.92 71.98 50.14 -4.90 0.74 49.85 -2.99 1.69 coo 12.19 31.08 87.29 11.13 32.66 86.38 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 42 3 # 42 A 241 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 265 GLU F 30 GLU^? 19.95 ZN ZN G2004 A 369 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 17.36 23.57 72.04 18.68 21.92 71.98 38.23 2.77 0.52 36.38 3.82 0.63 coo 12.19 31.08 87.29 11.13 32.66 86.38 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 43 3 # 43 A 241 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 265 GLU A 30 GLU^? 19.82 ZN ZN E2002 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 17.36 23.57 72.04 18.68 21.92 71.98 31.22 6.85 -4.51 33.04 5.76 -4.61 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 44 3 # 44 A 241 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 265 GLU J 30 GLU^? 21.96 ZN ZN E2002 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 17.36 23.57 72.04 18.68 21.92 71.98 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 45 3 # 45 A 241 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 265 GLU J 30 GLU^? 21.96 ZN ZN E2002 A 369 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 17.36 23.57 72.04 18.68 21.92 71.98 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 46 3 # 46 A 241 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 265 GLU J 24 GLU.? 19.48 ZN ZN J2001 A 369 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 17.36 23.57 72.04 18.68 21.92 71.98 43.53 -25.45 -26.61 43.80 -24.04 -28.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 47 3 # 47 A 241 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 265 GLU J 30 GLU^? 21.96 ZN ZN E2002 A 369 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 17.36 23.57 72.04 18.68 21.92 71.98 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 48 3 # 48 A 241 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 265 GLU J 30 GLU^? 21.96 ZN ZN E2002 A 369 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 17.36 23.57 72.04 18.68 21.92 71.98 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 49 3 # 49 A 241 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 265 GLU G 24 GLU~? 19.71 ZN ZN G2004 A 369 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 17.36 23.57 72.04 18.68 21.92 71.98 35.34 -19.32 28.91 34.28 -18.98 30.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 50 3 # 50 A 241 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 265 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 369 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 17.36 23.57 72.04 18.68 21.92 71.98 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 51 3 # 51 A 241 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 265 GLU B 30 GLU^? 21.92 ZN ZN G2004 A 369 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.88 -7.29 24.59 18.95 -7.88 24.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 52 3 # 52 A 241 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 265 GLU F 30 GLU^? 19.95 ZN ZN G2004 A 369 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 17.36 23.57 72.04 18.68 21.92 71.98 38.23 2.77 0.52 36.38 3.82 0.63 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 53 3 # 53 A 241 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 265 GLU F 30 GLU^? 19.95 ZN ZN G2004 A 369 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 17.36 23.57 72.04 18.68 21.92 71.98 38.23 2.77 0.52 36.38 3.82 0.63 coo 12.19 31.08 87.29 11.13 32.66 86.38 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 54 3 # 54 A 241 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 265 GLU F 24 GLU.? 19.67 ZN ZN G2004 A 369 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 17.36 23.57 72.04 18.68 21.92 71.98 50.14 -4.90 0.74 49.85 -2.99 1.69 coo 12.19 31.08 87.29 11.13 32.66 86.38 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 55 3 # 55 A 241 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 265 GLU F 30 GLU^? 19.95 ZN ZN G2004 A 369 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 17.36 23.57 72.04 18.68 21.92 71.98 38.23 2.77 0.52 36.38 3.82 0.63 coo 12.19 31.08 87.29 11.13 32.66 86.38 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 56 3 # 56 A 241 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 265 GLU F 30 GLU^? 19.95 ZN ZN G2004 A 369 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 17.36 23.57 72.04 18.68 21.92 71.98 38.23 2.77 0.52 36.38 3.82 0.63 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 57 3 # 57 A 241 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 265 GLU H 24 GLU~? 35.52 ZN ZN B2003 A 369 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 17.36 23.57 72.04 18.68 21.92 71.98 20.30 -49.47 18.65 18.48 -50.29 19.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 58 3 # 58 A 241 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 265 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 369 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 17.36 23.57 72.04 18.68 21.92 71.98 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 59 3 # 59 A 241 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 265 GLU C 30 GLU^? 20.32 ZN ZN B2003 A 369 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 1.09 -37.94 15.82 2.89 -38.82 16.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 60 3 # 60 A 241 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 265 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 369 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 61 3 # 61 A 241 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 265 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 369 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 62 3 # 62 A 241 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 265 GLU G 24 GLU~? 19.71 ZN ZN G2004 A 369 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 35.34 -19.32 28.91 34.28 -18.98 30.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 63 3 # 63 A 241 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 265 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 369 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 64 3 # 64 A 241 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 265 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 369 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 65 3 # 65 A 241 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 265 GLU I 24 GLU~? 19.88 ZN ZN J2001 A 369 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 17.36 23.57 72.04 18.68 21.92 71.98 25.57 -52.88 -14.93 24.90 -53.17 -16.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 66 3 # 66 A 241 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 265 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 369 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 17.36 23.57 72.04 18.68 21.92 71.98 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 67 3 # 67 A 241 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 265 GLU D 30 GLU^? 25.95 ZN ZN J2001 A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.60 -42.69 -18.81 7.22 -43.92 -18.20 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 68 3 # 68 A 241 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 265 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 17.36 23.57 72.04 18.68 21.92 71.98 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 69 3 # 69 A 241 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 265 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 369 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 17.36 23.57 72.04 18.68 21.92 71.98 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 70 3 # 70 A 241 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 265 GLU H 24 GLU~? 35.52 ZN ZN B2003 A 369 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 17.36 23.57 72.04 18.68 21.92 71.98 20.30 -49.47 18.65 18.48 -50.29 19.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 71 3 # 71 A 241 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 265 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 369 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 17.36 23.57 72.04 18.68 21.92 71.98 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 72 3 # 72 A 241 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 265 GLU H 30 GLU^? 26.29 ZN ZN B2003 A 369 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 17.36 23.57 72.04 18.68 21.92 71.98 8.76 -43.18 14.57 6.72 -43.67 14.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 73 3 # 73 A 241 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 265 GLU J 24 GLU.? 19.48 ZN ZN J2001 A 369 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 17.36 23.57 72.04 18.68 21.92 71.98 43.53 -25.45 -26.61 43.80 -24.04 -28.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 74 3 # 74 A 241 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 265 GLU J 30 GLU^? 21.96 ZN ZN E2002 A 369 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 17.36 23.57 72.04 18.68 21.92 71.98 33.28 -16.74 -28.58 31.82 -15.19 -28.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 75 3 # 75 A 241 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 265 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 369 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 76 3 # 76 A 241 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 265 GLU I 24 GLU~? 19.88 ZN ZN J2001 A 369 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 25.57 -52.88 -14.93 24.90 -53.17 -16.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.01 -35.27 -13.87 27.04 -33.54 -13.28 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 77 3 # 77 A 241 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 265 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 369 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.01 -35.27 -13.87 27.04 -33.54 -13.28 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 78 3 # 78 A 241 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 265 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 369 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 24.29 -34.17 -32.69 23.20 -35.63 -31.63 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 78 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 279 GLU A 64 GLU.? 24.42 ZN ZN E2002 A 369 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 16.54 46.37 63.94 14.77 45.79 62.95 7.18 3.59 -5.93 6.39 1.65 -6.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 279 GLU B 67 GLU^? 26.37 ZN ZN B2003 A 369 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 16.54 46.37 63.94 14.77 45.79 62.95 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 54 ASP~? 25.58 ZN ZN G2004 A 279 GLU A 20 GLU~? -13.24 ZN ZN E2002s A 369 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.11 8.17 8.99 18.99 8.60 11.06 coo 16.54 46.37 63.94 14.77 45.79 62.95 18.69 9.20 -10.94 17.52 9.95 -12.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 54 ASP~? 25.58 ZN ZN G2004 A 279 GLU A 64 GLU.? 24.42 ZN ZN E2002 A 369 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.11 8.17 8.99 18.99 8.60 11.06 coo 16.54 46.37 63.94 14.77 45.79 62.95 7.18 3.59 -5.93 6.39 1.65 -6.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 279 GLU C 67 GLU.? 23.10 ZN ZN B2003 A 369 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 16.54 46.37 63.94 14.77 45.79 62.95 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 279 GLU B 64 GLU.? 24.26 ZN ZN B2003 A 369 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 16.54 46.37 63.94 14.77 45.79 62.95 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 279 GLU C 67 GLU.? 23.10 ZN ZN B2003 A 369 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 16.54 46.37 63.94 14.77 45.79 62.95 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 54 ASP~? -2.43 ZN ZN B2003s A 279 GLU B 20 GLU~? 25.90 ZN ZN B2003 A 369 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 16.54 46.37 63.94 14.77 45.79 62.95 7.89 1.30 17.42 7.18 2.96 16.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 54 ASP~? -2.43 ZN ZN B2003s A 279 GLU B 64 GLU.? 24.26 ZN ZN B2003 A 369 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 16.54 46.37 63.94 14.77 45.79 62.95 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 279 GLU C 64 GLU.? 25.72 ZN ZN B2003 A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 16.54 46.37 63.94 14.77 45.79 62.95 -7.33 -19.22 1.68 -6.59 -18.32 -0.10 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 279 GLU C 67 GLU.? 23.10 ZN ZN B2003 A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 16.54 46.37 63.94 14.77 45.79 62.95 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 279 GLU D 67 GLU^? 32.75 ZN ZN B2003 A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 16.54 46.37 63.94 14.77 45.79 62.95 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 279 GLU C 20 GLU~? -13.13 ZN ZN B2003s A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 16.54 46.37 63.94 14.77 45.79 62.95 -6.90 -26.36 14.56 -8.07 -24.73 15.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 279 GLU C 64 GLU.? 25.72 ZN ZN B2003 A 369 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 16.54 46.37 63.94 14.77 45.79 62.95 -7.33 -19.22 1.68 -6.59 -18.32 -0.10 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 279 GLU E 67 GLU^? 26.75 ZN ZN E2002 A 369 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 16.54 46.37 63.94 14.77 45.79 62.95 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 279 GLU D 64 GLU.? 37.94 ZN ZN E2002 A 369 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 16.54 46.37 63.94 14.77 45.79 62.95 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 279 GLU D 67 GLU^? 32.75 ZN ZN B2003 A 369 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 16.54 46.37 63.94 14.77 45.79 62.95 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 279 GLU E 67 GLU^? 26.75 ZN ZN E2002 A 369 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 16.54 46.37 63.94 14.77 45.79 62.95 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP D 54 ASP~? 25.75 ZN ZN J2001 A 279 GLU D 20 GLU~? 40.68 ZN ZN J2001 A 369 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 16.54 46.37 63.94 14.77 45.79 62.95 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP D 54 ASP~? 25.75 ZN ZN J2001 A 279 GLU D 64 GLU.? 37.94 ZN ZN E2002 A 369 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 16.54 46.37 63.94 14.77 45.79 62.95 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 279 GLU A 67 GLU^? 23.17 ZN ZN E2002 A 369 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 16.54 46.37 63.94 14.77 45.79 62.95 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 279 GLU A 64 GLU.? 24.42 ZN ZN E2002 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 16.54 46.37 63.94 14.77 45.79 62.95 7.18 3.59 -5.93 6.39 1.65 -6.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 23 3 # 23 A 241 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 279 GLU A 67 GLU^? 23.17 ZN ZN E2002 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 16.54 46.37 63.94 14.77 45.79 62.95 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 24 3 # 24 A 241 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 279 GLU E 64 GLU.? 24.43 ZN ZN E2002 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 16.54 46.37 63.94 14.77 45.79 62.95 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 25 3 # 25 A 241 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 279 GLU E 20 GLU~? 26.08 ZN ZN E2002 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 16.54 46.37 63.94 14.77 45.79 62.95 9.85 -13.14 -31.23 7.79 -13.45 -31.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 26 3 # 26 A 241 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 279 GLU E 64 GLU.? 24.43 ZN ZN E2002 A 369 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 16.54 46.37 63.94 14.77 45.79 62.95 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 27 3 # 27 A 241 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 279 GLU F 64 GLU.? 24.41 ZN ZN G2004 A 369 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 16.54 46.37 63.94 14.77 45.79 62.95 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 28 3 # 28 A 241 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 279 GLU J 67 GLU^? 26.37 ZN ZN J2001 A 369 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 16.54 46.37 63.94 14.77 45.79 62.95 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 29 3 # 29 A 241 ASP F 54 ASP~? 25.15 ZN ZN E2002 A 279 GLU F 20 GLU~? -13.12 ZN ZN G2004s A 369 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 16.54 46.37 63.94 14.77 45.79 62.95 46.58 -6.83 6.99 47.75 -7.54 8.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 30 3 # 30 A 241 ASP F 54 ASP~? 25.15 ZN ZN E2002 A 279 GLU F 64 GLU.? 24.41 ZN ZN G2004 A 369 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 16.54 46.37 63.94 14.77 45.79 62.95 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 12.19 31.08 87.29 11.13 32.66 86.38 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 31 3 # 31 A 241 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 279 GLU F 67 GLU^? 23.19 ZN ZN G2004 A 369 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 16.54 46.37 63.94 14.77 45.79 62.95 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 32 3 # 32 A 241 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 279 GLU F 64 GLU.? 24.41 ZN ZN G2004 A 369 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 16.54 46.37 63.94 14.77 45.79 62.95 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 33 3 # 33 A 241 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 279 GLU F 67 GLU^? 23.19 ZN ZN G2004 A 369 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 16.54 46.37 63.94 14.77 45.79 62.95 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 34 3 # 34 A 241 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 279 GLU G 64 GLU.? 24.28 ZN ZN G2004 A 369 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 16.54 46.37 63.94 14.77 45.79 62.95 39.99 -27.18 15.98 39.71 -28.44 14.30 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 35 3 # 35 A 241 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 279 GLU G 20 GLU~? 25.94 ZN ZN G2004 A 369 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 31.62 -25.65 27.15 32.27 -27.58 27.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 36 3 # 36 A 241 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 279 GLU G 64 GLU.? 24.28 ZN ZN G2004 A 369 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 11.74 38.14 80.19 10.63 36.40 80.65 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 39.99 -27.18 15.98 39.71 -28.44 14.30 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 37 3 # 37 A 241 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 279 GLU G 67 GLU^? 26.62 ZN ZN G2004 A 369 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 16.54 46.37 63.94 14.77 45.79 62.95 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 38 3 # 38 A 241 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 279 GLU G 67 GLU^? 26.62 ZN ZN G2004 A 369 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 39 3 # 39 A 241 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 279 GLU H 67 GLU^? 32.59 ZN ZN J2001 A 369 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 40 3 # 40 A 241 ASP H 54 ASP~? 25.78 ZN ZN B2003 A 279 GLU H 20 GLU~? 40.75 ZN ZN B2003 A 369 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 16.54 46.37 63.94 14.77 45.79 62.95 20.26 -50.51 11.36 21.36 -52.05 10.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 41 3 # 41 A 241 ASP H 54 ASP~? 25.78 ZN ZN B2003 A 279 GLU H 64 GLU.? 37.89 ZN ZN G2004 A 369 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 16.54 46.37 63.94 14.77 45.79 62.95 32.53 -42.71 11.25 33.49 -41.02 10.38 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 42 3 # 42 A 241 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 279 GLU H 67 GLU^? 32.59 ZN ZN J2001 A 369 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 16.54 46.37 63.94 14.77 45.79 62.95 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 43 3 # 43 A 241 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 279 GLU I 20 GLU~? -12.94 ZN ZN J2001s A 369 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 16.54 46.37 63.94 14.77 45.79 62.95 28.55 -46.90 -18.54 30.50 -46.99 -19.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 44 3 # 44 A 241 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 279 GLU I 64 GLU.? 25.65 ZN ZN J2001 A 369 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 16.54 46.37 63.94 14.77 45.79 62.95 34.90 -43.61 -5.62 35.57 -42.49 -3.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 45 3 # 45 A 241 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 279 GLU I 67 GLU^? 22.99 ZN ZN J2001 A 369 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 16.54 46.37 63.94 14.77 45.79 62.95 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 46 3 # 46 A 241 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 279 GLU I 67 GLU^? 22.99 ZN ZN J2001 A 369 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 16.54 46.37 63.94 14.77 45.79 62.95 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 12.19 31.08 87.29 11.13 32.66 86.38 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 47 3 # 47 A 241 ASP J 54 ASP~? -2.24 ZN ZN J2001s A 279 GLU J 20 GLU~? 25.99 ZN ZN J2001 A 369 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 16.54 46.37 63.94 14.77 45.79 62.95 45.09 -20.14 -21.38 46.92 -19.89 -20.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 48 3 # 48 A 241 ASP J 54 ASP~? -2.24 ZN ZN J2001s A 279 GLU J 64 GLU.? 23.99 ZN ZN J2001 A 369 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 11.74 38.14 80.19 10.63 36.40 80.65 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 16.54 46.37 63.94 14.77 45.79 62.95 44.01 -30.69 -11.59 43.10 -30.84 -9.69 coo 12.19 31.08 87.29 11.13 32.66 86.38 24.29 -34.17 -32.69 23.20 -35.63 -31.63 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 48 hits 1m53_c06 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 12 GLY.? 16.77 ZN ZN E2002 A 501 ASP B 39 ASP.? 27.28 ZN ZN B2003 B 367 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 13.30 -3.59 -12.73 12.78 -3.06 -12.48 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 19 GLY~? 15.01 ZN ZN E2002 A 501 ASP B 39 ASP.? 27.28 ZN ZN B2003 B 367 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 65 GLY.? 22.58 ZN ZN E2002 A 501 ASP E 39 ASP.? 27.23 ZN ZN E2002 B 367 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 9.87 0.02 -5.68 10.10 -0.01 -4.96 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 65 GLY.? 22.58 ZN ZN E2002 A 501 ASP E 54 ASP~? -2.11 ZN ZN E2002s B 367 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 9.87 0.02 -5.68 10.10 -0.01 -4.96 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 12 GLY.? 29.28 ZN ZN B2003 A 501 ASP C 39 ASP.? 16.40 ZN ZN B2003 B 367 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.23 -2.77 3.74 9.49 -2.75 4.04 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY B 19 GLY~? 21.58 ZN ZN B2003 A 501 ASP C 39 ASP.? 16.40 ZN ZN B2003 B 367 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY B 59 GLY.? 10.36 ZN ZN B2003 A 501 ASP A 53 ASP~? 26.24 ZN ZN G2004 B 367 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 1.90 -12.37 18.50 1.89 -12.74 17.75 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 17.64 3.84 11.72 15.55 3.44 11.90 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 65 GLY.? 22.65 ZN ZN B2003 A 501 ASP A 39 ASP.? 16.23 ZN ZN E2002 B 367 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 3.22 -7.02 6.74 3.19 -7.63 7.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 65 GLY.? 22.65 ZN ZN B2003 A 501 ASP A 54 ASP~? 25.58 ZN ZN G2004 B 367 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 3.22 -7.02 6.74 3.19 -7.63 7.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.11 8.17 8.99 18.99 8.60 11.06 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY C 12 GLY~? 16.92 ZN ZN B2003 A 501 ASP D 39 ASP.? 32.27 ZN ZN B2003 B 367 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 1.25 -16.50 8.28 0.53 -16.71 7.98 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY C 19 GLY~? 15.35 ZN ZN B2003 A 501 ASP D 39 ASP.? 32.27 ZN ZN B2003 B 367 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY C 59 GLY.? 27.39 ZN ZN B2003 A 501 ASP B 53 ASP~? 5.10 ZN ZN B2003 B 367 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -6.42 -33.04 1.21 -6.03 -32.50 0.78 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.76 -33.59 -9.48 20.18 -32.83 -6.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY C 65 GLY.? 22.60 ZN ZN B2003 A 501 ASP B 39 ASP.? 27.28 ZN ZN B2003 B 367 TYR H 32 TYR^? 29.55 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.28 -20.23 2.31 -3.22 -20.84 1.83 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.73 -43.63 9.08 8.41 -44.48 10.38 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY C 65 GLY.? 22.60 ZN ZN B2003 A 501 ASP B 54 ASP~? -2.43 ZN ZN B2003s B 367 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.28 -20.23 2.31 -3.22 -20.84 1.83 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY D 12 GLY.? 30.67 ZN ZN B2003 A 501 ASP E 39 ASP.? 27.23 ZN ZN E2002 B 367 TYR H 32 TYR^? 29.55 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.47 -26.02 -5.45 -1.91 -25.74 -6.02 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.73 -43.63 9.08 8.41 -44.48 10.38 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY D 19 GLY~? 34.83 ZN ZN J2001 A 501 ASP E 39 ASP.? 27.23 ZN ZN E2002 B 367 TYR H 32 TYR^? 29.55 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.73 -43.63 9.08 8.41 -44.48 10.38 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY D 59 GLY.? 30.11 ZN ZN J2001 A 501 ASP C 53 ASP~? 35.43 ZN ZN B2003 B 367 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 2.84 -26.21 -24.49 3.04 -25.55 -24.01 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY D 65 GLY.? 37.87 ZN ZN E2002 A 501 ASP C 39 ASP.? 16.40 ZN ZN B2003 B 367 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.41 -21.75 -13.31 -0.91 -21.85 -13.90 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.53 -40.66 -20.20 16.59 -42.17 -21.51 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY D 65 GLY.? 37.87 ZN ZN E2002 A 501 ASP C 54 ASP~? 34.22 ZN ZN B2003 B 367 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.41 -21.75 -13.31 -0.91 -21.85 -13.90 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY E 12 GLY.? 29.18 ZN ZN E2002 A 501 ASP A 39 ASP.? 16.23 ZN ZN E2002 B 367 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 6.03 -17.90 -18.46 5.93 -17.12 -18.66 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.53 -40.66 -20.20 16.59 -42.17 -21.51 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY E 19 GLY~? 21.67 ZN ZN E2002 A 501 ASP A 39 ASP.? 16.23 ZN ZN E2002 B 367 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.53 -40.66 -20.20 16.59 -42.17 -21.51 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY E 65 GLY.? 22.85 ZN ZN E2002 A 501 ASP D 39 ASP.? 32.27 ZN ZN B2003 B 367 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 6.97 -9.67 -17.96 7.60 -9.21 -17.79 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY E 65 GLY.? 22.85 ZN ZN E2002 A 501 ASP D 54 ASP~? 25.75 ZN ZN J2001 B 367 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 6.97 -9.67 -17.96 7.60 -9.21 -17.79 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY F 12 GLY.? 16.71 ZN ZN G2004 A 501 ASP J 39 ASP.? 27.27 ZN ZN J2001 B 367 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 38.22 -18.03 8.72 38.92 -18.19 8.48 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 25 3 # 25 A 465 GLY F 19 GLY~? 15.06 ZN ZN G2004 A 501 ASP J 39 ASP.? 27.27 ZN ZN J2001 B 367 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 26 3 # 26 A 465 GLY F 59 GLY.? 27.43 ZN ZN G2004 A 501 ASP G 53 ASP~? 4.94 ZN ZN G2004 B 367 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 45.66 -10.77 -7.58 45.22 -11.43 -7.55 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 27 3 # 27 A 465 GLY F 65 GLY.? 22.55 ZN ZN G2004 A 501 ASP G 39 ASP.? 27.24 ZN ZN G2004 B 367 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 43.02 -19.23 1.70 42.92 -18.94 1.00 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 28 3 # 28 A 465 GLY F 65 GLY.? 22.55 ZN ZN G2004 A 501 ASP G 54 ASP~? -2.04 ZN ZN G2004s B 367 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 43.02 -19.23 1.70 42.92 -18.94 1.00 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 29 3 # 29 A 465 GLY G 12 GLY.? 29.13 ZN ZN G2004 A 501 ASP F 39 ASP.? 16.21 ZN ZN G2004 B 367 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 29.44 -31.51 14.55 30.18 -31.23 14.75 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 30 3 # 30 A 465 GLY G 19 GLY~? 21.50 ZN ZN G2004 A 501 ASP F 39 ASP.? 16.21 ZN ZN G2004 B 367 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 31 3 # 31 A 465 GLY G 65 GLY.? 22.69 ZN ZN G2004 A 501 ASP H 39 ASP.? 32.15 ZN ZN J2001 B 367 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 36.11 -26.47 13.94 36.18 -25.70 13.80 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 32 3 # 32 A 465 GLY G 65 GLY.? 22.69 ZN ZN G2004 A 501 ASP H 54 ASP~? 25.78 ZN ZN B2003 B 367 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 36.11 -26.47 13.94 36.18 -25.70 13.80 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.76 -33.59 -9.48 20.18 -32.83 -6.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 33 3 # 33 A 465 GLY H 12 GLY.? 30.71 ZN ZN J2001 A 501 ASP G 39 ASP.? 27.24 ZN ZN G2004 B 367 TYR D 32 TYR^? 29.54 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 26.09 -42.02 1.53 26.51 -42.29 2.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 4.78 -40.18 -12.99 5.15 -42.55 -14.41 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 34 3 # 34 A 465 GLY H 19 GLY~? 34.96 ZN ZN B2003 A 501 ASP G 39 ASP.? 27.24 ZN ZN G2004 B 367 TYR D 32 TYR^? 29.54 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 4.78 -40.18 -12.99 5.15 -42.55 -14.41 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 35 3 # 35 A 465 GLY H 59 GLY~? 30.00 ZN ZN B2003 A 501 ASP I 53 ASP~? 35.51 ZN ZN J2001 B 367 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 23.71 -38.32 20.60 24.20 -37.78 20.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 36 3 # 36 A 465 GLY H 65 GLY.? 37.58 ZN ZN G2004 A 501 ASP I 39 ASP.? 16.30 ZN ZN J2001 B 367 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 29.91 -39.66 9.38 29.48 -39.47 9.99 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 37 3 # 37 A 465 GLY H 65 GLY.? 37.58 ZN ZN G2004 A 501 ASP I 54 ASP~? 33.46 ZN ZN J2001 B 367 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 29.91 -39.66 9.38 29.48 -39.47 9.99 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 38 3 # 38 A 465 GLY I 12 GLY.? 16.89 ZN ZN J2001 A 501 ASP H 39 ASP.? 32.15 ZN ZN J2001 B 367 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 33.08 -34.86 -12.28 33.22 -35.59 -11.99 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 39 3 # 39 A 465 GLY I 19 GLY~? 15.19 ZN ZN J2001 A 501 ASP H 39 ASP.? 32.15 ZN ZN J2001 B 367 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 40 3 # 40 A 465 GLY I 59 GLY.? 27.32 ZN ZN J2001 A 501 ASP J 53 ASP~? 5.09 ZN ZN J2001 B 367 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 22.54 -49.72 -5.18 22.76 -49.15 -4.67 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 41 3 # 41 A 465 GLY I 65 GLY.? 22.65 ZN ZN J2001 A 501 ASP J 39 ASP.? 27.27 ZN ZN J2001 B 367 TYR D 32 TYR^? 29.54 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 32.06 -40.56 -6.20 31.46 -40.88 -5.85 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 4.78 -40.18 -12.99 5.15 -42.55 -14.41 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 42 3 # 42 A 465 GLY I 65 GLY.? 22.65 ZN ZN J2001 A 501 ASP J 54 ASP~? -2.24 ZN ZN J2001s B 367 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 32.06 -40.56 -6.20 31.46 -40.88 -5.85 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 31.03 -12.70 0.17 30.17 -14.19 -2.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 43 3 # 43 A 465 GLY J 12 GLY.? 29.28 ZN ZN J2001 A 501 ASP I 39 ASP.? 16.30 ZN ZN J2001 B 367 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 40.43 -20.16 -7.78 40.79 -20.81 -8.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 44 3 # 44 A 465 GLY J 19 GLY~? 21.52 ZN ZN J2001 A 501 ASP I 39 ASP.? 16.30 ZN ZN J2001 B 367 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 45 3 # 45 A 465 GLY J 59 GLY.? 10.51 ZN ZN J2001 A 501 ASP F 53 ASP~? 26.13 ZN ZN E2002 B 367 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 36.39 -32.17 -22.43 36.06 -32.36 -21.69 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 46 3 # 46 A 465 GLY J 65 GLY.? 22.67 ZN ZN J2001 A 501 ASP F 39 ASP.? 16.21 ZN ZN G2004 B 367 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 40.24 -28.46 -10.68 39.76 -28.75 -11.23 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 47 3 # 47 A 465 GLY J 65 GLY.? 22.67 ZN ZN J2001 A 501 ASP F 54 ASP~? 25.15 ZN ZN E2002 B 367 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 40.24 -28.46 -10.68 39.76 -28.75 -11.23 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 23.80 -20.63 11.40 24.84 -19.26 9.19 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 47 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 12 GLY.? 16.77 ZN ZN E2002 D 501 ASP B 39 ASP.? 27.28 ZN ZN B2003 E 367 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 13.30 -3.59 -12.73 12.78 -3.06 -12.48 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 19 GLY~? 15.01 ZN ZN E2002 D 501 ASP B 39 ASP.? 27.28 ZN ZN B2003 E 367 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 65 GLY.? 22.58 ZN ZN E2002 D 501 ASP E 39 ASP.? 27.23 ZN ZN E2002 E 367 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 9.87 0.02 -5.68 10.10 -0.01 -4.96 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 12 GLY.? 29.28 ZN ZN B2003 D 501 ASP C 39 ASP.? 16.40 ZN ZN B2003 E 367 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.23 -2.77 3.74 9.49 -2.75 4.04 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 19 GLY~? 21.58 ZN ZN B2003 D 501 ASP C 39 ASP.? 16.40 ZN ZN B2003 E 367 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 65 GLY.? 22.65 ZN ZN B2003 D 501 ASP A 39 ASP.? 16.23 ZN ZN E2002 E 367 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 3.22 -7.02 6.74 3.19 -7.63 7.25 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 65 GLY.? 22.65 ZN ZN B2003 D 501 ASP A 54 ASP~? 25.58 ZN ZN G2004 E 367 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 3.22 -7.02 6.74 3.19 -7.63 7.25 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.11 8.17 8.99 18.99 8.60 11.06 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY C 12 GLY~? 16.92 ZN ZN B2003 D 501 ASP D 39 ASP.? 32.27 ZN ZN B2003 E 367 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 1.25 -16.50 8.28 0.53 -16.71 7.98 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY C 19 GLY~? 15.35 ZN ZN B2003 D 501 ASP D 39 ASP.? 32.27 ZN ZN B2003 E 367 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY C 65 GLY.? 22.60 ZN ZN B2003 D 501 ASP B 39 ASP.? 27.28 ZN ZN B2003 E 367 TYR H 32 TYR^? 29.55 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.28 -20.23 2.31 -3.22 -20.84 1.83 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 10.73 -43.63 9.08 8.41 -44.48 10.38 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY C 65 GLY.? 22.60 ZN ZN B2003 D 501 ASP B 54 ASP~? -2.43 ZN ZN B2003s E 367 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.28 -20.23 2.31 -3.22 -20.84 1.83 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY D 12 GLY.? 30.67 ZN ZN B2003 D 501 ASP E 39 ASP.? 27.23 ZN ZN E2002 E 367 TYR H 32 TYR^? 29.55 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.47 -26.02 -5.45 -1.91 -25.74 -6.02 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 10.73 -43.63 9.08 8.41 -44.48 10.38 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY D 19 GLY~? 34.83 ZN ZN J2001 D 501 ASP E 39 ASP.? 27.23 ZN ZN E2002 E 367 TYR H 32 TYR^? 29.55 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 10.73 -43.63 9.08 8.41 -44.48 10.38 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY D 59 GLY.? 30.11 ZN ZN J2001 D 501 ASP C 53 ASP~? 35.43 ZN ZN B2003 E 367 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 2.84 -26.21 -24.49 3.04 -25.55 -24.01 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY D 65 GLY.? 37.87 ZN ZN E2002 D 501 ASP C 39 ASP.? 16.40 ZN ZN B2003 E 367 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.41 -21.75 -13.31 -0.91 -21.85 -13.90 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.53 -40.66 -20.20 16.59 -42.17 -21.51 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY D 65 GLY.? 37.87 ZN ZN E2002 D 501 ASP C 54 ASP~? 34.22 ZN ZN B2003 E 367 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.41 -21.75 -13.31 -0.91 -21.85 -13.90 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY E 12 GLY.? 29.18 ZN ZN E2002 D 501 ASP A 39 ASP.? 16.23 ZN ZN E2002 E 367 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 6.03 -17.90 -18.46 5.93 -17.12 -18.66 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.53 -40.66 -20.20 16.59 -42.17 -21.51 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY E 19 GLY~? 21.67 ZN ZN E2002 D 501 ASP A 39 ASP.? 16.23 ZN ZN E2002 E 367 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.53 -40.66 -20.20 16.59 -42.17 -21.51 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY E 65 GLY.? 22.85 ZN ZN E2002 D 501 ASP D 39 ASP.? 32.27 ZN ZN B2003 E 367 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 6.97 -9.67 -17.96 7.60 -9.21 -17.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY E 65 GLY.? 22.85 ZN ZN E2002 D 501 ASP D 54 ASP~? 25.75 ZN ZN J2001 E 367 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 6.97 -9.67 -17.96 7.60 -9.21 -17.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY F 12 GLY.? 16.71 ZN ZN G2004 D 501 ASP J 39 ASP.? 27.27 ZN ZN J2001 E 367 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 38.22 -18.03 8.72 38.92 -18.19 8.48 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY F 19 GLY~? 15.06 ZN ZN G2004 D 501 ASP J 39 ASP.? 27.27 ZN ZN J2001 E 367 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY F 65 GLY.? 22.55 ZN ZN G2004 D 501 ASP G 39 ASP.? 27.24 ZN ZN G2004 E 367 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 43.02 -19.23 1.70 42.92 -18.94 1.00 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY G 12 GLY.? 29.13 ZN ZN G2004 D 501 ASP F 39 ASP.? 16.21 ZN ZN G2004 E 367 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 29.44 -31.51 14.55 30.18 -31.23 14.75 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY G 19 GLY~? 21.50 ZN ZN G2004 D 501 ASP F 39 ASP.? 16.21 ZN ZN G2004 E 367 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 26 3 # 26 D 465 GLY G 65 GLY.? 22.69 ZN ZN G2004 D 501 ASP H 39 ASP.? 32.15 ZN ZN J2001 E 367 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 36.11 -26.47 13.94 36.18 -25.70 13.80 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 27 3 # 27 D 465 GLY G 65 GLY.? 22.69 ZN ZN G2004 D 501 ASP H 54 ASP~? 25.78 ZN ZN B2003 E 367 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 36.11 -26.47 13.94 36.18 -25.70 13.80 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.76 -33.59 -9.48 20.18 -32.83 -6.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 28 3 # 28 D 465 GLY H 12 GLY.? 30.71 ZN ZN J2001 D 501 ASP G 39 ASP.? 27.24 ZN ZN G2004 E 367 TYR D 32 TYR^? 29.54 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 26.09 -42.02 1.53 26.51 -42.29 2.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 4.78 -40.18 -12.99 5.15 -42.55 -14.41 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 29 3 # 29 D 465 GLY H 19 GLY~? 34.96 ZN ZN B2003 D 501 ASP G 39 ASP.? 27.24 ZN ZN G2004 E 367 TYR D 32 TYR^? 29.54 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 4.78 -40.18 -12.99 5.15 -42.55 -14.41 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 30 3 # 30 D 465 GLY H 59 GLY~? 30.00 ZN ZN B2003 D 501 ASP I 53 ASP~? 35.51 ZN ZN J2001 E 367 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 23.71 -38.32 20.60 24.20 -37.78 20.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 31 3 # 31 D 465 GLY H 65 GLY.? 37.58 ZN ZN G2004 D 501 ASP I 39 ASP.? 16.30 ZN ZN J2001 E 367 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 29.91 -39.66 9.38 29.48 -39.47 9.99 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 32 3 # 32 D 465 GLY H 65 GLY.? 37.58 ZN ZN G2004 D 501 ASP I 54 ASP~? 33.46 ZN ZN J2001 E 367 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 29.91 -39.66 9.38 29.48 -39.47 9.99 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 33 3 # 33 D 465 GLY I 12 GLY.? 16.89 ZN ZN J2001 D 501 ASP H 39 ASP.? 32.15 ZN ZN J2001 E 367 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 33.08 -34.86 -12.28 33.22 -35.59 -11.99 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 34 3 # 34 D 465 GLY I 19 GLY~? 15.19 ZN ZN J2001 D 501 ASP H 39 ASP.? 32.15 ZN ZN J2001 E 367 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 35 3 # 35 D 465 GLY I 59 GLY.? 27.32 ZN ZN J2001 D 501 ASP J 53 ASP~? 5.09 ZN ZN J2001 E 367 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 22.54 -49.72 -5.18 22.76 -49.15 -4.67 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 36 3 # 36 D 465 GLY I 65 GLY.? 22.65 ZN ZN J2001 D 501 ASP J 39 ASP.? 27.27 ZN ZN J2001 E 367 TYR D 32 TYR^? 29.54 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.06 -40.56 -6.20 31.46 -40.88 -5.85 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 4.78 -40.18 -12.99 5.15 -42.55 -14.41 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 37 3 # 37 D 465 GLY I 65 GLY.? 22.65 ZN ZN J2001 D 501 ASP J 54 ASP~? -2.24 ZN ZN J2001s E 367 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.06 -40.56 -6.20 31.46 -40.88 -5.85 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 31.03 -12.70 0.17 30.17 -14.19 -2.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 38 3 # 38 D 465 GLY J 12 GLY.? 29.28 ZN ZN J2001 D 501 ASP I 39 ASP.? 16.30 ZN ZN J2001 E 367 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 40.43 -20.16 -7.78 40.79 -20.81 -8.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 39 3 # 39 D 465 GLY J 19 GLY~? 21.52 ZN ZN J2001 D 501 ASP I 39 ASP.? 16.30 ZN ZN J2001 E 367 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 40 3 # 40 D 465 GLY J 65 GLY.? 22.67 ZN ZN J2001 D 501 ASP F 39 ASP.? 16.21 ZN ZN G2004 E 367 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 40.24 -28.46 -10.68 39.76 -28.75 -11.23 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 41 3 # 41 D 465 GLY J 65 GLY.? 22.67 ZN ZN J2001 D 501 ASP F 54 ASP~? 25.15 ZN ZN E2002 E 367 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 40.24 -28.46 -10.68 39.76 -28.75 -11.23 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 23.80 -20.63 11.40 24.84 -19.26 9.19 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 41 hits 1mro_c01 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 33 SER^? 10.82 ZN ZN E2002 A 154 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 261 ARG F 76 ARG^? 8.13 ZN ZN E2002 coo 16.10 74.10 3.11 17.18 73.52 5.20 24.11 0.27 -11.15 22.21 1.00 -12.37 coo 16.07 84.71 8.14 15.20 82.81 8.14 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 10.59 77.85 4.81 13.09 76.36 5.76 23.22 4.91 -15.14 20.87 6.80 -15.45 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER B 33 SER^? 25.06 ZN ZN G2004 A 154 ASP A 54 ASP~? 25.58 ZN ZN G2004 A 261 ARG G 76 ARG^? 28.48 ZN ZN G2004 coo 16.10 74.10 3.11 17.18 73.52 5.20 16.53 -3.90 13.46 15.60 -2.57 11.76 coo 16.07 84.71 8.14 15.20 82.81 8.14 19.11 8.17 8.99 18.99 8.60 11.06 coo 10.59 77.85 4.81 13.09 76.36 5.76 15.16 1.90 14.98 12.60 3.57 14.85 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER C 33 SER^? 10.88 ZN ZN B2003 A 154 ASP B 54 ASP~? -2.43 ZN ZN B2003s A 261 ARG H 76 ARG^? 8.16 ZN ZN B2003 coo 16.10 74.10 3.11 17.18 73.52 5.20 3.43 -26.43 14.79 2.44 -24.23 14.78 coo 16.07 84.71 8.14 15.20 82.81 8.14 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 10.59 77.85 4.81 13.09 76.36 5.76 -1.06 -24.66 18.73 -3.81 -23.46 18.10 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER D 33 SER^? 35.89 ZN ZN J2001 A 154 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 261 ARG I 76 ARG^? 39.27 ZN ZN B2003 coo 16.10 74.10 3.11 17.18 73.52 5.20 2.59 -36.27 -9.47 0.68 -35.09 -8.48 coo 16.07 84.71 8.14 15.20 82.81 8.14 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 10.59 77.85 4.81 13.09 76.36 5.76 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER E 33 SER^? 25.01 ZN ZN J2001 A 154 ASP D 54 ASP~? 25.75 ZN ZN J2001 A 261 ARG J 76 ARG^? 28.65 ZN ZN J2001 coo 16.10 74.10 3.11 17.18 73.52 5.20 15.44 -19.85 -25.13 13.12 -20.20 -24.71 coo 16.07 84.71 8.14 15.20 82.81 8.14 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 10.59 77.85 4.81 13.09 76.36 5.76 11.46 -20.49 -30.64 9.14 -18.90 -31.92 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER F 33 SER^? 10.76 ZN ZN G2004 A 154 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 261 ARG A 76 ARG^? 8.06 ZN ZN G2004 coo 16.10 74.10 3.11 17.18 73.52 5.20 36.12 -6.61 7.18 37.60 -7.96 8.48 coo 16.07 84.71 8.14 15.20 82.81 8.14 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 10.59 77.85 4.81 13.09 76.36 5.76 40.48 -5.18 11.11 43.34 -6.18 11.48 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 7 3 # 7 A 62 SER G 33 SER^? 25.21 ZN ZN B2003 A 154 ASP H 54 ASP~? 25.78 ZN ZN B2003 A 261 ARG B 76 ARG^? 28.58 ZN ZN B2003 coo 16.10 74.10 3.11 17.18 73.52 5.20 23.02 -24.31 21.04 24.40 -26.04 22.01 coo 16.07 84.71 8.14 15.20 82.81 8.14 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 10.59 77.85 4.81 13.09 76.36 5.76 24.39 -28.01 26.54 26.98 -29.30 27.59 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 8 3 # 8 A 62 SER H 33 SER^? 35.60 ZN ZN B2003 A 154 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 261 ARG C 76 ARG^? 39.61 ZN ZN J2001 coo 16.10 74.10 3.11 17.18 73.52 5.20 15.17 -43.47 5.63 17.27 -44.35 4.77 coo 16.07 84.71 8.14 15.20 82.81 8.14 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 10.59 77.85 4.81 13.09 76.36 5.76 15.69 -49.41 6.25 17.68 -51.76 6.33 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 9 3 # 9 A 62 SER I 33 SER^? 10.94 ZN ZN J2001 A 154 ASP J 54 ASP~? -2.24 ZN ZN J2001s A 261 ARG D 76 ARG^? 8.12 ZN ZN J2001 coo 16.10 74.10 3.11 17.18 73.52 5.20 23.35 -37.96 -18.73 25.76 -37.61 -18.66 coo 16.07 84.71 8.14 15.20 82.81 8.14 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 10.59 77.85 4.81 13.09 76.36 5.76 27.03 -40.97 -22.65 29.39 -42.82 -22.15 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 10 3 # 10 A 62 SER J 33 SER^? 25.08 ZN ZN E2002 A 154 ASP F 54 ASP~? 25.15 ZN ZN E2002 A 261 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 16.10 74.10 3.11 17.18 73.52 5.20 36.27 -15.21 -17.30 38.62 -15.44 -16.82 coo 16.07 84.71 8.14 15.20 82.81 8.14 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 10.59 77.85 4.81 13.09 76.36 5.76 42.07 -13.66 -19.07 44.91 -14.78 -18.77 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 10 hits 1o98_c00 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 96 GLU J 51 GLU~? 6.72 ZN ZN J2001 A 132 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 31.23 12.29 16.44 30.82 11.56 18.39 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 26.82 3.20 24.36 27.99 4.86 24.98 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 29.99 0.62 22.18 30.38 6.69 20.81 26.17 -30.49 -34.43 27.88 -35.84 -34.06 1onr_c00 source 1onr TRANSALDOLASE B : 1 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP D 48 ASP.? 19.00 ZN ZN J2001 B 96 GLU J 51 GLU~? 6.72 ZN ZN J2001 B 132 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 31.16 57.31 -0.94 30.73 56.64 1.01 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 26.69 48.45 7.18 27.85 50.13 7.74 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 29.82 45.80 5.07 30.26 51.81 3.56 26.17 -30.49 -34.43 27.88 -35.84 -34.06 1onr_c01 source 1onr TRANSALDOLASE B : 1 hits 1onr_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 247 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 342 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 44.36 35.68 9.71 43.29 36.20 11.51 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 41.40 28.81 12.91 40.82 30.90 12.97 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 40.37 33.11 18.06 39.99 34.93 17.06 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 1oyg_c00 source 1oyg LEVANSUCRASE : 1 hits 1oyg_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 4 ALA^? 18.57 ZN ZN G2004 A 126 LEU A 46 LEU^? 18.84 ZN ZN G2004 A 158 GLU A 51 GLU~? 22.57 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.58 0.21 4.86 27.26 0.45 5.58 coo -4.62 32.83 147.14 -5.50 32.85 149.12 27.31 5.53 9.20 25.86 4.27 8.20 coo -0.83 29.57 149.77 -0.39 31.47 148.95 23.15 8.42 10.27 24.62 9.66 9.42 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 4 ALA^? 18.57 ZN ZN G2004 A 126 LEU A 72 LEU^? 19.94 ZN ZN G2004 A 158 GLU A 70 GLU^? 23.78 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.58 0.21 4.86 27.26 0.45 5.58 coo -4.62 32.83 147.14 -5.50 32.85 149.12 28.14 -5.55 3.29 27.37 -7.11 1.85 coo -0.83 29.57 149.77 -0.39 31.47 148.95 21.92 -8.51 2.63 23.34 -9.97 2.05 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 21 ALA~? 19.92 ZN ZN E2002 A 126 LEU A 63 LEU.? 23.46 ZN ZN E2002 A 158 GLU A 64 GLU.? 24.42 ZN ZN E2002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 16.87 9.08 -5.24 15.53 8.40 -5.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 12.39 4.70 -1.97 13.55 6.56 -1.90 coo -0.83 29.57 149.77 -0.39 31.47 148.95 7.18 3.59 -5.93 6.39 1.65 -6.13 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 42 ALA^? 20.93 ZN ZN E2002 A 126 LEU A 43 LEU^? 22.42 ZN ZN E2002 A 158 GLU A 30 GLU^? 19.82 ZN ZN E2002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 25.20 2.24 -2.23 24.01 2.94 -1.52 coo -4.62 32.83 147.14 -5.50 32.85 149.12 29.85 3.38 -1.37 31.87 3.33 -0.54 coo -0.83 29.57 149.77 -0.39 31.47 148.95 31.22 6.85 -4.51 33.04 5.76 -4.61 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA B 4 ALA^? 13.81 ZN ZN B2003 A 126 LEU B 43 LEU^? 19.01 ZN ZN B2003 A 158 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.60 -18.17 21.35 13.14 -18.50 21.07 coo -4.62 32.83 147.14 -5.50 32.85 149.12 16.22 -11.51 22.35 17.65 -12.65 23.56 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 4 ALA^? 13.81 ZN ZN B2003 A 126 LEU B 46 LEU^? 9.45 ZN ZN B2003 A 158 GLU B 51 GLU~? 6.60 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.60 -18.17 21.35 13.14 -18.50 21.07 coo -4.62 32.83 147.14 -5.50 32.85 149.12 9.51 -19.51 26.22 9.15 -19.11 24.09 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.51 -19.61 26.84 5.05 -18.05 28.12 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 4 ALA^? 13.81 ZN ZN B2003 A 126 LEU B 72 LEU^? 20.12 ZN ZN B2003 A 158 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.60 -18.17 21.35 13.14 -18.50 21.07 coo -4.62 32.83 147.14 -5.50 32.85 149.12 17.34 -19.76 16.17 17.99 -19.00 14.20 coo -0.83 29.57 149.77 -0.39 31.47 148.95 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 21 ALA~? 18.57 ZN ZN B2003 A 126 LEU B 63 LEU.? 16.73 ZN ZN B2003 A 158 GLU B 64 GLU.? 24.26 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 4.56 -3.70 17.93 3.73 -4.11 16.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 1.91 -8.27 13.09 2.23 -7.21 14.95 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.77 -5.06 7.96 0.08 -4.98 5.99 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 42 ALA^? 16.34 ZN ZN B2003 A 126 LEU B 43 LEU^? 19.01 ZN ZN B2003 A 158 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.31 -10.73 18.58 11.78 -11.01 18.51 coo -4.62 32.83 147.14 -5.50 32.85 149.12 16.22 -11.51 22.35 17.65 -12.65 23.56 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA C 4 ALA^? 28.51 ZN ZN B2003 A 126 LEU C 46 LEU^? 31.38 ZN ZN B2003 A 158 GLU C 51 GLU~? 32.75 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 5.41 -39.88 5.21 4.55 -39.53 4.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 0.06 -43.84 3.06 0.85 -41.94 2.44 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -4.31 -42.77 0.97 -4.72 -44.13 2.55 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA C 4 ALA^? 28.51 ZN ZN B2003 A 126 LEU C 72 LEU^? 27.51 ZN ZN B2003 A 158 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 5.41 -39.88 5.21 4.55 -39.53 4.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 10.33 -36.20 4.09 11.33 -34.25 4.27 coo -0.83 29.57 149.77 -0.39 31.47 148.95 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA C 42 ALA^? 20.98 ZN ZN B2003 A 126 LEU C 43 LEU^? 22.60 ZN ZN B2003 A 158 GLU C 30 GLU^? 20.32 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 2.10 -33.69 9.44 0.99 -33.67 8.41 coo -4.62 32.83 147.14 -5.50 32.85 149.12 3.49 -37.81 11.71 4.87 -39.48 12.21 coo -0.83 29.57 149.77 -0.39 31.47 148.95 1.09 -37.94 15.82 2.89 -38.82 16.50 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA D 4 ALA^? 18.42 ZN ZN J2001 A 126 LEU D 46 LEU^? 18.86 ZN ZN J2001 A 158 GLU D 51 GLU~? 22.34 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.82 -34.77 -21.43 13.64 -33.41 -22.07 coo -4.62 32.83 147.14 -5.50 32.85 149.12 12.25 -34.15 -28.27 11.70 -32.70 -26.74 coo -0.83 29.57 149.77 -0.39 31.47 148.95 8.97 -31.18 -30.90 8.55 -33.28 -31.15 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA D 4 ALA^? 18.42 ZN ZN J2001 A 126 LEU D 72 LEU^? 19.92 ZN ZN J2001 A 158 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.82 -34.77 -21.43 13.64 -33.41 -22.07 coo -4.62 32.83 147.14 -5.50 32.85 149.12 16.52 -32.56 -16.44 16.57 -31.77 -14.34 coo -0.83 29.57 149.77 -0.39 31.47 148.95 15.16 -26.68 -14.16 16.30 -26.65 -12.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 A 70 ALA D 21 ALA~? 36.39 ZN ZN J2001 A 126 LEU D 63 LEU.? 35.27 ZN ZN J2001 A 158 GLU D 64 GLU.? 37.94 ZN ZN E2002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -3.64 -31.02 -19.45 -3.85 -29.57 -19.10 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -1.42 -24.66 -19.21 -1.70 -26.51 -20.32 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 A 70 ALA D 42 ALA^? 26.46 ZN ZN J2001 A 126 LEU D 43 LEU^? 22.73 ZN ZN J2001 A 158 GLU D 30 GLU^? 25.95 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 6.79 -34.86 -17.54 6.23 -33.71 -18.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.78 -39.02 -19.13 10.42 -40.48 -19.41 coo -0.83 29.57 149.77 -0.39 31.47 148.95 5.60 -42.69 -18.81 7.22 -43.92 -18.20 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 A 70 ALA E 4 ALA^? 13.80 ZN ZN E2002 A 126 LEU E 43 LEU^? 18.93 ZN ZN E2002 A 158 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.27 -10.13 -21.56 27.61 -8.90 -20.94 coo -4.62 32.83 147.14 -5.50 32.85 149.12 25.23 -13.72 -26.60 27.34 -14.03 -26.94 coo -0.83 29.57 149.77 -0.39 31.47 148.95 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 A 70 ALA E 4 ALA^? 13.80 ZN ZN E2002 A 126 LEU E 46 LEU^? 9.49 ZN ZN E2002 A 158 GLU E 51 GLU~? 6.76 ZN ZN E2002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.27 -10.13 -21.56 27.61 -8.90 -20.94 coo -4.62 32.83 147.14 -5.50 32.85 149.12 29.25 -3.63 -24.45 27.71 -4.39 -23.11 coo -0.83 29.57 149.77 -0.39 31.47 148.95 27.30 0.80 -24.68 27.41 0.15 -26.66 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 A 70 ALA E 4 ALA^? 13.80 ZN ZN E2002 A 126 LEU E 72 LEU^? 20.10 ZN ZN E2002 A 158 GLU E 70 GLU^? 21.70 ZN ZN E2002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.27 -10.13 -21.56 27.61 -8.90 -20.94 coo -4.62 32.83 147.14 -5.50 32.85 149.12 27.61 -13.73 -16.73 26.39 -15.29 -15.70 coo -0.83 29.57 149.77 -0.39 31.47 148.95 22.93 -13.24 -13.07 23.13 -14.10 -11.19 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 A 70 ALA E 21 ALA~? 18.69 ZN ZN E2002 A 126 LEU E 63 LEU.? 16.87 ZN ZN E2002 A 158 GLU E 64 GLU.? 24.43 ZN ZN E2002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 11.86 -8.13 -28.52 11.01 -7.64 -27.33 coo -4.62 32.83 147.14 -5.50 32.85 149.12 10.64 -5.80 -21.80 11.28 -5.71 -23.88 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.37 -6.45 -19.88 3.54 -7.63 -18.34 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 A 70 ALA E 42 ALA^? 16.45 ZN ZN E2002 A 126 LEU E 43 LEU^? 18.93 ZN ZN E2002 A 158 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 21.06 -12.81 -24.50 20.41 -11.39 -24.39 coo -4.62 32.83 147.14 -5.50 32.85 149.12 25.23 -13.72 -26.60 27.34 -14.03 -26.94 coo -0.83 29.57 149.77 -0.39 31.47 148.95 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 A 70 ALA F 4 ALA^? 18.52 ZN ZN E2002 A 126 LEU F 46 LEU^? 18.78 ZN ZN E2002 A 158 GLU F 51 GLU~? 22.25 ZN ZN E2002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.88 -2.80 -8.80 34.75 -3.84 -9.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 39.08 -1.29 -13.10 38.84 -3.16 -12.08 coo -0.83 29.57 149.77 -0.39 31.47 148.95 43.48 -3.42 -14.09 43.92 -1.45 -13.50 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 A 70 ALA F 4 ALA^? 18.52 ZN ZN E2002 A 126 LEU F 72 LEU^? 19.85 ZN ZN E2002 A 158 GLU F 70 GLU^? 24.01 ZN ZN E2002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.88 -2.80 -8.80 34.75 -3.84 -9.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 29.07 -6.10 -7.31 28.12 -7.56 -5.90 coo -0.83 29.57 149.77 -0.39 31.47 148.95 29.66 -12.84 -6.57 27.71 -12.58 -5.78 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 A 70 ALA F 21 ALA~? 19.80 ZN ZN G2004 A 126 LEU F 63 LEU.? 23.36 ZN ZN G2004 A 158 GLU F 64 GLU.? 24.41 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 47.33 -8.56 1.29 47.38 -10.07 1.08 coo -4.62 32.83 147.14 -5.50 32.85 149.12 45.76 -14.56 -1.98 46.71 -12.58 -2.14 coo -0.83 29.57 149.77 -0.39 31.47 148.95 47.46 -19.49 2.08 46.38 -21.31 2.06 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 A 70 ALA F 42 ALA^? 20.89 ZN ZN G2004 A 126 LEU F 43 LEU^? 22.49 ZN ZN G2004 A 158 GLU F 30 GLU^? 19.95 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 37.29 -4.71 -1.70 38.52 -5.38 -2.39 coo -4.62 32.83 147.14 -5.50 32.85 149.12 35.99 -0.09 -2.58 34.82 1.61 -3.38 coo -0.83 29.57 149.77 -0.39 31.47 148.95 38.23 2.77 0.52 36.38 3.82 0.63 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 A 70 ALA G 4 ALA^? 13.82 ZN ZN G2004 A 126 LEU G 43 LEU^? 19.00 ZN ZN G2004 A 158 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 25.06 -8.26 17.54 26.44 -8.23 16.91 coo -4.62 32.83 147.14 -5.50 32.85 149.12 23.43 -12.73 22.70 22.02 -11.08 22.97 coo -0.83 29.57 149.77 -0.39 31.47 148.95 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 A 70 ALA G 4 ALA^? 13.82 ZN ZN G2004 A 126 LEU G 46 LEU^? 9.61 ZN ZN G2004 A 158 GLU G 51 GLU~? 6.79 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 25.06 -8.26 17.54 26.44 -8.23 16.91 coo -4.62 32.83 147.14 -5.50 32.85 149.12 30.07 -4.18 20.40 30.26 -5.96 19.13 coo -0.83 29.57 149.77 -0.39 31.47 148.95 34.98 -4.76 20.96 34.28 -3.47 22.45 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 A 70 ALA G 4 ALA^? 13.82 ZN ZN G2004 A 126 LEU G 72 LEU^? 20.18 ZN ZN G2004 A 158 GLU G 70 GLU^? 21.12 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 25.06 -8.26 17.54 26.44 -8.23 16.91 coo -4.62 32.83 147.14 -5.50 32.85 149.12 22.24 -10.70 12.78 21.39 -12.46 11.73 coo -0.83 29.57 149.77 -0.39 31.47 148.95 24.92 -14.52 9.07 24.76 -14.12 6.99 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 A 70 ALA G 21 ALA~? 18.51 ZN ZN G2004 A 126 LEU G 63 LEU.? 16.66 ZN ZN G2004 A 158 GLU G 64 GLU.? 24.28 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 35.03 -21.49 24.39 35.78 -22.00 23.15 coo -4.62 32.83 147.14 -5.50 32.85 149.12 37.55 -21.34 17.82 37.28 -20.70 19.90 coo -0.83 29.57 149.77 -0.39 31.47 148.95 39.99 -27.18 15.98 39.71 -28.44 14.30 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 A 70 ALA G 42 ALA^? 16.36 ZN ZN G2004 A 126 LEU G 43 LEU^? 19.00 ZN ZN G2004 A 158 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 26.32 -15.83 20.54 27.87 -15.68 20.40 coo -4.62 32.83 147.14 -5.50 32.85 149.12 23.43 -12.73 22.70 22.02 -11.08 22.97 coo -0.83 29.57 149.77 -0.39 31.47 148.95 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 31 3 # 31 A 70 ALA H 4 ALA^? 18.45 ZN ZN B2003 A 126 LEU H 43 LEU^? 22.67 ZN ZN B2003 A 158 GLU H 30 GLU^? 26.29 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 10.91 -33.06 17.47 12.20 -32.60 18.13 coo -4.62 32.83 147.14 -5.50 32.85 149.12 9.73 -39.43 14.95 7.67 -38.73 15.37 coo -0.83 29.57 149.77 -0.39 31.47 148.95 8.76 -43.18 14.57 6.72 -43.67 14.36 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 32 3 # 32 A 70 ALA H 4 ALA^? 18.45 ZN ZN B2003 A 126 LEU H 46 LEU^? 18.73 ZN ZN B2003 A 158 GLU H 51 GLU~? 22.00 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 10.91 -33.06 17.47 12.20 -32.60 18.13 coo -4.62 32.83 147.14 -5.50 32.85 149.12 12.14 -34.12 24.27 13.74 -33.70 22.88 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.31 -35.44 26.90 14.59 -36.70 27.16 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 33 3 # 33 A 70 ALA H 4 ALA^? 18.45 ZN ZN B2003 A 126 LEU H 72 LEU^? 19.88 ZN ZN B2003 A 158 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 10.91 -33.06 17.47 12.20 -32.60 18.13 coo -4.62 32.83 147.14 -5.50 32.85 149.12 11.42 -29.71 12.49 11.99 -29.31 10.40 coo -0.83 29.57 149.77 -0.39 31.47 148.95 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 34 3 # 34 A 70 ALA H 21 ALA~? 36.49 ZN ZN B2003 A 126 LEU H 63 LEU~? 35.24 ZN ZN B2003 A 158 GLU H 64 GLU.? 37.89 ZN ZN G2004 coo -2.29 37.66 144.73 -1.46 37.12 145.87 22.57 -46.57 15.45 24.03 -46.18 15.20 coo -4.62 32.83 147.14 -5.50 32.85 149.12 26.96 -41.38 15.10 25.62 -42.73 16.16 coo -0.83 29.57 149.77 -0.39 31.47 148.95 32.53 -42.71 11.25 33.49 -41.02 10.38 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 35 3 # 35 A 70 ALA I 4 ALA^? 28.54 ZN ZN J2001 A 126 LEU I 46 LEU^? 31.31 ZN ZN J2001 A 158 GLU I 51 GLU~? 32.52 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 10.71 -42.92 -9.19 11.36 -43.44 -7.92 coo -4.62 32.83 147.14 -5.50 32.85 149.12 9.74 -49.43 -7.17 11.25 -48.04 -6.49 coo -0.83 29.57 149.77 -0.39 31.47 148.95 12.78 -53.14 -4.97 11.98 -53.78 -6.83 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 36 3 # 36 A 70 ALA I 4 ALA^? 28.54 ZN ZN J2001 A 126 LEU I 52 LEU~? 31.27 ZN ZN J2001 A 158 GLU I 51 GLU~? 32.52 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 10.71 -42.92 -9.19 11.36 -43.44 -7.92 coo -4.62 32.83 147.14 -5.50 32.85 149.12 13.08 -46.75 -3.17 13.44 -44.75 -3.90 coo -0.83 29.57 149.77 -0.39 31.47 148.95 12.78 -53.14 -4.97 11.98 -53.78 -6.83 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 37 3 # 37 A 70 ALA I 4 ALA^? 28.54 ZN ZN J2001 A 126 LEU I 72 LEU^? 27.55 ZN ZN J2001 A 158 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 10.71 -42.92 -9.19 11.36 -43.44 -7.92 coo -4.62 32.83 147.14 -5.50 32.85 149.12 11.53 -36.83 -8.03 12.58 -34.89 -8.05 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 38 3 # 38 A 70 ALA I 42 ALA^? 20.90 ZN ZN J2001 A 126 LEU I 43 LEU^? 22.57 ZN ZN J2001 A 158 GLU I 30 GLU^? 20.10 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 17.70 -42.69 -13.42 18.31 -43.66 -12.42 coo -4.62 32.83 147.14 -5.50 32.85 149.12 13.46 -43.60 -15.66 11.33 -43.29 -16.16 coo -0.83 29.57 149.77 -0.39 31.47 148.95 14.49 -45.59 -19.94 12.92 -44.37 -20.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 39 3 # 39 A 70 ALA J 4 ALA^? 13.86 ZN ZN J2001 A 126 LEU J 72 LEU^? 20.16 ZN ZN J2001 A 158 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 24.92 -24.16 -25.33 25.32 -25.58 -24.95 coo -4.62 32.83 147.14 -5.50 32.85 149.12 22.24 -22.50 -20.15 22.51 -21.56 -18.17 coo -0.83 29.57 149.77 -0.39 31.47 148.95 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 40 3 # 40 A 70 ALA J 42 ALA^? 16.44 ZN ZN J2001 A 126 LEU J 43 LEU^? 19.05 ZN ZN J2001 A 158 GLU J 30 GLU^? 21.96 ZN ZN E2002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 32.05 -21.47 -22.61 32.66 -22.92 -22.56 coo -4.62 32.83 147.14 -5.50 32.85 149.12 29.92 -19.38 -26.40 28.12 -18.76 -27.46 coo -0.83 29.57 149.77 -0.39 31.47 148.95 33.28 -16.74 -28.58 31.82 -15.19 -28.83 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 40 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 4 ALA^? 18.57 ZN ZN G2004 B 126 LEU A 46 LEU^? 18.84 ZN ZN G2004 B 158 GLU A 51 GLU~? 22.57 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.58 0.21 4.86 27.26 0.45 5.58 coo -34.22 5.06 149.25 -33.65 4.24 151.15 27.31 5.53 9.20 25.86 4.27 8.20 coo -33.03 9.93 151.71 -34.98 9.38 151.11 23.15 8.42 10.27 24.62 9.66 9.42 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 4 ALA^? 18.57 ZN ZN G2004 B 126 LEU A 72 LEU^? 19.94 ZN ZN G2004 B 158 GLU A 70 GLU^? 23.78 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.58 0.21 4.86 27.26 0.45 5.58 coo -34.22 5.06 149.25 -33.65 4.24 151.15 28.14 -5.55 3.29 27.37 -7.11 1.85 coo -33.03 9.93 151.71 -34.98 9.38 151.11 21.92 -8.51 2.63 23.34 -9.97 2.05 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 21 ALA~? 19.92 ZN ZN E2002 B 126 LEU A 63 LEU.? 23.46 ZN ZN E2002 B 158 GLU A 64 GLU.? 24.42 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 16.87 9.08 -5.24 15.53 8.40 -5.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 12.39 4.70 -1.97 13.55 6.56 -1.90 coo -33.03 9.93 151.71 -34.98 9.38 151.11 7.18 3.59 -5.93 6.39 1.65 -6.13 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 42 ALA^? 20.93 ZN ZN E2002 B 126 LEU A 43 LEU^? 22.42 ZN ZN E2002 B 158 GLU A 30 GLU^? 19.82 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 25.20 2.24 -2.23 24.01 2.94 -1.52 coo -34.22 5.06 149.25 -33.65 4.24 151.15 29.85 3.38 -1.37 31.87 3.33 -0.54 coo -33.03 9.93 151.71 -34.98 9.38 151.11 31.22 6.85 -4.51 33.04 5.76 -4.61 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA B 4 ALA^? 13.81 ZN ZN B2003 B 126 LEU B 43 LEU^? 19.01 ZN ZN B2003 B 158 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.60 -18.17 21.35 13.14 -18.50 21.07 coo -34.22 5.06 149.25 -33.65 4.24 151.15 16.22 -11.51 22.35 17.65 -12.65 23.56 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA B 4 ALA^? 13.81 ZN ZN B2003 B 126 LEU B 46 LEU^? 9.45 ZN ZN B2003 B 158 GLU B 51 GLU~? 6.60 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.60 -18.17 21.35 13.14 -18.50 21.07 coo -34.22 5.06 149.25 -33.65 4.24 151.15 9.51 -19.51 26.22 9.15 -19.11 24.09 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.51 -19.61 26.84 5.05 -18.05 28.12 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA B 4 ALA^? 13.81 ZN ZN B2003 B 126 LEU B 72 LEU^? 20.12 ZN ZN B2003 B 158 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.60 -18.17 21.35 13.14 -18.50 21.07 coo -34.22 5.06 149.25 -33.65 4.24 151.15 17.34 -19.76 16.17 17.99 -19.00 14.20 coo -33.03 9.93 151.71 -34.98 9.38 151.11 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 21 ALA~? 18.57 ZN ZN B2003 B 126 LEU B 63 LEU.? 16.73 ZN ZN B2003 B 158 GLU B 64 GLU.? 24.26 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 4.56 -3.70 17.93 3.73 -4.11 16.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 1.91 -8.27 13.09 2.23 -7.21 14.95 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.77 -5.06 7.96 0.08 -4.98 5.99 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 42 ALA^? 16.34 ZN ZN B2003 B 126 LEU B 43 LEU^? 19.01 ZN ZN B2003 B 158 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.31 -10.73 18.58 11.78 -11.01 18.51 coo -34.22 5.06 149.25 -33.65 4.24 151.15 16.22 -11.51 22.35 17.65 -12.65 23.56 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA C 4 ALA^? 28.51 ZN ZN B2003 B 126 LEU C 43 LEU^? 22.60 ZN ZN B2003 B 158 GLU C 30 GLU^? 20.32 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 5.41 -39.88 5.21 4.55 -39.53 4.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 3.49 -37.81 11.71 4.87 -39.48 12.21 coo -33.03 9.93 151.71 -34.98 9.38 151.11 1.09 -37.94 15.82 2.89 -38.82 16.50 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA C 4 ALA^? 28.51 ZN ZN B2003 B 126 LEU C 46 LEU^? 31.38 ZN ZN B2003 B 158 GLU C 51 GLU~? 32.75 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 5.41 -39.88 5.21 4.55 -39.53 4.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 0.06 -43.84 3.06 0.85 -41.94 2.44 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -4.31 -42.77 0.97 -4.72 -44.13 2.55 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA C 4 ALA^? 28.51 ZN ZN B2003 B 126 LEU C 72 LEU^? 27.51 ZN ZN B2003 B 158 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 5.41 -39.88 5.21 4.55 -39.53 4.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 10.33 -36.20 4.09 11.33 -34.25 4.27 coo -33.03 9.93 151.71 -34.98 9.38 151.11 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA C 42 ALA^? 20.98 ZN ZN B2003 B 126 LEU C 43 LEU^? 22.60 ZN ZN B2003 B 158 GLU C 30 GLU^? 20.32 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 2.10 -33.69 9.44 0.99 -33.67 8.41 coo -34.22 5.06 149.25 -33.65 4.24 151.15 3.49 -37.81 11.71 4.87 -39.48 12.21 coo -33.03 9.93 151.71 -34.98 9.38 151.11 1.09 -37.94 15.82 2.89 -38.82 16.50 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA D 4 ALA^? 18.42 ZN ZN J2001 B 126 LEU D 46 LEU^? 18.86 ZN ZN J2001 B 158 GLU D 51 GLU~? 22.34 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.82 -34.77 -21.43 13.64 -33.41 -22.07 coo -34.22 5.06 149.25 -33.65 4.24 151.15 12.25 -34.15 -28.27 11.70 -32.70 -26.74 coo -33.03 9.93 151.71 -34.98 9.38 151.11 8.97 -31.18 -30.90 8.55 -33.28 -31.15 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 B 70 ALA D 4 ALA^? 18.42 ZN ZN J2001 B 126 LEU D 72 LEU^? 19.92 ZN ZN J2001 B 158 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.82 -34.77 -21.43 13.64 -33.41 -22.07 coo -34.22 5.06 149.25 -33.65 4.24 151.15 16.52 -32.56 -16.44 16.57 -31.77 -14.34 coo -33.03 9.93 151.71 -34.98 9.38 151.11 15.16 -26.68 -14.16 16.30 -26.65 -12.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 B 70 ALA D 21 ALA~? 36.39 ZN ZN J2001 B 126 LEU D 63 LEU.? 35.27 ZN ZN J2001 B 158 GLU D 64 GLU.? 37.94 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -3.64 -31.02 -19.45 -3.85 -29.57 -19.10 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -1.42 -24.66 -19.21 -1.70 -26.51 -20.32 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 B 70 ALA D 42 ALA^? 26.46 ZN ZN J2001 B 126 LEU D 43 LEU^? 22.73 ZN ZN J2001 B 158 GLU D 30 GLU^? 25.95 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 6.79 -34.86 -17.54 6.23 -33.71 -18.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.78 -39.02 -19.13 10.42 -40.48 -19.41 coo -33.03 9.93 151.71 -34.98 9.38 151.11 5.60 -42.69 -18.81 7.22 -43.92 -18.20 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 B 70 ALA E 4 ALA^? 13.80 ZN ZN E2002 B 126 LEU E 43 LEU^? 18.93 ZN ZN E2002 B 158 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.27 -10.13 -21.56 27.61 -8.90 -20.94 coo -34.22 5.06 149.25 -33.65 4.24 151.15 25.23 -13.72 -26.60 27.34 -14.03 -26.94 coo -33.03 9.93 151.71 -34.98 9.38 151.11 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 B 70 ALA E 4 ALA^? 13.80 ZN ZN E2002 B 126 LEU E 46 LEU^? 9.49 ZN ZN E2002 B 158 GLU E 51 GLU~? 6.76 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.27 -10.13 -21.56 27.61 -8.90 -20.94 coo -34.22 5.06 149.25 -33.65 4.24 151.15 29.25 -3.63 -24.45 27.71 -4.39 -23.11 coo -33.03 9.93 151.71 -34.98 9.38 151.11 27.30 0.80 -24.68 27.41 0.15 -26.66 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 B 70 ALA E 4 ALA^? 13.80 ZN ZN E2002 B 126 LEU E 72 LEU^? 20.10 ZN ZN E2002 B 158 GLU E 70 GLU^? 21.70 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.27 -10.13 -21.56 27.61 -8.90 -20.94 coo -34.22 5.06 149.25 -33.65 4.24 151.15 27.61 -13.73 -16.73 26.39 -15.29 -15.70 coo -33.03 9.93 151.71 -34.98 9.38 151.11 22.93 -13.24 -13.07 23.13 -14.10 -11.19 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 B 70 ALA E 21 ALA~? 18.69 ZN ZN E2002 B 126 LEU E 63 LEU.? 16.87 ZN ZN E2002 B 158 GLU E 64 GLU.? 24.43 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 11.86 -8.13 -28.52 11.01 -7.64 -27.33 coo -34.22 5.06 149.25 -33.65 4.24 151.15 10.64 -5.80 -21.80 11.28 -5.71 -23.88 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.37 -6.45 -19.88 3.54 -7.63 -18.34 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 B 70 ALA F 4 ALA^? 18.52 ZN ZN E2002 B 126 LEU F 43 LEU^? 22.49 ZN ZN G2004 B 158 GLU F 30 GLU^? 19.95 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.88 -2.80 -8.80 34.75 -3.84 -9.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 35.99 -0.09 -2.58 34.82 1.61 -3.38 coo -33.03 9.93 151.71 -34.98 9.38 151.11 38.23 2.77 0.52 36.38 3.82 0.63 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 B 70 ALA F 4 ALA^? 18.52 ZN ZN E2002 B 126 LEU F 46 LEU^? 18.78 ZN ZN E2002 B 158 GLU F 51 GLU~? 22.25 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.88 -2.80 -8.80 34.75 -3.84 -9.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 39.08 -1.29 -13.10 38.84 -3.16 -12.08 coo -33.03 9.93 151.71 -34.98 9.38 151.11 43.48 -3.42 -14.09 43.92 -1.45 -13.50 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 B 70 ALA F 4 ALA^? 18.52 ZN ZN E2002 B 126 LEU F 72 LEU^? 19.85 ZN ZN E2002 B 158 GLU F 70 GLU^? 24.01 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.88 -2.80 -8.80 34.75 -3.84 -9.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 29.07 -6.10 -7.31 28.12 -7.56 -5.90 coo -33.03 9.93 151.71 -34.98 9.38 151.11 29.66 -12.84 -6.57 27.71 -12.58 -5.78 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 B 70 ALA F 21 ALA~? 19.80 ZN ZN G2004 B 126 LEU F 63 LEU.? 23.36 ZN ZN G2004 B 158 GLU F 64 GLU.? 24.41 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 47.33 -8.56 1.29 47.38 -10.07 1.08 coo -34.22 5.06 149.25 -33.65 4.24 151.15 45.76 -14.56 -1.98 46.71 -12.58 -2.14 coo -33.03 9.93 151.71 -34.98 9.38 151.11 47.46 -19.49 2.08 46.38 -21.31 2.06 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 B 70 ALA F 42 ALA^? 20.89 ZN ZN G2004 B 126 LEU F 43 LEU^? 22.49 ZN ZN G2004 B 158 GLU F 30 GLU^? 19.95 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 37.29 -4.71 -1.70 38.52 -5.38 -2.39 coo -34.22 5.06 149.25 -33.65 4.24 151.15 35.99 -0.09 -2.58 34.82 1.61 -3.38 coo -33.03 9.93 151.71 -34.98 9.38 151.11 38.23 2.77 0.52 36.38 3.82 0.63 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 B 70 ALA G 4 ALA^? 13.82 ZN ZN G2004 B 126 LEU G 43 LEU^? 19.00 ZN ZN G2004 B 158 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 25.06 -8.26 17.54 26.44 -8.23 16.91 coo -34.22 5.06 149.25 -33.65 4.24 151.15 23.43 -12.73 22.70 22.02 -11.08 22.97 coo -33.03 9.93 151.71 -34.98 9.38 151.11 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 B 70 ALA G 4 ALA^? 13.82 ZN ZN G2004 B 126 LEU G 46 LEU^? 9.61 ZN ZN G2004 B 158 GLU G 51 GLU~? 6.79 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 25.06 -8.26 17.54 26.44 -8.23 16.91 coo -34.22 5.06 149.25 -33.65 4.24 151.15 30.07 -4.18 20.40 30.26 -5.96 19.13 coo -33.03 9.93 151.71 -34.98 9.38 151.11 34.98 -4.76 20.96 34.28 -3.47 22.45 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 B 70 ALA G 4 ALA^? 13.82 ZN ZN G2004 B 126 LEU G 72 LEU^? 20.18 ZN ZN G2004 B 158 GLU G 70 GLU^? 21.12 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 25.06 -8.26 17.54 26.44 -8.23 16.91 coo -34.22 5.06 149.25 -33.65 4.24 151.15 22.24 -10.70 12.78 21.39 -12.46 11.73 coo -33.03 9.93 151.71 -34.98 9.38 151.11 24.92 -14.52 9.07 24.76 -14.12 6.99 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 B 70 ALA G 21 ALA~? 18.51 ZN ZN G2004 B 126 LEU G 63 LEU.? 16.66 ZN ZN G2004 B 158 GLU G 64 GLU.? 24.28 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 35.03 -21.49 24.39 35.78 -22.00 23.15 coo -34.22 5.06 149.25 -33.65 4.24 151.15 37.55 -21.34 17.82 37.28 -20.70 19.90 coo -33.03 9.93 151.71 -34.98 9.38 151.11 39.99 -27.18 15.98 39.71 -28.44 14.30 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 31 3 # 31 B 70 ALA H 4 ALA^? 18.45 ZN ZN B2003 B 126 LEU H 43 LEU^? 22.67 ZN ZN B2003 B 158 GLU H 30 GLU^? 26.29 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 10.91 -33.06 17.47 12.20 -32.60 18.13 coo -34.22 5.06 149.25 -33.65 4.24 151.15 9.73 -39.43 14.95 7.67 -38.73 15.37 coo -33.03 9.93 151.71 -34.98 9.38 151.11 8.76 -43.18 14.57 6.72 -43.67 14.36 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 32 3 # 32 B 70 ALA H 4 ALA^? 18.45 ZN ZN B2003 B 126 LEU H 46 LEU^? 18.73 ZN ZN B2003 B 158 GLU H 51 GLU~? 22.00 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 10.91 -33.06 17.47 12.20 -32.60 18.13 coo -34.22 5.06 149.25 -33.65 4.24 151.15 12.14 -34.12 24.27 13.74 -33.70 22.88 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.31 -35.44 26.90 14.59 -36.70 27.16 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 33 3 # 33 B 70 ALA H 4 ALA^? 18.45 ZN ZN B2003 B 126 LEU H 72 LEU^? 19.88 ZN ZN B2003 B 158 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 10.91 -33.06 17.47 12.20 -32.60 18.13 coo -34.22 5.06 149.25 -33.65 4.24 151.15 11.42 -29.71 12.49 11.99 -29.31 10.40 coo -33.03 9.93 151.71 -34.98 9.38 151.11 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 34 3 # 34 B 70 ALA H 21 ALA~? 36.49 ZN ZN B2003 B 126 LEU H 63 LEU~? 35.24 ZN ZN B2003 B 158 GLU H 64 GLU.? 37.89 ZN ZN G2004 coo -39.79 4.61 147.27 -39.61 5.56 148.47 22.57 -46.57 15.45 24.03 -46.18 15.20 coo -34.22 5.06 149.25 -33.65 4.24 151.15 26.96 -41.38 15.10 25.62 -42.73 16.16 coo -33.03 9.93 151.71 -34.98 9.38 151.11 32.53 -42.71 11.25 33.49 -41.02 10.38 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 35 3 # 35 B 70 ALA I 4 ALA^? 28.54 ZN ZN J2001 B 126 LEU I 46 LEU^? 31.31 ZN ZN J2001 B 158 GLU I 51 GLU~? 32.52 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 10.71 -42.92 -9.19 11.36 -43.44 -7.92 coo -34.22 5.06 149.25 -33.65 4.24 151.15 9.74 -49.43 -7.17 11.25 -48.04 -6.49 coo -33.03 9.93 151.71 -34.98 9.38 151.11 12.78 -53.14 -4.97 11.98 -53.78 -6.83 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 36 3 # 36 B 70 ALA I 4 ALA^? 28.54 ZN ZN J2001 B 126 LEU I 52 LEU~? 31.27 ZN ZN J2001 B 158 GLU I 51 GLU~? 32.52 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 10.71 -42.92 -9.19 11.36 -43.44 -7.92 coo -34.22 5.06 149.25 -33.65 4.24 151.15 13.08 -46.75 -3.17 13.44 -44.75 -3.90 coo -33.03 9.93 151.71 -34.98 9.38 151.11 12.78 -53.14 -4.97 11.98 -53.78 -6.83 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 37 3 # 37 B 70 ALA I 4 ALA^? 28.54 ZN ZN J2001 B 126 LEU I 72 LEU^? 27.55 ZN ZN J2001 B 158 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 10.71 -42.92 -9.19 11.36 -43.44 -7.92 coo -34.22 5.06 149.25 -33.65 4.24 151.15 11.53 -36.83 -8.03 12.58 -34.89 -8.05 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 38 3 # 38 B 70 ALA I 42 ALA^? 20.90 ZN ZN J2001 B 126 LEU I 43 LEU^? 22.57 ZN ZN J2001 B 158 GLU I 30 GLU^? 20.10 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 17.70 -42.69 -13.42 18.31 -43.66 -12.42 coo -34.22 5.06 149.25 -33.65 4.24 151.15 13.46 -43.60 -15.66 11.33 -43.29 -16.16 coo -33.03 9.93 151.71 -34.98 9.38 151.11 14.49 -45.59 -19.94 12.92 -44.37 -20.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 39 3 # 39 B 70 ALA J 4 ALA^? 13.86 ZN ZN J2001 B 126 LEU J 43 LEU^? 19.05 ZN ZN J2001 B 158 GLU J 30 GLU^? 21.96 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 24.92 -24.16 -25.33 25.32 -25.58 -24.95 coo -34.22 5.06 149.25 -33.65 4.24 151.15 29.92 -19.38 -26.40 28.12 -18.76 -27.46 coo -33.03 9.93 151.71 -34.98 9.38 151.11 33.28 -16.74 -28.58 31.82 -15.19 -28.83 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 40 3 # 40 B 70 ALA J 4 ALA^? 13.86 ZN ZN J2001 B 126 LEU J 46 LEU.? 9.51 ZN ZN J2001 B 158 GLU J 51 GLU~? 6.72 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 24.92 -24.16 -25.33 25.32 -25.58 -24.95 coo -34.22 5.06 149.25 -33.65 4.24 151.15 26.41 -29.17 -30.16 26.91 -29.22 -28.03 coo -33.03 9.93 151.71 -34.98 9.38 151.11 28.89 -33.61 -30.77 29.81 -32.28 -32.11 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 41 3 # 41 B 70 ALA J 4 ALA^? 13.86 ZN ZN J2001 B 126 LEU J 72 LEU^? 20.16 ZN ZN J2001 B 158 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 24.92 -24.16 -25.33 25.32 -25.58 -24.95 coo -34.22 5.06 149.25 -33.65 4.24 151.15 22.24 -22.50 -20.15 22.51 -21.56 -18.17 coo -33.03 9.93 151.71 -34.98 9.38 151.11 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 42 3 # 42 B 70 ALA J 21 ALA~? 18.64 ZN ZN J2001 B 126 LEU J 63 LEU.? 16.78 ZN ZN J2001 B 158 GLU J 64 GLU.? 23.99 ZN ZN J2001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 42.52 -25.55 -21.89 42.55 -26.50 -20.67 coo -34.22 5.06 149.25 -33.65 4.24 151.15 39.78 -30.03 -16.98 40.54 -29.37 -18.93 coo -33.03 9.93 151.71 -34.98 9.38 151.11 44.01 -30.69 -11.59 43.10 -30.84 -9.69 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 43 3 # 43 B 70 ALA J 42 ALA^? 16.44 ZN ZN J2001 B 126 LEU J 43 LEU^? 19.05 ZN ZN J2001 B 158 GLU J 30 GLU^? 21.96 ZN ZN E2002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 32.05 -21.47 -22.61 32.66 -22.92 -22.56 coo -34.22 5.06 149.25 -33.65 4.24 151.15 29.92 -19.38 -26.40 28.12 -18.76 -27.46 coo -33.03 9.93 151.71 -34.98 9.38 151.11 33.28 -16.74 -28.58 31.82 -15.19 -28.83 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 43 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 4 ALA^? 18.57 ZN ZN G2004 C 126 LEU A 46 LEU^? 18.84 ZN ZN G2004 C 158 GLU A 51 GLU~? 22.57 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.58 0.21 4.86 27.26 0.45 5.58 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 27.31 5.53 9.20 25.86 4.27 8.20 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 23.15 8.42 10.27 24.62 9.66 9.42 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 4 ALA^? 18.57 ZN ZN G2004 C 126 LEU A 72 LEU^? 19.94 ZN ZN G2004 C 158 GLU A 70 GLU^? 23.78 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.58 0.21 4.86 27.26 0.45 5.58 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 28.14 -5.55 3.29 27.37 -7.11 1.85 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 21.92 -8.51 2.63 23.34 -9.97 2.05 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 21 ALA~? 19.92 ZN ZN E2002 C 126 LEU A 63 LEU.? 23.46 ZN ZN E2002 C 158 GLU A 64 GLU.? 24.42 ZN ZN E2002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 16.87 9.08 -5.24 15.53 8.40 -5.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 12.39 4.70 -1.97 13.55 6.56 -1.90 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 7.18 3.59 -5.93 6.39 1.65 -6.13 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 42 ALA^? 20.93 ZN ZN E2002 C 126 LEU A 43 LEU^? 22.42 ZN ZN E2002 C 158 GLU A 30 GLU^? 19.82 ZN ZN E2002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 25.20 2.24 -2.23 24.01 2.94 -1.52 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 29.85 3.38 -1.37 31.87 3.33 -0.54 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 31.22 6.85 -4.51 33.04 5.76 -4.61 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA B 4 ALA^? 13.81 ZN ZN B2003 C 126 LEU B 43 LEU^? 19.01 ZN ZN B2003 C 158 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.60 -18.17 21.35 13.14 -18.50 21.07 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 16.22 -11.51 22.35 17.65 -12.65 23.56 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 4 ALA^? 13.81 ZN ZN B2003 C 126 LEU B 46 LEU^? 9.45 ZN ZN B2003 C 158 GLU B 51 GLU~? 6.60 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.60 -18.17 21.35 13.14 -18.50 21.07 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.51 -19.51 26.22 9.15 -19.11 24.09 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.51 -19.61 26.84 5.05 -18.05 28.12 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 4 ALA^? 13.81 ZN ZN B2003 C 126 LEU B 72 LEU^? 20.12 ZN ZN B2003 C 158 GLU B 70 GLU^? 21.67 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.60 -18.17 21.35 13.14 -18.50 21.07 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 17.34 -19.76 16.17 17.99 -19.00 14.20 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 13.72 -19.93 10.32 15.66 -20.41 9.75 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 21 ALA~? 18.57 ZN ZN B2003 C 126 LEU B 63 LEU.? 16.73 ZN ZN B2003 C 158 GLU B 64 GLU.? 24.26 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 4.56 -3.70 17.93 3.73 -4.11 16.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 1.91 -8.27 13.09 2.23 -7.21 14.95 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.77 -5.06 7.96 0.08 -4.98 5.99 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 42 ALA^? 16.34 ZN ZN B2003 C 126 LEU B 43 LEU^? 19.01 ZN ZN B2003 C 158 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.31 -10.73 18.58 11.78 -11.01 18.51 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 16.22 -11.51 22.35 17.65 -12.65 23.56 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA C 4 ALA^? 28.51 ZN ZN B2003 C 126 LEU C 46 LEU^? 31.38 ZN ZN B2003 C 158 GLU C 51 GLU~? 32.75 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 5.41 -39.88 5.21 4.55 -39.53 4.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 0.06 -43.84 3.06 0.85 -41.94 2.44 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -4.31 -42.77 0.97 -4.72 -44.13 2.55 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA C 4 ALA^? 28.51 ZN ZN B2003 C 126 LEU C 72 LEU^? 27.51 ZN ZN B2003 C 158 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 5.41 -39.88 5.21 4.55 -39.53 4.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 10.33 -36.20 4.09 11.33 -34.25 4.27 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA C 42 ALA^? 20.98 ZN ZN B2003 C 126 LEU C 43 LEU^? 22.60 ZN ZN B2003 C 158 GLU C 30 GLU^? 20.32 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 2.10 -33.69 9.44 0.99 -33.67 8.41 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 3.49 -37.81 11.71 4.87 -39.48 12.21 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 1.09 -37.94 15.82 2.89 -38.82 16.50 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA D 4 ALA^? 18.42 ZN ZN J2001 C 126 LEU D 46 LEU^? 18.86 ZN ZN J2001 C 158 GLU D 51 GLU~? 22.34 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.82 -34.77 -21.43 13.64 -33.41 -22.07 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 12.25 -34.15 -28.27 11.70 -32.70 -26.74 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 8.97 -31.18 -30.90 8.55 -33.28 -31.15 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 C 70 ALA D 4 ALA^? 18.42 ZN ZN J2001 C 126 LEU D 72 LEU^? 19.92 ZN ZN J2001 C 158 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.82 -34.77 -21.43 13.64 -33.41 -22.07 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 16.52 -32.56 -16.44 16.57 -31.77 -14.34 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 15.16 -26.68 -14.16 16.30 -26.65 -12.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 C 70 ALA D 21 ALA~? 36.39 ZN ZN J2001 C 126 LEU D 63 LEU.? 35.27 ZN ZN J2001 C 158 GLU D 64 GLU.? 37.94 ZN ZN E2002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -3.64 -31.02 -19.45 -3.85 -29.57 -19.10 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -1.42 -24.66 -19.21 -1.70 -26.51 -20.32 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 C 70 ALA D 42 ALA^? 26.46 ZN ZN J2001 C 126 LEU D 43 LEU^? 22.73 ZN ZN J2001 C 158 GLU D 30 GLU^? 25.95 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 6.79 -34.86 -17.54 6.23 -33.71 -18.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.78 -39.02 -19.13 10.42 -40.48 -19.41 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 5.60 -42.69 -18.81 7.22 -43.92 -18.20 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 C 70 ALA E 4 ALA^? 13.80 ZN ZN E2002 C 126 LEU E 43 LEU^? 18.93 ZN ZN E2002 C 158 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.27 -10.13 -21.56 27.61 -8.90 -20.94 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 25.23 -13.72 -26.60 27.34 -14.03 -26.94 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 C 70 ALA E 4 ALA^? 13.80 ZN ZN E2002 C 126 LEU E 46 LEU^? 9.49 ZN ZN E2002 C 158 GLU E 51 GLU~? 6.76 ZN ZN E2002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.27 -10.13 -21.56 27.61 -8.90 -20.94 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 29.25 -3.63 -24.45 27.71 -4.39 -23.11 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 27.30 0.80 -24.68 27.41 0.15 -26.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 C 70 ALA E 4 ALA^? 13.80 ZN ZN E2002 C 126 LEU E 72 LEU^? 20.10 ZN ZN E2002 C 158 GLU E 70 GLU^? 21.70 ZN ZN E2002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.27 -10.13 -21.56 27.61 -8.90 -20.94 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 27.61 -13.73 -16.73 26.39 -15.29 -15.70 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 22.93 -13.24 -13.07 23.13 -14.10 -11.19 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 C 70 ALA E 21 ALA~? 18.69 ZN ZN E2002 C 126 LEU E 63 LEU.? 16.87 ZN ZN E2002 C 158 GLU E 64 GLU.? 24.43 ZN ZN E2002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 11.86 -8.13 -28.52 11.01 -7.64 -27.33 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 10.64 -5.80 -21.80 11.28 -5.71 -23.88 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.37 -6.45 -19.88 3.54 -7.63 -18.34 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 C 70 ALA E 42 ALA^? 16.45 ZN ZN E2002 C 126 LEU E 43 LEU^? 18.93 ZN ZN E2002 C 158 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 21.06 -12.81 -24.50 20.41 -11.39 -24.39 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 25.23 -13.72 -26.60 27.34 -14.03 -26.94 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 C 70 ALA F 4 ALA^? 18.52 ZN ZN E2002 C 126 LEU F 46 LEU^? 18.78 ZN ZN E2002 C 158 GLU F 51 GLU~? 22.25 ZN ZN E2002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.88 -2.80 -8.80 34.75 -3.84 -9.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 39.08 -1.29 -13.10 38.84 -3.16 -12.08 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 43.48 -3.42 -14.09 43.92 -1.45 -13.50 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 C 70 ALA F 4 ALA^? 18.52 ZN ZN E2002 C 126 LEU F 72 LEU^? 19.85 ZN ZN E2002 C 158 GLU F 70 GLU^? 24.01 ZN ZN E2002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.88 -2.80 -8.80 34.75 -3.84 -9.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 29.07 -6.10 -7.31 28.12 -7.56 -5.90 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 29.66 -12.84 -6.57 27.71 -12.58 -5.78 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 C 70 ALA F 21 ALA~? 19.80 ZN ZN G2004 C 126 LEU F 63 LEU.? 23.36 ZN ZN G2004 C 158 GLU F 64 GLU.? 24.41 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 47.33 -8.56 1.29 47.38 -10.07 1.08 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 45.76 -14.56 -1.98 46.71 -12.58 -2.14 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 47.46 -19.49 2.08 46.38 -21.31 2.06 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 C 70 ALA F 42 ALA^? 20.89 ZN ZN G2004 C 126 LEU F 43 LEU^? 22.49 ZN ZN G2004 C 158 GLU F 30 GLU^? 19.95 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 37.29 -4.71 -1.70 38.52 -5.38 -2.39 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 35.99 -0.09 -2.58 34.82 1.61 -3.38 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 38.23 2.77 0.52 36.38 3.82 0.63 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 C 70 ALA G 4 ALA^? 13.82 ZN ZN G2004 C 126 LEU G 43 LEU^? 19.00 ZN ZN G2004 C 158 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 25.06 -8.26 17.54 26.44 -8.23 16.91 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 23.43 -12.73 22.70 22.02 -11.08 22.97 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 C 70 ALA G 4 ALA^? 13.82 ZN ZN G2004 C 126 LEU G 46 LEU^? 9.61 ZN ZN G2004 C 158 GLU G 51 GLU~? 6.79 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 25.06 -8.26 17.54 26.44 -8.23 16.91 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 30.07 -4.18 20.40 30.26 -5.96 19.13 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 34.98 -4.76 20.96 34.28 -3.47 22.45 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 C 70 ALA G 4 ALA^? 13.82 ZN ZN G2004 C 126 LEU G 72 LEU^? 20.18 ZN ZN G2004 C 158 GLU G 70 GLU^? 21.12 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 25.06 -8.26 17.54 26.44 -8.23 16.91 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 22.24 -10.70 12.78 21.39 -12.46 11.73 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 24.92 -14.52 9.07 24.76 -14.12 6.99 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 C 70 ALA G 21 ALA~? 18.51 ZN ZN G2004 C 126 LEU G 63 LEU.? 16.66 ZN ZN G2004 C 158 GLU G 64 GLU.? 24.28 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 35.03 -21.49 24.39 35.78 -22.00 23.15 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 37.55 -21.34 17.82 37.28 -20.70 19.90 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 39.99 -27.18 15.98 39.71 -28.44 14.30 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 C 70 ALA G 42 ALA^? 16.36 ZN ZN G2004 C 126 LEU G 43 LEU^? 19.00 ZN ZN G2004 C 158 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 26.32 -15.83 20.54 27.87 -15.68 20.40 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 23.43 -12.73 22.70 22.02 -11.08 22.97 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 31 3 # 31 C 70 ALA H 4 ALA^? 18.45 ZN ZN B2003 C 126 LEU H 43 LEU^? 22.67 ZN ZN B2003 C 158 GLU H 30 GLU^? 26.29 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 10.91 -33.06 17.47 12.20 -32.60 18.13 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.73 -39.43 14.95 7.67 -38.73 15.37 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 8.76 -43.18 14.57 6.72 -43.67 14.36 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 32 3 # 32 C 70 ALA H 4 ALA^? 18.45 ZN ZN B2003 C 126 LEU H 46 LEU^? 18.73 ZN ZN B2003 C 158 GLU H 51 GLU~? 22.00 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 10.91 -33.06 17.47 12.20 -32.60 18.13 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 12.14 -34.12 24.27 13.74 -33.70 22.88 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.31 -35.44 26.90 14.59 -36.70 27.16 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 33 3 # 33 C 70 ALA H 4 ALA^? 18.45 ZN ZN B2003 C 126 LEU H 72 LEU^? 19.88 ZN ZN B2003 C 158 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 10.91 -33.06 17.47 12.20 -32.60 18.13 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 11.42 -29.71 12.49 11.99 -29.31 10.40 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 34 3 # 34 C 70 ALA H 21 ALA~? 36.49 ZN ZN B2003 C 126 LEU H 63 LEU~? 35.24 ZN ZN B2003 C 158 GLU H 64 GLU.? 37.89 ZN ZN G2004 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 22.57 -46.57 15.45 24.03 -46.18 15.20 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 26.96 -41.38 15.10 25.62 -42.73 16.16 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 32.53 -42.71 11.25 33.49 -41.02 10.38 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 35 3 # 35 C 70 ALA I 4 ALA^? 28.54 ZN ZN J2001 C 126 LEU I 46 LEU^? 31.31 ZN ZN J2001 C 158 GLU I 51 GLU~? 32.52 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 10.71 -42.92 -9.19 11.36 -43.44 -7.92 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.74 -49.43 -7.17 11.25 -48.04 -6.49 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 12.78 -53.14 -4.97 11.98 -53.78 -6.83 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 36 3 # 36 C 70 ALA I 4 ALA^? 28.54 ZN ZN J2001 C 126 LEU I 52 LEU~? 31.27 ZN ZN J2001 C 158 GLU I 51 GLU~? 32.52 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 10.71 -42.92 -9.19 11.36 -43.44 -7.92 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 13.08 -46.75 -3.17 13.44 -44.75 -3.90 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 12.78 -53.14 -4.97 11.98 -53.78 -6.83 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 37 3 # 37 C 70 ALA I 4 ALA^? 28.54 ZN ZN J2001 C 126 LEU I 72 LEU^? 27.55 ZN ZN J2001 C 158 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 10.71 -42.92 -9.19 11.36 -43.44 -7.92 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 11.53 -36.83 -8.03 12.58 -34.89 -8.05 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 38 3 # 38 C 70 ALA I 42 ALA^? 20.90 ZN ZN J2001 C 126 LEU I 43 LEU^? 22.57 ZN ZN J2001 C 158 GLU I 30 GLU^? 20.10 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 17.70 -42.69 -13.42 18.31 -43.66 -12.42 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 13.46 -43.60 -15.66 11.33 -43.29 -16.16 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 14.49 -45.59 -19.94 12.92 -44.37 -20.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 39 3 # 39 C 70 ALA J 4 ALA^? 13.86 ZN ZN J2001 C 126 LEU J 72 LEU^? 20.16 ZN ZN J2001 C 158 GLU J 70 GLU^? 22.09 ZN ZN J2001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 24.92 -24.16 -25.33 25.32 -25.58 -24.95 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 22.24 -22.50 -20.15 22.51 -21.56 -18.17 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 23.81 -25.23 -14.59 22.89 -24.29 -12.95 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 40 3 # 40 C 70 ALA J 42 ALA^? 16.44 ZN ZN J2001 C 126 LEU J 43 LEU^? 19.05 ZN ZN J2001 C 158 GLU J 30 GLU^? 21.96 ZN ZN E2002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 32.05 -21.47 -22.61 32.66 -22.92 -22.56 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 29.92 -19.38 -26.40 28.12 -18.76 -27.46 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 33.28 -16.74 -28.58 31.82 -15.19 -28.83 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 40 hits 1pjh_c02 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN B 16 GLN~? 29.51 ZN ZN B2003 294 GLU B 24 GLU~? 19.88 ZN ZN B2003 304 ARG G 76 ARG^? 28.48 ZN ZN G2004 coo 15.89 18.45 46.53 15.82 16.91 48.02 9.49 2.71 13.32 9.74 4.80 12.97 coo 22.84 13.44 52.91 20.84 13.18 52.38 4.20 -2.38 22.67 5.80 -1.47 23.74 coo 8.71 17.11 46.51 7.23 17.64 49.20 15.16 1.90 14.98 12.60 3.57 14.85 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN B 27 GLN.? 7.28 ZN ZN B2003 294 GLU B 50 GLU~? -2.41 ZN ZN B2003s 304 ARG B 45 ARG^? 19.26 ZN ZN B2003 coo 15.89 18.45 46.53 15.82 16.91 48.02 6.18 -14.72 26.39 4.16 -14.59 25.66 coo 22.84 13.44 52.91 20.84 13.18 52.38 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 8.71 17.11 46.51 7.23 17.64 49.20 14.90 -14.60 27.65 17.88 -13.95 27.44 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN D 27 GLN.? 26.21 ZN ZN J2001 294 GLU D 24 GLU~? 35.30 ZN ZN J2001 304 ARG D 45 ARG^? 20.03 ZN ZN J2001 coo 15.89 18.45 46.53 15.82 16.91 48.02 6.21 -33.40 -28.41 4.77 -31.82 -28.54 coo 22.84 13.44 52.91 20.84 13.18 52.38 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 coo 8.71 17.11 46.51 7.23 17.64 49.20 10.69 -40.60 -24.75 11.69 -42.61 -22.61 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 4 3 # 4 111 GLN D 27 GLN.? 26.21 ZN ZN J2001 294 GLU D 50 GLU.? 17.54 ZN ZN J2001 304 ARG D 45 ARG^? 20.03 ZN ZN J2001 coo 15.89 18.45 46.53 15.82 16.91 48.02 6.21 -33.40 -28.41 4.77 -31.82 -28.54 coo 22.84 13.44 52.91 20.84 13.18 52.38 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 8.71 17.11 46.51 7.23 17.64 49.20 10.69 -40.60 -24.75 11.69 -42.61 -22.61 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 5 3 # 5 111 GLN E 16 GLN~? 29.65 ZN ZN E2002 294 GLU E 24 GLU~? 19.82 ZN ZN E2002 304 ARG J 76 ARG^? 28.65 ZN ZN J2001 coo 15.89 18.45 46.53 15.82 16.91 48.02 7.46 -16.23 -29.30 6.09 -17.47 -30.36 coo 22.84 13.44 52.91 20.84 13.18 52.38 13.67 -6.82 -33.09 14.57 -7.33 -34.94 coo 8.71 17.11 46.51 7.23 17.64 49.20 11.46 -20.49 -30.64 9.14 -18.90 -31.92 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 6 3 # 6 111 GLN E 27 GLN.? 7.45 ZN ZN E2002 294 GLU E 50 GLU~? -2.01 ZN ZN E2002s 304 ARG E 45 ARG^? 19.39 ZN ZN E2002 coo 15.89 18.45 46.53 15.82 16.91 48.02 24.75 -2.56 -27.59 23.17 -1.23 -27.07 coo 22.84 13.44 52.91 20.84 13.18 52.38 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 8.71 17.11 46.51 7.23 17.64 49.20 29.50 -9.81 -28.77 30.55 -12.66 -29.14 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 7 3 # 7 111 GLN F 27 GLN.? 25.94 ZN ZN E2002 294 GLU F 50 GLU.? 17.33 ZN ZN E2002 304 ARG F 45 ARG^? 20.07 ZN ZN E2002 coo 15.89 18.45 46.53 15.82 16.91 48.02 44.03 -2.34 -10.11 45.58 -3.81 -9.90 coo 22.84 13.44 52.91 20.84 13.18 52.38 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 8.71 17.11 46.51 7.23 17.64 49.20 37.54 3.46 -7.45 35.47 4.92 -5.67 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 8 3 # 8 111 GLN G 27 GLN.? 7.24 ZN ZN G2004 294 GLU G 50 GLU~? -2.28 ZN ZN G2004s 304 ARG G 45 ARG^? 19.42 ZN ZN G2004 coo 15.89 18.45 46.53 15.82 16.91 48.02 33.29 -7.45 23.57 35.31 -7.97 23.08 coo 22.84 13.44 52.91 20.84 13.18 52.38 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 8.71 17.11 46.51 7.23 17.64 49.20 24.66 -6.90 24.79 21.69 -7.61 25.11 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 9 3 # 9 111 GLN H 27 GLN.? 26.14 ZN ZN B2003 294 GLU H 24 GLU~? 35.52 ZN ZN B2003 304 ARG H 45 ARG^? 19.95 ZN ZN B2003 coo 15.89 18.45 46.53 15.82 16.91 48.02 15.79 -39.01 24.25 17.87 -39.49 24.43 coo 22.84 13.44 52.91 20.84 13.18 52.38 20.30 -49.47 18.65 18.48 -50.29 19.42 coo 8.71 17.11 46.51 7.23 17.64 49.20 7.47 -38.69 20.81 5.22 -38.73 18.67 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 10 3 # 10 111 GLN H 27 GLN.? 26.14 ZN ZN B2003 294 GLU H 50 GLU.? 17.57 ZN ZN B2003 304 ARG H 45 ARG^? 19.95 ZN ZN B2003 coo 15.89 18.45 46.53 15.82 16.91 48.02 15.79 -39.01 24.25 17.87 -39.49 24.43 coo 22.84 13.44 52.91 20.84 13.18 52.38 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 8.71 17.11 46.51 7.23 17.64 49.20 7.47 -38.69 20.81 5.22 -38.73 18.67 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 11 3 # 11 111 GLN I 27 GLN.? 29.09 ZN ZN J2001 294 GLU I 24 GLU~? 19.88 ZN ZN J2001 304 ARG I 45 ARG^? 26.51 ZN ZN J2001 coo 15.89 18.45 46.53 15.82 16.91 48.02 14.64 -52.38 -8.68 16.50 -52.94 -7.79 coo 22.84 13.44 52.91 20.84 13.18 52.38 25.57 -52.88 -14.93 24.90 -53.17 -16.94 coo 8.71 17.11 46.51 7.23 17.64 49.20 9.19 -47.86 -14.39 8.02 -46.02 -16.58 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 12 3 # 12 111 GLN I 27 GLN.? 29.09 ZN ZN J2001 294 GLU I 50 GLU~? 38.38 ZN ZN B2003 304 ARG I 45 ARG^? 26.51 ZN ZN J2001 coo 15.89 18.45 46.53 15.82 16.91 48.02 14.64 -52.38 -8.68 16.50 -52.94 -7.79 coo 22.84 13.44 52.91 20.84 13.18 52.38 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 8.71 17.11 46.51 7.23 17.64 49.20 9.19 -47.86 -14.39 8.02 -46.02 -16.58 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 13 3 # 13 111 GLN J 16 GLN~? 29.83 ZN ZN J2001 294 GLU J 24 GLU.? 19.48 ZN ZN J2001 304 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 15.89 18.45 46.53 15.82 16.91 48.02 45.73 -18.03 -17.12 47.36 -16.75 -16.59 coo 22.84 13.44 52.91 20.84 13.18 52.38 43.53 -25.45 -26.61 43.80 -24.04 -28.14 coo 8.71 17.11 46.51 7.23 17.64 49.20 42.07 -13.66 -19.07 44.91 -14.78 -18.77 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 14 3 # 14 111 GLN J 27 GLN.? 7.43 ZN ZN J2001 294 GLU J 50 GLU~? -2.50 ZN ZN J2001s 304 ARG J 45 ARG^? 19.30 ZN ZN J2001 coo 15.89 18.45 46.53 15.82 16.91 48.02 32.11 -29.81 -30.36 33.38 -31.34 -29.56 coo 22.84 13.44 52.91 20.84 13.18 52.38 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 8.71 17.11 46.51 7.23 17.64 49.20 27.80 -22.06 -31.67 26.75 -19.22 -31.33 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 14 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 76 ARG^? 8.06 ZN ZN G2004 A 479 PHE A 75 PHE^? 9.36 ZN ZN G2004 A 483 GLU G 50 GLU~? -2.28 ZN ZN G2004s coo 17.33 52.29 2.24 18.71 54.03 0.18 40.48 -5.18 11.11 43.34 -6.18 11.48 coo 20.06 57.44 1.28 18.39 56.19 3.12 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 37.44 -1.74 17.09 38.96 -3.21 16.73 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG B 76 ARG^? 28.58 ZN ZN B2003 A 479 PHE B 75 PHE^? 21.46 ZN ZN B2003 A 483 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 17.33 52.29 2.24 18.71 54.03 0.18 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 20.06 57.44 1.28 18.39 56.19 3.12 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG D 76 ARG^? 8.12 ZN ZN J2001 A 479 PHE D 75 PHE^? 9.38 ZN ZN J2001 A 483 GLU J 50 GLU~? -2.50 ZN ZN J2001s coo 17.33 52.29 2.24 18.71 54.03 0.18 27.03 -40.97 -22.65 29.39 -42.82 -22.15 coo 20.06 57.44 1.28 18.39 56.19 3.12 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 26.62 -37.54 -29.35 27.87 -38.52 -28.01 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG E 76 ARG^? 28.35 ZN ZN E2002 A 479 PHE E 75 PHE^? 21.52 ZN ZN E2002 A 483 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo 17.33 52.29 2.24 18.71 54.03 0.18 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 20.06 57.44 1.28 18.39 56.19 3.12 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG F 76 ARG^? 8.13 ZN ZN E2002 A 479 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 483 GLU E 50 GLU~? -2.01 ZN ZN E2002s coo 17.33 52.29 2.24 18.71 54.03 0.18 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 20.06 57.44 1.28 18.39 56.19 3.12 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 27.40 4.08 -19.70 26.14 4.32 -21.40 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 A 264 ARG G 76 ARG^? 28.48 ZN ZN G2004 A 479 PHE G 75 PHE^? 21.55 ZN ZN G2004 A 483 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo 17.33 52.29 2.24 18.71 54.03 0.18 15.16 1.90 14.98 12.60 3.57 14.85 coo 20.06 57.44 1.28 18.39 56.19 3.12 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 A 264 ARG H 76 ARG^? 8.16 ZN ZN B2003 A 479 PHE H 75 PHE^? 9.39 ZN ZN B2003 A 483 GLU B 50 GLU~? -2.41 ZN ZN B2003s coo 17.33 52.29 2.24 18.71 54.03 0.18 -1.06 -24.66 18.73 -3.81 -23.46 18.10 coo 20.06 57.44 1.28 18.39 56.19 3.12 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 2.06 -23.31 25.35 0.50 -22.72 24.07 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 A 264 ARG I 76 ARG^? 39.27 ZN ZN B2003 A 479 PHE I 75 PHE^? 34.28 ZN ZN B2003 A 483 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 17.33 52.29 2.24 18.71 54.03 0.18 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 coo 20.06 57.44 1.28 18.39 56.19 3.12 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 9 3 # 9 A 264 ARG J 76 ARG^? 28.65 ZN ZN J2001 A 479 PHE J 75 PHE^? 21.52 ZN ZN J2001 A 483 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 17.33 52.29 2.24 18.71 54.03 0.18 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 20.06 57.44 1.28 18.39 56.19 3.12 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 15.39 -26.34 -33.01 16.88 -27.76 -33.58 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 9 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 76 ARG^? 8.06 ZN ZN G2004 B 479 PHE A 75 PHE^? 9.36 ZN ZN G2004 B 483 GLU G 50 GLU~? -2.28 ZN ZN G2004s coo -26.72 93.28 20.13 -28.02 93.55 17.39 40.48 -5.18 11.11 43.34 -6.18 11.48 coo -29.34 90.48 15.69 -27.62 89.95 17.80 33.57 -5.35 11.77 34.08 -8.03 11.19 coo -26.63 95.49 14.65 -25.77 93.77 13.77 37.44 -1.74 17.09 38.96 -3.21 16.73 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG B 76 ARG^? 28.58 ZN ZN B2003 B 479 PHE B 75 PHE^? 21.46 ZN ZN B2003 B 483 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo -26.72 93.28 20.13 -28.02 93.55 17.39 24.39 -28.01 26.54 26.98 -29.30 27.59 coo -29.34 90.48 15.69 -27.62 89.95 17.80 18.81 -27.58 22.03 20.66 -28.34 20.09 coo -26.63 95.49 14.65 -25.77 93.77 13.77 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG D 76 ARG^? 8.12 ZN ZN J2001 B 479 PHE D 75 PHE^? 9.38 ZN ZN J2001 B 483 GLU J 50 GLU~? -2.50 ZN ZN J2001s coo -26.72 93.28 20.13 -28.02 93.55 17.39 27.03 -40.97 -22.65 29.39 -42.82 -22.15 coo -29.34 90.48 15.69 -27.62 89.95 17.80 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo -26.63 95.49 14.65 -25.77 93.77 13.77 26.62 -37.54 -29.35 27.87 -38.52 -28.01 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG E 76 ARG^? 28.35 ZN ZN E2002 B 479 PHE E 75 PHE^? 21.52 ZN ZN E2002 B 483 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo -26.72 93.28 20.13 -28.02 93.55 17.39 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo -29.34 90.48 15.69 -27.62 89.95 17.80 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo -26.63 95.49 14.65 -25.77 93.77 13.77 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG F 76 ARG^? 8.13 ZN ZN E2002 B 479 PHE F 75 PHE^? 9.34 ZN ZN E2002 B 483 GLU E 50 GLU~? -2.01 ZN ZN E2002s coo -26.72 93.28 20.13 -28.02 93.55 17.39 23.22 4.91 -15.14 20.87 6.80 -15.45 coo -29.34 90.48 15.69 -27.62 89.95 17.80 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo -26.63 95.49 14.65 -25.77 93.77 13.77 27.40 4.08 -19.70 26.14 4.32 -21.40 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 B 264 ARG G 76 ARG^? 28.48 ZN ZN G2004 B 479 PHE G 75 PHE^? 21.55 ZN ZN G2004 B 483 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo -26.72 93.28 20.13 -28.02 93.55 17.39 15.16 1.90 14.98 12.60 3.57 14.85 coo -29.34 90.48 15.69 -27.62 89.95 17.80 20.76 -0.83 11.86 18.80 -1.37 9.95 coo -26.63 95.49 14.65 -25.77 93.77 13.77 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 B 264 ARG H 76 ARG^? 8.16 ZN ZN B2003 B 479 PHE H 75 PHE^? 9.39 ZN ZN B2003 B 483 GLU B 50 GLU~? -2.41 ZN ZN B2003s coo -26.72 93.28 20.13 -28.02 93.55 17.39 -1.06 -24.66 18.73 -3.81 -23.46 18.10 coo -29.34 90.48 15.69 -27.62 89.95 17.80 6.01 -24.34 18.97 5.28 -22.77 16.79 coo -26.63 95.49 14.65 -25.77 93.77 13.77 2.06 -23.31 25.35 0.50 -22.72 24.07 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 B 264 ARG I 76 ARG^? 39.27 ZN ZN B2003 B 479 PHE I 75 PHE^? 34.28 ZN ZN B2003 B 483 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 coo -29.34 90.48 15.69 -27.62 89.95 17.80 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 9 3 # 9 B 264 ARG J 76 ARG^? 28.65 ZN ZN J2001 B 479 PHE J 75 PHE^? 21.52 ZN ZN J2001 B 483 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo -26.72 93.28 20.13 -28.02 93.55 17.39 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo -29.34 90.48 15.69 -27.62 89.95 17.80 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo -26.63 95.49 14.65 -25.77 93.77 13.77 15.39 -26.34 -33.01 16.88 -27.76 -33.58 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 9 hits 1pow_c03 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 68 ARG^? 28.72 ZN ZN B2003 C 163 TYR A 38 TYR.? 23.20 ZN ZN E2002 C 236 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 39.01 29.77 22.02 37.48 31.30 19.84 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 39.51 34.34 13.63 37.63 32.61 14.79 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 45.78 31.11 9.51 44.25 30.06 10.53 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 68 ARG^? 23.11 ZN ZN B2003 C 163 TYR B 38 TYR.? 23.16 ZN ZN B2003 C 236 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 39.01 29.77 22.02 37.48 31.30 19.84 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 39.51 34.34 13.63 37.63 32.61 14.79 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 45.78 31.11 9.51 44.25 30.06 10.53 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG C 68 ARG^? 29.54 ZN ZN B2003 C 163 TYR C 38 TYR.? 23.27 ZN ZN B2003 C 236 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 39.01 29.77 22.02 37.48 31.30 19.84 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 39.51 34.34 13.63 37.63 32.61 14.79 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 45.78 31.11 9.51 44.25 30.06 10.53 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG E 68 ARG^? 24.88 ZN ZN E2002 C 163 TYR E 38 TYR.? 23.24 ZN ZN E2002 C 236 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 39.01 29.77 22.02 37.48 31.30 19.84 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 39.51 34.34 13.63 37.63 32.61 14.79 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 45.78 31.11 9.51 44.25 30.06 10.53 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG F 68 ARG^? 28.83 ZN ZN J2001 C 163 TYR F 38 TYR.? 23.19 ZN ZN G2004 C 236 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 39.01 29.77 22.02 37.48 31.30 19.84 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 39.51 34.34 13.63 37.63 32.61 14.79 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 45.78 31.11 9.51 44.25 30.06 10.53 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 110 ARG G 68 ARG^? 22.94 ZN ZN G2004 C 163 TYR G 38 TYR.? 23.24 ZN ZN G2004 C 236 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 39.01 29.77 22.02 37.48 31.30 19.84 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 39.51 34.34 13.63 37.63 32.61 14.79 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 45.78 31.11 9.51 44.25 30.06 10.53 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 110 ARG H 68 ARG^? 29.79 ZN ZN G2004 C 163 TYR H 38 TYR.? 28.65 ZN ZN B2003 C 236 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 39.01 29.77 22.02 37.48 31.30 19.84 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 39.51 34.34 13.63 37.63 32.61 14.79 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 45.78 31.11 9.51 44.25 30.06 10.53 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 110 ARG I 68 ARG^? 29.76 ZN ZN J2001 C 163 TYR I 38 TYR.? 23.18 ZN ZN J2001 C 236 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 39.01 29.77 22.02 37.48 31.30 19.84 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 39.51 34.34 13.63 37.63 32.61 14.79 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 45.78 31.11 9.51 44.25 30.06 10.53 26.01 -35.27 -13.87 27.04 -33.54 -13.28 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 68 ARG^? 28.72 ZN ZN B2003 D 163 TYR A 38 TYR.? 23.20 ZN ZN E2002 D 236 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 68 ARG^? 23.11 ZN ZN B2003 D 163 TYR B 38 TYR.? 23.16 ZN ZN B2003 D 236 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG C 68 ARG^? 29.54 ZN ZN B2003 D 163 TYR C 38 TYR.? 23.27 ZN ZN B2003 D 236 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG E 68 ARG^? 24.88 ZN ZN E2002 D 163 TYR E 38 TYR.? 23.24 ZN ZN E2002 D 236 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG F 68 ARG^? 28.83 ZN ZN J2001 D 163 TYR F 38 TYR.? 23.19 ZN ZN G2004 D 236 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 110 ARG G 68 ARG^? 22.94 ZN ZN G2004 D 163 TYR G 38 TYR.? 23.24 ZN ZN G2004 D 236 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 110 ARG H 68 ARG^? 29.79 ZN ZN G2004 D 163 TYR H 38 TYR.? 28.65 ZN ZN B2003 D 236 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 110 ARG I 68 ARG^? 29.76 ZN ZN J2001 D 163 TYR I 38 TYR.? 23.18 ZN ZN J2001 D 236 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 26.01 -35.27 -13.87 27.04 -33.54 -13.28 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 38 TYR.? 23.20 ZN ZN E2002 A 236 ASP A 39 ASP.? 16.23 ZN ZN E2002 C 110 ARG A 68 ARG^? 28.72 ZN ZN B2003 coo 55.48 26.51 40.65 55.39 23.99 39.43 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 48.87 29.19 44.63 49.10 27.34 43.63 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 52.39 23.42 32.10 54.51 23.27 34.29 14.21 -9.24 0.28 13.24 -12.17 0.61 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 38 TYR.? 23.16 ZN ZN B2003 A 236 ASP B 39 ASP.? 27.28 ZN ZN B2003 C 110 ARG B 68 ARG^? 23.11 ZN ZN B2003 coo 55.48 26.51 40.65 55.39 23.99 39.43 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 48.87 29.19 44.63 49.10 27.34 43.63 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 52.39 23.42 32.10 54.51 23.27 34.29 9.32 -17.65 5.25 11.20 -19.96 4.50 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR C 38 TYR.? 23.27 ZN ZN B2003 A 236 ASP C 39 ASP.? 16.40 ZN ZN B2003 C 110 ARG C 68 ARG^? 29.54 ZN ZN B2003 coo 55.48 26.51 40.65 55.39 23.99 39.43 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 48.87 29.19 44.63 49.10 27.34 43.63 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 52.39 23.42 32.10 54.51 23.27 34.29 6.46 -25.65 -2.21 6.49 -23.14 -4.00 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR E 38 TYR.? 23.24 ZN ZN E2002 A 236 ASP E 39 ASP.? 27.23 ZN ZN E2002 C 110 ARG E 68 ARG^? 24.88 ZN ZN E2002 coo 55.48 26.51 40.65 55.39 23.99 39.43 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 48.87 29.19 44.63 49.10 27.34 43.63 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 52.39 23.42 32.10 54.51 23.27 34.29 14.73 -11.32 -9.64 13.98 -11.79 -6.67 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR F 38 TYR.? 23.19 ZN ZN G2004 A 236 ASP F 39 ASP.? 16.21 ZN ZN G2004 C 110 ARG F 68 ARG^? 28.83 ZN ZN J2001 coo 55.48 26.51 40.65 55.39 23.99 39.43 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 48.87 29.19 44.63 49.10 27.34 43.63 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 52.39 23.42 32.10 54.51 23.27 34.29 32.78 -19.96 -4.34 30.63 -22.19 -4.53 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR G 38 TYR.? 23.24 ZN ZN G2004 A 236 ASP G 39 ASP.? 27.24 ZN ZN G2004 C 110 ARG G 68 ARG^? 22.94 ZN ZN G2004 coo 55.48 26.51 40.65 55.39 23.99 39.43 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 48.87 29.19 44.63 49.10 27.34 43.63 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 52.39 23.42 32.10 54.51 23.27 34.29 30.64 -21.00 5.54 28.49 -18.97 4.58 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR H 38 TYR.? 28.65 ZN ZN B2003 A 236 ASP H 39 ASP.? 32.15 ZN ZN J2001 C 110 ARG H 68 ARG^? 29.79 ZN ZN G2004 coo 55.48 26.51 40.65 55.39 23.99 39.43 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 48.87 29.19 44.63 49.10 27.34 43.63 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 52.39 23.42 32.10 54.51 23.27 34.29 24.82 -29.19 7.91 24.68 -26.94 5.81 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR I 38 TYR.? 23.18 ZN ZN J2001 A 236 ASP I 39 ASP.? 16.30 ZN ZN J2001 C 110 ARG I 68 ARG^? 29.76 ZN ZN J2001 coo 55.48 26.51 40.65 55.39 23.99 39.43 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 48.87 29.19 44.63 49.10 27.34 43.63 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 52.39 23.42 32.10 54.51 23.27 34.29 23.15 -33.63 -1.82 24.18 -35.52 0.40 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR J 38 TYR.? 23.16 ZN ZN J2001 A 236 ASP J 39 ASP.? 27.27 ZN ZN J2001 C 110 ARG J 68 ARG^? 19.63 ZN ZN J2001 coo 55.48 26.51 40.65 55.39 23.99 39.43 28.75 -20.75 -12.61 27.09 -22.87 -11.86 coo 48.87 29.19 44.63 49.10 27.34 43.63 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 52.39 23.42 32.10 54.51 23.27 34.29 27.83 -27.99 -9.38 27.89 -30.88 -10.49 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 38 TYR.? 23.20 ZN ZN E2002 B 236 ASP A 39 ASP.? 16.23 ZN ZN E2002 D 110 ARG A 68 ARG^? 28.72 ZN ZN B2003 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 14.21 -9.24 0.28 13.24 -12.17 0.61 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 38 TYR.? 23.16 ZN ZN B2003 B 236 ASP B 39 ASP.? 27.28 ZN ZN B2003 D 110 ARG B 68 ARG^? 23.11 ZN ZN B2003 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 9.32 -17.65 5.25 11.20 -19.96 4.50 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR C 38 TYR.? 23.27 ZN ZN B2003 B 236 ASP C 39 ASP.? 16.40 ZN ZN B2003 D 110 ARG C 68 ARG^? 29.54 ZN ZN B2003 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 6.46 -25.65 -2.21 6.49 -23.14 -4.00 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR E 38 TYR.? 23.24 ZN ZN E2002 B 236 ASP E 39 ASP.? 27.23 ZN ZN E2002 D 110 ARG E 68 ARG^? 24.88 ZN ZN E2002 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 14.73 -11.32 -9.64 13.98 -11.79 -6.67 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR F 38 TYR.? 23.19 ZN ZN G2004 B 236 ASP F 39 ASP.? 16.21 ZN ZN G2004 D 110 ARG F 68 ARG^? 28.83 ZN ZN J2001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 32.78 -19.96 -4.34 30.63 -22.19 -4.53 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR G 38 TYR.? 23.24 ZN ZN G2004 B 236 ASP G 39 ASP.? 27.24 ZN ZN G2004 D 110 ARG G 68 ARG^? 22.94 ZN ZN G2004 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 30.64 -21.00 5.54 28.49 -18.97 4.58 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR H 38 TYR.? 28.65 ZN ZN B2003 B 236 ASP H 39 ASP.? 32.15 ZN ZN J2001 D 110 ARG H 68 ARG^? 29.79 ZN ZN G2004 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 24.82 -29.19 7.91 24.68 -26.94 5.81 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR I 38 TYR.? 23.18 ZN ZN J2001 B 236 ASP I 39 ASP.? 16.30 ZN ZN J2001 D 110 ARG I 68 ARG^? 29.76 ZN ZN J2001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 23.15 -33.63 -1.82 24.18 -35.52 0.40 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 68 ARG^? 28.72 ZN ZN B2003 G 163 TYR A 38 TYR.? 23.20 ZN ZN E2002 G 236 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 68 ARG^? 23.11 ZN ZN B2003 G 163 TYR B 38 TYR.? 23.16 ZN ZN B2003 G 236 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG C 68 ARG^? 29.54 ZN ZN B2003 G 163 TYR C 38 TYR.? 23.27 ZN ZN B2003 G 236 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG E 68 ARG^? 24.88 ZN ZN E2002 G 163 TYR E 38 TYR.? 23.24 ZN ZN E2002 G 236 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG F 68 ARG^? 28.83 ZN ZN J2001 G 163 TYR F 38 TYR.? 23.19 ZN ZN G2004 G 236 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 110 ARG G 68 ARG^? 22.94 ZN ZN G2004 G 163 TYR G 38 TYR.? 23.24 ZN ZN G2004 G 236 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 110 ARG H 68 ARG^? 29.79 ZN ZN G2004 G 163 TYR H 38 TYR.? 28.65 ZN ZN B2003 G 236 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 110 ARG I 68 ARG^? 29.76 ZN ZN J2001 G 163 TYR I 38 TYR.? 23.18 ZN ZN J2001 G 236 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 26.01 -35.27 -13.87 27.04 -33.54 -13.28 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 68 ARG^? 28.72 ZN ZN B2003 H 163 TYR A 38 TYR.? 23.20 ZN ZN E2002 H 236 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 68 ARG^? 23.11 ZN ZN B2003 H 163 TYR B 38 TYR.? 23.16 ZN ZN B2003 H 236 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG C 68 ARG^? 29.54 ZN ZN B2003 H 163 TYR C 38 TYR.? 23.27 ZN ZN B2003 H 236 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG E 68 ARG^? 24.88 ZN ZN E2002 H 163 TYR E 38 TYR.? 23.24 ZN ZN E2002 H 236 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG F 68 ARG^? 28.83 ZN ZN J2001 H 163 TYR F 38 TYR.? 23.19 ZN ZN G2004 H 236 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 110 ARG G 68 ARG^? 22.94 ZN ZN G2004 H 163 TYR G 38 TYR.? 23.24 ZN ZN G2004 H 236 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 110 ARG H 68 ARG^? 29.79 ZN ZN G2004 H 163 TYR H 38 TYR.? 28.65 ZN ZN B2003 H 236 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 110 ARG I 68 ARG^? 29.76 ZN ZN J2001 H 163 TYR I 38 TYR.? 23.18 ZN ZN J2001 H 236 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 26.01 -35.27 -13.87 27.04 -33.54 -13.28 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 38 TYR.? 23.20 ZN ZN E2002 E 236 ASP A 39 ASP.? 16.23 ZN ZN E2002 G 110 ARG A 68 ARG^? 28.72 ZN ZN B2003 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 14.21 -9.24 0.28 13.24 -12.17 0.61 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 38 TYR.? 23.16 ZN ZN B2003 E 236 ASP B 39 ASP.? 27.28 ZN ZN B2003 G 110 ARG B 68 ARG^? 23.11 ZN ZN B2003 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 9.32 -17.65 5.25 11.20 -19.96 4.50 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR C 38 TYR.? 23.27 ZN ZN B2003 E 236 ASP C 39 ASP.? 16.40 ZN ZN B2003 G 110 ARG C 68 ARG^? 29.54 ZN ZN B2003 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 6.46 -25.65 -2.21 6.49 -23.14 -4.00 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR E 38 TYR.? 23.24 ZN ZN E2002 E 236 ASP E 39 ASP.? 27.23 ZN ZN E2002 G 110 ARG E 68 ARG^? 24.88 ZN ZN E2002 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 14.73 -11.32 -9.64 13.98 -11.79 -6.67 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR F 38 TYR.? 23.19 ZN ZN G2004 E 236 ASP F 39 ASP.? 16.21 ZN ZN G2004 G 110 ARG F 68 ARG^? 28.83 ZN ZN J2001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 32.78 -19.96 -4.34 30.63 -22.19 -4.53 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR G 38 TYR.? 23.24 ZN ZN G2004 E 236 ASP G 39 ASP.? 27.24 ZN ZN G2004 G 110 ARG G 68 ARG^? 22.94 ZN ZN G2004 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 30.64 -21.00 5.54 28.49 -18.97 4.58 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR H 38 TYR.? 28.65 ZN ZN B2003 E 236 ASP H 39 ASP.? 32.15 ZN ZN J2001 G 110 ARG H 68 ARG^? 29.79 ZN ZN G2004 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 24.82 -29.19 7.91 24.68 -26.94 5.81 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR I 38 TYR.? 23.18 ZN ZN J2001 E 236 ASP I 39 ASP.? 16.30 ZN ZN J2001 G 110 ARG I 68 ARG^? 29.76 ZN ZN J2001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 23.15 -33.63 -1.82 24.18 -35.52 0.40 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR J 38 TYR.? 23.16 ZN ZN J2001 E 236 ASP J 39 ASP.? 27.27 ZN ZN J2001 G 110 ARG J 68 ARG^? 19.63 ZN ZN J2001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 28.75 -20.75 -12.61 27.09 -22.87 -11.86 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 27.83 -27.99 -9.38 27.89 -30.88 -10.49 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 38 TYR.? 23.20 ZN ZN E2002 F 236 ASP A 39 ASP.? 16.23 ZN ZN E2002 H 110 ARG A 68 ARG^? 28.72 ZN ZN B2003 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 14.21 -9.24 0.28 13.24 -12.17 0.61 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 38 TYR.? 23.16 ZN ZN B2003 F 236 ASP B 39 ASP.? 27.28 ZN ZN B2003 H 110 ARG B 68 ARG^? 23.11 ZN ZN B2003 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 9.32 -17.65 5.25 11.20 -19.96 4.50 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR C 38 TYR.? 23.27 ZN ZN B2003 F 236 ASP C 39 ASP.? 16.40 ZN ZN B2003 H 110 ARG C 68 ARG^? 29.54 ZN ZN B2003 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 6.46 -25.65 -2.21 6.49 -23.14 -4.00 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR E 38 TYR.? 23.24 ZN ZN E2002 F 236 ASP E 39 ASP.? 27.23 ZN ZN E2002 H 110 ARG E 68 ARG^? 24.88 ZN ZN E2002 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 14.73 -11.32 -9.64 13.98 -11.79 -6.67 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR F 38 TYR.? 23.19 ZN ZN G2004 F 236 ASP F 39 ASP.? 16.21 ZN ZN G2004 H 110 ARG F 68 ARG^? 28.83 ZN ZN J2001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 32.78 -19.96 -4.34 30.63 -22.19 -4.53 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR G 38 TYR.? 23.24 ZN ZN G2004 F 236 ASP G 39 ASP.? 27.24 ZN ZN G2004 H 110 ARG G 68 ARG^? 22.94 ZN ZN G2004 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 30.64 -21.00 5.54 28.49 -18.97 4.58 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR H 38 TYR.? 28.65 ZN ZN B2003 F 236 ASP H 39 ASP.? 32.15 ZN ZN J2001 H 110 ARG H 68 ARG^? 29.79 ZN ZN G2004 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 24.82 -29.19 7.91 24.68 -26.94 5.81 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR I 38 TYR.? 23.18 ZN ZN J2001 F 236 ASP I 39 ASP.? 16.30 ZN ZN J2001 H 110 ARG I 68 ARG^? 29.76 ZN ZN J2001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 23.15 -33.63 -1.82 24.18 -35.52 0.40 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 256 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 329 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 28.46 69.88 26.74 30.40 70.70 26.53 26.93 6.24 15.37 25.45 7.75 15.31 coo 30.54 71.65 32.58 31.73 72.26 30.92 22.23 3.81 17.00 24.22 3.69 17.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 256 GLU A 51 GLU~? 22.57 ZN ZN G2004 A 329 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 28.46 69.88 26.74 30.40 70.70 26.53 26.93 6.24 15.37 25.45 7.75 15.31 coo 30.54 71.65 32.58 31.73 72.26 30.92 23.15 8.42 10.27 24.62 9.66 9.42 coo 37.87 70.12 31.80 36.61 69.74 30.15 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 256 GLU A 50 GLU~? 17.52 ZN ZN G2004 A 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 28.46 69.88 26.74 30.40 70.70 26.53 17.64 3.84 11.72 15.55 3.44 11.90 coo 30.54 71.65 32.58 31.73 72.26 30.92 22.23 3.81 17.00 24.22 3.69 17.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 256 GLU A 51 GLU~? 22.57 ZN ZN G2004 A 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 28.46 69.88 26.74 30.40 70.70 26.53 17.64 3.84 11.72 15.55 3.44 11.90 coo 30.54 71.65 32.58 31.73 72.26 30.92 23.15 8.42 10.27 24.62 9.66 9.42 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1qho_c04 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 256 GLU B 50 GLU~? -2.41 ZN ZN B2003s A 329 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 28.46 69.88 26.74 30.40 70.70 26.53 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 30.54 71.65 32.58 31.73 72.26 30.92 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1qho_c04 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 256 GLU B 51 GLU~? 6.60 ZN ZN B2003 A 329 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 30.54 71.65 32.58 31.73 72.26 30.92 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1qho_c04 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 256 GLU B 51 GLU~? 6.60 ZN ZN B2003 A 329 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 28.46 69.88 26.74 30.40 70.70 26.53 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 30.54 71.65 32.58 31.73 72.26 30.92 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1qho_c04 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 256 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 329 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 30.54 71.65 32.58 31.73 72.26 30.92 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 37.87 70.12 31.80 36.61 69.74 30.15 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1qho_c04 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 256 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 329 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 30.54 71.65 32.58 31.73 72.26 30.92 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 37.87 70.12 31.80 36.61 69.74 30.15 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1qho_c04 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 256 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 30.54 71.65 32.58 31.73 72.26 30.92 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1qho_c04 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 256 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 30.54 71.65 32.58 31.73 72.26 30.92 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1qho_c04 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 256 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 329 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 30.54 71.65 32.58 31.73 72.26 30.92 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 37.87 70.12 31.80 36.61 69.74 30.15 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1qho_c04 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 256 GLU D 51 GLU~? 22.34 ZN ZN J2001 A 329 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 30.54 71.65 32.58 31.73 72.26 30.92 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1qho_c04 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 256 GLU D 50 GLU.? 17.54 ZN ZN J2001 A 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 30.54 71.65 32.58 31.73 72.26 30.92 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 37.87 70.12 31.80 36.61 69.74 30.15 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1qho_c04 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 256 GLU D 51 GLU~? 22.34 ZN ZN J2001 A 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 30.54 71.65 32.58 31.73 72.26 30.92 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1qho_c04 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 256 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 329 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 28.46 69.88 26.74 30.40 70.70 26.53 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 30.54 71.65 32.58 31.73 72.26 30.92 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 37.87 70.12 31.80 36.61 69.74 30.15 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1qho_c04 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 256 GLU E 51 GLU~? 6.76 ZN ZN E2002 A 329 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 30.54 71.65 32.58 31.73 72.26 30.92 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1qho_c04 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 256 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 28.46 69.88 26.74 30.40 70.70 26.53 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 30.54 71.65 32.58 31.73 72.26 30.92 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 256 GLU E 50 GLU~? -2.01 ZN ZN E2002s A 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 28.46 69.88 26.74 30.40 70.70 26.53 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 30.54 71.65 32.58 31.73 72.26 30.92 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 256 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 329 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 28.46 69.88 26.74 30.40 70.70 26.53 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 30.54 71.65 32.58 31.73 72.26 30.92 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 37.87 70.12 31.80 36.61 69.74 30.15 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1qho_c04 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 256 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 329 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 28.46 69.88 26.74 30.40 70.70 26.53 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 30.54 71.65 32.58 31.73 72.26 30.92 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 37.87 70.12 31.80 36.61 69.74 30.15 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1qho_c04 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 256 GLU F 50 GLU.? 17.33 ZN ZN E2002 A 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 28.46 69.88 26.74 30.40 70.70 26.53 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 30.54 71.65 32.58 31.73 72.26 30.92 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 37.87 70.12 31.80 36.61 69.74 30.15 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 256 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 28.46 69.88 26.74 30.40 70.70 26.53 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 30.54 71.65 32.58 31.73 72.26 30.92 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 37.87 70.12 31.80 36.61 69.74 30.15 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP F 54 ASP~? 25.15 ZN ZN E2002 A 256 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 28.46 69.88 26.74 30.40 70.70 26.53 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 30.54 71.65 32.58 31.73 72.26 30.92 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 37.87 70.12 31.80 36.61 69.74 30.15 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 256 GLU G 50 GLU~? -2.28 ZN ZN G2004s A 329 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo 28.46 69.88 26.74 30.40 70.70 26.53 33.55 0.62 19.07 33.72 1.88 17.35 coo 30.54 71.65 32.58 31.73 72.26 30.92 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 37.87 70.12 31.80 36.61 69.74 30.15 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1qho_c04 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 256 GLU G 51 GLU~? 6.79 ZN ZN G2004 A 329 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 28.46 69.88 26.74 30.40 70.70 26.53 33.55 0.62 19.07 33.72 1.88 17.35 coo 30.54 71.65 32.58 31.73 72.26 30.92 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1qho_c04 ALPHA-AMYLASE user 27 3 # 27 A 228 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 256 GLU G 51 GLU~? 6.79 ZN ZN G2004 A 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 28.46 69.88 26.74 30.40 70.70 26.53 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 30.54 71.65 32.58 31.73 72.26 30.92 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1qho_c04 ALPHA-AMYLASE user 28 3 # 28 A 228 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 256 GLU G 51 GLU~? 6.79 ZN ZN G2004 A 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 28.46 69.88 26.74 30.40 70.70 26.53 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 30.54 71.65 32.58 31.73 72.26 30.92 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1qho_c04 ALPHA-AMYLASE user 29 3 # 29 A 228 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 256 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 329 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 30.54 71.65 32.58 31.73 72.26 30.92 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 37.87 70.12 31.80 36.61 69.74 30.15 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1qho_c04 ALPHA-AMYLASE user 30 3 # 30 A 228 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 256 GLU H 51 GLU~? 22.00 ZN ZN B2003 A 329 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 30.54 71.65 32.58 31.73 72.26 30.92 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1qho_c04 ALPHA-AMYLASE user 31 3 # 31 A 228 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 256 GLU H 50 GLU.? 17.57 ZN ZN B2003 A 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 30.54 71.65 32.58 31.73 72.26 30.92 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 37.87 70.12 31.80 36.61 69.74 30.15 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1qho_c04 ALPHA-AMYLASE user 32 3 # 32 A 228 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 256 GLU H 51 GLU~? 22.00 ZN ZN B2003 A 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 30.54 71.65 32.58 31.73 72.26 30.92 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1qho_c04 ALPHA-AMYLASE user 33 3 # 33 A 228 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 256 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 329 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 30.54 71.65 32.58 31.73 72.26 30.92 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 37.87 70.12 31.80 36.61 69.74 30.15 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1qho_c04 ALPHA-AMYLASE user 34 3 # 34 A 228 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 256 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 329 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 30.54 71.65 32.58 31.73 72.26 30.92 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 37.87 70.12 31.80 36.61 69.74 30.15 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1qho_c04 ALPHA-AMYLASE user 35 3 # 35 A 228 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 256 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 329 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 30.54 71.65 32.58 31.73 72.26 30.92 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1qho_c04 ALPHA-AMYLASE user 36 3 # 36 A 228 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 256 GLU I 50 GLU~? 38.38 ZN ZN B2003 A 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 30.54 71.65 32.58 31.73 72.26 30.92 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 37.87 70.12 31.80 36.61 69.74 30.15 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1qho_c04 ALPHA-AMYLASE user 37 3 # 37 A 228 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 256 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 30.54 71.65 32.58 31.73 72.26 30.92 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1qho_c04 ALPHA-AMYLASE user 38 3 # 38 A 228 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 256 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 30.54 71.65 32.58 31.73 72.26 30.92 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1qho_c04 ALPHA-AMYLASE user 39 3 # 39 A 228 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 256 GLU J 50 GLU~? -2.50 ZN ZN J2001s A 329 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 28.46 69.88 26.74 30.40 70.70 26.53 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 30.54 71.65 32.58 31.73 72.26 30.92 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 37.87 70.12 31.80 36.61 69.74 30.15 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 40 3 # 40 A 228 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 256 GLU J 51 GLU~? 6.72 ZN ZN J2001 A 329 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 30.54 71.65 32.58 31.73 72.26 30.92 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 37.87 70.12 31.80 36.61 69.74 30.15 28.87 -37.23 -24.52 29.85 -38.89 -23.63 1qho_c04 source 1qho ALPHA-AMYLASE : 40 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 261 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 329 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo 28.46 69.88 26.74 30.40 70.70 26.53 26.93 6.24 15.37 25.45 7.75 15.31 coo 34.02 79.89 42.60 34.73 78.01 41.86 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 37.87 70.12 31.80 36.61 69.74 30.15 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 261 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 329 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 28.46 69.88 26.74 30.40 70.70 26.53 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 34.02 79.89 42.60 34.73 78.01 41.86 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 261 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 329 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 34.02 79.89 42.60 34.73 78.01 41.86 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 37.87 70.12 31.80 36.61 69.74 30.15 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 261 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 329 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 34.02 79.89 42.60 34.73 78.01 41.86 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 37.87 70.12 31.80 36.61 69.74 30.15 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 261 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 329 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 28.46 69.88 26.74 30.40 70.70 26.53 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 34.02 79.89 42.60 34.73 78.01 41.86 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 37.87 70.12 31.80 36.61 69.74 30.15 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 261 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 329 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo 28.46 69.88 26.74 30.40 70.70 26.53 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 34.02 79.89 42.60 34.73 78.01 41.86 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 37.87 70.12 31.80 36.61 69.74 30.15 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 261 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 329 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo 28.46 69.88 26.74 30.40 70.70 26.53 33.55 0.62 19.07 33.72 1.88 17.35 coo 34.02 79.89 42.60 34.73 78.01 41.86 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 37.87 70.12 31.80 36.61 69.74 30.15 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 261 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 329 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 34.02 79.89 42.60 34.73 78.01 41.86 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 37.87 70.12 31.80 36.61 69.74 30.15 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 261 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 329 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 28.46 69.88 26.74 30.40 70.70 26.53 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 34.02 79.89 42.60 34.73 78.01 41.86 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 37.87 70.12 31.80 36.61 69.74 30.15 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1qho_c05 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 261 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 329 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 28.46 69.88 26.74 30.40 70.70 26.53 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 34.02 79.89 42.60 34.73 78.01 41.86 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 32.59 -34.93 -27.29 32.02 -36.71 -28.24 1qho_c05 source 1qho ALPHA-AMYLASE : 10 hits 1qho_c05 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 75 PHE^? 9.36 ZN ZN G2004 A 201 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 227 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 23.39 49.81 32.16 21.33 51.68 32.26 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 25.52 45.12 37.98 23.98 46.65 37.85 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 12.68 46.83 36.69 18.26 48.67 34.51 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE D 75 PHE^? 9.38 ZN ZN J2001 A 201 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 227 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 23.39 49.81 32.16 21.33 51.68 32.26 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 25.52 45.12 37.98 23.98 46.65 37.85 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 12.68 46.83 36.69 18.26 48.67 34.51 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 201 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 227 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 23.39 49.81 32.16 21.33 51.68 32.26 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 25.52 45.12 37.98 23.98 46.65 37.85 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 12.68 46.83 36.69 18.26 48.67 34.51 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE H 75 PHE^? 9.39 ZN ZN B2003 A 201 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 227 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 23.39 49.81 32.16 21.33 51.68 32.26 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 25.52 45.12 37.98 23.98 46.65 37.85 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 8.29 -20.33 30.47 2.92 -21.23 29.89 1qz9_c02 source 1qz9 KYNURENINASE : 4 hits 1qz9_c02 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 19 GLY~? 15.01 ZN ZN E2002 B 17 GLN A 16 GLN~? 8.86 ZN ZN E2002 B 140 GLU A 20 GLU~? -13.24 ZN ZN E2002s coo 61.49 19.86 5.96 61.52 19.46 5.16 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 63.76 11.90 7.93 65.18 13.07 6.77 17.90 4.40 -14.76 17.54 4.89 -16.79 coo 66.44 19.00 7.38 67.69 17.67 8.37 18.69 9.20 -10.94 17.52 9.95 -12.50 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY C 19 GLY~? 15.35 ZN ZN B2003 B 17 GLN C 16 GLN~? 8.88 ZN ZN B2003 B 140 GLU C 20 GLU~? -13.13 ZN ZN B2003s coo 61.49 19.86 5.96 61.52 19.46 5.16 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 63.76 11.90 7.93 65.18 13.07 6.77 -3.18 -21.19 15.30 -3.89 -19.78 16.71 coo 66.44 19.00 7.38 67.69 17.67 8.37 -6.90 -26.36 14.56 -8.07 -24.73 15.22 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY D 19 GLY~? 34.83 ZN ZN J2001 B 17 GLN D 16 GLN~? 38.00 ZN ZN B2003 B 140 GLU D 20 GLU~? 40.68 ZN ZN J2001 coo 61.49 19.86 5.96 61.52 19.46 5.16 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 63.76 11.90 7.93 65.18 13.07 6.77 -5.95 -34.65 -9.91 -7.94 -35.26 -9.42 coo 66.44 19.00 7.38 67.69 17.67 8.37 -5.97 -35.19 -15.56 -7.76 -34.99 -14.40 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY F 19 GLY~? 15.06 ZN ZN G2004 B 17 GLN F 16 GLN~? 8.74 ZN ZN G2004 B 140 GLU F 20 GLU~? -13.12 ZN ZN G2004s coo 61.49 19.86 5.96 61.52 19.46 5.16 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 63.76 11.90 7.93 65.18 13.07 6.77 43.08 -9.74 10.82 43.38 -10.14 12.88 coo 66.44 19.00 7.38 67.69 17.67 8.37 46.58 -6.83 6.99 47.75 -7.54 8.57 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 5 3 # 5 A 261 GLY I 19 GLY~? 15.19 ZN ZN J2001 B 17 GLN I 16 GLN~? 8.71 ZN ZN J2001 B 140 GLU I 20 GLU~? -12.94 ZN ZN J2001s coo 61.49 19.86 5.96 61.52 19.46 5.16 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 63.76 11.90 7.93 65.18 13.07 6.77 31.04 -41.10 -19.37 32.61 -40.90 -20.76 coo 66.44 19.00 7.38 67.69 17.67 8.37 28.55 -46.90 -18.54 30.50 -46.99 -19.33 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 5 hits 1t4c_c02 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU A 51 GLU~? 22.57 ZN ZN G2004 A 87 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 89 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 23.15 8.42 10.27 24.62 9.66 9.42 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 26.93 6.24 15.37 25.45 7.75 15.31 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 A 85 GLU C 50 GLU~? 38.46 ZN ZN J2001 A 87 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 89 GLU C 51 GLU~? 32.75 ZN ZN B2003 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -4.31 -42.77 0.97 -4.72 -44.13 2.55 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 A 85 GLU C 51 GLU~? 32.75 ZN ZN B2003 A 87 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 89 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 A 85 GLU D 51 GLU~? 22.34 ZN ZN J2001 A 87 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 89 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 15.39 -26.34 -33.01 16.88 -27.76 -33.58 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 A 85 GLU F 51 GLU~? 22.25 ZN ZN E2002 A 87 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 89 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 6 3 # 6 A 85 GLU H 51 GLU~? 22.00 ZN ZN B2003 A 87 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 89 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 7 3 # 7 A 85 GLU I 51 GLU~? 32.52 ZN ZN J2001 A 87 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 89 GLU I 50 GLU~? 38.38 ZN ZN B2003 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 9.27 -51.61 2.10 7.43 -50.53 2.04 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 7 hits 1un1_c00 naa= 3 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 B 85 GLU A 51 GLU~? 22.57 ZN ZN G2004 B 87 ASP A 48 ASP~? 19.05 ZN ZN G2004 B 89 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo 19.32 178.30 3.72 20.56 176.87 2.77 23.15 8.42 10.27 24.62 9.66 9.42 coo 22.91 179.81 6.56 22.10 178.65 5.00 26.93 6.24 15.37 25.45 7.75 15.31 coo 26.74 177.55 7.48 27.16 177.47 5.41 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 B 85 GLU C 50 GLU~? 38.46 ZN ZN J2001 B 87 ASP C 48 ASP~? 37.52 ZN ZN B2003 B 89 GLU C 51 GLU~? 32.75 ZN ZN B2003 coo 19.32 178.30 3.72 20.56 176.87 2.77 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 22.91 179.81 6.56 22.10 178.65 5.00 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 26.74 177.55 7.48 27.16 177.47 5.41 -4.31 -42.77 0.97 -4.72 -44.13 2.55 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 B 85 GLU C 51 GLU~? 32.75 ZN ZN B2003 B 87 ASP C 48 ASP~? 37.52 ZN ZN B2003 B 89 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 19.32 178.30 3.72 20.56 176.87 2.77 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 22.91 179.81 6.56 22.10 178.65 5.00 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 26.74 177.55 7.48 27.16 177.47 5.41 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 B 85 GLU D 51 GLU~? 22.34 ZN ZN J2001 B 87 ASP D 48 ASP.? 19.00 ZN ZN J2001 B 89 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 19.32 178.30 3.72 20.56 176.87 2.77 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 22.91 179.81 6.56 22.10 178.65 5.00 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 26.74 177.55 7.48 27.16 177.47 5.41 15.39 -26.34 -33.01 16.88 -27.76 -33.58 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 B 85 GLU F 51 GLU~? 22.25 ZN ZN E2002 B 87 ASP F 48 ASP.? 18.92 ZN ZN E2002 B 89 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo 19.32 178.30 3.72 20.56 176.87 2.77 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 22.91 179.81 6.56 22.10 178.65 5.00 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 26.74 177.55 7.48 27.16 177.47 5.41 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 6 3 # 6 B 85 GLU H 51 GLU~? 22.00 ZN ZN B2003 B 87 ASP H 48 ASP.? 18.83 ZN ZN B2003 B 89 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 19.32 178.30 3.72 20.56 176.87 2.77 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 22.91 179.81 6.56 22.10 178.65 5.00 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 26.74 177.55 7.48 27.16 177.47 5.41 17.55 -27.49 28.97 15.58 -26.87 29.52 1un1_c01 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 6 hits 1un1_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 48 ASP~? 19.05 ZN ZN G2004 255 GLU A 50 GLU~? 17.52 ZN ZN G2004 329 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 52.57 37.12 10.17 53.37 35.95 11.75 22.23 3.81 17.00 24.22 3.69 17.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 48 ASP~? 19.05 ZN ZN G2004 255 GLU A 51 GLU~? 22.57 ZN ZN G2004 329 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 52.57 37.12 10.17 53.37 35.95 11.75 23.15 8.42 10.27 24.62 9.66 9.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 53 ASP~? 26.24 ZN ZN G2004 255 GLU A 51 GLU~? 22.57 ZN ZN G2004 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 52.57 37.12 10.17 53.37 35.95 11.75 23.15 8.42 10.27 24.62 9.66 9.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 48 ASP~? 8.81 ZN ZN B2003 255 GLU B 50 GLU~? -2.41 ZN ZN B2003s 329 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 49.16 35.16 15.19 51.08 34.43 15.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 52.57 37.12 10.17 53.37 35.95 11.75 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 48 ASP~? 8.81 ZN ZN B2003 255 GLU B 51 GLU~? 6.60 ZN ZN B2003 329 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 52.57 37.12 10.17 53.37 35.95 11.75 4.51 -19.61 26.84 5.05 -18.05 28.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP C 48 ASP~? 37.52 ZN ZN B2003 255 GLU C 50 GLU~? 38.46 ZN ZN J2001 329 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 52.57 37.12 10.17 53.37 35.95 11.75 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP C 48 ASP~? 37.52 ZN ZN B2003 255 GLU C 51 GLU~? 32.75 ZN ZN B2003 329 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 52.57 37.12 10.17 53.37 35.95 11.75 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP C 53 ASP~? 35.43 ZN ZN B2003 255 GLU C 51 GLU~? 32.75 ZN ZN B2003 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 52.57 37.12 10.17 53.37 35.95 11.75 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP C 54 ASP~? 34.22 ZN ZN B2003 255 GLU C 51 GLU~? 32.75 ZN ZN B2003 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 52.57 37.12 10.17 53.37 35.95 11.75 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP D 48 ASP.? 19.00 ZN ZN J2001 255 GLU D 50 GLU.? 17.54 ZN ZN J2001 329 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 52.57 37.12 10.17 53.37 35.95 11.75 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP D 48 ASP.? 19.00 ZN ZN J2001 255 GLU D 51 GLU~? 22.34 ZN ZN J2001 329 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 52.57 37.12 10.17 53.37 35.95 11.75 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP D 53 ASP~? 26.48 ZN ZN J2001 255 GLU D 50 GLU.? 17.54 ZN ZN J2001 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 52.57 37.12 10.17 53.37 35.95 11.75 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP D 53 ASP~? 26.48 ZN ZN J2001 255 GLU D 51 GLU~? 22.34 ZN ZN J2001 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 52.57 37.12 10.17 53.37 35.95 11.75 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP E 48 ASP~? 8.41 ZN ZN E2002 255 GLU E 50 GLU~? -2.01 ZN ZN E2002s 329 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 49.16 35.16 15.19 51.08 34.43 15.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 52.57 37.12 10.17 53.37 35.95 11.75 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP E 48 ASP~? 8.41 ZN ZN E2002 255 GLU E 51 GLU~? 6.76 ZN ZN E2002 329 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 52.57 37.12 10.17 53.37 35.95 11.75 27.30 0.80 -24.68 27.41 0.15 -26.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP E 53 ASP~? 5.07 ZN ZN E2002 255 GLU E 50 GLU~? -2.01 ZN ZN E2002s 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 52.57 37.12 10.17 53.37 35.95 11.75 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP E 54 ASP~? -2.11 ZN ZN E2002s 255 GLU E 50 GLU~? -2.01 ZN ZN E2002s 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 52.57 37.12 10.17 53.37 35.95 11.75 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP F 48 ASP.? 18.92 ZN ZN E2002 255 GLU F 50 GLU.? 17.33 ZN ZN E2002 329 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 52.57 37.12 10.17 53.37 35.95 11.75 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP F 48 ASP.? 18.92 ZN ZN E2002 255 GLU F 51 GLU~? 22.25 ZN ZN E2002 329 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 52.57 37.12 10.17 53.37 35.95 11.75 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP F 53 ASP~? 26.13 ZN ZN E2002 255 GLU F 51 GLU~? 22.25 ZN ZN E2002 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 52.57 37.12 10.17 53.37 35.95 11.75 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP F 54 ASP~? 25.15 ZN ZN E2002 255 GLU F 51 GLU~? 22.25 ZN ZN E2002 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 52.57 37.12 10.17 53.37 35.95 11.75 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP G 48 ASP~? 8.81 ZN ZN G2004 255 GLU G 50 GLU~? -2.28 ZN ZN G2004s 329 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo 49.16 35.16 15.19 51.08 34.43 15.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 52.57 37.12 10.17 53.37 35.95 11.75 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP G 48 ASP~? 8.81 ZN ZN G2004 255 GLU G 51 GLU~? 6.79 ZN ZN G2004 329 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 52.57 37.12 10.17 53.37 35.95 11.75 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP G 53 ASP~? 4.94 ZN ZN G2004 255 GLU G 51 GLU~? 6.79 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 52.57 37.12 10.17 53.37 35.95 11.75 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP G 54 ASP~? -2.04 ZN ZN G2004s 255 GLU G 51 GLU~? 6.79 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 52.57 37.12 10.17 53.37 35.95 11.75 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP H 48 ASP.? 18.83 ZN ZN B2003 255 GLU H 50 GLU.? 17.57 ZN ZN B2003 329 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 52.57 37.12 10.17 53.37 35.95 11.75 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP H 48 ASP.? 18.83 ZN ZN B2003 255 GLU H 50 GLU.? 17.57 ZN ZN B2003 329 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 52.57 37.12 10.17 53.37 35.95 11.75 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP H 48 ASP.? 18.83 ZN ZN B2003 255 GLU H 51 GLU~? 22.00 ZN ZN B2003 329 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 52.57 37.12 10.17 53.37 35.95 11.75 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 255 GLU H 50 GLU.? 17.57 ZN ZN B2003 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 52.57 37.12 10.17 53.37 35.95 11.75 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 255 GLU H 51 GLU~? 22.00 ZN ZN B2003 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 52.57 37.12 10.17 53.37 35.95 11.75 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 31 3 # 31 199 ASP I 48 ASP~? 38.35 ZN ZN J2001 255 GLU I 50 GLU~? 38.38 ZN ZN B2003 329 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 52.57 37.12 10.17 53.37 35.95 11.75 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 32 3 # 32 199 ASP I 48 ASP~? 38.35 ZN ZN J2001 255 GLU I 50 GLU~? 38.38 ZN ZN B2003 329 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 52.57 37.12 10.17 53.37 35.95 11.75 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 33 3 # 33 199 ASP I 48 ASP~? 38.35 ZN ZN J2001 255 GLU I 51 GLU~? 32.52 ZN ZN J2001 329 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 52.57 37.12 10.17 53.37 35.95 11.75 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 34 3 # 34 199 ASP I 53 ASP~? 35.51 ZN ZN J2001 255 GLU I 51 GLU~? 32.52 ZN ZN J2001 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 52.57 37.12 10.17 53.37 35.95 11.75 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 35 3 # 35 199 ASP I 54 ASP~? 33.46 ZN ZN J2001 255 GLU I 51 GLU~? 32.52 ZN ZN J2001 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 52.57 37.12 10.17 53.37 35.95 11.75 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 36 3 # 36 199 ASP J 48 ASP~? 8.01 ZN ZN J2001 255 GLU J 50 GLU~? -2.50 ZN ZN J2001s 329 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 49.16 35.16 15.19 51.08 34.43 15.65 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 52.57 37.12 10.17 53.37 35.95 11.75 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 37 3 # 37 199 ASP J 48 ASP~? 8.01 ZN ZN J2001 255 GLU J 51 GLU~? 6.72 ZN ZN J2001 329 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 52.57 37.12 10.17 53.37 35.95 11.75 28.89 -33.61 -30.77 29.81 -32.28 -32.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 28.87 -37.23 -24.52 29.85 -38.89 -23.63 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 37 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 48 ASP~? 19.05 ZN ZN G2004 218 GLU F 67 GLU^? 23.19 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 48 ASP~? 19.05 ZN ZN G2004 218 GLU G 67 GLU^? 26.62 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 53 ASP~? 26.24 ZN ZN G2004 218 GLU F 67 GLU^? 23.19 ZN ZN G2004 329 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 53 ASP~? 26.24 ZN ZN G2004 218 GLU G 24 GLU~? 19.71 ZN ZN G2004 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 35.34 -19.32 28.91 34.28 -18.98 30.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 53 ASP~? 26.24 ZN ZN G2004 218 GLU G 67 GLU^? 26.62 ZN ZN G2004 329 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 48 ASP~? 8.81 ZN ZN B2003 218 GLU A 70 GLU^? 23.78 ZN ZN G2004 329 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 70.09 11.71 8.46 70.56 12.89 6.77 21.92 -8.51 2.63 23.34 -9.97 2.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 48 ASP~? 8.81 ZN ZN B2003 218 GLU A 70 GLU^? 23.78 ZN ZN G2004 329 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 49.16 35.16 15.19 51.08 34.43 15.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 70.09 11.71 8.46 70.56 12.89 6.77 21.92 -8.51 2.63 23.34 -9.97 2.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 48 ASP~? 8.81 ZN ZN B2003 218 GLU G 67 GLU^? 26.62 ZN ZN G2004 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 70.09 11.71 8.46 70.56 12.89 6.77 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 48 ASP~? 8.81 ZN ZN B2003 218 GLU H 67 GLU^? 32.59 ZN ZN J2001 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 70.09 11.71 8.46 70.56 12.89 6.77 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 53 ASP~? 5.10 ZN ZN B2003 218 GLU G 67 GLU^? 26.62 ZN ZN G2004 329 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 53 ASP~? 5.10 ZN ZN B2003 218 GLU H 67 GLU^? 32.59 ZN ZN J2001 329 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP C 48 ASP~? 37.52 ZN ZN B2003 218 GLU B 70 GLU^? 21.67 ZN ZN B2003 329 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 70.09 11.71 8.46 70.56 12.89 6.77 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP C 48 ASP~? 37.52 ZN ZN B2003 218 GLU B 70 GLU^? 21.67 ZN ZN B2003 329 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 70.09 11.71 8.46 70.56 12.89 6.77 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP C 48 ASP~? 37.52 ZN ZN B2003 218 GLU H 67 GLU^? 32.59 ZN ZN J2001 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 70.09 11.71 8.46 70.56 12.89 6.77 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP C 48 ASP~? 37.52 ZN ZN B2003 218 GLU I 67 GLU^? 22.99 ZN ZN J2001 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 70.09 11.71 8.46 70.56 12.89 6.77 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP C 53 ASP~? 35.43 ZN ZN B2003 218 GLU H 67 GLU^? 32.59 ZN ZN J2001 329 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP C 53 ASP~? 35.43 ZN ZN B2003 218 GLU I 24 GLU~? 19.88 ZN ZN J2001 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 25.57 -52.88 -14.93 24.90 -53.17 -16.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP C 53 ASP~? 35.43 ZN ZN B2003 218 GLU I 67 GLU^? 22.99 ZN ZN J2001 329 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP D 48 ASP.? 19.00 ZN ZN J2001 218 GLU I 67 GLU^? 22.99 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 70.09 11.71 8.46 70.56 12.89 6.77 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP D 48 ASP.? 19.00 ZN ZN J2001 218 GLU J 67 GLU^? 26.37 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 70.09 11.71 8.46 70.56 12.89 6.77 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP D 53 ASP~? 26.48 ZN ZN J2001 218 GLU I 67 GLU^? 22.99 ZN ZN J2001 329 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 70.09 11.71 8.46 70.56 12.89 6.77 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP D 53 ASP~? 26.48 ZN ZN J2001 218 GLU J 24 GLU.? 19.48 ZN ZN J2001 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 70.09 11.71 8.46 70.56 12.89 6.77 43.53 -25.45 -26.61 43.80 -24.04 -28.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP D 53 ASP~? 26.48 ZN ZN J2001 218 GLU J 67 GLU^? 26.37 ZN ZN J2001 329 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 70.09 11.71 8.46 70.56 12.89 6.77 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP E 48 ASP~? 8.41 ZN ZN E2002 218 GLU D 50 GLU.? 17.54 ZN ZN J2001 329 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 49.16 35.16 15.19 51.08 34.43 15.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP E 48 ASP~? 8.41 ZN ZN E2002 218 GLU D 70 GLU^? 24.25 ZN ZN J2001 329 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP E 48 ASP~? 8.41 ZN ZN E2002 218 GLU D 70 GLU^? 24.25 ZN ZN J2001 329 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 49.16 35.16 15.19 51.08 34.43 15.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP E 48 ASP~? 8.41 ZN ZN E2002 218 GLU F 67 GLU^? 23.19 ZN ZN G2004 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP E 48 ASP~? 8.41 ZN ZN E2002 218 GLU J 67 GLU^? 26.37 ZN ZN J2001 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP E 53 ASP~? 5.07 ZN ZN E2002 218 GLU F 67 GLU^? 23.19 ZN ZN G2004 329 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 70.09 11.71 8.46 70.56 12.89 6.77 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP E 53 ASP~? 5.07 ZN ZN E2002 218 GLU J 67 GLU^? 26.37 ZN ZN J2001 329 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 70.09 11.71 8.46 70.56 12.89 6.77 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 31 3 # 31 199 ASP F 48 ASP.? 18.92 ZN ZN E2002 218 GLU A 67 GLU^? 23.17 ZN ZN E2002 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 32 3 # 32 199 ASP F 48 ASP.? 18.92 ZN ZN E2002 218 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 33 3 # 33 199 ASP F 53 ASP~? 26.13 ZN ZN E2002 218 GLU A 67 GLU^? 23.17 ZN ZN E2002 329 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 34 3 # 34 199 ASP F 53 ASP~? 26.13 ZN ZN E2002 218 GLU E 24 GLU~? 19.82 ZN ZN E2002 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 70.09 11.71 8.46 70.56 12.89 6.77 13.67 -6.82 -33.09 14.57 -7.33 -34.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 35 3 # 35 199 ASP F 53 ASP~? 26.13 ZN ZN E2002 218 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 70.09 11.71 8.46 70.56 12.89 6.77 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 36 3 # 36 199 ASP G 48 ASP~? 8.81 ZN ZN G2004 218 GLU A 67 GLU^? 23.17 ZN ZN E2002 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 37 3 # 37 199 ASP G 48 ASP~? 8.81 ZN ZN G2004 218 GLU B 67 GLU^? 26.37 ZN ZN B2003 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 70.09 11.71 8.46 70.56 12.89 6.77 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 38 3 # 38 199 ASP G 48 ASP~? 8.81 ZN ZN G2004 218 GLU H 50 GLU.? 17.57 ZN ZN B2003 329 ASP G 54 ASP~? -2.04 ZN ZN G2004s coo 49.16 35.16 15.19 51.08 34.43 15.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 70.09 11.71 8.46 70.56 12.89 6.77 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 38.23 -8.03 19.86 39.37 -6.28 19.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 39 3 # 39 199 ASP G 53 ASP~? 4.94 ZN ZN G2004 218 GLU A 67 GLU^? 23.17 ZN ZN E2002 329 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 40 3 # 40 199 ASP G 53 ASP~? 4.94 ZN ZN G2004 218 GLU B 67 GLU^? 26.37 ZN ZN B2003 329 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 70.09 11.71 8.46 70.56 12.89 6.77 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 41 3 # 41 199 ASP H 48 ASP.? 18.83 ZN ZN B2003 218 GLU B 67 GLU^? 26.37 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 70.09 11.71 8.46 70.56 12.89 6.77 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 42 3 # 42 199 ASP H 48 ASP.? 18.83 ZN ZN B2003 218 GLU C 67 GLU.? 23.10 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 70.09 11.71 8.46 70.56 12.89 6.77 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 43 3 # 43 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 218 GLU B 24 GLU~? 19.88 ZN ZN B2003 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 4.20 -2.38 22.67 5.80 -1.47 23.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 44 3 # 44 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 218 GLU B 67 GLU^? 26.37 ZN ZN B2003 329 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 45 3 # 45 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 218 GLU C 67 GLU.? 23.10 ZN ZN B2003 329 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 46 3 # 46 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 218 GLU G 50 GLU~? -2.28 ZN ZN G2004s 329 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 37.44 -1.74 17.09 38.96 -3.21 16.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 47 3 # 47 199 ASP I 48 ASP~? 38.35 ZN ZN J2001 218 GLU C 20 GLU~? -13.13 ZN ZN B2003s 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 -6.90 -26.36 14.56 -8.07 -24.73 15.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 48 3 # 48 199 ASP I 48 ASP~? 38.35 ZN ZN J2001 218 GLU C 67 GLU.? 23.10 ZN ZN B2003 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 49 3 # 49 199 ASP I 48 ASP~? 38.35 ZN ZN J2001 218 GLU D 67 GLU^? 32.75 ZN ZN B2003 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 50 3 # 50 199 ASP I 53 ASP~? 35.51 ZN ZN J2001 218 GLU C 24 GLU~? 19.76 ZN ZN B2003 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 70.09 11.71 8.46 70.56 12.89 6.77 -10.63 -31.97 11.09 -10.50 -32.62 13.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 51 3 # 51 199 ASP I 53 ASP~? 35.51 ZN ZN J2001 218 GLU C 67 GLU.? 23.10 ZN ZN B2003 329 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 70.09 11.71 8.46 70.56 12.89 6.77 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 52 3 # 52 199 ASP I 53 ASP~? 35.51 ZN ZN J2001 218 GLU D 67 GLU^? 32.75 ZN ZN B2003 329 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 70.09 11.71 8.46 70.56 12.89 6.77 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 53 3 # 53 199 ASP J 48 ASP~? 8.01 ZN ZN J2001 218 GLU D 67 GLU^? 32.75 ZN ZN B2003 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 54 3 # 54 199 ASP J 48 ASP~? 8.01 ZN ZN J2001 218 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 55 3 # 55 199 ASP J 48 ASP~? 8.01 ZN ZN J2001 218 GLU F 50 GLU.? 17.33 ZN ZN E2002 329 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 49.16 35.16 15.19 51.08 34.43 15.65 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 56 3 # 56 199 ASP J 53 ASP~? 5.09 ZN ZN J2001 218 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.01 -35.27 -13.87 27.04 -33.54 -13.28 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 56 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 39 ASP.? 16.23 ZN ZN E2002 242 GLU B 67 GLU^? 26.37 ZN ZN B2003 329 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 30.42 34.74 5.00 29.09 35.09 3.38 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 48 ASP~? 19.05 ZN ZN G2004 242 GLU A 24 GLU.? 19.69 ZN ZN E2002 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.93 6.24 15.37 25.45 7.75 15.31 coo 30.42 34.74 5.00 29.09 35.09 3.38 18.55 13.29 -4.55 20.34 13.88 -5.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 53 ASP~? 26.24 ZN ZN G2004 242 GLU A 64 GLU.? 24.42 ZN ZN E2002 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 30.42 34.74 5.00 29.09 35.09 3.38 7.18 3.59 -5.93 6.39 1.65 -6.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 53 ASP~? 26.24 ZN ZN G2004 242 GLU A 67 GLU^? 23.17 ZN ZN E2002 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 30.42 34.74 5.00 29.09 35.09 3.38 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 53 ASP~? 26.24 ZN ZN G2004 242 GLU B 64 GLU.? 24.26 ZN ZN B2003 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 30.42 34.74 5.00 29.09 35.09 3.38 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 53 ASP~? 26.24 ZN ZN G2004 242 GLU B 67 GLU^? 26.37 ZN ZN B2003 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.64 3.84 11.72 15.55 3.44 11.90 coo 30.42 34.74 5.00 29.09 35.09 3.38 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 54 ASP~? 25.58 ZN ZN G2004 242 GLU A 64 GLU.? 24.42 ZN ZN E2002 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 19.11 8.17 8.99 18.99 8.60 11.06 coo 30.42 34.74 5.00 29.09 35.09 3.38 7.18 3.59 -5.93 6.39 1.65 -6.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 54 ASP~? 25.58 ZN ZN G2004 242 GLU A 67 GLU^? 23.17 ZN ZN E2002 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 19.11 8.17 8.99 18.99 8.60 11.06 coo 30.42 34.74 5.00 29.09 35.09 3.38 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 54 ASP~? 25.58 ZN ZN G2004 242 GLU B 67 GLU^? 26.37 ZN ZN B2003 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 19.11 8.17 8.99 18.99 8.60 11.06 coo 30.42 34.74 5.00 29.09 35.09 3.38 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 39 ASP.? 27.28 ZN ZN B2003 242 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 39 ASP.? 27.28 ZN ZN B2003 242 GLU H 70 GLU^? 24.54 ZN ZN B2003 329 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 17.08 -28.12 10.05 16.94 -27.02 8.23 coo 59.16 37.82 13.95 57.63 37.03 15.12 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP B 48 ASP~? 8.81 ZN ZN B2003 242 GLU B 24 GLU~? 19.88 ZN ZN B2003 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 30.42 34.74 5.00 29.09 35.09 3.38 4.20 -2.38 22.67 5.80 -1.47 23.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP B 53 ASP~? 5.10 ZN ZN B2003 242 GLU B 64 GLU.? 24.26 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 30.42 34.74 5.00 29.09 35.09 3.38 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP B 53 ASP~? 5.10 ZN ZN B2003 242 GLU B 67 GLU^? 26.37 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 30.42 34.74 5.00 29.09 35.09 3.38 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP B 53 ASP~? 5.10 ZN ZN B2003 242 GLU C 64 GLU.? 25.72 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 30.42 34.74 5.00 29.09 35.09 3.38 -7.33 -19.22 1.68 -6.59 -18.32 -0.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP B 53 ASP~? 5.10 ZN ZN B2003 242 GLU C 67 GLU.? 23.10 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP B 54 ASP~? -2.43 ZN ZN B2003s 242 GLU B 64 GLU.? 24.26 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 30.42 34.74 5.00 29.09 35.09 3.38 -0.77 -5.06 7.96 0.08 -4.98 5.99 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP B 54 ASP~? -2.43 ZN ZN B2003s 242 GLU B 67 GLU^? 26.37 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 30.42 34.74 5.00 29.09 35.09 3.38 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP B 54 ASP~? -2.43 ZN ZN B2003s 242 GLU C 67 GLU.? 23.10 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP C 39 ASP.? 16.40 ZN ZN B2003 242 GLU D 67 GLU^? 32.75 ZN ZN B2003 329 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP C 39 ASP.? 16.40 ZN ZN B2003 242 GLU I 70 GLU^? 28.28 ZN ZN J2001 329 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 30.42 34.74 5.00 29.09 35.09 3.38 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP C 48 ASP~? 37.52 ZN ZN B2003 242 GLU C 24 GLU~? 19.76 ZN ZN B2003 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 30.42 34.74 5.00 29.09 35.09 3.38 -10.63 -31.97 11.09 -10.50 -32.62 13.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP C 53 ASP~? 35.43 ZN ZN B2003 242 GLU C 64 GLU.? 25.72 ZN ZN B2003 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 -7.33 -19.22 1.68 -6.59 -18.32 -0.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP C 53 ASP~? 35.43 ZN ZN B2003 242 GLU C 67 GLU.? 23.10 ZN ZN B2003 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP C 53 ASP~? 35.43 ZN ZN B2003 242 GLU D 64 GLU.? 37.94 ZN ZN E2002 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP C 54 ASP~? 34.22 ZN ZN B2003 242 GLU C 64 GLU.? 25.72 ZN ZN B2003 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 30.42 34.74 5.00 29.09 35.09 3.38 -7.33 -19.22 1.68 -6.59 -18.32 -0.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP C 54 ASP~? 34.22 ZN ZN B2003 242 GLU C 67 GLU.? 23.10 ZN ZN B2003 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP D 39 ASP.? 32.27 ZN ZN B2003 242 GLU B 70 GLU^? 21.67 ZN ZN B2003 329 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP D 39 ASP.? 32.27 ZN ZN B2003 242 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 30.42 34.74 5.00 29.09 35.09 3.38 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP D 39 ASP.? 32.27 ZN ZN B2003 242 GLU J 70 GLU^? 22.09 ZN ZN J2001 329 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 30.42 34.74 5.00 29.09 35.09 3.38 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 31 3 # 31 199 ASP D 48 ASP.? 19.00 ZN ZN J2001 242 GLU D 24 GLU~? 35.30 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 30.42 34.74 5.00 29.09 35.09 3.38 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 32 3 # 32 199 ASP D 53 ASP~? 26.48 ZN ZN J2001 242 GLU D 64 GLU.? 37.94 ZN ZN E2002 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 30.42 34.74 5.00 29.09 35.09 3.38 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 33 3 # 33 199 ASP D 53 ASP~? 26.48 ZN ZN J2001 242 GLU E 64 GLU.? 24.43 ZN ZN E2002 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 30.42 34.74 5.00 29.09 35.09 3.38 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 34 3 # 34 199 ASP D 53 ASP~? 26.48 ZN ZN J2001 242 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 30.42 34.74 5.00 29.09 35.09 3.38 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 35 3 # 35 199 ASP D 53 ASP~? 26.48 ZN ZN J2001 242 GLU E 70 GLU^? 21.70 ZN ZN E2002 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 30.42 34.74 5.00 29.09 35.09 3.38 22.93 -13.24 -13.07 23.13 -14.10 -11.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 36 3 # 36 199 ASP D 54 ASP~? 25.75 ZN ZN J2001 242 GLU D 64 GLU.? 37.94 ZN ZN E2002 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 30.42 34.74 5.00 29.09 35.09 3.38 -5.06 -20.63 -15.26 -4.16 -19.11 -14.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 37 3 # 37 199 ASP D 54 ASP~? 25.75 ZN ZN J2001 242 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 30.42 34.74 5.00 29.09 35.09 3.38 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 38 3 # 38 199 ASP E 39 ASP.? 27.23 ZN ZN E2002 242 GLU C 67 GLU.? 23.10 ZN ZN B2003 329 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 39 3 # 39 199 ASP E 39 ASP.? 27.23 ZN ZN E2002 242 GLU F 70 GLU^? 24.01 ZN ZN E2002 329 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 30.42 34.74 5.00 29.09 35.09 3.38 29.66 -12.84 -6.57 27.71 -12.58 -5.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 40 3 # 40 199 ASP E 48 ASP~? 8.41 ZN ZN E2002 242 GLU E 24 GLU~? 19.82 ZN ZN E2002 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.67 -6.82 -33.09 14.57 -7.33 -34.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 41 3 # 41 199 ASP E 53 ASP~? 5.07 ZN ZN E2002 242 GLU A 64 GLU.? 24.42 ZN ZN E2002 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 30.42 34.74 5.00 29.09 35.09 3.38 7.18 3.59 -5.93 6.39 1.65 -6.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 42 3 # 42 199 ASP E 53 ASP~? 5.07 ZN ZN E2002 242 GLU E 64 GLU.? 24.43 ZN ZN E2002 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 30.42 34.74 5.00 29.09 35.09 3.38 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 43 3 # 43 199 ASP E 53 ASP~? 5.07 ZN ZN E2002 242 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 30.42 34.74 5.00 29.09 35.09 3.38 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 44 3 # 44 199 ASP E 54 ASP~? -2.11 ZN ZN E2002s 242 GLU E 64 GLU.? 24.43 ZN ZN E2002 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 4.37 -6.45 -19.88 3.54 -7.63 -18.34 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 45 3 # 45 199 ASP E 54 ASP~? -2.11 ZN ZN E2002s 242 GLU E 67 GLU^? 26.75 ZN ZN E2002 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 46 3 # 46 199 ASP F 39 ASP.? 16.21 ZN ZN G2004 242 GLU B 70 GLU^? 21.67 ZN ZN B2003 329 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 47 3 # 47 199 ASP F 39 ASP.? 16.21 ZN ZN G2004 242 GLU J 67 GLU^? 26.37 ZN ZN J2001 329 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 30.42 34.74 5.00 29.09 35.09 3.38 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 48 3 # 48 199 ASP F 48 ASP.? 18.92 ZN ZN E2002 242 GLU F 24 GLU.? 19.67 ZN ZN G2004 329 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 30.42 34.74 5.00 29.09 35.09 3.38 50.14 -4.90 0.74 49.85 -2.99 1.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 49 3 # 49 199 ASP F 53 ASP~? 26.13 ZN ZN E2002 242 GLU F 64 GLU.? 24.41 ZN ZN G2004 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 30.42 34.74 5.00 29.09 35.09 3.38 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 50 3 # 50 199 ASP F 53 ASP~? 26.13 ZN ZN E2002 242 GLU F 67 GLU^? 23.19 ZN ZN G2004 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 30.42 34.74 5.00 29.09 35.09 3.38 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 51 3 # 51 199 ASP F 53 ASP~? 26.13 ZN ZN E2002 242 GLU J 64 GLU.? 23.99 ZN ZN J2001 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 30.42 34.74 5.00 29.09 35.09 3.38 44.01 -30.69 -11.59 43.10 -30.84 -9.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 52 3 # 52 199 ASP F 53 ASP~? 26.13 ZN ZN E2002 242 GLU J 67 GLU^? 26.37 ZN ZN J2001 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 30.42 34.74 5.00 29.09 35.09 3.38 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 53 3 # 53 199 ASP F 54 ASP~? 25.15 ZN ZN E2002 242 GLU F 64 GLU.? 24.41 ZN ZN G2004 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 30.42 34.74 5.00 29.09 35.09 3.38 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 54 3 # 54 199 ASP F 54 ASP~? 25.15 ZN ZN E2002 242 GLU F 67 GLU^? 23.19 ZN ZN G2004 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 30.42 34.74 5.00 29.09 35.09 3.38 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 55 3 # 55 199 ASP F 54 ASP~? 25.15 ZN ZN E2002 242 GLU J 67 GLU^? 26.37 ZN ZN J2001 329 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 30.42 34.74 5.00 29.09 35.09 3.38 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 56 3 # 56 199 ASP G 39 ASP.? 27.24 ZN ZN G2004 242 GLU A 70 GLU^? 23.78 ZN ZN G2004 329 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 30.42 34.74 5.00 29.09 35.09 3.38 21.92 -8.51 2.63 23.34 -9.97 2.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 57 3 # 57 199 ASP G 39 ASP.? 27.24 ZN ZN G2004 242 GLU I 67 GLU^? 22.99 ZN ZN J2001 329 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 30.42 34.74 5.00 29.09 35.09 3.38 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 58 3 # 58 199 ASP G 48 ASP~? 8.81 ZN ZN G2004 242 GLU G 24 GLU~? 19.71 ZN ZN G2004 329 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 33.55 0.62 19.07 33.72 1.88 17.35 coo 30.42 34.74 5.00 29.09 35.09 3.38 35.34 -19.32 28.91 34.28 -18.98 30.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 59 3 # 59 199 ASP G 53 ASP~? 4.94 ZN ZN G2004 242 GLU F 64 GLU.? 24.41 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 60 3 # 60 199 ASP G 53 ASP~? 4.94 ZN ZN G2004 242 GLU G 64 GLU.? 24.28 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 39.99 -27.18 15.98 39.71 -28.44 14.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 61 3 # 61 199 ASP G 53 ASP~? 4.94 ZN ZN G2004 242 GLU G 67 GLU^? 26.62 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 62 3 # 62 199 ASP G 54 ASP~? -2.04 ZN ZN G2004s 242 GLU F 64 GLU.? 24.41 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 47.46 -19.49 2.08 46.38 -21.31 2.06 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 63 3 # 63 199 ASP G 54 ASP~? -2.04 ZN ZN G2004s 242 GLU G 64 GLU.? 24.28 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 39.99 -27.18 15.98 39.71 -28.44 14.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 64 3 # 64 199 ASP G 54 ASP~? -2.04 ZN ZN G2004s 242 GLU G 67 GLU^? 26.62 ZN ZN G2004 329 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 65 3 # 65 199 ASP H 39 ASP.? 32.15 ZN ZN J2001 242 GLU B 70 GLU^? 21.67 ZN ZN B2003 329 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 66 3 # 66 199 ASP H 39 ASP.? 32.15 ZN ZN J2001 242 GLU G 67 GLU^? 26.62 ZN ZN G2004 329 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 30.42 34.74 5.00 29.09 35.09 3.38 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 67 3 # 67 199 ASP H 48 ASP.? 18.83 ZN ZN B2003 242 GLU H 24 GLU~? 35.52 ZN ZN B2003 329 ASP B 48 ASP~? 8.81 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 30.42 34.74 5.00 29.09 35.09 3.38 20.30 -49.47 18.65 18.48 -50.29 19.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.05 -23.93 28.50 5.91 -26.02 28.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 68 3 # 68 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 242 GLU G 64 GLU.? 24.28 ZN ZN G2004 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 39.99 -27.18 15.98 39.71 -28.44 14.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 69 3 # 69 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 242 GLU G 70 GLU^? 21.12 ZN ZN G2004 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 24.92 -14.52 9.07 24.76 -14.12 6.99 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 70 3 # 70 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 242 GLU H 64 GLU.? 37.89 ZN ZN G2004 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 32.53 -42.71 11.25 33.49 -41.02 10.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 71 3 # 71 199 ASP H 53 ASP~? 26.49 ZN ZN B2003 242 GLU H 67 GLU^? 32.59 ZN ZN J2001 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 72 3 # 72 199 ASP H 54 ASP~? 25.78 ZN ZN B2003 242 GLU G 67 GLU^? 26.62 ZN ZN G2004 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 30.42 34.74 5.00 29.09 35.09 3.38 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 73 3 # 73 199 ASP H 54 ASP~? 25.78 ZN ZN B2003 242 GLU H 64 GLU.? 37.89 ZN ZN G2004 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 30.42 34.74 5.00 29.09 35.09 3.38 32.53 -42.71 11.25 33.49 -41.02 10.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 74 3 # 74 199 ASP H 54 ASP~? 25.78 ZN ZN B2003 242 GLU H 67 GLU^? 32.59 ZN ZN J2001 329 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 30.42 34.74 5.00 29.09 35.09 3.38 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 75 3 # 75 199 ASP I 39 ASP.? 16.30 ZN ZN J2001 242 GLU C 70 GLU^? 28.30 ZN ZN B2003 329 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 30.42 34.74 5.00 29.09 35.09 3.38 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 59.16 37.82 13.95 57.63 37.03 15.12 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 76 3 # 76 199 ASP I 39 ASP.? 16.30 ZN ZN J2001 242 GLU H 67 GLU^? 32.59 ZN ZN J2001 329 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 30.42 34.74 5.00 29.09 35.09 3.38 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 77 3 # 77 199 ASP I 48 ASP~? 38.35 ZN ZN J2001 242 GLU I 24 GLU~? 19.88 ZN ZN J2001 329 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 30.42 34.74 5.00 29.09 35.09 3.38 25.57 -52.88 -14.93 24.90 -53.17 -16.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 78 3 # 78 199 ASP I 53 ASP~? 35.51 ZN ZN J2001 242 GLU H 64 GLU.? 37.89 ZN ZN G2004 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 30.42 34.74 5.00 29.09 35.09 3.38 32.53 -42.71 11.25 33.49 -41.02 10.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 79 3 # 79 199 ASP I 53 ASP~? 35.51 ZN ZN J2001 242 GLU I 64 GLU.? 25.65 ZN ZN J2001 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 30.42 34.74 5.00 29.09 35.09 3.38 34.90 -43.61 -5.62 35.57 -42.49 -3.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 80 3 # 80 199 ASP I 53 ASP~? 35.51 ZN ZN J2001 242 GLU I 67 GLU^? 22.99 ZN ZN J2001 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 30.42 34.74 5.00 29.09 35.09 3.38 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 81 3 # 81 199 ASP I 54 ASP~? 33.46 ZN ZN J2001 242 GLU H 64 GLU.? 37.89 ZN ZN G2004 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 30.42 34.74 5.00 29.09 35.09 3.38 32.53 -42.71 11.25 33.49 -41.02 10.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 82 3 # 82 199 ASP I 54 ASP~? 33.46 ZN ZN J2001 242 GLU H 67 GLU^? 32.59 ZN ZN J2001 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 30.42 34.74 5.00 29.09 35.09 3.38 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 83 3 # 83 199 ASP I 54 ASP~? 33.46 ZN ZN J2001 242 GLU I 64 GLU.? 25.65 ZN ZN J2001 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 30.42 34.74 5.00 29.09 35.09 3.38 34.90 -43.61 -5.62 35.57 -42.49 -3.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 84 3 # 84 199 ASP I 54 ASP~? 33.46 ZN ZN J2001 242 GLU I 67 GLU^? 22.99 ZN ZN J2001 329 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 30.42 34.74 5.00 29.09 35.09 3.38 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 85 3 # 85 199 ASP J 39 ASP.? 27.27 ZN ZN J2001 242 GLU D 70 GLU^? 24.25 ZN ZN J2001 329 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 30.42 34.74 5.00 29.09 35.09 3.38 15.16 -26.68 -14.16 16.30 -26.65 -12.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 86 3 # 86 199 ASP J 48 ASP~? 8.01 ZN ZN J2001 242 GLU J 24 GLU.? 19.48 ZN ZN J2001 329 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 43.53 -25.45 -26.61 43.80 -24.04 -28.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 87 3 # 87 199 ASP J 53 ASP~? 5.09 ZN ZN J2001 242 GLU I 64 GLU.? 25.65 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 34.90 -43.61 -5.62 35.57 -42.49 -3.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 88 3 # 88 199 ASP J 53 ASP~? 5.09 ZN ZN J2001 242 GLU I 67 GLU^? 22.99 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 89 3 # 89 199 ASP J 53 ASP~? 5.09 ZN ZN J2001 242 GLU J 64 GLU.? 23.99 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 44.01 -30.69 -11.59 43.10 -30.84 -9.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 90 3 # 90 199 ASP J 53 ASP~? 5.09 ZN ZN J2001 242 GLU J 67 GLU^? 26.37 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 91 3 # 91 199 ASP J 54 ASP~? -2.24 ZN ZN J2001s 242 GLU I 67 GLU^? 22.99 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 30.42 34.74 5.00 29.09 35.09 3.38 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 92 3 # 92 199 ASP J 54 ASP~? -2.24 ZN ZN J2001s 242 GLU J 64 GLU.? 23.99 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 30.42 34.74 5.00 29.09 35.09 3.38 44.01 -30.69 -11.59 43.10 -30.84 -9.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 93 3 # 93 199 ASP J 54 ASP~? -2.24 ZN ZN J2001s 242 GLU J 67 GLU^? 26.37 ZN ZN J2001 329 ASP J 48 ASP~? 8.01 ZN ZN J2001 coo 49.16 35.16 15.19 51.08 34.43 15.65 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 30.42 34.74 5.00 29.09 35.09 3.38 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 24.29 -34.17 -32.69 23.20 -35.63 -31.63 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 93 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU B 70 GLU^? 21.67 ZN ZN B2003 A 596 ARG B 68 ARG^? 23.11 ZN ZN B2003 A 647 ARG B 9 ARG^? 25.60 ZN ZN B2003 coo 69.13 32.20 28.58 68.39 32.96 30.44 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 70.89 37.31 29.70 69.54 36.29 32.39 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 66.09 40.54 34.70 66.92 37.69 35.49 12.25 -11.70 3.79 14.09 -14.14 4.30 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU C 67 GLU.? 23.10 ZN ZN B2003 A 596 ARG C 11 ARG~? 22.62 ZN ZN B2003 A 647 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo 69.13 32.20 28.58 68.39 32.96 30.44 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 70.89 37.31 29.70 69.54 36.29 32.39 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo 66.09 40.54 34.70 66.92 37.69 35.49 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU C 70 GLU^? 28.30 ZN ZN B2003 A 596 ARG C 68 ARG^? 29.54 ZN ZN B2003 A 647 ARG C 9 ARG^? 24.24 ZN ZN B2003 coo 69.13 32.20 28.58 68.39 32.96 30.44 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 70.89 37.31 29.70 69.54 36.29 32.39 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 66.09 40.54 34.70 66.92 37.69 35.49 7.07 -21.17 3.13 9.35 -23.17 2.50 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU D 67 GLU^? 32.75 ZN ZN B2003 A 596 ARG D 11 ARG.? 35.27 ZN ZN B2003 A 647 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo 69.13 32.20 28.58 68.39 32.96 30.44 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 70.89 37.31 29.70 69.54 36.29 32.39 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 66.09 40.54 34.70 66.92 37.69 35.49 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU E 67 GLU^? 26.75 ZN ZN E2002 A 596 ARG E 11 ARG.? 26.51 ZN ZN E2002 A 647 ARG E 14 ARG~? 23.50 ZN ZN E2002 coo 69.13 32.20 28.58 68.39 32.96 30.44 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 70.89 37.31 29.70 69.54 36.29 32.39 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo 66.09 40.54 34.70 66.92 37.69 35.49 4.33 -11.23 -21.43 5.19 -9.07 -23.42 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU F 67 GLU^? 23.19 ZN ZN G2004 A 596 ARG F 11 ARG.? 21.89 ZN ZN G2004 A 647 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo 69.13 32.20 28.58 68.39 32.96 30.44 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 70.89 37.31 29.70 69.54 36.29 32.39 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 66.09 40.54 34.70 66.92 37.69 35.49 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 7 3 # 7 A 581 GLU H 67 GLU^? 32.59 ZN ZN J2001 A 596 ARG H 11 ARG.? 35.53 ZN ZN J2001 A 647 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo 69.13 32.20 28.58 68.39 32.96 30.44 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 70.89 37.31 29.70 69.54 36.29 32.39 31.27 -41.17 3.82 32.37 -41.49 6.67 coo 66.09 40.54 34.70 66.92 37.69 35.49 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 8 3 # 8 A 581 GLU I 70 GLU^? 28.28 ZN ZN J2001 A 596 ARG I 68 ARG^? 29.76 ZN ZN J2001 A 647 ARG I 9 ARG^? 24.03 ZN ZN J2001 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 70.89 37.31 29.70 69.54 36.29 32.39 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 66.09 40.54 34.70 66.92 37.69 35.49 26.01 -32.03 -7.10 23.09 -31.05 -6.77 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 9 3 # 9 A 581 GLU J 70 GLU^? 22.09 ZN ZN J2001 A 596 ARG J 68 ARG^? 19.63 ZN ZN J2001 A 647 ARG J 9 ARG^? 25.67 ZN ZN J2001 coo 69.13 32.20 28.58 68.39 32.96 30.44 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 70.89 37.31 29.70 69.54 36.29 32.39 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 66.09 40.54 34.70 66.92 37.69 35.49 31.54 -22.75 -7.85 28.47 -22.56 -8.20 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 9 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU B 70 GLU^? 21.67 ZN ZN B2003 B 596 ARG B 68 ARG^? 23.11 ZN ZN B2003 B 647 ARG B 9 ARG^? 25.60 ZN ZN B2003 coo 38.22 57.83 70.36 36.82 56.74 69.18 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 34.24 60.89 68.08 33.31 57.93 67.63 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 31.43 57.38 61.97 31.90 55.58 64.41 12.25 -11.70 3.79 14.09 -14.14 4.30 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU C 67 GLU.? 23.10 ZN ZN B2003 B 596 ARG C 11 ARG~? 22.62 ZN ZN B2003 B 647 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo 38.22 57.83 70.36 36.82 56.74 69.18 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 34.24 60.89 68.08 33.31 57.93 67.63 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo 31.43 57.38 61.97 31.90 55.58 64.41 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU C 70 GLU^? 28.30 ZN ZN B2003 B 596 ARG C 68 ARG^? 29.54 ZN ZN B2003 B 647 ARG C 9 ARG^? 24.24 ZN ZN B2003 coo 38.22 57.83 70.36 36.82 56.74 69.18 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 34.24 60.89 68.08 33.31 57.93 67.63 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 31.43 57.38 61.97 31.90 55.58 64.41 7.07 -21.17 3.13 9.35 -23.17 2.50 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU D 67 GLU^? 32.75 ZN ZN B2003 B 596 ARG D 11 ARG.? 35.27 ZN ZN B2003 B 647 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo 38.22 57.83 70.36 36.82 56.74 69.18 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 34.24 60.89 68.08 33.31 57.93 67.63 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 31.43 57.38 61.97 31.90 55.58 64.41 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU E 67 GLU^? 26.75 ZN ZN E2002 B 596 ARG E 11 ARG.? 26.51 ZN ZN E2002 B 647 ARG E 14 ARG~? 23.50 ZN ZN E2002 coo 38.22 57.83 70.36 36.82 56.74 69.18 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 34.24 60.89 68.08 33.31 57.93 67.63 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo 31.43 57.38 61.97 31.90 55.58 64.41 4.33 -11.23 -21.43 5.19 -9.07 -23.42 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU F 67 GLU^? 23.19 ZN ZN G2004 B 596 ARG F 11 ARG.? 21.89 ZN ZN G2004 B 647 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo 38.22 57.83 70.36 36.82 56.74 69.18 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 34.24 60.89 68.08 33.31 57.93 67.63 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 31.43 57.38 61.97 31.90 55.58 64.41 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 7 3 # 7 B 581 GLU H 67 GLU^? 32.59 ZN ZN J2001 B 596 ARG H 11 ARG.? 35.53 ZN ZN J2001 B 647 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo 38.22 57.83 70.36 36.82 56.74 69.18 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 34.24 60.89 68.08 33.31 57.93 67.63 31.27 -41.17 3.82 32.37 -41.49 6.67 coo 31.43 57.38 61.97 31.90 55.58 64.41 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 8 3 # 8 B 581 GLU I 70 GLU^? 28.28 ZN ZN J2001 B 596 ARG I 68 ARG^? 29.76 ZN ZN J2001 B 647 ARG I 9 ARG^? 24.03 ZN ZN J2001 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 34.24 60.89 68.08 33.31 57.93 67.63 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 31.43 57.38 61.97 31.90 55.58 64.41 26.01 -32.03 -7.10 23.09 -31.05 -6.77 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 9 3 # 9 B 581 GLU J 70 GLU^? 22.09 ZN ZN J2001 B 596 ARG J 68 ARG^? 19.63 ZN ZN J2001 B 647 ARG J 9 ARG^? 25.67 ZN ZN J2001 coo 38.22 57.83 70.36 36.82 56.74 69.18 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 34.24 60.89 68.08 33.31 57.93 67.63 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 31.43 57.38 61.97 31.90 55.58 64.41 31.54 -22.75 -7.85 28.47 -22.56 -8.20 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 9 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU B 70 GLU^? 21.67 ZN ZN B2003 C 596 ARG B 68 ARG^? 23.11 ZN ZN B2003 C 647 ARG B 9 ARG^? 25.60 ZN ZN B2003 coo 11.31 31.26 27.00 13.31 30.71 26.58 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 13.44 32.78 22.07 15.56 30.91 23.37 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 21.00 33.35 22.82 19.83 30.82 24.09 12.25 -11.70 3.79 14.09 -14.14 4.30 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU C 67 GLU.? 23.10 ZN ZN B2003 C 596 ARG C 11 ARG~? 22.62 ZN ZN B2003 C 647 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo 11.31 31.26 27.00 13.31 30.71 26.58 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 13.44 32.78 22.07 15.56 30.91 23.37 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo 21.00 33.35 22.82 19.83 30.82 24.09 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU C 70 GLU^? 28.30 ZN ZN B2003 C 596 ARG C 68 ARG^? 29.54 ZN ZN B2003 C 647 ARG C 9 ARG^? 24.24 ZN ZN B2003 coo 11.31 31.26 27.00 13.31 30.71 26.58 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 13.44 32.78 22.07 15.56 30.91 23.37 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.07 -21.17 3.13 9.35 -23.17 2.50 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU D 67 GLU^? 32.75 ZN ZN B2003 C 596 ARG D 11 ARG.? 35.27 ZN ZN B2003 C 647 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo 11.31 31.26 27.00 13.31 30.71 26.58 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 13.44 32.78 22.07 15.56 30.91 23.37 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 21.00 33.35 22.82 19.83 30.82 24.09 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU E 67 GLU^? 26.75 ZN ZN E2002 C 596 ARG E 11 ARG.? 26.51 ZN ZN E2002 C 647 ARG E 14 ARG~? 23.50 ZN ZN E2002 coo 11.31 31.26 27.00 13.31 30.71 26.58 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 13.44 32.78 22.07 15.56 30.91 23.37 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo 21.00 33.35 22.82 19.83 30.82 24.09 4.33 -11.23 -21.43 5.19 -9.07 -23.42 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU F 67 GLU^? 23.19 ZN ZN G2004 C 596 ARG F 11 ARG.? 21.89 ZN ZN G2004 C 647 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo 11.31 31.26 27.00 13.31 30.71 26.58 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 13.44 32.78 22.07 15.56 30.91 23.37 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 21.00 33.35 22.82 19.83 30.82 24.09 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 7 3 # 7 C 581 GLU H 67 GLU^? 32.59 ZN ZN J2001 C 596 ARG H 11 ARG.? 35.53 ZN ZN J2001 C 647 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo 11.31 31.26 27.00 13.31 30.71 26.58 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 13.44 32.78 22.07 15.56 30.91 23.37 31.27 -41.17 3.82 32.37 -41.49 6.67 coo 21.00 33.35 22.82 19.83 30.82 24.09 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 8 3 # 8 C 581 GLU I 70 GLU^? 28.28 ZN ZN J2001 C 596 ARG I 68 ARG^? 29.76 ZN ZN J2001 C 647 ARG I 9 ARG^? 24.03 ZN ZN J2001 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 13.44 32.78 22.07 15.56 30.91 23.37 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 21.00 33.35 22.82 19.83 30.82 24.09 26.01 -32.03 -7.10 23.09 -31.05 -6.77 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 9 3 # 9 C 581 GLU J 70 GLU^? 22.09 ZN ZN J2001 C 596 ARG J 68 ARG^? 19.63 ZN ZN J2001 C 647 ARG J 9 ARG^? 25.67 ZN ZN J2001 coo 11.31 31.26 27.00 13.31 30.71 26.58 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 21.00 33.35 22.82 19.83 30.82 24.09 31.54 -22.75 -7.85 28.47 -22.56 -8.20 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 9 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU B 70 GLU^? 21.67 ZN ZN B2003 D 596 ARG B 68 ARG^? 23.11 ZN ZN B2003 D 647 ARG B 9 ARG^? 25.60 ZN ZN B2003 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 13.72 -19.93 10.32 15.66 -20.41 9.75 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 9.32 -17.65 5.25 11.20 -19.96 4.50 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 12.25 -11.70 3.79 14.09 -14.14 4.30 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU C 67 GLU.? 23.10 ZN ZN B2003 D 596 ARG C 11 ARG~? 22.62 ZN ZN B2003 D 647 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 1.93 -19.21 0.76 2.90 -17.72 1.93 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU C 70 GLU^? 28.30 ZN ZN B2003 D 596 ARG C 68 ARG^? 29.54 ZN ZN B2003 D 647 ARG C 9 ARG^? 24.24 ZN ZN B2003 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 9.84 -30.97 0.37 11.69 -30.07 0.80 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 7.07 -21.17 3.13 9.35 -23.17 2.50 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU D 67 GLU^? 32.75 ZN ZN B2003 D 596 ARG D 11 ARG.? 35.27 ZN ZN B2003 D 647 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU E 67 GLU^? 26.75 ZN ZN E2002 D 596 ARG E 11 ARG.? 26.51 ZN ZN E2002 D 647 ARG E 14 ARG~? 23.50 ZN ZN E2002 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 4.33 -11.23 -21.43 5.19 -9.07 -23.42 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU F 67 GLU^? 23.19 ZN ZN G2004 D 596 ARG F 11 ARG.? 21.89 ZN ZN G2004 D 647 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 37.21 -21.03 1.43 36.13 -21.58 3.16 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 41.25 -22.37 6.05 44.11 -21.50 5.36 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 7 3 # 7 D 581 GLU H 67 GLU^? 32.59 ZN ZN J2001 D 596 ARG H 11 ARG.? 35.53 ZN ZN J2001 D 647 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 28.08 -35.86 5.95 28.23 -36.02 3.84 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 31.27 -41.17 3.82 32.37 -41.49 6.67 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 8 3 # 8 D 581 GLU I 70 GLU^? 28.28 ZN ZN J2001 D 596 ARG I 68 ARG^? 29.76 ZN ZN J2001 D 647 ARG I 9 ARG^? 24.03 ZN ZN J2001 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 26.01 -32.03 -7.10 23.09 -31.05 -6.77 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 9 3 # 9 D 581 GLU J 70 GLU^? 22.09 ZN ZN J2001 D 596 ARG J 68 ARG^? 19.63 ZN ZN J2001 D 647 ARG J 9 ARG^? 25.67 ZN ZN J2001 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 31.54 -22.75 -7.85 28.47 -22.56 -8.20 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 9 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU B 67 GLU^? 26.37 ZN ZN B2003 E 596 ARG B 11 ARG.? 26.38 ZN ZN B2003 E 647 ARG B 14 ARG~? 23.18 ZN ZN B2003 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 4.66 -4.03 2.41 2.15 -4.03 4.16 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 3.43 -2.45 7.59 1.92 -2.40 10.28 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU B 70 GLU^? 21.67 ZN ZN B2003 E 596 ARG B 68 ARG^? 23.11 ZN ZN B2003 E 647 ARG B 9 ARG^? 25.60 ZN ZN B2003 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 13.72 -19.93 10.32 15.66 -20.41 9.75 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.25 -11.70 3.79 14.09 -14.14 4.30 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU C 67 GLU.? 23.10 ZN ZN B2003 E 596 ARG C 11 ARG~? 22.62 ZN ZN B2003 E 647 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU C 70 GLU^? 28.30 ZN ZN B2003 E 596 ARG C 68 ARG^? 29.54 ZN ZN B2003 E 647 ARG C 9 ARG^? 24.24 ZN ZN B2003 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 9.84 -30.97 0.37 11.69 -30.07 0.80 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.07 -21.17 3.13 9.35 -23.17 2.50 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU D 67 GLU^? 32.75 ZN ZN B2003 E 596 ARG D 11 ARG.? 35.27 ZN ZN B2003 E 647 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU E 67 GLU^? 26.75 ZN ZN E2002 E 596 ARG E 11 ARG.? 26.51 ZN ZN E2002 E 647 ARG E 14 ARG~? 23.50 ZN ZN E2002 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 4.33 -11.23 -21.43 5.19 -9.07 -23.42 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 7 3 # 7 E 581 GLU F 67 GLU^? 23.19 ZN ZN G2004 E 596 ARG F 11 ARG.? 21.89 ZN ZN G2004 E 647 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 41.25 -22.37 6.05 44.11 -21.50 5.36 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 8 3 # 8 E 581 GLU G 67 GLU^? 26.62 ZN ZN G2004 E 596 ARG G 11 ARG.? 26.12 ZN ZN G2004 E 647 ARG G 14 ARG~? 23.24 ZN ZN G2004 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 34.84 -31.69 12.58 37.28 -30.08 13.59 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 36.11 -29.59 17.58 37.55 -27.64 19.46 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 9 3 # 9 E 581 GLU H 67 GLU^? 32.59 ZN ZN J2001 E 596 ARG H 11 ARG.? 35.53 ZN ZN J2001 E 647 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 28.08 -35.86 5.95 28.23 -36.02 3.84 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 31.27 -41.17 3.82 32.37 -41.49 6.67 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 10 3 # 10 E 581 GLU I 70 GLU^? 28.28 ZN ZN J2001 E 596 ARG I 68 ARG^? 29.76 ZN ZN J2001 E 647 ARG I 9 ARG^? 24.03 ZN ZN J2001 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 26.01 -32.03 -7.10 23.09 -31.05 -6.77 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 11 3 # 11 E 581 GLU J 67 GLU^? 26.37 ZN ZN J2001 E 596 ARG J 11 ARG.? 26.46 ZN ZN J2001 E 647 ARG J 14 ARG~? 23.19 ZN ZN J2001 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 42.15 -25.47 -6.25 43.21 -27.78 -7.96 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 43.92 -26.01 -11.47 44.79 -27.17 -14.19 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 12 3 # 12 E 581 GLU J 70 GLU^? 22.09 ZN ZN J2001 E 596 ARG J 68 ARG^? 19.63 ZN ZN J2001 E 647 ARG J 9 ARG^? 25.67 ZN ZN J2001 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 31.54 -22.75 -7.85 28.47 -22.56 -8.20 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 12 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU B 70 GLU^? 21.67 ZN ZN B2003 F 596 ARG B 68 ARG^? 23.11 ZN ZN B2003 F 647 ARG B 9 ARG^? 25.60 ZN ZN B2003 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 13.72 -19.93 10.32 15.66 -20.41 9.75 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 9.32 -17.65 5.25 11.20 -19.96 4.50 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 12.25 -11.70 3.79 14.09 -14.14 4.30 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU C 67 GLU.? 23.10 ZN ZN B2003 F 596 ARG C 11 ARG~? 22.62 ZN ZN B2003 F 647 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 1.93 -19.21 0.76 2.90 -17.72 1.93 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -1.98 -15.22 3.59 -4.40 -16.94 2.77 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU C 70 GLU^? 28.30 ZN ZN B2003 F 596 ARG C 68 ARG^? 29.54 ZN ZN B2003 F 647 ARG C 9 ARG^? 24.24 ZN ZN B2003 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 9.84 -30.97 0.37 11.69 -30.07 0.80 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 7.07 -21.17 3.13 9.35 -23.17 2.50 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU D 67 GLU^? 32.75 ZN ZN B2003 F 596 ARG D 11 ARG.? 35.27 ZN ZN B2003 F 647 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 3.20 -21.78 -9.91 2.84 -21.14 -7.93 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU E 67 GLU^? 26.75 ZN ZN E2002 F 596 ARG E 11 ARG.? 26.51 ZN ZN E2002 F 647 ARG E 14 ARG~? 23.50 ZN ZN E2002 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 3.07 -13.39 -16.26 3.11 -10.68 -17.74 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 4.33 -11.23 -21.43 5.19 -9.07 -23.42 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 6 3 # 6 F 581 GLU F 67 GLU^? 23.19 ZN ZN G2004 F 596 ARG F 11 ARG.? 21.89 ZN ZN G2004 F 647 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 37.21 -21.03 1.43 36.13 -21.58 3.16 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 41.25 -22.37 6.05 44.11 -21.50 5.36 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 7 3 # 7 F 581 GLU H 67 GLU^? 32.59 ZN ZN J2001 F 596 ARG H 11 ARG.? 35.53 ZN ZN J2001 F 647 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 28.08 -35.86 5.95 28.23 -36.02 3.84 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 31.27 -41.17 3.82 32.37 -41.49 6.67 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 8 3 # 8 F 581 GLU I 70 GLU^? 28.28 ZN ZN J2001 F 596 ARG I 68 ARG^? 29.76 ZN ZN J2001 F 647 ARG I 9 ARG^? 24.03 ZN ZN J2001 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.40 -34.53 -4.29 16.28 -32.45 -4.67 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 26.01 -32.03 -7.10 23.09 -31.05 -6.77 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 9 3 # 9 F 581 GLU J 70 GLU^? 22.09 ZN ZN J2001 F 596 ARG J 68 ARG^? 19.63 ZN ZN J2001 F 647 ARG J 9 ARG^? 25.67 ZN ZN J2001 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 23.81 -25.23 -14.59 22.89 -24.29 -12.95 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 31.54 -22.75 -7.85 28.47 -22.56 -8.20 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 9 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 13 ASN.? 18.92 ZN ZN E2002 457 GLY A 65 GLY.? 22.58 ZN ZN E2002 459 GLU A 64 GLU.? 24.42 ZN ZN E2002 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 10.06 -0.38 -14.52 8.62 -0.07 -12.98 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 9.87 0.02 -5.68 10.10 -0.01 -4.96 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 7.18 3.59 -5.93 6.39 1.65 -6.13 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 13 ASN.? 18.92 ZN ZN E2002 457 GLY A 65 GLY.? 22.58 ZN ZN E2002 459 GLU A 67 GLU^? 23.17 ZN ZN E2002 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 10.06 -0.38 -14.52 8.62 -0.07 -12.98 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 9.87 0.02 -5.68 10.10 -0.01 -4.96 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 11.19 -6.14 -5.41 11.52 -7.30 -7.13 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN A 13 ASN.? 18.92 ZN ZN E2002 457 GLY E 65 GLY.? 22.85 ZN ZN E2002 459 GLU E 64 GLU.? 24.43 ZN ZN E2002 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 10.06 -0.38 -14.52 8.62 -0.07 -12.98 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 6.97 -9.67 -17.96 7.60 -9.21 -17.79 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 4.37 -6.45 -19.88 3.54 -7.63 -18.34 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN B 13 ASN.? 30.05 ZN ZN B2003 457 GLY A 65 GLY.? 22.58 ZN ZN E2002 459 GLU A 64 GLU.? 24.42 ZN ZN E2002 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 7.00 0.81 3.82 5.31 -0.29 3.06 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 9.87 0.02 -5.68 10.10 -0.01 -4.96 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 7.18 3.59 -5.93 6.39 1.65 -6.13 ULMN 3 1vom_c00 MYOSIN user 5 3 # 5 233 ASN B 13 ASN.? 30.05 ZN ZN B2003 457 GLY B 65 GLY.? 22.65 ZN ZN B2003 459 GLU B 64 GLU.? 24.26 ZN ZN B2003 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 7.00 0.81 3.82 5.31 -0.29 3.06 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 3.22 -7.02 6.74 3.19 -7.63 7.25 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -0.77 -5.06 7.96 0.08 -4.98 5.99 ULMN 3 1vom_c00 MYOSIN user 6 3 # 6 233 ASN B 13 ASN.? 30.05 ZN ZN B2003 457 GLY B 65 GLY.? 22.65 ZN ZN B2003 459 GLU B 67 GLU^? 26.37 ZN ZN B2003 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 7.00 0.81 3.82 5.31 -0.29 3.06 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 3.22 -7.02 6.74 3.19 -7.63 7.25 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 6.86 -10.14 3.77 7.81 -9.34 2.09 ULMN 3 1vom_c00 MYOSIN user 7 3 # 7 233 ASN C 13 ASN~? 18.60 ZN ZN B2003 457 GLY B 65 GLY.? 22.65 ZN ZN B2003 459 GLU B 64 GLU.? 24.26 ZN ZN B2003 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -2.99 -14.51 9.33 -4.22 -14.45 7.58 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 3.22 -7.02 6.74 3.19 -7.63 7.25 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -0.77 -5.06 7.96 0.08 -4.98 5.99 ULMN 3 1vom_c00 MYOSIN user 8 3 # 8 233 ASN C 13 ASN~? 18.60 ZN ZN B2003 457 GLY C 65 GLY.? 22.60 ZN ZN B2003 459 GLU C 67 GLU.? 23.10 ZN ZN B2003 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -2.99 -14.51 9.33 -4.22 -14.45 7.58 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -3.28 -20.23 2.31 -3.22 -20.84 1.83 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 1.93 -19.21 0.76 2.90 -17.72 1.93 ULMN 3 1vom_c00 MYOSIN user 9 3 # 9 233 ASN D 13 ASN.? 32.45 ZN ZN B2003 457 GLY D 65 GLY.? 37.87 ZN ZN E2002 459 GLU D 67 GLU^? 32.75 ZN ZN B2003 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -6.19 -25.17 -6.31 -5.74 -23.25 -7.14 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -1.41 -21.75 -13.31 -0.91 -21.85 -13.90 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 3.20 -21.78 -9.91 2.84 -21.14 -7.93 ULMN 3 1vom_c00 MYOSIN user 10 3 # 10 233 ASN E 13 ASN.? 29.96 ZN ZN E2002 457 GLY E 65 GLY.? 22.85 ZN ZN E2002 459 GLU E 64 GLU.? 24.43 ZN ZN E2002 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 2.16 -16.32 -20.92 1.73 -14.91 -19.36 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 6.97 -9.67 -17.96 7.60 -9.21 -17.79 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 4.37 -6.45 -19.88 3.54 -7.63 -18.34 ULMN 3 1vom_c00 MYOSIN user 11 3 # 11 233 ASN E 13 ASN.? 29.96 ZN ZN E2002 457 GLY E 65 GLY.? 22.85 ZN ZN E2002 459 GLU E 67 GLU^? 26.75 ZN ZN E2002 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 2.16 -16.32 -20.92 1.73 -14.91 -19.36 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 6.97 -9.67 -17.96 7.60 -9.21 -17.79 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 8.68 -12.43 -13.50 7.80 -14.23 -12.82 ULMN 3 1vom_c00 MYOSIN user 12 3 # 12 233 ASN F 13 ASN.? 18.86 ZN ZN G2004 457 GLY F 65 GLY.? 22.55 ZN ZN G2004 459 GLU F 64 GLU.? 24.41 ZN ZN G2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 42.65 -19.04 10.62 42.72 -20.75 9.34 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 43.02 -19.23 1.70 42.92 -18.94 1.00 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 47.46 -19.49 2.08 46.38 -21.31 2.06 ULMN 3 1vom_c00 MYOSIN user 13 3 # 13 233 ASN F 13 ASN.? 18.86 ZN ZN G2004 457 GLY F 65 GLY.? 22.55 ZN ZN G2004 459 GLU F 67 GLU^? 23.19 ZN ZN G2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 42.65 -19.04 10.62 42.72 -20.75 9.34 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 43.02 -19.23 1.70 42.92 -18.94 1.00 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 37.21 -21.03 1.43 36.13 -21.58 3.16 ULMN 3 1vom_c00 MYOSIN user 14 3 # 14 233 ASN F 13 ASN.? 18.86 ZN ZN G2004 457 GLY G 65 GLY.? 22.69 ZN ZN G2004 459 GLU G 64 GLU.? 24.28 ZN ZN G2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 42.65 -19.04 10.62 42.72 -20.75 9.34 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 36.11 -26.47 13.94 36.18 -25.70 13.80 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 39.99 -27.18 15.98 39.71 -28.44 14.30 ULMN 3 1vom_c00 MYOSIN user 15 3 # 15 233 ASN G 13 ASN.? 29.78 ZN ZN G2004 457 GLY G 65 GLY.? 22.69 ZN ZN G2004 459 GLU G 64 GLU.? 24.28 ZN ZN G2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 32.81 -34.02 16.87 34.16 -33.61 15.27 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 36.11 -26.47 13.94 36.18 -25.70 13.80 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 39.99 -27.18 15.98 39.71 -28.44 14.30 ULMN 3 1vom_c00 MYOSIN user 16 3 # 16 233 ASN G 13 ASN.? 29.78 ZN ZN G2004 457 GLY G 65 GLY.? 22.69 ZN ZN G2004 459 GLU G 67 GLU^? 26.62 ZN ZN G2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 32.81 -34.02 16.87 34.16 -33.61 15.27 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 36.11 -26.47 13.94 36.18 -25.70 13.80 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 32.75 -26.36 9.71 31.95 -28.10 8.81 ULMN 3 1vom_c00 MYOSIN user 17 3 # 17 233 ASN G 13 ASN.? 29.78 ZN ZN G2004 457 GLY H 65 GLY.? 37.58 ZN ZN G2004 459 GLU H 64 GLU.? 37.89 ZN ZN G2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 32.81 -34.02 16.87 34.16 -33.61 15.27 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 29.91 -39.66 9.38 29.48 -39.47 9.99 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 32.53 -42.71 11.25 33.49 -41.02 10.38 ULMN 3 1vom_c00 MYOSIN user 18 3 # 18 233 ASN H 13 ASN.? 32.33 ZN ZN J2001 457 GLY H 65 GLY.? 37.58 ZN ZN G2004 459 GLU H 64 GLU.? 37.89 ZN ZN G2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 28.96 -45.87 2.39 30.48 -44.50 3.04 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 29.91 -39.66 9.38 29.48 -39.47 9.99 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 32.53 -42.71 11.25 33.49 -41.02 10.38 ULMN 3 1vom_c00 MYOSIN user 19 3 # 19 233 ASN H 13 ASN.? 32.33 ZN ZN J2001 457 GLY H 65 GLY.? 37.58 ZN ZN G2004 459 GLU H 67 GLU^? 32.59 ZN ZN J2001 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 28.96 -45.87 2.39 30.48 -44.50 3.04 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 29.91 -39.66 9.38 29.48 -39.47 9.99 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 28.08 -35.86 5.95 28.23 -36.02 3.84 ULMN 3 1vom_c00 MYOSIN user 20 3 # 20 233 ASN I 13 ASN.? 18.64 ZN ZN J2001 457 GLY I 65 GLY.? 22.65 ZN ZN J2001 459 GLU I 67 GLU^? 22.99 ZN ZN J2001 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 36.86 -37.66 -13.37 37.50 -38.40 -11.47 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 32.06 -40.56 -6.20 31.46 -40.88 -5.85 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 30.11 -35.47 -4.88 30.75 -33.82 -6.03 ULMN 3 1vom_c00 MYOSIN user 21 3 # 21 233 ASN I 13 ASN.? 18.64 ZN ZN J2001 457 GLY J 65 GLY.? 22.67 ZN ZN J2001 459 GLU J 64 GLU.? 23.99 ZN ZN J2001 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 36.86 -37.66 -13.37 37.50 -38.40 -11.47 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 40.24 -28.46 -10.68 39.76 -28.75 -11.23 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 44.01 -30.69 -11.59 43.10 -30.84 -9.69 ULMN 3 1vom_c00 MYOSIN user 22 3 # 22 233 ASN J 13 ASN.? 30.13 ZN ZN J2001 457 GLY F 65 GLY.? 22.55 ZN ZN G2004 459 GLU F 64 GLU.? 24.41 ZN ZN G2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 45.13 -21.25 -7.78 45.09 -23.23 -6.98 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 43.02 -19.23 1.70 42.92 -18.94 1.00 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 47.46 -19.49 2.08 46.38 -21.31 2.06 ULMN 3 1vom_c00 MYOSIN user 23 3 # 23 233 ASN J 13 ASN.? 30.13 ZN ZN J2001 457 GLY J 65 GLY.? 22.67 ZN ZN J2001 459 GLU J 64 GLU.? 23.99 ZN ZN J2001 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 45.13 -21.25 -7.78 45.09 -23.23 -6.98 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 40.24 -28.46 -10.68 39.76 -28.75 -11.23 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 44.01 -30.69 -11.59 43.10 -30.84 -9.69 ULMN 3 1vom_c00 MYOSIN user 24 3 # 24 233 ASN J 13 ASN.? 30.13 ZN ZN J2001 457 GLY J 65 GLY.? 22.67 ZN ZN J2001 459 GLU J 67 GLU^? 26.37 ZN ZN J2001 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 45.13 -21.25 -7.78 45.09 -23.23 -6.98 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 40.24 -28.46 -10.68 39.76 -28.75 -11.23 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 35.73 -26.90 -7.66 35.82 -25.49 -6.10 1vom_c00 source 1vom MYOSIN : 24 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR E 32 TYR^? 21.25 ZN ZN J2001 A 317 GLU E 30 GLU^? 22.13 ZN ZN J2001 A 365 ARG J 80 ARG.? 22.24 ZN ZN E2002 coo 1.77 6.56 57.05 3.05 7.44 59.37 20.11 -18.94 -28.19 21.99 -18.75 -30.24 coo 3.06 2.85 52.79 4.83 3.89 53.24 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 3.82 17.09 49.56 4.09 14.32 50.84 15.29 -10.38 -39.34 14.75 -7.48 -38.50 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR G 32 TYR^? 21.21 ZN ZN B2003 A 317 GLU G 30 GLU^? 22.02 ZN ZN B2003 A 365 ARG B 80 ARG.? 21.50 ZN ZN G2004 coo 1.77 6.56 57.05 3.05 7.44 59.37 21.50 -19.82 24.15 20.71 -18.09 26.19 coo 3.06 2.85 52.79 4.83 3.89 53.24 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 3.82 17.09 49.56 4.09 14.32 50.84 32.12 -19.85 34.68 34.30 -17.68 34.59 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR I 32 TYR^? 15.25 ZN ZN J2001 A 317 GLU I 30 GLU^? 20.10 ZN ZN J2001 A 365 ARG D 80 ARG.? 21.06 ZN ZN J2001 coo 1.77 6.56 57.05 3.05 7.44 59.37 18.53 -40.66 -20.20 16.59 -42.17 -21.51 coo 3.06 2.85 52.79 4.83 3.89 53.24 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 3.82 17.09 49.56 4.09 14.32 50.84 25.19 -53.81 -20.43 26.22 -56.09 -18.61 1vzx_c02 source 1vzx 2.04.01.0087 : 3 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR E 32 TYR^? 21.25 ZN ZN J2001 B1317 GLU E 30 GLU^? 22.13 ZN ZN J2001 B1365 ARG J 80 ARG.? 22.24 ZN ZN E2002 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 20.11 -18.94 -28.19 21.99 -18.75 -30.24 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 24.42 -14.74 -31.13 25.58 -16.52 -31.18 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 15.29 -10.38 -39.34 14.75 -7.48 -38.50 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR G 32 TYR^? 21.21 ZN ZN B2003 B1317 GLU G 30 GLU^? 22.02 ZN ZN B2003 B1365 ARG B 80 ARG.? 21.50 ZN ZN G2004 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 21.50 -19.82 24.15 20.71 -18.09 26.19 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 22.93 -14.21 27.25 20.84 -13.89 27.07 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 32.12 -19.85 34.68 34.30 -17.68 34.59 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR I 32 TYR^? 15.25 ZN ZN J2001 B1317 GLU I 30 GLU^? 20.10 ZN ZN J2001 B1365 ARG D 80 ARG.? 21.06 ZN ZN J2001 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 18.53 -40.66 -20.20 16.59 -42.17 -21.51 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 14.49 -45.59 -19.94 12.92 -44.37 -20.65 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 25.19 -53.81 -20.43 26.22 -56.09 -18.61 1vzx_c03 source 1vzx 2.04.01.0087 : 3 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 78 TYR.? 11.65 ZN ZN G2004 A 40 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 103 LEU F 18 LEU~? 18.80 ZN ZN G2004 coo 12.09 16.13 10.57 11.28 18.80 10.73 42.29 -5.11 6.34 41.03 -7.11 7.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 11.83 18.73 16.99 10.99 19.71 15.26 42.79 -12.74 2.82 43.10 -14.72 1.96 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 78 TYR.? 24.55 ZN ZN G2004 A 40 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 103 LEU G 18 LEU~? 20.69 ZN ZN G2004 coo 12.09 16.13 10.57 11.28 18.80 10.73 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 7.55 25.51 14.34 9.65 25.73 14.24 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 11.83 18.73 16.99 10.99 19.71 15.26 32.80 -24.24 19.43 34.34 -24.33 17.90 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR C 78 TYR^? 35.69 ZN ZN B2003 A 40 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 103 LEU H 18 LEU~? 36.27 ZN ZN B2003 coo 12.09 16.13 10.57 11.28 18.80 10.73 16.52 -47.66 10.31 18.03 -47.38 7.99 coo 7.55 25.51 14.34 9.65 25.73 14.24 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 11.83 18.73 16.99 10.99 19.71 15.26 24.00 -43.28 10.54 25.82 -42.11 10.65 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR D 78 TYR.? 11.76 ZN ZN J2001 A 40 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 103 LEU I 18 LEU~? 18.94 ZN ZN J2001 coo 12.09 16.13 10.57 11.28 18.80 10.73 24.81 -44.15 -19.15 26.32 -41.78 -18.93 coo 7.55 25.51 14.34 9.65 25.73 14.24 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 11.83 18.73 16.99 10.99 19.71 15.26 28.19 -43.10 -11.41 29.15 -42.94 -9.46 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR E 78 TYR.? 24.67 ZN ZN J2001 A 40 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 103 LEU J 18 LEU~? 20.91 ZN ZN J2001 coo 12.09 16.13 10.57 11.28 18.80 10.73 40.71 -17.77 -21.60 40.95 -16.95 -18.92 coo 7.55 25.51 14.34 9.65 25.73 14.24 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 11.83 18.73 16.99 10.99 19.71 15.26 40.22 -24.23 -16.13 40.12 -26.00 -14.88 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR F 32 TYR^? 15.23 ZN ZN G2004 A 40 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 103 LEU A 72 LEU^? 19.94 ZN ZN G2004 coo 12.09 16.13 10.57 11.28 18.80 10.73 36.01 -1.70 4.51 36.34 1.00 3.95 coo 7.55 25.51 14.34 9.65 25.73 14.24 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 11.83 18.73 16.99 10.99 19.71 15.26 28.14 -5.55 3.29 27.37 -7.11 1.85 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR F 78 TYR.? 11.63 ZN ZN E2002 A 40 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 103 LEU A 18 LEU~? 18.84 ZN ZN E2002 coo 12.09 16.13 10.57 11.28 18.80 10.73 22.38 6.39 -10.32 21.34 4.29 -11.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 11.83 18.73 16.99 10.99 19.71 15.26 15.57 3.11 -6.71 13.63 2.37 -6.07 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR G 78 TYR.? 24.68 ZN ZN B2003 A 40 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 103 LEU B 18 LEU~? 20.87 ZN ZN B2003 coo 12.09 16.13 10.57 11.28 18.80 10.73 12.17 -1.26 17.53 12.70 -0.59 14.88 coo 7.55 25.51 14.34 9.65 25.73 14.24 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 11.83 18.73 16.99 10.99 19.71 15.26 6.73 -4.94 12.17 5.26 -5.89 10.88 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR H 78 TYR.? 11.76 ZN ZN B2003 A 40 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 103 LEU C 18 LEU~? 19.07 ZN ZN B2003 coo 12.09 16.13 10.57 11.28 18.80 10.73 -2.69 -28.08 15.14 -1.32 -25.64 14.90 coo 7.55 25.51 14.34 9.65 25.73 14.24 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 11.83 18.73 16.99 10.99 19.71 15.26 -3.45 -24.88 7.32 -3.74 -23.85 5.41 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR I 78 TYR.? 35.62 ZN ZN J2001 A 40 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 103 LEU D 18 LEU~? 36.37 ZN ZN J2001 coo 12.09 16.13 10.57 11.28 18.80 10.73 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 coo 7.55 25.51 14.34 9.65 25.73 14.24 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 11.83 18.73 16.99 10.99 19.71 15.26 -1.68 -28.37 -14.22 -1.35 -26.27 -14.71 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR J 78 TYR.? 24.76 ZN ZN E2002 A 40 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 103 LEU E 18 LEU~? 20.78 ZN ZN E2002 coo 12.09 16.13 10.57 11.28 18.80 10.73 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 7.55 25.51 14.34 9.65 25.73 14.24 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 11.83 18.73 16.99 10.99 19.71 15.26 10.52 -11.36 -23.39 9.76 -9.98 -21.91 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 11 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 78 TYR.? 11.65 ZN ZN G2004 B 40 ASP F 39 ASP.? 16.21 ZN ZN G2004 B 103 LEU F 18 LEU~? 18.80 ZN ZN G2004 coo 14.25 20.09 37.35 13.48 17.40 37.38 42.29 -5.11 6.34 41.03 -7.11 7.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 12.89 17.60 31.13 12.34 16.51 32.90 42.79 -12.74 2.82 43.10 -14.72 1.96 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 78 TYR.? 24.55 ZN ZN G2004 B 40 ASP G 39 ASP.? 27.24 ZN ZN G2004 B 103 LEU G 18 LEU~? 20.69 ZN ZN G2004 coo 14.25 20.09 37.35 13.48 17.40 37.38 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 9.39 10.77 34.53 11.50 10.63 34.41 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 12.89 17.60 31.13 12.34 16.51 32.90 32.80 -24.24 19.43 34.34 -24.33 17.90 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR C 78 TYR^? 35.69 ZN ZN B2003 B 40 ASP H 39 ASP.? 32.15 ZN ZN J2001 B 103 LEU H 18 LEU~? 36.27 ZN ZN B2003 coo 14.25 20.09 37.35 13.48 17.40 37.38 16.52 -47.66 10.31 18.03 -47.38 7.99 coo 9.39 10.77 34.53 11.50 10.63 34.41 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 12.89 17.60 31.13 12.34 16.51 32.90 24.00 -43.28 10.54 25.82 -42.11 10.65 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR D 78 TYR.? 11.76 ZN ZN J2001 B 40 ASP I 39 ASP.? 16.30 ZN ZN J2001 B 103 LEU I 18 LEU~? 18.94 ZN ZN J2001 coo 14.25 20.09 37.35 13.48 17.40 37.38 24.81 -44.15 -19.15 26.32 -41.78 -18.93 coo 9.39 10.77 34.53 11.50 10.63 34.41 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 12.89 17.60 31.13 12.34 16.51 32.90 28.19 -43.10 -11.41 29.15 -42.94 -9.46 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR E 78 TYR.? 24.67 ZN ZN J2001 B 40 ASP J 39 ASP.? 27.27 ZN ZN J2001 B 103 LEU J 18 LEU~? 20.91 ZN ZN J2001 coo 14.25 20.09 37.35 13.48 17.40 37.38 40.71 -17.77 -21.60 40.95 -16.95 -18.92 coo 9.39 10.77 34.53 11.50 10.63 34.41 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 12.89 17.60 31.13 12.34 16.51 32.90 40.22 -24.23 -16.13 40.12 -26.00 -14.88 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR F 78 TYR.? 11.63 ZN ZN E2002 B 40 ASP A 39 ASP.? 16.23 ZN ZN E2002 B 103 LEU A 18 LEU~? 18.84 ZN ZN E2002 coo 14.25 20.09 37.35 13.48 17.40 37.38 22.38 6.39 -10.32 21.34 4.29 -11.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 12.89 17.60 31.13 12.34 16.51 32.90 15.57 3.11 -6.71 13.63 2.37 -6.07 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR G 78 TYR.? 24.68 ZN ZN B2003 B 40 ASP B 39 ASP.? 27.28 ZN ZN B2003 B 103 LEU B 18 LEU~? 20.87 ZN ZN B2003 coo 14.25 20.09 37.35 13.48 17.40 37.38 12.17 -1.26 17.53 12.70 -0.59 14.88 coo 9.39 10.77 34.53 11.50 10.63 34.41 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 12.89 17.60 31.13 12.34 16.51 32.90 6.73 -4.94 12.17 5.26 -5.89 10.88 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR H 78 TYR.? 11.76 ZN ZN B2003 B 40 ASP C 39 ASP.? 16.40 ZN ZN B2003 B 103 LEU C 18 LEU~? 19.07 ZN ZN B2003 coo 14.25 20.09 37.35 13.48 17.40 37.38 -2.69 -28.08 15.14 -1.32 -25.64 14.90 coo 9.39 10.77 34.53 11.50 10.63 34.41 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 12.89 17.60 31.13 12.34 16.51 32.90 -3.45 -24.88 7.32 -3.74 -23.85 5.41 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR J 78 TYR.? 24.76 ZN ZN E2002 B 40 ASP E 39 ASP.? 27.23 ZN ZN E2002 B 103 LEU E 18 LEU~? 20.78 ZN ZN E2002 coo 14.25 20.09 37.35 13.48 17.40 37.38 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 9.39 10.77 34.53 11.50 10.63 34.41 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 12.89 17.60 31.13 12.34 16.51 32.90 10.52 -11.36 -23.39 9.76 -9.98 -21.91 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 9 hits 1vzz_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA B 23 ALA~? 19.50 ZN ZN B2003 B 126 ARG G 80 ARG.? 23.71 ZN ZN B2003 B 138 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo 2.11 4.00 19.31 3.14 4.86 19.99 8.44 -4.88 21.55 9.06 -3.51 21.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 6.63 1.91 25.77 5.01 2.67 23.24 coo 6.10 2.00 25.24 6.12 1.84 23.13 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA B 74 ALA^? 18.49 ZN ZN B2003 B 126 ARG B 45 ARG^? 19.26 ZN ZN B2003 B 138 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 2.11 4.00 19.31 3.14 4.86 19.99 17.93 -22.48 22.28 18.36 -21.34 23.15 coo 2.45 5.53 11.28 3.59 7.56 13.29 14.90 -14.60 27.65 17.88 -13.95 27.44 coo 6.10 2.00 25.24 6.12 1.84 23.13 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA D 21 ALA~? 36.39 ZN ZN J2001 B 126 ARG D 14 ARG~? 40.72 ZN ZN B2003 B 138 GLU D 24 GLU~? 35.30 ZN ZN J2001 coo 2.11 4.00 19.31 3.14 4.86 19.99 -3.64 -31.02 -19.45 -3.85 -29.57 -19.10 coo 2.45 5.53 11.28 3.59 7.56 13.29 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 coo 6.10 2.00 25.24 6.12 1.84 23.13 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA E 23 ALA~? 19.67 ZN ZN E2002 B 126 ARG J 80 ARG.? 22.24 ZN ZN E2002 B 138 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo 2.11 4.00 19.31 3.14 4.86 19.99 16.58 -9.86 -30.44 15.89 -10.90 -31.31 coo 2.45 5.53 11.28 3.59 7.56 13.29 15.29 -10.38 -39.34 14.75 -7.48 -38.50 coo 6.10 2.00 25.24 6.12 1.84 23.13 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA E 74 ALA^? 18.45 ZN ZN E2002 B 126 ARG E 45 ARG^? 19.39 ZN ZN E2002 B 138 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo 2.11 4.00 19.31 3.14 4.86 19.99 33.20 -11.19 -19.37 33.16 -11.71 -20.77 coo 2.45 5.53 11.28 3.59 7.56 13.29 29.50 -9.81 -28.77 30.55 -12.66 -29.14 coo 6.10 2.00 25.24 6.12 1.84 23.13 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA G 23 ALA~? 19.48 ZN ZN G2004 B 126 ARG B 80 ARG.? 21.50 ZN ZN G2004 B 138 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo 2.11 4.00 19.31 3.14 4.86 19.99 31.15 -18.18 26.45 30.57 -19.27 27.34 coo 2.45 5.53 11.28 3.59 7.56 13.29 32.12 -19.85 34.68 34.30 -17.68 34.59 coo 6.10 2.00 25.24 6.12 1.84 23.13 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 B 124 ALA G 74 ALA^? 18.58 ZN ZN G2004 B 126 ARG G 45 ARG^? 19.42 ZN ZN G2004 B 138 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo 2.11 4.00 19.31 3.14 4.86 19.99 21.64 -4.56 15.34 21.18 -4.94 16.73 coo 2.45 5.53 11.28 3.59 7.56 13.29 24.66 -6.90 24.79 21.69 -7.61 25.11 coo 6.10 2.00 25.24 6.12 1.84 23.13 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 B 124 ALA H 23 ALA~? 32.86 ZN ZN B2003 B 126 ARG C 80 ARG.? 36.99 ZN ZN B2003 B 138 GLU H 30 GLU^? 26.29 ZN ZN B2003 coo 2.11 4.00 19.31 3.14 4.86 19.99 17.16 -46.07 16.52 16.70 -47.27 15.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 16.13 -52.20 20.46 17.69 -52.87 23.04 coo 6.10 2.00 25.24 6.12 1.84 23.13 8.76 -43.18 14.57 6.72 -43.67 14.36 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 B 124 ALA I 23 ALA~? 17.40 ZN ZN J2001 B 126 ARG D 80 ARG.? 21.06 ZN ZN J2001 B 138 GLU I 30 GLU^? 20.10 ZN ZN J2001 coo 2.11 4.00 19.31 3.14 4.86 19.99 22.18 -48.95 -15.71 22.79 -48.66 -17.06 coo 2.45 5.53 11.28 3.59 7.56 13.29 25.19 -53.81 -20.43 26.22 -56.09 -18.61 coo 6.10 2.00 25.24 6.12 1.84 23.13 14.49 -45.59 -19.94 12.92 -44.37 -20.65 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 B 124 ALA I 74 ALA^? 31.19 ZN ZN J2001 B 126 ARG I 45 ARG^? 26.51 ZN ZN J2001 B 138 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 2.11 4.00 19.31 3.14 4.86 19.99 5.80 -40.70 -8.02 5.78 -41.01 -9.50 coo 2.45 5.53 11.28 3.59 7.56 13.29 9.19 -47.86 -14.39 8.02 -46.02 -16.58 coo 6.10 2.00 25.24 6.12 1.84 23.13 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 B 124 ALA J 23 ALA~? 19.58 ZN ZN J2001 B 126 ARG E 80 ARG.? 21.10 ZN ZN J2001 B 138 GLU J 30 GLU^? 21.96 ZN ZN E2002 coo 2.11 4.00 19.31 3.14 4.86 19.99 39.46 -22.73 -25.55 40.41 -21.57 -25.51 coo 2.45 5.53 11.28 3.59 7.56 13.29 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo 6.10 2.00 25.24 6.12 1.84 23.13 33.28 -16.74 -28.58 31.82 -15.19 -28.83 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 B 124 ALA J 74 ALA^? 18.57 ZN ZN J2001 B 126 ARG J 45 ARG^? 19.30 ZN ZN J2001 B 138 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 2.11 4.00 19.31 3.14 4.86 19.99 19.54 -23.33 -26.22 20.33 -22.37 -27.09 coo 2.45 5.53 11.28 3.59 7.56 13.29 27.80 -22.06 -31.67 26.75 -19.22 -31.33 coo 6.10 2.00 25.24 6.12 1.84 23.13 15.39 -26.34 -33.01 16.88 -27.76 -33.58 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 12 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA B 23 ALA~? 19.50 ZN ZN B2003 C 126 ARG G 80 ARG.? 23.71 ZN ZN B2003 C 138 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 8.44 -4.88 21.55 9.06 -3.51 21.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 6.63 1.91 25.77 5.01 2.67 23.24 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA B 74 ALA^? 18.49 ZN ZN B2003 C 126 ARG B 45 ARG^? 19.26 ZN ZN B2003 C 138 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 17.93 -22.48 22.28 18.36 -21.34 23.15 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 14.90 -14.60 27.65 17.88 -13.95 27.44 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA D 21 ALA~? 36.39 ZN ZN J2001 C 126 ARG D 14 ARG~? 40.72 ZN ZN B2003 C 138 GLU D 24 GLU~? 35.30 ZN ZN J2001 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -3.64 -31.02 -19.45 -3.85 -29.57 -19.10 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA E 23 ALA~? 19.67 ZN ZN E2002 C 126 ARG J 80 ARG.? 22.24 ZN ZN E2002 C 138 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 16.58 -9.86 -30.44 15.89 -10.90 -31.31 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 15.29 -10.38 -39.34 14.75 -7.48 -38.50 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA E 74 ALA^? 18.45 ZN ZN E2002 C 126 ARG E 45 ARG^? 19.39 ZN ZN E2002 C 138 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 33.20 -11.19 -19.37 33.16 -11.71 -20.77 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 29.50 -9.81 -28.77 30.55 -12.66 -29.14 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA G 23 ALA~? 19.48 ZN ZN G2004 C 126 ARG B 80 ARG.? 21.50 ZN ZN G2004 C 138 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 31.15 -18.18 26.45 30.57 -19.27 27.34 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 32.12 -19.85 34.68 34.30 -17.68 34.59 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA G 74 ALA^? 18.58 ZN ZN G2004 C 126 ARG G 45 ARG^? 19.42 ZN ZN G2004 C 138 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 21.64 -4.56 15.34 21.18 -4.94 16.73 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 24.66 -6.90 24.79 21.69 -7.61 25.11 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA H 23 ALA~? 32.86 ZN ZN B2003 C 126 ARG C 80 ARG.? 36.99 ZN ZN B2003 C 138 GLU H 30 GLU^? 26.29 ZN ZN B2003 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 17.16 -46.07 16.52 16.70 -47.27 15.72 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 16.13 -52.20 20.46 17.69 -52.87 23.04 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 8.76 -43.18 14.57 6.72 -43.67 14.36 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 C 124 ALA I 74 ALA^? 31.19 ZN ZN J2001 C 126 ARG I 45 ARG^? 26.51 ZN ZN J2001 C 138 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 5.80 -40.70 -8.02 5.78 -41.01 -9.50 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 9.19 -47.86 -14.39 8.02 -46.02 -16.58 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 C 124 ALA J 23 ALA~? 19.58 ZN ZN J2001 C 126 ARG E 80 ARG.? 21.10 ZN ZN J2001 C 138 GLU J 30 GLU^? 21.96 ZN ZN E2002 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 39.46 -22.73 -25.55 40.41 -21.57 -25.51 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 33.28 -16.74 -28.58 31.82 -15.19 -28.83 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 C 124 ALA J 74 ALA^? 18.57 ZN ZN J2001 C 126 ARG J 45 ARG^? 19.30 ZN ZN J2001 C 138 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 19.54 -23.33 -26.22 20.33 -22.37 -27.09 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 27.80 -22.06 -31.67 26.75 -19.22 -31.33 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 15.39 -26.34 -33.01 16.88 -27.76 -33.58 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA B 23 ALA~? 19.50 ZN ZN B2003 D 126 ARG G 80 ARG.? 23.71 ZN ZN B2003 D 138 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 8.44 -4.88 21.55 9.06 -3.51 21.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 6.63 1.91 25.77 5.01 2.67 23.24 coo 6.23 0.50 57.10 5.93 0.72 59.19 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 74 ALA^? 18.49 ZN ZN B2003 D 126 ARG B 45 ARG^? 19.26 ZN ZN B2003 D 138 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 17.93 -22.48 22.28 18.36 -21.34 23.15 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 14.90 -14.60 27.65 17.88 -13.95 27.44 coo 6.23 0.50 57.10 5.93 0.72 59.19 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA D 21 ALA~? 36.39 ZN ZN J2001 D 126 ARG D 14 ARG~? 40.72 ZN ZN B2003 D 138 GLU D 24 GLU~? 35.30 ZN ZN J2001 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -3.64 -31.02 -19.45 -3.85 -29.57 -19.10 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 coo 6.23 0.50 57.10 5.93 0.72 59.19 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA E 23 ALA~? 19.67 ZN ZN E2002 D 126 ARG J 80 ARG.? 22.24 ZN ZN E2002 D 138 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 16.58 -9.86 -30.44 15.89 -10.90 -31.31 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 15.29 -10.38 -39.34 14.75 -7.48 -38.50 coo 6.23 0.50 57.10 5.93 0.72 59.19 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA G 23 ALA~? 19.48 ZN ZN G2004 D 126 ARG B 80 ARG.? 21.50 ZN ZN G2004 D 138 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 31.15 -18.18 26.45 30.57 -19.27 27.34 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 32.12 -19.85 34.68 34.30 -17.68 34.59 coo 6.23 0.50 57.10 5.93 0.72 59.19 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA H 23 ALA~? 32.86 ZN ZN B2003 D 126 ARG C 80 ARG.? 36.99 ZN ZN B2003 D 138 GLU H 30 GLU^? 26.29 ZN ZN B2003 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 17.16 -46.07 16.52 16.70 -47.27 15.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 16.13 -52.20 20.46 17.69 -52.87 23.04 coo 6.23 0.50 57.10 5.93 0.72 59.19 8.76 -43.18 14.57 6.72 -43.67 14.36 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA I 23 ALA~? 17.40 ZN ZN J2001 D 126 ARG D 80 ARG.? 21.06 ZN ZN J2001 D 138 GLU I 30 GLU^? 20.10 ZN ZN J2001 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 22.18 -48.95 -15.71 22.79 -48.66 -17.06 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 25.19 -53.81 -20.43 26.22 -56.09 -18.61 coo 6.23 0.50 57.10 5.93 0.72 59.19 14.49 -45.59 -19.94 12.92 -44.37 -20.65 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 D 124 ALA J 23 ALA~? 19.58 ZN ZN J2001 D 126 ARG E 80 ARG.? 21.10 ZN ZN J2001 D 138 GLU J 30 GLU^? 21.96 ZN ZN E2002 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 39.46 -22.73 -25.55 40.41 -21.57 -25.51 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo 6.23 0.50 57.10 5.93 0.72 59.19 33.28 -16.74 -28.58 31.82 -15.19 -28.83 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 D 124 ALA J 74 ALA^? 18.57 ZN ZN J2001 D 126 ARG J 45 ARG^? 19.30 ZN ZN J2001 D 138 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 19.54 -23.33 -26.22 20.33 -22.37 -27.09 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 27.80 -22.06 -31.67 26.75 -19.22 -31.33 coo 6.23 0.50 57.10 5.93 0.72 59.19 15.39 -26.34 -33.01 16.88 -27.76 -33.58 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 9 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 23 ALA~? 17.29 ZN ZN E2002 E 126 ARG F 80 ARG.? 21.51 ZN ZN E2002 E 138 GLU A 30 GLU^? 19.82 ZN ZN E2002 coo -4.56 10.03 62.36 -4.38 11.31 61.55 22.15 9.43 -4.56 22.41 9.69 -6.04 coo -3.02 12.00 70.07 -1.94 13.84 67.82 21.15 15.99 -8.11 19.39 17.73 -6.23 coo -8.67 12.22 56.54 -8.68 12.09 58.65 31.22 6.85 -4.51 33.04 5.76 -4.61 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 23 ALA~? 19.50 ZN ZN B2003 E 126 ARG G 80 ARG.? 23.71 ZN ZN B2003 E 138 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo -4.56 10.03 62.36 -4.38 11.31 61.55 8.44 -4.88 21.55 9.06 -3.51 21.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 6.63 1.91 25.77 5.01 2.67 23.24 coo -8.67 12.22 56.54 -8.68 12.09 58.65 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA B 74 ALA^? 18.49 ZN ZN B2003 E 126 ARG B 45 ARG^? 19.26 ZN ZN B2003 E 138 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo -4.56 10.03 62.36 -4.38 11.31 61.55 17.93 -22.48 22.28 18.36 -21.34 23.15 coo -3.02 12.00 70.07 -1.94 13.84 67.82 14.90 -14.60 27.65 17.88 -13.95 27.44 coo -8.67 12.22 56.54 -8.68 12.09 58.65 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA E 23 ALA~? 19.67 ZN ZN E2002 E 126 ARG J 80 ARG.? 22.24 ZN ZN E2002 E 138 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo -4.56 10.03 62.36 -4.38 11.31 61.55 16.58 -9.86 -30.44 15.89 -10.90 -31.31 coo -3.02 12.00 70.07 -1.94 13.84 67.82 15.29 -10.38 -39.34 14.75 -7.48 -38.50 coo -8.67 12.22 56.54 -8.68 12.09 58.65 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA F 23 ALA~? 17.33 ZN ZN G2004 E 126 ARG A 80 ARG.? 21.33 ZN ZN G2004 E 138 GLU F 30 GLU^? 19.95 ZN ZN G2004 coo -4.56 10.03 62.36 -4.38 11.31 61.55 45.03 -3.79 0.54 45.02 -3.39 2.01 coo -3.02 12.00 70.07 -1.94 13.84 67.82 51.38 -0.29 4.19 53.35 -1.78 2.33 coo -8.67 12.22 56.54 -8.68 12.09 58.65 38.23 2.77 0.52 36.38 3.82 0.63 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA G 23 ALA~? 19.48 ZN ZN G2004 E 126 ARG B 80 ARG.? 21.50 ZN ZN G2004 E 138 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo -4.56 10.03 62.36 -4.38 11.31 61.55 31.15 -18.18 26.45 30.57 -19.27 27.34 coo -3.02 12.00 70.07 -1.94 13.84 67.82 32.12 -19.85 34.68 34.30 -17.68 34.59 coo -8.67 12.22 56.54 -8.68 12.09 58.65 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 E 124 ALA H 23 ALA~? 32.86 ZN ZN B2003 E 126 ARG C 80 ARG.? 36.99 ZN ZN B2003 E 138 GLU H 30 GLU^? 26.29 ZN ZN B2003 coo -4.56 10.03 62.36 -4.38 11.31 61.55 17.16 -46.07 16.52 16.70 -47.27 15.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 16.13 -52.20 20.46 17.69 -52.87 23.04 coo -8.67 12.22 56.54 -8.68 12.09 58.65 8.76 -43.18 14.57 6.72 -43.67 14.36 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 E 124 ALA I 23 ALA~? 17.40 ZN ZN J2001 E 126 ARG D 80 ARG.? 21.06 ZN ZN J2001 E 138 GLU I 30 GLU^? 20.10 ZN ZN J2001 coo -4.56 10.03 62.36 -4.38 11.31 61.55 22.18 -48.95 -15.71 22.79 -48.66 -17.06 coo -3.02 12.00 70.07 -1.94 13.84 67.82 25.19 -53.81 -20.43 26.22 -56.09 -18.61 coo -8.67 12.22 56.54 -8.68 12.09 58.65 14.49 -45.59 -19.94 12.92 -44.37 -20.65 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 E 124 ALA J 23 ALA~? 19.58 ZN ZN J2001 E 126 ARG E 80 ARG.? 21.10 ZN ZN J2001 E 138 GLU J 30 GLU^? 21.96 ZN ZN E2002 coo -4.56 10.03 62.36 -4.38 11.31 61.55 39.46 -22.73 -25.55 40.41 -21.57 -25.51 coo -3.02 12.00 70.07 -1.94 13.84 67.82 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo -8.67 12.22 56.54 -8.68 12.09 58.65 33.28 -16.74 -28.58 31.82 -15.19 -28.83 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 E 124 ALA J 74 ALA^? 18.57 ZN ZN J2001 E 126 ARG J 45 ARG^? 19.30 ZN ZN J2001 E 138 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo -4.56 10.03 62.36 -4.38 11.31 61.55 19.54 -23.33 -26.22 20.33 -22.37 -27.09 coo -3.02 12.00 70.07 -1.94 13.84 67.82 27.80 -22.06 -31.67 26.75 -19.22 -31.33 coo -8.67 12.22 56.54 -8.68 12.09 58.65 15.39 -26.34 -33.01 16.88 -27.76 -33.58 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 10 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA B 23 ALA~? 19.50 ZN ZN B2003 F 126 ARG G 80 ARG.? 23.71 ZN ZN B2003 F 138 GLU B 30 GLU^? 21.92 ZN ZN G2004 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 8.44 -4.88 21.55 9.06 -3.51 21.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 6.63 1.91 25.77 5.01 2.67 23.24 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 16.88 -7.29 24.59 18.95 -7.88 24.75 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA B 74 ALA^? 18.49 ZN ZN B2003 F 126 ARG B 45 ARG^? 19.26 ZN ZN B2003 F 138 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 17.93 -22.48 22.28 18.36 -21.34 23.15 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 14.90 -14.60 27.65 17.88 -13.95 27.44 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA D 21 ALA~? 36.39 ZN ZN J2001 F 126 ARG D 14 ARG~? 40.72 ZN ZN B2003 F 138 GLU D 24 GLU~? 35.30 ZN ZN J2001 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -3.64 -31.02 -19.45 -3.85 -29.57 -19.10 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -4.91 -35.26 -22.64 -4.64 -37.30 -23.26 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA E 23 ALA~? 19.67 ZN ZN E2002 F 126 ARG J 80 ARG.? 22.24 ZN ZN E2002 F 138 GLU E 30 GLU^? 22.13 ZN ZN J2001 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 16.58 -9.86 -30.44 15.89 -10.90 -31.31 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 15.29 -10.38 -39.34 14.75 -7.48 -38.50 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 24.42 -14.74 -31.13 25.58 -16.52 -31.18 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA E 74 ALA^? 18.45 ZN ZN E2002 F 126 ARG E 45 ARG^? 19.39 ZN ZN E2002 F 138 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 33.20 -11.19 -19.37 33.16 -11.71 -20.77 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 29.50 -9.81 -28.77 30.55 -12.66 -29.14 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA G 23 ALA~? 19.48 ZN ZN G2004 F 126 ARG B 80 ARG.? 21.50 ZN ZN G2004 F 138 GLU G 30 GLU^? 22.02 ZN ZN B2003 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 31.15 -18.18 26.45 30.57 -19.27 27.34 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 32.12 -19.85 34.68 34.30 -17.68 34.59 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 22.93 -14.21 27.25 20.84 -13.89 27.07 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA G 74 ALA^? 18.58 ZN ZN G2004 F 126 ARG G 45 ARG^? 19.42 ZN ZN G2004 F 138 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 21.64 -4.56 15.34 21.18 -4.94 16.73 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 24.66 -6.90 24.79 21.69 -7.61 25.11 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA H 23 ALA~? 32.86 ZN ZN B2003 F 126 ARG C 80 ARG.? 36.99 ZN ZN B2003 F 138 GLU H 30 GLU^? 26.29 ZN ZN B2003 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 17.16 -46.07 16.52 16.70 -47.27 15.72 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 16.13 -52.20 20.46 17.69 -52.87 23.04 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 8.76 -43.18 14.57 6.72 -43.67 14.36 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 F 124 ALA I 74 ALA^? 31.19 ZN ZN J2001 F 126 ARG I 45 ARG^? 26.51 ZN ZN J2001 F 138 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 5.80 -40.70 -8.02 5.78 -41.01 -9.50 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 9.19 -47.86 -14.39 8.02 -46.02 -16.58 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 F 124 ALA J 23 ALA~? 19.58 ZN ZN J2001 F 126 ARG E 80 ARG.? 21.10 ZN ZN J2001 F 138 GLU J 30 GLU^? 21.96 ZN ZN E2002 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 39.46 -22.73 -25.55 40.41 -21.57 -25.51 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 46.22 -20.80 -30.79 45.58 -23.77 -31.33 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 33.28 -16.74 -28.58 31.82 -15.19 -28.83 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 F 124 ALA J 74 ALA^? 18.57 ZN ZN J2001 F 126 ARG J 45 ARG^? 19.30 ZN ZN J2001 F 138 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 19.54 -23.33 -26.22 20.33 -22.37 -27.09 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 27.80 -22.06 -31.67 26.75 -19.22 -31.33 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 15.39 -26.34 -33.01 16.88 -27.76 -33.58 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 12 GLY.? 16.77 ZN ZN E2002 B 175 ARG E 68 ARG^? 24.88 ZN ZN E2002 B 242 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo 99.45 58.28 3.33 99.57 58.61 4.10 13.30 -3.59 -12.73 12.78 -3.06 -12.48 coo 106.37 63.53 0.89 108.02 63.40 -1.62 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 100.93 69.04 4.38 99.52 68.48 2.09 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 19 GLY~? 15.01 ZN ZN E2002 B 175 ARG F 76 ARG^? 8.13 ZN ZN E2002 B 242 TYR A 32 TYR^? 15.05 ZN ZN E2002 coo 99.45 58.28 3.33 99.57 58.61 4.10 19.43 5.06 -8.24 18.81 5.59 -8.02 coo 106.37 63.53 0.89 108.02 63.40 -1.62 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 100.93 69.04 4.38 99.52 68.48 2.09 28.44 2.72 -8.58 30.61 4.34 -7.97 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 36 GLY.? 18.46 ZN ZN E2002 B 175 ARG E 68 ARG^? 24.88 ZN ZN E2002 B 242 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 99.45 58.28 3.33 99.57 58.61 4.10 25.01 -9.23 -10.02 24.42 -8.92 -10.43 coo 106.37 63.53 0.89 108.02 63.40 -1.62 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 12 GLY.? 29.28 ZN ZN B2003 B 175 ARG A 68 ARG^? 28.72 ZN ZN B2003 B 242 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 99.45 58.28 3.33 99.57 58.61 4.10 10.23 -2.77 3.74 9.49 -2.75 4.04 coo 106.37 63.53 0.89 108.02 63.40 -1.62 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 100.93 69.04 4.38 99.52 68.48 2.09 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 19 GLY~? 21.58 ZN ZN B2003 B 175 ARG G 76 ARG^? 28.48 ZN ZN G2004 B 242 TYR B 32 TYR^? 21.26 ZN ZN G2004 coo 99.45 58.28 3.33 99.57 58.61 4.10 9.50 -3.40 15.53 8.72 -3.14 15.65 coo 106.37 63.53 0.89 108.02 63.40 -1.62 15.16 1.90 14.98 12.60 3.57 14.85 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.09 -5.37 18.66 18.87 -5.22 21.34 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY B 36 GLY.? 22.00 ZN ZN G2004 B 175 ARG A 68 ARG^? 28.72 ZN ZN B2003 B 242 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo 99.45 58.28 3.33 99.57 58.61 4.10 21.59 -9.33 6.89 21.01 -8.79 6.78 coo 106.37 63.53 0.89 108.02 63.40 -1.62 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 100.93 69.04 4.38 99.52 68.48 2.09 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY C 12 GLY~? 16.92 ZN ZN B2003 B 175 ARG B 68 ARG^? 23.11 ZN ZN B2003 B 242 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 99.45 58.28 3.33 99.57 58.61 4.10 1.25 -16.50 8.28 0.53 -16.71 7.98 coo 106.37 63.53 0.89 108.02 63.40 -1.62 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 100.93 69.04 4.38 99.52 68.48 2.09 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY C 19 GLY~? 15.35 ZN ZN B2003 B 175 ARG H 76 ARG^? 8.16 ZN ZN B2003 B 242 TYR C 32 TYR^? 15.32 ZN ZN B2003 coo 99.45 58.28 3.33 99.57 58.61 4.10 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -1.06 -24.66 18.73 -3.81 -23.46 18.10 coo 100.93 69.04 4.38 99.52 68.48 2.09 3.47 -31.95 16.21 3.09 -34.42 17.45 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 9 3 # 9 B 137 GLY C 36 GLY.? 18.57 ZN ZN B2003 B 175 ARG B 68 ARG^? 23.11 ZN ZN B2003 B 242 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 99.45 58.28 3.33 99.57 58.61 4.10 12.11 -24.01 11.10 11.56 -23.46 11.17 coo 106.37 63.53 0.89 108.02 63.40 -1.62 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 100.93 69.04 4.38 99.52 68.48 2.09 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 10 3 # 10 B 137 GLY D 12 GLY.? 30.67 ZN ZN B2003 B 175 ARG C 68 ARG^? 29.54 ZN ZN B2003 B 242 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -1.47 -26.02 -5.45 -1.91 -25.74 -6.02 coo 106.37 63.53 0.89 108.02 63.40 -1.62 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 100.93 69.04 4.38 99.52 68.48 2.09 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 11 3 # 11 B 137 GLY D 19 GLY~? 34.83 ZN ZN J2001 B 175 ARG I 76 ARG^? 39.27 ZN ZN B2003 B 242 TYR D 32 TYR^? 29.54 ZN ZN J2001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -1.38 -32.89 -14.92 -2.03 -32.56 -15.32 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 coo 100.93 69.04 4.38 99.52 68.48 2.09 4.78 -40.18 -12.99 5.15 -42.55 -14.41 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 12 3 # 12 B 137 GLY D 36 GLY.? 32.57 ZN ZN B2003 B 175 ARG C 68 ARG^? 29.54 ZN ZN B2003 B 242 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 99.45 58.28 3.33 99.57 58.61 4.10 9.85 -32.90 -3.74 9.09 -32.64 -3.84 coo 106.37 63.53 0.89 108.02 63.40 -1.62 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 100.93 69.04 4.38 99.52 68.48 2.09 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 13 3 # 13 B 137 GLY E 12 GLY.? 29.18 ZN ZN E2002 B 175 ARG D 68 ARG^? 31.20 ZN ZN E2002 B 242 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 99.45 58.28 3.33 99.57 58.61 4.10 6.03 -17.90 -18.46 5.93 -17.12 -18.66 coo 106.37 63.53 0.89 108.02 63.40 -1.62 10.24 -20.71 -11.26 11.91 -20.64 -8.66 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 14 3 # 14 B 137 GLY E 19 GLY~? 21.67 ZN ZN E2002 B 175 ARG J 76 ARG^? 28.65 ZN ZN J2001 B 242 TYR E 32 TYR^? 21.25 ZN ZN J2001 coo 99.45 58.28 3.33 99.57 58.61 4.10 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo 106.37 63.53 0.89 108.02 63.40 -1.62 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 100.93 69.04 4.38 99.52 68.48 2.09 20.11 -18.94 -28.19 21.99 -18.75 -30.24 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 15 3 # 15 B 137 GLY E 36 GLY.? 22.06 ZN ZN J2001 B 175 ARG D 68 ARG^? 31.20 ZN ZN E2002 B 242 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo 99.45 58.28 3.33 99.57 58.61 4.10 17.76 -24.27 -16.69 17.02 -24.07 -16.89 coo 106.37 63.53 0.89 108.02 63.40 -1.62 10.24 -20.71 -11.26 11.91 -20.64 -8.66 coo 100.93 69.04 4.38 99.52 68.48 2.09 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 16 3 # 16 B 137 GLY F 12 GLY.? 16.71 ZN ZN G2004 B 175 ARG G 68 ARG^? 22.94 ZN ZN G2004 B 242 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo 99.45 58.28 3.33 99.57 58.61 4.10 38.22 -18.03 8.72 38.92 -18.19 8.48 coo 106.37 63.53 0.89 108.02 63.40 -1.62 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 100.93 69.04 4.38 99.52 68.48 2.09 31.03 -12.70 0.17 30.17 -14.19 -2.05 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 17 3 # 17 B 137 GLY F 19 GLY~? 15.06 ZN ZN G2004 B 175 ARG A 76 ARG^? 8.06 ZN ZN G2004 B 242 TYR F 32 TYR^? 15.23 ZN ZN G2004 coo 99.45 58.28 3.33 99.57 58.61 4.10 42.63 -8.41 4.21 43.39 -8.66 4.04 coo 106.37 63.53 0.89 108.02 63.40 -1.62 40.48 -5.18 11.11 43.34 -6.18 11.48 coo 100.93 69.04 4.38 99.52 68.48 2.09 36.01 -1.70 4.51 36.34 1.00 3.95 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 18 3 # 18 B 137 GLY F 36 GLY.? 18.56 ZN ZN G2004 B 175 ARG G 68 ARG^? 22.94 ZN ZN G2004 B 242 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 99.45 58.28 3.33 99.57 58.61 4.10 27.33 -10.66 6.03 27.95 -10.99 6.43 coo 106.37 63.53 0.89 108.02 63.40 -1.62 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 100.93 69.04 4.38 99.52 68.48 2.09 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 19 3 # 19 B 137 GLY G 12 GLY.? 29.13 ZN ZN G2004 B 175 ARG H 68 ARG^? 29.79 ZN ZN G2004 B 242 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 99.45 58.28 3.33 99.57 58.61 4.10 29.44 -31.51 14.55 30.18 -31.23 14.75 coo 106.37 63.53 0.89 108.02 63.40 -1.62 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 100.93 69.04 4.38 99.52 68.48 2.09 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 20 3 # 20 B 137 GLY G 19 GLY~? 21.50 ZN ZN G2004 B 175 ARG B 76 ARG^? 28.58 ZN ZN B2003 B 242 TYR G 32 TYR^? 21.21 ZN ZN B2003 coo 99.45 58.28 3.33 99.57 58.61 4.10 30.06 -23.20 23.00 30.85 -23.34 23.22 coo 106.37 63.53 0.89 108.02 63.40 -1.62 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 100.93 69.04 4.38 99.52 68.48 2.09 21.50 -19.82 24.15 20.71 -18.09 26.19 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 21 3 # 21 B 137 GLY G 36 GLY.? 21.99 ZN ZN B2003 B 175 ARG H 68 ARG^? 29.79 ZN ZN G2004 B 242 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 99.45 58.28 3.33 99.57 58.61 4.10 17.97 -24.43 12.71 18.50 -24.97 12.93 coo 106.37 63.53 0.89 108.02 63.40 -1.62 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 100.93 69.04 4.38 99.52 68.48 2.09 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 22 3 # 22 B 137 GLY H 12 GLY.? 30.71 ZN ZN J2001 B 175 ARG I 68 ARG^? 29.76 ZN ZN J2001 B 242 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 99.45 58.28 3.33 99.57 58.61 4.10 26.09 -42.02 1.53 26.51 -42.29 2.12 coo 106.37 63.53 0.89 108.02 63.40 -1.62 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 100.93 69.04 4.38 99.52 68.48 2.09 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 23 3 # 23 B 137 GLY H 19 GLY~? 34.96 ZN ZN B2003 B 175 ARG C 76 ARG^? 39.61 ZN ZN J2001 B 242 TYR H 32 TYR^? 29.55 ZN ZN B2003 coo 99.45 58.28 3.33 99.57 58.61 4.10 20.02 -45.41 10.65 20.57 -45.78 11.10 coo 106.37 63.53 0.89 108.02 63.40 -1.62 15.69 -49.41 6.25 17.68 -51.76 6.33 coo 100.93 69.04 4.38 99.52 68.48 2.09 10.73 -43.63 9.08 8.41 -44.48 10.38 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 24 3 # 24 B 137 GLY H 36 GLY.? 32.47 ZN ZN B2003 B 175 ARG I 68 ARG^? 29.76 ZN ZN J2001 B 242 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo 99.45 58.28 3.33 99.57 58.61 4.10 14.40 -35.53 -0.18 15.01 -36.05 -0.15 coo 106.37 63.53 0.89 108.02 63.40 -1.62 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 100.93 69.04 4.38 99.52 68.48 2.09 20.76 -33.59 -9.48 20.18 -32.83 -6.85 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 25 3 # 25 B 137 GLY I 12 GLY.? 16.89 ZN ZN J2001 B 175 ARG J 68 ARG^? 19.63 ZN ZN J2001 B 242 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo 99.45 58.28 3.33 99.57 58.61 4.10 33.08 -34.86 -12.28 33.22 -35.59 -11.99 coo 106.37 63.53 0.89 108.02 63.40 -1.62 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 100.93 69.04 4.38 99.52 68.48 2.09 20.76 -33.59 -9.48 20.18 -32.83 -6.85 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 26 3 # 26 B 137 GLY I 19 GLY~? 15.19 ZN ZN J2001 B 175 ARG D 76 ARG^? 8.12 ZN ZN J2001 B 242 TYR I 32 TYR^? 15.25 ZN ZN J2001 coo 99.45 58.28 3.33 99.57 58.61 4.10 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo 106.37 63.53 0.89 108.02 63.40 -1.62 27.03 -40.97 -22.65 29.39 -42.82 -22.15 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.53 -40.66 -20.20 16.59 -42.17 -21.51 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 27 3 # 27 B 137 GLY I 36 GLY.? 18.47 ZN ZN J2001 B 175 ARG J 68 ARG^? 19.63 ZN ZN J2001 B 242 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 99.45 58.28 3.33 99.57 58.61 4.10 21.13 -29.09 -15.26 21.86 -29.39 -15.29 coo 106.37 63.53 0.89 108.02 63.40 -1.62 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 100.93 69.04 4.38 99.52 68.48 2.09 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 28 3 # 28 B 137 GLY J 12 GLY.? 29.28 ZN ZN J2001 B 175 ARG F 68 ARG^? 28.83 ZN ZN J2001 B 242 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 99.45 58.28 3.33 99.57 58.61 4.10 40.43 -20.16 -7.78 40.79 -20.81 -8.06 coo 106.37 63.53 0.89 108.02 63.40 -1.62 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 100.93 69.04 4.38 99.52 68.48 2.09 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 29 3 # 29 B 137 GLY J 19 GLY~? 21.52 ZN ZN J2001 B 175 ARG E 76 ARG^? 28.35 ZN ZN E2002 B 242 TYR J 32 TYR^? 21.12 ZN ZN E2002 coo 99.45 58.28 3.33 99.57 58.61 4.10 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo 106.37 63.53 0.89 108.02 63.40 -1.62 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 100.93 69.04 4.38 99.52 68.48 2.09 34.34 -14.57 -22.60 34.05 -13.83 -25.28 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 30 3 # 30 B 137 GLY J 36 GLY.? 21.93 ZN ZN E2002 B 175 ARG F 68 ARG^? 28.83 ZN ZN J2001 B 242 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo 99.45 58.28 3.33 99.57 58.61 4.10 29.00 -13.68 -10.93 29.75 -13.88 -10.77 coo 106.37 63.53 0.89 108.02 63.40 -1.62 32.78 -19.96 -4.34 30.63 -22.19 -4.53 coo 100.93 69.04 4.38 99.52 68.48 2.09 31.03 -12.70 0.17 30.17 -14.19 -2.05 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 30 hits 1xva_c03 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 48 ASP~? 19.05 ZN ZN G2004 219 GLU A 50 GLU~? 17.52 ZN ZN G2004 294 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.93 6.24 15.37 25.45 7.75 15.31 coo 25.84 105.87 9.06 27.86 105.55 8.74 22.23 3.81 17.00 24.22 3.69 17.74 coo 33.16 106.80 7.72 33.34 104.87 6.92 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 48 ASP~? 19.05 ZN ZN G2004 219 GLU A 51 GLU~? 22.57 ZN ZN G2004 294 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.93 6.24 15.37 25.45 7.75 15.31 coo 25.84 105.87 9.06 27.86 105.55 8.74 23.15 8.42 10.27 24.62 9.66 9.42 coo 33.16 106.80 7.72 33.34 104.87 6.92 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 53 ASP~? 26.24 ZN ZN G2004 219 GLU A 50 GLU~? 17.52 ZN ZN G2004 294 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 17.64 3.84 11.72 15.55 3.44 11.90 coo 25.84 105.87 9.06 27.86 105.55 8.74 22.23 3.81 17.00 24.22 3.69 17.74 coo 33.16 106.80 7.72 33.34 104.87 6.92 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 53 ASP~? 26.24 ZN ZN G2004 219 GLU A 51 GLU~? 22.57 ZN ZN G2004 294 ASP A 48 ASP~? 19.05 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 17.64 3.84 11.72 15.55 3.44 11.90 coo 25.84 105.87 9.06 27.86 105.55 8.74 23.15 8.42 10.27 24.62 9.66 9.42 coo 33.16 106.80 7.72 33.34 104.87 6.92 26.93 6.24 15.37 25.45 7.75 15.31 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 48 ASP~? 8.81 ZN ZN B2003 219 GLU B 50 GLU~? -2.41 ZN ZN B2003s 294 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 27.89 102.52 14.98 29.35 101.92 13.57 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 25.84 105.87 9.06 27.86 105.55 8.74 2.06 -23.31 25.35 0.50 -22.72 24.07 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP C 48 ASP~? 37.52 ZN ZN B2003 219 GLU C 50 GLU~? 38.46 ZN ZN J2001 294 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 25.84 105.87 9.06 27.86 105.55 8.74 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 coo 33.16 106.80 7.72 33.34 104.87 6.92 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP C 48 ASP~? 37.52 ZN ZN B2003 219 GLU C 51 GLU~? 32.75 ZN ZN B2003 294 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 25.84 105.87 9.06 27.86 105.55 8.74 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 33.16 106.80 7.72 33.34 104.87 6.92 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP C 53 ASP~? 35.43 ZN ZN B2003 219 GLU C 51 GLU~? 32.75 ZN ZN B2003 294 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 25.84 105.87 9.06 27.86 105.55 8.74 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 33.16 106.80 7.72 33.34 104.87 6.92 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP D 48 ASP.? 19.00 ZN ZN J2001 219 GLU D 50 GLU.? 17.54 ZN ZN J2001 294 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 25.84 105.87 9.06 27.86 105.55 8.74 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 33.16 106.80 7.72 33.34 104.87 6.92 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP D 48 ASP.? 19.00 ZN ZN J2001 219 GLU D 51 GLU~? 22.34 ZN ZN J2001 294 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 25.84 105.87 9.06 27.86 105.55 8.74 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP D 53 ASP~? 26.48 ZN ZN J2001 219 GLU D 50 GLU.? 17.54 ZN ZN J2001 294 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 25.84 105.87 9.06 27.86 105.55 8.74 15.39 -26.34 -33.01 16.88 -27.76 -33.58 coo 33.16 106.80 7.72 33.34 104.87 6.92 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP D 53 ASP~? 26.48 ZN ZN J2001 219 GLU D 51 GLU~? 22.34 ZN ZN J2001 294 ASP D 48 ASP.? 19.00 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 25.84 105.87 9.06 27.86 105.55 8.74 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 15.19 -31.94 -33.41 13.49 -31.02 -34.27 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP E 48 ASP~? 8.41 ZN ZN E2002 219 GLU E 50 GLU~? -2.01 ZN ZN E2002s 294 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 27.89 102.52 14.98 29.35 101.92 13.57 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 25.84 105.87 9.06 27.86 105.55 8.74 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP E 54 ASP~? -2.11 ZN ZN E2002s 219 GLU E 50 GLU~? -2.01 ZN ZN E2002s 294 ASP E 48 ASP~? 8.41 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 25.84 105.87 9.06 27.86 105.55 8.74 27.40 4.08 -19.70 26.14 4.32 -21.40 coo 33.16 106.80 7.72 33.34 104.87 6.92 31.72 1.73 -23.06 32.51 2.58 -21.24 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP F 48 ASP.? 18.92 ZN ZN E2002 219 GLU F 50 GLU.? 17.33 ZN ZN E2002 294 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 25.84 105.87 9.06 27.86 105.55 8.74 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 33.16 106.80 7.72 33.34 104.87 6.92 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP F 48 ASP.? 18.92 ZN ZN E2002 219 GLU F 51 GLU~? 22.25 ZN ZN E2002 294 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 25.84 105.87 9.06 27.86 105.55 8.74 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 33.16 106.80 7.72 33.34 104.87 6.92 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP F 53 ASP~? 26.13 ZN ZN E2002 219 GLU F 50 GLU.? 17.33 ZN ZN E2002 294 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 25.84 105.87 9.06 27.86 105.55 8.74 40.13 -6.47 -21.09 39.03 -4.82 -21.88 coo 33.16 106.80 7.72 33.34 104.87 6.92 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 18 3 # 18 193 ASP F 53 ASP~? 26.13 ZN ZN E2002 219 GLU F 51 GLU~? 22.25 ZN ZN E2002 294 ASP F 48 ASP.? 18.92 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 25.84 105.87 9.06 27.86 105.55 8.74 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 33.16 106.80 7.72 33.34 104.87 6.92 39.90 -1.26 -19.29 41.88 -2.04 -19.24 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 19 3 # 19 193 ASP G 48 ASP~? 8.81 ZN ZN G2004 219 GLU G 51 GLU~? 6.79 ZN ZN G2004 294 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 33.55 0.62 19.07 33.72 1.88 17.35 coo 25.84 105.87 9.06 27.86 105.55 8.74 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 33.16 106.80 7.72 33.34 104.87 6.92 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 20 3 # 20 193 ASP G 53 ASP~? 4.94 ZN ZN G2004 219 GLU G 51 GLU~? 6.79 ZN ZN G2004 294 ASP G 48 ASP~? 8.81 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 25.84 105.87 9.06 27.86 105.55 8.74 34.98 -4.76 20.96 34.28 -3.47 22.45 coo 33.16 106.80 7.72 33.34 104.87 6.92 33.55 0.62 19.07 33.72 1.88 17.35 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 21 3 # 21 193 ASP H 48 ASP.? 18.83 ZN ZN B2003 219 GLU H 50 GLU.? 17.57 ZN ZN B2003 294 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 25.84 105.87 9.06 27.86 105.55 8.74 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 22 3 # 22 193 ASP H 48 ASP.? 18.83 ZN ZN B2003 219 GLU H 51 GLU~? 22.00 ZN ZN B2003 294 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 25.84 105.87 9.06 27.86 105.55 8.74 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 23 3 # 23 193 ASP H 53 ASP~? 26.49 ZN ZN B2003 219 GLU H 50 GLU.? 17.57 ZN ZN B2003 294 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 25.84 105.87 9.06 27.86 105.55 8.74 17.55 -27.49 28.97 15.58 -26.87 29.52 coo 33.16 106.80 7.72 33.34 104.87 6.92 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 24 3 # 24 193 ASP H 53 ASP~? 26.49 ZN ZN B2003 219 GLU H 51 GLU~? 22.00 ZN ZN B2003 294 ASP H 48 ASP.? 18.83 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 25.84 105.87 9.06 27.86 105.55 8.74 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 33.16 106.80 7.72 33.34 104.87 6.92 12.54 -30.52 29.41 14.40 -31.25 30.10 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 25 3 # 25 193 ASP I 48 ASP~? 38.35 ZN ZN J2001 219 GLU I 50 GLU~? 38.38 ZN ZN B2003 294 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 25.84 105.87 9.06 27.86 105.55 8.74 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 33.16 106.80 7.72 33.34 104.87 6.92 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 26 3 # 26 193 ASP I 48 ASP~? 38.35 ZN ZN J2001 219 GLU I 50 GLU~? 38.38 ZN ZN B2003 294 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 25.84 105.87 9.06 27.86 105.55 8.74 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 33.16 106.80 7.72 33.34 104.87 6.92 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 27 3 # 27 193 ASP I 48 ASP~? 38.35 ZN ZN J2001 219 GLU I 51 GLU~? 32.52 ZN ZN J2001 294 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 25.84 105.87 9.06 27.86 105.55 8.74 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 28 3 # 28 193 ASP I 53 ASP~? 35.51 ZN ZN J2001 219 GLU I 50 GLU~? 38.38 ZN ZN B2003 294 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 25.84 105.87 9.06 27.86 105.55 8.74 9.27 -51.61 2.10 7.43 -50.53 2.04 coo 33.16 106.80 7.72 33.34 104.87 6.92 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 29 3 # 29 193 ASP I 53 ASP~? 35.51 ZN ZN J2001 219 GLU I 51 GLU~? 32.52 ZN ZN J2001 294 ASP I 48 ASP~? 38.35 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 25.84 105.87 9.06 27.86 105.55 8.74 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 6.36 -52.06 -2.59 7.56 -53.72 -1.99 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 30 3 # 30 193 ASP J 48 ASP~? 8.01 ZN ZN J2001 219 GLU J 50 GLU~? -2.50 ZN ZN J2001s 294 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 27.89 102.52 14.98 29.35 101.92 13.57 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 25.84 105.87 9.06 27.86 105.55 8.74 26.62 -37.54 -29.35 27.87 -38.52 -28.01 coo 33.16 106.80 7.72 33.34 104.87 6.92 32.59 -34.93 -27.29 32.02 -36.71 -28.24 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 30 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 39 ASP.? 16.23 ZN ZN E2002 231 ASP F 53 ASP~? 26.13 ZN ZN E2002 294 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 14.74 93.05 -1.00 14.30 94.22 0.73 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 39 ASP.? 16.23 ZN ZN E2002 231 ASP J 39 ASP.? 27.27 ZN ZN J2001 294 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 14.74 93.05 -1.00 14.30 94.22 0.73 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 33.16 106.80 7.72 33.34 104.87 6.92 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 48 ASP~? 19.05 ZN ZN G2004 231 ASP F 39 ASP.? 16.21 ZN ZN G2004 294 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.93 6.24 15.37 25.45 7.75 15.31 coo 14.74 93.05 -1.00 14.30 94.22 0.73 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 33.16 106.80 7.72 33.34 104.87 6.92 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 48 ASP~? 19.05 ZN ZN G2004 231 ASP F 39 ASP.? 16.21 ZN ZN G2004 294 ASP A 54 ASP~? 25.58 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.93 6.24 15.37 25.45 7.75 15.31 coo 14.74 93.05 -1.00 14.30 94.22 0.73 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 33.16 106.80 7.72 33.34 104.87 6.92 19.11 8.17 8.99 18.99 8.60 11.06 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 53 ASP~? 26.24 ZN ZN G2004 231 ASP G 53 ASP~? 4.94 ZN ZN G2004 294 ASP B 39 ASP.? 27.28 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 17.64 3.84 11.72 15.55 3.44 11.90 coo 14.74 93.05 -1.00 14.30 94.22 0.73 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 33.16 106.80 7.72 33.34 104.87 6.92 14.11 -6.67 8.34 14.38 -6.43 6.26 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 39 ASP.? 27.28 ZN ZN B2003 231 ASP F 39 ASP.? 16.21 ZN ZN G2004 294 ASP A 53 ASP~? 26.24 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 14.74 93.05 -1.00 14.30 94.22 0.73 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 33.16 106.80 7.72 33.34 104.87 6.92 17.64 3.84 11.72 15.55 3.44 11.90 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP B 48 ASP~? 8.81 ZN ZN B2003 231 ASP G 39 ASP.? 27.24 ZN ZN G2004 294 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 14.74 93.05 -1.00 14.30 94.22 0.73 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP B 48 ASP~? 8.81 ZN ZN B2003 231 ASP G 39 ASP.? 27.24 ZN ZN G2004 294 ASP B 54 ASP~? -2.43 ZN ZN B2003s coo 27.89 102.52 14.98 29.35 101.92 13.57 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 14.74 93.05 -1.00 14.30 94.22 0.73 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.40 -16.75 23.23 0.16 -18.07 24.23 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP B 53 ASP~? 5.10 ZN ZN B2003 231 ASP H 53 ASP~? 26.49 ZN ZN B2003 294 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 14.74 93.05 -1.00 14.30 94.22 0.73 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 33.16 106.80 7.72 33.34 104.87 6.92 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP B 53 ASP~? 5.10 ZN ZN B2003 231 ASP H 54 ASP~? 25.78 ZN ZN B2003 294 ASP C 39 ASP.? 16.40 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 14.74 93.05 -1.00 14.30 94.22 0.73 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 4.44 -22.79 9.98 5.37 -21.07 9.21 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP C 39 ASP.? 16.40 ZN ZN B2003 231 ASP G 39 ASP.? 27.24 ZN ZN G2004 294 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 14.74 93.05 -1.00 14.30 94.22 0.73 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP C 39 ASP.? 16.40 ZN ZN B2003 231 ASP H 53 ASP~? 26.49 ZN ZN B2003 294 ASP B 53 ASP~? 5.10 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 14.74 93.05 -1.00 14.30 94.22 0.73 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.23 -21.28 20.51 -0.75 -21.23 19.69 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP C 48 ASP~? 37.52 ZN ZN B2003 231 ASP H 39 ASP.? 32.15 ZN ZN J2001 294 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 33.16 106.80 7.72 33.34 104.87 6.92 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP C 48 ASP~? 37.52 ZN ZN B2003 231 ASP H 39 ASP.? 32.15 ZN ZN J2001 294 ASP C 54 ASP~? 34.22 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 33.16 106.80 7.72 33.34 104.87 6.92 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP C 53 ASP~? 35.43 ZN ZN B2003 231 ASP H 39 ASP.? 32.15 ZN ZN J2001 294 ASP C 48 ASP~? 37.52 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 33.16 106.80 7.72 33.34 104.87 6.92 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP C 53 ASP~? 35.43 ZN ZN B2003 231 ASP I 53 ASP~? 35.51 ZN ZN J2001 294 ASP D 39 ASP.? 32.27 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 14.74 93.05 -1.00 14.30 94.22 0.73 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 33.16 106.80 7.72 33.34 104.87 6.92 3.81 -30.41 -7.79 4.09 -29.17 -6.11 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP D 39 ASP.? 32.27 ZN ZN B2003 231 ASP H 39 ASP.? 32.15 ZN ZN J2001 294 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 33.16 106.80 7.72 33.34 104.87 6.92 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 18 3 # 18 193 ASP D 39 ASP.? 32.27 ZN ZN B2003 231 ASP I 53 ASP~? 35.51 ZN ZN J2001 294 ASP C 53 ASP~? 35.43 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 14.74 93.05 -1.00 14.30 94.22 0.73 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 33.16 106.80 7.72 33.34 104.87 6.92 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 19 3 # 19 193 ASP D 48 ASP.? 19.00 ZN ZN J2001 231 ASP I 39 ASP.? 16.30 ZN ZN J2001 294 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 33.16 106.80 7.72 33.34 104.87 6.92 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 20 3 # 20 193 ASP D 48 ASP.? 19.00 ZN ZN J2001 231 ASP I 39 ASP.? 16.30 ZN ZN J2001 294 ASP D 54 ASP~? 25.75 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 33.16 106.80 7.72 33.34 104.87 6.92 6.44 -27.97 -29.88 7.08 -27.17 -31.74 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 21 3 # 21 193 ASP D 53 ASP~? 26.48 ZN ZN J2001 231 ASP J 53 ASP~? 5.09 ZN ZN J2001 294 ASP E 39 ASP.? 27.23 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 14.74 93.05 -1.00 14.30 94.22 0.73 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 33.16 106.80 7.72 33.34 104.87 6.92 13.06 -18.68 -19.48 12.16 -19.44 -17.76 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 22 3 # 22 193 ASP E 39 ASP.? 27.23 ZN ZN E2002 231 ASP I 39 ASP.? 16.30 ZN ZN J2001 294 ASP D 53 ASP~? 26.48 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 14.74 93.05 -1.00 14.30 94.22 0.73 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 33.16 106.80 7.72 33.34 104.87 6.92 10.06 -24.15 -28.86 8.79 -22.48 -29.14 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 23 3 # 23 193 ASP E 48 ASP~? 8.41 ZN ZN E2002 231 ASP J 39 ASP.? 27.27 ZN ZN J2001 294 ASP E 53 ASP~? 5.07 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 33.16 106.80 7.72 33.34 104.87 6.92 23.14 2.30 -18.88 21.70 3.71 -18.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 24 3 # 24 193 ASP E 48 ASP~? 8.41 ZN ZN E2002 231 ASP J 39 ASP.? 27.27 ZN ZN J2001 294 ASP E 54 ASP~? -2.11 ZN ZN E2002s coo 27.89 102.52 14.98 29.35 101.92 13.57 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.00 1.44 -23.80 22.91 3.31 -23.38 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 25 3 # 25 193 ASP E 53 ASP~? 5.07 ZN ZN E2002 231 ASP F 53 ASP~? 26.13 ZN ZN E2002 294 ASP A 39 ASP.? 16.23 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 19.72 -3.56 -10.13 18.70 -5.29 -10.73 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 26 3 # 26 193 ASP F 39 ASP.? 16.21 ZN ZN G2004 231 ASP A 53 ASP~? 26.24 ZN ZN G2004 294 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 14.74 93.05 -1.00 14.30 94.22 0.73 17.64 3.84 11.72 15.55 3.44 11.90 coo 33.16 106.80 7.72 33.34 104.87 6.92 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 27 3 # 27 193 ASP F 39 ASP.? 16.21 ZN ZN G2004 231 ASP B 39 ASP.? 27.28 ZN ZN B2003 294 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 14.74 93.05 -1.00 14.30 94.22 0.73 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 33.16 106.80 7.72 33.34 104.87 6.92 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 28 3 # 28 193 ASP F 48 ASP.? 18.92 ZN ZN E2002 231 ASP A 39 ASP.? 16.23 ZN ZN E2002 294 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 33.16 106.80 7.72 33.34 104.87 6.92 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 29 3 # 29 193 ASP F 48 ASP.? 18.92 ZN ZN E2002 231 ASP A 39 ASP.? 16.23 ZN ZN E2002 294 ASP F 54 ASP~? 25.15 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 33.16 106.80 7.72 33.34 104.87 6.92 45.65 -7.17 -13.11 45.66 -6.91 -15.22 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 30 3 # 30 193 ASP F 53 ASP~? 26.13 ZN ZN E2002 231 ASP E 53 ASP~? 5.07 ZN ZN E2002 294 ASP J 39 ASP.? 27.27 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo 14.74 93.05 -1.00 14.30 94.22 0.73 23.14 2.30 -18.88 21.70 3.71 -18.16 coo 33.16 106.80 7.72 33.34 104.87 6.92 35.13 -18.57 -12.25 34.79 -18.46 -10.18 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 31 3 # 31 193 ASP G 39 ASP.? 27.24 ZN ZN G2004 231 ASP C 39 ASP.? 16.40 ZN ZN B2003 294 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 14.74 93.05 -1.00 14.30 94.22 0.73 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 32 3 # 32 193 ASP G 48 ASP~? 8.81 ZN ZN G2004 231 ASP B 39 ASP.? 27.28 ZN ZN B2003 294 ASP G 53 ASP~? 4.94 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 33.55 0.62 19.07 33.72 1.88 17.35 coo 14.74 93.05 -1.00 14.30 94.22 0.73 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 33.16 106.80 7.72 33.34 104.87 6.92 38.40 -6.52 14.99 40.34 -7.05 14.26 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 33 3 # 33 193 ASP G 53 ASP~? 4.94 ZN ZN G2004 231 ASP A 53 ASP~? 26.24 ZN ZN G2004 294 ASP F 39 ASP.? 16.21 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 38.40 -6.52 14.99 40.34 -7.05 14.26 coo 14.74 93.05 -1.00 14.30 94.22 0.73 17.64 3.84 11.72 15.55 3.44 11.90 coo 33.16 106.80 7.72 33.34 104.87 6.92 35.01 -12.42 6.08 34.01 -14.14 6.70 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 34 3 # 34 193 ASP H 39 ASP.? 32.15 ZN ZN J2001 231 ASP C 53 ASP~? 35.43 ZN ZN B2003 294 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 35 3 # 35 193 ASP H 39 ASP.? 32.15 ZN ZN J2001 231 ASP D 39 ASP.? 32.27 ZN ZN B2003 294 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 14.74 93.05 -1.00 14.30 94.22 0.73 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 33.16 106.80 7.72 33.34 104.87 6.92 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 36 3 # 36 193 ASP H 48 ASP.? 18.83 ZN ZN B2003 231 ASP C 39 ASP.? 16.40 ZN ZN B2003 294 ASP H 53 ASP~? 26.49 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 14.74 93.05 -1.00 14.30 94.22 0.73 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.01 -31.06 24.97 24.10 -31.35 25.29 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 37 3 # 37 193 ASP H 48 ASP.? 18.83 ZN ZN B2003 231 ASP C 39 ASP.? 16.40 ZN ZN B2003 294 ASP H 54 ASP~? 25.78 ZN ZN B2003 coo 27.89 102.52 14.98 29.35 101.92 13.57 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 14.74 93.05 -1.00 14.30 94.22 0.73 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 20.28 -36.09 25.85 20.67 -35.47 27.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 38 3 # 38 193 ASP H 53 ASP~? 26.49 ZN ZN B2003 231 ASP B 53 ASP~? 5.10 ZN ZN B2003 294 ASP G 39 ASP.? 27.24 ZN ZN G2004 coo 27.89 102.52 14.98 29.35 101.92 13.57 22.01 -31.06 24.97 24.10 -31.35 25.29 coo 14.74 93.05 -1.00 14.30 94.22 0.73 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo 33.16 106.80 7.72 33.34 104.87 6.92 25.21 -25.73 15.58 24.96 -27.01 13.97 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 39 3 # 39 193 ASP I 39 ASP.? 16.30 ZN ZN J2001 231 ASP D 53 ASP~? 26.48 ZN ZN J2001 294 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 14.74 93.05 -1.00 14.30 94.22 0.73 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 40 3 # 40 193 ASP I 39 ASP.? 16.30 ZN ZN J2001 231 ASP E 39 ASP.? 27.23 ZN ZN E2002 294 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 14.74 93.05 -1.00 14.30 94.22 0.73 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 41 3 # 41 193 ASP I 48 ASP~? 38.35 ZN ZN J2001 231 ASP D 39 ASP.? 32.27 ZN ZN B2003 294 ASP I 53 ASP~? 35.51 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 14.74 93.05 -1.00 14.30 94.22 0.73 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 33.16 106.80 7.72 33.34 104.87 6.92 15.88 -49.61 0.98 17.43 -49.51 2.42 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 42 3 # 42 193 ASP I 48 ASP~? 38.35 ZN ZN J2001 231 ASP D 39 ASP.? 32.27 ZN ZN B2003 294 ASP I 54 ASP~? 33.46 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 14.74 93.05 -1.00 14.30 94.22 0.73 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 33.16 106.80 7.72 33.34 104.87 6.92 17.18 -52.79 -3.01 18.10 -54.51 -2.17 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 43 3 # 43 193 ASP I 53 ASP~? 35.51 ZN ZN J2001 231 ASP C 53 ASP~? 35.43 ZN ZN B2003 294 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 44 3 # 44 193 ASP I 53 ASP~? 35.51 ZN ZN J2001 231 ASP C 54 ASP~? 34.22 ZN ZN B2003 294 ASP H 39 ASP.? 32.15 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.88 -49.61 0.98 17.43 -49.51 2.42 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 33.16 106.80 7.72 33.34 104.87 6.92 19.73 -39.62 3.70 20.63 -38.69 2.04 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 45 3 # 45 193 ASP J 39 ASP.? 27.27 ZN ZN J2001 231 ASP A 39 ASP.? 16.23 ZN ZN E2002 294 ASP F 53 ASP~? 26.13 ZN ZN E2002 coo 27.89 102.52 14.98 29.35 101.92 13.57 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 33.16 106.80 7.72 33.34 104.87 6.92 42.45 -10.50 -15.74 43.20 -12.48 -15.86 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 46 3 # 46 193 ASP J 48 ASP~? 8.01 ZN ZN J2001 231 ASP E 39 ASP.? 27.23 ZN ZN E2002 294 ASP J 53 ASP~? 5.09 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 14.74 93.05 -1.00 14.30 94.22 0.73 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 28.87 -37.23 -24.52 29.85 -38.89 -23.63 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 47 3 # 47 193 ASP J 48 ASP~? 8.01 ZN ZN J2001 231 ASP E 39 ASP.? 27.23 ZN ZN E2002 294 ASP J 54 ASP~? -2.24 ZN ZN J2001s coo 27.89 102.52 14.98 29.35 101.92 13.57 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 14.74 93.05 -1.00 14.30 94.22 0.73 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 32.59 -34.93 -27.29 32.02 -36.71 -28.24 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 48 3 # 48 193 ASP J 53 ASP~? 5.09 ZN ZN J2001 231 ASP D 53 ASP~? 26.48 ZN ZN J2001 294 ASP I 39 ASP.? 16.30 ZN ZN J2001 coo 27.89 102.52 14.98 29.35 101.92 13.57 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo 14.74 93.05 -1.00 14.30 94.22 0.73 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 26.01 -35.27 -13.87 27.04 -33.54 -13.28 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 48 hits 2amg_c06 naa= 3 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 1 3 # 1 105 GLU A 51 GLU~? 22.57 ZN ZN G2004 107 ASP A 48 ASP~? 19.05 ZN ZN G2004 109 GLU A 50 GLU~? 17.52 ZN ZN G2004 coo 15.97 13.58 10.29 15.12 15.36 9.48 23.15 8.42 10.27 24.62 9.66 9.42 coo 20.07 16.34 11.47 18.03 16.15 11.04 26.93 6.24 15.37 25.45 7.75 15.31 coo 20.99 19.84 9.56 19.07 20.34 10.22 22.23 3.81 17.00 24.22 3.69 17.74 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 2 3 # 2 105 GLU C 51 GLU~? 32.75 ZN ZN B2003 107 ASP C 48 ASP~? 37.52 ZN ZN B2003 109 GLU C 50 GLU~? 38.46 ZN ZN J2001 coo 15.97 13.58 10.29 15.12 15.36 9.48 -4.31 -42.77 0.97 -4.72 -44.13 2.55 coo 20.07 16.34 11.47 18.03 16.15 11.04 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 20.99 19.84 9.56 19.07 20.34 10.22 -1.22 -45.28 -6.26 0.34 -46.73 -6.05 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 3 3 # 3 105 GLU D 51 GLU~? 22.34 ZN ZN J2001 107 ASP D 48 ASP.? 19.00 ZN ZN J2001 109 GLU D 50 GLU.? 17.54 ZN ZN J2001 coo 15.97 13.58 10.29 15.12 15.36 9.48 8.97 -31.18 -30.90 8.55 -33.28 -31.15 coo 20.07 16.34 11.47 18.03 16.15 11.04 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 20.99 19.84 9.56 19.07 20.34 10.22 15.39 -26.34 -33.01 16.88 -27.76 -33.58 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 4 3 # 4 105 GLU F 51 GLU~? 22.25 ZN ZN E2002 107 ASP F 48 ASP.? 18.92 ZN ZN E2002 109 GLU F 50 GLU.? 17.33 ZN ZN E2002 coo 15.97 13.58 10.29 15.12 15.36 9.48 43.48 -3.42 -14.09 43.92 -1.45 -13.50 coo 20.07 16.34 11.47 18.03 16.15 11.04 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 20.99 19.84 9.56 19.07 20.34 10.22 40.13 -6.47 -21.09 39.03 -4.82 -21.88 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 5 3 # 5 105 GLU H 51 GLU~? 22.00 ZN ZN B2003 107 ASP H 48 ASP.? 18.83 ZN ZN B2003 109 GLU H 50 GLU.? 17.57 ZN ZN B2003 coo 15.97 13.58 10.29 15.12 15.36 9.48 16.31 -35.44 26.90 14.59 -36.70 27.16 coo 20.07 16.34 11.47 18.03 16.15 11.04 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 20.99 19.84 9.56 19.07 20.34 10.22 17.55 -27.49 28.97 15.58 -26.87 29.52 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 6 3 # 6 105 GLU I 51 GLU~? 32.52 ZN ZN J2001 107 ASP I 48 ASP~? 38.35 ZN ZN J2001 109 GLU I 50 GLU~? 38.38 ZN ZN B2003 coo 15.97 13.58 10.29 15.12 15.36 9.48 12.78 -53.14 -4.97 11.98 -53.78 -6.83 coo 20.07 16.34 11.47 18.03 16.15 11.04 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 20.99 19.84 9.56 19.07 20.34 10.22 9.27 -51.61 2.10 7.43 -50.53 2.04 2ayh_c00 source 2ayh 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROLASE (E.C.: 6 hits 2ayh_c00 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 9 ARG^? 24.21 ZN ZN E2002 A 161 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 174 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 9 ARG^? 24.21 ZN ZN E2002 A 161 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 174 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG B 9 ARG^? 25.60 ZN ZN B2003 A 161 ASP C 39 ASP.? 16.40 ZN ZN B2003 A 174 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 12.25 -11.70 3.79 14.09 -14.14 4.30 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG C 9 ARG^? 24.24 ZN ZN B2003 A 161 ASP B 39 ASP.? 27.28 ZN ZN B2003 A 174 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG C 9 ARG^? 24.24 ZN ZN B2003 A 161 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 174 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG D 9 ARG^? 32.06 ZN ZN J2001 A 161 ASP E 39 ASP.? 27.23 ZN ZN E2002 A 174 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 161 ASP A 39 ASP.? 16.23 ZN ZN E2002 A 174 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 161 ASP D 39 ASP.? 32.27 ZN ZN B2003 A 174 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG F 9 ARG^? 24.10 ZN ZN G2004 A 161 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 174 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 10 3 # 10 A 14 ARG F 9 ARG^? 24.10 ZN ZN G2004 A 161 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 174 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 11 3 # 11 A 14 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 161 ASP F 39 ASP.? 16.21 ZN ZN G2004 A 174 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 31.03 -12.70 0.17 30.17 -14.19 -2.05 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 12 3 # 12 A 14 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 161 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 174 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 13 3 # 13 A 14 ARG H 9 ARG^? 32.17 ZN ZN B2003 A 161 ASP G 39 ASP.? 27.24 ZN ZN G2004 A 174 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 14 3 # 14 A 14 ARG I 9 ARG^? 24.03 ZN ZN J2001 A 161 ASP H 39 ASP.? 32.15 ZN ZN J2001 A 174 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 15 3 # 15 A 14 ARG I 9 ARG^? 24.03 ZN ZN J2001 A 161 ASP J 39 ASP.? 27.27 ZN ZN J2001 A 174 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 16 3 # 16 A 14 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 161 ASP I 39 ASP.? 16.30 ZN ZN J2001 A 174 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 20.76 -33.59 -9.48 20.18 -32.83 -6.85 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 16 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 9 ARG^? 24.21 ZN ZN E2002 B 161 ASP B 39 ASP.? 27.28 ZN ZN B2003 B 174 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo -14.86 10.19 8.14 -14.82 12.31 8.42 14.11 -6.67 8.34 14.38 -6.43 6.26 coo -21.46 12.70 8.53 -19.04 12.30 7.24 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 9 ARG^? 24.21 ZN ZN E2002 B 161 ASP E 39 ASP.? 27.23 ZN ZN E2002 B 174 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo -14.86 10.19 8.14 -14.82 12.31 8.42 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo -21.46 12.70 8.53 -19.04 12.30 7.24 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG B 9 ARG^? 25.60 ZN ZN B2003 B 161 ASP C 39 ASP.? 16.40 ZN ZN B2003 B 174 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 12.25 -11.70 3.79 14.09 -14.14 4.30 coo -14.86 10.19 8.14 -14.82 12.31 8.42 4.44 -22.79 9.98 5.37 -21.07 9.21 coo -21.46 12.70 8.53 -19.04 12.30 7.24 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG C 9 ARG^? 24.24 ZN ZN B2003 B 161 ASP B 39 ASP.? 27.28 ZN ZN B2003 B 174 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -14.86 10.19 8.14 -14.82 12.31 8.42 14.11 -6.67 8.34 14.38 -6.43 6.26 coo -21.46 12.70 8.53 -19.04 12.30 7.24 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG C 9 ARG^? 24.24 ZN ZN B2003 B 161 ASP D 39 ASP.? 32.27 ZN ZN B2003 B 174 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -14.86 10.19 8.14 -14.82 12.31 8.42 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo -21.46 12.70 8.53 -19.04 12.30 7.24 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG D 9 ARG^? 32.06 ZN ZN J2001 B 161 ASP E 39 ASP.? 27.23 ZN ZN E2002 B 174 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo -14.86 10.19 8.14 -14.82 12.31 8.42 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo -21.46 12.70 8.53 -19.04 12.30 7.24 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG E 9 ARG^? 26.78 ZN ZN E2002 B 161 ASP A 39 ASP.? 16.23 ZN ZN E2002 B 174 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo -14.86 10.19 8.14 -14.82 12.31 8.42 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo -21.46 12.70 8.53 -19.04 12.30 7.24 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG E 9 ARG^? 26.78 ZN ZN E2002 B 161 ASP D 39 ASP.? 32.27 ZN ZN B2003 B 174 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo -14.86 10.19 8.14 -14.82 12.31 8.42 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo -21.46 12.70 8.53 -19.04 12.30 7.24 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG F 9 ARG^? 24.10 ZN ZN G2004 B 161 ASP G 39 ASP.? 27.24 ZN ZN G2004 B 174 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 32.42 -18.19 2.00 30.08 -17.10 0.27 coo -14.86 10.19 8.14 -14.82 12.31 8.42 25.21 -25.73 15.58 24.96 -27.01 13.97 coo -21.46 12.70 8.53 -19.04 12.30 7.24 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 10 3 # 10 B 14 ARG F 9 ARG^? 24.10 ZN ZN G2004 B 161 ASP J 39 ASP.? 27.27 ZN ZN J2001 B 174 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 32.42 -18.19 2.00 30.08 -17.10 0.27 coo -14.86 10.19 8.14 -14.82 12.31 8.42 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo -21.46 12.70 8.53 -19.04 12.30 7.24 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 11 3 # 11 B 14 ARG G 9 ARG^? 25.73 ZN ZN G2004 B 161 ASP F 39 ASP.? 16.21 ZN ZN G2004 B 174 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 26.96 -25.00 8.90 25.51 -22.83 7.22 coo -14.86 10.19 8.14 -14.82 12.31 8.42 35.01 -12.42 6.08 34.01 -14.14 6.70 coo -21.46 12.70 8.53 -19.04 12.30 7.24 31.03 -12.70 0.17 30.17 -14.19 -2.05 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 12 3 # 12 B 14 ARG G 9 ARG^? 25.73 ZN ZN G2004 B 161 ASP H 39 ASP.? 32.15 ZN ZN J2001 B 174 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 26.96 -25.00 8.90 25.51 -22.83 7.22 coo -14.86 10.19 8.14 -14.82 12.31 8.42 19.73 -39.62 3.70 20.63 -38.69 2.04 coo -21.46 12.70 8.53 -19.04 12.30 7.24 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 13 3 # 13 B 14 ARG H 9 ARG^? 32.17 ZN ZN B2003 B 161 ASP G 39 ASP.? 27.24 ZN ZN G2004 B 174 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 23.61 -33.80 3.29 21.83 -31.31 3.74 coo -14.86 10.19 8.14 -14.82 12.31 8.42 25.21 -25.73 15.58 24.96 -27.01 13.97 coo -21.46 12.70 8.53 -19.04 12.30 7.24 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 14 3 # 14 B 14 ARG I 9 ARG^? 24.03 ZN ZN J2001 B 161 ASP H 39 ASP.? 32.15 ZN ZN J2001 B 174 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo -14.86 10.19 8.14 -14.82 12.31 8.42 19.73 -39.62 3.70 20.63 -38.69 2.04 coo -21.46 12.70 8.53 -19.04 12.30 7.24 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 15 3 # 15 B 14 ARG I 9 ARG^? 24.03 ZN ZN J2001 B 161 ASP J 39 ASP.? 27.27 ZN ZN J2001 B 174 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo -14.86 10.19 8.14 -14.82 12.31 8.42 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo -21.46 12.70 8.53 -19.04 12.30 7.24 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 16 3 # 16 B 14 ARG J 9 ARG^? 25.67 ZN ZN J2001 B 161 ASP I 39 ASP.? 16.30 ZN ZN J2001 B 174 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo -14.86 10.19 8.14 -14.82 12.31 8.42 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo -21.46 12.70 8.53 -19.04 12.30 7.24 20.76 -33.59 -9.48 20.18 -32.83 -6.85 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 16 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 9 ARG^? 24.21 ZN ZN E2002 C 161 ASP B 39 ASP.? 27.28 ZN ZN B2003 C 174 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 2.84 19.43 40.34 1.59 20.35 37.65 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo -0.62 11.10 28.05 -0.65 13.15 27.46 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 5.94 13.28 27.17 3.53 13.05 28.58 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 9 ARG^? 24.21 ZN ZN E2002 C 161 ASP E 39 ASP.? 27.23 ZN ZN E2002 C 174 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 2.84 19.43 40.34 1.59 20.35 37.65 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo -0.62 11.10 28.05 -0.65 13.15 27.46 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 5.94 13.28 27.17 3.53 13.05 28.58 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG B 9 ARG^? 25.60 ZN ZN B2003 C 161 ASP C 39 ASP.? 16.40 ZN ZN B2003 C 174 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo 2.84 19.43 40.34 1.59 20.35 37.65 12.25 -11.70 3.79 14.09 -14.14 4.30 coo -0.62 11.10 28.05 -0.65 13.15 27.46 4.44 -22.79 9.98 5.37 -21.07 9.21 coo 5.94 13.28 27.17 3.53 13.05 28.58 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG C 9 ARG^? 24.24 ZN ZN B2003 C 161 ASP B 39 ASP.? 27.28 ZN ZN B2003 C 174 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 2.84 19.43 40.34 1.59 20.35 37.65 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -0.62 11.10 28.05 -0.65 13.15 27.46 14.11 -6.67 8.34 14.38 -6.43 6.26 coo 5.94 13.28 27.17 3.53 13.05 28.58 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG C 9 ARG^? 24.24 ZN ZN B2003 C 161 ASP D 39 ASP.? 32.27 ZN ZN B2003 C 174 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo 2.84 19.43 40.34 1.59 20.35 37.65 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -0.62 11.10 28.05 -0.65 13.15 27.46 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo 5.94 13.28 27.17 3.53 13.05 28.58 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG D 9 ARG^? 32.06 ZN ZN J2001 C 161 ASP E 39 ASP.? 27.23 ZN ZN E2002 C 174 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 2.84 19.43 40.34 1.59 20.35 37.65 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo -0.62 11.10 28.05 -0.65 13.15 27.46 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo 5.94 13.28 27.17 3.53 13.05 28.58 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG E 9 ARG^? 26.78 ZN ZN E2002 C 161 ASP A 39 ASP.? 16.23 ZN ZN E2002 C 174 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo 2.84 19.43 40.34 1.59 20.35 37.65 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo -0.62 11.10 28.05 -0.65 13.15 27.46 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo 5.94 13.28 27.17 3.53 13.05 28.58 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG F 9 ARG^? 24.10 ZN ZN G2004 C 161 ASP G 39 ASP.? 27.24 ZN ZN G2004 C 174 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 2.84 19.43 40.34 1.59 20.35 37.65 32.42 -18.19 2.00 30.08 -17.10 0.27 coo -0.62 11.10 28.05 -0.65 13.15 27.46 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 5.94 13.28 27.17 3.53 13.05 28.58 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG F 9 ARG^? 24.10 ZN ZN G2004 C 161 ASP J 39 ASP.? 27.27 ZN ZN J2001 C 174 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 2.84 19.43 40.34 1.59 20.35 37.65 32.42 -18.19 2.00 30.08 -17.10 0.27 coo -0.62 11.10 28.05 -0.65 13.15 27.46 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo 5.94 13.28 27.17 3.53 13.05 28.58 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 10 3 # 10 C 14 ARG G 9 ARG^? 25.73 ZN ZN G2004 C 161 ASP F 39 ASP.? 16.21 ZN ZN G2004 C 174 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo 2.84 19.43 40.34 1.59 20.35 37.65 26.96 -25.00 8.90 25.51 -22.83 7.22 coo -0.62 11.10 28.05 -0.65 13.15 27.46 35.01 -12.42 6.08 34.01 -14.14 6.70 coo 5.94 13.28 27.17 3.53 13.05 28.58 31.03 -12.70 0.17 30.17 -14.19 -2.05 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 11 3 # 11 C 14 ARG H 9 ARG^? 32.17 ZN ZN B2003 C 161 ASP G 39 ASP.? 27.24 ZN ZN G2004 C 174 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 2.84 19.43 40.34 1.59 20.35 37.65 23.61 -33.80 3.29 21.83 -31.31 3.74 coo -0.62 11.10 28.05 -0.65 13.15 27.46 25.21 -25.73 15.58 24.96 -27.01 13.97 coo 5.94 13.28 27.17 3.53 13.05 28.58 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 12 3 # 12 C 14 ARG I 9 ARG^? 24.03 ZN ZN J2001 C 161 ASP H 39 ASP.? 32.15 ZN ZN J2001 C 174 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo 2.84 19.43 40.34 1.59 20.35 37.65 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo -0.62 11.10 28.05 -0.65 13.15 27.46 19.73 -39.62 3.70 20.63 -38.69 2.04 coo 5.94 13.28 27.17 3.53 13.05 28.58 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 13 3 # 13 C 14 ARG J 9 ARG^? 25.67 ZN ZN J2001 C 161 ASP I 39 ASP.? 16.30 ZN ZN J2001 C 174 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo 2.84 19.43 40.34 1.59 20.35 37.65 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo -0.62 11.10 28.05 -0.65 13.15 27.46 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo 5.94 13.28 27.17 3.53 13.05 28.58 20.76 -33.59 -9.48 20.18 -32.83 -6.85 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 13 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 9 ARG^? 24.21 ZN ZN E2002 D 161 ASP B 39 ASP.? 27.28 ZN ZN B2003 D 174 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 14.11 -6.67 8.34 14.38 -6.43 6.26 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 9 ARG^? 24.21 ZN ZN E2002 D 161 ASP E 39 ASP.? 27.23 ZN ZN E2002 D 174 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG B 9 ARG^? 25.60 ZN ZN B2003 D 161 ASP C 39 ASP.? 16.40 ZN ZN B2003 D 174 TYR C 38 TYR.? 23.27 ZN ZN B2003 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 12.25 -11.70 3.79 14.09 -14.14 4.30 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 4.44 -22.79 9.98 5.37 -21.07 9.21 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 8.45 -26.45 5.41 9.25 -26.71 2.72 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG C 9 ARG^? 24.24 ZN ZN B2003 D 161 ASP B 39 ASP.? 27.28 ZN ZN B2003 D 174 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 14.11 -6.67 8.34 14.38 -6.43 6.26 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG C 9 ARG^? 24.24 ZN ZN B2003 D 161 ASP D 39 ASP.? 32.27 ZN ZN B2003 D 174 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG D 9 ARG^? 32.06 ZN ZN J2001 D 161 ASP E 39 ASP.? 27.23 ZN ZN E2002 D 174 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG E 9 ARG^? 26.78 ZN ZN E2002 D 161 ASP A 39 ASP.? 16.23 ZN ZN E2002 D 174 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG E 9 ARG^? 26.78 ZN ZN E2002 D 161 ASP D 39 ASP.? 32.27 ZN ZN B2003 D 174 TYR D 38 TYR.? 28.62 ZN ZN J2001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 10.18 -28.96 -9.74 11.62 -26.73 -10.53 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG F 9 ARG^? 24.10 ZN ZN G2004 D 161 ASP G 39 ASP.? 27.24 ZN ZN G2004 D 174 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 32.42 -18.19 2.00 30.08 -17.10 0.27 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 25.21 -25.73 15.58 24.96 -27.01 13.97 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 10 3 # 10 D 14 ARG F 9 ARG^? 24.10 ZN ZN G2004 D 161 ASP J 39 ASP.? 27.27 ZN ZN J2001 D 174 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 32.42 -18.19 2.00 30.08 -17.10 0.27 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 11 3 # 11 D 14 ARG G 9 ARG^? 25.73 ZN ZN G2004 D 161 ASP F 39 ASP.? 16.21 ZN ZN G2004 D 174 TYR F 38 TYR.? 23.19 ZN ZN G2004 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 26.96 -25.00 8.90 25.51 -22.83 7.22 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 35.01 -12.42 6.08 34.01 -14.14 6.70 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 31.03 -12.70 0.17 30.17 -14.19 -2.05 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 12 3 # 12 D 14 ARG G 9 ARG^? 25.73 ZN ZN G2004 D 161 ASP H 39 ASP.? 32.15 ZN ZN J2001 D 174 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 26.96 -25.00 8.90 25.51 -22.83 7.22 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 19.73 -39.62 3.70 20.63 -38.69 2.04 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 13 3 # 13 D 14 ARG H 9 ARG^? 32.17 ZN ZN B2003 D 161 ASP G 39 ASP.? 27.24 ZN ZN G2004 D 174 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 23.61 -33.80 3.29 21.83 -31.31 3.74 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 25.21 -25.73 15.58 24.96 -27.01 13.97 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 23.80 -20.63 11.40 24.84 -19.26 9.19 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 14 3 # 14 D 14 ARG I 9 ARG^? 24.03 ZN ZN J2001 D 161 ASP H 39 ASP.? 32.15 ZN ZN J2001 D 174 TYR H 38 TYR.? 28.65 ZN ZN B2003 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 19.73 -39.62 3.70 20.63 -38.69 2.04 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 17.79 -33.38 5.74 18.94 -30.96 6.49 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 15 3 # 15 D 14 ARG I 9 ARG^? 24.03 ZN ZN J2001 D 161 ASP J 39 ASP.? 27.27 ZN ZN J2001 D 174 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 16 3 # 16 D 14 ARG J 9 ARG^? 25.67 ZN ZN J2001 D 161 ASP I 39 ASP.? 16.30 ZN ZN J2001 D 174 TYR I 38 TYR.? 23.18 ZN ZN J2001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 20.76 -33.59 -9.48 20.18 -32.83 -6.85 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 16 hits 2c7v_c11 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 67 GLU^? 23.17 ZN ZN E2002 A 156 GLU E 67 GLU^? 26.75 ZN ZN E2002 A 194 ASN A 13 ASN.? 18.92 ZN ZN E2002 coo 74.14 15.91 8.55 72.08 15.36 8.63 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 67.47 20.07 1.34 65.99 20.06 2.88 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 67.44 25.26 13.91 67.54 23.65 15.28 10.06 -0.38 -14.52 8.62 -0.07 -12.98 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU B 67 GLU^? 26.37 ZN ZN B2003 A 156 GLU A 67 GLU^? 23.17 ZN ZN E2002 A 194 ASN B 13 ASN.? 30.05 ZN ZN B2003 coo 74.14 15.91 8.55 72.08 15.36 8.63 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 67.47 20.07 1.34 65.99 20.06 2.88 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 67.44 25.26 13.91 67.54 23.65 15.28 7.00 0.81 3.82 5.31 -0.29 3.06 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU C 67 GLU.? 23.10 ZN ZN B2003 A 156 GLU B 67 GLU^? 26.37 ZN ZN B2003 A 194 ASN C 13 ASN~? 18.60 ZN ZN B2003 coo 74.14 15.91 8.55 72.08 15.36 8.63 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 67.47 20.07 1.34 65.99 20.06 2.88 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 67.44 25.26 13.91 67.54 23.65 15.28 -2.99 -14.51 9.33 -4.22 -14.45 7.58 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU F 67 GLU^? 23.19 ZN ZN G2004 A 156 GLU G 67 GLU^? 26.62 ZN ZN G2004 A 194 ASN F 13 ASN.? 18.86 ZN ZN G2004 coo 74.14 15.91 8.55 72.08 15.36 8.63 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 67.47 20.07 1.34 65.99 20.06 2.88 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 67.44 25.26 13.91 67.54 23.65 15.28 42.65 -19.04 10.62 42.72 -20.75 9.34 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU I 67 GLU^? 22.99 ZN ZN J2001 A 156 GLU J 67 GLU^? 26.37 ZN ZN J2001 A 194 ASN I 13 ASN.? 18.64 ZN ZN J2001 coo 74.14 15.91 8.55 72.08 15.36 8.63 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 67.47 20.07 1.34 65.99 20.06 2.88 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 67.44 25.26 13.91 67.54 23.65 15.28 36.86 -37.66 -13.37 37.50 -38.40 -11.47 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU J 67 GLU^? 26.37 ZN ZN J2001 A 156 GLU F 67 GLU^? 23.19 ZN ZN G2004 A 194 ASN J 13 ASN.? 30.13 ZN ZN J2001 coo 74.14 15.91 8.55 72.08 15.36 8.63 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 67.47 20.07 1.34 65.99 20.06 2.88 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 67.44 25.26 13.91 67.54 23.65 15.28 45.13 -21.25 -7.78 45.09 -23.23 -6.98 2dbt_c00 source 2dbt CHITINASE C : 6 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 67 GLU^? 23.17 ZN ZN E2002 B 156 GLU E 67 GLU^? 26.75 ZN ZN E2002 B 194 ASN A 13 ASN.? 18.92 ZN ZN E2002 coo 45.64 63.11 17.20 47.48 62.43 16.45 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 54.43 67.89 19.82 55.62 67.90 18.07 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 49.79 70.75 7.78 50.10 68.90 6.86 10.06 -0.38 -14.52 8.62 -0.07 -12.98 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU B 67 GLU^? 26.37 ZN ZN B2003 B 156 GLU A 67 GLU^? 23.17 ZN ZN E2002 B 194 ASN B 13 ASN.? 30.05 ZN ZN B2003 coo 45.64 63.11 17.20 47.48 62.43 16.45 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 54.43 67.89 19.82 55.62 67.90 18.07 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 49.79 70.75 7.78 50.10 68.90 6.86 7.00 0.81 3.82 5.31 -0.29 3.06 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU C 67 GLU.? 23.10 ZN ZN B2003 B 156 GLU B 67 GLU^? 26.37 ZN ZN B2003 B 194 ASN C 13 ASN~? 18.60 ZN ZN B2003 coo 45.64 63.11 17.20 47.48 62.43 16.45 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 54.43 67.89 19.82 55.62 67.90 18.07 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 49.79 70.75 7.78 50.10 68.90 6.86 -2.99 -14.51 9.33 -4.22 -14.45 7.58 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU F 67 GLU^? 23.19 ZN ZN G2004 B 156 GLU G 67 GLU^? 26.62 ZN ZN G2004 B 194 ASN F 13 ASN.? 18.86 ZN ZN G2004 coo 45.64 63.11 17.20 47.48 62.43 16.45 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 54.43 67.89 19.82 55.62 67.90 18.07 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 49.79 70.75 7.78 50.10 68.90 6.86 42.65 -19.04 10.62 42.72 -20.75 9.34 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU I 67 GLU^? 22.99 ZN ZN J2001 B 156 GLU J 67 GLU^? 26.37 ZN ZN J2001 B 194 ASN I 13 ASN.? 18.64 ZN ZN J2001 coo 45.64 63.11 17.20 47.48 62.43 16.45 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 54.43 67.89 19.82 55.62 67.90 18.07 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 49.79 70.75 7.78 50.10 68.90 6.86 36.86 -37.66 -13.37 37.50 -38.40 -11.47 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU J 67 GLU^? 26.37 ZN ZN J2001 B 156 GLU F 67 GLU^? 23.19 ZN ZN G2004 B 194 ASN J 13 ASN.? 30.13 ZN ZN J2001 coo 45.64 63.11 17.20 47.48 62.43 16.45 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 54.43 67.89 19.82 55.62 67.90 18.07 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 49.79 70.75 7.78 50.10 68.90 6.86 45.13 -21.25 -7.78 45.09 -23.23 -6.98 2dbt_c01 source 2dbt CHITINASE C : 6 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 67 GLU^? 23.17 ZN ZN E2002 C 156 GLU E 67 GLU^? 26.75 ZN ZN E2002 C 194 ASN A 13 ASN.? 18.92 ZN ZN E2002 coo 41.23 29.31 13.28 43.03 29.85 12.29 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 44.75 23.09 5.51 46.77 22.91 6.12 8.68 -12.43 -13.50 7.80 -14.23 -12.82 coo 49.75 21.00 18.12 50.45 23.02 18.26 10.06 -0.38 -14.52 8.62 -0.07 -12.98 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU B 67 GLU^? 26.37 ZN ZN B2003 C 156 GLU A 67 GLU^? 23.17 ZN ZN E2002 C 194 ASN B 13 ASN.? 30.05 ZN ZN B2003 coo 41.23 29.31 13.28 43.03 29.85 12.29 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 44.75 23.09 5.51 46.77 22.91 6.12 11.19 -6.14 -5.41 11.52 -7.30 -7.13 coo 49.75 21.00 18.12 50.45 23.02 18.26 7.00 0.81 3.82 5.31 -0.29 3.06 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU C 67 GLU.? 23.10 ZN ZN B2003 C 156 GLU B 67 GLU^? 26.37 ZN ZN B2003 C 194 ASN C 13 ASN~? 18.60 ZN ZN B2003 coo 41.23 29.31 13.28 43.03 29.85 12.29 1.93 -19.21 0.76 2.90 -17.72 1.93 coo 44.75 23.09 5.51 46.77 22.91 6.12 6.86 -10.14 3.77 7.81 -9.34 2.09 coo 49.75 21.00 18.12 50.45 23.02 18.26 -2.99 -14.51 9.33 -4.22 -14.45 7.58 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU F 67 GLU^? 23.19 ZN ZN G2004 C 156 GLU G 67 GLU^? 26.62 ZN ZN G2004 C 194 ASN F 13 ASN.? 18.86 ZN ZN G2004 coo 41.23 29.31 13.28 43.03 29.85 12.29 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 44.75 23.09 5.51 46.77 22.91 6.12 32.75 -26.36 9.71 31.95 -28.10 8.81 coo 49.75 21.00 18.12 50.45 23.02 18.26 42.65 -19.04 10.62 42.72 -20.75 9.34 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU I 67 GLU^? 22.99 ZN ZN J2001 C 156 GLU J 67 GLU^? 26.37 ZN ZN J2001 C 194 ASN I 13 ASN.? 18.64 ZN ZN J2001 coo 41.23 29.31 13.28 43.03 29.85 12.29 30.11 -35.47 -4.88 30.75 -33.82 -6.03 coo 44.75 23.09 5.51 46.77 22.91 6.12 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 49.75 21.00 18.12 50.45 23.02 18.26 36.86 -37.66 -13.37 37.50 -38.40 -11.47 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU J 67 GLU^? 26.37 ZN ZN J2001 C 156 GLU F 67 GLU^? 23.19 ZN ZN G2004 C 194 ASN J 13 ASN.? 30.13 ZN ZN J2001 coo 41.23 29.31 13.28 43.03 29.85 12.29 35.73 -26.90 -7.66 35.82 -25.49 -6.10 coo 44.75 23.09 5.51 46.77 22.91 6.12 37.21 -21.03 1.43 36.13 -21.58 3.16 coo 49.75 21.00 18.12 50.45 23.02 18.26 45.13 -21.25 -7.78 45.09 -23.23 -6.98 2dbt_c02 source 2dbt CHITINASE C : 6 hits 2dbt_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 75 PHE^? 9.36 ZN ZN G2004 A 245 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 273 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 33.55 0.62 19.07 33.72 1.88 17.35 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE B 75 PHE^? 21.46 ZN ZN B2003 A 245 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 273 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 12.54 -30.52 29.41 14.40 -31.25 30.10 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE C 75 PHE^? 34.12 ZN ZN J2001 A 245 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 273 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE D 75 PHE^? 9.38 ZN ZN J2001 A 245 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 273 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE E 75 PHE^? 21.52 ZN ZN E2002 A 245 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 273 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 245 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 273 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 31.72 1.73 -23.06 32.51 2.58 -21.24 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE G 75 PHE^? 21.55 ZN ZN G2004 A 245 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 273 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 26.93 6.24 15.37 25.45 7.75 15.31 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE H 75 PHE^? 9.39 ZN ZN B2003 A 245 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 273 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 6.05 -23.93 28.50 5.91 -26.02 28.02 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE I 75 PHE^? 34.28 ZN ZN B2003 A 245 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 273 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE J 75 PHE^? 21.52 ZN ZN J2001 A 245 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 273 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 26.17 -30.49 -34.43 27.88 -35.84 -34.06 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 10 hits 2gsa_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 75 PHE^? 9.36 ZN ZN G2004 A 263 ASP G 48 ASP~? 8.81 ZN ZN G2004 A 292 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 51.51 50.32 16.39 52.13 49.68 13.75 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 33.55 0.62 19.07 33.72 1.88 17.35 coo 63.95 45.30 16.71 59.11 49.15 16.05 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 75 PHE^? 9.36 ZN ZN G2004 A 263 ASP G 54 ASP~? -2.04 ZN ZN G2004s A 292 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 51.51 50.32 16.39 52.13 49.68 13.75 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 63.95 45.30 16.71 59.11 49.15 16.05 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 75 PHE^? 21.46 ZN ZN B2003 A 263 ASP H 48 ASP.? 18.83 ZN ZN B2003 A 292 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 51.51 50.32 16.39 52.13 49.68 13.75 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 54.43 44.82 23.74 55.21 45.06 21.80 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 63.95 45.30 16.71 59.11 49.15 16.05 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE C 75 PHE^? 34.12 ZN ZN J2001 A 263 ASP I 48 ASP~? 38.35 ZN ZN J2001 A 292 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 51.51 50.32 16.39 52.13 49.68 13.75 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 54.43 44.82 23.74 55.21 45.06 21.80 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 63.95 45.30 16.71 59.11 49.15 16.05 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE C 75 PHE^? 34.12 ZN ZN J2001 A 263 ASP I 54 ASP~? 33.46 ZN ZN J2001 A 292 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 51.51 50.32 16.39 52.13 49.68 13.75 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 54.43 44.82 23.74 55.21 45.06 21.80 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 63.95 45.30 16.71 59.11 49.15 16.05 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE D 75 PHE^? 9.38 ZN ZN J2001 A 263 ASP J 48 ASP~? 8.01 ZN ZN J2001 A 292 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 51.51 50.32 16.39 52.13 49.68 13.75 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 54.43 44.82 23.74 55.21 45.06 21.80 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 63.95 45.30 16.71 59.11 49.15 16.05 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE D 75 PHE^? 9.38 ZN ZN J2001 A 263 ASP J 54 ASP~? -2.24 ZN ZN J2001s A 292 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 51.51 50.32 16.39 52.13 49.68 13.75 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 54.43 44.82 23.74 55.21 45.06 21.80 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 63.95 45.30 16.71 59.11 49.15 16.05 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE E 75 PHE^? 21.52 ZN ZN E2002 A 263 ASP F 48 ASP.? 18.92 ZN ZN E2002 A 292 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 51.51 50.32 16.39 52.13 49.68 13.75 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 54.43 44.82 23.74 55.21 45.06 21.80 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 63.95 45.30 16.71 59.11 49.15 16.05 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 177 PHE E 75 PHE^? 21.52 ZN ZN E2002 A 263 ASP F 54 ASP~? 25.15 ZN ZN E2002 A 292 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 51.51 50.32 16.39 52.13 49.68 13.75 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 54.43 44.82 23.74 55.21 45.06 21.80 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 63.95 45.30 16.71 59.11 49.15 16.05 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 177 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 263 ASP E 48 ASP~? 8.41 ZN ZN E2002 A 292 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 51.51 50.32 16.39 52.13 49.68 13.75 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 54.43 44.82 23.74 55.21 45.06 21.80 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 63.95 45.30 16.71 59.11 49.15 16.05 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 177 PHE F 75 PHE^? 9.34 ZN ZN E2002 A 263 ASP E 54 ASP~? -2.11 ZN ZN E2002s A 292 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 51.51 50.32 16.39 52.13 49.68 13.75 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 54.43 44.82 23.74 55.21 45.06 21.80 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 177 PHE G 75 PHE^? 21.55 ZN ZN G2004 A 263 ASP A 48 ASP~? 19.05 ZN ZN G2004 A 292 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 51.51 50.32 16.39 52.13 49.68 13.75 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 54.43 44.82 23.74 55.21 45.06 21.80 26.93 6.24 15.37 25.45 7.75 15.31 coo 63.95 45.30 16.71 59.11 49.15 16.05 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 177 PHE G 75 PHE^? 21.55 ZN ZN G2004 A 263 ASP A 54 ASP~? 25.58 ZN ZN G2004 A 292 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 51.51 50.32 16.39 52.13 49.68 13.75 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 54.43 44.82 23.74 55.21 45.06 21.80 19.11 8.17 8.99 18.99 8.60 11.06 coo 63.95 45.30 16.71 59.11 49.15 16.05 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 177 PHE H 75 PHE^? 9.39 ZN ZN B2003 A 263 ASP B 48 ASP~? 8.81 ZN ZN B2003 A 292 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 51.51 50.32 16.39 52.13 49.68 13.75 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 54.43 44.82 23.74 55.21 45.06 21.80 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 63.95 45.30 16.71 59.11 49.15 16.05 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 177 PHE H 75 PHE^? 9.39 ZN ZN B2003 A 263 ASP B 54 ASP~? -2.43 ZN ZN B2003s A 292 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 51.51 50.32 16.39 52.13 49.68 13.75 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 54.43 44.82 23.74 55.21 45.06 21.80 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 177 PHE I 75 PHE^? 34.28 ZN ZN B2003 A 263 ASP C 48 ASP~? 37.52 ZN ZN B2003 A 292 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 51.51 50.32 16.39 52.13 49.68 13.75 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 54.43 44.82 23.74 55.21 45.06 21.80 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 63.95 45.30 16.71 59.11 49.15 16.05 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 A 177 PHE I 75 PHE^? 34.28 ZN ZN B2003 A 263 ASP C 54 ASP~? 34.22 ZN ZN B2003 A 292 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 51.51 50.32 16.39 52.13 49.68 13.75 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 54.43 44.82 23.74 55.21 45.06 21.80 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 63.95 45.30 16.71 59.11 49.15 16.05 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 A 177 PHE J 75 PHE^? 21.52 ZN ZN J2001 A 263 ASP D 48 ASP.? 19.00 ZN ZN J2001 A 292 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 51.51 50.32 16.39 52.13 49.68 13.75 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 54.43 44.82 23.74 55.21 45.06 21.80 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 63.95 45.30 16.71 59.11 49.15 16.05 26.17 -30.49 -34.43 27.88 -35.84 -34.06 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 18 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 75 PHE^? 9.36 ZN ZN G2004 B 263 ASP G 48 ASP~? 8.81 ZN ZN G2004 B 292 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 49.99 26.05 6.28 51.46 26.87 8.49 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 33.55 0.62 19.07 33.72 1.88 17.35 coo 60.53 31.67 0.97 57.79 27.51 3.63 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 75 PHE^? 9.36 ZN ZN G2004 B 263 ASP G 54 ASP~? -2.04 ZN ZN G2004s B 292 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 49.99 26.05 6.28 51.46 26.87 8.49 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 60.53 31.67 0.97 57.79 27.51 3.63 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE B 75 PHE^? 21.46 ZN ZN B2003 B 263 ASP H 54 ASP~? 25.78 ZN ZN B2003 B 292 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 49.99 26.05 6.28 51.46 26.87 8.49 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 20.28 -36.09 25.85 20.67 -35.47 27.83 coo 60.53 31.67 0.97 57.79 27.51 3.63 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE C 75 PHE^? 34.12 ZN ZN J2001 B 263 ASP I 48 ASP~? 38.35 ZN ZN J2001 B 292 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 49.99 26.05 6.28 51.46 26.87 8.49 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 60.53 31.67 0.97 57.79 27.51 3.63 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE C 75 PHE^? 34.12 ZN ZN J2001 B 263 ASP I 54 ASP~? 33.46 ZN ZN J2001 B 292 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 49.99 26.05 6.28 51.46 26.87 8.49 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 60.53 31.67 0.97 57.79 27.51 3.63 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE D 75 PHE^? 9.38 ZN ZN J2001 B 263 ASP J 54 ASP~? -2.24 ZN ZN J2001s B 292 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 49.99 26.05 6.28 51.46 26.87 8.49 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 60.53 31.67 0.97 57.79 27.51 3.63 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE E 75 PHE^? 21.52 ZN ZN E2002 B 263 ASP F 54 ASP~? 25.15 ZN ZN E2002 B 292 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 49.99 26.05 6.28 51.46 26.87 8.49 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 60.53 31.67 0.97 57.79 27.51 3.63 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE F 75 PHE^? 9.34 ZN ZN E2002 B 263 ASP E 54 ASP~? -2.11 ZN ZN E2002s B 292 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 49.99 26.05 6.28 51.46 26.87 8.49 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE G 75 PHE^? 21.55 ZN ZN G2004 B 263 ASP A 54 ASP~? 25.58 ZN ZN G2004 B 292 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 49.99 26.05 6.28 51.46 26.87 8.49 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 19.11 8.17 8.99 18.99 8.60 11.06 coo 60.53 31.67 0.97 57.79 27.51 3.63 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE H 75 PHE^? 9.39 ZN ZN B2003 B 263 ASP B 48 ASP~? 8.81 ZN ZN B2003 B 292 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 49.99 26.05 6.28 51.46 26.87 8.49 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 60.53 31.67 0.97 57.79 27.51 3.63 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 177 PHE H 75 PHE^? 9.39 ZN ZN B2003 B 263 ASP B 54 ASP~? -2.43 ZN ZN B2003s B 292 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 49.99 26.05 6.28 51.46 26.87 8.49 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 177 PHE I 75 PHE^? 34.28 ZN ZN B2003 B 263 ASP C 54 ASP~? 34.22 ZN ZN B2003 B 292 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 49.99 26.05 6.28 51.46 26.87 8.49 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 60.53 31.67 0.97 57.79 27.51 3.63 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 177 PHE J 75 PHE^? 21.52 ZN ZN J2001 B 263 ASP D 54 ASP~? 25.75 ZN ZN J2001 B 292 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 49.99 26.05 6.28 51.46 26.87 8.49 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 6.44 -27.97 -29.88 7.08 -27.17 -31.74 coo 60.53 31.67 0.97 57.79 27.51 3.63 12.18 -35.43 -32.57 13.23 -33.76 -37.61 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 13 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 75 PHE^? 9.36 ZN ZN G2004 C 263 ASP G 48 ASP~? 8.81 ZN ZN G2004 C 292 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 33.55 0.62 19.07 33.72 1.88 17.35 coo 12.82 3.49 4.98 17.80 5.59 1.90 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 75 PHE^? 9.36 ZN ZN G2004 C 263 ASP G 54 ASP~? -2.04 ZN ZN G2004s C 292 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 33.57 -5.35 11.77 34.08 -8.03 11.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 38.23 -8.03 19.86 39.37 -6.28 19.45 coo 12.82 3.49 4.98 17.80 5.59 1.90 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 75 PHE^? 21.46 ZN ZN B2003 C 263 ASP H 48 ASP.? 18.83 ZN ZN B2003 C 292 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 18.81 -27.58 22.03 20.66 -28.34 20.09 coo 19.84 12.02 9.33 18.68 11.23 7.75 12.54 -30.52 29.41 14.40 -31.25 30.10 coo 12.82 3.49 4.98 17.80 5.59 1.90 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE C 75 PHE^? 34.12 ZN ZN J2001 C 263 ASP I 48 ASP~? 38.35 ZN ZN J2001 C 292 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 19.84 12.02 9.33 18.68 11.23 7.75 6.36 -52.06 -2.59 7.56 -53.72 -1.99 coo 12.82 3.49 4.98 17.80 5.59 1.90 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE C 75 PHE^? 34.12 ZN ZN J2001 C 263 ASP I 54 ASP~? 33.46 ZN ZN J2001 C 292 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 12.90 -45.40 0.73 15.45 -44.24 0.66 coo 19.84 12.02 9.33 18.68 11.23 7.75 17.18 -52.79 -3.01 18.10 -54.51 -2.17 coo 12.82 3.49 4.98 17.80 5.59 1.90 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE D 75 PHE^? 9.38 ZN ZN J2001 C 263 ASP J 48 ASP~? 8.01 ZN ZN J2001 C 292 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 19.84 12.02 9.33 18.68 11.23 7.75 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo 12.82 3.49 4.98 17.80 5.59 1.90 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE D 75 PHE^? 9.38 ZN ZN J2001 C 263 ASP J 54 ASP~? -2.24 ZN ZN J2001s C 292 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 23.86 -34.63 -23.00 25.58 -34.34 -20.82 coo 19.84 12.02 9.33 18.68 11.23 7.75 32.59 -34.93 -27.29 32.02 -36.71 -28.24 coo 12.82 3.49 4.98 17.80 5.59 1.90 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE E 75 PHE^? 21.52 ZN ZN E2002 C 263 ASP F 48 ASP.? 18.92 ZN ZN E2002 C 292 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 19.84 12.02 9.33 18.68 11.23 7.75 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo 12.82 3.49 4.98 17.80 5.59 1.90 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 177 PHE E 75 PHE^? 21.52 ZN ZN E2002 C 263 ASP F 54 ASP~? 25.15 ZN ZN E2002 C 292 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 36.89 -10.20 -15.79 37.34 -12.18 -13.88 coo 19.84 12.02 9.33 18.68 11.23 7.75 45.65 -7.17 -13.11 45.66 -6.91 -15.22 coo 12.82 3.49 4.98 17.80 5.59 1.90 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 177 PHE F 75 PHE^? 9.34 ZN ZN E2002 C 263 ASP E 48 ASP~? 8.41 ZN ZN E2002 C 292 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 19.84 12.02 9.33 18.68 11.23 7.75 31.72 1.73 -23.06 32.51 2.58 -21.24 coo 12.82 3.49 4.98 17.80 5.59 1.90 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 177 PHE F 75 PHE^? 9.34 ZN ZN E2002 C 263 ASP E 54 ASP~? -2.11 ZN ZN E2002s C 292 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 26.50 -1.32 -15.73 23.91 -2.16 -15.15 coo 19.84 12.02 9.33 18.68 11.23 7.75 22.00 1.44 -23.80 22.91 3.31 -23.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 177 PHE G 75 PHE^? 21.55 ZN ZN G2004 C 263 ASP A 48 ASP~? 19.05 ZN ZN G2004 C 292 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 19.84 12.02 9.33 18.68 11.23 7.75 26.93 6.24 15.37 25.45 7.75 15.31 coo 12.82 3.49 4.98 17.80 5.59 1.90 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 177 PHE G 75 PHE^? 21.55 ZN ZN G2004 C 263 ASP A 54 ASP~? 25.58 ZN ZN G2004 C 292 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 20.76 -0.83 11.86 18.80 -1.37 9.95 coo 19.84 12.02 9.33 18.68 11.23 7.75 19.11 8.17 8.99 18.99 8.60 11.06 coo 12.82 3.49 4.98 17.80 5.59 1.90 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 177 PHE H 75 PHE^? 9.39 ZN ZN B2003 C 263 ASP B 48 ASP~? 8.81 ZN ZN B2003 C 292 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 19.84 12.02 9.33 18.68 11.23 7.75 6.05 -23.93 28.50 5.91 -26.02 28.02 coo 12.82 3.49 4.98 17.80 5.59 1.90 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 177 PHE H 75 PHE^? 9.39 ZN ZN B2003 C 263 ASP B 54 ASP~? -2.43 ZN ZN B2003s C 292 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 6.01 -24.34 18.97 5.28 -22.77 16.79 coo 19.84 12.02 9.33 18.68 11.23 7.75 1.40 -16.75 23.23 0.16 -18.07 24.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 C 177 PHE I 75 PHE^? 34.28 ZN ZN B2003 C 263 ASP C 48 ASP~? 37.52 ZN ZN B2003 C 292 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 19.84 12.02 9.33 18.68 11.23 7.75 -1.25 -47.92 -1.47 -3.15 -46.99 -1.66 coo 12.82 3.49 4.98 17.80 5.59 1.90 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 C 177 PHE I 75 PHE^? 34.28 ZN ZN B2003 C 263 ASP C 54 ASP~? 34.22 ZN ZN B2003 C 292 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 2.19 -39.31 -4.75 1.83 -36.53 -4.75 coo 19.84 12.02 9.33 18.68 11.23 7.75 -6.35 -39.10 -0.71 -6.98 -40.50 -2.17 coo 12.82 3.49 4.98 17.80 5.59 1.90 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 C 177 PHE J 75 PHE^? 21.52 ZN ZN J2001 C 263 ASP D 48 ASP.? 19.00 ZN ZN J2001 C 292 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 14.70 -25.12 -25.98 13.02 -23.90 -24.14 coo 19.84 12.02 9.33 18.68 11.23 7.75 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo 12.82 3.49 4.98 17.80 5.59 1.90 26.17 -30.49 -34.43 27.88 -35.84 -34.06 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 18 hits 2oat_c05 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 39 ASP.? 16.23 ZN ZN E2002 166 GLY A 59 GLY.? 27.43 ZN ZN E2002 169 GLU A 51 GLU~? 22.57 ZN ZN G2004 coo 8.28 6.87 1.62 10.08 5.77 1.34 19.72 -3.56 -10.13 18.70 -5.29 -10.73 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.67 6.43 3.53 15.30 5.71 3.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 23.15 8.42 10.27 24.62 9.66 9.42 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 48 ASP~? 19.05 ZN ZN G2004 166 GLY B 19 GLY~? 21.58 ZN ZN B2003 169 GLU B 24 GLU~? 19.88 ZN ZN B2003 coo 8.28 6.87 1.62 10.08 5.77 1.34 26.93 6.24 15.37 25.45 7.75 15.31 coo -8.58 13.22 3.21 -8.90 13.15 4.05 9.50 -3.40 15.53 8.72 -3.14 15.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 4.20 -2.38 22.67 5.80 -1.47 23.74 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 39 ASP.? 27.28 ZN ZN B2003 166 GLY B 59 GLY.? 10.36 ZN ZN B2003 169 GLU B 51 GLU~? 6.60 ZN ZN B2003 coo 8.28 6.87 1.62 10.08 5.77 1.34 14.11 -6.67 8.34 14.38 -6.43 6.26 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.90 -12.37 18.50 1.89 -12.74 17.75 coo -16.67 7.89 2.78 -17.65 6.56 1.49 4.51 -19.61 26.84 5.05 -18.05 28.12 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 39 ASP.? 27.28 ZN ZN B2003 166 GLY C 12 GLY~? 16.92 ZN ZN B2003 169 GLU C 64 GLU.? 25.72 ZN ZN B2003 coo 8.28 6.87 1.62 10.08 5.77 1.34 14.11 -6.67 8.34 14.38 -6.43 6.26 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.25 -16.50 8.28 0.53 -16.71 7.98 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.33 -19.22 1.68 -6.59 -18.32 -0.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 48 ASP~? 8.81 ZN ZN B2003 166 GLY C 19 GLY~? 15.35 ZN ZN B2003 169 GLU C 24 GLU~? 19.76 ZN ZN B2003 coo 8.28 6.87 1.62 10.08 5.77 1.34 6.05 -23.93 28.50 5.91 -26.02 28.02 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -2.97 -27.20 11.21 -3.76 -27.09 10.99 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -10.63 -31.97 11.09 -10.50 -32.62 13.14 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP C 39 ASP.? 16.40 ZN ZN B2003 166 GLY C 59 GLY.? 27.39 ZN ZN B2003 169 GLU C 51 GLU~? 32.75 ZN ZN B2003 coo 8.28 6.87 1.62 10.08 5.77 1.34 4.44 -22.79 9.98 5.37 -21.07 9.21 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -6.42 -33.04 1.21 -6.03 -32.50 0.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -4.31 -42.77 0.97 -4.72 -44.13 2.55 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP D 39 ASP.? 32.27 ZN ZN B2003 166 GLY D 59 GLY.? 30.11 ZN ZN J2001 169 GLU D 51 GLU~? 22.34 ZN ZN J2001 coo 8.28 6.87 1.62 10.08 5.77 1.34 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo -8.58 13.22 3.21 -8.90 13.15 4.05 2.84 -26.21 -24.49 3.04 -25.55 -24.01 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.97 -31.18 -30.90 8.55 -33.28 -31.15 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP D 39 ASP.? 32.27 ZN ZN B2003 166 GLY E 12 GLY.? 29.18 ZN ZN E2002 169 GLU E 64 GLU.? 24.43 ZN ZN E2002 coo 8.28 6.87 1.62 10.08 5.77 1.34 3.81 -30.41 -7.79 4.09 -29.17 -6.11 coo -8.58 13.22 3.21 -8.90 13.15 4.05 6.03 -17.90 -18.46 5.93 -17.12 -18.66 coo -16.67 7.89 2.78 -17.65 6.56 1.49 4.37 -6.45 -19.88 3.54 -7.63 -18.34 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP D 48 ASP.? 19.00 ZN ZN J2001 166 GLY E 19 GLY~? 21.67 ZN ZN E2002 169 GLU E 24 GLU~? 19.82 ZN ZN E2002 coo 8.28 6.87 1.62 10.08 5.77 1.34 15.19 -31.94 -33.41 13.49 -31.02 -34.27 coo -8.58 13.22 3.21 -8.90 13.15 4.05 12.77 -13.27 -26.94 12.26 -12.65 -27.17 coo -16.67 7.89 2.78 -17.65 6.56 1.49 13.67 -6.82 -33.09 14.57 -7.33 -34.94 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP E 39 ASP.? 27.23 ZN ZN E2002 166 GLY A 12 GLY.? 16.77 ZN ZN E2002 169 GLU A 64 GLU.? 24.42 ZN ZN E2002 coo 8.28 6.87 1.62 10.08 5.77 1.34 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 13.30 -3.59 -12.73 12.78 -3.06 -12.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 7.18 3.59 -5.93 6.39 1.65 -6.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP E 39 ASP.? 27.23 ZN ZN E2002 166 GLY E 59 GLY.? 10.38 ZN ZN E2002 169 GLU E 51 GLU~? 6.76 ZN ZN E2002 coo 8.28 6.87 1.62 10.08 5.77 1.34 13.06 -18.68 -19.48 12.16 -19.44 -17.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 16.45 -2.18 -23.20 16.26 -2.28 -22.43 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.30 0.80 -24.68 27.41 0.15 -26.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP E 48 ASP~? 8.41 ZN ZN E2002 166 GLY A 19 GLY~? 15.01 ZN ZN E2002 169 GLU A 24 GLU.? 19.69 ZN ZN E2002 coo 8.28 6.87 1.62 10.08 5.77 1.34 31.72 1.73 -23.06 32.51 2.58 -21.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 19.43 5.06 -8.24 18.81 5.59 -8.02 coo -16.67 7.89 2.78 -17.65 6.56 1.49 18.55 13.29 -4.55 20.34 13.88 -5.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP F 39 ASP.? 16.21 ZN ZN G2004 166 GLY F 59 GLY.? 27.43 ZN ZN G2004 169 GLU F 51 GLU~? 22.25 ZN ZN E2002 coo 8.28 6.87 1.62 10.08 5.77 1.34 35.01 -12.42 6.08 34.01 -14.14 6.70 coo -8.58 13.22 3.21 -8.90 13.15 4.05 45.66 -10.77 -7.58 45.22 -11.43 -7.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.48 -3.42 -14.09 43.92 -1.45 -13.50 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP F 48 ASP.? 18.92 ZN ZN E2002 166 GLY J 19 GLY~? 21.52 ZN ZN J2001 169 GLU J 24 GLU.? 19.48 ZN ZN J2001 coo 8.28 6.87 1.62 10.08 5.77 1.34 39.90 -1.26 -19.29 41.88 -2.04 -19.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 40.18 -21.19 -19.60 40.83 -21.72 -19.70 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.53 -25.45 -26.61 43.80 -24.04 -28.14 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP G 39 ASP.? 27.24 ZN ZN G2004 166 GLY F 12 GLY.? 16.71 ZN ZN G2004 169 GLU F 64 GLU.? 24.41 ZN ZN G2004 coo 8.28 6.87 1.62 10.08 5.77 1.34 25.21 -25.73 15.58 24.96 -27.01 13.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 38.22 -18.03 8.72 38.92 -18.19 8.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 47.46 -19.49 2.08 46.38 -21.31 2.06 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP G 39 ASP.? 27.24 ZN ZN G2004 166 GLY G 59 GLY.? 10.21 ZN ZN G2004 169 GLU G 51 GLU~? 6.79 ZN ZN G2004 coo 8.28 6.87 1.62 10.08 5.77 1.34 25.21 -25.73 15.58 24.96 -27.01 13.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 37.75 -14.51 19.27 37.80 -14.73 18.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 34.98 -4.76 20.96 34.28 -3.47 22.45 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP G 48 ASP~? 8.81 ZN ZN G2004 166 GLY F 19 GLY~? 15.06 ZN ZN G2004 169 GLU F 24 GLU.? 19.67 ZN ZN G2004 coo 8.28 6.87 1.62 10.08 5.77 1.34 33.55 0.62 19.07 33.72 1.88 17.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 42.63 -8.41 4.21 43.39 -8.66 4.04 coo -16.67 7.89 2.78 -17.65 6.56 1.49 50.14 -4.90 0.74 49.85 -2.99 1.69 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP H 39 ASP.? 32.15 ZN ZN J2001 166 GLY G 12 GLY.? 29.13 ZN ZN G2004 169 GLU G 64 GLU.? 24.28 ZN ZN G2004 coo 8.28 6.87 1.62 10.08 5.77 1.34 19.73 -39.62 3.70 20.63 -38.69 2.04 coo -8.58 13.22 3.21 -8.90 13.15 4.05 29.44 -31.51 14.55 30.18 -31.23 14.75 coo -16.67 7.89 2.78 -17.65 6.56 1.49 39.99 -27.18 15.98 39.71 -28.44 14.30 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP H 39 ASP.? 32.15 ZN ZN J2001 166 GLY H 59 GLY~? 30.00 ZN ZN B2003 169 GLU H 51 GLU~? 22.00 ZN ZN B2003 coo 8.28 6.87 1.62 10.08 5.77 1.34 19.73 -39.62 3.70 20.63 -38.69 2.04 coo -8.58 13.22 3.21 -8.90 13.15 4.05 23.71 -38.32 20.60 24.20 -37.78 20.18 coo -16.67 7.89 2.78 -17.65 6.56 1.49 16.31 -35.44 26.90 14.59 -36.70 27.16 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP H 48 ASP.? 18.83 ZN ZN B2003 166 GLY G 19 GLY~? 21.50 ZN ZN G2004 169 GLU G 24 GLU~? 19.71 ZN ZN G2004 coo 8.28 6.87 1.62 10.08 5.77 1.34 12.54 -30.52 29.41 14.40 -31.25 30.10 coo -8.58 13.22 3.21 -8.90 13.15 4.05 30.06 -23.20 23.00 30.85 -23.34 23.22 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.34 -19.32 28.91 34.28 -18.98 30.72 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP I 39 ASP.? 16.30 ZN ZN J2001 166 GLY H 12 GLY.? 30.71 ZN ZN J2001 169 GLU H 64 GLU.? 37.89 ZN ZN G2004 coo 8.28 6.87 1.62 10.08 5.77 1.34 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo -8.58 13.22 3.21 -8.90 13.15 4.05 26.09 -42.02 1.53 26.51 -42.29 2.12 coo -16.67 7.89 2.78 -17.65 6.56 1.49 32.53 -42.71 11.25 33.49 -41.02 10.38 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP I 39 ASP.? 16.30 ZN ZN J2001 166 GLY I 59 GLY.? 27.32 ZN ZN J2001 169 GLU I 51 GLU~? 32.52 ZN ZN J2001 coo 8.28 6.87 1.62 10.08 5.77 1.34 26.01 -35.27 -13.87 27.04 -33.54 -13.28 coo -8.58 13.22 3.21 -8.90 13.15 4.05 22.54 -49.72 -5.18 22.76 -49.15 -4.67 coo -16.67 7.89 2.78 -17.65 6.56 1.49 12.78 -53.14 -4.97 11.98 -53.78 -6.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP J 39 ASP.? 27.27 ZN ZN J2001 166 GLY I 12 GLY.? 16.89 ZN ZN J2001 169 GLU I 64 GLU.? 25.65 ZN ZN J2001 coo 8.28 6.87 1.62 10.08 5.77 1.34 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo -8.58 13.22 3.21 -8.90 13.15 4.05 33.08 -34.86 -12.28 33.22 -35.59 -11.99 coo -16.67 7.89 2.78 -17.65 6.56 1.49 34.90 -43.61 -5.62 35.57 -42.49 -3.95 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP J 39 ASP.? 27.27 ZN ZN J2001 166 GLY J 59 GLY.? 10.51 ZN ZN J2001 169 GLU J 51 GLU~? 6.72 ZN ZN J2001 coo 8.28 6.87 1.62 10.08 5.77 1.34 35.13 -18.57 -12.25 34.79 -18.46 -10.18 coo -8.58 13.22 3.21 -8.90 13.15 4.05 36.39 -32.17 -22.43 36.06 -32.36 -21.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 28.89 -33.61 -30.77 29.81 -32.28 -32.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 25 3 # 25 141 ASP J 48 ASP~? 8.01 ZN ZN J2001 166 GLY I 19 GLY~? 15.19 ZN ZN J2001 169 GLU I 24 GLU~? 19.88 ZN ZN J2001 coo 8.28 6.87 1.62 10.08 5.77 1.34 24.29 -34.17 -32.69 23.20 -35.63 -31.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 25.86 -43.85 -15.31 26.37 -44.47 -15.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 25.57 -52.88 -14.93 24.90 -53.17 -16.94 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 25 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 32 TYR^? 15.05 ZN ZN E2002 A 214 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 256 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 28.44 2.72 -8.58 30.61 4.34 -7.97 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.14 2.30 -18.88 21.70 3.71 -18.16 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 78 TYR.? 11.65 ZN ZN G2004 A 214 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 256 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 42.29 -5.11 6.34 41.03 -7.11 7.84 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 38.40 -6.52 14.99 40.34 -7.05 14.26 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR B 32 TYR^? 21.26 ZN ZN G2004 A 214 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 256 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 18.09 -5.37 18.66 18.87 -5.22 21.34 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 17.64 3.84 11.72 15.55 3.44 11.90 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR B 78 TYR.? 24.55 ZN ZN G2004 A 214 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 256 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 27.46 -23.45 25.85 26.96 -25.77 24.34 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 22.01 -31.06 24.97 24.10 -31.35 25.29 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR C 32 TYR^? 15.32 ZN ZN B2003 A 214 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 256 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.47 -31.95 16.21 3.09 -34.42 17.45 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR C 78 TYR^? 35.69 ZN ZN B2003 A 214 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 256 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 16.52 -47.66 10.31 18.03 -47.38 7.99 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 15.88 -49.61 0.98 17.43 -49.51 2.42 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR D 32 TYR^? 29.54 ZN ZN J2001 A 214 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 256 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 4.78 -40.18 -12.99 5.15 -42.55 -14.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR D 78 TYR.? 11.76 ZN ZN J2001 A 214 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 256 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 24.81 -44.15 -19.15 26.32 -41.78 -18.93 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR E 32 TYR^? 21.25 ZN ZN J2001 A 214 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 256 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 20.11 -18.94 -28.19 21.99 -18.75 -30.24 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR E 78 TYR.? 24.67 ZN ZN J2001 A 214 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 256 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 40.71 -17.77 -21.60 40.95 -16.95 -18.92 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR F 32 TYR^? 15.23 ZN ZN G2004 A 214 ASP G 53 ASP~? 4.94 ZN ZN G2004 A 256 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 36.01 -1.70 4.51 36.34 1.00 3.95 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 38.40 -6.52 14.99 40.34 -7.05 14.26 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR F 78 TYR.? 11.63 ZN ZN E2002 A 214 ASP E 53 ASP~? 5.07 ZN ZN E2002 A 256 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 22.38 6.39 -10.32 21.34 4.29 -11.84 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.14 2.30 -18.88 21.70 3.71 -18.16 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 13 3 # 13 A 122 TYR G 32 TYR^? 21.21 ZN ZN B2003 A 214 ASP H 53 ASP~? 26.49 ZN ZN B2003 A 256 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 21.50 -19.82 24.15 20.71 -18.09 26.19 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 22.01 -31.06 24.97 24.10 -31.35 25.29 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 14 3 # 14 A 122 TYR G 78 TYR.? 24.68 ZN ZN B2003 A 214 ASP A 53 ASP~? 26.24 ZN ZN G2004 A 256 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 12.17 -1.26 17.53 12.70 -0.59 14.88 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 17.64 3.84 11.72 15.55 3.44 11.90 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 15 3 # 15 A 122 TYR H 32 TYR^? 29.55 ZN ZN B2003 A 214 ASP I 53 ASP~? 35.51 ZN ZN J2001 A 256 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 10.73 -43.63 9.08 8.41 -44.48 10.38 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 15.88 -49.61 0.98 17.43 -49.51 2.42 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 16 3 # 16 A 122 TYR H 78 TYR.? 11.76 ZN ZN B2003 A 214 ASP B 53 ASP~? 5.10 ZN ZN B2003 A 256 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -2.69 -28.08 15.14 -1.32 -25.64 14.90 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 17 3 # 17 A 122 TYR I 32 TYR^? 15.25 ZN ZN J2001 A 214 ASP J 53 ASP~? 5.09 ZN ZN J2001 A 256 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 18.53 -40.66 -20.20 16.59 -42.17 -21.51 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 18 3 # 18 A 122 TYR I 78 TYR.? 35.62 ZN ZN J2001 A 214 ASP C 53 ASP~? 35.43 ZN ZN B2003 A 256 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 19 3 # 19 A 122 TYR J 32 TYR^? 21.12 ZN ZN E2002 A 214 ASP F 53 ASP~? 26.13 ZN ZN E2002 A 256 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 34.34 -14.57 -22.60 34.05 -13.83 -25.28 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 20 3 # 20 A 122 TYR J 78 TYR.? 24.76 ZN ZN E2002 A 214 ASP D 53 ASP~? 26.48 ZN ZN J2001 A 256 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 12.18 -35.43 -32.57 13.23 -33.76 -37.61 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 20 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 32 TYR^? 15.05 ZN ZN E2002 B 214 ASP E 53 ASP~? 5.07 ZN ZN E2002 B 256 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo -32.67 22.74 10.17 -32.85 23.98 7.70 28.44 2.72 -8.58 30.61 4.34 -7.97 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.14 2.30 -18.88 21.70 3.71 -18.16 coo -16.04 12.06 11.09 -17.97 10.54 5.71 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 78 TYR.? 11.65 ZN ZN G2004 B 214 ASP G 53 ASP~? 4.94 ZN ZN G2004 B 256 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo -32.67 22.74 10.17 -32.85 23.98 7.70 42.29 -5.11 6.34 41.03 -7.11 7.84 coo -26.88 17.61 16.89 -26.08 17.11 15.00 38.40 -6.52 14.99 40.34 -7.05 14.26 coo -16.04 12.06 11.09 -17.97 10.54 5.71 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR B 32 TYR^? 21.26 ZN ZN G2004 B 214 ASP A 53 ASP~? 26.24 ZN ZN G2004 B 256 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo -32.67 22.74 10.17 -32.85 23.98 7.70 18.09 -5.37 18.66 18.87 -5.22 21.34 coo -26.88 17.61 16.89 -26.08 17.11 15.00 17.64 3.84 11.72 15.55 3.44 11.90 coo -16.04 12.06 11.09 -17.97 10.54 5.71 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR B 78 TYR.? 24.55 ZN ZN G2004 B 214 ASP H 53 ASP~? 26.49 ZN ZN B2003 B 256 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo -32.67 22.74 10.17 -32.85 23.98 7.70 27.46 -23.45 25.85 26.96 -25.77 24.34 coo -26.88 17.61 16.89 -26.08 17.11 15.00 22.01 -31.06 24.97 24.10 -31.35 25.29 coo -16.04 12.06 11.09 -17.97 10.54 5.71 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR C 32 TYR^? 15.32 ZN ZN B2003 B 214 ASP B 53 ASP~? 5.10 ZN ZN B2003 B 256 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.47 -31.95 16.21 3.09 -34.42 17.45 coo -26.88 17.61 16.89 -26.08 17.11 15.00 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR C 78 TYR^? 35.69 ZN ZN B2003 B 214 ASP I 53 ASP~? 35.51 ZN ZN J2001 B 256 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 16.52 -47.66 10.31 18.03 -47.38 7.99 coo -26.88 17.61 16.89 -26.08 17.11 15.00 15.88 -49.61 0.98 17.43 -49.51 2.42 coo -16.04 12.06 11.09 -17.97 10.54 5.71 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR D 32 TYR^? 29.54 ZN ZN J2001 B 214 ASP C 53 ASP~? 35.43 ZN ZN B2003 B 256 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo -32.67 22.74 10.17 -32.85 23.98 7.70 4.78 -40.18 -12.99 5.15 -42.55 -14.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR D 78 TYR.? 11.76 ZN ZN J2001 B 214 ASP J 53 ASP~? 5.09 ZN ZN J2001 B 256 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 24.81 -44.15 -19.15 26.32 -41.78 -18.93 coo -26.88 17.61 16.89 -26.08 17.11 15.00 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo -16.04 12.06 11.09 -17.97 10.54 5.71 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR E 32 TYR^? 21.25 ZN ZN J2001 B 214 ASP D 53 ASP~? 26.48 ZN ZN J2001 B 256 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 20.11 -18.94 -28.19 21.99 -18.75 -30.24 coo -26.88 17.61 16.89 -26.08 17.11 15.00 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo -16.04 12.06 11.09 -17.97 10.54 5.71 12.18 -35.43 -32.57 13.23 -33.76 -37.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR E 78 TYR.? 24.67 ZN ZN J2001 B 214 ASP F 53 ASP~? 26.13 ZN ZN E2002 B 256 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo -32.67 22.74 10.17 -32.85 23.98 7.70 40.71 -17.77 -21.60 40.95 -16.95 -18.92 coo -26.88 17.61 16.89 -26.08 17.11 15.00 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo -16.04 12.06 11.09 -17.97 10.54 5.71 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR F 32 TYR^? 15.23 ZN ZN G2004 B 214 ASP G 53 ASP~? 4.94 ZN ZN G2004 B 256 LYS G 47 LYS.? 12.02 ZN ZN G2004 coo -32.67 22.74 10.17 -32.85 23.98 7.70 36.01 -1.70 4.51 36.34 1.00 3.95 coo -26.88 17.61 16.89 -26.08 17.11 15.00 38.40 -6.52 14.99 40.34 -7.05 14.26 coo -16.04 12.06 11.09 -17.97 10.54 5.71 31.18 -0.58 22.88 32.81 3.34 24.43 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 12 3 # 12 B 122 TYR F 78 TYR.? 11.63 ZN ZN E2002 B 214 ASP E 53 ASP~? 5.07 ZN ZN E2002 B 256 LYS E 47 LYS.? 6.58 ZN ZN E2002 coo -32.67 22.74 10.17 -32.85 23.98 7.70 22.38 6.39 -10.32 21.34 4.29 -11.84 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.14 2.30 -18.88 21.70 3.71 -18.16 coo -16.04 12.06 11.09 -17.97 10.54 5.71 31.89 -0.94 -26.86 29.14 3.95 -26.91 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 13 3 # 13 B 122 TYR G 32 TYR^? 21.21 ZN ZN B2003 B 214 ASP H 53 ASP~? 26.49 ZN ZN B2003 B 256 LYS H 47 LYS.? 19.70 ZN ZN B2003 coo -32.67 22.74 10.17 -32.85 23.98 7.70 21.50 -19.82 24.15 20.71 -18.09 26.19 coo -26.88 17.61 16.89 -26.08 17.11 15.00 22.01 -31.06 24.97 24.10 -31.35 25.29 coo -16.04 12.06 11.09 -17.97 10.54 5.71 10.99 -34.83 28.58 12.07 -33.13 33.66 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 14 3 # 14 B 122 TYR G 78 TYR.? 24.68 ZN ZN B2003 B 214 ASP A 53 ASP~? 26.24 ZN ZN G2004 B 256 LYS A 47 LYS.? 18.77 ZN ZN G2004 coo -32.67 22.74 10.17 -32.85 23.98 7.70 12.17 -1.26 17.53 12.70 -0.59 14.88 coo -26.88 17.61 16.89 -26.08 17.11 15.00 17.64 3.84 11.72 15.55 3.44 11.90 coo -16.04 12.06 11.09 -17.97 10.54 5.71 28.57 8.89 11.92 28.49 10.48 16.93 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 15 3 # 15 B 122 TYR H 32 TYR^? 29.55 ZN ZN B2003 B 214 ASP I 53 ASP~? 35.51 ZN ZN J2001 B 256 LYS I 47 LYS.? 39.82 ZN ZN J2001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 10.73 -43.63 9.08 8.41 -44.48 10.38 coo -26.88 17.61 16.89 -26.08 17.11 15.00 15.88 -49.61 0.98 17.43 -49.51 2.42 coo -16.04 12.06 11.09 -17.97 10.54 5.71 7.62 -53.38 -6.85 6.38 -57.85 -3.68 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 16 3 # 16 B 122 TYR H 78 TYR.? 11.76 ZN ZN B2003 B 214 ASP B 53 ASP~? 5.10 ZN ZN B2003 B 256 LYS B 47 LYS.? 6.04 ZN ZN B2003 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -2.69 -28.08 15.14 -1.32 -25.64 14.90 coo -26.88 17.61 16.89 -26.08 17.11 15.00 1.23 -21.28 20.51 -0.75 -21.23 19.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 8.29 -20.33 30.47 2.92 -21.23 29.89 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 17 3 # 17 B 122 TYR I 32 TYR^? 15.25 ZN ZN J2001 B 214 ASP J 53 ASP~? 5.09 ZN ZN J2001 B 256 LYS J 47 LYS.? 6.30 ZN ZN J2001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 18.53 -40.66 -20.20 16.59 -42.17 -21.51 coo -26.88 17.61 16.89 -26.08 17.11 15.00 28.87 -37.23 -24.52 29.85 -38.89 -23.63 coo -16.04 12.06 11.09 -17.97 10.54 5.71 26.17 -30.49 -34.43 27.88 -35.84 -34.06 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 18 3 # 18 B 122 TYR I 78 TYR.? 35.62 ZN ZN J2001 B 214 ASP C 53 ASP~? 35.43 ZN ZN B2003 B 256 LYS C 47 LYS.? 38.38 ZN ZN B2003 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -3.27 -38.37 -5.09 -4.20 -36.97 -6.38 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -1.77 -47.88 3.17 -5.89 -51.57 3.00 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 19 3 # 19 B 122 TYR J 32 TYR^? 21.12 ZN ZN E2002 B 214 ASP F 53 ASP~? 26.13 ZN ZN E2002 B 256 LYS F 47 LYS.? 21.75 ZN ZN E2002 coo -32.67 22.74 10.17 -32.85 23.98 7.70 34.34 -14.57 -22.60 34.05 -13.83 -25.28 coo -26.88 17.61 16.89 -26.08 17.11 15.00 42.45 -10.50 -15.74 43.20 -12.48 -15.86 coo -16.04 12.06 11.09 -17.97 10.54 5.71 41.41 1.47 -15.85 45.79 3.58 -18.60 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 20 3 # 20 B 122 TYR J 78 TYR.? 24.76 ZN ZN E2002 B 214 ASP D 53 ASP~? 26.48 ZN ZN J2001 B 256 LYS D 47 LYS.? 19.69 ZN ZN J2001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo -26.88 17.61 16.89 -26.08 17.11 15.00 10.06 -24.15 -28.86 8.79 -22.48 -29.14 coo -16.04 12.06 11.09 -17.97 10.54 5.71 12.18 -35.43 -32.57 13.23 -33.76 -37.61 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 20 hits 2tpl_c05 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 9 ARG^? 24.21 ZN ZN E2002 127 ARG E 68 ARG^? 24.88 ZN ZN E2002 270 GLU A 70 GLU^? 23.78 ZN ZN G2004 coo -1.14 25.72 1.64 0.76 28.10 1.50 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.92 -8.51 2.63 23.34 -9.97 2.05 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG B 68 ARG^? 23.11 ZN ZN B2003 127 ARG C 9 ARG^? 24.24 ZN ZN B2003 270 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG B 68 ARG^? 23.11 ZN ZN B2003 127 ARG C 9 ARG^? 24.24 ZN ZN B2003 270 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 7.07 -21.17 3.13 9.35 -23.17 2.50 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG C 9 ARG^? 24.24 ZN ZN B2003 127 ARG B 68 ARG^? 23.11 ZN ZN B2003 270 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 9.32 -17.65 5.25 11.20 -19.96 4.50 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG C 9 ARG^? 24.24 ZN ZN B2003 127 ARG B 68 ARG^? 23.11 ZN ZN B2003 270 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 9.32 -17.65 5.25 11.20 -19.96 4.50 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG C 68 ARG^? 29.54 ZN ZN B2003 127 ARG D 9 ARG^? 32.06 ZN ZN J2001 270 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo -1.14 25.72 1.64 0.76 28.10 1.50 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG H 9 ARG^? 32.17 ZN ZN B2003 127 ARG I 68 ARG^? 29.76 ZN ZN J2001 270 GLU H 70 GLU^? 24.54 ZN ZN B2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 17.08 -28.12 10.05 16.94 -27.02 8.23 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG I 9 ARG^? 24.03 ZN ZN J2001 127 ARG J 68 ARG^? 19.63 ZN ZN J2001 270 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo -1.14 25.72 1.64 0.76 28.10 1.50 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 15.16 -26.68 -14.16 16.30 -26.65 -12.35 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 9 3 # 9 71 ARG I 9 ARG^? 24.03 ZN ZN J2001 127 ARG J 68 ARG^? 19.63 ZN ZN J2001 270 GLU I 70 GLU^? 28.28 ZN ZN J2001 coo -1.14 25.72 1.64 0.76 28.10 1.50 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 16.40 -34.53 -4.29 16.28 -32.45 -4.67 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 10 3 # 10 71 ARG I 68 ARG^? 29.76 ZN ZN J2001 127 ARG H 9 ARG^? 32.17 ZN ZN B2003 270 GLU C 70 GLU^? 28.30 ZN ZN B2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 23.61 -33.80 3.29 21.83 -31.31 3.74 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 9.84 -30.97 0.37 11.69 -30.07 0.80 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 11 3 # 11 71 ARG J 68 ARG^? 19.63 ZN ZN J2001 127 ARG I 9 ARG^? 24.03 ZN ZN J2001 270 GLU D 70 GLU^? 24.25 ZN ZN J2001 coo -1.14 25.72 1.64 0.76 28.10 1.50 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 15.16 -26.68 -14.16 16.30 -26.65 -12.35 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 11 hits 5cpa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 13 ASN.? 18.92 ZN ZN E2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 10.06 -0.38 -14.52 8.62 -0.07 -12.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN B 13 ASN.? 30.05 ZN ZN B2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 7.00 0.81 3.82 5.31 -0.29 3.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN C 13 ASN~? 18.60 ZN ZN B2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.99 -14.51 9.33 -4.22 -14.45 7.58 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN D 13 ASN.? 32.45 ZN ZN B2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.19 -25.17 -6.31 -5.74 -23.25 -7.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN E 13 ASN.? 29.96 ZN ZN E2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.16 -16.32 -20.92 1.73 -14.91 -19.36 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN F 13 ASN.? 18.86 ZN ZN G2004 coo 5.80 63.03 55.85 5.52 65.03 56.45 42.65 -19.04 10.62 42.72 -20.75 9.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN G 13 ASN.? 29.78 ZN ZN G2004 coo 5.80 63.03 55.85 5.52 65.03 56.45 32.81 -34.02 16.87 34.16 -33.61 15.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN H 13 ASN.? 32.33 ZN ZN J2001 coo 5.80 63.03 55.85 5.52 65.03 56.45 28.96 -45.87 2.39 30.48 -44.50 3.04 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN I 13 ASN.? 18.64 ZN ZN J2001 coo 5.80 63.03 55.85 5.52 65.03 56.45 36.86 -37.66 -13.37 37.50 -38.40 -11.47 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN J 13 ASN.? 30.13 ZN ZN J2001 coo 5.80 63.03 55.85 5.52 65.03 56.45 45.13 -21.25 -7.78 45.09 -23.23 -6.98 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 10 hits 1kbk_p00 naa= 1 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 76 ARG^? 8.06 ZN ZN G2004 A 188 TYR F 32 TYR^? 15.23 ZN ZN G2004 A 190 SER F 33 SER^? 10.76 ZN ZN G2004 coo 37.69 7.64 13.51 38.82 8.84 16.11 40.48 -5.18 11.11 43.34 -6.18 11.48 coo 47.14 12.10 13.73 48.75 12.33 16.01 36.01 -1.70 4.51 36.34 1.00 3.95 coo 43.77 6.93 15.46 45.49 7.21 17.11 36.12 -6.61 7.18 37.60 -7.96 8.48 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG B 76 ARG^? 28.58 ZN ZN B2003 A 188 TYR G 32 TYR^? 21.21 ZN ZN B2003 A 190 SER G 33 SER^? 25.21 ZN ZN B2003 coo 37.69 7.64 13.51 38.82 8.84 16.11 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 47.14 12.10 13.73 48.75 12.33 16.01 21.50 -19.82 24.15 20.71 -18.09 26.19 coo 43.77 6.93 15.46 45.49 7.21 17.11 23.02 -24.31 21.04 24.40 -26.04 22.01 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG D 76 ARG^? 8.12 ZN ZN J2001 A 188 TYR I 32 TYR^? 15.25 ZN ZN J2001 A 190 SER I 33 SER^? 10.94 ZN ZN J2001 coo 37.69 7.64 13.51 38.82 8.84 16.11 27.03 -40.97 -22.65 29.39 -42.82 -22.15 coo 47.14 12.10 13.73 48.75 12.33 16.01 18.53 -40.66 -20.20 16.59 -42.17 -21.51 coo 43.77 6.93 15.46 45.49 7.21 17.11 23.35 -37.96 -18.73 25.76 -37.61 -18.66 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG E 76 ARG^? 28.35 ZN ZN E2002 A 188 TYR J 32 TYR^? 21.12 ZN ZN E2002 A 190 SER J 33 SER^? 25.08 ZN ZN E2002 coo 37.69 7.64 13.51 38.82 8.84 16.11 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 47.14 12.10 13.73 48.75 12.33 16.01 34.34 -14.57 -22.60 34.05 -13.83 -25.28 coo 43.77 6.93 15.46 45.49 7.21 17.11 36.27 -15.21 -17.30 38.62 -15.44 -16.82 ULMN 3 2p3i_p00 VP4 user 5 3 # 5 A 101 ARG F 76 ARG^? 8.13 ZN ZN E2002 A 188 TYR A 32 TYR^? 15.05 ZN ZN E2002 A 190 SER A 33 SER^? 10.82 ZN ZN E2002 coo 37.69 7.64 13.51 38.82 8.84 16.11 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 47.14 12.10 13.73 48.75 12.33 16.01 28.44 2.72 -8.58 30.61 4.34 -7.97 coo 43.77 6.93 15.46 45.49 7.21 17.11 24.11 0.27 -11.15 22.21 1.00 -12.37 ULMN 3 2p3i_p00 VP4 user 6 3 # 6 A 101 ARG G 76 ARG^? 28.48 ZN ZN G2004 A 188 TYR B 32 TYR^? 21.26 ZN ZN G2004 A 190 SER B 33 SER^? 25.06 ZN ZN G2004 coo 37.69 7.64 13.51 38.82 8.84 16.11 15.16 1.90 14.98 12.60 3.57 14.85 coo 47.14 12.10 13.73 48.75 12.33 16.01 18.09 -5.37 18.66 18.87 -5.22 21.34 coo 43.77 6.93 15.46 45.49 7.21 17.11 16.53 -3.90 13.46 15.60 -2.57 11.76 ULMN 3 2p3i_p00 VP4 user 7 3 # 7 A 101 ARG H 76 ARG^? 8.16 ZN ZN B2003 A 188 TYR C 32 TYR^? 15.32 ZN ZN B2003 A 190 SER C 33 SER^? 10.88 ZN ZN B2003 coo 37.69 7.64 13.51 38.82 8.84 16.11 -1.06 -24.66 18.73 -3.81 -23.46 18.10 coo 47.14 12.10 13.73 48.75 12.33 16.01 3.47 -31.95 16.21 3.09 -34.42 17.45 coo 43.77 6.93 15.46 45.49 7.21 17.11 3.43 -26.43 14.79 2.44 -24.23 14.78 ULMN 3 2p3i_p00 VP4 user 8 3 # 8 A 101 ARG J 76 ARG^? 28.65 ZN ZN J2001 A 188 TYR E 32 TYR^? 21.25 ZN ZN J2001 A 190 SER E 33 SER^? 25.01 ZN ZN J2001 coo 37.69 7.64 13.51 38.82 8.84 16.11 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 47.14 12.10 13.73 48.75 12.33 16.01 20.11 -18.94 -28.19 21.99 -18.75 -30.24 coo 43.77 6.93 15.46 45.49 7.21 17.11 15.44 -19.85 -25.13 13.12 -20.20 -24.71 2p3i_p00 source 2p3i VP4 : 8 hits 2p3i_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 9 ARG^? 24.21 ZN ZN E2002 B 6 THR A 69 THR^? 26.27 ZN ZN E2002 B 8 THR A 71 THR^? 21.22 ZN ZN G2004 coo 40.52 16.08 100.90 37.97 16.41 102.60 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 36.11 13.64 95.03 34.54 14.86 95.91 18.03 -4.50 0.71 18.21 -2.81 2.09 coo 32.72 8.05 92.39 31.25 9.11 91.35 23.68 -4.10 4.25 23.22 -2.25 5.25 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 9 ARG^? 24.21 ZN ZN E2002 B 6 THR E 69 THR^? 16.01 ZN ZN E2002 B 8 THR E 71 THR^? 13.78 ZN ZN E2002 coo 40.52 16.08 100.90 37.97 16.41 102.60 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 36.11 13.64 95.03 34.54 14.86 95.91 17.79 -10.58 -14.66 18.15 -8.82 -15.96 coo 32.72 8.05 92.39 31.25 9.11 91.35 24.40 -10.24 -16.13 24.48 -8.33 -17.23 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG B 9 ARG^? 25.60 ZN ZN B2003 B 6 THR B 69 THR^? 16.06 ZN ZN B2003 B 8 THR B 71 THR^? 13.82 ZN ZN B2003 coo 40.52 16.08 100.90 37.97 16.41 102.60 12.25 -11.70 3.79 14.09 -14.14 4.30 coo 36.11 13.64 95.03 34.54 14.86 95.91 9.70 -15.82 10.21 8.54 -15.58 12.01 coo 32.72 8.05 92.39 31.25 9.11 91.35 12.70 -19.33 15.10 11.14 -19.20 16.66 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG C 9 ARG^? 24.24 ZN ZN B2003 B 6 THR B 69 THR^? 16.06 ZN ZN B2003 B 8 THR B 71 THR^? 13.82 ZN ZN B2003 coo 40.52 16.08 100.90 37.97 16.41 102.60 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 36.11 13.64 95.03 34.54 14.86 95.91 9.70 -15.82 10.21 8.54 -15.58 12.01 coo 32.72 8.05 92.39 31.25 9.11 91.35 12.70 -19.33 15.10 11.14 -19.20 16.66 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG C 9 ARG^? 24.24 ZN ZN B2003 B 6 THR C 69 THR^? 25.61 ZN ZN B2003 B 8 THR C 71 THR^? 28.45 ZN ZN B2003 coo 40.52 16.08 100.90 37.97 16.41 102.60 7.07 -21.17 3.13 9.35 -23.17 2.50 coo 36.11 13.64 95.03 34.54 14.86 95.91 4.35 -28.40 0.65 2.70 -29.74 0.98 coo 32.72 8.05 92.39 31.25 9.11 91.35 6.76 -34.52 1.34 4.84 -35.45 1.00 ULMN 3 1b01_d00 GENE REGULATION/DNA user 6 3 # 6 B 4 ARG C 68 ARG^? 29.54 ZN ZN B2003 B 6 THR C 71 THR^? 28.45 ZN ZN B2003 B 8 THR H 35 THR.? 33.55 ZN ZN J2001 coo 40.52 16.08 100.90 37.97 16.41 102.60 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 36.11 13.64 95.03 34.54 14.86 95.91 6.76 -34.52 1.34 4.84 -35.45 1.00 coo 32.72 8.05 92.39 31.25 9.11 91.35 13.28 -39.16 0.08 11.42 -39.66 -0.90 ULMN 3 1b01_d00 GENE REGULATION/DNA user 7 3 # 7 B 4 ARG D 9 ARG^? 32.06 ZN ZN J2001 B 6 THR C 69 THR^? 25.61 ZN ZN B2003 B 8 THR C 71 THR^? 28.45 ZN ZN B2003 coo 40.52 16.08 100.90 37.97 16.41 102.60 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 36.11 13.64 95.03 34.54 14.86 95.91 4.35 -28.40 0.65 2.70 -29.74 0.98 coo 32.72 8.05 92.39 31.25 9.11 91.35 6.76 -34.52 1.34 4.84 -35.45 1.00 ULMN 3 1b01_d00 GENE REGULATION/DNA user 8 3 # 8 B 4 ARG D 9 ARG^? 32.06 ZN ZN J2001 B 6 THR D 69 THR^? 27.18 ZN ZN J2001 B 8 THR D 71 THR^? 21.16 ZN ZN J2001 coo 40.52 16.08 100.90 37.97 16.41 102.60 6.94 -24.21 -7.19 9.96 -24.60 -7.73 coo 36.11 13.64 95.03 34.54 14.86 95.91 9.39 -25.08 -15.29 8.95 -25.33 -17.44 coo 32.72 8.05 92.39 31.25 9.11 91.35 13.92 -28.99 -18.23 13.08 -28.88 -20.23 ULMN 3 1b01_d00 GENE REGULATION/DNA user 9 3 # 9 B 4 ARG E 9 ARG^? 26.78 ZN ZN E2002 B 6 THR D 69 THR^? 27.18 ZN ZN J2001 B 8 THR D 71 THR^? 21.16 ZN ZN J2001 coo 40.52 16.08 100.90 37.97 16.41 102.60 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 36.11 13.64 95.03 34.54 14.86 95.91 9.39 -25.08 -15.29 8.95 -25.33 -17.44 coo 32.72 8.05 92.39 31.25 9.11 91.35 13.92 -28.99 -18.23 13.08 -28.88 -20.23 ULMN 3 1b01_d00 GENE REGULATION/DNA user 10 3 # 10 B 4 ARG E 9 ARG^? 26.78 ZN ZN E2002 B 6 THR E 69 THR^? 16.01 ZN ZN E2002 B 8 THR E 71 THR^? 13.78 ZN ZN E2002 coo 40.52 16.08 100.90 37.97 16.41 102.60 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 36.11 13.64 95.03 34.54 14.86 95.91 17.79 -10.58 -14.66 18.15 -8.82 -15.96 coo 32.72 8.05 92.39 31.25 9.11 91.35 24.40 -10.24 -16.13 24.48 -8.33 -17.23 ULMN 3 1b01_d00 GENE REGULATION/DNA user 11 3 # 11 B 4 ARG F 9 ARG^? 24.10 ZN ZN G2004 B 6 THR F 69 THR^? 26.39 ZN ZN G2004 B 8 THR F 71 THR^? 20.96 ZN ZN E2002 coo 40.52 16.08 100.90 37.97 16.41 102.60 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 36.11 13.64 95.03 34.54 14.86 95.91 35.08 -14.35 -4.72 36.44 -13.45 -6.17 coo 32.72 8.05 92.39 31.25 9.11 91.35 32.58 -9.20 -8.27 34.39 -8.53 -9.31 ULMN 3 1b01_d00 GENE REGULATION/DNA user 12 3 # 12 B 4 ARG F 9 ARG^? 24.10 ZN ZN G2004 B 6 THR G 69 THR^? 15.88 ZN ZN G2004 B 8 THR G 71 THR^? 13.81 ZN ZN G2004 coo 40.52 16.08 100.90 37.97 16.41 102.60 32.42 -18.19 2.00 30.08 -17.10 0.27 coo 36.11 13.64 95.03 34.54 14.86 95.91 29.93 -17.60 10.74 31.15 -16.29 12.05 coo 32.72 8.05 92.39 31.25 9.11 91.35 26.87 -11.68 12.08 28.45 -10.63 13.19 ULMN 3 1b01_d00 GENE REGULATION/DNA user 13 3 # 13 B 4 ARG G 9 ARG^? 25.73 ZN ZN G2004 B 6 THR G 69 THR^? 15.88 ZN ZN G2004 B 8 THR G 71 THR^? 13.81 ZN ZN G2004 coo 40.52 16.08 100.90 37.97 16.41 102.60 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 36.11 13.64 95.03 34.54 14.86 95.91 29.93 -17.60 10.74 31.15 -16.29 12.05 coo 32.72 8.05 92.39 31.25 9.11 91.35 26.87 -11.68 12.08 28.45 -10.63 13.19 ULMN 3 1b01_d00 GENE REGULATION/DNA user 14 3 # 14 B 4 ARG G 9 ARG^? 25.73 ZN ZN G2004 B 6 THR H 69 THR^? 27.20 ZN ZN B2003 B 8 THR H 71 THR^? 21.04 ZN ZN B2003 coo 40.52 16.08 100.90 37.97 16.41 102.60 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 36.11 13.64 95.03 34.54 14.86 95.91 21.51 -32.17 11.34 21.52 -32.68 13.48 coo 32.72 8.05 92.39 31.25 9.11 91.35 15.82 -30.13 14.22 16.16 -30.88 16.24 ULMN 3 1b01_d00 GENE REGULATION/DNA user 15 3 # 15 B 4 ARG H 9 ARG^? 32.17 ZN ZN B2003 B 6 THR H 69 THR^? 27.20 ZN ZN B2003 B 8 THR H 71 THR^? 21.04 ZN ZN B2003 coo 40.52 16.08 100.90 37.97 16.41 102.60 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 36.11 13.64 95.03 34.54 14.86 95.91 21.51 -32.17 11.34 21.52 -32.68 13.48 coo 32.72 8.05 92.39 31.25 9.11 91.35 15.82 -30.13 14.22 16.16 -30.88 16.24 ULMN 3 1b01_d00 GENE REGULATION/DNA user 16 3 # 16 B 4 ARG H 9 ARG^? 32.17 ZN ZN B2003 B 6 THR I 69 THR^? 27.03 ZN ZN J2001 B 8 THR I 71 THR^? 28.48 ZN ZN J2001 coo 40.52 16.08 100.90 37.97 16.41 102.60 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 36.11 13.64 95.03 34.54 14.86 95.91 21.24 -38.06 -4.56 20.38 -39.74 -3.52 coo 32.72 8.05 92.39 31.25 9.11 91.35 14.74 -39.08 -5.30 14.88 -41.19 -4.86 ULMN 3 1b01_d00 GENE REGULATION/DNA user 17 3 # 17 B 4 ARG I 9 ARG^? 24.03 ZN ZN J2001 B 6 THR I 69 THR^? 27.03 ZN ZN J2001 B 8 THR I 71 THR^? 28.48 ZN ZN J2001 coo 40.52 16.08 100.90 37.97 16.41 102.60 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 36.11 13.64 95.03 34.54 14.86 95.91 21.24 -38.06 -4.56 20.38 -39.74 -3.52 coo 32.72 8.05 92.39 31.25 9.11 91.35 14.74 -39.08 -5.30 14.88 -41.19 -4.86 ULMN 3 1b01_d00 GENE REGULATION/DNA user 18 3 # 18 B 4 ARG I 9 ARG^? 24.03 ZN ZN J2001 B 6 THR J 69 THR^? 15.86 ZN ZN J2001 B 8 THR J 71 THR^? 13.85 ZN ZN J2001 coo 40.52 16.08 100.90 37.97 16.41 102.60 26.01 -32.03 -7.10 23.09 -31.05 -6.77 coo 36.11 13.64 95.03 34.54 14.86 95.91 29.38 -27.38 -14.35 29.15 -29.28 -15.43 coo 32.72 8.05 92.39 31.25 9.11 91.35 24.87 -26.33 -19.10 25.70 -27.64 -20.65 ULMN 3 1b01_d00 GENE REGULATION/DNA user 19 3 # 19 B 4 ARG J 9 ARG^? 25.67 ZN ZN J2001 B 6 THR F 69 THR^? 26.39 ZN ZN G2004 B 8 THR F 71 THR^? 20.96 ZN ZN E2002 coo 40.52 16.08 100.90 37.97 16.41 102.60 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 36.11 13.64 95.03 34.54 14.86 95.91 35.08 -14.35 -4.72 36.44 -13.45 -6.17 coo 32.72 8.05 92.39 31.25 9.11 91.35 32.58 -9.20 -8.27 34.39 -8.53 -9.31 ULMN 3 1b01_d00 GENE REGULATION/DNA user 20 3 # 20 B 4 ARG J 9 ARG^? 25.67 ZN ZN J2001 B 6 THR J 69 THR^? 15.86 ZN ZN J2001 B 8 THR J 71 THR^? 13.85 ZN ZN J2001 coo 40.52 16.08 100.90 37.97 16.41 102.60 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 36.11 13.64 95.03 34.54 14.86 95.91 29.38 -27.38 -14.35 29.15 -29.28 -15.43 coo 32.72 8.05 92.39 31.25 9.11 91.35 24.87 -26.33 -19.10 25.70 -27.64 -20.65 1b01_d00 source 1b01 GENE REGULATION/DNA : 20 hits 1b01_d00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 16 GLN~? 8.86 ZN ZN E2002 A 11 ASN A 13 ASN.? 18.92 ZN ZN E2002 A 13 ARG A 11 ARG.? 22.81 ZN ZN E2002 coo 33.45 2.10 7.21 34.51 1.09 5.67 17.90 4.40 -14.76 17.54 4.89 -16.79 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 10.06 -0.38 -14.52 8.62 -0.07 -12.98 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 8.14 -2.39 -10.44 6.98 -0.33 -8.47 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN C 16 GLN~? 8.88 ZN ZN B2003 A 11 ASN C 13 ASN~? 18.60 ZN ZN B2003 A 13 ARG C 11 ARG~? 22.62 ZN ZN B2003 coo 33.45 2.10 7.21 34.51 1.09 5.67 -3.18 -21.19 15.30 -3.89 -19.78 16.71 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -2.99 -14.51 9.33 -4.22 -14.45 7.58 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -1.98 -15.22 3.59 -4.40 -16.94 2.77 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 3 3 # 3 A 9 GLN C 58 GLN.? 34.39 ZN ZN B2003 A 11 ASN D 13 ASN.? 32.45 ZN ZN B2003 A 13 ARG D 11 ARG.? 35.27 ZN ZN B2003 coo 33.45 2.10 7.21 34.51 1.09 5.67 -8.49 -33.56 -4.21 -7.44 -34.28 -5.93 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -6.19 -25.17 -6.31 -5.74 -23.25 -7.14 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -3.12 -21.06 -7.48 -4.20 -20.85 -10.34 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 4 3 # 4 A 9 GLN C 58 GLN.? 34.39 ZN ZN B2003 A 11 ASN D 13 ASN.? 32.45 ZN ZN B2003 A 13 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo 33.45 2.10 7.21 34.51 1.09 5.67 -8.49 -33.56 -4.21 -7.44 -34.28 -5.93 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -6.19 -25.17 -6.31 -5.74 -23.25 -7.14 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 5 3 # 5 A 9 GLN F 16 GLN~? 8.74 ZN ZN G2004 A 11 ASN F 13 ASN.? 18.86 ZN ZN G2004 A 13 ARG F 11 ARG.? 21.89 ZN ZN G2004 coo 33.45 2.10 7.21 34.51 1.09 5.67 43.08 -9.74 10.82 43.38 -10.14 12.88 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 42.65 -19.04 10.62 42.72 -20.75 9.34 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 41.25 -22.37 6.05 44.11 -21.50 5.36 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 6 3 # 6 A 9 GLN I 16 GLN~? 8.71 ZN ZN J2001 A 11 ASN I 13 ASN.? 18.64 ZN ZN J2001 A 13 ARG I 11 ARG.? 22.73 ZN ZN J2001 coo 33.45 2.10 7.21 34.51 1.09 5.67 31.04 -41.10 -19.37 32.61 -40.90 -20.76 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 36.86 -37.66 -13.37 37.50 -38.40 -11.47 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 35.67 -37.65 -8.31 35.98 -40.29 -6.76 1bdv_d00 source 1bdv GENE REGULATION/DNA : 6 hits 1bdv_d00 naa= 3 ULMN 4 1cf7_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 17 ARG A 11 ARG.? 22.81 ZN ZN E2002 A 56 ARG E 9 ARG^? 26.78 ZN ZN E2002 A 57 ARG E 68 ARG^? 24.88 ZN ZN E2002 A 59 TYR E 38 TYR.? 23.24 ZN ZN E2002 coo 23.81 34.86 13.48 26.88 35.12 13.67 8.14 -2.39 -10.44 6.98 -0.33 -8.47 coo 34.72 21.75 14.37 35.68 23.54 16.67 12.49 -16.84 -13.02 14.60 -17.67 -10.91 coo 28.85 24.84 16.33 31.23 25.02 14.35 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 34.87 18.31 18.80 34.65 15.66 17.89 18.24 -17.31 -15.44 18.90 -15.79 -13.18 ULMN 4 1cf7_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 17 ARG B 68 ARG^? 23.11 ZN ZN B2003 A 56 ARG A 9 ARG^? 24.21 ZN ZN E2002 A 57 ARG A 68 ARG^? 28.72 ZN ZN B2003 A 59 TYR A 38 TYR.? 23.20 ZN ZN E2002 coo 23.81 34.86 13.48 26.88 35.12 13.67 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 34.72 21.75 14.37 35.68 23.54 16.67 15.84 -8.62 -5.83 17.97 -10.19 -4.21 coo 28.85 24.84 16.33 31.23 25.02 14.35 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 34.87 18.31 18.80 34.65 15.66 17.89 21.46 -7.15 -4.15 20.57 -8.66 -1.95 ULMN 4 1cf7_d00 TRANSCRIPTION/DNA user 3 4 # 3 A 17 ARG C 68 ARG^? 29.54 ZN ZN B2003 A 56 ARG B 9 ARG^? 25.60 ZN ZN B2003 A 57 ARG B 68 ARG^? 23.11 ZN ZN B2003 A 59 TYR B 38 TYR.? 23.16 ZN ZN B2003 coo 23.81 34.86 13.48 26.88 35.12 13.67 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 34.72 21.75 14.37 35.68 23.54 16.67 12.25 -11.70 3.79 14.09 -14.14 4.30 coo 28.85 24.84 16.33 31.23 25.02 14.35 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 34.87 18.31 18.80 34.65 15.66 17.89 15.69 -13.23 8.64 14.60 -15.68 7.86 ULMN 4 1cf7_d00 TRANSCRIPTION/DNA user 4 4 # 4 A 17 ARG I 11 ARG.? 22.73 ZN ZN J2001 A 56 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 57 ARG J 68 ARG^? 19.63 ZN ZN J2001 A 59 TYR J 38 TYR.? 23.16 ZN ZN J2001 coo 23.81 34.86 13.48 26.88 35.12 13.67 35.67 -37.65 -8.31 35.98 -40.29 -6.76 coo 34.72 21.75 14.37 35.68 23.54 16.67 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 28.85 24.84 16.33 31.23 25.02 14.35 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 34.87 18.31 18.80 34.65 15.66 17.89 28.75 -20.75 -12.61 27.09 -22.87 -11.86 ULMN 4 1cf7_d00 TRANSCRIPTION/DNA user 5 4 # 5 A 17 ARG J 9 ARG^? 25.67 ZN ZN J2001 A 56 ARG G 9 ARG^? 25.73 ZN ZN G2004 A 57 ARG G 68 ARG^? 22.94 ZN ZN G2004 A 59 TYR G 38 TYR.? 23.24 ZN ZN G2004 coo 23.81 34.86 13.48 26.88 35.12 13.67 31.54 -22.75 -7.85 28.47 -22.56 -8.20 coo 34.72 21.75 14.37 35.68 23.54 16.67 26.96 -25.00 8.90 25.51 -22.83 7.22 coo 28.85 24.84 16.33 31.23 25.02 14.35 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 34.87 18.31 18.80 34.65 15.66 17.89 23.80 -20.63 11.40 24.84 -19.26 9.19 1cf7_d00 source 1cf7 TRANSCRIPTION/DNA : 5 hits 1cf7_d00 naa= 4 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 32 TYR^? 15.05 ZN ZN E2002 I 306 VAL A 41 VAL^? 18.95 ZN ZN E2002 I 308 VAL A 6 VAL^? 23.88 ZN ZN G2004 coo 26.18 35.24 6.87 24.33 35.18 8.97 28.44 2.72 -8.58 30.61 4.34 -7.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.91 -0.75 -4.52 26.68 -2.10 -4.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.06 -1.30 0.85 22.64 -0.11 2.05 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 38 TYR.? 23.20 ZN ZN E2002 I 306 VAL A 6 VAL^? 23.88 ZN ZN G2004 I 308 VAL A 31 VAL^? 16.73 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.06 -1.30 0.85 22.64 -0.11 2.05 coo 16.43 30.18 9.35 15.05 30.67 11.01 25.78 4.70 -5.73 23.63 5.19 -5.62 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 38 TYR.? 23.20 ZN ZN E2002 I 306 VAL A 41 VAL^? 18.95 ZN ZN E2002 I 308 VAL A 31 VAL^? 16.73 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.91 -0.75 -4.52 26.68 -2.10 -4.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 25.78 4.70 -5.73 23.63 5.19 -5.62 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 78 TYR.? 11.65 ZN ZN G2004 I 306 VAL F 31 VAL^? 16.82 ZN ZN G2004 I 308 VAL F 28 VAL^? 22.38 ZN ZN G2004 coo 26.18 35.24 6.87 24.33 35.18 8.97 42.29 -5.11 6.34 41.03 -7.11 7.84 coo 23.55 29.53 9.81 23.15 27.39 10.24 39.10 -2.99 1.69 40.66 -4.55 1.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 42.15 -1.51 -4.33 42.08 -3.31 -3.05 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 78 TYR.? 11.65 ZN ZN G2004 I 306 VAL F 31 VAL^? 16.82 ZN ZN G2004 I 308 VAL F 41 VAL^? 18.99 ZN ZN G2004 coo 26.18 35.24 6.87 24.33 35.18 8.97 42.29 -5.11 6.34 41.03 -7.11 7.84 coo 23.55 29.53 9.81 23.15 27.39 10.24 39.10 -2.99 1.69 40.66 -4.55 1.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 34.81 -6.51 0.56 32.76 -5.67 0.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 32 TYR^? 21.26 ZN ZN G2004 I 306 VAL B 41 VAL^? 21.13 ZN ZN B2003 I 308 VAL B 6 VAL^? 15.49 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.09 -5.37 18.66 18.87 -5.22 21.34 coo 23.55 29.53 9.81 23.15 27.39 10.24 15.29 -10.10 15.43 17.22 -11.17 15.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.94 -14.95 16.15 10.74 -15.07 16.59 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 38 TYR.? 23.16 ZN ZN B2003 I 306 VAL B 6 VAL^? 15.49 ZN ZN B2003 I 308 VAL B 31 VAL^? 19.97 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.94 -14.95 16.15 10.74 -15.07 16.59 coo 16.43 30.18 9.35 15.05 30.67 11.01 13.91 -6.57 19.51 11.87 -6.02 18.72 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 38 TYR.? 23.16 ZN ZN B2003 I 306 VAL B 41 VAL^? 21.13 ZN ZN B2003 I 308 VAL B 31 VAL^? 19.97 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 23.55 29.53 9.81 23.15 27.39 10.24 15.29 -10.10 15.43 17.22 -11.17 15.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 13.91 -6.57 19.51 11.87 -6.02 18.72 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 78 TYR.? 24.55 ZN ZN G2004 I 306 VAL G 31 VAL^? 20.00 ZN ZN G2004 I 308 VAL G 28 VAL^? 14.29 ZN ZN G2004 coo 26.18 35.24 6.87 24.33 35.18 8.97 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 23.55 29.53 9.81 23.15 27.39 10.24 25.63 -18.28 23.97 27.74 -19.12 23.92 coo 16.43 30.18 9.35 15.05 30.67 11.01 29.79 -12.45 24.77 30.27 -14.26 23.65 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 78 TYR.? 24.55 ZN ZN G2004 I 306 VAL G 31 VAL^? 20.00 ZN ZN G2004 I 308 VAL G 41 VAL^? 21.16 ZN ZN G2004 coo 26.18 35.24 6.87 24.33 35.18 8.97 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 23.55 29.53 9.81 23.15 27.39 10.24 25.63 -18.28 23.97 27.74 -19.12 23.92 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.30 -18.31 18.59 22.31 -17.55 17.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR C 32 TYR^? 15.32 ZN ZN B2003 I 306 VAL C 41 VAL^? 19.02 ZN ZN B2003 I 308 VAL C 6 VAL^? 24.46 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.47 -31.95 16.21 3.09 -34.42 17.45 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.65 -30.91 9.92 6.78 -31.40 10.19 coo 16.43 30.18 9.35 15.05 30.67 11.01 4.66 -33.71 5.14 2.84 -33.92 3.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR C 38 TYR.? 23.27 ZN ZN B2003 I 306 VAL C 6 VAL^? 24.46 ZN ZN B2003 I 308 VAL C 31 VAL^? 16.84 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.66 -33.71 5.14 2.84 -33.92 3.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 0.45 -32.72 13.09 -1.06 -31.52 12.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR C 38 TYR.? 23.27 ZN ZN B2003 I 306 VAL C 41 VAL^? 19.02 ZN ZN B2003 I 308 VAL C 31 VAL^? 16.84 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.65 -30.91 9.92 6.78 -31.40 10.19 coo 16.43 30.18 9.35 15.05 30.67 11.01 0.45 -32.72 13.09 -1.06 -31.52 12.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR C 78 TYR^? 35.69 ZN ZN B2003 I 306 VAL H 31 VAL^? 30.05 ZN ZN B2003 I 308 VAL H 28 VAL^? 27.00 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.52 -47.66 10.31 18.03 -47.38 7.99 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.88 -43.40 12.62 16.08 -43.65 12.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 14.07 -42.10 19.23 15.51 -42.13 17.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR D 32 TYR^? 29.54 ZN ZN J2001 I 306 VAL D 41 VAL^? 26.97 ZN ZN J2001 I 308 VAL D 6 VAL^? 24.03 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 4.78 -40.18 -12.99 5.15 -42.55 -14.41 coo 23.55 29.53 9.81 23.15 27.39 10.24 7.29 -34.49 -13.77 9.09 -35.46 -13.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.27 -31.49 -17.49 9.28 -30.24 -19.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR D 38 TYR.? 28.62 ZN ZN J2001 I 306 VAL D 6 VAL^? 24.03 ZN ZN J2001 I 308 VAL D 31 VAL^? 29.92 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.18 -28.96 -9.74 11.62 -26.73 -10.53 coo 23.55 29.53 9.81 23.15 27.39 10.24 10.27 -31.49 -17.49 9.28 -30.24 -19.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.59 -37.71 -16.46 2.03 -36.23 -16.97 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR D 38 TYR.? 28.62 ZN ZN J2001 I 306 VAL D 41 VAL^? 26.97 ZN ZN J2001 I 308 VAL D 31 VAL^? 29.92 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.18 -28.96 -9.74 11.62 -26.73 -10.53 coo 23.55 29.53 9.81 23.15 27.39 10.24 7.29 -34.49 -13.77 9.09 -35.46 -13.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.59 -37.71 -16.46 2.03 -36.23 -16.97 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR D 78 TYR.? 11.76 ZN ZN J2001 I 306 VAL I 31 VAL^? 16.86 ZN ZN J2001 I 308 VAL I 28 VAL^? 22.52 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 24.81 -44.15 -19.15 26.32 -41.78 -18.93 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.25 -43.63 -17.09 21.00 -44.45 -16.01 coo 16.43 30.18 9.35 15.05 30.67 11.01 16.51 -48.99 -13.37 18.29 -47.72 -13.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR D 78 TYR.? 11.76 ZN ZN J2001 I 306 VAL I 31 VAL^? 16.86 ZN ZN J2001 I 308 VAL I 41 VAL^? 18.93 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 24.81 -44.15 -19.15 26.32 -41.78 -18.93 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.25 -43.63 -17.09 21.00 -44.45 -16.01 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.91 -39.12 -13.88 17.36 -37.59 -14.27 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR E 32 TYR^? 21.25 ZN ZN J2001 I 306 VAL E 41 VAL^? 21.18 ZN ZN E2002 I 308 VAL E 6 VAL^? 15.47 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.11 -18.94 -28.19 21.99 -18.75 -30.24 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.96 -15.78 -22.50 21.67 -17.08 -21.86 coo 16.43 30.18 9.35 15.05 30.67 11.01 22.40 -11.70 -19.81 21.66 -9.59 -20.08 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR E 38 TYR.? 23.24 ZN ZN E2002 I 306 VAL E 6 VAL^? 15.47 ZN ZN E2002 I 308 VAL E 31 VAL^? 20.05 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 23.55 29.53 9.81 23.15 27.39 10.24 22.40 -11.70 -19.81 21.66 -9.59 -20.08 coo 16.43 30.18 9.35 15.05 30.67 11.01 19.36 -14.61 -27.96 17.59 -13.18 -27.95 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR E 38 TYR.? 23.24 ZN ZN E2002 I 306 VAL E 41 VAL^? 21.18 ZN ZN E2002 I 308 VAL E 31 VAL^? 20.05 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.96 -15.78 -22.50 21.67 -17.08 -21.86 coo 16.43 30.18 9.35 15.05 30.67 11.01 19.36 -14.61 -27.96 17.59 -13.18 -27.95 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR E 78 TYR.? 24.67 ZN ZN J2001 I 306 VAL J 31 VAL^? 20.05 ZN ZN J2001 I 308 VAL J 28 VAL^? 14.38 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 40.71 -17.77 -21.60 40.95 -16.95 -18.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 35.33 -18.82 -23.49 36.77 -20.42 -22.75 coo 16.43 30.18 9.35 15.05 30.67 11.01 33.99 -24.35 -28.04 34.75 -24.31 -25.95 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR E 78 TYR.? 24.67 ZN ZN J2001 I 306 VAL J 31 VAL^? 20.05 ZN ZN J2001 I 308 VAL J 41 VAL^? 21.17 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 40.71 -17.77 -21.60 40.95 -16.95 -18.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 35.33 -18.82 -23.49 36.77 -20.42 -22.75 coo 16.43 30.18 9.35 15.05 30.67 11.01 31.57 -19.50 -19.46 29.68 -18.37 -19.46 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 25 3 # 25 I 303 TYR F 32 TYR^? 15.23 ZN ZN G2004 I 306 VAL F 41 VAL^? 18.99 ZN ZN G2004 I 308 VAL F 6 VAL^? 23.76 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 36.01 -1.70 4.51 36.34 1.00 3.95 coo 23.55 29.53 9.81 23.15 27.39 10.24 34.81 -6.51 0.56 32.76 -5.67 0.38 coo 16.43 30.18 9.35 15.05 30.67 11.01 34.78 -7.53 -4.87 36.58 -8.08 -6.05 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 26 3 # 26 I 303 TYR F 38 TYR.? 23.19 ZN ZN G2004 I 306 VAL F 6 VAL^? 23.76 ZN ZN E2002 I 308 VAL F 31 VAL^? 16.82 ZN ZN G2004 coo 26.18 35.24 6.87 24.33 35.18 8.97 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 23.55 29.53 9.81 23.15 27.39 10.24 34.78 -7.53 -4.87 36.58 -8.08 -6.05 coo 16.43 30.18 9.35 15.05 30.67 11.01 39.10 -2.99 1.69 40.66 -4.55 1.60 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 27 3 # 27 I 303 TYR F 38 TYR.? 23.19 ZN ZN G2004 I 306 VAL F 41 VAL^? 18.99 ZN ZN G2004 I 308 VAL F 31 VAL^? 16.82 ZN ZN G2004 coo 26.18 35.24 6.87 24.33 35.18 8.97 31.03 -12.70 0.17 30.17 -14.19 -2.05 coo 23.55 29.53 9.81 23.15 27.39 10.24 34.81 -6.51 0.56 32.76 -5.67 0.38 coo 16.43 30.18 9.35 15.05 30.67 11.01 39.10 -2.99 1.69 40.66 -4.55 1.60 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 28 3 # 28 I 303 TYR F 78 TYR.? 11.63 ZN ZN E2002 I 306 VAL A 31 VAL^? 16.73 ZN ZN E2002 I 308 VAL A 28 VAL^? 22.36 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 22.38 6.39 -10.32 21.34 4.29 -11.84 coo 23.55 29.53 9.81 23.15 27.39 10.24 25.78 4.70 -5.73 23.63 5.19 -5.62 coo 16.43 30.18 9.35 15.05 30.67 11.01 25.54 8.14 0.35 24.01 7.14 -0.88 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 29 3 # 29 I 303 TYR F 78 TYR.? 11.63 ZN ZN E2002 I 306 VAL A 31 VAL^? 16.73 ZN ZN E2002 I 308 VAL A 41 VAL^? 18.95 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 22.38 6.39 -10.32 21.34 4.29 -11.84 coo 23.55 29.53 9.81 23.15 27.39 10.24 25.78 4.70 -5.73 23.63 5.19 -5.62 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.91 -0.75 -4.52 26.68 -2.10 -4.33 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 30 3 # 30 I 303 TYR G 32 TYR^? 21.21 ZN ZN B2003 I 306 VAL G 41 VAL^? 21.16 ZN ZN G2004 I 308 VAL G 6 VAL^? 15.43 ZN ZN G2004 coo 26.18 35.24 6.87 24.33 35.18 8.97 21.50 -19.82 24.15 20.71 -18.09 26.19 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.30 -18.31 18.59 22.31 -17.55 17.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 26.64 -14.14 15.76 28.82 -13.75 16.02 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 31 3 # 31 I 303 TYR G 38 TYR.? 23.24 ZN ZN G2004 I 306 VAL G 41 VAL^? 21.16 ZN ZN G2004 I 308 VAL G 31 VAL^? 20.00 ZN ZN G2004 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.30 -18.31 18.59 22.31 -17.55 17.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 25.63 -18.28 23.97 27.74 -19.12 23.92 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 32 3 # 32 I 303 TYR G 78 TYR.? 24.68 ZN ZN B2003 I 306 VAL B 31 VAL^? 19.97 ZN ZN B2003 I 308 VAL B 28 VAL^? 14.42 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 12.17 -1.26 17.53 12.70 -0.59 14.88 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.91 -6.57 19.51 11.87 -6.02 18.72 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.85 -10.26 24.01 9.56 -9.67 21.92 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 33 3 # 33 I 303 TYR G 78 TYR.? 24.68 ZN ZN B2003 I 306 VAL B 31 VAL^? 19.97 ZN ZN B2003 I 308 VAL B 41 VAL^? 21.13 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 12.17 -1.26 17.53 12.70 -0.59 14.88 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.91 -6.57 19.51 11.87 -6.02 18.72 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.29 -10.10 15.43 17.22 -11.17 15.55 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 34 3 # 34 I 303 TYR H 32 TYR^? 29.55 ZN ZN B2003 I 306 VAL H 41 VAL^? 27.00 ZN ZN B2003 I 308 VAL H 6 VAL^? 24.01 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.73 -43.63 9.08 8.41 -44.48 10.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.49 -38.65 9.82 12.74 -37.53 9.11 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.57 -34.48 13.48 17.11 -34.67 15.05 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 35 3 # 35 I 303 TYR H 38 TYR.? 28.65 ZN ZN B2003 I 306 VAL H 6 VAL^? 24.01 ZN ZN B2003 I 308 VAL H 31 VAL^? 30.05 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 23.55 29.53 9.81 23.15 27.39 10.24 15.57 -34.48 13.48 17.11 -34.67 15.05 coo 16.43 30.18 9.35 15.05 30.67 11.01 13.88 -43.40 12.62 16.08 -43.65 12.65 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 36 3 # 36 I 303 TYR H 38 TYR.? 28.65 ZN ZN B2003 I 306 VAL H 41 VAL^? 27.00 ZN ZN B2003 I 308 VAL H 31 VAL^? 30.05 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.49 -38.65 9.82 12.74 -37.53 9.11 coo 16.43 30.18 9.35 15.05 30.67 11.01 13.88 -43.40 12.62 16.08 -43.65 12.65 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 37 3 # 37 I 303 TYR H 78 TYR.? 11.76 ZN ZN B2003 I 306 VAL C 31 VAL^? 16.84 ZN ZN B2003 I 308 VAL C 28 VAL^? 22.70 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.69 -28.08 15.14 -1.32 -25.64 14.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.45 -32.72 13.09 -1.06 -31.52 12.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 -2.80 -37.79 9.20 -2.57 -35.63 8.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 38 3 # 38 I 303 TYR H 78 TYR.? 11.76 ZN ZN B2003 I 306 VAL C 31 VAL^? 16.84 ZN ZN B2003 I 308 VAL C 41 VAL^? 19.02 ZN ZN B2003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.69 -28.08 15.14 -1.32 -25.64 14.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.45 -32.72 13.09 -1.06 -31.52 12.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 4.65 -30.91 9.92 6.78 -31.40 10.19 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 39 3 # 39 I 303 TYR I 32 TYR^? 15.25 ZN ZN J2001 I 306 VAL I 41 VAL^? 18.93 ZN ZN J2001 I 308 VAL I 6 VAL^? 24.43 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.53 -40.66 -20.20 16.59 -42.17 -21.51 coo 23.55 29.53 9.81 23.15 27.39 10.24 18.91 -39.12 -13.88 17.36 -37.59 -14.27 coo 16.43 30.18 9.35 15.05 30.67 11.01 16.43 -40.46 -9.13 17.11 -42.13 -7.90 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 40 3 # 40 I 303 TYR I 38 TYR.? 23.18 ZN ZN J2001 I 306 VAL I 6 VAL^? 24.43 ZN ZN J2001 I 308 VAL I 31 VAL^? 16.86 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 23.55 29.53 9.81 23.15 27.39 10.24 16.43 -40.46 -9.13 17.11 -42.13 -7.90 coo 16.43 30.18 9.35 15.05 30.67 11.01 19.25 -43.63 -17.09 21.00 -44.45 -16.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 41 3 # 41 I 303 TYR I 38 TYR.? 23.18 ZN ZN J2001 I 306 VAL I 41 VAL^? 18.93 ZN ZN J2001 I 308 VAL I 31 VAL^? 16.86 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 23.55 29.53 9.81 23.15 27.39 10.24 18.91 -39.12 -13.88 17.36 -37.59 -14.27 coo 16.43 30.18 9.35 15.05 30.67 11.01 19.25 -43.63 -17.09 21.00 -44.45 -16.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 42 3 # 42 I 303 TYR I 78 TYR.? 35.62 ZN ZN J2001 I 306 VAL D 31 VAL^? 29.92 ZN ZN J2001 I 308 VAL D 28 VAL^? 26.78 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.59 -37.71 -16.46 2.03 -36.23 -16.97 coo 16.43 30.18 9.35 15.05 30.67 11.01 4.57 -36.44 -23.28 3.97 -35.18 -21.60 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 43 3 # 43 I 303 TYR I 78 TYR.? 35.62 ZN ZN J2001 I 306 VAL D 31 VAL^? 29.92 ZN ZN J2001 I 308 VAL D 41 VAL^? 26.97 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -1.58 -37.23 -14.36 -2.10 -35.76 -12.05 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.59 -37.71 -16.46 2.03 -36.23 -16.97 coo 16.43 30.18 9.35 15.05 30.67 11.01 7.29 -34.49 -13.77 9.09 -35.46 -13.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 44 3 # 44 I 303 TYR J 32 TYR^? 21.12 ZN ZN E2002 I 306 VAL J 41 VAL^? 21.17 ZN ZN J2001 I 308 VAL J 6 VAL^? 15.52 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 34.34 -14.57 -22.60 34.05 -13.83 -25.28 coo 23.55 29.53 9.81 23.15 27.39 10.24 31.57 -19.50 -19.46 29.68 -18.37 -19.46 coo 16.43 30.18 9.35 15.05 30.67 11.01 28.49 -23.96 -20.15 29.49 -25.91 -20.54 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 45 3 # 45 I 303 TYR J 38 TYR.? 23.16 ZN ZN J2001 I 306 VAL J 6 VAL^? 15.52 ZN ZN J2001 I 308 VAL J 31 VAL^? 20.05 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 28.75 -20.75 -12.61 27.09 -22.87 -11.86 coo 23.55 29.53 9.81 23.15 27.39 10.24 28.49 -23.96 -20.15 29.49 -25.91 -20.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 35.33 -18.82 -23.49 36.77 -20.42 -22.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 46 3 # 46 I 303 TYR J 38 TYR.? 23.16 ZN ZN J2001 I 306 VAL J 41 VAL^? 21.17 ZN ZN J2001 I 308 VAL J 31 VAL^? 20.05 ZN ZN J2001 coo 26.18 35.24 6.87 24.33 35.18 8.97 28.75 -20.75 -12.61 27.09 -22.87 -11.86 coo 23.55 29.53 9.81 23.15 27.39 10.24 31.57 -19.50 -19.46 29.68 -18.37 -19.46 coo 16.43 30.18 9.35 15.05 30.67 11.01 35.33 -18.82 -23.49 36.77 -20.42 -22.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 47 3 # 47 I 303 TYR J 78 TYR.? 24.76 ZN ZN E2002 I 306 VAL E 31 VAL^? 20.05 ZN ZN E2002 I 308 VAL E 28 VAL^? 14.37 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.36 -14.61 -27.96 17.59 -13.18 -27.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 22.24 -8.11 -28.76 20.45 -8.58 -27.62 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 48 3 # 48 I 303 TYR J 78 TYR.? 24.76 ZN ZN E2002 I 306 VAL E 31 VAL^? 20.05 ZN ZN E2002 I 308 VAL E 41 VAL^? 21.18 ZN ZN E2002 coo 26.18 35.24 6.87 24.33 35.18 8.97 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.36 -14.61 -27.96 17.59 -13.18 -27.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 19.96 -15.78 -22.50 21.67 -17.08 -21.86 1cqt_d00 source 1cqt GENE REGULATION/DNA : 48 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 10 PRO^? 18.38 ZN ZN E2002 A 272 LEU A 40 LEU^? 15.93 ZN ZN E2002 A 276 ARG F 76 ARG^? 8.13 ZN ZN E2002 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 16.41 -2.02 -8.51 15.31 -3.11 -6.88 coo 10.97 0.43 16.73 11.31 2.11 18.06 21.05 -0.01 -6.78 19.90 1.41 -8.05 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 23.22 4.91 -15.14 20.87 6.80 -15.45 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 37 PRO.? 21.35 ZN ZN E2002 A 272 LEU A 7 LEU^? 23.24 ZN ZN E2002 A 276 ARG A 68 ARG^? 28.72 ZN ZN B2003 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 23.52 -11.24 -6.48 22.63 -10.09 -8.25 coo 10.97 0.43 16.73 11.31 2.11 18.06 23.31 -5.28 -1.57 25.41 -6.05 -1.37 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 14.21 -9.24 0.28 13.24 -12.17 0.61 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO B 10 PRO^? 23.56 ZN ZN B2003 A 272 LEU B 40 LEU^? 22.02 ZN ZN B2003 A 276 ARG G 76 ARG^? 28.48 ZN ZN G2004 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 10.35 -6.35 8.49 9.43 -8.08 7.33 coo 10.97 0.43 16.73 11.31 2.11 18.06 12.88 -7.34 13.02 11.69 -5.55 12.96 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 15.16 1.90 14.98 12.60 3.57 14.85 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 37 PRO.? 24.87 ZN ZN G2004 A 272 LEU B 7 LEU^? 20.85 ZN ZN B2003 A 276 ARG B 68 ARG^? 23.11 ZN ZN B2003 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 19.98 -13.27 6.00 19.43 -11.13 5.55 coo 10.97 0.43 16.73 11.31 2.11 18.06 15.15 -14.46 11.88 16.75 -15.30 13.16 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 9.32 -17.65 5.25 11.20 -19.96 4.50 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO C 10 PRO.? 18.54 ZN ZN B2003 A 272 LEU C 40 LEU^? 16.09 ZN ZN B2003 A 276 ARG H 76 ARG^? 8.16 ZN ZN B2003 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 1.07 -23.12 7.30 1.70 -22.17 5.34 coo 10.97 0.43 16.73 11.31 2.11 18.06 2.12 -27.24 9.52 0.39 -26.18 10.30 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -1.06 -24.66 18.73 -3.81 -23.46 18.10 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO C 37 PRO.? 21.43 ZN ZN B2003 A 272 LEU C 7 LEU^? 23.09 ZN ZN B2003 A 276 ARG C 68 ARG^? 29.54 ZN ZN B2003 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 13.22 -24.59 7.08 11.54 -23.43 8.08 coo 10.97 0.43 16.73 11.31 2.11 18.06 7.55 -29.94 5.40 9.22 -31.23 6.04 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 6.46 -25.65 -2.21 6.49 -23.14 -4.00 ULMN 3 1emh_d00 HYDROLASE/DNA user 7 3 # 7 A 271 PRO D 10 PRO^? 35.38 ZN ZN J2001 A 272 LEU D 40 LEU^? 32.50 ZN ZN J2001 A 276 ARG I 76 ARG^? 39.27 ZN ZN B2003 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 1.59 -27.84 -10.18 2.59 -25.84 -10.47 coo 10.97 0.43 16.73 11.31 2.11 18.06 3.74 -32.03 -12.56 1.58 -31.91 -12.50 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 ULMN 3 1emh_d00 HYDROLASE/DNA user 8 3 # 8 A 271 PRO D 37 PRO.? 31.21 ZN ZN J2001 A 272 LEU D 7 LEU^? 25.06 ZN ZN J2001 A 276 ARG D 68 ARG^? 31.20 ZN ZN E2002 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 12.52 -29.97 -5.40 10.41 -29.96 -4.64 coo 10.97 0.43 16.73 11.31 2.11 18.06 11.27 -30.19 -13.02 12.87 -31.72 -12.72 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 10.24 -20.71 -11.26 11.91 -20.64 -8.66 ULMN 3 1emh_d00 HYDROLASE/DNA user 9 3 # 9 A 271 PRO F 10 PRO^? 18.27 ZN ZN G2004 A 272 LEU F 40 LEU^? 15.96 ZN ZN G2004 A 276 ARG A 76 ARG^? 8.06 ZN ZN G2004 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 37.98 -14.41 4.53 37.63 -15.92 2.92 coo 10.97 0.43 16.73 11.31 2.11 18.06 37.42 -9.43 2.73 39.23 -9.64 3.98 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 40.48 -5.18 11.11 43.34 -6.18 11.48 ULMN 3 1emh_d00 HYDROLASE/DNA user 10 3 # 10 A 271 PRO H 10 PRO^? 35.40 ZN ZN B2003 A 272 LEU H 40 LEU^? 32.62 ZN ZN B2003 A 276 ARG C 76 ARG^? 39.61 ZN ZN J2001 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 22.87 -40.25 5.97 24.16 -38.49 6.51 coo 10.97 0.43 16.73 11.31 2.11 18.06 18.35 -40.57 8.50 19.27 -42.54 8.43 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 15.69 -49.41 6.25 17.68 -51.76 6.33 ULMN 3 1emh_d00 HYDROLASE/DNA user 11 3 # 11 A 271 PRO H 37 PRO.? 31.11 ZN ZN B2003 A 272 LEU H 7 LEU^? 25.16 ZN ZN B2003 A 276 ARG H 68 ARG^? 29.79 ZN ZN G2004 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 15.67 -31.85 1.60 16.71 -33.61 0.70 coo 10.97 0.43 16.73 11.31 2.11 18.06 16.25 -32.95 9.01 14.12 -32.36 8.61 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 24.82 -29.19 7.91 24.68 -26.94 5.81 ULMN 3 1emh_d00 HYDROLASE/DNA user 12 3 # 12 A 271 PRO I 10 PRO^? 18.40 ZN ZN J2001 A 272 LEU I 40 LEU^? 15.95 ZN ZN J2001 A 276 ARG D 76 ARG^? 8.12 ZN ZN J2001 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 27.90 -37.79 -11.48 27.86 -37.20 -9.31 coo 10.97 0.43 16.73 11.31 2.11 18.06 23.38 -39.51 -13.55 25.16 -40.47 -14.38 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 27.03 -40.97 -22.65 29.39 -42.82 -22.15 ULMN 3 1emh_d00 HYDROLASE/DNA user 13 3 # 13 A 271 PRO I 37 PRO.? 21.28 ZN ZN J2001 A 272 LEU I 7 LEU^? 23.08 ZN ZN J2001 A 276 ARG I 68 ARG^? 29.76 ZN ZN J2001 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 19.88 -28.82 -11.21 21.81 -29.45 -12.23 coo 10.97 0.43 16.73 11.31 2.11 18.06 18.24 -36.04 -9.29 16.35 -35.24 -10.05 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 23.15 -33.63 -1.82 24.18 -35.52 0.40 ULMN 3 1emh_d00 HYDROLASE/DNA user 14 3 # 14 A 271 PRO J 10 PRO^? 23.71 ZN ZN J2001 A 272 LEU J 40 LEU^? 22.15 ZN ZN J2001 A 276 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 37.23 -21.75 -12.22 36.24 -23.57 -11.31 coo 10.97 0.43 16.73 11.31 2.11 18.06 35.15 -20.15 -17.02 37.26 -20.22 -16.77 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 42.07 -13.66 -19.07 44.91 -14.78 -18.77 ULMN 3 1emh_d00 HYDROLASE/DNA user 15 3 # 15 A 271 PRO J 37 PRO.? 24.89 ZN ZN E2002 A 272 LEU J 7 LEU^? 21.08 ZN ZN J2001 A 276 ARG J 68 ARG^? 19.63 ZN ZN J2001 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 26.42 -17.06 -9.89 28.57 -16.44 -9.55 coo 10.97 0.43 16.73 11.31 2.11 18.06 27.69 -21.87 -15.95 26.02 -20.60 -16.66 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 27.83 -27.99 -9.38 27.89 -30.88 -10.49 1emh_d00 source 1emh HYDROLASE/DNA : 15 hits 1emh_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 45 ARG^? 20.10 ZN ZN G2004 E 41 TYR F 32 TYR^? 15.23 ZN ZN G2004 E 83 ARG D 14 ARG~? 40.72 ZN ZN B2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 32.14 6.60 3.52 34.39 5.41 1.81 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 36.01 -1.70 4.51 36.34 1.00 3.95 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -5.59 -24.57 -12.49 -6.13 -23.84 -15.44 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG A 68 ARG^? 28.72 ZN ZN B2003 E 41 TYR A 38 TYR.? 23.20 ZN ZN E2002 E 83 ARG D 80 ARG.? 21.06 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 21.46 -7.15 -4.15 20.57 -8.66 -1.95 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 25.19 -53.81 -20.43 26.22 -56.09 -18.61 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG A 68 ARG^? 28.72 ZN ZN B2003 E 41 TYR B 38 TYR.? 23.16 ZN ZN B2003 E 83 ARG D 80 ARG.? 21.06 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 14.21 -9.24 0.28 13.24 -12.17 0.61 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 25.19 -53.81 -20.43 26.22 -56.09 -18.61 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG A 76 ARG^? 8.06 ZN ZN G2004 E 41 TYR F 32 TYR^? 15.23 ZN ZN G2004 E 83 ARG D 76 ARG^? 8.12 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 40.48 -5.18 11.11 43.34 -6.18 11.48 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 36.01 -1.70 4.51 36.34 1.00 3.95 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 27.03 -40.97 -22.65 29.39 -42.82 -22.15 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG B 9 ARG^? 25.60 ZN ZN B2003 E 41 TYR B 38 TYR.? 23.16 ZN ZN B2003 E 83 ARG D 80 ARG.? 21.06 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 12.25 -11.70 3.79 14.09 -14.14 4.30 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 25.19 -53.81 -20.43 26.22 -56.09 -18.61 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG B 45 ARG^? 19.26 ZN ZN B2003 E 41 TYR G 32 TYR^? 21.21 ZN ZN B2003 E 83 ARG E 14 ARG~? 23.50 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 14.90 -14.60 27.65 17.88 -13.95 27.44 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 21.50 -19.82 24.15 20.71 -18.09 26.19 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 4.33 -11.23 -21.43 5.19 -9.07 -23.42 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 7 3 # 7 E 40 ARG B 68 ARG^? 23.11 ZN ZN B2003 E 41 TYR B 38 TYR.? 23.16 ZN ZN B2003 E 83 ARG E 80 ARG.? 21.10 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 9.32 -17.65 5.25 11.20 -19.96 4.50 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 15.69 -13.23 8.64 14.60 -15.68 7.86 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 46.22 -20.80 -30.79 45.58 -23.77 -31.33 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 8 3 # 8 E 40 ARG B 76 ARG^? 28.58 ZN ZN B2003 E 41 TYR B 78 TYR.? 24.55 ZN ZN G2004 E 83 ARG E 11 ARG.? 26.51 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 3.07 -13.39 -16.26 3.11 -10.68 -17.74 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 9 3 # 9 E 40 ARG B 76 ARG^? 28.58 ZN ZN B2003 E 41 TYR B 78 TYR.? 24.55 ZN ZN G2004 E 83 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 42.07 -13.66 -19.07 44.91 -14.78 -18.77 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 10 3 # 10 E 40 ARG B 76 ARG^? 28.58 ZN ZN B2003 E 41 TYR B 78 TYR.? 24.55 ZN ZN G2004 E 83 ARG F 76 ARG^? 8.13 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 23.22 4.91 -15.14 20.87 6.80 -15.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 11 3 # 11 E 40 ARG B 76 ARG^? 28.58 ZN ZN B2003 E 41 TYR G 32 TYR^? 21.21 ZN ZN B2003 E 83 ARG E 76 ARG^? 28.35 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 24.39 -28.01 26.54 26.98 -29.30 27.59 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 21.50 -19.82 24.15 20.71 -18.09 26.19 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 42.07 -13.66 -19.07 44.91 -14.78 -18.77 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 12 3 # 12 E 40 ARG C 45 ARG^? 26.07 ZN ZN B2003 E 41 TYR H 32 TYR^? 29.55 ZN ZN B2003 E 83 ARG A 14 ARG~? 19.76 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 1.94 -44.34 10.41 3.55 -43.42 12.90 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 10.73 -43.63 9.08 8.41 -44.48 10.38 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 9.80 2.36 -9.66 10.15 5.25 -8.72 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 13 3 # 13 E 40 ARG C 68 ARG^? 29.54 ZN ZN B2003 E 41 TYR C 38 TYR.? 23.27 ZN ZN B2003 E 83 ARG A 80 ARG.? 21.33 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 6.46 -25.65 -2.21 6.49 -23.14 -4.00 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 8.45 -26.45 5.41 9.25 -26.71 2.72 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 51.38 -0.29 4.19 53.35 -1.78 2.33 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 14 3 # 14 E 40 ARG C 76 ARG^? 39.61 ZN ZN J2001 E 41 TYR H 32 TYR^? 29.55 ZN ZN B2003 E 83 ARG A 76 ARG^? 8.06 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 15.69 -49.41 6.25 17.68 -51.76 6.33 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 10.73 -43.63 9.08 8.41 -44.48 10.38 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 40.48 -5.18 11.11 43.34 -6.18 11.48 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 15 3 # 15 E 40 ARG D 45 ARG^? 20.03 ZN ZN J2001 E 41 TYR I 32 TYR^? 15.25 ZN ZN J2001 E 83 ARG B 14 ARG~? 23.18 ZN ZN B2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 10.69 -40.60 -24.75 11.69 -42.61 -22.61 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 18.53 -40.66 -20.20 16.59 -42.17 -21.51 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 3.43 -2.45 7.59 1.92 -2.40 10.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 16 3 # 16 E 40 ARG D 68 ARG^? 31.20 ZN ZN E2002 E 41 TYR D 38 TYR.? 28.62 ZN ZN J2001 E 83 ARG B 80 ARG.? 21.50 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 10.24 -20.71 -11.26 11.91 -20.64 -8.66 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 10.18 -28.96 -9.74 11.62 -26.73 -10.53 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 32.12 -19.85 34.68 34.30 -17.68 34.59 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 17 3 # 17 E 40 ARG D 76 ARG^? 8.12 ZN ZN J2001 E 41 TYR I 32 TYR^? 15.25 ZN ZN J2001 E 83 ARG B 76 ARG^? 28.58 ZN ZN B2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 27.03 -40.97 -22.65 29.39 -42.82 -22.15 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 18.53 -40.66 -20.20 16.59 -42.17 -21.51 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 24.39 -28.01 26.54 26.98 -29.30 27.59 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 18 3 # 18 E 40 ARG E 45 ARG^? 19.39 ZN ZN E2002 E 41 TYR J 32 TYR^? 21.12 ZN ZN E2002 E 83 ARG C 14 ARG~? 19.88 ZN ZN B2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 29.50 -9.81 -28.77 30.55 -12.66 -29.14 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 34.34 -14.57 -22.60 34.05 -13.83 -25.28 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -5.73 -18.63 6.20 -7.86 -20.84 6.40 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 19 3 # 19 E 40 ARG E 68 ARG^? 24.88 ZN ZN E2002 E 41 TYR E 38 TYR.? 23.24 ZN ZN E2002 E 83 ARG C 80 ARG.? 36.99 ZN ZN B2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 14.73 -11.32 -9.64 13.98 -11.79 -6.67 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 18.24 -17.31 -15.44 18.90 -15.79 -13.18 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 16.13 -52.20 20.46 17.69 -52.87 23.04 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 20 3 # 20 E 40 ARG E 76 ARG^? 28.35 ZN ZN E2002 E 41 TYR J 32 TYR^? 21.12 ZN ZN E2002 E 83 ARG C 76 ARG^? 39.61 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 42.07 -13.66 -19.07 44.91 -14.78 -18.77 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 34.34 -14.57 -22.60 34.05 -13.83 -25.28 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 15.69 -49.41 6.25 17.68 -51.76 6.33 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 21 3 # 21 E 40 ARG F 45 ARG^? 20.07 ZN ZN E2002 E 41 TYR A 32 TYR^? 15.05 ZN ZN E2002 E 83 ARG H 14 ARG~? 40.46 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 37.54 3.46 -7.45 35.47 4.92 -5.67 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 28.44 2.72 -8.58 30.61 4.34 -7.97 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 29.55 -44.56 8.18 29.86 -45.04 11.21 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 22 3 # 22 E 40 ARG F 76 ARG^? 8.13 ZN ZN E2002 E 41 TYR A 32 TYR^? 15.05 ZN ZN E2002 E 83 ARG H 76 ARG^? 8.16 ZN ZN B2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 23.22 4.91 -15.14 20.87 6.80 -15.45 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 28.44 2.72 -8.58 30.61 4.34 -7.97 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -1.06 -24.66 18.73 -3.81 -23.46 18.10 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 23 3 # 23 E 40 ARG G 45 ARG^? 19.42 ZN ZN G2004 E 41 TYR B 32 TYR^? 21.26 ZN ZN G2004 E 83 ARG I 14 ARG~? 20.11 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 24.66 -6.90 24.79 21.69 -7.61 25.11 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 18.09 -5.37 18.66 18.87 -5.22 21.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 34.67 -42.08 -10.26 33.76 -45.02 -10.11 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 24 3 # 24 E 40 ARG G 68 ARG^? 22.94 ZN ZN G2004 E 41 TYR G 38 TYR.? 23.24 ZN ZN G2004 E 83 ARG I 80 ARG.? 37.40 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 30.64 -21.00 5.54 28.49 -18.97 4.58 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 23.80 -20.63 11.40 24.84 -19.26 9.19 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -5.55 -40.08 -24.00 -7.09 -38.67 -26.29 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 25 3 # 25 E 40 ARG G 76 ARG^? 28.48 ZN ZN G2004 E 41 TYR B 32 TYR^? 21.26 ZN ZN G2004 E 83 ARG I 76 ARG^? 39.27 ZN ZN B2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 15.16 1.90 14.98 12.60 3.57 14.85 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 18.09 -5.37 18.66 18.87 -5.22 21.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 26 3 # 26 E 40 ARG H 9 ARG^? 32.17 ZN ZN B2003 E 41 TYR H 38 TYR.? 28.65 ZN ZN B2003 E 83 ARG F 80 ARG.? 21.51 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 23.61 -33.80 3.29 21.83 -31.31 3.74 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 21.15 15.99 -8.11 19.39 17.73 -6.23 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 27 3 # 27 E 40 ARG H 45 ARG^? 19.95 ZN ZN B2003 E 41 TYR C 32 TYR^? 15.32 ZN ZN B2003 E 83 ARG J 14 ARG~? 23.19 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 7.47 -38.69 20.81 5.22 -38.73 18.67 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 3.47 -31.95 16.21 3.09 -34.42 17.45 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 43.92 -26.01 -11.47 44.79 -27.17 -14.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 28 3 # 28 E 40 ARG H 68 ARG^? 29.79 ZN ZN G2004 E 41 TYR H 38 TYR.? 28.65 ZN ZN B2003 E 83 ARG J 80 ARG.? 22.24 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 24.82 -29.19 7.91 24.68 -26.94 5.81 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 15.29 -10.38 -39.34 14.75 -7.48 -38.50 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 29 3 # 29 E 40 ARG H 76 ARG^? 8.16 ZN ZN B2003 E 41 TYR C 32 TYR^? 15.32 ZN ZN B2003 E 83 ARG J 76 ARG^? 28.65 ZN ZN J2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -1.06 -24.66 18.73 -3.81 -23.46 18.10 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 3.47 -31.95 16.21 3.09 -34.42 17.45 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 11.46 -20.49 -30.64 9.14 -18.90 -31.92 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 30 3 # 30 E 40 ARG I 45 ARG^? 26.51 ZN ZN J2001 E 41 TYR D 32 TYR^? 29.54 ZN ZN J2001 E 83 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 9.19 -47.86 -14.39 8.02 -46.02 -16.58 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 4.78 -40.18 -12.99 5.15 -42.55 -14.41 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 31 3 # 31 E 40 ARG I 68 ARG^? 29.76 ZN ZN J2001 E 41 TYR H 38 TYR.? 28.65 ZN ZN B2003 E 83 ARG F 80 ARG.? 21.51 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 17.79 -33.38 5.74 18.94 -30.96 6.49 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 21.15 15.99 -8.11 19.39 17.73 -6.23 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 32 3 # 32 E 40 ARG I 68 ARG^? 29.76 ZN ZN J2001 E 41 TYR I 38 TYR.? 23.18 ZN ZN J2001 E 83 ARG F 80 ARG.? 21.51 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 23.15 -33.63 -1.82 24.18 -35.52 0.40 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 20.76 -33.59 -9.48 20.18 -32.83 -6.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 21.15 15.99 -8.11 19.39 17.73 -6.23 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 33 3 # 33 E 40 ARG I 76 ARG^? 39.27 ZN ZN B2003 E 41 TYR D 32 TYR^? 29.54 ZN ZN J2001 E 83 ARG F 76 ARG^? 8.13 ZN ZN E2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -2.74 -38.69 -10.00 -5.78 -38.27 -9.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 4.78 -40.18 -12.99 5.15 -42.55 -14.41 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 23.22 4.91 -15.14 20.87 6.80 -15.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 34 3 # 34 E 40 ARG J 45 ARG^? 19.30 ZN ZN J2001 E 41 TYR E 32 TYR^? 21.25 ZN ZN J2001 E 83 ARG G 14 ARG~? 23.24 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 27.80 -22.06 -31.67 26.75 -19.22 -31.33 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 20.11 -18.94 -28.19 21.99 -18.75 -30.24 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 36.11 -29.59 17.58 37.55 -27.64 19.46 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 35 3 # 35 E 40 ARG J 68 ARG^? 19.63 ZN ZN J2001 E 41 TYR J 38 TYR.? 23.16 ZN ZN J2001 E 83 ARG G 80 ARG.? 23.71 ZN ZN B2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 27.83 -27.99 -9.38 27.89 -30.88 -10.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 28.75 -20.75 -12.61 27.09 -22.87 -11.86 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 6.63 1.91 25.77 5.01 2.67 23.24 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 36 3 # 36 E 40 ARG J 76 ARG^? 28.65 ZN ZN J2001 E 41 TYR E 32 TYR^? 21.25 ZN ZN J2001 E 83 ARG G 76 ARG^? 28.48 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 20.11 -18.94 -28.19 21.99 -18.75 -30.24 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 15.16 1.90 14.98 12.60 3.57 14.85 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 37 3 # 37 E 40 ARG J 76 ARG^? 28.65 ZN ZN J2001 E 41 TYR J 78 TYR.? 24.76 ZN ZN E2002 E 83 ARG A 76 ARG^? 8.06 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 40.48 -5.18 11.11 43.34 -6.18 11.48 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 38 3 # 38 E 40 ARG J 76 ARG^? 28.65 ZN ZN J2001 E 41 TYR J 78 TYR.? 24.76 ZN ZN E2002 E 83 ARG F 14 ARG~? 19.67 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 45.17 -17.96 5.85 47.53 -16.30 4.80 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 39 3 # 39 E 40 ARG J 76 ARG^? 28.65 ZN ZN J2001 E 41 TYR J 78 TYR.? 24.76 ZN ZN E2002 E 83 ARG G 11 ARG.? 26.12 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 34.84 -31.69 12.58 37.28 -30.08 13.59 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 40 3 # 40 E 40 ARG J 76 ARG^? 28.65 ZN ZN J2001 E 41 TYR J 78 TYR.? 24.76 ZN ZN E2002 E 83 ARG G 76 ARG^? 28.48 ZN ZN G2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 11.46 -20.49 -30.64 9.14 -18.90 -31.92 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 13.85 -15.66 -29.81 12.10 -17.30 -28.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 15.16 1.90 14.98 12.60 3.57 14.85 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 40 hits 1id3_d00 naa= 3 ULMN 4 2bgw_d00 HYDROLASE user 1 4 # 1 A 86 ALA B 23 ALA~? 19.50 ZN ZN B2003 A 87 GLU B 24 GLU~? 19.88 ZN ZN B2003 A 123 TYR G 78 TYR.? 24.68 ZN ZN B2003 A 182 ARG G 80 ARG.? 23.71 ZN ZN B2003 coo 33.66 63.14 16.62 34.95 63.46 15.91 8.44 -4.88 21.55 9.06 -3.51 21.47 coo 28.97 64.99 12.92 27.92 64.06 11.28 4.20 -2.38 22.67 5.80 -1.47 23.74 coo 38.40 63.73 13.00 38.79 62.53 10.47 12.17 -1.26 17.53 12.70 -0.59 14.88 coo 29.35 67.59 19.60 30.93 68.47 17.09 6.63 1.91 25.77 5.01 2.67 23.24 ULMN 4 2bgw_d00 HYDROLASE user 2 4 # 2 A 86 ALA F 23 ALA~? 17.33 ZN ZN G2004 A 87 GLU F 24 GLU.? 19.67 ZN ZN G2004 A 123 TYR A 78 TYR.? 11.65 ZN ZN G2004 A 182 ARG A 80 ARG.? 21.33 ZN ZN G2004 coo 33.66 63.14 16.62 34.95 63.46 15.91 45.03 -3.79 0.54 45.02 -3.39 2.01 coo 28.97 64.99 12.92 27.92 64.06 11.28 50.14 -4.90 0.74 49.85 -2.99 1.69 coo 38.40 63.73 13.00 38.79 62.53 10.47 42.29 -5.11 6.34 41.03 -7.11 7.84 coo 29.35 67.59 19.60 30.93 68.47 17.09 51.38 -0.29 4.19 53.35 -1.78 2.33 ULMN 4 2bgw_d00 HYDROLASE user 3 4 # 3 A 86 ALA G 23 ALA~? 19.48 ZN ZN G2004 A 87 GLU G 24 GLU~? 19.71 ZN ZN G2004 A 123 TYR B 78 TYR.? 24.55 ZN ZN G2004 A 182 ARG B 80 ARG.? 21.50 ZN ZN G2004 coo 33.66 63.14 16.62 34.95 63.46 15.91 31.15 -18.18 26.45 30.57 -19.27 27.34 coo 28.97 64.99 12.92 27.92 64.06 11.28 35.34 -19.32 28.91 34.28 -18.98 30.72 coo 38.40 63.73 13.00 38.79 62.53 10.47 27.46 -23.45 25.85 26.96 -25.77 24.34 coo 29.35 67.59 19.60 30.93 68.47 17.09 32.12 -19.85 34.68 34.30 -17.68 34.59 ULMN 4 2bgw_d00 HYDROLASE user 4 4 # 4 A 86 ALA H 23 ALA~? 32.86 ZN ZN B2003 A 87 GLU H 24 GLU~? 35.52 ZN ZN B2003 A 123 TYR C 78 TYR^? 35.69 ZN ZN B2003 A 182 ARG C 80 ARG.? 36.99 ZN ZN B2003 coo 33.66 63.14 16.62 34.95 63.46 15.91 17.16 -46.07 16.52 16.70 -47.27 15.72 coo 28.97 64.99 12.92 27.92 64.06 11.28 20.30 -49.47 18.65 18.48 -50.29 19.42 coo 38.40 63.73 13.00 38.79 62.53 10.47 16.52 -47.66 10.31 18.03 -47.38 7.99 coo 29.35 67.59 19.60 30.93 68.47 17.09 16.13 -52.20 20.46 17.69 -52.87 23.04 ULMN 4 2bgw_d00 HYDROLASE user 5 4 # 5 A 86 ALA J 23 ALA~? 19.58 ZN ZN J2001 A 87 GLU J 24 GLU.? 19.48 ZN ZN J2001 A 123 TYR E 78 TYR.? 24.67 ZN ZN J2001 A 182 ARG E 80 ARG.? 21.10 ZN ZN J2001 coo 33.66 63.14 16.62 34.95 63.46 15.91 39.46 -22.73 -25.55 40.41 -21.57 -25.51 coo 28.97 64.99 12.92 27.92 64.06 11.28 43.53 -25.45 -26.61 43.80 -24.04 -28.14 coo 38.40 63.73 13.00 38.79 62.53 10.47 40.71 -17.77 -21.60 40.95 -16.95 -18.92 coo 29.35 67.59 19.60 30.93 68.47 17.09 46.22 -20.80 -30.79 45.58 -23.77 -31.33 2bgw_d00 source 2bgw HYDROLASE : 5 hits 2bgw_d00 naa= 4 ULMN 4 2wwy_d00 HYDROLASE/DNA user 1 4 # 1 B 562 THR A 3 THR^? 17.13 ZN ZN G2004 B 563 ALA A 74 ALA^? 13.77 ZN ZN G2004 B 564 TYR F 32 TYR^? 15.23 ZN ZN G2004 B 565 ALA A 4 ALA^? 18.57 ZN ZN G2004 coo -5.20 24.72 16.34 -4.97 25.16 14.25 31.40 2.44 6.14 32.79 2.66 4.51 coo -7.97 22.24 17.04 -9.46 22.49 16.89 32.45 -2.50 7.64 33.20 -1.63 6.65 coo -9.19 19.01 13.84 -11.68 18.26 14.90 36.01 -1.70 4.51 36.34 1.00 3.95 coo -3.33 20.88 13.35 -3.51 21.15 11.86 28.58 0.21 4.86 27.26 0.45 5.58 ULMN 4 2wwy_d00 HYDROLASE/DNA user 2 4 # 2 B 562 THR B 3 THR^? 17.46 ZN ZN B2003 B 563 ALA B 74 ALA^? 18.49 ZN ZN B2003 B 564 TYR G 32 TYR^? 21.21 ZN ZN B2003 B 565 ALA B 4 ALA^? 13.81 ZN ZN B2003 coo -5.20 24.72 16.34 -4.97 25.16 14.25 15.45 -18.63 25.07 17.11 -17.25 25.42 coo -7.97 22.24 17.04 -9.46 22.49 16.89 17.93 -22.48 22.28 18.36 -21.34 23.15 coo -9.19 19.01 13.84 -11.68 18.26 14.90 21.50 -19.82 24.15 20.71 -18.09 26.19 coo -3.33 20.88 13.35 -3.51 21.15 11.86 14.60 -18.17 21.35 13.14 -18.50 21.07 ULMN 4 2wwy_d00 HYDROLASE/DNA user 3 4 # 3 B 562 THR C 3 THR^? 28.49 ZN ZN B2003 B 563 ALA C 74 ALA^? 31.37 ZN ZN B2003 B 564 TYR H 32 TYR^? 29.55 ZN ZN B2003 B 565 ALA C 4 ALA^? 28.51 ZN ZN B2003 coo -5.20 24.72 16.34 -4.97 25.16 14.25 4.98 -43.31 6.77 5.68 -43.40 8.80 coo -7.97 22.24 17.04 -9.46 22.49 16.89 9.85 -43.01 3.92 9.61 -43.24 5.40 coo -9.19 19.01 13.84 -11.68 18.26 14.90 10.73 -43.63 9.08 8.41 -44.48 10.38 coo -3.33 20.88 13.35 -3.51 21.15 11.86 5.41 -39.88 5.21 4.55 -39.53 4.00 ULMN 4 2wwy_d00 HYDROLASE/DNA user 4 4 # 4 B 562 THR D 3 THR^? 17.12 ZN ZN J2001 B 563 ALA D 74 ALA^? 13.84 ZN ZN J2001 B 564 TYR I 32 TYR^? 15.25 ZN ZN J2001 B 565 ALA D 4 ALA^? 18.42 ZN ZN J2001 coo -5.20 24.72 16.34 -4.97 25.16 14.25 14.49 -37.59 -23.92 14.22 -39.41 -22.73 coo -7.97 22.24 17.04 -9.46 22.49 16.89 19.07 -36.11 -21.79 18.30 -37.42 -21.64 coo -9.19 19.01 13.84 -11.68 18.26 14.90 18.53 -40.66 -20.20 16.59 -42.17 -21.51 coo -3.33 20.88 13.35 -3.51 21.15 11.86 13.82 -34.77 -21.43 13.64 -33.41 -22.07 ULMN 4